data_2mqc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mqc _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.9 m -132.1 123.96 28.2 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 170.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -88.4 155.41 19.71 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.71 118.35 24.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.971 2.108 . . . . 0.0 105.823 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -150.15 67.98 0.98 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.952 0.901 . . . . 0.0 110.226 -166.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -152.27 -169.33 3.32 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.026 1.33 . . . . 0.0 109.029 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.443 ' CE2' ' HG ' ' A' ' 92' ' ' LEU . 5.7 m-85 -77.99 -89.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 166.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -164.67 -41.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.424 1.49 . . . . 0.0 110.846 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -107.39 74.75 0.98 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.53 72.91 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 112.999 -1.91 . . . . 0.0 113.408 147.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -153.13 169.93 32.06 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-O 122.746 1.192 . . . . 0.0 112.924 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -135.67 13.7 3.43 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.089 1.756 . . . . 0.0 110.474 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p -152.98 125.86 8.4 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 120.499 -1.375 . . . . 0.0 112.833 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.65 153.37 23.51 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.688 1.195 . . . . 0.0 110.283 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.5 m -146.88 143.61 28.67 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.988 2.115 . . . . 0.0 105.75 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.77 152.14 50.82 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.15 0.886 . . . . 0.0 109.758 170.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -134.16 67.52 73.2 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.587 -0.72 . . . . 0.0 109.171 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.59 179.53 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.308 2.005 . . . . 0.0 112.029 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -149.1 174.9 11.83 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.409 ' C ' ' HG ' ' A' ' 27' ' ' SER . 40.8 t0 56.31 -85.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 129.112 2.965 . . . . 0.0 111.172 170.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.409 ' HG ' ' C ' ' A' ' 26' ' ' ASP . 36.0 m -153.66 106.25 2.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.265 1.826 . . . . 0.0 106.363 161.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -135.43 107.7 7.26 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.129 -1.607 . . . . 0.0 111.017 167.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.56 150.29 35.22 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.635 1.974 . . . . 0.0 108.546 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.38 -169.5 40.53 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.3 p -100.99 120.57 40.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.836 1.655 . . . . 0.0 110.256 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -127.12 -173.86 3.01 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.712 0.805 . . . . 0.0 113.065 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.5 mt -129.13 155.47 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 127.219 2.207 . . . . 0.0 106.265 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 53.8 mt -135.83 149.68 49.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.996 1.271 . . . . 0.0 112.808 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -78.59 87.49 4.54 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.836 1.655 . . . . 0.0 108.941 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mt -123.69 152.69 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.71 1.204 . . . . 0.0 107.958 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 m -121.64 133.85 54.98 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.474 1.109 . . . . 0.0 109.072 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.2 t -157.08 81.71 0.92 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.17 0.988 . . . . 0.0 108.522 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -152.27 170.8 19.14 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.094 -1.004 . . . . 0.0 110.044 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.53 126.79 50.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 167.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -98.02 131.17 44.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -170.14 162.35 8.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.2 -113.35 2.86 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -141.22 51.55 1.59 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.298 1.439 . . . . 0.0 107.337 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 t -155.15 165.58 36.25 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.61 1.564 . . . . 0.0 109.151 -170.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.4 p -134.71 102.32 5.24 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -71.23 118.34 13.89 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 164.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.37 163.82 10.06 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.705 0.764 . . . . 0.0 109.955 166.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.5 mt -134.89 129.36 34.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.051 170.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.8 m -59.78 163.47 4.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 122.551 1.167 . . . . 0.0 110.139 163.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -134.34 165.97 23.9 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.507 170.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.95 164.21 22.8 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.609 1.164 . . . . 0.0 108.811 173.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.53 168.77 22.58 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.465 1.506 . . . . 0.0 109.867 -169.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 p 178.49 168.36 0.84 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.74 1.616 . . . . 0.0 110.572 161.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.62 -110.27 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.83 163.14 14.82 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.925 0.89 . . . . 0.0 110.376 168.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p -71.77 -38.96 70.27 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.353 1.461 . . . . 0.0 112.369 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -90.23 21.56 3.74 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.269 1.427 . . . . 0.0 112.831 -159.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.54 133.14 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -132.42 132.53 42.89 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.372 1.069 . . . . 0.0 109.379 -164.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.81 135.62 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.834 0.826 . . . . 0.0 110.297 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.71 75.28 1.52 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.457 0.703 . . . . 0.0 109.154 172.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 55.02 -117.22 7.84 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m -77.94 51.04 0.92 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.06 0.944 . . . . 0.0 111.612 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.63 152.08 34.82 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.63 139.63 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.7 m -145.38 150.26 36.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 164.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -139.46 119.19 13.19 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.53 161.91 29.3 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.473 1.509 . . . . 0.0 110.372 -174.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -86.25 146.18 26.63 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.488 -0.757 . . . . 0.0 110.79 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -66.58 144.47 98.65 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -158.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.79 -9.75 6.39 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.525 2.816 . . . . 0.0 115.432 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -151.98 170.08 20.74 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.593 1.157 . . . . 0.0 108.246 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -81.12 -12.39 59.26 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.775 0.83 . . . . 0.0 113.078 -164.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.44 165.14 2.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 123.775 0.672 . . . . 0.0 109.633 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -107.5 121.38 44.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 168.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -105.38 170.41 7.9 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 126.448 1.899 . . . . 0.0 108.039 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.4 m -104.77 109.9 22.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 155.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.85 139.09 36.0 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 163.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 tp -138.79 133.09 31.65 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.299 1.049 . . . . 0.0 109.93 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -142.49 148.37 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.075 0.852 . . . . 0.0 109.027 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 m -104.82 176.73 5.06 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.491 1.517 . . . . 0.0 109.116 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.7 165.24 34.03 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.82 1.248 . . . . 0.0 109.798 162.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -151.94 158.3 42.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.782 2.033 . . . . 0.0 108.815 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.412 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 26.5 tt0 -97.87 161.32 13.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.423 1.01 . . . . 0.0 110.309 -173.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.81 -69.06 0.15 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.646 1.179 . . . . 0.0 112.99 173.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -88.97 -12.53 41.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.638 1.108 . . . . 0.0 112.428 -176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.2 t -132.04 -153.23 0.54 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.852 1.661 . . . . 0.0 109.249 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.25 46.87 0.88 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -164.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 85' ' ' GLN 0.35 0.0 OUTLIER -68.18 92.29 0.4 Allowed 'General case' 0 C--N 1.341 0.239 0 CA-C-N 118.238 1.019 . . . . 0.0 108.967 179.546 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 p -96.47 133.44 40.91 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 174.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.443 ' HG ' ' CE2' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -124.88 161.41 26.62 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 166.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.44 125.01 52.59 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.15 132.09 53.42 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -128.49 143.92 51.06 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.524 1.53 . . . . 0.0 108.391 171.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 mp -135.45 117.42 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 168.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 69.6 t -107.31 94.57 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -106.34 144.08 28.27 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.09 156.88 62.48 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.208 1.939 . . . . 0.0 107.624 165.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.07 166.88 27.5 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 121.269 -0.491 . . . . 0.0 113.418 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.18 0 C-N-CA 125.336 1.454 . . . . 0.0 109.636 -174.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 m -102.02 101.98 12.43 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -76.53 154.57 34.44 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 168.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -137.63 120.92 16.93 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 128.124 2.57 . . . . 0.0 105.424 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -148.32 43.87 1.04 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.239 1.016 . . . . 0.0 110.255 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 p -141.83 -176.75 4.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.886 1.274 . . . . 0.0 109.673 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -176.5 0.97 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.868 -1.145 . . . . 0.0 111.856 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.03 -20.79 6.18 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 162.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.92 -6.85 59.0 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -161.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.07 64.18 0.43 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 167.06 -165.16 38.39 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 p -151.49 45.23 0.79 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.246 1.418 . . . . 0.0 112.691 170.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.75 179.11 6.76 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.209 -1.557 . . . . 0.0 109.692 169.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.1 113.8 14.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.113 1.765 . . . . 0.0 107.955 172.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.5 m -133.72 130.24 37.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.041 -1.836 . . . . 0.0 106.041 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -129.65 147.1 51.41 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -124.12 67.24 43.78 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -69.44 177.09 5.7 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.83 1.687 . . . . 0.0 110.879 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -143.47 173.92 11.21 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.891 1.677 . . . . 0.0 107.29 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 55.19 -85.25 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.688 1.995 . . . . 0.0 112.234 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.2 m -154.36 102.59 2.44 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.6 2.36 . . . . 0.0 107.977 156.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.4 m -131.62 88.84 2.62 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 119.909 1.231 . . . . 0.0 111.22 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.61 167.12 23.0 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.435 1.894 . . . . 0.0 110.177 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.52 -161.1 31.1 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 p -97.42 123.42 41.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.774 1.229 . . . . 0.0 109.078 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -139.32 -169.22 2.62 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.711 1.605 . . . . 0.0 110.219 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 mt -138.39 144.91 29.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.268 1.427 . . . . 0.0 107.232 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.5 mt -129.21 161.84 29.22 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.597 1.559 . . . . 0.0 107.456 170.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -114.91 103.24 10.74 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.995 0.816 . . . . 0.0 111.447 -163.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.3 138.7 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.83 1.652 . . . . 0.0 109.126 -172.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 m -91.34 110.92 22.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.242 1.417 . . . . 0.0 109.536 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.5 m -138.27 78.68 1.69 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -160.36 164.78 32.19 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.381 0.672 . . . . 0.0 111.345 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.24 151.83 29.16 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.073 0.949 . . . . 0.0 109.363 166.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -121.67 125.68 47.22 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 127.163 2.185 . . . . 0.0 108.917 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.6 t -167.44 162.45 14.57 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.108 0.963 . . . . 0.0 109.014 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.19 -101.69 0.21 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 125.982 1.753 . . . . 0.0 109.62 -172.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -142.57 35.97 1.46 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.904 1.281 . . . . 0.0 110.403 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 m -155.81 169.54 24.15 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.133 -0.98 . . . . 0.0 110.485 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -115.37 155.71 26.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 156.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -138.86 121.99 16.87 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 126.097 1.759 . . . . 0.0 106.537 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.88 158.11 28.81 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.713 0.633 . . . . 0.0 109.812 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.6 mt -121.61 140.9 51.66 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.6 m -67.41 170.68 7.02 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 124.68 1.237 . . . . 0.0 109.839 172.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -138.63 174.56 10.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.782 1.233 . . . . 0.0 109.011 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.29 150.81 26.27 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 156.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.43 145.79 49.29 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 156.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.7 m -155.31 124.33 6.19 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.86 -161.23 9.71 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -156.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.72 19.14 10.4 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -171.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m 76.36 8.05 3.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 130.018 3.327 . . . . 0.0 114.874 168.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -111.83 7.34 20.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.487 0.715 . . . . 0.0 112.435 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 mt -135.39 140.6 44.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -134.82 140.52 45.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.925 2.09 . . . . 0.0 107.736 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.3 t -141.89 109.69 2.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.23 172.36 8.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.191 1.396 . . . . 0.0 109.689 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.24 -12.73 25.43 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.531 1.062 . . . . 0.0 114.477 -174.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -156.35 34.85 0.32 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.85 1.325 . . . . 0.0 110.476 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 t -159.25 161.95 36.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.664 1.12 . . . . 0.0 109.722 -170.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.18 139.43 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.584 1.154 . . . . 0.0 109.712 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.7 m -143.11 154.6 44.09 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.26 -0.9 . . . . 0.0 109.073 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -145.1 154.32 42.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 160.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -92.46 -166.2 1.49 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -118.47 169.84 9.44 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 122.901 1.334 . . . . 0.0 109.293 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -82.56 154.19 68.46 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 125.959 1.704 . . . . 0.0 112.247 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -88.99 -4.52 6.06 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.968 3.112 . . . . 0.0 114.853 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.18 167.79 10.38 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.716 0.806 . . . . 0.0 109.153 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.62 -3.28 55.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.964 0.905 . . . . 0.0 112.889 -169.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.5 164.16 25.67 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.037 -0.414 . . . . 0.0 110.779 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -95.92 135.3 37.85 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.879 1.272 . . . . 0.0 107.998 173.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -145.32 119.02 9.17 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.5 m -59.02 123.61 17.15 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -70.93 153.73 51.54 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.5 tp -146.85 117.52 7.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.504 1.522 . . . . 0.0 108.251 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.7 p -135.62 165.64 29.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 126.528 1.931 . . . . 0.0 106.235 165.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 m -124.96 171.52 10.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.814 1.646 . . . . 0.0 106.924 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.83 156.66 43.71 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 121.507 -0.745 . . . . 0.0 109.275 153.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -147.21 134.88 21.06 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.184 1.394 . . . . 0.0 107.361 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.05 174.66 4.34 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.89 0.876 . . . . 0.0 112.03 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -63.56 -84.97 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.2 2.6 . . . . 0.0 111.365 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -74.68 -32.65 62.28 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.083 -1.011 . . . . 0.0 110.343 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m -78.4 -159.11 0.15 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.731 1.213 . . . . 0.0 111.122 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.84 18.04 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 N-CA-C 116.775 1.47 . . . . 0.0 116.775 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -63.8 170.6 3.27 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.284 2.042 . . . . 0.0 108.451 146.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.1 p -134.35 156.28 48.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.5 mt -113.75 167.48 10.59 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 163.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.4 m -135.49 117.84 15.68 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.77 122.62 33.67 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 172.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -128.53 91.63 3.27 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -83.98 122.27 37.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 169.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.15 91.09 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 165.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.66 146.42 34.67 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.124 -176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 175.52 10.16 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 125.142 3.895 . . . . 0.0 110.694 169.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.97 173.38 19.88 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.8 pttt . . . . . 0 C--O 1.231 0.114 0 C-N-CA 125.252 1.421 . . . . 0.0 111.486 -177.852 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 121.004 0.431 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -135.5 106.17 6.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.666 1.586 . . . . 0.0 107.182 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -83.85 153.88 23.78 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 172.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.63 146.28 52.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.399 1.88 . . . . 0.0 108.273 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -168.51 42.02 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.235 1.014 . . . . 0.0 111.819 -160.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.4 p -142.52 176.73 8.79 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.749 -1.22 . . . . 0.0 111.03 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -84.64 158.99 20.68 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 165.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.0 59.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.572 0.349 . . . . 0.0 111.829 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.09 -8.23 29.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.183 1.393 . . . . 0.0 113.24 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.33 2.66 21.44 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 124.382 0.991 . . . . 0.0 112.948 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.53 177.3 17.06 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 119.24 1.52 . . . . 0.0 112.23 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 p -117.63 25.68 10.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.328 1.051 . . . . 0.0 109.628 172.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.3 t -144.85 147.95 33.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.49 -0.756 . . . . 0.0 109.212 171.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -99.52 140.4 33.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.888 1.675 . . . . 0.0 107.581 166.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.3 m -142.13 92.32 2.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.654 -1.609 . . . . 0.0 106.654 168.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.17 152.9 36.54 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.058 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -129.54 83.79 63.71 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 168.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.51 170.57 19.07 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.726 2.951 . . . . 0.0 110.46 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -155.4 165.68 35.88 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.872 1.669 . . . . 0.0 107.457 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t70 66.62 -78.69 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.104 2.161 . . . . 0.0 113.576 158.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.3 m -75.91 5.48 6.41 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.475 1.488 . . . . 0.0 112.859 165.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.255 3.8 p 58.81 -163.8 0.21 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.333 1.453 . . . . 0.0 111.173 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.11 172.45 0.2 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.306 1.042 . . . . 0.0 112.465 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.51 -160.1 14.31 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.37 112.48 18.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -131.76 -168.88 2.1 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.278 1.431 . . . . 0.0 110.762 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.8 mt -134.66 111.38 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.993 1.717 . . . . 0.0 107.159 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 74.2 mt -82.51 158.11 23.3 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.565 1.146 . . . . 0.0 110.859 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.56 80.69 4.31 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.53 128.82 57.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -95.57 120.03 35.11 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.644 1.178 . . . . 0.0 108.758 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.1 p -147.64 93.61 2.24 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.831 0.742 . . . . 0.0 109.209 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -157.06 169.11 25.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.278 0.631 . . . . 0.0 109.413 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.21 120.14 30.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.403 1.481 . . . . 0.0 107.472 172.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -93.47 132.62 37.56 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 t -168.14 154.78 7.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 54.18 -101.26 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -144.97 53.05 1.21 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.597 1.189 . . . . 0.0 109.119 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.4 m -155.34 168.01 28.49 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.534 -1.354 . . . . 0.0 110.862 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.29 87.76 2.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.416 1.486 . . . . 0.0 107.848 169.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.29 116.0 7.58 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.79 153.04 44.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.23 138.78 52.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 168.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 m -84.23 177.08 8.34 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.691 0.619 . . . . 0.0 110.042 168.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.4 p90 -132.9 169.91 16.09 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.829 1.252 . . . . 0.0 107.669 166.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -130.68 134.24 46.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.77 149.71 39.49 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.605 1.162 . . . . 0.0 109.614 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 p -165.33 144.78 6.64 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.525 0.679 . . . . 0.0 112.002 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.15 -119.15 1.19 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -47.97 147.39 2.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.904 2.082 . . . . 0.0 113.368 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.0 m -75.16 -12.91 60.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.021 1.328 . . . . 0.0 114.313 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -116.28 20.29 14.35 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.741 1.216 . . . . 0.0 111.259 -164.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 mt -133.97 104.31 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -117.17 144.57 44.59 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -166.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 p -145.56 140.39 22.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.386 0.613 . . . . 0.0 110.961 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.7 88.51 1.34 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.12 -123.35 24.55 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.925 1.25 . . . . 0.0 112.056 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 p -81.22 56.53 2.88 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.674 1.19 . . . . 0.0 110.034 171.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 m -152.28 148.6 27.73 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.863 1.665 . . . . 0.0 106.837 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.13 159.28 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 162.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -136.72 150.46 48.44 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 147.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -130.66 163.22 27.67 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 162.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -124.53 168.39 13.16 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.107 1.363 . . . . 0.0 108.813 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -120.47 161.67 20.85 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.95 0.881 . . . . 0.0 110.287 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.92 165.32 22.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 125.009 1.324 . . . . 0.0 111.622 -162.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.27 -34.59 0.55 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.133 1.888 . . . . 0.0 111.704 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.02 162.69 18.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.851 0.834 . . . . 0.0 109.447 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -82.25 12.91 3.86 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.131 -0.981 . . . . 0.0 110.408 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -68.75 164.41 21.81 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 162.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -124.03 132.93 53.74 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.566 -0.709 . . . . 0.0 109.36 -170.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -130.08 90.69 3.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.591 0.632 . . . . 0.0 111.365 -154.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.5 m -70.04 105.09 2.75 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -80.43 160.97 44.36 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 118.842 -0.977 . . . . 0.0 111.311 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.7 tp -159.93 72.82 0.52 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.435 1.118 . . . . 0.0 113.433 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.2 t -88.12 150.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 120.266 -1.521 . . . . 0.0 109.947 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.6 m -91.61 150.03 21.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 168.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.14 105.94 5.16 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.887 0.875 . . . . 0.0 109.271 162.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -95.19 141.76 28.42 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.277 1.431 . . . . 0.0 109.173 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -64.39 163.44 13.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.994 1.318 . . . . 0.0 110.801 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -56.28 -37.12 69.41 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.99 1.316 . . . . 0.0 112.905 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -135.59 -28.01 1.14 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -167.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -78.96 -156.42 0.1 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 166.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.42 -11.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 CA-C-O 118.323 -1.265 . . . . 0.0 114.475 -172.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.46 110.37 1.09 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.371 1.585 . . . . 0.0 110.388 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.0 p -76.07 116.63 16.96 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.03 118.29 23.42 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 m -75.96 145.0 40.66 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 tt -138.07 106.36 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -170.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -121.32 87.62 2.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.596 0.759 . . . . 0.0 110.024 -170.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.19 123.97 21.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 167.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.18 93.1 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 163.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -106.3 157.55 34.67 Favored Pre-proline 0 C--O 1.237 0.442 0 CA-C-O 117.641 -1.171 . . . . 0.0 109.641 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -69.94 -164.63 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.416 4.078 . . . . 0.0 111.374 172.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -132.63 143.6 15.28 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.017 0.818 . . . . 0.0 111.645 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt . . . . . 0 N--CA 1.467 0.407 0 C-N-CA 127.34 2.256 . . . . 0.0 111.262 -168.181 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 t -81.03 140.14 35.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -115.81 104.6 11.81 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.624 1.57 . . . . 0.0 109.216 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -85.3 114.75 22.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 1.7 t80 -147.89 77.09 1.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -152.05 169.37 22.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.122 0.969 . . . . 0.0 108.59 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -68.54 169.85 10.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.371 0.605 . . . . 0.0 109.604 164.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.47 -14.44 28.48 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.791 0.836 . . . . 0.0 111.457 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.4 p30 -105.66 -4.94 20.45 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -162.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.09 -56.41 0.04 OUTLIER Glycine 0 C--N 1.335 0.473 0 O-C-N 121.903 -0.498 . . . . 0.0 112.533 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.14 -115.27 0.55 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 118.792 1.296 . . . . 0.0 112.271 -168.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.5 p -127.05 19.56 7.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.629 0.772 . . . . 0.0 112.079 -170.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -149.88 157.46 43.2 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.349 -1.469 . . . . 0.0 110.546 167.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -123.92 152.61 42.23 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 165.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -143.55 133.7 24.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.5 156.6 38.73 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.869 1.268 . . . . 0.0 108.162 -178.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -140.81 54.7 4.91 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 126.735 2.014 . . . . 0.0 111.389 -167.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.67 165.54 31.66 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 120.91 1.361 . . . . 0.0 110.858 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.5 162.46 35.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.936 0.895 . . . . 0.0 109.672 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.6 t70 67.26 -76.18 0.05 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.885 2.074 . . . . 0.0 110.347 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.0 t -162.13 89.73 0.72 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.828 1.251 . . . . 0.0 108.115 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.25 98.32 3.49 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.605 1.093 . . . . 0.0 112.123 171.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.12 168.46 19.96 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.11 -0.994 . . . . 0.0 109.285 167.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.6 -165.79 32.6 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 167.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.1 p -82.25 132.54 35.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 169.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -144.76 -177.58 5.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.698 1.199 . . . . 0.0 109.692 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.9 mt -129.02 157.47 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.4 mt -136.47 147.31 47.1 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.594 1.958 . . . . 0.0 107.822 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.52 93.54 6.69 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.72 131.42 72.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.71 1.204 . . . . 0.0 108.459 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 84.4 m -91.05 138.84 31.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.323 1.449 . . . . 0.0 108.854 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.9 p -155.88 74.89 0.88 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.796 -0.565 . . . . 0.0 110.6 -173.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -155.73 172.58 18.08 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.129 -0.982 . . . . 0.0 112.92 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 135.58 52.66 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.644 1.178 . . . . 0.0 109.86 172.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -114.34 128.9 56.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 125.367 1.467 . . . . 0.0 109.406 -172.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.4 t -170.29 159.23 7.1 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.46 0.704 . . . . 0.0 109.476 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.61 -93.4 0.08 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 125.1 1.333 . . . . 0.0 110.258 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -153.65 36.12 0.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.285 1.434 . . . . 0.0 109.508 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t -149.19 164.91 33.4 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.906 -1.121 . . . . 0.0 111.094 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 p -130.79 114.19 15.02 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.761 1.624 . . . . 0.0 107.939 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -88.7 130.09 35.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 163.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.57 165.05 21.91 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 124.0 0.813 . . . . 0.0 108.94 166.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.48 128.12 45.2 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.076 1.351 . . . . 0.0 108.473 173.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.5 m -73.85 163.35 28.05 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.631 0.729 . . . . 0.0 109.494 168.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -139.33 172.56 12.64 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.81 2.044 . . . . 0.0 109.565 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -143.68 164.04 31.57 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 167.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.18 -176.18 3.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.713 1.605 . . . . 0.0 110.413 -172.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m 174.59 143.77 0.05 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 128.042 2.537 . . . . 0.0 109.184 151.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.92 -110.1 0.23 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 167.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.73 142.61 54.94 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.355 1.062 . . . . 0.0 108.795 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 m -65.63 -8.21 19.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -111.08 15.5 21.6 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.347 1.459 . . . . 0.0 111.853 -174.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.7 mt -128.88 133.29 66.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -130.46 147.64 52.18 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.729 1.212 . . . . 0.0 109.475 -173.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.09 99.49 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -89.62 63.26 6.17 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.707 2.003 . . . . 0.0 109.599 174.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.6 -120.94 22.63 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 -162.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.6 p -65.88 -24.65 66.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.362 1.081 . . . . 0.0 113.688 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.6 94.85 6.38 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 119.679 1.127 . . . . 0.0 109.594 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.28 151.21 10.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.589 1.155 . . . . 0.0 108.122 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -150.81 158.4 44.09 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.029 -1.669 . . . . 0.0 109.055 164.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -153.81 162.27 41.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 165.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.39 156.22 24.87 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.59 1.156 . . . . 0.0 108.104 172.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.44 141.14 58.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.517 0.675 . . . . 0.0 109.331 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.72 145.29 98.03 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.926 0.89 . . . . 0.0 110.806 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -86.57 -4.83 8.28 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.018 3.145 . . . . 0.0 113.123 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.94 162.42 18.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.073 0.949 . . . . 0.0 109.163 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -12.12 33.66 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.59 159.79 31.7 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.87 -0.519 . . . . 0.0 110.359 171.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.43 140.99 38.62 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 163.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -148.2 82.53 1.49 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.08 0.952 . . . . 0.0 108.832 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.7 m -63.18 104.43 0.59 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.629 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.6 169.46 54.73 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 tt -159.9 125.33 4.08 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.089 0.556 . . . . 0.0 110.155 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.69 167.18 3.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 118.31 0.504 . . . . 0.0 110.182 174.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.04 161.36 15.6 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 167.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 mp -137.88 154.3 49.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.129 1.372 . . . . 0.0 107.37 169.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -137.88 146.4 43.32 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 163.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.416 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -85.2 171.53 11.89 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.877 0.736 . . . . 0.0 109.789 172.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.42 -78.9 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.769 1.628 . . . . 0.0 110.582 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -86.99 -21.41 26.18 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.063 -1.023 . . . . 0.0 111.896 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.46 -175.17 5.56 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.136 -0.978 . . . . 0.0 108.851 175.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.74 10.7 0.03 OUTLIER Glycine 0 N--CA 1.462 0.373 0 O-C-N 119.804 -1.81 . . . . 0.0 115.932 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -58.44 159.04 6.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.136 1.468 . . . . 0.0 108.381 155.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.1 p -119.67 107.5 13.31 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.7 mt -76.06 164.4 26.17 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 m -141.0 148.4 40.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.57 117.54 11.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -114.28 144.21 43.6 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.9 mt -135.05 98.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 -171.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.2 68.22 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -90.18 165.06 25.33 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.324 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.79 -166.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 124.225 3.283 . . . . 0.0 116.855 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.61 153.9 16.68 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 158.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt . . . . . 0 CA--C 1.517 -0.305 0 C-N-CA 125.057 1.343 . . . . 0.0 109.712 -164.528 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 m -84.84 120.37 26.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -96.86 132.94 42.11 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -102.12 123.41 45.93 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -154.48 67.49 0.71 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.832 0.853 . . . . 0.0 109.486 -171.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.7 p -155.73 -157.23 0.71 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.631 155.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -83.56 152.2 24.98 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.764 1.165 . . . . 0.0 108.217 166.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.85 -22.87 49.24 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.662 0.785 . . . . 0.0 111.544 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -60.61 -6.61 1.74 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.281 0.633 . . . . 0.0 111.934 163.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.81 10.19 73.05 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 118.851 -0.972 . . . . 0.0 112.0 168.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.56 -174.41 24.0 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 118.494 1.147 . . . . 0.0 111.857 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.7 p -128.78 20.62 6.0 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 124.204 1.002 . . . . 0.0 112.565 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.83 177.96 9.9 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 120.203 1.365 . . . . 0.0 112.772 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -148.21 135.55 20.48 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.343 166.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -138.59 108.46 6.31 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.611 1.164 . . . . 0.0 109.605 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -102.64 158.22 16.39 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 110.67 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -136.78 56.15 12.42 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.147 1.779 . . . . 0.0 110.157 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.55 177.8 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.891 2.394 . . . . 0.0 110.973 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -157.29 175.84 13.48 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.104 1.362 . . . . 0.0 111.837 171.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.9 t70 66.03 -81.73 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.578 2.751 . . . . 0.0 113.233 -174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.7 p -148.62 6.81 0.74 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.571 1.149 . . . . 0.0 113.611 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -78.63 86.23 4.62 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.195 -0.941 . . . . 0.0 111.394 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.6 153.99 42.36 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.685 1.994 . . . . 0.0 108.525 170.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.57 160.79 9.55 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.8 p -66.22 130.21 42.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.197 0.599 . . . . 0.0 111.904 -166.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -129.13 -171.77 2.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.694 0.759 . . . . 0.0 112.037 170.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.1 mt -126.07 160.48 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.2 mt -134.6 159.08 42.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.18 43.51 0.88 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.925 1.29 . . . . 0.0 110.928 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.435 ' CG2' ' HE2' ' A' ' 90' ' ' LYS . 98.9 mt -70.89 142.52 15.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.362 1.465 . . . . 0.0 108.555 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.38 106.23 14.69 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.181 1.392 . . . . 0.0 108.132 -174.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -135.77 66.17 1.51 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.992 0.917 . . . . 0.0 110.119 -170.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -150.62 170.95 17.94 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.242 -0.912 . . . . 0.0 112.158 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.7 pttt -110.6 160.81 16.33 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.27 1.028 . . . . 0.0 108.234 164.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -136.5 133.68 36.78 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 166.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.5 t -171.51 157.37 4.79 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.622 1.169 . . . . 0.0 108.448 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.36 -94.48 0.1 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -152.71 35.04 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.211 0.604 . . . . 0.0 111.634 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 t -147.62 170.18 18.05 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 120.996 -1.065 . . . . 0.0 111.106 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.2 p -121.2 96.73 5.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.148 1.379 . . . . 0.0 109.143 164.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.06 120.69 18.01 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 169.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.98 165.56 15.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.273 0.559 . . . . 0.0 109.633 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.49 131.85 55.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 168.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.83 170.32 4.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.251 2.22 . . . . 0.0 110.736 172.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -165.67 167.98 16.67 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.339 1.056 . . . . 0.0 111.617 167.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -155.25 154.87 32.83 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.35 1.86 . . . . 0.0 109.072 165.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.75 178.1 4.72 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.83 1.652 . . . . 0.0 111.268 -172.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.6 p -158.52 127.53 5.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.566 0.746 . . . . 0.0 111.782 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.08 -134.98 3.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.271 1.415 . . . . 0.0 110.346 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.25 147.26 10.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.485 1.914 . . . . 0.0 112.865 -174.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.54 6.1 1.56 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.782 2.433 . . . . 0.0 114.758 -172.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -133.04 10.53 4.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.125 1.77 . . . . 0.0 111.589 -173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.73 108.82 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -106.12 144.28 33.06 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.733 2.013 . . . . 0.0 108.237 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.38 130.57 24.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 172.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.41 70.36 1.42 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 49.64 -117.99 5.1 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -169.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 p -71.36 34.94 0.05 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.671 1.588 . . . . 0.0 114.273 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.2 t -147.81 148.28 30.74 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 p -149.47 155.55 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -171.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.19 138.61 13.85 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.801 1.241 . . . . 0.0 108.396 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -122.16 126.7 48.88 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 166.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.89 147.78 25.73 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.334 0.654 . . . . 0.0 110.172 -169.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -73.0 158.27 35.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.664 1.221 . . . . 0.0 110.4 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -103.73 147.11 33.74 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 126.695 1.998 . . . . 0.0 109.365 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -84.75 -4.25 9.88 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 124.548 3.499 . . . . 0.0 113.233 -163.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.38 153.57 22.04 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.695 -1.253 . . . . 0.0 107.733 166.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 4.81 11.21 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.207 1.003 . . . . 0.0 112.208 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -70.82 154.42 41.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.143 -0.973 . . . . 0.0 109.486 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.4 ttm105 -77.26 148.68 35.62 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 167.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -131.07 146.95 52.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 155.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.7 m -83.06 148.33 27.6 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 156.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.26 157.36 15.4 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 125.103 1.335 . . . . 0.0 109.772 169.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.6 tp -153.08 126.65 8.75 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.611 0.765 . . . . 0.0 109.042 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 158.18 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 119.475 1.034 . . . . 0.0 109.549 167.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -100.7 155.61 17.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mp -132.54 168.12 18.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.187 1.795 . . . . 0.0 109.229 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -151.24 -160.2 1.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.28 1.832 . . . . 0.0 107.162 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.457 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -134.12 171.47 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.703 1.201 . . . . 0.0 108.07 170.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -51.35 -63.32 1.17 Allowed 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.593 1.557 . . . . 0.0 110.201 170.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -107.44 -27.18 10.59 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.763 1.225 . . . . 0.0 111.995 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 t -99.72 -168.64 1.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.893 1.277 . . . . 0.0 111.667 -174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.0 50.66 0.69 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 126.559 2.028 . . . . 0.0 109.702 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.457 ' HE3' ' OE1' ' A' ' 85' ' ' GLN . 3.4 mtmp? -61.39 97.16 0.06 Allowed 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 158.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.4 p -96.9 104.53 16.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.45 155.68 20.32 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 m -135.79 64.58 1.57 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.489 1.516 . . . . 0.0 107.067 -157.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.38 107.36 2.83 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -164.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -112.33 133.19 54.57 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.01 139.73 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.67 72.09 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -108.79 144.97 30.67 Favored Pre-proline 0 C--O 1.23 0.077 0 CA-C-O 117.366 -1.302 . . . . 0.0 108.017 -172.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.28 173.2 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.623 2.882 . . . . 0.0 110.463 169.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.67 169.68 37.49 Favored Glycine 0 C--N 1.331 0.255 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? . . . . . 0 C--O 1.233 0.204 0 C-N-CA 123.047 0.539 . . . . 0.0 109.766 -168.293 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.1 m -124.23 148.83 47.04 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.483 1.113 . . . . 0.0 108.442 166.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -124.55 159.05 31.51 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.379 1.072 . . . . 0.0 111.104 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -129.98 112.73 13.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.442 1.897 . . . . 0.0 106.344 -171.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -143.96 68.67 1.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.275 1.43 . . . . 0.0 108.801 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 p -154.26 173.06 16.66 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.991 0.917 . . . . 0.0 108.712 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -64.07 170.08 3.89 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 149.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.36 -23.43 30.15 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.812 -0.555 . . . . 0.0 111.498 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -148.67 31.23 0.8 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.953 0.901 . . . . 0.0 110.189 -166.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.38 3.15 0.06 OUTLIER Glycine 0 C--N 1.342 0.916 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 -169.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.9 -123.06 6.24 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 120.03 1.915 . . . . 0.0 110.077 174.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 p -135.65 25.3 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.534 1.167 . . . . 0.0 111.764 -167.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -160.26 163.52 33.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.3 155.2 42.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 161.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m -142.59 127.93 18.82 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -118.9 146.9 44.55 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -122.12 65.58 21.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 C-N-CA 124.787 1.235 . . . . 0.0 108.657 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.14 169.14 9.69 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.774 2.316 . . . . 0.0 111.391 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.38 -176.45 5.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t0 55.13 -78.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.43 2.292 . . . . 0.0 113.897 171.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -154.12 110.82 3.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 156.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -149.58 90.85 1.75 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.905 1.23 . . . . 0.0 111.841 167.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.61 177.82 7.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.092 1.757 . . . . 0.0 108.988 169.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.45 -157.77 27.5 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 170.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.2 p -124.57 105.57 9.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.835 1.654 . . . . 0.0 110.081 -170.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -124.16 -171.01 2.24 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.63 160.78 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.837 2.055 . . . . 0.0 107.197 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.3 mt -138.43 164.12 30.15 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.076 1.351 . . . . 0.0 110.61 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -83.83 89.07 7.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.308 1.843 . . . . 0.0 111.809 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.1 152.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 172.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.19 120.25 39.83 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.106 1.762 . . . . 0.0 106.659 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 p -155.0 70.53 0.76 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.686 0.794 . . . . 0.0 109.711 -161.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -159.94 176.86 11.38 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.62 0.768 . . . . 0.0 111.285 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 151.74 49.47 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.711 1.605 . . . . 0.0 109.682 168.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -131.48 130.78 42.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 126.07 1.748 . . . . 0.0 109.215 -167.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.7 t -177.47 144.61 0.4 Allowed 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.168 1.387 . . . . 0.0 108.821 -174.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.33 -88.79 0.2 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 125.947 1.737 . . . . 0.0 112.663 164.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -159.57 33.35 0.19 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.652 1.581 . . . . 0.0 109.172 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -145.9 155.59 42.97 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.619 -1.3 . . . . 0.0 109.564 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.03 80.91 1.85 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.335 1.064 . . . . 0.0 110.007 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -67.22 118.66 10.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.063 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.68 155.35 40.24 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.591 0.632 . . . . 0.0 109.46 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.5 128.28 50.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.021 1.329 . . . . 0.0 108.909 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 t -78.37 178.62 7.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.372 1.069 . . . . 0.0 110.749 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -147.27 -167.73 2.86 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.834 2.054 . . . . 0.0 109.169 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -139.96 -178.16 5.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.861 1.664 . . . . 0.0 107.466 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.36 156.7 47.37 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 165.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.01 150.29 5.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.121 0.969 . . . . 0.0 109.545 165.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.67 -102.65 0.22 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 171.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.56 151.24 47.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.104 0.962 . . . . 0.0 109.729 170.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 m -86.89 -34.16 19.52 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -72.59 19.8 0.08 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.967 1.707 . . . . 0.0 113.635 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mt -130.05 129.67 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -100.4 167.95 10.06 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.673 1.589 . . . . 0.0 108.659 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.97 151.08 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 166.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.59 68.82 1.08 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 166.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.14 -117.83 8.21 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.4 p -72.46 48.48 0.19 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.368 1.867 . . . . 0.0 112.192 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -151.59 147.6 26.97 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.691 1.597 . . . . 0.0 108.497 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -144.65 130.8 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.742 1.217 . . . . 0.0 109.238 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 m -143.19 152.51 41.85 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -153.17 150.46 29.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.611 0.764 . . . . 0.0 109.783 173.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.33 175.2 9.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.824 1.249 . . . . 0.0 108.819 168.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -89.82 175.65 7.14 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.475 1.131 . . . . 0.0 108.577 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -66.93 165.68 24.74 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 120.313 -1.492 . . . . 0.0 113.791 173.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -94.73 -4.62 2.32 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.693 3.595 . . . . 0.0 113.457 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.96 153.21 51.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.805 1.242 . . . . 0.0 108.889 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . 0.338 0.0 OUTLIER -90.14 35.61 0.86 Allowed 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.082 -1.011 . . . . 0.0 111.954 -168.045 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -86.11 167.31 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 167.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.83 136.88 32.86 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 166.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -151.81 162.15 41.51 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.838 0.855 . . . . 0.0 109.741 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.2 t -117.53 158.64 24.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 160.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.78 165.23 28.18 Favored Glycine 0 C--O 1.239 0.457 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 159.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.1 tp -158.21 100.29 1.68 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 m -84.68 -165.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 49.6 m -145.45 146.32 31.46 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 119.447 -2.033 . . . . 0.0 105.831 157.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.26 137.02 54.87 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 170.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -123.29 119.89 31.47 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.327 1.451 . . . . 0.0 108.221 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -65.32 148.46 51.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.453 1.101 . . . . 0.0 109.541 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -50.83 -84.92 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.864 2.466 . . . . 0.0 113.624 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -80.36 -15.8 56.02 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.367 -0.833 . . . . 0.0 111.445 -174.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.82 -153.47 0.33 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.556 1.942 . . . . 0.0 108.739 173.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.43 1.51 0.03 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-O 117.897 -1.501 . . . . 0.0 114.551 -174.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.59 102.14 2.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.887 1.844 . . . . 0.0 106.664 169.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 p -69.49 152.11 45.23 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.751 0.657 . . . . 0.0 110.101 -169.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.18 169.28 8.58 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.336 1.054 . . . . 0.0 108.773 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -147.89 146.33 29.0 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.017 1.327 . . . . 0.0 107.841 -169.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.9 tp -139.35 110.65 6.97 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 128.651 2.78 . . . . 0.0 105.909 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -128.52 128.11 43.68 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.0 mt -134.63 77.81 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -163.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 86.2 t -75.81 99.06 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.08 155.0 43.25 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 124.593 1.157 . . . . 0.0 111.94 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.49 -168.82 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 124.231 3.287 . . . . 0.0 108.883 160.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -139.74 167.5 25.31 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 118.786 -1.674 . . . . 0.0 114.994 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.117 0 CA-C-N 114.456 -0.872 . . . . 0.0 112.341 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -89.58 125.79 35.36 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 166.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -102.33 152.93 20.51 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.927 1.291 . . . . 0.0 109.638 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.06 110.74 10.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.297 2.239 . . . . 0.0 106.571 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.9 46.79 1.75 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.762 1.625 . . . . 0.0 108.529 -175.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -160.36 157.34 27.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.941 1.696 . . . . 0.0 107.625 -170.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -73.67 170.83 14.43 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.184 0.993 . . . . 0.0 109.5 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.41 -36.3 45.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.286 0.634 . . . . 0.0 112.641 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -142.49 47.28 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.33 -1.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 -172.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.59 -112.68 4.61 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 120.914 2.357 . . . . 0.0 109.111 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.3 p -119.98 7.31 10.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.268 1.034 . . . . 0.0 112.598 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 t -137.88 158.14 44.96 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.451 1.023 . . . . 0.0 108.58 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -102.85 165.31 11.12 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 148.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.4 m -141.14 163.16 33.72 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 153.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -144.81 150.6 37.45 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -131.96 77.34 72.01 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 126.955 2.102 . . . . 0.0 106.475 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.59 177.02 8.0 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.845 1.696 . . . . 0.0 109.757 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -151.88 161.19 43.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 108.879 172.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 54.52 -85.34 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.444 2.697 . . . . 0.0 110.488 -167.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t -150.24 106.04 3.42 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 165.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -128.55 89.96 2.98 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 122.432 1.11 . . . . 0.0 108.664 156.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.5 149.03 50.66 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.922 2.089 . . . . 0.0 106.844 164.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.04 -139.03 4.97 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 p -129.91 116.04 18.06 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.775 1.63 . . . . 0.0 110.321 -171.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -146.44 -171.74 3.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.781 1.233 . . . . 0.0 111.873 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.6 mt -133.16 130.2 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.201 1.8 . . . . 0.0 107.273 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.2 mt -91.63 161.59 14.86 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.453 1.501 . . . . 0.0 109.419 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.2 78.84 4.0 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mt -90.35 133.05 33.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.865 2.066 . . . . 0.0 107.397 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 m -110.4 107.98 17.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -135.53 67.65 1.48 Allowed 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.029 0.932 . . . . 0.0 108.771 -163.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -154.37 176.22 12.59 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.25 -0.906 . . . . 0.0 111.808 -176.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.96 154.56 40.99 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 125.94 1.696 . . . . 0.0 108.988 170.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -141.36 126.82 18.8 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.93 1.292 . . . . 0.0 109.938 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.6 t -177.62 160.06 1.53 Allowed 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.135 1.374 . . . . 0.0 108.932 -176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.4 -103.56 0.32 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -146.04 29.5 1.08 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.158 0.983 . . . . 0.0 111.871 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -146.85 169.34 19.32 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.216 -0.927 . . . . 0.0 110.064 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.48 113.2 10.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.514 1.525 . . . . 0.0 109.064 -172.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.85 108.96 20.02 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.68 109.84 3.99 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.479 1.036 . . . . 0.0 109.217 169.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.77 134.64 52.57 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -66.75 163.23 19.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.384 1.474 . . . . 0.0 108.996 166.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -149.42 -172.87 4.24 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.1 -175.15 5.21 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 153.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.33 166.38 19.6 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.745 1.618 . . . . 0.0 108.277 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.62 149.84 20.65 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 161.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.27 -142.92 8.31 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -64.95 143.34 58.01 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.278 0.631 . . . . 0.0 111.043 -168.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.82 -0.76 4.48 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.104 1.762 . . . . 0.0 114.782 -170.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -117.81 11.56 13.59 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.032 1.733 . . . . 0.0 111.653 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.02 133.03 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -134.5 111.37 10.04 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.977 1.711 . . . . 0.0 106.892 -165.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.4 t -112.56 98.33 6.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -94.41 79.29 3.89 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.32 -107.78 0.47 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 126.215 1.864 . . . . 0.0 111.44 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m -73.83 -19.25 60.8 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.821 1.248 . . . . 0.0 112.764 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -88.08 160.06 17.97 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.45 1.023 . . . . 0.0 110.694 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -132.04 145.64 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 167.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -150.74 148.79 28.98 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.05 160.56 42.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -125.45 148.87 48.67 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.357 1.063 . . . . 0.0 108.289 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -62.92 170.86 2.44 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 123.621 1.677 . . . . 0.0 112.537 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.488 HD22 ' HA2' ' A' ' 100' ' ' GLY . 21.5 p30 -78.03 157.18 79.02 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.069 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.43 -6.16 7.15 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.02 2.48 . . . . 0.0 112.397 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.93 154.47 46.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.96 1.304 . . . . 0.0 109.221 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 40.79 0.77 Allowed 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.793 1.237 . . . . 0.0 111.065 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.29 170.33 9.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.288 1.435 . . . . 0.0 109.884 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.82 113.04 20.47 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.1 mtp85 -135.14 -170.44 2.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.122 0.969 . . . . 0.0 109.609 -170.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.7 t -147.2 156.89 43.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.486 -1.384 . . . . 0.0 108.108 161.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -84.7 174.07 49.74 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 159.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.5 tp -162.67 80.21 0.5 Allowed 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.53 178.06 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 120.629 -1.294 . . . . 0.0 110.005 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.4 m -134.38 141.51 46.88 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.949 -1.095 . . . . 0.0 108.566 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -127.83 151.45 49.03 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.901 1.68 . . . . 0.0 107.846 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.38 134.97 20.96 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.735 0.698 . . . . 0.0 109.454 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -77.12 154.65 33.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.416 1.087 . . . . 0.0 110.564 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -53.45 -69.49 0.12 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.989 2.116 . . . . 0.0 113.001 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -85.12 -23.51 28.41 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.053 0.541 . . . . 0.0 111.132 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -86.08 -153.64 0.19 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.318 1.847 . . . . 0.0 109.878 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.26 -13.28 0.02 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-O 118.193 -1.337 . . . . 0.0 115.645 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.71 121.54 10.66 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.959 1.879 . . . . 0.0 106.932 169.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.2 p -81.38 145.11 30.98 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -93.5 158.23 15.81 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 168.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 m -124.98 152.54 44.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.63 1.172 . . . . 0.0 110.153 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tt -152.72 109.29 3.43 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -170.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -117.25 137.32 52.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.305 1.042 . . . . 0.0 109.391 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.8 mt -135.72 94.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -171.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.6 t -99.28 80.76 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -89.81 166.01 22.45 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 125.313 1.445 . . . . 0.0 110.126 -172.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -60.91 -172.05 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.824 3.016 . . . . 0.0 112.018 160.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . 0.488 ' HA2' HD22 ' A' ' 71' ' ' ASN . . . -121.26 139.04 12.93 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 124.817 1.198 . . . . 0.0 112.1 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm . . . . . 0 N--CA 1.463 0.177 0 C-N-CA 125.343 1.457 . . . . 0.0 110.372 -175.22 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -147.93 103.79 3.52 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -77.11 155.0 32.69 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -137.31 109.08 7.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.141 2.577 . . . . 0.0 106.367 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -132.73 93.03 3.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -164.66 161.17 20.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.347 1.059 . . . . 0.0 110.179 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -66.44 167.76 10.13 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.493 -0.754 . . . . 0.0 108.966 163.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -114.89 -0.78 13.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.234 1.013 . . . . 0.0 111.89 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -145.92 51.18 1.17 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 166.85 -97.57 0.14 Allowed Glycine 0 CA--C 1.523 0.564 0 O-C-N 121.371 -0.831 . . . . 0.0 111.109 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.65 -112.24 0.26 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 118.065 0.933 . . . . 0.0 112.379 -171.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.2 p -138.44 16.09 2.75 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.97 0.908 . . . . 0.0 112.242 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 t -152.95 140.93 20.26 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.438 1.017 . . . . 0.0 109.49 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.29 157.09 17.37 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.021 0.929 . . . . 0.0 109.893 174.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -150.82 102.14 2.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 154.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -89.04 155.57 19.39 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 118.819 -1.153 . . . . 0.0 109.482 165.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -128.88 69.24 80.36 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 126.396 1.879 . . . . 0.0 108.774 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.94 170.83 14.7 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.354 2.036 . . . . 0.0 111.144 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.0 158.5 42.12 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.455 0.702 . . . . 0.0 110.505 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.4 t70 62.52 -72.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.016 2.126 . . . . 0.0 113.662 -171.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 m -165.57 75.84 0.24 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.937 1.695 . . . . 0.0 108.687 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.42 98.8 6.09 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.342 1.057 . . . . 0.0 110.098 174.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.3 165.1 28.09 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.318 2.247 . . . . 0.0 106.448 167.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 143.68 174.61 16.09 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 119.76 1.164 . . . . 0.0 112.088 165.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.5 p -92.01 113.17 25.37 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.895 0.478 . . . . 0.0 110.707 -161.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -122.76 -167.11 1.53 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.255 1.022 . . . . 0.0 112.945 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mt -135.67 143.21 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 127.771 2.429 . . . . 0.0 105.194 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.9 mt -123.16 162.88 21.66 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.294 1.038 . . . . 0.0 110.067 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -104.63 86.19 2.45 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.234 1.414 . . . . 0.0 107.187 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -114.52 128.43 71.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 m -79.31 115.16 18.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.139 1.376 . . . . 0.0 108.129 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.2 p -143.68 73.38 1.39 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.375 0.534 . . . . 0.0 111.126 -174.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -155.84 167.67 29.65 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.669 -0.644 . . . . 0.0 112.407 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.41 133.58 55.62 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -103.78 142.74 33.84 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.834 0.854 . . . . 0.0 109.174 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.59 76.96 0.97 Allowed 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -156.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.75 -94.55 0.09 OUTLIER Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.862 1.22 . . . . 0.0 111.035 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -113.87 9.85 17.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 m -134.76 153.68 51.91 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.566 0.746 . . . . 0.0 110.957 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -139.1 92.19 2.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.712 1.605 . . . . 0.0 110.193 -168.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.97 115.53 16.84 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.43 152.69 45.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.16 148.95 42.51 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.393 1.077 . . . . 0.0 108.149 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.2 p -87.95 -179.42 6.22 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.792 0.837 . . . . 0.0 110.175 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -143.71 154.29 43.33 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 109.512 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -89.48 160.06 16.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.04 1.336 . . . . 0.0 108.538 160.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.75 163.11 26.91 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.832 2.053 . . . . 0.0 106.434 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 m -170.86 141.8 1.81 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.332 0.969 . . . . 0.0 109.284 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.93 -128.75 3.84 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.226 1.393 . . . . 0.0 110.245 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.92 136.73 4.48 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.113 2.565 . . . . 0.0 111.699 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -71.58 4.32 3.21 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 -165.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -139.66 15.58 2.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.874 0.869 . . . . 0.0 112.338 -160.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.7 mt -123.42 87.88 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -73.33 126.57 30.44 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.9 t -137.38 84.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.93 59.07 3.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.679 1.192 . . . . 0.0 109.145 -173.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.31 -115.88 8.33 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -172.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -75.65 39.04 0.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.86 1.664 . . . . 0.0 112.8 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 m -152.4 149.14 28.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.78 139.52 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 t -143.32 108.8 5.07 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.09 106.71 17.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 165.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -66.81 168.01 10.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.383 1.473 . . . . 0.0 110.822 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -85.03 -176.85 6.38 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.431 -0.793 . . . . 0.0 109.162 171.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -112.03 161.07 27.54 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.882 1.673 . . . . 0.0 108.44 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -86.79 -10.41 6.1 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.795 2.33 . . . . 0.0 113.375 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.83 167.07 13.98 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.934 1.293 . . . . 0.0 110.732 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -100.01 13.26 34.59 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.763 1.024 . . . . 0.0 113.763 -175.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.95 171.77 13.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 164.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -108.7 144.33 36.62 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.63 -0.668 . . . . 0.0 109.604 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.69 165.74 18.67 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.237 -0.914 . . . . 0.0 109.272 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.2 m -117.33 117.55 29.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 158.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.72 158.59 52.46 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.8 tp -155.18 111.35 3.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.94 0.87 . . . . 0.0 109.629 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.1 t -130.53 124.19 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.9 m -87.7 135.98 33.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 175.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.35 145.7 38.4 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.751 0.82 . . . . 0.0 108.901 167.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -134.57 139.87 45.7 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 173.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -71.52 160.04 33.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.198 0.999 . . . . 0.0 109.322 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -50.44 -33.35 20.69 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.109 1.363 . . . . 0.0 113.937 168.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -127.95 -36.06 2.02 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 t -88.22 -156.2 0.35 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.564 0.746 . . . . 0.0 110.054 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.64 10.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.627 0 CA-C-O 118.113 -1.381 . . . . 0.0 114.937 -171.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.91 94.27 1.05 Allowed 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.141 1.97 . . . . 0.0 107.147 169.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 p -72.8 113.67 10.1 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mp -75.0 130.13 38.83 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 t -88.18 152.63 21.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 tt -149.02 98.54 2.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -172.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -105.47 149.61 26.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.2 134.89 41.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 168.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 t -121.4 79.4 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -84.79 164.08 43.7 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.68 1.192 . . . . 0.0 110.704 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.26 179.61 3.32 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.448 2.765 . . . . 0.0 110.518 160.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.95 147.82 18.89 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.106 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm . . . . . 0 C--O 1.236 0.352 0 C-N-CA 126.206 1.802 . . . . 0.0 111.455 -166.782 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -97.77 100.63 12.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -79.2 157.07 27.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.106 0.479 . . . . 0.0 110.153 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -131.42 107.01 8.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -130.79 69.06 1.47 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.35 2.26 . . . . 0.0 105.663 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.6 p -163.41 -174.98 3.99 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.893 -0.504 . . . . 0.0 111.724 165.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -65.66 173.37 2.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.486 0.585 . . . . 0.0 109.688 161.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -112.47 -8.11 13.89 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -156.67 58.02 0.55 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.055 0.931 . . . . 0.0 108.888 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.3 -91.66 0.08 OUTLIER Glycine 0 C--N 1.331 0.286 0 O-C-N 121.405 -0.809 . . . . 0.0 111.779 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.33 -123.31 0.78 Allowed Glycine 0 C--N 1.333 0.362 0 CA-C-N 117.781 0.79 . . . . 0.0 113.007 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 p -138.81 12.32 2.68 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.223 1.409 . . . . 0.0 114.127 -169.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 t -157.38 146.64 20.03 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 118.467 -1.293 . . . . 0.0 111.7 169.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.5 137.76 33.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.375 160.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m -136.05 162.16 33.67 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 170.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -152.81 154.47 35.22 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 159.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.4 54.64 14.18 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.602 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.57 174.52 9.23 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.23 1.286 . . . . 0.0 111.167 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -159.46 169.54 23.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t70 65.16 -78.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.48 1.912 . . . . 0.0 111.231 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 m -169.07 110.44 0.49 Allowed 'General case' 0 C--O 1.238 0.496 0 C-N-CA 128.479 2.712 . . . . 0.0 106.702 160.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.6 m -138.89 24.75 2.57 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.78 146.71 49.6 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.173 -0.954 . . . . 0.0 110.445 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.73 -158.95 27.37 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -121.98 116.11 23.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.385 1.474 . . . . 0.0 110.173 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -122.14 -177.85 3.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.317 1.447 . . . . 0.0 110.639 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mt -132.03 156.59 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 127.287 2.235 . . . . 0.0 105.897 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.5 mt -134.06 179.04 6.5 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.648 1.579 . . . . 0.0 109.287 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -109.31 71.57 0.77 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.651 1.181 . . . . 0.0 109.461 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 97.2 mt -97.5 138.88 21.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.38 131.32 51.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.46 1.504 . . . . 0.0 107.421 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.1 t -148.61 81.98 1.46 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -154.2 173.17 16.47 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.764 -0.585 . . . . 0.0 111.394 173.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.68 137.25 54.37 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.778 1.631 . . . . 0.0 108.602 169.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -115.29 134.63 54.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.307 1.843 . . . . 0.0 107.011 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.1 t -174.85 157.79 2.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.67 -110.8 0.89 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -135.12 32.4 3.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.844 1.258 . . . . 0.0 109.476 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m -144.53 161.55 38.81 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.884 0.874 . . . . 0.0 110.784 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 p -127.66 103.21 7.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.025 1.33 . . . . 0.0 108.002 166.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -78.57 116.33 18.88 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.35 148.48 46.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -112.65 142.95 44.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.09 163.47 20.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.797 0.839 . . . . 0.0 110.514 166.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -140.1 158.4 44.12 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.585 1.154 . . . . 0.0 108.898 165.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -138.26 151.16 47.37 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.4 162.14 36.19 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.369 1.068 . . . . 0.0 110.736 -163.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -168.96 152.42 5.23 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.292 1.037 . . . . 0.0 109.495 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.59 -138.88 5.47 Favored Glycine 0 C--N 1.333 0.38 0 O-C-N 121.506 -0.746 . . . . 0.0 111.709 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.84 137.33 50.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.153 1.381 . . . . 0.0 111.133 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.5 m -69.4 3.43 2.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.745 2.418 . . . . 0.0 116.364 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -126.98 6.58 6.58 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.276 1.43 . . . . 0.0 111.963 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 34.6 mt -117.27 91.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -76.77 110.23 11.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.614 1.166 . . . . 0.0 108.724 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.0 p -94.41 143.13 12.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.17 0.988 . . . . 0.0 108.461 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.67 46.08 1.69 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.744 0.783 . . . . 0.0 111.061 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.18 -113.5 5.42 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.5 p -71.99 -7.35 48.2 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.2 m -110.31 144.65 38.72 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 119.671 1.123 . . . . 0.0 109.623 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.62 157.11 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.888 1.675 . . . . 0.0 107.775 -176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.29 152.58 26.21 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.529 1.132 . . . . 0.0 108.432 162.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -154.4 173.36 16.33 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.966 0.906 . . . . 0.0 109.557 159.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.93 170.81 8.06 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.784 1.233 . . . . 0.0 110.686 166.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -80.9 158.75 25.18 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 122.509 1.147 . . . . 0.0 108.305 165.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.63 167.37 5.74 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 126.304 1.842 . . . . 0.0 112.362 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -92.1 -10.8 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.377 3.385 . . . . 0.0 115.726 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.82 141.87 29.5 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 120.558 1.526 . . . . 0.0 109.926 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.559 ' CD ' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -72.0 8.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 128.668 2.787 . . . . 0.0 114.0 -155.042 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -61.58 166.65 4.0 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 163.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.4 ttm-85 -126.21 118.9 26.12 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.086 1.354 . . . . 0.0 110.253 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -136.94 -168.94 2.37 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.562 1.145 . . . . 0.0 110.25 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.8 t -131.82 156.12 46.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.653 0.781 . . . . 0.0 109.238 162.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.81 -179.3 40.43 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 160.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.7 tp -147.82 160.36 42.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.736 1.214 . . . . 0.0 108.383 159.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -135.78 151.48 29.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 163.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.2 m -124.37 154.87 39.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.01 167.38 22.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.266 1.027 . . . . 0.0 109.968 -174.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -137.89 158.28 44.68 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 125.167 1.387 . . . . 0.0 108.077 167.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -114.98 139.46 49.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -44.7 -73.16 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.037 1.735 . . . . 0.0 113.743 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.26 -8.75 54.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.691 1.996 . . . . 0.0 112.957 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.76 -153.37 0.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.459 2.304 . . . . 0.0 106.771 174.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 0.21 0.04 OUTLIER Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.11 -1.519 . . . . 0.0 115.931 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -58.85 153.3 17.41 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 126.568 1.947 . . . . 0.0 110.925 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 p -122.42 146.79 47.03 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.5 mt -117.39 -170.42 1.85 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.845 1.658 . . . . 0.0 106.639 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.54 161.08 39.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.104 1.362 . . . . 0.0 108.776 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 tp -136.45 77.92 1.68 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.548 1.939 . . . . 0.0 108.438 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -82.25 89.08 6.5 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.687 -0.633 . . . . 0.0 110.312 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.4 mt -83.68 92.47 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.6 87.64 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.13 160.75 31.34 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 118.281 0.491 . . . . 0.0 109.895 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -78.4 171.54 16.73 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.749 1.632 . . . . 0.0 109.781 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.92 164.53 32.59 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.46 170.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm . . . . . 0 C--O 1.239 0.543 0 CA-C-N 114.036 -1.082 . . . . 0.0 108.231 -163.344 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.64 111.48 21.32 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.145 0.978 . . . . 0.0 108.522 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -88.24 166.3 14.44 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 163.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -144.15 102.83 3.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.468 1.907 . . . . 0.0 106.333 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -128.63 65.23 1.42 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.819 1.648 . . . . 0.0 109.042 -169.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.68 174.06 12.56 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.037 -1.039 . . . . 0.0 110.195 172.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -62.98 149.45 44.83 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.948 1.249 . . . . 0.0 107.63 155.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.37 -24.41 59.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.149 -174.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -93.52 17.3 11.8 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.203 1.001 . . . . 0.0 111.845 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.32 58.03 1.17 Allowed Glycine 0 C--N 1.337 0.586 0 O-C-N 121.769 -0.582 . . . . 0.0 111.943 168.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.06 -169.39 38.22 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.61 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 p -137.82 7.19 2.72 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.778 1.231 . . . . 0.0 112.74 -163.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 t -162.05 159.85 26.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.187 -0.946 . . . . 0.0 109.102 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.72 129.03 55.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 167.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.2 m -132.73 119.64 20.6 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 166.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.56 145.31 42.77 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -130.5 74.03 80.63 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -75.12 174.59 12.54 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.419 2.079 . . . . 0.0 110.709 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -137.9 -1.84 1.96 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -162.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.03 -66.22 0.35 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.013 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.4 t -157.92 9.81 0.17 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.397 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.65 92.2 0.32 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.387 1.449 . . . . 0.0 112.692 -167.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.82 147.01 28.25 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.9 2.48 . . . . 0.0 106.834 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.01 -179.68 40.6 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 121.497 1.953 . . . . 0.0 110.066 -172.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.5 m -99.67 117.26 33.64 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.949 0.9 . . . . 0.0 109.774 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -139.71 -165.94 1.98 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.032 1.333 . . . . 0.0 110.599 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.0 mt -128.83 155.92 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.33 1.852 . . . . 0.0 107.485 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.2 mt -133.58 156.09 48.47 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.55 1.94 . . . . 0.0 106.729 173.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.22 98.06 7.66 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.92 142.89 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.96 112.98 23.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.18 55.93 1.62 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -174.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -152.39 168.02 26.81 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.02 -1.05 . . . . 0.0 113.524 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.3 145.33 47.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.971 1.309 . . . . 0.0 109.144 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.44 ' HE3' ' CG2' ' A' ' 46' ' ' THR . 18.3 ttmt -112.95 143.82 43.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.806 2.442 . . . . 0.0 106.779 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.8 t -172.99 172.02 4.07 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.073 2.149 . . . . 0.0 105.606 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.43 -102.56 0.04 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 126.19 1.852 . . . . 0.0 112.407 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -146.37 41.46 1.15 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.902 1.681 . . . . 0.0 109.188 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -146.26 169.22 19.22 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.005 0.922 . . . . 0.0 110.61 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.44 ' CG2' ' HE3' ' A' ' 41' ' ' LYS . 52.3 p -135.16 104.66 6.0 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.992 0.917 . . . . 0.0 110.461 165.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -80.44 121.42 25.72 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 172.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.75 151.42 47.48 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 166.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.45 114.14 21.35 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.692 1.597 . . . . 0.0 106.871 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 m -67.45 150.15 49.29 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.994 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -120.17 160.57 22.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.465 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -107.15 165.13 11.59 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.035 1.734 . . . . 0.0 107.825 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.19 144.36 19.8 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.702 1.201 . . . . 0.0 108.327 166.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.67 152.4 27.06 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.306 0.643 . . . . 0.0 109.985 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.92 -62.16 0.11 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.01 148.82 39.75 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.229 1.012 . . . . 0.0 110.389 -168.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -60.07 -10.72 4.61 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.637 1.975 . . . . 0.0 114.952 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -130.72 14.38 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.429 1.492 . . . . 0.0 111.066 -163.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.42 ' HA ' ' CD1' ' A' ' 68' ' ' TYR . 23.6 mt -127.36 86.5 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -172.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -104.24 141.78 35.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.106 1.362 . . . . 0.0 111.522 -170.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.03 100.56 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.858 0.863 . . . . 0.0 109.552 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -100.51 51.96 0.88 Allowed 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.606 -1.309 . . . . 0.0 109.921 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.66 -113.76 6.17 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.4 p -78.1 53.29 1.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.665 1.232 . . . . 0.0 110.773 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.9 m -165.02 150.52 9.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.605 2.362 . . . . 0.0 107.263 167.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.33 140.95 28.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.0 t -155.69 102.97 2.24 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.42 ' CD1' ' HA ' ' A' ' 59' ' ' ILE . 4.4 m-30 -113.96 136.72 52.58 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -103.7 172.02 7.03 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.001 1.321 . . . . 0.0 111.554 -173.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.42 156.71 36.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.89 0.853 . . . . 0.0 111.106 163.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -68.12 165.56 32.06 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.26 1.824 . . . . 0.0 110.888 165.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -88.27 -11.51 4.32 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.91 2.407 . . . . 0.0 113.969 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.03 159.71 38.01 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.204 1.002 . . . . 0.0 109.811 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 0.6 3.51 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.09 165.12 11.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.557 0.743 . . . . 0.0 109.615 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -92.06 146.42 23.75 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 168.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -136.98 154.81 50.32 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.6 m -113.48 106.43 14.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 163.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.39 149.67 47.93 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.5 tp -162.66 118.45 1.86 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.075 0.938 . . . . 0.0 109.53 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.66 166.81 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.195 0.998 . . . . 0.0 109.183 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.7 m -121.52 144.54 48.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 169.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.58 160.58 28.08 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.356 1.863 . . . . 0.0 110.095 172.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -148.8 137.96 21.62 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.759 1.224 . . . . 0.0 108.257 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -68.35 165.59 18.37 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -55.56 -84.94 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.815 2.046 . . . . 0.0 111.553 170.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -91.42 -3.14 56.97 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.971 -1.081 . . . . 0.0 113.268 -167.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 t -116.27 -154.51 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.242 2.217 . . . . 0.0 108.028 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.06 41.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.528 0 O-C-N 120.941 -1.099 . . . . 0.0 110.54 -159.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . 0.305 0.0 OUTLIER -65.24 138.5 58.27 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 153.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.1 p -110.39 140.97 44.08 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 159.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.3 mt -121.24 112.04 18.14 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.9 m -65.07 137.72 57.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tt -140.48 96.61 3.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.094 0.861 . . . . 0.0 110.072 -175.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -98.23 137.18 37.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mp -118.53 117.54 54.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 158.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.3 t -108.79 79.15 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -106.14 158.94 31.38 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 123.377 0.671 . . . . 0.0 110.899 -171.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -65.66 -178.08 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.289 2.659 . . . . 0.0 109.979 162.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.2 165.27 22.58 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 121.854 -0.529 . . . . 0.0 112.38 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm . . . . . 0 C--N 1.326 -0.416 0 C-N-CA 124.034 0.934 . . . . 0.0 110.812 -158.737 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.54 144.36 50.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.919 1.688 . . . . 0.0 109.188 175.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CZ ' ' HE2' ' A' ' 40' ' ' LYS . 6.8 m-85 -127.2 136.98 52.8 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.981 1.712 . . . . 0.0 107.715 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.63 115.17 22.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.989 2.116 . . . . 0.0 107.898 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.44 75.2 1.5 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.861 2.064 . . . . 0.0 105.797 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -170.25 174.89 5.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.677 0.791 . . . . 0.0 110.288 -175.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -82.95 157.49 22.98 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.664 -0.647 . . . . 0.0 109.938 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.4 -63.99 1.29 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.279 0.561 . . . . 0.0 109.724 165.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -107.92 28.37 8.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.062 1.745 . . . . 0.0 111.027 -160.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.4 -11.43 0.07 OUTLIER Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 170.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.04 -119.31 4.51 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 120.336 2.068 . . . . 0.0 113.796 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.17 9.14 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.636 1.174 . . . . 0.0 112.843 -165.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 t -154.13 -173.4 4.56 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.978 0.808 . . . . 0.0 110.534 161.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.96 105.61 5.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 127.785 2.434 . . . . 0.0 109.322 -171.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -130.35 88.84 2.69 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -83.97 136.48 34.05 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -121.45 70.65 24.42 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.815 1.246 . . . . 0.0 108.392 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.53 171.89 12.31 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.767 1.645 . . . . 0.0 110.307 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -153.43 157.62 40.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.75 1.22 . . . . 0.0 108.276 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.28 -85.52 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.583 2.353 . . . . 0.0 110.106 -170.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 t -146.44 96.43 2.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.979 1.712 . . . . 0.0 108.928 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 m -146.63 89.42 1.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.828 -1.17 . . . . 0.0 112.207 162.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.09 135.9 43.55 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.682 1.193 . . . . 0.0 108.417 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.34 -172.31 40.11 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-N 118.871 0.759 . . . . 0.0 112.498 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.0 p -111.33 108.69 18.38 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.21 1.404 . . . . 0.0 109.683 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -132.81 -174.86 3.59 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.015 1.326 . . . . 0.0 112.89 -175.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 mt -140.57 125.22 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.094 1.358 . . . . 0.0 107.91 -169.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.3 mt -109.17 165.73 11.38 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.997 1.319 . . . . 0.0 110.57 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -84.51 83.63 7.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.076 0.941 . . . . 0.0 110.888 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.0 mt -109.36 119.55 58.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.46 1.104 . . . . 0.0 109.449 -170.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.5 m -84.77 135.3 34.18 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.549 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.7 t -155.19 89.27 1.2 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -162.75 165.89 24.97 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.925 0.89 . . . . 0.0 111.506 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.586 ' HE2' ' CZ ' ' A' ' 9' ' ' TYR . 11.0 ptpt -110.71 161.19 16.01 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.206 1.003 . . . . 0.0 109.113 172.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -134.17 124.98 26.94 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 125.968 1.707 . . . . 0.0 108.001 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.0 t -173.82 175.54 2.85 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.104 1.362 . . . . 0.0 108.073 173.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.56 -107.52 0.92 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -152.15 68.23 0.87 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.617 1.567 . . . . 0.0 107.499 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.8 m -160.87 172.21 17.38 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.687 1.995 . . . . 0.0 110.653 171.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 p -135.39 89.5 2.52 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.076 0.951 . . . . 0.0 110.147 161.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -79.13 140.04 37.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.698 1.135 . . . . 0.0 109.963 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.96 166.79 5.34 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.165 1.386 . . . . 0.0 111.417 171.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.5 mt -137.32 134.46 36.08 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.839 0.855 . . . . 0.0 109.512 162.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.5 p -71.63 173.68 7.76 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.817 1.647 . . . . 0.0 110.357 171.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -145.69 179.86 7.15 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.806 1.243 . . . . 0.0 111.318 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -125.88 162.44 25.18 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 127.27 2.228 . . . . 0.0 107.734 170.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.92 156.8 43.36 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.596 0.758 . . . . 0.0 109.236 165.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p 174.56 154.19 0.13 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.946 1.298 . . . . 0.0 112.64 167.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.41 -96.47 0.1 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.779 2.133 . . . . 0.0 109.055 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.21 167.72 11.7 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.898 0.849 . . . . 0.0 111.426 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.5 m -93.08 5.03 52.93 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -125.64 21.4 7.74 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.881 1.672 . . . . 0.0 112.461 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.7 mt -134.84 114.22 17.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -165.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -124.0 149.26 46.24 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.06 0.944 . . . . 0.0 109.898 -166.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -132.55 155.27 41.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -171.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.01 179.0 7.47 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.416 1.086 . . . . 0.0 108.849 165.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.72 -18.71 32.74 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 116.484 1.353 . . . . 0.0 116.484 -163.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 m -145.03 8.01 1.22 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.323 1.561 . . . . 0.0 111.16 163.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -109.99 151.45 27.13 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.697 1.599 . . . . 0.0 109.387 -163.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.19 138.25 53.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -142.18 152.26 42.98 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -159.23 168.02 27.54 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.855 0.862 . . . . 0.0 108.841 163.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -119.47 166.98 12.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.419 1.088 . . . . 0.0 110.565 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.13 175.31 7.62 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.403 1.097 . . . . 0.0 111.161 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -99.8 166.94 11.88 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.957 2.503 . . . . 0.0 110.945 -170.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -76.76 -28.6 6.25 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.826 2.351 . . . . 0.0 114.775 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.91 168.5 19.67 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.673 1.124 . . . . 0.0 110.883 -165.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -75.0 1.11 13.73 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 120.733 -1.229 . . . . 0.0 111.918 -170.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -65.0 161.25 19.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.231 0.538 . . . . 0.0 110.749 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.92 129.13 34.18 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.81 101.96 8.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 167.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.6 m -91.1 106.82 18.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 162.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.32 160.93 53.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.0 tp -161.46 93.94 0.95 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.38 0.59 . . . . 0.0 111.818 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 m -86.28 179.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.966 -0.458 . . . . 0.0 111.983 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.96 164.53 14.01 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 161.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -134.01 164.78 26.54 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.848 1.659 . . . . 0.0 108.87 165.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -151.66 153.18 33.91 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 164.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -80.03 171.88 14.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 172.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -55.56 -39.41 70.6 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.902 1.281 . . . . 0.0 112.031 168.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -126.04 -44.97 1.73 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.893 -1.129 . . . . 0.0 111.845 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.4 t -79.47 -169.56 1.96 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.75 10.49 0.04 OUTLIER Glycine 0 C--O 1.223 -0.582 0 CA-C-O 117.09 -1.95 . . . . 0.0 116.422 -159.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.34 91.89 0.05 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 120.74 2.27 . . . . 0.0 109.194 169.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 p -71.6 145.01 49.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.1 mt -102.09 -179.06 3.89 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.16 -0.963 . . . . 0.0 108.57 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.93 86.73 1.87 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.148 1.379 . . . . 0.0 110.681 -167.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.99 73.12 8.04 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.469 1.108 . . . . 0.0 109.473 -169.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -78.4 91.77 4.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.3 mt -87.49 102.41 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.08 81.51 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -172.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -95.98 156.37 37.24 Favored Pre-proline 0 C--O 1.242 0.674 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.451 -171.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -61.89 156.79 46.86 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.692 1.594 . . . . 0.0 108.715 162.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.78 153.17 25.59 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 125.405 1.482 . . . . 0.0 110.759 -172.049 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.2 t -82.68 105.82 14.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.453 1.101 . . . . 0.0 108.351 -174.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -89.72 146.53 24.44 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.028 -1.045 . . . . 0.0 110.453 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -132.41 112.04 11.82 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.843 1.657 . . . . 0.0 108.884 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -144.51 92.32 2.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.036 0.934 . . . . 0.0 108.849 173.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 p -166.93 167.77 14.51 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.666 0.787 . . . . 0.0 110.018 172.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -72.97 172.33 11.15 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.027 0.531 . . . . 0.0 110.537 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.37 -22.1 44.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.463 0.705 . . . . 0.0 111.209 170.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -79.15 20.78 0.48 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.299 1.84 . . . . 0.0 112.468 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.88 52.17 52.2 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.636 -1.29 . . . . 0.0 112.693 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.92 -173.12 40.48 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.394 0.597 . . . . 0.0 113.564 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -131.96 17.3 4.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.108 2.163 . . . . 0.0 111.83 -166.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 t -151.58 137.42 18.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.521 -1.362 . . . . 0.0 108.835 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -108.08 125.49 51.64 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.0 m -130.69 93.71 3.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.04 143.82 31.28 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -122.09 65.91 21.89 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.85 1.26 . . . . 0.0 110.504 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.29 -176.49 2.95 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.031 1.821 . . . . 0.0 110.407 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -162.18 165.53 26.8 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.909 1.284 . . . . 0.0 108.023 -169.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 59.06 -77.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.651 2.38 . . . . 0.0 112.716 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.1 t -160.01 124.0 3.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.328 1.451 . . . . 0.0 107.584 149.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.93 31.31 3.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.947 0.794 . . . . 0.0 112.472 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.96 126.1 28.69 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.773 1.229 . . . . 0.0 111.221 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.04 -159.57 16.23 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.7 p -123.55 116.55 23.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.652 1.181 . . . . 0.0 109.265 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -130.14 -177.57 4.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.538 1.535 . . . . 0.0 110.821 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.1 mt -135.27 148.13 28.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.4 mt -128.11 161.12 29.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.612 1.165 . . . . 0.0 109.574 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -91.13 108.73 20.07 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.63 1.572 . . . . 0.0 108.668 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -119.82 138.63 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 C-N-CA 125.633 1.573 . . . . 0.0 107.954 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 m -79.92 129.33 34.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 117.868 -1.063 . . . . 0.0 108.852 164.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -148.29 71.61 1.17 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.199 1.363 . . . . 0.0 111.527 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -153.49 171.21 19.04 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.157 -0.965 . . . . 0.0 112.227 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.99 144.21 49.95 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.905 1.682 . . . . 0.0 108.827 167.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -117.42 133.8 55.56 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -172.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t 175.02 -171.47 0.06 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.603 2.361 . . . . 0.0 105.867 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 55.29 -107.93 0.88 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -143.21 26.05 1.68 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.16 0.984 . . . . 0.0 110.027 167.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.3 m -150.81 -164.89 2.12 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.002 1.321 . . . . 0.0 110.411 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 p -130.37 99.02 4.87 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.037 2.135 . . . . 0.0 107.856 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -73.05 123.03 22.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.32 161.21 14.39 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.656 0.782 . . . . 0.0 110.045 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.1 mt -138.03 153.49 49.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.223 1.009 . . . . 0.0 108.863 169.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -115.19 164.96 13.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.217 1.407 . . . . 0.0 109.808 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -145.71 165.69 28.03 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -168.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -121.83 153.91 37.74 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 127.441 2.297 . . . . 0.0 109.282 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.45 148.31 31.13 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.974 1.709 . . . . 0.0 108.157 169.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -166.94 154.55 9.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.305 0.642 . . . . 0.0 111.102 168.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.53 -69.23 0.06 OUTLIER Glycine 0 C--N 1.337 0.613 0 CA-C-O 121.322 0.401 . . . . 0.0 113.125 172.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.447 ' H ' HG11 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -75.74 -173.12 2.12 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.585 1.954 . . . . 0.0 109.69 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.21 23.14 11.48 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.5 1.52 . . . . 0.0 113.691 168.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -135.42 -3.24 2.41 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.7 mt -119.3 122.77 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.918 2.087 . . . . 0.0 107.955 -167.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -123.54 165.56 16.93 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.388 -0.82 . . . . 0.0 110.965 -169.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.7 p -146.64 140.78 20.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.131 0.972 . . . . 0.0 108.56 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.01 66.88 1.48 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.38 -119.05 15.45 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.939 -2.065 . . . . 0.0 107.939 -165.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.5 p -56.82 -25.24 55.54 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.127 1.771 . . . . 0.0 114.265 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 m -93.28 146.62 23.57 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.444 1.097 . . . . 0.0 109.366 -167.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.45 145.17 23.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.585 1.154 . . . . 0.0 109.197 -173.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 m -143.25 154.39 43.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -152.09 125.58 8.84 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 168.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -105.94 114.61 28.86 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.264 10.6 pt-20 -75.37 165.68 24.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.982 0.896 . . . . 0.0 112.939 -166.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.35 149.81 97.93 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.75 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -74.81 -9.57 21.11 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.041 2.494 . . . . 0.0 113.071 -169.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.53 -178.65 3.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.597 1.189 . . . . 0.0 110.728 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.97 13.87 21.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.216 1.806 . . . . 0.0 112.157 -170.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -80.04 152.51 29.36 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 172.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -82.75 138.44 34.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.744 1.218 . . . . 0.0 107.931 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -144.09 92.55 2.34 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.222 1.374 . . . . 0.0 111.327 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 45.6 m -68.87 115.61 8.4 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.181 -0.324 . . . . 0.0 110.514 173.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.24 162.56 29.69 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.157 0.884 . . . . 0.0 112.91 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.1 tp -162.69 115.11 1.62 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.82 1.248 . . . . 0.0 111.247 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.447 HG11 ' H ' ' A' ' 56' ' ' ASP . 3.2 m -103.19 179.32 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.357 1.063 . . . . 0.0 109.828 164.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 m -129.38 162.87 27.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 163.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.74 158.82 43.41 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 125.794 1.638 . . . . 0.0 112.406 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -150.54 159.89 44.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.501 1.12 . . . . 0.0 109.548 168.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -103.76 164.69 11.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.275 1.43 . . . . 0.0 110.256 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -54.99 -57.15 12.84 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.736 1.214 . . . . 0.0 113.345 -172.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -118.59 -6.64 10.67 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.239 0.616 . . . . 0.0 112.468 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.1 m -80.3 -154.64 0.1 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.088 0.955 . . . . 0.0 109.562 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.04 -1.24 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 118.138 -1.368 . . . . 0.0 115.502 173.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -64.1 107.4 1.27 Allowed 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.029 1.914 . . . . 0.0 106.721 170.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.1 p -63.32 155.3 29.09 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 161.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.3 mt -101.74 -166.11 1.26 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 164.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t -146.32 111.68 5.47 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 160.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.9 tp -83.78 122.24 28.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -120.74 154.25 35.89 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -131.43 121.47 48.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 103.711 -2.699 . . . . 0.0 103.711 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.7 t -127.47 105.85 14.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.64 165.84 22.76 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 124.257 1.023 . . . . 0.0 111.142 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -63.51 -177.97 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.516 2.144 . . . . 0.0 110.867 156.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.32 175.11 18.77 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.458 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt . . . . . 0 C--O 1.236 0.351 0 C-N-CA 124.877 1.271 . . . . 0.0 112.054 -173.22 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.67 122.62 45.09 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 168.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -85.85 155.42 20.98 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 164.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -134.72 103.52 5.67 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.406 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 2.8 t80 -139.71 86.27 2.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 170.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.67 -170.03 3.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.838 2.055 . . . . 0.0 105.843 171.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -78.18 -89.31 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 166.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.79 -61.97 0.12 Allowed 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 119.073 -2.267 . . . . 0.0 110.788 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 p30 -127.12 2.48 6.47 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.844 2.058 . . . . 0.0 110.697 -167.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.25 -73.08 1.19 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 107.711 -2.155 . . . . 0.0 107.711 170.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.55 -154.8 25.55 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.7 p -79.85 20.11 0.64 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.468 1.907 . . . . 0.0 110.909 171.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.7 t -158.94 156.85 30.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.661 -1.274 . . . . 0.0 108.77 -165.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.9 157.4 46.47 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 157.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.0 m -131.45 152.34 50.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 158.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -133.94 150.78 51.31 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -127.88 74.33 78.7 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 126.11 1.764 . . . . 0.0 107.425 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.33 175.2 4.29 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.346 2.03 . . . . 0.0 109.846 167.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -161.03 173.92 14.51 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.395 -0.816 . . . . 0.0 109.11 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t0 55.93 -84.04 0.01 OUTLIER 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.963 2.505 . . . . 0.0 111.485 -173.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -145.39 125.71 13.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.103 2.561 . . . . 0.0 105.199 148.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 m -148.87 112.34 5.01 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.773 1.169 . . . . 0.0 110.4 163.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.6 179.24 6.68 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.0 1.72 . . . . 0.0 108.668 161.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.33 -176.56 32.91 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 174.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 m -109.17 101.61 10.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.835 1.254 . . . . 0.0 109.876 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -115.36 -165.01 0.99 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.465 1.906 . . . . 0.0 111.166 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.0 mt -127.53 148.14 32.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.586 1.554 . . . . 0.0 107.426 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.5 mt -132.03 165.32 24.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.849 2.059 . . . . 0.0 107.154 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.04 105.91 14.81 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -172.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.7 mt -132.52 142.13 43.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.67 1.588 . . . . 0.0 107.789 -163.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -112.23 129.9 56.11 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.063 1.345 . . . . 0.0 108.226 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -147.78 78.04 1.44 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.084 0.468 . . . . 0.0 110.162 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -157.04 175.76 13.65 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.774 -1.204 . . . . 0.0 111.567 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.58 148.54 43.2 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.989 0.916 . . . . 0.0 109.209 161.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -114.67 123.43 49.26 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 126.506 1.922 . . . . 0.0 107.413 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 t -173.98 -166.66 0.31 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.967 1.707 . . . . 0.0 107.113 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.33 -103.63 0.13 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.184 1.849 . . . . 0.0 109.552 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -147.11 21.14 1.23 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.976 0.91 . . . . 0.0 110.656 171.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 m -156.33 173.92 16.16 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 120.327 -1.483 . . . . 0.0 111.39 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -130.24 105.69 8.08 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.829 1.652 . . . . 0.0 107.087 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -83.23 139.83 32.88 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.2 146.12 45.77 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.641 0.655 . . . . 0.0 110.945 172.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.9 mt -101.77 133.14 46.96 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 165.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -73.2 166.52 22.99 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.753 1.221 . . . . 0.0 109.126 171.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.1 p90 -148.28 179.32 7.86 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.279 1.032 . . . . 0.0 111.844 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.93 172.31 12.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.782 1.633 . . . . 0.0 110.471 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.82 161.13 32.45 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.524 1.93 . . . . 0.0 109.617 169.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.9 p -153.64 140.25 18.88 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 163.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.19 -138.05 5.08 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.56 131.03 6.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.182 2.593 . . . . 0.0 111.076 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 m -80.27 30.99 0.27 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.93 1.292 . . . . 0.0 113.818 -173.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -133.52 23.65 4.04 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.584 1.554 . . . . 0.0 110.299 172.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -144.98 107.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -119.9 164.44 16.05 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.82 1.248 . . . . 0.0 108.925 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.34 152.76 13.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.281 0.562 . . . . 0.0 110.801 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.7 169.18 18.06 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 128.672 2.789 . . . . 0.0 109.433 166.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -58.68 -32.96 70.55 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.879 -0.4 . . . . 0.0 113.538 -177.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.36 11.5 8.7 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 t -153.47 142.81 21.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 119.553 1.069 . . . . 0.0 108.859 -170.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.7 t -120.91 150.97 23.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -171.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -139.0 134.18 32.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 165.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -127.34 138.15 52.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 155.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -99.33 -172.93 2.36 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -101.42 168.96 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.634 1.207 . . . . 0.0 108.825 170.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -76.28 160.54 77.62 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 124.738 1.215 . . . . 0.0 108.98 167.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -75.19 -47.23 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.245 1.964 . . . . 0.0 110.549 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.14 165.88 12.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.0 110.696 -170.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.23 2.32 50.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.049 0.94 . . . . 0.0 113.071 -171.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.42 148.85 46.51 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.523 -0.735 . . . . 0.0 110.129 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 139.6 58.38 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.65 0.78 . . . . 0.0 108.945 174.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -129.58 151.02 50.65 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.892 0.877 . . . . 0.0 109.858 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.9 m -120.61 100.65 7.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.849 1.26 . . . . 0.0 107.654 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.97 140.59 33.08 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.1 tp -152.79 103.18 2.75 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 117.886 0.843 . . . . 0.0 108.801 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.3 m -107.59 163.62 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 118.826 0.739 . . . . 0.0 110.592 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.6 m -107.72 158.08 17.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mp -138.22 158.46 44.25 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.313 1.845 . . . . 0.0 108.542 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.21 142.91 18.69 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.662 0.664 . . . . 0.0 110.678 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 88' ' ' SER . 7.9 tt0 -77.92 165.32 24.25 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 127.851 2.46 . . . . 0.0 111.013 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.63 -85.95 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.054 2.142 . . . . 0.0 112.719 167.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -89.53 -8.27 53.13 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.896 -1.127 . . . . 0.0 111.957 -168.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.412 ' H ' ' HG2' ' A' ' 85' ' ' GLN . 0.2 OUTLIER -136.95 -153.87 0.52 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.624 2.37 . . . . 0.0 108.076 177.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.92 44.52 0.02 OUTLIER Glycine 0 C--N 1.334 0.433 0 CA-C-N 120.467 1.485 . . . . 0.0 113.228 -151.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 103.18 0.15 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 148.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.6 p -69.25 133.35 47.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.75 155.53 19.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.37 151.65 21.94 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 157.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 tt -149.94 112.38 4.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.09 140.21 51.4 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -128.67 128.53 67.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 167.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.6 t -109.67 96.62 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 168.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -109.07 165.17 13.13 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 118.012 -0.994 . . . . 0.0 108.513 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -55.71 -162.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.553 1 C-N-CA 126.231 4.621 . . . . 0.0 112.906 163.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.49 168.91 13.97 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 116.745 -2.645 . . . . 0.0 112.679 147.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt . . . . . 0 CA--C 1.536 0.436 0 C-N-CA 124.969 1.308 . . . . 0.0 111.072 -168.188 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -139.95 104.98 4.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.578 2.351 . . . . 0.0 107.878 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -86.02 152.8 22.62 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.797 1.239 . . . . 0.0 109.848 171.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.46 134.16 45.9 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.23 1.412 . . . . 0.0 107.332 -171.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -153.07 62.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.254 0.622 . . . . 0.0 111.173 -173.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.1 p -151.7 -169.24 3.31 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.017 -1.052 . . . . 0.0 110.663 176.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.507 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 70.3 m-85 -75.94 177.0 7.34 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 121.395 -0.816 . . . . 0.0 109.345 157.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.21 -23.7 14.0 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.609 1.164 . . . . 0.0 111.388 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -145.76 3.13 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.491 0.716 . . . . 0.0 112.28 -174.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.83 -79.42 1.46 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.507 ' H ' ' HB2' ' A' ' 13' ' ' TYR . . . 162.57 -125.12 1.37 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.436 1.97 . . . . 0.0 108.923 -172.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 p -135.25 17.19 3.43 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.577 1.551 . . . . 0.0 111.913 -168.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.51 175.11 12.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 120.471 -1.393 . . . . 0.0 110.827 166.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 122.53 32.46 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.785 2.034 . . . . 0.0 107.029 -173.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.4 m -149.62 88.27 1.55 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.58 139.24 38.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -124.88 74.62 65.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 170.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.89 173.86 11.35 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.258 2.639 . . . . 0.0 110.229 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.61 147.57 25.51 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.496 -0.752 . . . . 0.0 111.41 -169.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 61.86 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.96 2.104 . . . . 0.0 108.974 -164.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.5 t -160.18 114.57 2.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 172.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.18 112.37 8.59 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.01 157.66 44.33 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.467 1.507 . . . . 0.0 109.279 -174.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.88 -178.52 31.55 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 160.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.4 p -102.34 113.73 27.29 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.147 1.379 . . . . 0.0 109.847 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -130.89 -170.2 2.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.78 1.232 . . . . 0.0 112.835 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 mt -131.3 151.66 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.717 2.407 . . . . 0.0 107.194 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.5 mt -131.87 154.82 48.8 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.23 1.812 . . . . 0.0 109.07 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -86.14 55.85 3.72 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.015 1.326 . . . . 0.0 110.099 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.0 mt -71.53 156.85 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.787 1.235 . . . . 0.0 110.327 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 m -127.69 107.69 10.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.135 1.774 . . . . 0.0 109.27 -169.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.37 86.77 1.35 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 122.561 0.344 . . . . 0.0 110.328 -174.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -156.11 165.01 37.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.539 0.336 . . . . 0.0 110.883 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.98 130.92 55.95 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.92 1.688 . . . . 0.0 109.5 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -116.35 127.53 54.75 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.554 1.941 . . . . 0.0 106.781 -170.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.6 t -168.99 143.33 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.93 -104.69 0.77 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -133.8 21.03 3.86 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.003 0.921 . . . . 0.0 111.166 -170.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -149.21 162.89 39.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.874 1.321 . . . . 0.0 110.253 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -132.39 115.23 15.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 130.038 3.335 . . . . 0.0 105.629 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.08 111.36 20.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -170.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.49 157.55 37.4 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.259 0.35 . . . . 0.0 110.804 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.31 130.56 40.96 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.48 1.512 . . . . 0.0 110.76 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -71.12 178.39 3.3 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.43 1.492 . . . . 0.0 110.978 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -147.43 177.35 9.3 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.502 1.121 . . . . 0.0 109.702 168.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.25 165.73 26.42 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.644 1.577 . . . . 0.0 109.85 166.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.33 156.55 44.73 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.225 1.81 . . . . 0.0 109.099 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.1 m -155.35 144.12 20.59 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.314 1.046 . . . . 0.0 110.216 173.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.85 -86.88 0.1 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 167.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.7 160.11 30.89 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.37 1.085 . . . . 0.0 111.426 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -82.47 -8.12 59.62 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -129.87 28.15 5.11 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.748 1.158 . . . . 0.0 112.32 -160.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.8 mt -132.76 101.81 4.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -75.32 133.1 41.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.208 1.003 . . . . 0.0 109.884 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.57 142.35 41.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.963 1.305 . . . . 0.0 109.919 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.16 155.79 41.18 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 126.3 1.84 . . . . 0.0 107.533 177.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.45 -11.13 46.47 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.889 0.757 . . . . 0.0 114.245 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.6 m -134.72 -4.86 2.51 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.451 1.125 . . . . 0.0 113.463 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.7 m -140.05 164.77 29.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.876 1.671 . . . . 0.0 110.361 -167.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.19 154.85 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.588 1.155 . . . . 0.0 108.255 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.1 159.5 42.87 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 158.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -132.8 107.82 8.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 165.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.46 166.89 15.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.508 0.671 . . . . 0.0 109.592 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.91 174.37 6.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -108.5 163.92 15.89 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.851 0.86 . . . . 0.0 111.123 -168.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -89.82 -11.76 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.141 3.228 . . . . 0.0 113.978 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.33 130.69 31.11 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -171.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.28 22.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.451 1.9 . . . . 0.0 112.301 -164.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -66.45 166.48 12.4 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 160.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -85.5 156.07 20.95 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 163.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -135.28 157.67 46.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 164.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.9 m -135.21 97.21 3.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.39 163.83 45.56 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 117.934 0.334 . . . . 0.0 113.112 -168.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 tp -153.84 125.77 7.79 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.786 1.635 . . . . 0.0 109.403 159.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.14 155.01 31.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 160.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.9 m -100.63 156.24 17.42 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 159.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.02 161.25 31.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.373 1.869 . . . . 0.0 107.719 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 88' ' ' SER . 68.6 tttt -139.81 145.39 38.1 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -70.91 171.81 10.05 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 168.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -56.27 -65.11 0.66 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.617 0.767 . . . . 0.0 111.855 172.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -118.07 5.18 12.03 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.845 1.258 . . . . 0.0 112.211 -167.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 84' ' ' LYS . 17.8 t -135.81 -158.87 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.301 1.44 . . . . 0.0 107.913 162.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.51 72.8 0.36 Allowed Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 106.489 -2.644 . . . . 0.0 106.489 -170.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -61.42 86.74 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 147.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 p -97.5 113.69 25.43 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 104.286 -2.486 . . . . 0.0 104.286 170.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.5 mt -131.61 157.54 43.4 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 m -120.44 114.61 22.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.118 1.326 . . . . 0.0 108.406 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.91 71.43 3.43 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.66 0.743 . . . . 0.0 112.167 -162.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -85.64 82.8 8.09 Favored 'General case' 0 C--O 1.226 -0.184 0 O-C-N 121.066 -1.021 . . . . 0.0 109.423 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.49 125.93 34.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 163.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.52 67.11 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -99.39 151.8 37.56 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 123.711 0.805 . . . . 0.0 112.098 -170.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.03 -172.14 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.724 3.616 . . . . 0.0 112.707 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.72 166.27 22.57 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.228 0 C-N-CA 125.545 1.538 . . . . 0.0 108.691 -163.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 m -92.99 129.44 38.9 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 166.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -106.73 148.51 28.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 162.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -126.66 105.64 8.84 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.414 1.486 . . . . 0.0 107.308 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.08 56.77 1.78 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.777 1.631 . . . . 0.0 109.456 -165.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.9 p -159.78 -175.69 5.29 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.368 1.067 . . . . 0.0 109.136 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -65.85 161.08 21.84 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.46 -15.85 25.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.104 0.961 . . . . 0.0 112.322 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -148.47 41.21 0.95 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.596 0.713 . . . . 0.0 111.434 -170.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.71 -83.63 0.05 OUTLIER Glycine 0 C--N 1.335 0.501 0 O-C-N 121.274 -0.891 . . . . 0.0 111.607 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.65 -125.37 0.78 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 117.136 0.468 . . . . 0.0 113.384 -171.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -139.22 10.51 2.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.102 0.961 . . . . 0.0 112.245 -163.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.39 173.16 17.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.919 2.088 . . . . 0.0 109.498 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -128.53 142.92 50.92 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 127.715 2.406 . . . . 0.0 108.716 173.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -153.22 90.73 1.45 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.716 1.207 . . . . 0.0 108.834 172.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.31 151.03 23.46 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 121.718 -0.614 . . . . 0.0 109.554 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -134.58 69.23 72.57 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.398 1.079 . . . . 0.0 109.342 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.73 175.32 9.07 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.436 2.091 . . . . 0.0 111.117 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -149.19 172.25 15.14 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.377 1.471 . . . . 0.0 107.962 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t0 59.79 -85.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.167 2.587 . . . . 0.0 109.979 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.4 p -142.29 4.13 1.58 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.641 1.176 . . . . 0.0 113.986 -176.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -78.4 67.92 4.29 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -163.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.5 117.74 19.21 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 127.086 2.154 . . . . 0.0 107.899 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.25 -163.09 26.35 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -167.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.4 p -116.99 114.41 23.75 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 117.766 0.783 . . . . 0.0 111.773 -162.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -133.58 -169.92 2.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.752 1.221 . . . . 0.0 110.77 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.8 mt -142.91 146.49 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.819 1.648 . . . . 0.0 107.091 -170.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.5 mt -126.37 175.81 7.58 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.064 1.345 . . . . 0.0 111.396 -171.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -110.81 91.77 3.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -164.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mt -125.92 150.84 31.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -163.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.02 134.14 54.65 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.6 t -153.19 44.88 0.65 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.448 1.099 . . . . 0.0 109.549 -172.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -140.03 169.06 18.39 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 120.73 -1.231 . . . . 0.0 111.765 -172.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -117.63 158.56 24.42 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.56 1.144 . . . . 0.0 109.175 168.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -138.73 135.59 34.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.928 1.691 . . . . 0.0 108.379 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.0 t -176.27 149.47 0.85 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.43 -101.86 0.32 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.959 1.266 . . . . 0.0 111.345 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -141.71 34.29 1.61 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.425 1.09 . . . . 0.0 110.953 -171.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 m -151.52 174.11 13.8 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.96 -1.087 . . . . 0.0 110.58 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -122.44 154.92 37.13 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 155.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -138.62 123.93 19.31 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.46 160.75 26.86 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.959 0.787 . . . . 0.0 109.793 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.81 -159.08 0.68 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 162.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.1 m -130.36 174.92 9.39 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.343 1.857 . . . . 0.0 108.458 169.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -152.51 173.41 15.18 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.691 -0.631 . . . . 0.0 111.761 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -143.55 172.64 12.52 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.062 1.345 . . . . 0.0 109.93 172.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.65 159.24 38.23 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.237 1.815 . . . . 0.0 109.112 -175.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 p 179.18 161.02 0.74 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.647 0.779 . . . . 0.0 111.418 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.66 -78.09 0.09 OUTLIER Glycine 0 C--N 1.334 0.471 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -102.66 -160.72 0.8 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.449 1.5 . . . . 0.0 110.832 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.3 p -123.98 14.59 9.21 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -133.43 28.27 4.03 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.744 1.218 . . . . 0.0 111.013 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -135.68 84.76 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -171.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -59.82 125.17 22.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.3 t -118.71 152.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 163.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.55 173.26 11.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 159.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.44 -50.9 12.89 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -125.99 40.89 3.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.986 0.914 . . . . 0.0 111.169 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.16 163.23 35.01 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.98 0.809 . . . . 0.0 110.647 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.74 142.87 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.323 1.449 . . . . 0.0 107.641 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.89 168.55 26.85 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.337 -1.477 . . . . 0.0 109.047 163.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.99 154.1 41.52 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 172.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.61 151.25 35.3 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 122.718 0.407 . . . . 0.0 110.04 175.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -72.41 169.83 15.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.883 0.849 . . . . 0.0 111.567 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.51 154.09 43.96 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 124.565 1.146 . . . . 0.0 110.514 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.42 -5.68 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.945 2.43 . . . . 0.0 113.426 -166.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.91 167.18 11.18 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.986 0.898 . . . . 0.0 109.971 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -77.12 0.56 21.13 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 120.841 -1.162 . . . . 0.0 111.954 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -59.64 144.03 48.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.153 0.981 . . . . 0.0 108.917 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -77.42 136.71 38.42 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 161.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -122.37 134.14 54.64 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.502 1.121 . . . . 0.0 108.996 -175.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.7 m -122.94 105.32 9.89 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.708 1.203 . . . . 0.0 108.016 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.75 167.28 52.75 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 tp -155.96 59.89 0.59 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.6 t -72.53 148.44 9.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 121.649 -0.657 . . . . 0.0 109.733 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -112.71 170.62 8.06 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.54 0.736 . . . . 0.0 109.264 169.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.422 ' H ' HG22 ' A' ' 82' ' ' THR . 4.5 mp -136.73 163.84 29.67 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.804 1.642 . . . . 0.0 109.444 175.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.482 ' HG2' ' H ' ' A' ' 85' ' ' GLN . 48.8 tttt -147.84 172.78 13.6 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.241 2.216 . . . . 0.0 106.621 163.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.482 ' H ' ' HG2' ' A' ' 84' ' ' LYS . 20.8 tt0 -126.24 162.55 25.19 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.398 1.479 . . . . 0.0 107.158 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -56.38 -59.3 5.17 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.685 0.794 . . . . 0.0 111.88 -165.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -99.93 -27.8 13.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 111.529 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -101.65 -162.51 0.94 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.261 1.024 . . . . 0.0 111.811 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.1 67.52 0.41 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -63.03 92.96 0.06 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 152.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.0 p -95.65 103.99 15.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 165.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.98 158.36 16.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.3 m -117.77 125.16 50.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 5.8 tp -107.92 95.83 5.96 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.476 1.511 . . . . 0.0 107.869 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -108.96 90.36 3.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 mp -72.44 141.59 16.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 160.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.8 t -128.03 92.97 2.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 165.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -112.67 147.45 37.16 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.697 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -67.44 -167.88 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.777 3.652 . . . . 0.0 110.777 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.8 160.28 26.59 Favored Glycine 0 C--O 1.24 0.5 0 O-C-N 121.769 -0.582 . . . . 0.0 111.905 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.238 0 C-N-CA 127.667 2.387 . . . . 0.0 108.191 -171.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 122.649 1.214 . . . . 0.0 107.965 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.2 t -74.02 145.46 44.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.635 1.574 . . . . 0.0 109.207 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -126.95 153.38 45.91 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.906 1.283 . . . . 0.0 109.307 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -134.81 115.28 13.5 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.951 2.1 . . . . 0.0 106.314 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 4.1 t80 -145.07 79.21 1.58 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.3 p -154.33 -175.88 5.61 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.967 0.507 . . . . 0.0 109.827 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.474 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 62.6 m-85 -63.89 165.19 9.05 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 157.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.48 -31.42 11.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.237 1.015 . . . . 0.0 110.972 168.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -130.53 73.77 1.56 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.56 -56.98 0.11 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.261 162.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.474 ' H ' ' HB2' ' A' ' 13' ' ' TYR . . . 158.42 -136.6 4.84 Favored Glycine 0 CA--C 1.52 0.347 0 O-C-N 121.92 -0.753 . . . . 0.0 112.629 -167.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 p -137.58 23.8 2.91 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.25 1.02 . . . . 0.0 112.168 -166.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 t -167.59 166.44 14.06 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.784 1.234 . . . . 0.0 110.845 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.22 135.92 53.65 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.831 2.853 . . . . 0.0 112.647 174.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 m -147.14 84.78 1.59 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.575 1.15 . . . . 0.0 108.005 173.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -83.07 140.75 32.49 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.67 77.19 37.6 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -74.49 168.14 25.51 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 120.939 1.093 . . . . 0.0 109.387 165.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -162.19 160.82 27.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.68 1.992 . . . . 0.0 106.675 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.5 t70 60.53 -80.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.703 1.601 . . . . 0.0 111.918 -167.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 t -165.21 85.64 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.772 1.229 . . . . 0.0 108.009 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.4 m -135.85 24.48 3.35 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.03 122.28 20.62 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.191 1.396 . . . . 0.0 108.895 169.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.31 -175.69 36.85 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 119.042 0.837 . . . . 0.0 111.155 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.4 p -96.59 126.95 42.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.201 1.4 . . . . 0.0 109.029 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -128.39 -177.49 4.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 169.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 mt -139.51 143.19 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 129.645 3.178 . . . . 0.0 105.554 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.7 mt -121.2 -168.68 1.71 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.118 1.767 . . . . 0.0 110.18 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -129.98 51.23 2.11 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.056 1.342 . . . . 0.0 109.026 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.4 mt -82.05 125.0 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.182 0.993 . . . . 0.0 108.937 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 m -71.05 134.68 47.28 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.566 1.546 . . . . 0.0 109.411 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -144.52 108.71 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -167.35 170.84 11.14 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.693 0.759 . . . . 0.0 110.907 160.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.74 135.04 54.38 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.245 1.818 . . . . 0.0 108.105 161.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -114.82 123.17 48.52 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 125.563 1.545 . . . . 0.0 109.347 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 t -159.74 153.24 22.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.88 -82.81 0.07 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.095 1.807 . . . . 0.0 110.687 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -145.92 -1.13 0.78 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.074 1.35 . . . . 0.0 111.539 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 p -134.5 172.62 12.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.128 -1.607 . . . . 0.0 112.461 -162.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.0 p -130.71 123.06 28.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 127.415 2.286 . . . . 0.0 106.877 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.23 109.12 20.42 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.56 155.23 40.82 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.299 0.64 . . . . 0.0 109.545 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.2 mt -121.33 147.27 45.9 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.637 0.775 . . . . 0.0 110.961 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -79.67 160.16 26.42 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 168.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -138.97 174.67 10.27 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.277 1.031 . . . . 0.0 111.737 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -150.01 148.49 29.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.676 1.191 . . . . 0.0 109.47 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.81 160.78 43.65 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.278 1.831 . . . . 0.0 109.458 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 p 174.85 145.99 0.07 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.337 0.655 . . . . 0.0 110.471 -176.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.54 -91.3 0.1 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 168.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.27 164.58 3.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.86 2.064 . . . . 0.0 111.288 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 m -92.46 -1.1 57.22 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.74 1.616 . . . . 0.0 115.143 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -129.54 29.84 5.01 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.198 1.399 . . . . 0.0 108.954 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.0 mt -142.81 88.29 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -88.42 171.89 9.78 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.939 0.896 . . . . 0.0 108.671 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -157.61 157.42 3.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.73 1.212 . . . . 0.0 108.752 166.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.45 -179.34 6.36 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.396 2.678 . . . . 0.0 108.014 172.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -45.18 -51.71 8.76 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.86 1.219 . . . . 0.0 113.544 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.0 m -124.87 -7.83 7.26 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 118.22 -0.895 . . . . 0.0 113.394 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 m -120.67 155.87 32.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.606 1.094 . . . . 0.0 110.625 -169.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -137.69 162.11 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.9 m -147.58 137.44 22.84 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 162.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -123.27 104.07 8.91 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -74.3 173.5 10.13 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 122.208 1.004 . . . . 0.0 112.365 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.424 ' HG3' HE22 ' A' ' 98' ' ' GLN . 4.9 tt0 -83.04 -165.71 1.15 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.153 2.181 . . . . 0.0 109.969 175.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -128.63 165.23 32.94 Favored Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 126.544 1.938 . . . . 0.0 109.492 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -93.91 -10.23 1.62 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.033 2.489 . . . . 0.0 113.226 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.27 139.65 51.73 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.734 1.214 . . . . 0.0 109.114 -171.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 12.12 8.19 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.283 0.633 . . . . 0.0 112.602 -160.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.53 158.25 36.44 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 170.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -67.84 159.28 30.69 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -132.83 145.22 50.77 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 m -118.41 77.69 1.19 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.312 1.445 . . . . 0.0 107.529 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.2 132.54 19.03 Favored Glycine 0 N--CA 1.464 0.552 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 tp -149.49 70.76 1.08 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.207 1.003 . . . . 0.0 112.3 -166.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.96 164.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.444 0.64 . . . . 0.0 110.337 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -111.93 158.01 19.99 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.271 1.029 . . . . 0.0 108.566 168.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.69 146.35 43.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 127.147 2.179 . . . . 0.0 107.35 -173.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -157.26 168.7 26.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.099 1.359 . . . . 0.0 107.797 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 5.8 tt0 -119.16 164.77 15.09 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.683 1.129 . . . . 0.0 110.61 -170.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -45.17 -55.87 5.34 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.55 1.94 . . . . 0.0 111.853 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -126.52 -1.73 6.81 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.089 1.756 . . . . 0.0 111.136 -169.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.38 -177.99 3.97 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.828 1.651 . . . . 0.0 110.945 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.4 8.55 0.09 OUTLIER Glycine 0 C--O 1.226 -0.401 0 C-N-CA 118.546 -1.788 . . . . 0.0 115.508 -149.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -78.2 97.29 5.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 p -78.69 114.19 17.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -167.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.16 130.04 35.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.7 m -83.4 125.51 31.76 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 165.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.94 104.16 10.25 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.969 1.708 . . . . 0.0 106.508 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -119.67 95.02 4.6 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.086 0.954 . . . . 0.0 109.797 -166.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.2 114.65 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 79.5 t -104.19 101.33 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.424 HE22 ' HG3' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -133.05 156.8 79.65 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.705 -177.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.85 -163.19 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.624 1 C-N-CA 126.589 4.859 . . . . 0.0 110.814 172.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.12 168.2 27.12 Favored Glycine 0 N--CA 1.445 -0.711 0 O-C-N 120.658 -1.276 . . . . 0.0 113.708 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.9 pttt . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 126.2 1.8 . . . . 0.0 110.159 175.312 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -136.37 110.26 8.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 165.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -79.29 153.59 29.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 163.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -121.7 117.9 27.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -137.96 60.56 1.62 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.913 0.863 . . . . 0.0 110.951 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 p -154.41 -167.44 2.62 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.45 1.1 . . . . 0.0 109.075 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -65.3 -179.6 0.62 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.375 0.67 . . . . 0.0 111.262 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.56 -28.15 12.34 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 121.316 -0.865 . . . . 0.0 111.573 162.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.89 12.2 2.45 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.354 0.662 . . . . 0.0 111.874 -165.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.71 -67.66 0.14 Allowed Glycine 0 C--N 1.335 0.512 0 O-C-N 121.254 -0.904 . . . . 0.0 113.537 -152.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.38 -126.66 2.85 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -153.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.1 p -144.16 3.63 1.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -171.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 m -162.96 174.53 12.22 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.333 1.424 . . . . 0.0 111.175 174.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 144.1 50.13 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 128.016 2.527 . . . . 0.0 113.962 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -141.6 146.76 36.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.352 1.461 . . . . 0.0 108.139 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -136.77 163.13 31.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.174 -0.954 . . . . 0.0 110.702 157.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -135.88 76.19 53.54 Favored Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.21 171.99 10.68 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.493 2.129 . . . . 0.0 109.213 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -160.54 0.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -153.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -165.9 -73.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.7 t -165.24 97.27 0.71 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.483 1.913 . . . . 0.0 106.879 167.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -123.74 24.49 8.41 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 168.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.83 155.03 40.87 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 166.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.87 -151.12 22.28 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.2 m -135.27 102.55 5.21 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.012 0.906 . . . . 0.0 112.659 -173.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -123.32 -164.63 1.23 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.628 1.171 . . . . 0.0 113.201 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 mt -138.13 158.35 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 127.711 2.405 . . . . 0.0 107.2 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 98.2 mt -132.89 173.1 11.75 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.086 1.755 . . . . 0.0 111.016 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -109.63 88.04 2.65 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.042 -1.037 . . . . 0.0 110.363 -156.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.443 ' CG2' ' HE3' ' A' ' 90' ' ' LYS . 6.6 mt -129.88 158.51 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.646 1.178 . . . . 0.0 109.712 -163.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 m -122.93 142.53 50.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.308 1.043 . . . . 0.0 109.68 -172.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 p -159.99 36.35 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.668 -0.645 . . . . 0.0 112.679 -161.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -128.51 169.3 14.52 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.339 -1.476 . . . . 0.0 110.955 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.8 121.16 38.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.98 1.312 . . . . 0.0 107.49 170.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -90.77 139.81 30.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.0 t -164.91 133.13 3.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 50.0 -98.0 0.02 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.986 1.279 . . . . 0.0 110.845 -173.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -130.43 21.34 5.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.28 1.032 . . . . 0.0 112.27 -164.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 t -148.64 176.72 10.11 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.315 1.416 . . . . 0.0 111.29 167.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 p -136.94 91.87 2.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.65 1.98 . . . . 0.0 109.593 -173.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.49 104.27 5.14 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.65 146.9 44.22 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 172.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.3 mt -117.93 149.03 41.58 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.073 0.949 . . . . 0.0 110.497 -175.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.1 m -65.64 164.58 14.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.495 164.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -144.47 173.81 11.47 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.101 1.36 . . . . 0.0 110.081 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -135.37 175.01 9.98 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.013 0.925 . . . . 0.0 109.778 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.48 152.09 39.23 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 125.531 1.532 . . . . 0.0 109.066 172.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.28 140.15 8.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.58 -127.72 1.66 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.73 162.35 8.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.941 2.096 . . . . 0.0 111.939 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.21 -18.64 57.58 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.353 1.861 . . . . 0.0 114.23 -168.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -121.22 15.01 11.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.291 1.836 . . . . 0.0 111.682 -165.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.7 mt -118.06 85.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.992 -2.595 . . . . 0.0 103.992 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -83.41 137.5 33.9 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.3 89.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -77.96 86.42 4.16 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -172.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.07 -104.42 0.88 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -97.61 -7.44 31.11 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.277 1.031 . . . . 0.0 113.089 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 m -83.69 164.56 19.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.696 1.135 . . . . 0.0 109.949 174.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.92 158.34 35.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.749 1.62 . . . . 0.0 108.274 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.8 t -156.42 158.53 37.47 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.156 1.782 . . . . 0.0 107.256 166.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -156.98 168.63 26.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 163.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.49 159.15 42.01 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.865 1.266 . . . . 0.0 107.818 -177.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -71.34 164.29 26.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.195 0.997 . . . . 0.0 113.15 -174.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -77.13 144.61 71.86 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.604 1.562 . . . . 0.0 108.623 168.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -90.13 -4.63 5.13 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.649 3.566 . . . . 0.0 113.648 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.98 161.58 13.93 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.173 -0.954 . . . . 0.0 109.927 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.55 62.93 0.85 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 123.334 1.54 . . . . 0.0 107.846 174.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -132.56 176.72 8.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.766 167.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -76.95 157.5 31.25 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 167.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.9 tpt85 -150.5 173.42 14.09 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 t -149.4 165.8 30.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 158.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.6 176.66 20.93 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 156.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tp -157.61 65.48 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.07 0.935 . . . . 0.0 113.109 177.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 m -76.62 171.76 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 121.123 -0.985 . . . . 0.0 111.071 -172.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -123.38 164.74 18.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.78 1.632 . . . . 0.0 108.48 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.04 170.65 11.53 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.817 1.247 . . . . 0.0 109.223 173.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -153.32 172.93 16.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.859 0.864 . . . . 0.0 109.651 161.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -111.7 172.23 7.02 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.379 0.991 . . . . 0.0 110.807 -176.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -56.63 -51.3 69.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.327 1.051 . . . . 0.0 112.153 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -111.17 -42.62 3.9 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.719 0.808 . . . . 0.0 109.766 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.4 -169.65 0.43 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.177 1.391 . . . . 0.0 111.301 -171.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -132.22 42.32 1.4 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 126.117 1.818 . . . . 0.0 109.023 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.443 ' HE3' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -58.34 97.61 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 117.78 0.79 . . . . 0.0 108.942 174.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -110.88 110.8 21.55 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.9 165.77 11.79 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 168.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.0 t -127.13 144.65 50.98 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.389 1.476 . . . . 0.0 107.891 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.83 104.38 8.01 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.606 1.562 . . . . 0.0 108.995 -170.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -116.94 101.4 8.48 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.373 0.669 . . . . 0.0 109.881 -169.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -98.01 86.67 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.48 88.57 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.94 158.77 41.4 Favored Pre-proline 0 C--O 1.24 0.596 0 C-N-CA 124.125 0.97 . . . . 0.0 111.577 -165.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.36 -163.39 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 124.312 3.341 . . . . 0.0 109.377 160.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.92 166.96 29.93 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 171.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.226 -0.145 0 C-N-CA 124.469 1.108 . . . . 0.0 110.404 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -79.72 127.19 31.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 168.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -108.75 152.53 24.72 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.278 0.945 . . . . 0.0 109.646 161.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -129.29 125.18 36.23 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.099 1.76 . . . . 0.0 106.91 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.96 23.42 0.5 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.618 1.967 . . . . 0.0 110.478 -169.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.4 p -149.68 174.08 12.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.3 1.04 . . . . 0.0 110.777 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -75.69 160.31 30.2 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.896 0.878 . . . . 0.0 112.482 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.87 -50.3 15.45 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.804 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -141.22 55.23 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.85 3.11 0.26 Allowed Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.394 -1.276 . . . . 0.0 113.593 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.25 -119.63 6.77 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 119.212 1.506 . . . . 0.0 110.977 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.94 5.58 2.83 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.124 0.962 . . . . 0.0 113.245 -173.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.7 162.51 39.8 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.472 0.709 . . . . 0.0 109.535 170.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.402 ' H ' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -112.71 139.76 48.05 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.065 1.746 . . . . 0.0 108.047 -175.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.2 m -146.9 89.19 1.79 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -91.49 136.16 33.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -118.98 64.37 6.59 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-O 118.678 -0.677 . . . . 0.0 110.307 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.11 -174.19 1.3 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.378 2.052 . . . . 0.0 111.462 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -117.17 -163.46 0.92 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.689 2.396 . . . . 0.0 109.935 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.425 ' C ' ' HG ' ' A' ' 27' ' ' SER . 0.4 OUTLIER -63.06 -18.26 63.17 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.727 1.611 . . . . 0.0 112.391 -174.021 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.425 ' HG ' ' C ' ' A' ' 26' ' ' ASP . 13.0 m -153.09 65.27 0.77 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.259 1.39 . . . . 0.0 112.185 178.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 t -150.95 24.89 0.74 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.16 167.68 4.85 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.092 -1.005 . . . . 0.0 110.495 159.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.01 -152.17 22.96 Favored Glycine 0 C--N 1.341 0.809 0 O-C-N 121.333 -0.854 . . . . 0.0 111.359 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -135.1 100.71 4.64 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.306 1.442 . . . . 0.0 111.017 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -118.83 -177.82 3.41 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.102 1.361 . . . . 0.0 112.717 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 mt -126.82 147.88 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.2 mt -119.49 173.98 6.66 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 127.013 2.125 . . . . 0.0 109.892 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -101.96 51.34 0.83 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 123.553 1.644 . . . . 0.0 109.928 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.0 mt -72.09 139.36 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.428 1.491 . . . . 0.0 107.199 174.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 m -113.37 132.47 55.59 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.9 t -152.49 72.69 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -167.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -158.21 172.73 17.86 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.49 -1.381 . . . . 0.0 111.372 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 146.43 42.76 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.813 0.845 . . . . 0.0 111.225 164.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -123.03 131.3 53.64 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.308 1.843 . . . . 0.0 109.027 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 t -165.89 171.4 12.73 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 105.685 -1.969 . . . . 0.0 105.685 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.49 -103.67 0.06 OUTLIER Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.526 1.536 . . . . 0.0 112.21 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -138.19 18.17 2.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.226 1.41 . . . . 0.0 111.697 -171.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 t -144.81 177.73 8.51 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.583 -1.323 . . . . 0.0 111.16 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.3 p -137.85 121.84 17.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.062 1.345 . . . . 0.0 109.081 167.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -93.22 118.54 31.37 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.9 156.9 28.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.3 0.64 . . . . 0.0 111.401 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.425 HD13 HE21 ' A' ' 85' ' ' GLN . 98.1 mt -120.31 133.8 55.39 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.541 1.136 . . . . 0.0 111.452 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.5 p -69.18 168.98 12.92 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.78 0.832 . . . . 0.0 109.498 164.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -144.09 166.16 25.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.033 0.933 . . . . 0.0 108.905 166.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -133.21 156.56 47.28 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.154 1.781 . . . . 0.0 108.203 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.68 141.24 25.47 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.989 1.316 . . . . 0.0 110.679 -166.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.84 157.92 8.54 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 119.576 1.08 . . . . 0.0 112.286 161.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.8 -100.69 0.15 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.075 1.797 . . . . 0.0 110.441 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.7 157.74 2.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.198 1.399 . . . . 0.0 109.939 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -79.4 -29.44 42.01 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.978 -1.076 . . . . 0.0 112.759 174.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -90.79 16.14 9.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.871 0.868 . . . . 0.0 111.742 -168.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mt -137.55 127.72 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -136.62 150.59 48.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.7 t -137.12 125.75 34.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -85.76 -178.6 6.66 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.916 0.887 . . . . 0.0 109.57 173.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.11 -8.53 43.62 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.989 -1.07 . . . . 0.0 114.435 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.7 p -144.86 -21.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.796 1.298 . . . . 0.0 113.12 166.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.1 m -104.02 156.87 17.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.046 1.294 . . . . 0.0 112.162 -168.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 t -95.63 158.64 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 126.417 1.887 . . . . 0.0 107.639 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.57 142.7 18.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.878 0.871 . . . . 0.0 108.881 163.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -148.74 148.5 30.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 161.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.58 -177.85 6.04 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.953 1.701 . . . . 0.0 109.058 174.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -119.29 165.97 13.6 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.284 1.034 . . . . 0.0 110.313 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.84 144.85 40.07 Favored Pre-proline 0 N--CA 1.453 -0.298 0 C-N-CA 124.147 0.979 . . . . 0.0 110.688 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -82.99 -6.06 11.32 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.68 3.586 . . . . 0.0 113.206 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.31 169.92 17.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.706 -0.621 . . . . 0.0 111.341 -164.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.23 1.87 14.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.602 173.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.21 135.49 46.1 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 165.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -72.26 167.1 21.09 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.331 1.052 . . . . 0.0 109.18 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 -130.4 161.72 30.74 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.515 -0.741 . . . . 0.0 109.255 165.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 46.1 m -137.68 84.13 2.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.45 142.43 48.31 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.1 tp -159.68 72.29 0.52 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 118.984 1.392 . . . . 0.0 112.388 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.24 173.6 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.183 -0.948 . . . . 0.0 109.99 167.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.9 m -117.69 153.02 34.07 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 164.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 mp -125.24 165.69 17.83 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.926 1.291 . . . . 0.0 109.464 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -157.21 161.7 39.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.051 1.74 . . . . 0.0 108.124 173.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.425 HE21 HD13 ' A' ' 49' ' ' LEU . 1.7 tt0 -105.99 169.4 8.52 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.075 1.35 . . . . 0.0 109.852 -164.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.71 -48.97 65.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -118.75 -18.73 8.88 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.2 m -97.53 -167.82 1.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.766 1.226 . . . . 0.0 108.497 162.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.79 31.0 0.15 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 119.21 -0.772 . . . . 0.0 111.427 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.89 112.72 1.96 Allowed 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 168.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 p -79.51 114.18 18.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.9 mp -88.57 165.96 14.47 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.313 1.045 . . . . 0.0 109.028 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.81 125.29 20.55 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.999 1.72 . . . . 0.0 107.838 174.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.12 86.02 5.25 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.328 1.451 . . . . 0.0 107.412 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -72.09 137.55 47.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.339 -1.476 . . . . 0.0 108.566 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 mp -130.62 116.53 35.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 162.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 68.6 t -116.0 71.81 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -106.12 154.41 39.62 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 121.571 -0.706 . . . . 0.0 110.711 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.76 174.64 6.31 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.655 2.903 . . . . 0.0 113.529 -172.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.57 113.63 3.68 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt . . . . . 0 C--O 1.234 0.271 0 CA-C-N 117.778 0.789 . . . . 0.0 110.006 178.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 C--O 1.233 0.23 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 m -113.31 99.54 7.87 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 163.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -74.27 153.17 39.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 161.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -128.1 116.75 20.45 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.08 46.54 1.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.725 1.21 . . . . 0.0 108.983 -170.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 m -154.28 -178.37 7.08 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.107 0.963 . . . . 0.0 110.188 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -74.22 -170.81 1.03 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.498 0.666 . . . . 0.0 109.59 169.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.0 40.14 3.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.667 1.987 . . . . 0.0 109.733 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -156.43 -1.05 0.13 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -161.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.41 -7.42 46.88 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 117.418 -1.768 . . . . 0.0 115.319 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.41 174.11 15.16 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 120.504 2.152 . . . . 0.0 114.035 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.3 p -136.34 44.3 2.42 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.417 1.487 . . . . 0.0 111.054 -176.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.82 165.16 9.86 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.787 -1.195 . . . . 0.0 108.537 165.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.14 141.04 43.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.99 1.316 . . . . 0.0 107.84 165.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.9 m -147.28 146.72 29.85 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 164.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -140.32 157.75 45.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.545 0.688 . . . . 0.0 110.818 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -132.73 66.24 76.09 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.594 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.24 175.32 4.11 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.069 3.179 . . . . 0.0 111.881 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.47 -171.6 2.16 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.968 0.907 . . . . 0.0 110.183 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.69 11.83 0.17 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.062 2.545 . . . . 0.0 115.117 -162.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.1 m -150.52 5.68 0.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.792 1.637 . . . . 0.0 113.635 171.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -95.26 86.94 4.68 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.296 1.407 . . . . 0.0 112.023 -166.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.77 158.48 43.85 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.629 -0.669 . . . . 0.0 112.499 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.86 -149.2 15.61 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 161.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -124.13 113.41 18.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.608 1.163 . . . . 0.0 109.946 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -116.98 -166.75 1.2 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.244 1.018 . . . . 0.0 112.915 176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.0 mt -132.14 157.08 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 128.067 2.547 . . . . 0.0 106.606 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.0 mt -131.06 172.49 12.03 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.668 1.987 . . . . 0.0 108.764 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -116.13 31.91 6.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.671 1.189 . . . . 0.0 111.918 -173.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.2 mt -52.96 147.91 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.911 2.085 . . . . 0.0 109.98 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 m -113.17 117.36 31.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.342 1.457 . . . . 0.0 107.994 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.9 t -141.46 82.21 1.81 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -153.95 169.21 24.0 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.294 -0.879 . . . . 0.0 111.34 175.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.94 129.6 51.78 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.516 1.527 . . . . 0.0 107.824 173.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -118.06 128.65 54.96 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -174.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 t -168.5 148.22 4.5 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.95 -107.09 0.57 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 125.416 1.484 . . . . 0.0 110.078 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -135.67 28.05 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.215 1.406 . . . . 0.0 110.084 -170.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.1 m -142.82 157.96 44.1 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.904 0.859 . . . . 0.0 111.165 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -123.84 124.71 43.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.477 1.911 . . . . 0.0 106.004 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.89 115.26 27.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 166.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.98 130.39 45.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 164.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.89 118.39 26.25 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 167.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 m -67.48 168.49 10.79 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 124.535 1.147 . . . . 0.0 109.541 164.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -150.09 175.46 11.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.797 1.639 . . . . 0.0 107.969 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -132.16 170.48 14.94 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 161.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.46 151.42 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.231 1.012 . . . . 0.0 108.892 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 p -158.98 141.43 14.06 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.989 -0.444 . . . . 0.0 109.815 -172.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.95 -105.1 0.23 Allowed Glycine 0 CA--C 1.52 0.375 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.68 161.62 20.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.381 1.473 . . . . 0.0 111.46 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 m -73.29 -51.83 16.12 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 126.116 1.766 . . . . 0.0 111.617 174.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -72.69 21.15 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.569 2.348 . . . . 0.0 113.21 -166.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.8 mt -133.63 140.5 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -127.17 132.12 50.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.8 t -139.85 110.1 4.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.41 87.0 1.85 Allowed 'General case' 0 N--CA 1.462 0.129 0 O-C-N 121.276 -0.89 . . . . 0.0 109.133 -172.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 47.07 -113.02 1.08 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.591 1.091 . . . . 0.0 110.979 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.9 m -79.81 36.92 0.34 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.834 1.653 . . . . 0.0 113.393 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.9 t -152.86 155.08 36.4 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 120.609 -1.307 . . . . 0.0 109.416 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 t -148.38 149.22 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.76 159.62 44.41 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.853 0.751 . . . . 0.0 110.724 163.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.83 127.2 17.73 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -81.2 160.27 24.37 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.308 1.052 . . . . 0.0 110.565 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.516 ' CD ' ' HE2' ' A' ' 101' ' ' LYS . 1.7 mt-10 -72.45 165.19 25.09 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 167.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -86.59 164.65 36.65 Favored Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 121.093 -1.005 . . . . 0.0 110.848 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.68 -8.19 5.26 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.242 3.294 . . . . 0.0 113.536 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.87 156.68 47.1 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.088 0.858 . . . . 0.0 110.142 -170.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.07 22.32 4.43 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.092 1.357 . . . . 0.0 112.105 -169.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -98.64 151.09 21.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -72.46 135.82 45.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.944 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 -113.6 123.5 50.12 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 171.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.3 m -76.55 104.32 7.0 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 155.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.51 142.13 45.61 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 163.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.95 131.43 25.32 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 164.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -139.45 143.39 31.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 165.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.4 m -113.56 156.56 23.41 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.628 1.571 . . . . 0.0 107.236 170.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.85 162.54 31.74 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.66 1.184 . . . . 0.0 110.78 172.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -146.06 127.7 15.19 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.549 0.613 . . . . 0.0 109.757 174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -65.2 156.49 31.63 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.006 1.323 . . . . 0.0 111.45 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -50.16 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.763 2.825 . . . . 0.0 112.281 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -72.27 -25.16 61.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.939 1.296 . . . . 0.0 111.092 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.7 -153.15 0.5 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.991 2.117 . . . . 0.0 109.119 -164.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.69 13.74 0.02 OUTLIER Glycine 0 C--N 1.335 0.473 0 CA-C-O 117.158 -1.912 . . . . 0.0 116.595 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -62.86 98.05 0.12 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.609 2.205 . . . . 0.0 106.531 157.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.6 p -65.42 166.92 9.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.7 mt -132.17 144.06 50.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 170.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 m -84.79 129.08 34.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 167.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.5 tp -97.52 127.39 43.44 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 156.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -136.64 117.38 14.03 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 mp -109.42 124.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 169.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.9 t -111.97 92.59 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.81 158.5 35.5 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.872 -171.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -69.73 -164.58 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 125.186 3.924 . . . . 0.0 111.726 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.59 161.93 30.45 Favored Glycine 0 C--N 1.334 0.426 0 O-C-N 120.364 -1.46 . . . . 0.0 111.975 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.516 ' HE2' ' CD ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.088 1.355 . . . . 0.0 111.254 -173.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.0 t . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.874 0.369 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 m -101.24 118.6 37.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.679 1.592 . . . . 0.0 109.672 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -89.1 141.53 28.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.544 0.738 . . . . 0.0 109.314 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -105.1 138.44 41.3 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.526 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 3.9 p90 -153.73 56.17 0.74 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.349 -170.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.6 p -159.45 -172.42 3.71 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.65 -1.281 . . . . 0.0 109.305 170.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -67.92 157.33 35.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.033 1.288 . . . . 0.0 108.172 165.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.74 -12.34 22.4 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.872 1.269 . . . . 0.0 110.603 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.68 74.98 1.47 Allowed 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 153.44 -85.88 0.14 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 159.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -164.61 -123.29 0.64 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -158.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -138.18 28.78 2.53 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.602 0.701 . . . . 0.0 111.072 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.47 144.0 10.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.017 1.281 . . . . 0.0 109.764 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -96.3 148.37 22.82 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 162.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.3 m -142.54 137.88 30.48 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 159.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -112.39 144.12 42.36 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 168.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.62 71.57 38.97 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.02 177.79 6.06 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.423 2.082 . . . . 0.0 111.194 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -151.18 176.77 10.86 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.612 1.165 . . . . 0.0 108.097 173.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 56.51 -74.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.28 2.632 . . . . 0.0 114.184 -172.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.2 t -176.89 82.16 0.02 OUTLIER 'General case' 0 C--O 1.236 0.365 0 C-N-CA 129.002 2.921 . . . . 0.0 105.396 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -132.43 65.83 1.57 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -172.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.83 175.25 6.42 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.767 1.627 . . . . 0.0 110.285 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.06 -162.41 36.22 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 119.612 1.097 . . . . 0.0 112.667 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.0 p -135.69 95.65 3.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.877 1.271 . . . . 0.0 110.093 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -114.3 -177.06 3.04 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.959 0.903 . . . . 0.0 111.992 -173.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.9 mt -127.47 120.42 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.02 172.34 9.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.45 1.1 . . . . 0.0 109.006 171.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -106.08 36.86 2.43 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.905 -1.122 . . . . 0.0 109.546 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.89 134.95 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.067 -1.021 . . . . 0.0 108.346 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.9 138.8 37.23 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.8 p -167.87 83.37 0.19 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -153.76 170.97 19.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.26 120.77 39.99 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 171.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -96.0 146.26 24.76 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.946 0.879 . . . . 0.0 109.193 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.57 176.89 11.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.22 -52.72 8.24 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.142 1.353 . . . . 0.0 112.844 -168.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -131.04 23.71 4.92 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.702 0.801 . . . . 0.0 111.717 -172.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -144.3 150.95 38.68 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 122.462 1.125 . . . . 0.0 109.158 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 p -148.04 85.72 1.55 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.691 1.996 . . . . 0.0 107.688 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -73.9 127.78 33.78 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 166.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.03 164.7 23.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 166.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.55 132.3 54.25 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 126.324 1.85 . . . . 0.0 107.146 164.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.1 m -77.05 174.2 10.93 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.877 0.846 . . . . 0.0 110.069 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -149.87 171.53 16.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.219 1.808 . . . . 0.0 107.932 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.08 174.91 10.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.377 1.871 . . . . 0.0 107.444 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.62 167.67 20.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.593 1.157 . . . . 0.0 109.723 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.0 p -156.41 148.93 23.59 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.633 1.173 . . . . 0.0 108.801 160.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.75 -141.8 8.05 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.543 1.544 . . . . 0.0 109.806 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.62 133.22 46.54 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.307 1.043 . . . . 0.0 110.26 -173.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 m -69.78 3.43 2.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.273 1.829 . . . . 0.0 115.019 -167.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.9 p-90 -117.96 13.74 14.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.121 2.169 . . . . 0.0 111.305 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.4 mt -129.14 99.0 4.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -91.65 144.35 25.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.94 143.23 40.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 166.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.68 172.05 9.59 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.721 2.008 . . . . 0.0 107.108 172.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.45 -15.24 3.98 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.434 1.492 . . . . 0.0 116.336 -167.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.78 4.3 0.75 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.781 1.232 . . . . 0.0 112.82 168.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -128.0 153.42 46.77 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.586 1.539 . . . . 0.0 110.56 -163.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.88 156.54 24.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.079 1.352 . . . . 0.0 108.247 -173.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.98 150.49 34.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 153.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.35 155.11 43.65 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 146.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.0 176.04 5.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.266 166.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 71' ' ' ASN . 12.9 tt0 -86.44 168.37 13.83 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.768 0.794 . . . . 0.0 110.107 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' A' ' 70' ' ' GLU . 12.3 p-10 -70.91 165.46 46.94 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.312 1.045 . . . . 0.0 110.176 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -95.3 -4.36 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.191 2.594 . . . . 0.0 114.293 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.32 166.04 25.59 Favored 'General case' 0 C--O 1.225 -0.228 0 O-C-N 121.362 -0.836 . . . . 0.0 111.834 -172.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 30.94 0.49 Allowed 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.621 -1.299 . . . . 0.0 112.044 -175.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -101.85 -175.96 2.99 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.373 1.069 . . . . 0.0 109.363 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -113.66 127.26 55.98 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 124.389 1.076 . . . . 0.0 111.705 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -159.22 103.19 1.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.816 0.846 . . . . 0.0 109.675 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.6 t -64.76 149.66 48.85 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 155.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.39 177.07 43.82 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 154.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tp -162.24 85.37 0.58 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.767 0.827 . . . . 0.0 109.803 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 m -79.9 169.83 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.217 -0.927 . . . . 0.0 111.123 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.6 m -116.74 153.33 32.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.026 2.131 . . . . 0.0 107.348 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 mp -135.95 163.01 31.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.668 1.187 . . . . 0.0 111.168 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -144.34 143.79 31.14 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.012 1.725 . . . . 0.0 108.003 167.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -79.16 165.96 22.74 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.401 1.48 . . . . 0.0 107.659 165.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.8 -83.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -81.89 -18.21 44.55 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.006 -1.684 . . . . 0.0 112.269 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.11 -162.51 0.94 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.28 26.04 0.24 Allowed Glycine 0 C--O 1.225 -0.424 0 O-C-N 119.66 -1.9 . . . . 0.0 110.919 -168.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.526 ' HE3' ' HA ' ' A' ' 11' ' ' PHE . 12.1 ttpp -47.97 129.93 14.95 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 127.749 2.419 . . . . 0.0 107.447 164.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 52.1 p -118.79 137.66 53.23 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.6 mt -139.49 155.47 47.54 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -102.03 160.17 14.73 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.974 0.91 . . . . 0.0 109.14 164.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tt -136.2 91.29 2.66 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -85.69 147.2 26.47 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.7 mt -137.18 80.09 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.98 93.75 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -171.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -117.18 160.5 37.12 Favored Pre-proline 0 C--O 1.242 0.685 0 C-N-CA 123.637 0.775 . . . . 0.0 110.525 -165.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -62.15 174.93 2.23 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.75 2.3 . . . . 0.0 109.912 165.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.96 162.81 23.12 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 163.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 124.378 1.071 . . . . 0.0 108.487 -173.031 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.782 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -135.17 -175.61 3.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.339 1.855 . . . . 0.0 108.96 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.8 mtp -125.55 163.94 21.62 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.668 1.587 . . . . 0.0 107.275 167.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.06 11.65 1.2 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.361 0.981 . . . . 0.0 113.511 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 m -81.75 159.19 66.88 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 119.194 1.497 . . . . 0.0 110.232 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.97 171.63 14.34 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.436 2.091 . . . . 0.0 110.968 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.4 p -60.63 148.78 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.529 0.732 . . . . 0.0 109.42 168.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.9 m -132.1 123.96 28.2 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 170.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -88.4 155.41 19.71 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.71 118.35 24.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.971 2.108 . . . . 0.0 105.823 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -150.15 67.98 0.98 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.952 0.901 . . . . 0.0 110.226 -166.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -152.27 -169.33 3.32 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.026 1.33 . . . . 0.0 109.029 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.443 ' CE2' ' HG ' ' A' ' 92' ' ' LEU . 5.7 m-85 -77.99 -89.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 166.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -164.67 -41.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.424 1.49 . . . . 0.0 110.846 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -107.39 74.75 0.98 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.53 72.91 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 112.999 -1.91 . . . . 0.0 113.408 147.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -153.13 169.93 32.06 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-O 122.746 1.192 . . . . 0.0 112.924 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -135.67 13.7 3.43 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.089 1.756 . . . . 0.0 110.474 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p -152.98 125.86 8.4 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 120.499 -1.375 . . . . 0.0 112.833 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.65 153.37 23.51 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.688 1.195 . . . . 0.0 110.283 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.5 m -146.88 143.61 28.67 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.988 2.115 . . . . 0.0 105.75 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.77 152.14 50.82 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.15 0.886 . . . . 0.0 109.758 170.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -134.16 67.52 73.2 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.587 -0.72 . . . . 0.0 109.171 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.59 179.53 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.308 2.005 . . . . 0.0 112.029 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -149.1 174.9 11.83 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.409 ' C ' ' HG ' ' A' ' 27' ' ' SER . 40.8 t0 56.31 -85.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 129.112 2.965 . . . . 0.0 111.172 170.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.409 ' HG ' ' C ' ' A' ' 26' ' ' ASP . 36.0 m -153.66 106.25 2.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.265 1.826 . . . . 0.0 106.363 161.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -135.43 107.7 7.26 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.129 -1.607 . . . . 0.0 111.017 167.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.56 150.29 35.22 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.635 1.974 . . . . 0.0 108.546 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.38 -169.5 40.53 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.3 p -100.99 120.57 40.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.836 1.655 . . . . 0.0 110.256 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -127.12 -173.86 3.01 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.712 0.805 . . . . 0.0 113.065 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.5 mt -129.13 155.47 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 127.219 2.207 . . . . 0.0 106.265 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 53.8 mt -135.83 149.68 49.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.996 1.271 . . . . 0.0 112.808 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -78.59 87.49 4.54 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.836 1.655 . . . . 0.0 108.941 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mt -123.69 152.69 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.71 1.204 . . . . 0.0 107.958 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 m -121.64 133.85 54.98 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.474 1.109 . . . . 0.0 109.072 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.2 t -157.08 81.71 0.92 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.17 0.988 . . . . 0.0 108.522 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -152.27 170.8 19.14 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.094 -1.004 . . . . 0.0 110.044 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.53 126.79 50.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 167.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -98.02 131.17 44.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -170.14 162.35 8.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.2 -113.35 2.86 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -141.22 51.55 1.59 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.298 1.439 . . . . 0.0 107.337 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 t -155.15 165.58 36.25 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.61 1.564 . . . . 0.0 109.151 -170.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.4 p -134.71 102.32 5.24 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -71.23 118.34 13.89 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 164.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.37 163.82 10.06 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.705 0.764 . . . . 0.0 109.955 166.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.5 mt -134.89 129.36 34.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.051 170.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.8 m -59.78 163.47 4.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 122.551 1.167 . . . . 0.0 110.139 163.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -134.34 165.97 23.9 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.507 170.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.95 164.21 22.8 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.609 1.164 . . . . 0.0 108.811 173.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.53 168.77 22.58 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.465 1.506 . . . . 0.0 109.867 -169.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 p 178.49 168.36 0.84 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.74 1.616 . . . . 0.0 110.572 161.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.62 -110.27 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.83 163.14 14.82 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.925 0.89 . . . . 0.0 110.376 168.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p -71.77 -38.96 70.27 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.353 1.461 . . . . 0.0 112.369 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -90.23 21.56 3.74 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.269 1.427 . . . . 0.0 112.831 -159.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.5 mt -130.54 133.14 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -170.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -132.42 132.53 42.89 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.372 1.069 . . . . 0.0 109.379 -164.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.81 135.62 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.834 0.826 . . . . 0.0 110.297 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.71 75.28 1.52 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.457 0.703 . . . . 0.0 109.154 172.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 55.02 -117.22 7.84 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m -77.94 51.04 0.92 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.06 0.944 . . . . 0.0 111.612 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.63 152.08 34.82 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.63 139.63 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.7 m -145.38 150.26 36.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 164.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -139.46 119.19 13.19 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.53 161.91 29.3 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.473 1.509 . . . . 0.0 110.372 -174.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -86.25 146.18 26.63 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.488 -0.757 . . . . 0.0 110.79 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -66.58 144.47 98.65 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -158.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.79 -9.75 6.39 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.525 2.816 . . . . 0.0 115.432 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -151.98 170.08 20.74 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.593 1.157 . . . . 0.0 108.246 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -81.12 -12.39 59.26 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.775 0.83 . . . . 0.0 113.078 -164.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.44 165.14 2.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 123.775 0.672 . . . . 0.0 109.633 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -107.5 121.38 44.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 168.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -105.38 170.41 7.9 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 126.448 1.899 . . . . 0.0 108.039 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.4 m -104.77 109.9 22.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 155.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.85 139.09 36.0 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 163.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 tp -138.79 133.09 31.65 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.299 1.049 . . . . 0.0 109.93 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 t -142.49 148.37 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.075 0.852 . . . . 0.0 109.027 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 m -104.82 176.73 5.06 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.491 1.517 . . . . 0.0 109.116 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.7 165.24 34.03 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.82 1.248 . . . . 0.0 109.798 162.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -151.94 158.3 42.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.782 2.033 . . . . 0.0 108.815 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.412 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 26.5 tt0 -97.87 161.32 13.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.423 1.01 . . . . 0.0 110.309 -173.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.81 -69.06 0.15 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.646 1.179 . . . . 0.0 112.99 173.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -88.97 -12.53 41.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.638 1.108 . . . . 0.0 112.428 -176.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.2 t -132.04 -153.23 0.54 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.852 1.661 . . . . 0.0 109.249 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.25 46.87 0.88 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -164.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.412 ' H ' ' HB2' ' A' ' 85' ' ' GLN 0.35 0.0 OUTLIER -68.18 92.29 0.4 Allowed 'General case' 0 C--N 1.341 0.239 0 CA-C-N 118.238 1.019 . . . . 0.0 108.967 179.546 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 p -96.47 133.44 40.91 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 174.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.443 ' HG ' ' CE2' ' A' ' 13' ' ' TYR . 0.4 OUTLIER -124.88 161.41 26.62 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 166.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.44 125.01 52.59 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.15 132.09 53.42 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -128.49 143.92 51.06 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.524 1.53 . . . . 0.0 108.391 171.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 mp -135.45 117.42 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 168.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 69.6 t -107.31 94.57 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -106.34 144.08 28.27 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.09 156.88 62.48 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.208 1.939 . . . . 0.0 107.624 165.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.07 166.88 27.5 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 121.269 -0.491 . . . . 0.0 113.418 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.62 159.34 39.82 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.336 1.454 . . . . 0.0 109.636 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.0 p -145.27 89.41 1.94 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.496 1.918 . . . . 0.0 106.085 160.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 m -147.42 156.65 43.07 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.8 pt -74.28 45.04 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.515 1.126 . . . . 0.0 112.878 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.07 0 O-C-N 119.89 -1.756 . . . . 0.0 106.655 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.202 0 CA-C-O 117.433 -1.759 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.6 p80 46.43 -164.37 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.542 1.137 . . . . 0.0 111.507 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 tpt -136.74 171.99 13.67 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.8 139.62 3.67 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.3 p -169.67 163.19 6.92 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 126.28 1.832 . . . . 0.0 107.814 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.36 156.82 63.3 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.728 1.619 . . . . 0.0 109.509 167.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.11 138.42 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 172.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 m -102.02 101.98 12.43 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -76.53 154.57 34.44 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 168.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -137.63 120.92 16.93 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 128.124 2.57 . . . . 0.0 105.424 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -148.32 43.87 1.04 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.239 1.016 . . . . 0.0 110.255 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 p -141.83 -176.75 4.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.886 1.274 . . . . 0.0 109.673 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -176.5 0.97 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.868 -1.145 . . . . 0.0 111.856 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.03 -20.79 6.18 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 162.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.92 -6.85 59.0 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -161.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.07 64.18 0.43 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 167.06 -165.16 38.39 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 p -151.49 45.23 0.79 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.246 1.418 . . . . 0.0 112.691 170.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.75 179.11 6.76 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.209 -1.557 . . . . 0.0 109.692 169.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.1 113.8 14.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.113 1.765 . . . . 0.0 107.955 172.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.5 m -133.72 130.24 37.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.041 -1.836 . . . . 0.0 106.041 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -129.65 147.1 51.41 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -124.12 67.24 43.78 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -69.44 177.09 5.7 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.83 1.687 . . . . 0.0 110.879 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -143.47 173.92 11.21 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.891 1.677 . . . . 0.0 107.29 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 55.19 -85.25 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.688 1.995 . . . . 0.0 112.234 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.2 m -154.36 102.59 2.44 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.6 2.36 . . . . 0.0 107.977 156.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.4 m -131.62 88.84 2.62 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 119.909 1.231 . . . . 0.0 111.22 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.61 167.12 23.0 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.435 1.894 . . . . 0.0 110.177 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.52 -161.1 31.1 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 p -97.42 123.42 41.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.774 1.229 . . . . 0.0 109.078 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -139.32 -169.22 2.62 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.711 1.605 . . . . 0.0 110.219 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 mt -138.39 144.91 29.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.268 1.427 . . . . 0.0 107.232 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.5 mt -129.21 161.84 29.22 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.597 1.559 . . . . 0.0 107.456 170.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -114.91 103.24 10.74 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.995 0.816 . . . . 0.0 111.447 -163.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.3 138.7 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.83 1.652 . . . . 0.0 109.126 -172.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 m -91.34 110.92 22.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.242 1.417 . . . . 0.0 109.536 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.5 m -138.27 78.68 1.69 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -160.36 164.78 32.19 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.381 0.672 . . . . 0.0 111.345 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.24 151.83 29.16 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.073 0.949 . . . . 0.0 109.363 166.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -121.67 125.68 47.22 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 127.163 2.185 . . . . 0.0 108.917 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.6 t -167.44 162.45 14.57 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.108 0.963 . . . . 0.0 109.014 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.19 -101.69 0.21 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 125.982 1.753 . . . . 0.0 109.62 -172.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -142.57 35.97 1.46 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.904 1.281 . . . . 0.0 110.403 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 m -155.81 169.54 24.15 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.133 -0.98 . . . . 0.0 110.485 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -115.37 155.71 26.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 156.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -138.86 121.99 16.87 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 126.097 1.759 . . . . 0.0 106.537 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.88 158.11 28.81 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.713 0.633 . . . . 0.0 109.812 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.6 mt -121.61 140.9 51.66 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.6 m -67.41 170.68 7.02 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 124.68 1.237 . . . . 0.0 109.839 172.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -138.63 174.56 10.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.782 1.233 . . . . 0.0 109.011 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.29 150.81 26.27 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 156.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.43 145.79 49.29 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 156.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.7 m -155.31 124.33 6.19 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.86 -161.23 9.71 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -156.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.72 19.14 10.4 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -171.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m 76.36 8.05 3.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 130.018 3.327 . . . . 0.0 114.874 168.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -111.83 7.34 20.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.487 0.715 . . . . 0.0 112.435 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 mt -135.39 140.6 44.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -134.82 140.52 45.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.925 2.09 . . . . 0.0 107.736 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.3 t -141.89 109.69 2.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.23 172.36 8.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.191 1.396 . . . . 0.0 109.689 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.24 -12.73 25.43 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.531 1.062 . . . . 0.0 114.477 -174.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -156.35 34.85 0.32 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.85 1.325 . . . . 0.0 110.476 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 t -159.25 161.95 36.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.664 1.12 . . . . 0.0 109.722 -170.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.18 139.43 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.584 1.154 . . . . 0.0 109.712 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.7 m -143.11 154.6 44.09 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.26 -0.9 . . . . 0.0 109.073 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -145.1 154.32 42.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 160.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -92.46 -166.2 1.49 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -118.47 169.84 9.44 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 122.901 1.334 . . . . 0.0 109.293 168.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -82.56 154.19 68.46 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 125.959 1.704 . . . . 0.0 112.247 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -88.99 -4.52 6.06 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.968 3.112 . . . . 0.0 114.853 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.18 167.79 10.38 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.716 0.806 . . . . 0.0 109.153 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.62 -3.28 55.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.964 0.905 . . . . 0.0 112.889 -169.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.5 164.16 25.67 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.037 -0.414 . . . . 0.0 110.779 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -95.92 135.3 37.85 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.879 1.272 . . . . 0.0 107.998 173.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -145.32 119.02 9.17 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.5 m -59.02 123.61 17.15 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -70.93 153.73 51.54 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.5 tp -146.85 117.52 7.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.504 1.522 . . . . 0.0 108.251 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.7 p -135.62 165.64 29.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 126.528 1.931 . . . . 0.0 106.235 165.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 m -124.96 171.52 10.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.814 1.646 . . . . 0.0 106.924 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.83 156.66 43.71 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 121.507 -0.745 . . . . 0.0 109.275 153.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -147.21 134.88 21.06 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.184 1.394 . . . . 0.0 107.361 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.05 174.66 4.34 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.89 0.876 . . . . 0.0 112.03 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -63.56 -84.97 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.2 2.6 . . . . 0.0 111.365 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -74.68 -32.65 62.28 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.083 -1.011 . . . . 0.0 110.343 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m -78.4 -159.11 0.15 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.731 1.213 . . . . 0.0 111.122 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.84 18.04 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 N-CA-C 116.775 1.47 . . . . 0.0 116.775 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -63.8 170.6 3.27 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.284 2.042 . . . . 0.0 108.451 146.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.1 p -134.35 156.28 48.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.5 mt -113.75 167.48 10.59 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 163.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.4 m -135.49 117.84 15.68 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.77 122.62 33.67 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 172.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -128.53 91.63 3.27 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -83.98 122.27 37.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 169.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.15 91.09 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 165.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.66 146.42 34.67 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.124 -176.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 175.52 10.16 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 125.142 3.895 . . . . 0.0 110.694 169.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.97 173.38 19.88 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -144.65 -177.67 5.62 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 125.252 1.421 . . . . 0.0 111.486 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -159.68 96.68 1.27 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.286 1.835 . . . . 0.0 106.556 171.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 m -145.98 164.64 31.41 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.404 1.081 . . . . 0.0 110.827 171.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.6 pt -74.45 64.88 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.703 1.601 . . . . 0.0 109.367 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 47.8 t0 . . . . . 0 C--O 1.254 1.298 0 CA-C-O 117.53 -1.224 . . . . 0.0 108.525 -161.346 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.156 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 74.34 -179.51 0.19 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.708 1.603 . . . . 0.0 112.286 164.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -153.86 172.6 17.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.975 2.51 . . . . 0.0 107.316 -166.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.34 -5.4 8.77 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.543 1.068 . . . . 0.0 113.197 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.4 p -58.39 152.17 45.24 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 118.364 1.082 . . . . 0.0 110.013 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.08 169.08 18.87 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.434 2.09 . . . . 0.0 112.52 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.04 151.41 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.384 1.074 . . . . 0.0 110.048 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -135.5 106.17 6.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.666 1.586 . . . . 0.0 107.182 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -83.85 153.88 23.78 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 172.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.63 146.28 52.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.399 1.88 . . . . 0.0 108.273 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -168.51 42.02 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.235 1.014 . . . . 0.0 111.819 -160.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.4 p -142.52 176.73 8.79 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.749 -1.22 . . . . 0.0 111.03 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -84.64 158.99 20.68 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 165.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.0 59.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.572 0.349 . . . . 0.0 111.829 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.09 -8.23 29.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.183 1.393 . . . . 0.0 113.24 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.33 2.66 21.44 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 124.382 0.991 . . . . 0.0 112.948 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.53 177.3 17.06 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 119.24 1.52 . . . . 0.0 112.23 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 p -117.63 25.68 10.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.328 1.051 . . . . 0.0 109.628 172.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.3 t -144.85 147.95 33.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.49 -0.756 . . . . 0.0 109.212 171.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -99.52 140.4 33.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.888 1.675 . . . . 0.0 107.581 166.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.3 m -142.13 92.32 2.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.654 -1.609 . . . . 0.0 106.654 168.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.17 152.9 36.54 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.058 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -129.54 83.79 63.71 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 168.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.51 170.57 19.07 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.726 2.951 . . . . 0.0 110.46 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -155.4 165.68 35.88 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.872 1.669 . . . . 0.0 107.457 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t70 66.62 -78.69 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.104 2.161 . . . . 0.0 113.576 158.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.3 m -75.91 5.48 6.41 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.475 1.488 . . . . 0.0 112.859 165.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.255 3.8 p 58.81 -163.8 0.21 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.333 1.453 . . . . 0.0 111.173 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.11 172.45 0.2 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.306 1.042 . . . . 0.0 112.465 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.51 -160.1 14.31 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.37 112.48 18.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -131.76 -168.88 2.1 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.278 1.431 . . . . 0.0 110.762 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.8 mt -134.66 111.38 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.993 1.717 . . . . 0.0 107.159 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 74.2 mt -82.51 158.11 23.3 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.565 1.146 . . . . 0.0 110.859 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.56 80.69 4.31 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.53 128.82 57.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -95.57 120.03 35.11 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.644 1.178 . . . . 0.0 108.758 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.1 p -147.64 93.61 2.24 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.831 0.742 . . . . 0.0 109.209 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -157.06 169.11 25.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.278 0.631 . . . . 0.0 109.413 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.21 120.14 30.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.403 1.481 . . . . 0.0 107.472 172.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -93.47 132.62 37.56 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 t -168.14 154.78 7.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 54.18 -101.26 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 176.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -144.97 53.05 1.21 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.597 1.189 . . . . 0.0 109.119 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.4 m -155.34 168.01 28.49 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.534 -1.354 . . . . 0.0 110.862 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.29 87.76 2.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.416 1.486 . . . . 0.0 107.848 169.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.29 116.0 7.58 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.79 153.04 44.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.23 138.78 52.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 168.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 m -84.23 177.08 8.34 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.691 0.619 . . . . 0.0 110.042 168.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.4 p90 -132.9 169.91 16.09 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.829 1.252 . . . . 0.0 107.669 166.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -130.68 134.24 46.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.77 149.71 39.49 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.605 1.162 . . . . 0.0 109.614 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 p -165.33 144.78 6.64 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.525 0.679 . . . . 0.0 112.002 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.15 -119.15 1.19 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -47.97 147.39 2.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.904 2.082 . . . . 0.0 113.368 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.0 m -75.16 -12.91 60.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.021 1.328 . . . . 0.0 114.313 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -116.28 20.29 14.35 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.741 1.216 . . . . 0.0 111.259 -164.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 mt -133.97 104.31 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -117.17 144.57 44.59 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -166.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.8 p -145.56 140.39 22.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.386 0.613 . . . . 0.0 110.961 -177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.7 88.51 1.34 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.12 -123.35 24.55 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.925 1.25 . . . . 0.0 112.056 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 p -81.22 56.53 2.88 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.674 1.19 . . . . 0.0 110.034 171.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 m -152.28 148.6 27.73 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.863 1.665 . . . . 0.0 106.837 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.13 159.28 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 162.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -136.72 150.46 48.44 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 147.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -130.66 163.22 27.67 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 162.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -124.53 168.39 13.16 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.107 1.363 . . . . 0.0 108.813 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -120.47 161.67 20.85 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.95 0.881 . . . . 0.0 110.287 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.92 165.32 22.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 125.009 1.324 . . . . 0.0 111.622 -162.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.27 -34.59 0.55 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.133 1.888 . . . . 0.0 111.704 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.02 162.69 18.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.851 0.834 . . . . 0.0 109.447 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -82.25 12.91 3.86 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.131 -0.981 . . . . 0.0 110.408 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -68.75 164.41 21.81 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 162.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -124.03 132.93 53.74 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.566 -0.709 . . . . 0.0 109.36 -170.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -130.08 90.69 3.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.591 0.632 . . . . 0.0 111.365 -154.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.5 m -70.04 105.09 2.75 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -80.43 160.97 44.36 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 118.842 -0.977 . . . . 0.0 111.311 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.7 tp -159.93 72.82 0.52 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.435 1.118 . . . . 0.0 113.433 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.2 t -88.12 150.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 120.266 -1.521 . . . . 0.0 109.947 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.6 m -91.61 150.03 21.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 168.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.14 105.94 5.16 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.887 0.875 . . . . 0.0 109.271 162.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -95.19 141.76 28.42 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.277 1.431 . . . . 0.0 109.173 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -64.39 163.44 13.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.994 1.318 . . . . 0.0 110.801 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -56.28 -37.12 69.41 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.99 1.316 . . . . 0.0 112.905 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -135.59 -28.01 1.14 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -167.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -78.96 -156.42 0.1 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 166.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.42 -11.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 CA-C-O 118.323 -1.265 . . . . 0.0 114.475 -172.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.46 110.37 1.09 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.371 1.585 . . . . 0.0 110.388 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.0 p -76.07 116.63 16.96 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.03 118.29 23.42 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 m -75.96 145.0 40.66 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 tt -138.07 106.36 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -170.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -121.32 87.62 2.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.596 0.759 . . . . 0.0 110.024 -170.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.19 123.97 21.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 167.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.18 93.1 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 163.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -106.3 157.55 34.67 Favored Pre-proline 0 C--O 1.237 0.442 0 CA-C-O 117.641 -1.171 . . . . 0.0 109.641 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -69.94 -164.63 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.416 4.078 . . . . 0.0 111.374 172.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -132.63 143.6 15.28 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.017 0.818 . . . . 0.0 111.645 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -93.94 160.9 14.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.34 2.256 . . . . 0.0 111.262 -168.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.32 92.48 0.98 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.7 m -144.66 172.87 12.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.547 0.689 . . . . 0.0 110.927 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.0 mt -77.47 81.27 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 169.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.4 t0 . . . . . 0 C--O 1.248 0.974 0 C-N-CA 124.672 1.189 . . . . 0.0 110.431 173.392 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.992 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -61.55 165.42 4.94 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.257 1.028 . . . . 0.0 108.666 156.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.1 mmt -145.81 168.28 21.16 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.658 2.383 . . . . 0.0 105.621 161.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.0 178.06 36.5 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 p -144.65 150.33 46.66 Favored Pre-proline 0 C--O 1.24 0.57 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.48 170.35 18.69 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.675 2.25 . . . . 0.0 110.677 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 t -70.49 112.22 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 124.161 0.984 . . . . 0.0 108.989 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 t -81.03 140.14 35.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -115.81 104.6 11.81 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.624 1.57 . . . . 0.0 109.216 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -85.3 114.75 22.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.416 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 1.7 t80 -147.89 77.09 1.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -152.05 169.37 22.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.122 0.969 . . . . 0.0 108.59 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -68.54 169.85 10.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.371 0.605 . . . . 0.0 109.604 164.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.47 -14.44 28.48 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.791 0.836 . . . . 0.0 111.457 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.4 p30 -105.66 -4.94 20.45 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -162.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.09 -56.41 0.04 OUTLIER Glycine 0 C--N 1.335 0.473 0 O-C-N 121.903 -0.498 . . . . 0.0 112.533 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.14 -115.27 0.55 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 118.792 1.296 . . . . 0.0 112.271 -168.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.5 p -127.05 19.56 7.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.629 0.772 . . . . 0.0 112.079 -170.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -149.88 157.46 43.2 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.349 -1.469 . . . . 0.0 110.546 167.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -123.92 152.61 42.23 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 165.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -143.55 133.7 24.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.5 156.6 38.73 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.869 1.268 . . . . 0.0 108.162 -178.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -140.81 54.7 4.91 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 126.735 2.014 . . . . 0.0 111.389 -167.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.67 165.54 31.66 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 120.91 1.361 . . . . 0.0 110.858 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.5 162.46 35.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.936 0.895 . . . . 0.0 109.672 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.6 t70 67.26 -76.18 0.05 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.885 2.074 . . . . 0.0 110.347 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.0 t -162.13 89.73 0.72 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.828 1.251 . . . . 0.0 108.115 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.25 98.32 3.49 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.605 1.093 . . . . 0.0 112.123 171.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.12 168.46 19.96 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.11 -0.994 . . . . 0.0 109.285 167.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.6 -165.79 32.6 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 167.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.1 p -82.25 132.54 35.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 169.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -144.76 -177.58 5.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.698 1.199 . . . . 0.0 109.692 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.9 mt -129.02 157.47 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.4 mt -136.47 147.31 47.1 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.594 1.958 . . . . 0.0 107.822 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.52 93.54 6.69 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.72 131.42 72.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.71 1.204 . . . . 0.0 108.459 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 84.4 m -91.05 138.84 31.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.323 1.449 . . . . 0.0 108.854 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.9 p -155.88 74.89 0.88 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.796 -0.565 . . . . 0.0 110.6 -173.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -155.73 172.58 18.08 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.129 -0.982 . . . . 0.0 112.92 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 135.58 52.66 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.644 1.178 . . . . 0.0 109.86 172.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -114.34 128.9 56.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 125.367 1.467 . . . . 0.0 109.406 -172.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.4 t -170.29 159.23 7.1 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.46 0.704 . . . . 0.0 109.476 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.61 -93.4 0.08 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 125.1 1.333 . . . . 0.0 110.258 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -153.65 36.12 0.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.285 1.434 . . . . 0.0 109.508 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t -149.19 164.91 33.4 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.906 -1.121 . . . . 0.0 111.094 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 p -130.79 114.19 15.02 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.761 1.624 . . . . 0.0 107.939 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -88.7 130.09 35.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 163.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.57 165.05 21.91 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 124.0 0.813 . . . . 0.0 108.94 166.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -127.48 128.12 45.2 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.076 1.351 . . . . 0.0 108.473 173.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.5 m -73.85 163.35 28.05 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.631 0.729 . . . . 0.0 109.494 168.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -139.33 172.56 12.64 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.81 2.044 . . . . 0.0 109.565 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -143.68 164.04 31.57 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 167.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.18 -176.18 3.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.713 1.605 . . . . 0.0 110.413 -172.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m 174.59 143.77 0.05 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 128.042 2.537 . . . . 0.0 109.184 151.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.92 -110.1 0.23 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 167.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.73 142.61 54.94 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.355 1.062 . . . . 0.0 108.795 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 m -65.63 -8.21 19.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -111.08 15.5 21.6 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.347 1.459 . . . . 0.0 111.853 -174.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.7 mt -128.88 133.29 66.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -130.46 147.64 52.18 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.729 1.212 . . . . 0.0 109.475 -173.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.09 99.49 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -89.62 63.26 6.17 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.707 2.003 . . . . 0.0 109.599 174.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.6 -120.94 22.63 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 -162.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.6 p -65.88 -24.65 66.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.362 1.081 . . . . 0.0 113.688 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.6 94.85 6.38 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 119.679 1.127 . . . . 0.0 109.594 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.28 151.21 10.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.589 1.155 . . . . 0.0 108.122 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -150.81 158.4 44.09 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.029 -1.669 . . . . 0.0 109.055 164.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -153.81 162.27 41.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 165.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.39 156.22 24.87 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.59 1.156 . . . . 0.0 108.104 172.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.44 141.14 58.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.517 0.675 . . . . 0.0 109.331 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.72 145.29 98.03 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.926 0.89 . . . . 0.0 110.806 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -86.57 -4.83 8.28 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.018 3.145 . . . . 0.0 113.123 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.94 162.42 18.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.073 0.949 . . . . 0.0 109.163 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -12.12 33.66 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.59 159.79 31.7 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.87 -0.519 . . . . 0.0 110.359 171.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.43 140.99 38.62 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 163.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -148.2 82.53 1.49 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.08 0.952 . . . . 0.0 108.832 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.7 m -63.18 104.43 0.59 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.629 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.6 169.46 54.73 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 tt -159.9 125.33 4.08 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.089 0.556 . . . . 0.0 110.155 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.69 167.18 3.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 118.31 0.504 . . . . 0.0 110.182 174.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.04 161.36 15.6 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 167.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.7 mp -137.88 154.3 49.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.129 1.372 . . . . 0.0 107.37 169.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -137.88 146.4 43.32 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 163.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.416 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -85.2 171.53 11.89 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.877 0.736 . . . . 0.0 109.789 172.094 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.42 -78.9 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.769 1.628 . . . . 0.0 110.582 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -86.99 -21.41 26.18 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.063 -1.023 . . . . 0.0 111.896 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.46 -175.17 5.56 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.136 -0.978 . . . . 0.0 108.851 175.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.74 10.7 0.03 OUTLIER Glycine 0 N--CA 1.462 0.373 0 O-C-N 119.804 -1.81 . . . . 0.0 115.932 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -58.44 159.04 6.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.136 1.468 . . . . 0.0 108.381 155.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.1 p -119.67 107.5 13.31 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 63.7 mt -76.06 164.4 26.17 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 m -141.0 148.4 40.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.57 117.54 11.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -114.28 144.21 43.6 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.9 mt -135.05 98.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 -171.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.2 68.22 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -90.18 165.06 25.33 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.324 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.79 -166.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 124.225 3.283 . . . . 0.0 116.855 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.61 153.9 16.68 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 158.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -129.45 126.08 37.93 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.057 1.343 . . . . 0.0 109.712 -164.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -152.3 88.93 1.39 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.296 1.039 . . . . 0.0 108.658 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.9 p -144.34 -165.25 2.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.774 1.23 . . . . 0.0 109.678 163.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.7 pt -102.09 14.83 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 126.594 1.957 . . . . 0.0 112.252 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.1 t70 . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.247 1.019 . . . . 0.0 112.845 -173.498 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.048 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 62.57 72.2 0.5 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.701 1.6 . . . . 0.0 111.597 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -135.53 162.15 33.49 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 167.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.97 63.34 0.05 OUTLIER Glycine 0 C--O 1.225 -0.416 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 p -160.27 163.99 20.73 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -64.79 165.26 21.56 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.016 1.811 . . . . 0.0 109.66 165.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.5 t -134.55 103.04 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.257 1.023 . . . . 0.0 108.375 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 m -84.84 120.37 26.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -96.86 132.94 42.11 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -102.12 123.41 45.93 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -154.48 67.49 0.71 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.832 0.853 . . . . 0.0 109.486 -171.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.7 p -155.73 -157.23 0.71 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.631 155.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -83.56 152.2 24.98 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.764 1.165 . . . . 0.0 108.217 166.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.85 -22.87 49.24 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.662 0.785 . . . . 0.0 111.544 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -60.61 -6.61 1.74 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.281 0.633 . . . . 0.0 111.934 163.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.81 10.19 73.05 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 118.851 -0.972 . . . . 0.0 112.0 168.018 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.56 -174.41 24.0 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 118.494 1.147 . . . . 0.0 111.857 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.7 p -128.78 20.62 6.0 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 124.204 1.002 . . . . 0.0 112.565 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.83 177.96 9.9 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 120.203 1.365 . . . . 0.0 112.772 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -148.21 135.55 20.48 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.343 166.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -138.59 108.46 6.31 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.611 1.164 . . . . 0.0 109.605 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -102.64 158.22 16.39 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 110.67 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -136.78 56.15 12.42 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.147 1.779 . . . . 0.0 110.157 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.55 177.8 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.891 2.394 . . . . 0.0 110.973 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -157.29 175.84 13.48 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.104 1.362 . . . . 0.0 111.837 171.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.9 t70 66.03 -81.73 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.578 2.751 . . . . 0.0 113.233 -174.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.7 p -148.62 6.81 0.74 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.571 1.149 . . . . 0.0 113.611 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -78.63 86.23 4.62 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.195 -0.941 . . . . 0.0 111.394 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.6 153.99 42.36 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.685 1.994 . . . . 0.0 108.525 170.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.57 160.79 9.55 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.8 p -66.22 130.21 42.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.197 0.599 . . . . 0.0 111.904 -166.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -129.13 -171.77 2.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.694 0.759 . . . . 0.0 112.037 170.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.1 mt -126.07 160.48 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.2 mt -134.6 159.08 42.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.18 43.51 0.88 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.925 1.29 . . . . 0.0 110.928 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.435 ' CG2' ' HE2' ' A' ' 90' ' ' LYS . 98.9 mt -70.89 142.52 15.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.362 1.465 . . . . 0.0 108.555 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.38 106.23 14.69 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.181 1.392 . . . . 0.0 108.132 -174.476 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -135.77 66.17 1.51 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.992 0.917 . . . . 0.0 110.119 -170.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -150.62 170.95 17.94 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.242 -0.912 . . . . 0.0 112.158 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 30.7 pttt -110.6 160.81 16.33 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.27 1.028 . . . . 0.0 108.234 164.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -136.5 133.68 36.78 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 166.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.5 t -171.51 157.37 4.79 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.622 1.169 . . . . 0.0 108.448 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.36 -94.48 0.1 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -152.71 35.04 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.211 0.604 . . . . 0.0 111.634 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 t -147.62 170.18 18.05 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 120.996 -1.065 . . . . 0.0 111.106 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.2 p -121.2 96.73 5.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.148 1.379 . . . . 0.0 109.143 164.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.06 120.69 18.01 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 169.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.98 165.56 15.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.273 0.559 . . . . 0.0 109.633 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.49 131.85 55.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 168.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.83 170.32 4.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.251 2.22 . . . . 0.0 110.736 172.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -165.67 167.98 16.67 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.339 1.056 . . . . 0.0 111.617 167.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -155.25 154.87 32.83 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.35 1.86 . . . . 0.0 109.072 165.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.75 178.1 4.72 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.83 1.652 . . . . 0.0 111.268 -172.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.6 p -158.52 127.53 5.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.566 0.746 . . . . 0.0 111.782 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.08 -134.98 3.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.271 1.415 . . . . 0.0 110.346 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.25 147.26 10.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.485 1.914 . . . . 0.0 112.865 -174.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.54 6.1 1.56 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.782 2.433 . . . . 0.0 114.758 -172.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 25.7 p-90 -133.04 10.53 4.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.125 1.77 . . . . 0.0 111.589 -173.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.73 108.82 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -106.12 144.28 33.06 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.733 2.013 . . . . 0.0 108.237 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.38 130.57 24.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 172.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.41 70.36 1.42 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 49.64 -117.99 5.1 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -169.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 p -71.36 34.94 0.05 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.671 1.588 . . . . 0.0 114.273 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.2 t -147.81 148.28 30.74 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 p -149.47 155.55 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -171.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.19 138.61 13.85 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.801 1.241 . . . . 0.0 108.396 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -122.16 126.7 48.88 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 166.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.89 147.78 25.73 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.334 0.654 . . . . 0.0 110.172 -169.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -73.0 158.27 35.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.664 1.221 . . . . 0.0 110.4 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -103.73 147.11 33.74 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 126.695 1.998 . . . . 0.0 109.365 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -84.75 -4.25 9.88 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 124.548 3.499 . . . . 0.0 113.233 -163.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.38 153.57 22.04 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.695 -1.253 . . . . 0.0 107.733 166.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 4.81 11.21 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.207 1.003 . . . . 0.0 112.208 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -70.82 154.42 41.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.143 -0.973 . . . . 0.0 109.486 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.4 ttm105 -77.26 148.68 35.62 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 167.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -131.07 146.95 52.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 155.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.7 m -83.06 148.33 27.6 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 156.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -119.26 157.36 15.4 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 125.103 1.335 . . . . 0.0 109.772 169.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.6 tp -153.08 126.65 8.75 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.611 0.765 . . . . 0.0 109.042 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 158.18 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 119.475 1.034 . . . . 0.0 109.549 167.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -100.7 155.61 17.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mp -132.54 168.12 18.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.187 1.795 . . . . 0.0 109.229 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -151.24 -160.2 1.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.28 1.832 . . . . 0.0 107.162 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.457 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -134.12 171.47 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.703 1.201 . . . . 0.0 108.07 170.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -51.35 -63.32 1.17 Allowed 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.593 1.557 . . . . 0.0 110.201 170.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -107.44 -27.18 10.59 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.763 1.225 . . . . 0.0 111.995 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 t -99.72 -168.64 1.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.893 1.277 . . . . 0.0 111.667 -174.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.0 50.66 0.69 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 126.559 2.028 . . . . 0.0 109.702 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.457 ' HE3' ' OE1' ' A' ' 85' ' ' GLN . 3.4 mtmp? -61.39 97.16 0.06 Allowed 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 158.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.4 p -96.9 104.53 16.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.45 155.68 20.32 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 m -135.79 64.58 1.57 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.489 1.516 . . . . 0.0 107.067 -157.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.38 107.36 2.83 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -164.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -112.33 133.19 54.57 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.01 139.73 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.67 72.09 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -108.79 144.97 30.67 Favored Pre-proline 0 C--O 1.23 0.077 0 CA-C-O 117.366 -1.302 . . . . 0.0 108.017 -172.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.28 173.2 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.623 2.882 . . . . 0.0 110.463 169.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.67 169.68 37.49 Favored Glycine 0 C--N 1.331 0.255 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -125.39 142.74 51.33 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.047 0.539 . . . . 0.0 109.766 -168.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -154.62 90.17 1.3 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.66 176.14 8.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.5 mm -83.22 82.07 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 164.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.249 1.072 0 C-N-CA 124.56 1.144 . . . . 0.0 109.488 171.666 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.636 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -151.37 121.16 7.03 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ttt -134.71 -166.4 1.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.744 1.217 . . . . 0.0 107.825 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.12 -45.52 3.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.8 m -50.67 144.48 12.71 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 124.966 1.306 . . . . 0.0 110.844 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.52 123.25 8.94 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.975 2.45 . . . . 0.0 110.137 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.96 149.72 3.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.1 m -124.23 148.83 47.04 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.483 1.113 . . . . 0.0 108.442 166.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -124.55 159.05 31.51 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.379 1.072 . . . . 0.0 111.104 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -129.98 112.73 13.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.442 1.897 . . . . 0.0 106.344 -171.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -143.96 68.67 1.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.275 1.43 . . . . 0.0 108.801 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 p -154.26 173.06 16.66 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.991 0.917 . . . . 0.0 108.712 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -64.07 170.08 3.89 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 149.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.36 -23.43 30.15 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.812 -0.555 . . . . 0.0 111.498 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -148.67 31.23 0.8 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.953 0.901 . . . . 0.0 110.189 -166.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.38 3.15 0.06 OUTLIER Glycine 0 C--N 1.342 0.916 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 -169.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.9 -123.06 6.24 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 120.03 1.915 . . . . 0.0 110.077 174.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 p -135.65 25.3 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.534 1.167 . . . . 0.0 111.764 -167.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -160.26 163.52 33.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.3 155.2 42.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 161.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m -142.59 127.93 18.82 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -118.9 146.9 44.55 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -122.12 65.58 21.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 C-N-CA 124.787 1.235 . . . . 0.0 108.657 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.14 169.14 9.69 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.774 2.316 . . . . 0.0 111.391 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.38 -176.45 5.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t0 55.13 -78.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.43 2.292 . . . . 0.0 113.897 171.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -154.12 110.82 3.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 156.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -149.58 90.85 1.75 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.905 1.23 . . . . 0.0 111.841 167.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.61 177.82 7.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.092 1.757 . . . . 0.0 108.988 169.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.45 -157.77 27.5 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 170.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.2 p -124.57 105.57 9.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.835 1.654 . . . . 0.0 110.081 -170.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -124.16 -171.01 2.24 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.63 160.78 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.837 2.055 . . . . 0.0 107.197 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.3 mt -138.43 164.12 30.15 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.076 1.351 . . . . 0.0 110.61 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -83.83 89.07 7.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.308 1.843 . . . . 0.0 111.809 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.1 152.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 172.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.19 120.25 39.83 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.106 1.762 . . . . 0.0 106.659 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 p -155.0 70.53 0.76 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.686 0.794 . . . . 0.0 109.711 -161.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -159.94 176.86 11.38 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.62 0.768 . . . . 0.0 111.285 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 151.74 49.47 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.711 1.605 . . . . 0.0 109.682 168.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -131.48 130.78 42.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 126.07 1.748 . . . . 0.0 109.215 -167.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.7 t -177.47 144.61 0.4 Allowed 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.168 1.387 . . . . 0.0 108.821 -174.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.33 -88.79 0.2 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 125.947 1.737 . . . . 0.0 112.663 164.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -159.57 33.35 0.19 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.652 1.581 . . . . 0.0 109.172 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -145.9 155.59 42.97 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.619 -1.3 . . . . 0.0 109.564 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.03 80.91 1.85 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.335 1.064 . . . . 0.0 110.007 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -67.22 118.66 10.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.063 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.68 155.35 40.24 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.591 0.632 . . . . 0.0 109.46 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.5 128.28 50.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.021 1.329 . . . . 0.0 108.909 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 t -78.37 178.62 7.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.372 1.069 . . . . 0.0 110.749 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -147.27 -167.73 2.86 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.834 2.054 . . . . 0.0 109.169 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -139.96 -178.16 5.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.861 1.664 . . . . 0.0 107.466 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.36 156.7 47.37 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 165.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.01 150.29 5.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.121 0.969 . . . . 0.0 109.545 165.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.67 -102.65 0.22 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 171.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.56 151.24 47.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.104 0.962 . . . . 0.0 109.729 170.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 m -86.89 -34.16 19.52 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -72.59 19.8 0.08 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.967 1.707 . . . . 0.0 113.635 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mt -130.05 129.67 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -100.4 167.95 10.06 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.673 1.589 . . . . 0.0 108.659 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.97 151.08 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 166.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.59 68.82 1.08 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 166.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.14 -117.83 8.21 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.4 p -72.46 48.48 0.19 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.368 1.867 . . . . 0.0 112.192 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -151.59 147.6 26.97 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.691 1.597 . . . . 0.0 108.497 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -144.65 130.8 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.742 1.217 . . . . 0.0 109.238 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 m -143.19 152.51 41.85 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -153.17 150.46 29.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.611 0.764 . . . . 0.0 109.783 173.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.33 175.2 9.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.824 1.249 . . . . 0.0 108.819 168.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -89.82 175.65 7.14 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.475 1.131 . . . . 0.0 108.577 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 29.4 p30 -66.93 165.68 24.74 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 120.313 -1.492 . . . . 0.0 113.791 173.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -94.73 -4.62 2.32 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.693 3.595 . . . . 0.0 113.457 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.96 153.21 51.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.805 1.242 . . . . 0.0 108.889 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . 0.338 0.0 OUTLIER -90.14 35.61 0.86 Allowed 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.082 -1.011 . . . . 0.0 111.954 -168.045 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -86.11 167.31 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 167.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.83 136.88 32.86 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 166.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -151.81 162.15 41.51 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.838 0.855 . . . . 0.0 109.741 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.2 t -117.53 158.64 24.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 160.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.78 165.23 28.18 Favored Glycine 0 C--O 1.239 0.457 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 159.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.1 tp -158.21 100.29 1.68 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 m -84.68 -165.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 49.6 m -145.45 146.32 31.46 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 119.447 -2.033 . . . . 0.0 105.831 157.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.26 137.02 54.87 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 170.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -123.29 119.89 31.47 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.327 1.451 . . . . 0.0 108.221 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -65.32 148.46 51.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.453 1.101 . . . . 0.0 109.541 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -50.83 -84.92 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.864 2.466 . . . . 0.0 113.624 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -80.36 -15.8 56.02 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.367 -0.833 . . . . 0.0 111.445 -174.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.82 -153.47 0.33 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.556 1.942 . . . . 0.0 108.739 173.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.43 1.51 0.03 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-O 117.897 -1.501 . . . . 0.0 114.551 -174.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.59 102.14 2.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.887 1.844 . . . . 0.0 106.664 169.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 p -69.49 152.11 45.23 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.751 0.657 . . . . 0.0 110.101 -169.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.18 169.28 8.58 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.336 1.054 . . . . 0.0 108.773 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -147.89 146.33 29.0 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.017 1.327 . . . . 0.0 107.841 -169.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.9 tp -139.35 110.65 6.97 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 128.651 2.78 . . . . 0.0 105.909 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -128.52 128.11 43.68 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.0 mt -134.63 77.81 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -163.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 86.2 t -75.81 99.06 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.08 155.0 43.25 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 124.593 1.157 . . . . 0.0 111.94 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.49 -168.82 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 124.231 3.287 . . . . 0.0 108.883 160.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -139.74 167.5 25.31 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 118.786 -1.674 . . . . 0.0 114.994 176.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.99 171.19 14.41 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.456 -0.872 . . . . 0.0 112.341 -175.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.3 p -160.87 91.78 0.9 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.289 2.236 . . . . 0.0 107.063 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 91.5 p -146.78 -164.15 1.92 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.021 0.928 . . . . 0.0 110.282 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.4 pt -107.42 8.41 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.782 1.233 . . . . 0.0 110.665 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.4 t0 . . . . . 0 C--O 1.245 0.826 0 C-N-CA 124.855 1.262 . . . . 0.0 109.327 175.462 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.23 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -140.15 97.47 3.24 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -162.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -163.3 -178.65 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.722 2.009 . . . . 0.0 106.633 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.98 -93.11 0.1 Allowed Glycine 0 C--O 1.227 -0.298 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.9 p -152.36 163.34 23.87 Favored Pre-proline 0 C--O 1.239 0.547 0 C-N-CA 124.328 1.051 . . . . 0.0 108.79 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.0 167.19 24.17 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.272 1.314 . . . . 0.0 111.953 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p -77.25 137.85 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 123.984 0.913 . . . . 0.0 110.371 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -89.58 125.79 35.36 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 166.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -102.33 152.93 20.51 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.927 1.291 . . . . 0.0 109.638 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.06 110.74 10.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.297 2.239 . . . . 0.0 106.571 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.9 46.79 1.75 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.762 1.625 . . . . 0.0 108.529 -175.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -160.36 157.34 27.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.941 1.696 . . . . 0.0 107.625 -170.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -73.67 170.83 14.43 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.184 0.993 . . . . 0.0 109.5 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.41 -36.3 45.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.286 0.634 . . . . 0.0 112.641 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -142.49 47.28 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.33 -1.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 -172.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.59 -112.68 4.61 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 120.914 2.357 . . . . 0.0 109.111 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.3 p -119.98 7.31 10.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.268 1.034 . . . . 0.0 112.598 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 t -137.88 158.14 44.96 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.451 1.023 . . . . 0.0 108.58 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -102.85 165.31 11.12 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 148.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.4 m -141.14 163.16 33.72 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 153.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -144.81 150.6 37.45 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -131.96 77.34 72.01 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 126.955 2.102 . . . . 0.0 106.475 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.59 177.02 8.0 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.845 1.696 . . . . 0.0 109.757 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -151.88 161.19 43.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 108.879 172.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 54.52 -85.34 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.444 2.697 . . . . 0.0 110.488 -167.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t -150.24 106.04 3.42 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 165.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -128.55 89.96 2.98 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 122.432 1.11 . . . . 0.0 108.664 156.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.5 149.03 50.66 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.922 2.089 . . . . 0.0 106.844 164.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.04 -139.03 4.97 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 p -129.91 116.04 18.06 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.775 1.63 . . . . 0.0 110.321 -171.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -146.44 -171.74 3.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.781 1.233 . . . . 0.0 111.873 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.6 mt -133.16 130.2 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.201 1.8 . . . . 0.0 107.273 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.2 mt -91.63 161.59 14.86 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.453 1.501 . . . . 0.0 109.419 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.2 78.84 4.0 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mt -90.35 133.05 33.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.865 2.066 . . . . 0.0 107.397 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 m -110.4 107.98 17.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -135.53 67.65 1.48 Allowed 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.029 0.932 . . . . 0.0 108.771 -163.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -154.37 176.22 12.59 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.25 -0.906 . . . . 0.0 111.808 -176.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.96 154.56 40.99 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 125.94 1.696 . . . . 0.0 108.988 170.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -141.36 126.82 18.8 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.93 1.292 . . . . 0.0 109.938 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.6 t -177.62 160.06 1.53 Allowed 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.135 1.374 . . . . 0.0 108.932 -176.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.4 -103.56 0.32 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -146.04 29.5 1.08 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.158 0.983 . . . . 0.0 111.871 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -146.85 169.34 19.32 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.216 -0.927 . . . . 0.0 110.064 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.48 113.2 10.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.514 1.525 . . . . 0.0 109.064 -172.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.85 108.96 20.02 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.68 109.84 3.99 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.479 1.036 . . . . 0.0 109.217 169.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.77 134.64 52.57 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -66.75 163.23 19.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.384 1.474 . . . . 0.0 108.996 166.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -149.42 -172.87 4.24 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.1 -175.15 5.21 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 153.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.33 166.38 19.6 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.745 1.618 . . . . 0.0 108.277 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.62 149.84 20.65 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 161.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.27 -142.92 8.31 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -64.95 143.34 58.01 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.278 0.631 . . . . 0.0 111.043 -168.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.82 -0.76 4.48 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.104 1.762 . . . . 0.0 114.782 -170.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -117.81 11.56 13.59 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.032 1.733 . . . . 0.0 111.653 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.02 133.03 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -134.5 111.37 10.04 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.977 1.711 . . . . 0.0 106.892 -165.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.4 t -112.56 98.33 6.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -94.41 79.29 3.89 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.32 -107.78 0.47 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 126.215 1.864 . . . . 0.0 111.44 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m -73.83 -19.25 60.8 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.821 1.248 . . . . 0.0 112.764 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -88.08 160.06 17.97 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.45 1.023 . . . . 0.0 110.694 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -132.04 145.64 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 167.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -150.74 148.79 28.98 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.05 160.56 42.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -125.45 148.87 48.67 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.357 1.063 . . . . 0.0 108.289 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -62.92 170.86 2.44 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 123.621 1.677 . . . . 0.0 112.537 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.488 HD22 ' HA2' ' A' ' 100' ' ' GLY . 21.5 p30 -78.03 157.18 79.02 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.069 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.43 -6.16 7.15 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.02 2.48 . . . . 0.0 112.397 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.93 154.47 46.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.96 1.304 . . . . 0.0 109.221 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 40.79 0.77 Allowed 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.793 1.237 . . . . 0.0 111.065 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.29 170.33 9.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.288 1.435 . . . . 0.0 109.884 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.82 113.04 20.47 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.1 mtp85 -135.14 -170.44 2.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.122 0.969 . . . . 0.0 109.609 -170.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.7 t -147.2 156.89 43.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.486 -1.384 . . . . 0.0 108.108 161.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -84.7 174.07 49.74 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 159.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.5 tp -162.67 80.21 0.5 Allowed 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.53 178.06 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 120.629 -1.294 . . . . 0.0 110.005 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.4 m -134.38 141.51 46.88 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.949 -1.095 . . . . 0.0 108.566 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -127.83 151.45 49.03 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.901 1.68 . . . . 0.0 107.846 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.38 134.97 20.96 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.735 0.698 . . . . 0.0 109.454 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -77.12 154.65 33.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.416 1.087 . . . . 0.0 110.564 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -53.45 -69.49 0.12 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.989 2.116 . . . . 0.0 113.001 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -85.12 -23.51 28.41 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.053 0.541 . . . . 0.0 111.132 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -86.08 -153.64 0.19 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.318 1.847 . . . . 0.0 109.878 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.26 -13.28 0.02 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-O 118.193 -1.337 . . . . 0.0 115.645 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.71 121.54 10.66 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.959 1.879 . . . . 0.0 106.932 169.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.2 p -81.38 145.11 30.98 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -93.5 158.23 15.81 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 168.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 m -124.98 152.54 44.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.63 1.172 . . . . 0.0 110.153 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tt -152.72 109.29 3.43 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -170.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -117.25 137.32 52.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.305 1.042 . . . . 0.0 109.391 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 10.8 mt -135.72 94.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -171.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.6 t -99.28 80.76 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -89.81 166.01 22.45 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 125.313 1.445 . . . . 0.0 110.126 -172.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -60.91 -172.05 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.824 3.016 . . . . 0.0 112.018 160.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.488 ' HA2' HD22 ' A' ' 71' ' ' ASN . . . -121.26 139.04 12.93 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 124.817 1.198 . . . . 0.0 112.1 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -114.18 152.71 30.79 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.343 1.457 . . . . 0.0 110.372 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -148.85 91.3 1.85 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 160.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.6 t -146.1 169.86 17.84 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.344 0.52 . . . . 0.0 110.8 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.9 mp -81.4 71.52 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 128.019 2.528 . . . . 0.0 106.945 -173.057 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 CA-C-O 118.198 -1.335 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.2 m170 43.93 73.67 0.14 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.852 1.826 . . . . 0.0 112.388 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -144.05 170.64 15.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.16 0.984 . . . . 0.0 108.722 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.44 -42.0 3.06 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 p -61.23 155.52 56.03 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.932 1.293 . . . . 0.0 111.893 171.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.41 162.68 32.65 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.781 2.321 . . . . 0.0 111.346 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.67 157.57 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -147.93 103.79 3.52 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -77.11 155.0 32.69 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -137.31 109.08 7.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.141 2.577 . . . . 0.0 106.367 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -132.73 93.03 3.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -164.66 161.17 20.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.347 1.059 . . . . 0.0 110.179 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -66.44 167.76 10.13 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.493 -0.754 . . . . 0.0 108.966 163.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -114.89 -0.78 13.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.234 1.013 . . . . 0.0 111.89 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -145.92 51.18 1.17 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 166.85 -97.57 0.14 Allowed Glycine 0 CA--C 1.523 0.564 0 O-C-N 121.371 -0.831 . . . . 0.0 111.109 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.65 -112.24 0.26 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 118.065 0.933 . . . . 0.0 112.379 -171.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.2 p -138.44 16.09 2.75 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.97 0.908 . . . . 0.0 112.242 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 t -152.95 140.93 20.26 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.438 1.017 . . . . 0.0 109.49 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.29 157.09 17.37 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.021 0.929 . . . . 0.0 109.893 174.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -150.82 102.14 2.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 154.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -89.04 155.57 19.39 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 118.819 -1.153 . . . . 0.0 109.482 165.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -128.88 69.24 80.36 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 126.396 1.879 . . . . 0.0 108.774 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.94 170.83 14.7 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.354 2.036 . . . . 0.0 111.144 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.0 158.5 42.12 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.455 0.702 . . . . 0.0 110.505 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.4 t70 62.52 -72.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.016 2.126 . . . . 0.0 113.662 -171.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 m -165.57 75.84 0.24 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.937 1.695 . . . . 0.0 108.687 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.42 98.8 6.09 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.342 1.057 . . . . 0.0 110.098 174.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.3 165.1 28.09 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.318 2.247 . . . . 0.0 106.448 167.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 143.68 174.61 16.09 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 119.76 1.164 . . . . 0.0 112.088 165.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.5 p -92.01 113.17 25.37 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.895 0.478 . . . . 0.0 110.707 -161.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -122.76 -167.11 1.53 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.255 1.022 . . . . 0.0 112.945 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mt -135.67 143.21 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 127.771 2.429 . . . . 0.0 105.194 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.9 mt -123.16 162.88 21.66 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.294 1.038 . . . . 0.0 110.067 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -104.63 86.19 2.45 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.234 1.414 . . . . 0.0 107.187 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -114.52 128.43 71.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 m -79.31 115.16 18.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.139 1.376 . . . . 0.0 108.129 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.2 p -143.68 73.38 1.39 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.375 0.534 . . . . 0.0 111.126 -174.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -155.84 167.67 29.65 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.669 -0.644 . . . . 0.0 112.407 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.41 133.58 55.62 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -103.78 142.74 33.84 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.834 0.854 . . . . 0.0 109.174 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.59 76.96 0.97 Allowed 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -156.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.75 -94.55 0.09 OUTLIER Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.862 1.22 . . . . 0.0 111.035 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -113.87 9.85 17.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 m -134.76 153.68 51.91 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.566 0.746 . . . . 0.0 110.957 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -139.1 92.19 2.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.712 1.605 . . . . 0.0 110.193 -168.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.97 115.53 16.84 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.43 152.69 45.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.16 148.95 42.51 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.393 1.077 . . . . 0.0 108.149 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.2 p -87.95 -179.42 6.22 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.792 0.837 . . . . 0.0 110.175 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -143.71 154.29 43.33 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 109.512 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -89.48 160.06 16.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.04 1.336 . . . . 0.0 108.538 160.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.75 163.11 26.91 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.832 2.053 . . . . 0.0 106.434 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 m -170.86 141.8 1.81 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.332 0.969 . . . . 0.0 109.284 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.93 -128.75 3.84 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.226 1.393 . . . . 0.0 110.245 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.92 136.73 4.48 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.113 2.565 . . . . 0.0 111.699 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -71.58 4.32 3.21 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 -165.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -139.66 15.58 2.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.874 0.869 . . . . 0.0 112.338 -160.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.7 mt -123.42 87.88 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -73.33 126.57 30.44 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.9 t -137.38 84.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.93 59.07 3.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.679 1.192 . . . . 0.0 109.145 -173.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.31 -115.88 8.33 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -172.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -75.65 39.04 0.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.86 1.664 . . . . 0.0 112.8 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 m -152.4 149.14 28.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.78 139.52 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 t -143.32 108.8 5.07 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.09 106.71 17.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 165.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -66.81 168.01 10.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.383 1.473 . . . . 0.0 110.822 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -85.03 -176.85 6.38 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.431 -0.793 . . . . 0.0 109.162 171.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -112.03 161.07 27.54 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.882 1.673 . . . . 0.0 108.44 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -86.79 -10.41 6.1 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.795 2.33 . . . . 0.0 113.375 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.83 167.07 13.98 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.934 1.293 . . . . 0.0 110.732 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -100.01 13.26 34.59 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.763 1.024 . . . . 0.0 113.763 -175.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.95 171.77 13.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 164.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -108.7 144.33 36.62 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.63 -0.668 . . . . 0.0 109.604 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.69 165.74 18.67 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.237 -0.914 . . . . 0.0 109.272 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.2 m -117.33 117.55 29.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 158.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.72 158.59 52.46 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.8 tp -155.18 111.35 3.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.94 0.87 . . . . 0.0 109.629 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.1 t -130.53 124.19 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.9 m -87.7 135.98 33.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 175.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.35 145.7 38.4 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.751 0.82 . . . . 0.0 108.901 167.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -134.57 139.87 45.7 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 173.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -71.52 160.04 33.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.198 0.999 . . . . 0.0 109.322 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -50.44 -33.35 20.69 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.109 1.363 . . . . 0.0 113.937 168.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -127.95 -36.06 2.02 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 t -88.22 -156.2 0.35 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.564 0.746 . . . . 0.0 110.054 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.64 10.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.627 0 CA-C-O 118.113 -1.381 . . . . 0.0 114.937 -171.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.91 94.27 1.05 Allowed 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.141 1.97 . . . . 0.0 107.147 169.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 p -72.8 113.67 10.1 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mp -75.0 130.13 38.83 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 t -88.18 152.63 21.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 tt -149.02 98.54 2.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -172.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -105.47 149.61 26.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.2 134.89 41.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 168.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 t -121.4 79.4 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -84.79 164.08 43.7 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.68 1.192 . . . . 0.0 110.704 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.26 179.61 3.32 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.448 2.765 . . . . 0.0 110.518 160.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.95 147.82 18.89 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.106 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -85.39 135.2 33.97 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.206 1.802 . . . . 0.0 111.455 -166.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.11 89.1 2.0 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 155.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.1 m -133.8 167.53 20.39 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -172.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.4 mt -85.46 68.7 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 173.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 C--O 1.244 0.77 0 C-N-CA 127.814 2.445 . . . . 0.0 107.294 -166.693 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.397 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -62.08 113.95 3.13 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 165.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.9 mtp -147.96 159.97 43.31 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.114 1.766 . . . . 0.0 106.679 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.63 105.52 2.52 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 107.648 -2.181 . . . . 0.0 107.648 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 p -165.13 156.57 12.96 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 123.869 0.868 . . . . 0.0 108.816 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.65 115.82 4.38 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.001 2.468 . . . . 0.0 110.523 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.71 117.48 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -97.77 100.63 12.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -79.2 157.07 27.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.106 0.479 . . . . 0.0 110.153 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -131.42 107.01 8.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -130.79 69.06 1.47 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.35 2.26 . . . . 0.0 105.663 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.6 p -163.41 -174.98 3.99 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.893 -0.504 . . . . 0.0 111.724 165.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -65.66 173.37 2.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.486 0.585 . . . . 0.0 109.688 161.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -112.47 -8.11 13.89 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -156.67 58.02 0.55 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.055 0.931 . . . . 0.0 108.888 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.3 -91.66 0.08 OUTLIER Glycine 0 C--N 1.331 0.286 0 O-C-N 121.405 -0.809 . . . . 0.0 111.779 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.33 -123.31 0.78 Allowed Glycine 0 C--N 1.333 0.362 0 CA-C-N 117.781 0.79 . . . . 0.0 113.007 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 p -138.81 12.32 2.68 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.223 1.409 . . . . 0.0 114.127 -169.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 t -157.38 146.64 20.03 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 118.467 -1.293 . . . . 0.0 111.7 169.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.5 137.76 33.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.375 160.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m -136.05 162.16 33.67 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 170.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -152.81 154.47 35.22 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 159.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.4 54.64 14.18 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.602 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.57 174.52 9.23 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.23 1.286 . . . . 0.0 111.167 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -159.46 169.54 23.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t70 65.16 -78.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.48 1.912 . . . . 0.0 111.231 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 m -169.07 110.44 0.49 Allowed 'General case' 0 C--O 1.238 0.496 0 C-N-CA 128.479 2.712 . . . . 0.0 106.702 160.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.6 m -138.89 24.75 2.57 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.78 146.71 49.6 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.173 -0.954 . . . . 0.0 110.445 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.73 -158.95 27.37 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -121.98 116.11 23.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.385 1.474 . . . . 0.0 110.173 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -122.14 -177.85 3.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.317 1.447 . . . . 0.0 110.639 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mt -132.03 156.59 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 127.287 2.235 . . . . 0.0 105.897 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.5 mt -134.06 179.04 6.5 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.648 1.579 . . . . 0.0 109.287 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -109.31 71.57 0.77 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.651 1.181 . . . . 0.0 109.461 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 97.2 mt -97.5 138.88 21.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.38 131.32 51.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.46 1.504 . . . . 0.0 107.421 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.1 t -148.61 81.98 1.46 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -154.2 173.17 16.47 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.764 -0.585 . . . . 0.0 111.394 173.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.68 137.25 54.37 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.778 1.631 . . . . 0.0 108.602 169.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -115.29 134.63 54.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.307 1.843 . . . . 0.0 107.011 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.1 t -174.85 157.79 2.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.67 -110.8 0.89 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -135.12 32.4 3.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.844 1.258 . . . . 0.0 109.476 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m -144.53 161.55 38.81 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.884 0.874 . . . . 0.0 110.784 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 p -127.66 103.21 7.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.025 1.33 . . . . 0.0 108.002 166.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -78.57 116.33 18.88 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.35 148.48 46.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -112.65 142.95 44.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.09 163.47 20.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.797 0.839 . . . . 0.0 110.514 166.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -140.1 158.4 44.12 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.585 1.154 . . . . 0.0 108.898 165.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -138.26 151.16 47.37 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.4 162.14 36.19 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.369 1.068 . . . . 0.0 110.736 -163.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -168.96 152.42 5.23 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.292 1.037 . . . . 0.0 109.495 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.59 -138.88 5.47 Favored Glycine 0 C--N 1.333 0.38 0 O-C-N 121.506 -0.746 . . . . 0.0 111.709 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -55.84 137.33 50.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.153 1.381 . . . . 0.0 111.133 -178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.5 m -69.4 3.43 2.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.745 2.418 . . . . 0.0 116.364 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -126.98 6.58 6.58 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.276 1.43 . . . . 0.0 111.963 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 34.6 mt -117.27 91.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -175.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -76.77 110.23 11.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.614 1.166 . . . . 0.0 108.724 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.0 p -94.41 143.13 12.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.17 0.988 . . . . 0.0 108.461 177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.67 46.08 1.69 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.744 0.783 . . . . 0.0 111.061 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.18 -113.5 5.42 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.5 p -71.99 -7.35 48.2 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.2 m -110.31 144.65 38.72 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 119.671 1.123 . . . . 0.0 109.623 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.62 157.11 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.888 1.675 . . . . 0.0 107.775 -176.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.29 152.58 26.21 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.529 1.132 . . . . 0.0 108.432 162.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -154.4 173.36 16.33 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.966 0.906 . . . . 0.0 109.557 159.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.93 170.81 8.06 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.784 1.233 . . . . 0.0 110.686 166.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -80.9 158.75 25.18 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 122.509 1.147 . . . . 0.0 108.305 165.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.63 167.37 5.74 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 126.304 1.842 . . . . 0.0 112.362 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -92.1 -10.8 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.377 3.385 . . . . 0.0 115.726 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.82 141.87 29.5 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 120.558 1.526 . . . . 0.0 109.926 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.559 ' CD ' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -72.0 8.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 128.668 2.787 . . . . 0.0 114.0 -155.042 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -61.58 166.65 4.0 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 163.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.4 ttm-85 -126.21 118.9 26.12 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.086 1.354 . . . . 0.0 110.253 -176.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -136.94 -168.94 2.37 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.562 1.145 . . . . 0.0 110.25 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 8.8 t -131.82 156.12 46.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.653 0.781 . . . . 0.0 109.238 162.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.81 -179.3 40.43 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 160.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.7 tp -147.82 160.36 42.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.736 1.214 . . . . 0.0 108.383 159.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -135.78 151.48 29.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 163.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.2 m -124.37 154.87 39.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.01 167.38 22.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.266 1.027 . . . . 0.0 109.968 -174.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -137.89 158.28 44.68 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 125.167 1.387 . . . . 0.0 108.077 167.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -114.98 139.46 49.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -44.7 -73.16 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.037 1.735 . . . . 0.0 113.743 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.26 -8.75 54.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.691 1.996 . . . . 0.0 112.957 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.76 -153.37 0.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.459 2.304 . . . . 0.0 106.771 174.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 0.21 0.04 OUTLIER Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.11 -1.519 . . . . 0.0 115.931 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -58.85 153.3 17.41 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 126.568 1.947 . . . . 0.0 110.925 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 p -122.42 146.79 47.03 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.5 mt -117.39 -170.42 1.85 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.845 1.658 . . . . 0.0 106.639 175.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.54 161.08 39.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.104 1.362 . . . . 0.0 108.776 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 tp -136.45 77.92 1.68 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.548 1.939 . . . . 0.0 108.438 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -82.25 89.08 6.5 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.687 -0.633 . . . . 0.0 110.312 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.4 mt -83.68 92.47 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 175.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.6 87.64 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.13 160.75 31.34 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 118.281 0.491 . . . . 0.0 109.895 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -78.4 171.54 16.73 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.749 1.632 . . . . 0.0 109.781 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.92 164.53 32.59 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.46 170.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -109.83 134.76 51.68 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.036 -1.082 . . . . 0.0 108.231 -163.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.86 90.45 1.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.64 -173.89 2.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.152 0.581 . . . . 0.0 109.763 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.49 43.89 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.583 1.553 . . . . 0.0 108.341 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 117.525 -1.226 . . . . 0.0 113.629 -160.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.846 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -153.73 129.32 9.98 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.253 1.421 . . . . 0.0 108.03 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.0 mtm -142.24 155.55 45.26 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.93 76.72 0.78 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.1 p -163.42 163.68 16.31 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.132 1.373 . . . . 0.0 108.783 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.19 -176.6 1.95 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.304 2.669 . . . . 0.0 111.436 171.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.3 t -79.67 113.34 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.637 1.175 . . . . 0.0 108.6 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.64 111.48 21.32 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.145 0.978 . . . . 0.0 108.522 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -88.24 166.3 14.44 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 163.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -144.15 102.83 3.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.468 1.907 . . . . 0.0 106.333 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -128.63 65.23 1.42 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.819 1.648 . . . . 0.0 109.042 -169.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.68 174.06 12.56 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.037 -1.039 . . . . 0.0 110.195 172.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -62.98 149.45 44.83 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.948 1.249 . . . . 0.0 107.63 155.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.37 -24.41 59.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.149 -174.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -93.52 17.3 11.8 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.203 1.001 . . . . 0.0 111.845 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.32 58.03 1.17 Allowed Glycine 0 C--N 1.337 0.586 0 O-C-N 121.769 -0.582 . . . . 0.0 111.943 168.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.06 -169.39 38.22 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.61 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 p -137.82 7.19 2.72 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.778 1.231 . . . . 0.0 112.74 -163.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 t -162.05 159.85 26.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.187 -0.946 . . . . 0.0 109.102 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.72 129.03 55.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 167.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.2 m -132.73 119.64 20.6 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 166.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.56 145.31 42.77 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -130.5 74.03 80.63 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -75.12 174.59 12.54 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.419 2.079 . . . . 0.0 110.709 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -137.9 -1.84 1.96 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -162.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.03 -66.22 0.35 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.013 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.4 t -157.92 9.81 0.17 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.397 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.65 92.2 0.32 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.387 1.449 . . . . 0.0 112.692 -167.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.82 147.01 28.25 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.9 2.48 . . . . 0.0 106.834 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.01 -179.68 40.6 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 121.497 1.953 . . . . 0.0 110.066 -172.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.5 m -99.67 117.26 33.64 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.949 0.9 . . . . 0.0 109.774 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -139.71 -165.94 1.98 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.032 1.333 . . . . 0.0 110.599 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.0 mt -128.83 155.92 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.33 1.852 . . . . 0.0 107.485 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.2 mt -133.58 156.09 48.47 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.55 1.94 . . . . 0.0 106.729 173.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.22 98.06 7.66 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.92 142.89 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.96 112.98 23.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.18 55.93 1.62 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -174.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -152.39 168.02 26.81 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.02 -1.05 . . . . 0.0 113.524 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.3 145.33 47.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.971 1.309 . . . . 0.0 109.144 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.44 ' HE3' ' CG2' ' A' ' 46' ' ' THR . 18.3 ttmt -112.95 143.82 43.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.806 2.442 . . . . 0.0 106.779 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.8 t -172.99 172.02 4.07 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.073 2.149 . . . . 0.0 105.606 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.43 -102.56 0.04 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 126.19 1.852 . . . . 0.0 112.407 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -146.37 41.46 1.15 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.902 1.681 . . . . 0.0 109.188 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -146.26 169.22 19.22 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.005 0.922 . . . . 0.0 110.61 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.44 ' CG2' ' HE3' ' A' ' 41' ' ' LYS . 52.3 p -135.16 104.66 6.0 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.992 0.917 . . . . 0.0 110.461 165.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -80.44 121.42 25.72 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 172.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.75 151.42 47.48 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 166.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.45 114.14 21.35 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.692 1.597 . . . . 0.0 106.871 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 m -67.45 150.15 49.29 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.994 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -120.17 160.57 22.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.465 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -107.15 165.13 11.59 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.035 1.734 . . . . 0.0 107.825 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.19 144.36 19.8 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.702 1.201 . . . . 0.0 108.327 166.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.67 152.4 27.06 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.306 0.643 . . . . 0.0 109.985 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.92 -62.16 0.11 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.01 148.82 39.75 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.229 1.012 . . . . 0.0 110.389 -168.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -60.07 -10.72 4.61 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.637 1.975 . . . . 0.0 114.952 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -130.72 14.38 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.429 1.492 . . . . 0.0 111.066 -163.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.42 ' HA ' ' CD1' ' A' ' 68' ' ' TYR . 23.6 mt -127.36 86.5 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -172.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -104.24 141.78 35.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.106 1.362 . . . . 0.0 111.522 -170.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.1 p -131.03 100.56 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.858 0.863 . . . . 0.0 109.552 -168.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -100.51 51.96 0.88 Allowed 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.606 -1.309 . . . . 0.0 109.921 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.66 -113.76 6.17 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.4 p -78.1 53.29 1.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.665 1.232 . . . . 0.0 110.773 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.9 m -165.02 150.52 9.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.605 2.362 . . . . 0.0 107.263 167.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.33 140.95 28.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.0 t -155.69 102.97 2.24 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.42 ' CD1' ' HA ' ' A' ' 59' ' ' ILE . 4.4 m-30 -113.96 136.72 52.58 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -103.7 172.02 7.03 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.001 1.321 . . . . 0.0 111.554 -173.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.42 156.71 36.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.89 0.853 . . . . 0.0 111.106 163.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -68.12 165.56 32.06 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.26 1.824 . . . . 0.0 110.888 165.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -88.27 -11.51 4.32 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.91 2.407 . . . . 0.0 113.969 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.03 159.71 38.01 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.204 1.002 . . . . 0.0 109.811 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 0.6 3.51 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.09 165.12 11.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.557 0.743 . . . . 0.0 109.615 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -92.06 146.42 23.75 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 168.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -136.98 154.81 50.32 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.6 m -113.48 106.43 14.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 163.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.39 149.67 47.93 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.5 tp -162.66 118.45 1.86 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.075 0.938 . . . . 0.0 109.53 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.66 166.81 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.195 0.998 . . . . 0.0 109.183 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.7 m -121.52 144.54 48.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 169.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -124.58 160.58 28.08 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.356 1.863 . . . . 0.0 110.095 172.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -148.8 137.96 21.62 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.759 1.224 . . . . 0.0 108.257 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -68.35 165.59 18.37 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -55.56 -84.94 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.815 2.046 . . . . 0.0 111.553 170.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -91.42 -3.14 56.97 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.971 -1.081 . . . . 0.0 113.268 -167.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 t -116.27 -154.51 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.242 2.217 . . . . 0.0 108.028 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.06 41.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.528 0 O-C-N 120.941 -1.099 . . . . 0.0 110.54 -159.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . 0.305 0.0 OUTLIER -65.24 138.5 58.27 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 153.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.1 p -110.39 140.97 44.08 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 159.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 86.3 mt -121.24 112.04 18.14 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -177.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.9 m -65.07 137.72 57.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tt -140.48 96.61 3.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.094 0.861 . . . . 0.0 110.072 -175.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -98.23 137.18 37.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mp -118.53 117.54 54.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 158.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.3 t -108.79 79.15 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -106.14 158.94 31.38 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 123.377 0.671 . . . . 0.0 110.899 -171.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -65.66 -178.08 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.289 2.659 . . . . 0.0 109.979 162.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.2 165.27 22.58 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 121.854 -0.529 . . . . 0.0 112.38 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -89.29 138.91 31.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.034 0.934 . . . . 0.0 110.812 -158.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 96.02 2.44 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 163.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.9 p -134.14 -165.0 1.58 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.317 1.047 . . . . 0.0 109.034 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.9 tp -109.89 14.96 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 125.49 1.516 . . . . 0.0 109.493 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--O 1.248 1.002 0 C-N-CA 124.69 1.196 . . . . 0.0 109.873 -177.969 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.237 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.35 77.72 1.13 Allowed 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.389 1.094 . . . . 0.0 108.14 -175.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mtm -164.43 174.71 10.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.381 2.272 . . . . 0.0 105.74 165.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.99 6.49 1.47 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.889 0.757 . . . . 0.0 112.275 -169.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.87 157.13 40.84 Favored Pre-proline 0 C--O 1.243 0.757 0 C-N-CA 126.705 2.002 . . . . 0.0 106.784 170.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.99 162.51 41.39 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.449 2.099 . . . . 0.0 109.243 172.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 p -72.06 147.22 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.54 144.36 50.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.919 1.688 . . . . 0.0 109.188 175.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CZ ' ' HE2' ' A' ' 40' ' ' LYS . 6.8 m-85 -127.2 136.98 52.8 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.981 1.712 . . . . 0.0 107.715 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.63 115.17 22.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.989 2.116 . . . . 0.0 107.898 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.44 75.2 1.5 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.861 2.064 . . . . 0.0 105.797 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -170.25 174.89 5.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.677 0.791 . . . . 0.0 110.288 -175.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -82.95 157.49 22.98 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.664 -0.647 . . . . 0.0 109.938 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.4 -63.99 1.29 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.279 0.561 . . . . 0.0 109.724 165.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -107.92 28.37 8.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.062 1.745 . . . . 0.0 111.027 -160.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.4 -11.43 0.07 OUTLIER Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 170.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.04 -119.31 4.51 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 120.336 2.068 . . . . 0.0 113.796 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.17 9.14 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.636 1.174 . . . . 0.0 112.843 -165.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 t -154.13 -173.4 4.56 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.978 0.808 . . . . 0.0 110.534 161.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.96 105.61 5.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 127.785 2.434 . . . . 0.0 109.322 -171.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -130.35 88.84 2.69 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -83.97 136.48 34.05 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -121.45 70.65 24.42 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.815 1.246 . . . . 0.0 108.392 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.53 171.89 12.31 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.767 1.645 . . . . 0.0 110.307 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -153.43 157.62 40.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.75 1.22 . . . . 0.0 108.276 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.28 -85.52 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.583 2.353 . . . . 0.0 110.106 -170.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 t -146.44 96.43 2.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.979 1.712 . . . . 0.0 108.928 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 m -146.63 89.42 1.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.828 -1.17 . . . . 0.0 112.207 162.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.09 135.9 43.55 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.682 1.193 . . . . 0.0 108.417 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.34 -172.31 40.11 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-N 118.871 0.759 . . . . 0.0 112.498 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.0 p -111.33 108.69 18.38 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.21 1.404 . . . . 0.0 109.683 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -132.81 -174.86 3.59 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.015 1.326 . . . . 0.0 112.89 -175.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 mt -140.57 125.22 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.094 1.358 . . . . 0.0 107.91 -169.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.3 mt -109.17 165.73 11.38 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.997 1.319 . . . . 0.0 110.57 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -84.51 83.63 7.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.076 0.941 . . . . 0.0 110.888 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.0 mt -109.36 119.55 58.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.46 1.104 . . . . 0.0 109.449 -170.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.5 m -84.77 135.3 34.18 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.549 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.7 t -155.19 89.27 1.2 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -162.75 165.89 24.97 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.925 0.89 . . . . 0.0 111.506 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.586 ' HE2' ' CZ ' ' A' ' 9' ' ' TYR . 11.0 ptpt -110.71 161.19 16.01 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.206 1.003 . . . . 0.0 109.113 172.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -134.17 124.98 26.94 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 125.968 1.707 . . . . 0.0 108.001 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.0 t -173.82 175.54 2.85 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.104 1.362 . . . . 0.0 108.073 173.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.56 -107.52 0.92 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -152.15 68.23 0.87 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.617 1.567 . . . . 0.0 107.499 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.8 m -160.87 172.21 17.38 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.687 1.995 . . . . 0.0 110.653 171.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 p -135.39 89.5 2.52 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.076 0.951 . . . . 0.0 110.147 161.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -79.13 140.04 37.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.698 1.135 . . . . 0.0 109.963 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.96 166.79 5.34 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.165 1.386 . . . . 0.0 111.417 171.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 22.5 mt -137.32 134.46 36.08 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.839 0.855 . . . . 0.0 109.512 162.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.5 p -71.63 173.68 7.76 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.817 1.647 . . . . 0.0 110.357 171.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -145.69 179.86 7.15 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.806 1.243 . . . . 0.0 111.318 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -125.88 162.44 25.18 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 127.27 2.228 . . . . 0.0 107.734 170.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.92 156.8 43.36 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.596 0.758 . . . . 0.0 109.236 165.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p 174.56 154.19 0.13 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.946 1.298 . . . . 0.0 112.64 167.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.41 -96.47 0.1 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.779 2.133 . . . . 0.0 109.055 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.21 167.72 11.7 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.898 0.849 . . . . 0.0 111.426 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.5 m -93.08 5.03 52.93 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -125.64 21.4 7.74 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.881 1.672 . . . . 0.0 112.461 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.7 mt -134.84 114.22 17.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -165.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -124.0 149.26 46.24 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.06 0.944 . . . . 0.0 109.898 -166.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -132.55 155.27 41.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -171.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.01 179.0 7.47 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.416 1.086 . . . . 0.0 108.849 165.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.72 -18.71 32.74 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 116.484 1.353 . . . . 0.0 116.484 -163.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 m -145.03 8.01 1.22 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.323 1.561 . . . . 0.0 111.16 163.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -109.99 151.45 27.13 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.697 1.599 . . . . 0.0 109.387 -163.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.19 138.25 53.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -142.18 152.26 42.98 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -159.23 168.02 27.54 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.855 0.862 . . . . 0.0 108.841 163.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -119.47 166.98 12.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.419 1.088 . . . . 0.0 110.565 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.13 175.31 7.62 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.403 1.097 . . . . 0.0 111.161 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -99.8 166.94 11.88 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.957 2.503 . . . . 0.0 110.945 -170.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -76.76 -28.6 6.25 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.826 2.351 . . . . 0.0 114.775 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.91 168.5 19.67 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.673 1.124 . . . . 0.0 110.883 -165.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -75.0 1.11 13.73 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 120.733 -1.229 . . . . 0.0 111.918 -170.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -65.0 161.25 19.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.231 0.538 . . . . 0.0 110.749 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.92 129.13 34.18 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.81 101.96 8.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 167.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.6 m -91.1 106.82 18.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 162.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.32 160.93 53.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.0 tp -161.46 93.94 0.95 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.38 0.59 . . . . 0.0 111.818 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 m -86.28 179.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.966 -0.458 . . . . 0.0 111.983 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.96 164.53 14.01 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 161.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.4 mp -134.01 164.78 26.54 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.848 1.659 . . . . 0.0 108.87 165.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -151.66 153.18 33.91 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 164.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -80.03 171.88 14.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 172.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -55.56 -39.41 70.6 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.902 1.281 . . . . 0.0 112.031 168.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -126.04 -44.97 1.73 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.893 -1.129 . . . . 0.0 111.845 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.4 t -79.47 -169.56 1.96 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.75 10.49 0.04 OUTLIER Glycine 0 C--O 1.223 -0.582 0 CA-C-O 117.09 -1.95 . . . . 0.0 116.422 -159.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.34 91.89 0.05 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 120.74 2.27 . . . . 0.0 109.194 169.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 p -71.6 145.01 49.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 75.1 mt -102.09 -179.06 3.89 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.16 -0.963 . . . . 0.0 108.57 176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.93 86.73 1.87 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.148 1.379 . . . . 0.0 110.681 -167.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.99 73.12 8.04 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.469 1.108 . . . . 0.0 109.473 -169.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -78.4 91.77 4.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.3 mt -87.49 102.41 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 176.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.08 81.51 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -172.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -95.98 156.37 37.24 Favored Pre-proline 0 C--O 1.242 0.674 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.451 -171.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -61.89 156.79 46.86 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.692 1.594 . . . . 0.0 108.715 162.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.78 153.17 25.59 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -94.95 155.33 16.79 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.405 1.482 . . . . 0.0 110.759 -172.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.06 101.72 0.87 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.5 p -147.15 179.41 7.65 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.162 0.985 . . . . 0.0 110.725 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.7 mp -77.44 84.92 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 103.825 -2.658 . . . . 0.0 103.825 160.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.456 -1.735 . . . . 0.0 109.869 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.141 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.9 p80 177.59 59.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -163.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -163.05 149.22 12.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.87 166.91 31.28 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 107.641 -2.184 . . . . 0.0 107.641 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 72.8 p -158.19 165.74 17.96 Favored Pre-proline 0 C--O 1.244 0.78 0 CA-C-N 117.745 0.772 . . . . 0.0 109.191 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -55.58 161.03 8.24 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.864 1.709 . . . . 0.0 110.99 163.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.9 p -74.83 113.92 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.69 1.196 . . . . 0.0 108.731 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.2 t -82.68 105.82 14.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.453 1.101 . . . . 0.0 108.351 -174.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -89.72 146.53 24.44 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.028 -1.045 . . . . 0.0 110.453 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -132.41 112.04 11.82 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.843 1.657 . . . . 0.0 108.884 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -144.51 92.32 2.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.036 0.934 . . . . 0.0 108.849 173.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 p -166.93 167.77 14.51 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.666 0.787 . . . . 0.0 110.018 172.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -72.97 172.33 11.15 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.027 0.531 . . . . 0.0 110.537 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.37 -22.1 44.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.463 0.705 . . . . 0.0 111.209 170.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -79.15 20.78 0.48 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.299 1.84 . . . . 0.0 112.468 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.88 52.17 52.2 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.636 -1.29 . . . . 0.0 112.693 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.92 -173.12 40.48 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.394 0.597 . . . . 0.0 113.564 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -131.96 17.3 4.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.108 2.163 . . . . 0.0 111.83 -166.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 t -151.58 137.42 18.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.521 -1.362 . . . . 0.0 108.835 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -108.08 125.49 51.64 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.0 m -130.69 93.71 3.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.04 143.82 31.28 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -122.09 65.91 21.89 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.85 1.26 . . . . 0.0 110.504 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.29 -176.49 2.95 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.031 1.821 . . . . 0.0 110.407 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -162.18 165.53 26.8 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.909 1.284 . . . . 0.0 108.023 -169.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 59.06 -77.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.651 2.38 . . . . 0.0 112.716 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.1 t -160.01 124.0 3.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.328 1.451 . . . . 0.0 107.584 149.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.93 31.31 3.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.947 0.794 . . . . 0.0 112.472 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.96 126.1 28.69 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.773 1.229 . . . . 0.0 111.221 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.04 -159.57 16.23 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.7 p -123.55 116.55 23.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.652 1.181 . . . . 0.0 109.265 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -130.14 -177.57 4.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.538 1.535 . . . . 0.0 110.821 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.1 mt -135.27 148.13 28.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.4 mt -128.11 161.12 29.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.612 1.165 . . . . 0.0 109.574 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -91.13 108.73 20.07 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.63 1.572 . . . . 0.0 108.668 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -119.82 138.63 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 C-N-CA 125.633 1.573 . . . . 0.0 107.954 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 m -79.92 129.33 34.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 117.868 -1.063 . . . . 0.0 108.852 164.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -148.29 71.61 1.17 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.199 1.363 . . . . 0.0 111.527 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -153.49 171.21 19.04 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.157 -0.965 . . . . 0.0 112.227 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.99 144.21 49.95 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.905 1.682 . . . . 0.0 108.827 167.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -117.42 133.8 55.56 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -172.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t 175.02 -171.47 0.06 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.603 2.361 . . . . 0.0 105.867 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 55.29 -107.93 0.88 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -143.21 26.05 1.68 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.16 0.984 . . . . 0.0 110.027 167.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.3 m -150.81 -164.89 2.12 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.002 1.321 . . . . 0.0 110.411 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 p -130.37 99.02 4.87 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.037 2.135 . . . . 0.0 107.856 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -73.05 123.03 22.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.32 161.21 14.39 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.656 0.782 . . . . 0.0 110.045 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.1 mt -138.03 153.49 49.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.223 1.009 . . . . 0.0 108.863 169.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -115.19 164.96 13.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.217 1.407 . . . . 0.0 109.808 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -145.71 165.69 28.03 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -168.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -121.83 153.91 37.74 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 127.441 2.297 . . . . 0.0 109.282 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.45 148.31 31.13 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.974 1.709 . . . . 0.0 108.157 169.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -166.94 154.55 9.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.305 0.642 . . . . 0.0 111.102 168.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.53 -69.23 0.06 OUTLIER Glycine 0 C--N 1.337 0.613 0 CA-C-O 121.322 0.401 . . . . 0.0 113.125 172.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.447 ' H ' HG11 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -75.74 -173.12 2.12 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.585 1.954 . . . . 0.0 109.69 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.21 23.14 11.48 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.5 1.52 . . . . 0.0 113.691 168.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -135.42 -3.24 2.41 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.7 mt -119.3 122.77 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.918 2.087 . . . . 0.0 107.955 -167.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -123.54 165.56 16.93 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.388 -0.82 . . . . 0.0 110.965 -169.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.7 p -146.64 140.78 20.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.131 0.972 . . . . 0.0 108.56 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.01 66.88 1.48 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.38 -119.05 15.45 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.939 -2.065 . . . . 0.0 107.939 -165.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.5 p -56.82 -25.24 55.54 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.127 1.771 . . . . 0.0 114.265 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 m -93.28 146.62 23.57 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.444 1.097 . . . . 0.0 109.366 -167.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.45 145.17 23.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.585 1.154 . . . . 0.0 109.197 -173.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 m -143.25 154.39 43.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -152.09 125.58 8.84 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 168.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -105.94 114.61 28.86 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.264 10.6 pt-20 -75.37 165.68 24.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.982 0.896 . . . . 0.0 112.939 -166.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.35 149.81 97.93 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.75 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -74.81 -9.57 21.11 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.041 2.494 . . . . 0.0 113.071 -169.417 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.53 -178.65 3.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.597 1.189 . . . . 0.0 110.728 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.97 13.87 21.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.216 1.806 . . . . 0.0 112.157 -170.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -80.04 152.51 29.36 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 172.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -82.75 138.44 34.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.744 1.218 . . . . 0.0 107.931 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -144.09 92.55 2.34 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.222 1.374 . . . . 0.0 111.327 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 45.6 m -68.87 115.61 8.4 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.181 -0.324 . . . . 0.0 110.514 173.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.24 162.56 29.69 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.157 0.884 . . . . 0.0 112.91 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.1 tp -162.69 115.11 1.62 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.82 1.248 . . . . 0.0 111.247 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.447 HG11 ' H ' ' A' ' 56' ' ' ASP . 3.2 m -103.19 179.32 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.357 1.063 . . . . 0.0 109.828 164.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 m -129.38 162.87 27.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 163.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -143.74 158.82 43.41 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 125.794 1.638 . . . . 0.0 112.406 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -150.54 159.89 44.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.501 1.12 . . . . 0.0 109.548 168.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -103.76 164.69 11.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.275 1.43 . . . . 0.0 110.256 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -54.99 -57.15 12.84 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.736 1.214 . . . . 0.0 113.345 -172.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -118.59 -6.64 10.67 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.239 0.616 . . . . 0.0 112.468 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.1 m -80.3 -154.64 0.1 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.088 0.955 . . . . 0.0 109.562 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.04 -1.24 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 118.138 -1.368 . . . . 0.0 115.502 173.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -64.1 107.4 1.27 Allowed 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.029 1.914 . . . . 0.0 106.721 170.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.1 p -63.32 155.3 29.09 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 161.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.3 mt -101.74 -166.11 1.26 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 164.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t -146.32 111.68 5.47 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 160.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.9 tp -83.78 122.24 28.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -120.74 154.25 35.89 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -131.43 121.47 48.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 103.711 -2.699 . . . . 0.0 103.711 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 45.7 t -127.47 105.85 14.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.64 165.84 22.76 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 124.257 1.023 . . . . 0.0 111.142 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -63.51 -177.97 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.516 2.144 . . . . 0.0 110.867 156.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.32 175.11 18.77 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.458 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -76.01 136.66 39.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.877 1.271 . . . . 0.0 112.054 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.53 8.07 0.09 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.976 2.11 . . . . 0.0 113.001 174.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.452 ' HG ' ' HB3' ' A' ' 105' ' ' ASP . 16.5 p -85.74 -173.02 4.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.321 1.049 . . . . 0.0 110.226 -162.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.5 mp -74.38 73.15 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 161.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.452 ' HB3' ' HG ' ' A' ' 103' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.922 0 C-N-CA 126.318 1.847 . . . . 0.0 106.853 173.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -67.88 161.68 25.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 169.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.4 tpt -64.5 144.34 57.26 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 157.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.04 -83.41 0.05 OUTLIER Glycine 0 C--O 1.225 -0.442 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 p -140.62 165.33 30.64 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 124.081 0.952 . . . . 0.0 109.52 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -61.3 136.72 65.95 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 N-CA-C 108.453 -1.403 . . . . 0.0 108.453 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 t -107.37 135.49 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 165.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.67 122.62 45.09 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 168.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -85.85 155.42 20.98 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 164.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -134.72 103.52 5.67 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.406 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 2.8 t80 -139.71 86.27 2.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 170.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.67 -170.03 3.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.838 2.055 . . . . 0.0 105.843 171.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -78.18 -89.31 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 166.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.79 -61.97 0.12 Allowed 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 119.073 -2.267 . . . . 0.0 110.788 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 p30 -127.12 2.48 6.47 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.844 2.058 . . . . 0.0 110.697 -167.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.25 -73.08 1.19 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 107.711 -2.155 . . . . 0.0 107.711 170.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.55 -154.8 25.55 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.7 p -79.85 20.11 0.64 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.468 1.907 . . . . 0.0 110.909 171.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.7 t -158.94 156.85 30.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.661 -1.274 . . . . 0.0 108.77 -165.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.9 157.4 46.47 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 157.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.0 m -131.45 152.34 50.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 158.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -133.94 150.78 51.31 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -127.88 74.33 78.7 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 126.11 1.764 . . . . 0.0 107.425 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.33 175.2 4.29 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.346 2.03 . . . . 0.0 109.846 167.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -161.03 173.92 14.51 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.395 -0.816 . . . . 0.0 109.11 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t0 55.93 -84.04 0.01 OUTLIER 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.963 2.505 . . . . 0.0 111.485 -173.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -145.39 125.71 13.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.103 2.561 . . . . 0.0 105.199 148.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 m -148.87 112.34 5.01 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.773 1.169 . . . . 0.0 110.4 163.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.6 179.24 6.68 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.0 1.72 . . . . 0.0 108.668 161.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.33 -176.56 32.91 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 174.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 m -109.17 101.61 10.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.835 1.254 . . . . 0.0 109.876 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -115.36 -165.01 0.99 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.465 1.906 . . . . 0.0 111.166 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.0 mt -127.53 148.14 32.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.586 1.554 . . . . 0.0 107.426 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.5 mt -132.03 165.32 24.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.849 2.059 . . . . 0.0 107.154 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.04 105.91 14.81 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -172.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.7 mt -132.52 142.13 43.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.67 1.588 . . . . 0.0 107.789 -163.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -112.23 129.9 56.11 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.063 1.345 . . . . 0.0 108.226 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -147.78 78.04 1.44 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.084 0.468 . . . . 0.0 110.162 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -157.04 175.76 13.65 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.774 -1.204 . . . . 0.0 111.567 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.58 148.54 43.2 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.989 0.916 . . . . 0.0 109.209 161.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -114.67 123.43 49.26 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 126.506 1.922 . . . . 0.0 107.413 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 t -173.98 -166.66 0.31 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.967 1.707 . . . . 0.0 107.113 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.33 -103.63 0.13 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.184 1.849 . . . . 0.0 109.552 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -147.11 21.14 1.23 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.976 0.91 . . . . 0.0 110.656 171.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 m -156.33 173.92 16.16 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 120.327 -1.483 . . . . 0.0 111.39 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -130.24 105.69 8.08 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.829 1.652 . . . . 0.0 107.087 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -83.23 139.83 32.88 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.2 146.12 45.77 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.641 0.655 . . . . 0.0 110.945 172.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.9 mt -101.77 133.14 46.96 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 165.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -73.2 166.52 22.99 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.753 1.221 . . . . 0.0 109.126 171.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.1 p90 -148.28 179.32 7.86 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.279 1.032 . . . . 0.0 111.844 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.93 172.31 12.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.782 1.633 . . . . 0.0 110.471 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.82 161.13 32.45 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.524 1.93 . . . . 0.0 109.617 169.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.9 p -153.64 140.25 18.88 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 163.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.19 -138.05 5.08 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.56 131.03 6.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.182 2.593 . . . . 0.0 111.076 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 m -80.27 30.99 0.27 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.93 1.292 . . . . 0.0 113.818 -173.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -133.52 23.65 4.04 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.584 1.554 . . . . 0.0 110.299 172.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -144.98 107.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -119.9 164.44 16.05 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.82 1.248 . . . . 0.0 108.925 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.34 152.76 13.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.281 0.562 . . . . 0.0 110.801 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.7 169.18 18.06 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 128.672 2.789 . . . . 0.0 109.433 166.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -58.68 -32.96 70.55 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.879 -0.4 . . . . 0.0 113.538 -177.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.36 11.5 8.7 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 t -153.47 142.81 21.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 119.553 1.069 . . . . 0.0 108.859 -170.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.7 t -120.91 150.97 23.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -171.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -139.0 134.18 32.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 165.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -127.34 138.15 52.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 155.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -99.33 -172.93 2.36 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -101.42 168.96 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.634 1.207 . . . . 0.0 108.825 170.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -76.28 160.54 77.62 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 124.738 1.215 . . . . 0.0 108.98 167.047 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -75.19 -47.23 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.245 1.964 . . . . 0.0 110.549 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.14 165.88 12.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.0 110.696 -170.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.23 2.32 50.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.049 0.94 . . . . 0.0 113.071 -171.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.42 148.85 46.51 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.523 -0.735 . . . . 0.0 110.129 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 139.6 58.38 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.65 0.78 . . . . 0.0 108.945 174.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -129.58 151.02 50.65 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.892 0.877 . . . . 0.0 109.858 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.9 m -120.61 100.65 7.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.849 1.26 . . . . 0.0 107.654 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.97 140.59 33.08 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.1 tp -152.79 103.18 2.75 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 117.886 0.843 . . . . 0.0 108.801 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.3 m -107.59 163.62 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 118.826 0.739 . . . . 0.0 110.592 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.6 m -107.72 158.08 17.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mp -138.22 158.46 44.25 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.313 1.845 . . . . 0.0 108.542 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.21 142.91 18.69 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.662 0.664 . . . . 0.0 110.678 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.412 ' HG2' ' H ' ' A' ' 88' ' ' SER . 7.9 tt0 -77.92 165.32 24.25 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 127.851 2.46 . . . . 0.0 111.013 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.63 -85.95 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.054 2.142 . . . . 0.0 112.719 167.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -89.53 -8.27 53.13 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.896 -1.127 . . . . 0.0 111.957 -168.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.412 ' H ' ' HG2' ' A' ' 85' ' ' GLN . 0.2 OUTLIER -136.95 -153.87 0.52 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.624 2.37 . . . . 0.0 108.076 177.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.92 44.52 0.02 OUTLIER Glycine 0 C--N 1.334 0.433 0 CA-C-N 120.467 1.485 . . . . 0.0 113.228 -151.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 103.18 0.15 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 148.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.6 p -69.25 133.35 47.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.75 155.53 19.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.37 151.65 21.94 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 157.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 tt -149.94 112.38 4.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.09 140.21 51.4 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -128.67 128.53 67.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 167.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.6 t -109.67 96.62 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 168.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -109.07 165.17 13.13 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 118.012 -0.994 . . . . 0.0 108.513 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -55.71 -162.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.553 1 C-N-CA 126.231 4.621 . . . . 0.0 112.906 163.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -120.49 168.91 13.97 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 116.745 -2.645 . . . . 0.0 112.679 147.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -103.6 158.86 16.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.969 1.308 . . . . 0.0 111.072 -168.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.41 103.01 0.72 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.447 2.299 . . . . 0.0 105.387 164.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 t -148.55 -175.72 5.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.425 1.011 . . . . 0.0 109.915 166.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -87.72 80.7 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t0 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 123.344 0.657 . . . . 0.0 110.024 177.722 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.21 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -59.36 155.32 14.92 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.444 1.122 . . . . 0.0 109.354 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.2 mtp -139.56 -168.1 2.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.834 1.653 . . . . 0.0 107.528 175.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.56 -43.18 3.16 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.4 p -49.39 144.53 8.64 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 124.693 1.197 . . . . 0.0 111.144 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.09 178.45 4.76 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.034 2.49 . . . . 0.0 110.86 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.87 162.19 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.34 1.056 . . . . 0.0 108.94 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -139.95 104.98 4.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.578 2.351 . . . . 0.0 107.878 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -86.02 152.8 22.62 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.797 1.239 . . . . 0.0 109.848 171.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.46 134.16 45.9 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.23 1.412 . . . . 0.0 107.332 -171.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -153.07 62.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.254 0.622 . . . . 0.0 111.173 -173.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.1 p -151.7 -169.24 3.31 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.017 -1.052 . . . . 0.0 110.663 176.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.507 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 70.3 m-85 -75.94 177.0 7.34 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 121.395 -0.816 . . . . 0.0 109.345 157.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.21 -23.7 14.0 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.609 1.164 . . . . 0.0 111.388 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -145.76 3.13 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.491 0.716 . . . . 0.0 112.28 -174.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.83 -79.42 1.46 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.507 ' H ' ' HB2' ' A' ' 13' ' ' TYR . . . 162.57 -125.12 1.37 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.436 1.97 . . . . 0.0 108.923 -172.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 p -135.25 17.19 3.43 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.577 1.551 . . . . 0.0 111.913 -168.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.51 175.11 12.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 120.471 -1.393 . . . . 0.0 110.827 166.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 122.53 32.46 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.785 2.034 . . . . 0.0 107.029 -173.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 26.4 m -149.62 88.27 1.55 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.58 139.24 38.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -124.88 74.62 65.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 170.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.89 173.86 11.35 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.258 2.639 . . . . 0.0 110.229 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.61 147.57 25.51 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.496 -0.752 . . . . 0.0 111.41 -169.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 61.86 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.96 2.104 . . . . 0.0 108.974 -164.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.5 t -160.18 114.57 2.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 172.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.18 112.37 8.59 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.01 157.66 44.33 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.467 1.507 . . . . 0.0 109.279 -174.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.88 -178.52 31.55 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 160.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.4 p -102.34 113.73 27.29 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.147 1.379 . . . . 0.0 109.847 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -130.89 -170.2 2.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.78 1.232 . . . . 0.0 112.835 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 mt -131.3 151.66 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.717 2.407 . . . . 0.0 107.194 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.5 mt -131.87 154.82 48.8 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.23 1.812 . . . . 0.0 109.07 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -86.14 55.85 3.72 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.015 1.326 . . . . 0.0 110.099 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.0 mt -71.53 156.85 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.787 1.235 . . . . 0.0 110.327 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 m -127.69 107.69 10.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.135 1.774 . . . . 0.0 109.27 -169.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.37 86.77 1.35 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 122.561 0.344 . . . . 0.0 110.328 -174.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -156.11 165.01 37.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.539 0.336 . . . . 0.0 110.883 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.98 130.92 55.95 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.92 1.688 . . . . 0.0 109.5 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -116.35 127.53 54.75 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.554 1.941 . . . . 0.0 106.781 -170.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.6 t -168.99 143.33 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.93 -104.69 0.77 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -133.8 21.03 3.86 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.003 0.921 . . . . 0.0 111.166 -170.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -149.21 162.89 39.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.874 1.321 . . . . 0.0 110.253 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -132.39 115.23 15.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 130.038 3.335 . . . . 0.0 105.629 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.08 111.36 20.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -170.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.49 157.55 37.4 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.259 0.35 . . . . 0.0 110.804 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.31 130.56 40.96 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.48 1.512 . . . . 0.0 110.76 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -71.12 178.39 3.3 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.43 1.492 . . . . 0.0 110.978 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -147.43 177.35 9.3 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.502 1.121 . . . . 0.0 109.702 168.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.25 165.73 26.42 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.644 1.577 . . . . 0.0 109.85 166.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.33 156.55 44.73 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.225 1.81 . . . . 0.0 109.099 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.1 m -155.35 144.12 20.59 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.314 1.046 . . . . 0.0 110.216 173.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.85 -86.88 0.1 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 167.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.7 160.11 30.89 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.37 1.085 . . . . 0.0 111.426 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -82.47 -8.12 59.62 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -129.87 28.15 5.11 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.748 1.158 . . . . 0.0 112.32 -160.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.8 mt -132.76 101.81 4.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -75.32 133.1 41.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.208 1.003 . . . . 0.0 109.884 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.57 142.35 41.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.963 1.305 . . . . 0.0 109.919 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.16 155.79 41.18 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 126.3 1.84 . . . . 0.0 107.533 177.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.45 -11.13 46.47 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.889 0.757 . . . . 0.0 114.245 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.6 m -134.72 -4.86 2.51 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.451 1.125 . . . . 0.0 113.463 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.7 m -140.05 164.77 29.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.876 1.671 . . . . 0.0 110.361 -167.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.19 154.85 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.588 1.155 . . . . 0.0 108.255 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.1 159.5 42.87 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 158.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -132.8 107.82 8.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 165.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.46 166.89 15.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.508 0.671 . . . . 0.0 109.592 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.91 174.37 6.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -108.5 163.92 15.89 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.851 0.86 . . . . 0.0 111.123 -168.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -89.82 -11.76 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.141 3.228 . . . . 0.0 113.978 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.33 130.69 31.11 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -171.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.28 22.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.451 1.9 . . . . 0.0 112.301 -164.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -66.45 166.48 12.4 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 160.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -85.5 156.07 20.95 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 163.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -135.28 157.67 46.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 164.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.9 m -135.21 97.21 3.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -176.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.39 163.83 45.56 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 117.934 0.334 . . . . 0.0 113.112 -168.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 tp -153.84 125.77 7.79 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.786 1.635 . . . . 0.0 109.403 159.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.14 155.01 31.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 160.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.9 m -100.63 156.24 17.42 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 159.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.02 161.25 31.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.373 1.869 . . . . 0.0 107.719 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.414 ' HE2' ' O ' ' A' ' 88' ' ' SER . 68.6 tttt -139.81 145.39 38.1 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -70.91 171.81 10.05 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 168.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -56.27 -65.11 0.66 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.617 0.767 . . . . 0.0 111.855 172.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -118.07 5.18 12.03 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.845 1.258 . . . . 0.0 112.211 -167.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.414 ' O ' ' HE2' ' A' ' 84' ' ' LYS . 17.8 t -135.81 -158.87 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.301 1.44 . . . . 0.0 107.913 162.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.51 72.8 0.36 Allowed Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 106.489 -2.644 . . . . 0.0 106.489 -170.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -61.42 86.74 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 147.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 p -97.5 113.69 25.43 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 104.286 -2.486 . . . . 0.0 104.286 170.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.5 mt -131.61 157.54 43.4 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 m -120.44 114.61 22.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.118 1.326 . . . . 0.0 108.406 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.91 71.43 3.43 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.66 0.743 . . . . 0.0 112.167 -162.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -85.64 82.8 8.09 Favored 'General case' 0 C--O 1.226 -0.184 0 O-C-N 121.066 -1.021 . . . . 0.0 109.423 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.49 125.93 34.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 163.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.52 67.11 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -99.39 151.8 37.56 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 123.711 0.805 . . . . 0.0 112.098 -170.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.03 -172.14 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.724 3.616 . . . . 0.0 112.707 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.72 166.27 22.57 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.97 144.8 50.18 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.545 1.538 . . . . 0.0 108.691 -163.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.9 p -152.34 64.63 0.82 Allowed 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.478 1.111 . . . . 0.0 109.848 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -140.03 -172.28 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.442 -0.786 . . . . 0.0 110.867 -164.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 49.1 mt -93.04 70.03 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 C--O 1.241 0.653 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -178.891 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.344 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -128.99 72.67 1.47 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 74.9 mtm -147.81 160.25 42.96 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 164.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.47 93.8 1.02 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 106.441 -2.663 . . . . 0.0 106.441 -168.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -145.69 158.52 49.66 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 124.236 1.014 . . . . 0.0 108.877 -166.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -67.56 173.12 9.36 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.393 2.062 . . . . 0.0 111.554 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.78 140.75 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.642 1.177 . . . . 0.0 109.231 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 m -92.99 129.44 38.9 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 166.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -106.73 148.51 28.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 162.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -126.66 105.64 8.84 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.414 1.486 . . . . 0.0 107.308 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.08 56.77 1.78 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.777 1.631 . . . . 0.0 109.456 -165.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.9 p -159.78 -175.69 5.29 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.368 1.067 . . . . 0.0 109.136 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -65.85 161.08 21.84 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.46 -15.85 25.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.104 0.961 . . . . 0.0 112.322 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -148.47 41.21 0.95 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.596 0.713 . . . . 0.0 111.434 -170.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.71 -83.63 0.05 OUTLIER Glycine 0 C--N 1.335 0.501 0 O-C-N 121.274 -0.891 . . . . 0.0 111.607 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.65 -125.37 0.78 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 117.136 0.468 . . . . 0.0 113.384 -171.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -139.22 10.51 2.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.102 0.961 . . . . 0.0 112.245 -163.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.39 173.16 17.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.919 2.088 . . . . 0.0 109.498 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -128.53 142.92 50.92 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 127.715 2.406 . . . . 0.0 108.716 173.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -153.22 90.73 1.45 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.716 1.207 . . . . 0.0 108.834 172.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.31 151.03 23.46 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 121.718 -0.614 . . . . 0.0 109.554 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -134.58 69.23 72.57 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.398 1.079 . . . . 0.0 109.342 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.73 175.32 9.07 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.436 2.091 . . . . 0.0 111.117 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -149.19 172.25 15.14 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.377 1.471 . . . . 0.0 107.962 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t0 59.79 -85.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.167 2.587 . . . . 0.0 109.979 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.4 p -142.29 4.13 1.58 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.641 1.176 . . . . 0.0 113.986 -176.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -78.4 67.92 4.29 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -163.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.5 117.74 19.21 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 127.086 2.154 . . . . 0.0 107.899 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.25 -163.09 26.35 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -167.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.4 p -116.99 114.41 23.75 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 117.766 0.783 . . . . 0.0 111.773 -162.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -133.58 -169.92 2.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.752 1.221 . . . . 0.0 110.77 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.8 mt -142.91 146.49 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.819 1.648 . . . . 0.0 107.091 -170.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.5 mt -126.37 175.81 7.58 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.064 1.345 . . . . 0.0 111.396 -171.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -110.81 91.77 3.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -164.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mt -125.92 150.84 31.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -163.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.02 134.14 54.65 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.6 t -153.19 44.88 0.65 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.448 1.099 . . . . 0.0 109.549 -172.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -140.03 169.06 18.39 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 120.73 -1.231 . . . . 0.0 111.765 -172.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -117.63 158.56 24.42 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.56 1.144 . . . . 0.0 109.175 168.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -138.73 135.59 34.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.928 1.691 . . . . 0.0 108.379 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.0 t -176.27 149.47 0.85 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.43 -101.86 0.32 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.959 1.266 . . . . 0.0 111.345 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -141.71 34.29 1.61 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.425 1.09 . . . . 0.0 110.953 -171.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 m -151.52 174.11 13.8 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.96 -1.087 . . . . 0.0 110.58 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -122.44 154.92 37.13 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 155.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -138.62 123.93 19.31 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.46 160.75 26.86 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.959 0.787 . . . . 0.0 109.793 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.81 -159.08 0.68 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 162.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.1 m -130.36 174.92 9.39 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.343 1.857 . . . . 0.0 108.458 169.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -152.51 173.41 15.18 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.691 -0.631 . . . . 0.0 111.761 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -143.55 172.64 12.52 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.062 1.345 . . . . 0.0 109.93 172.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.65 159.24 38.23 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.237 1.815 . . . . 0.0 109.112 -175.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 p 179.18 161.02 0.74 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.647 0.779 . . . . 0.0 111.418 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.66 -78.09 0.09 OUTLIER Glycine 0 C--N 1.334 0.471 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -102.66 -160.72 0.8 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.449 1.5 . . . . 0.0 110.832 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.3 p -123.98 14.59 9.21 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -133.43 28.27 4.03 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.744 1.218 . . . . 0.0 111.013 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -135.68 84.76 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -171.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -59.82 125.17 22.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.3 t -118.71 152.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 163.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.55 173.26 11.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 159.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.44 -50.9 12.89 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -125.99 40.89 3.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.986 0.914 . . . . 0.0 111.169 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.16 163.23 35.01 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.98 0.809 . . . . 0.0 110.647 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.74 142.87 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.323 1.449 . . . . 0.0 107.641 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.89 168.55 26.85 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.337 -1.477 . . . . 0.0 109.047 163.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.99 154.1 41.52 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 172.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.61 151.25 35.3 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 122.718 0.407 . . . . 0.0 110.04 175.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -72.41 169.83 15.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.883 0.849 . . . . 0.0 111.567 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.51 154.09 43.96 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 124.565 1.146 . . . . 0.0 110.514 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.42 -5.68 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.945 2.43 . . . . 0.0 113.426 -166.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.91 167.18 11.18 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.986 0.898 . . . . 0.0 109.971 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -77.12 0.56 21.13 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 120.841 -1.162 . . . . 0.0 111.954 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -59.64 144.03 48.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.153 0.981 . . . . 0.0 108.917 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -77.42 136.71 38.42 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 161.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -122.37 134.14 54.64 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.502 1.121 . . . . 0.0 108.996 -175.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.7 m -122.94 105.32 9.89 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.708 1.203 . . . . 0.0 108.016 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.75 167.28 52.75 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 tp -155.96 59.89 0.59 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.6 t -72.53 148.44 9.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 121.649 -0.657 . . . . 0.0 109.733 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.422 HG22 ' H ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -112.71 170.62 8.06 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.54 0.736 . . . . 0.0 109.264 169.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.422 ' H ' HG22 ' A' ' 82' ' ' THR . 4.5 mp -136.73 163.84 29.67 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.804 1.642 . . . . 0.0 109.444 175.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.482 ' HG2' ' H ' ' A' ' 85' ' ' GLN . 48.8 tttt -147.84 172.78 13.6 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.241 2.216 . . . . 0.0 106.621 163.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.482 ' H ' ' HG2' ' A' ' 84' ' ' LYS . 20.8 tt0 -126.24 162.55 25.19 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.398 1.479 . . . . 0.0 107.158 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -56.38 -59.3 5.17 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.685 0.794 . . . . 0.0 111.88 -165.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -99.93 -27.8 13.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 111.529 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -101.65 -162.51 0.94 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.261 1.024 . . . . 0.0 111.811 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.1 67.52 0.41 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -63.03 92.96 0.06 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 152.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.0 p -95.65 103.99 15.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 165.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.98 158.36 16.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.3 m -117.77 125.16 50.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.429 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 5.8 tp -107.92 95.83 5.96 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.476 1.511 . . . . 0.0 107.869 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -108.96 90.36 3.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 mp -72.44 141.59 16.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 160.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.8 t -128.03 92.97 2.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 165.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -112.67 147.45 37.16 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.697 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -67.44 -167.88 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.777 3.652 . . . . 0.0 110.777 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.8 160.28 26.59 Favored Glycine 0 C--O 1.24 0.5 0 O-C-N 121.769 -0.582 . . . . 0.0 111.905 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.93 177.37 7.88 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.667 2.387 . . . . 0.0 108.191 -171.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.2 p -148.38 97.26 2.73 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.9 p -130.12 -164.86 1.46 Allowed 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 125.015 1.326 . . . . 0.0 108.324 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.45 66.4 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 C--O 1.249 1.05 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 174.194 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.684 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -129.08 84.67 2.25 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -167.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.9 ptm -72.2 144.58 48.46 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.07 67.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -176.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.8 p -149.0 165.33 17.99 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 123.828 0.851 . . . . 0.0 109.401 174.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.68 -176.92 2.22 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.092 1.862 . . . . 0.0 110.958 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.8 95.95 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 127.29 2.236 . . . . 0.0 107.965 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.2 t -74.02 145.46 44.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.635 1.574 . . . . 0.0 109.207 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -126.95 153.38 45.91 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.906 1.283 . . . . 0.0 109.307 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -134.81 115.28 13.5 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.951 2.1 . . . . 0.0 106.314 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.402 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 4.1 t80 -145.07 79.21 1.58 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.3 p -154.33 -175.88 5.61 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.967 0.507 . . . . 0.0 109.827 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.474 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 62.6 m-85 -63.89 165.19 9.05 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 157.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.48 -31.42 11.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.237 1.015 . . . . 0.0 110.972 168.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -130.53 73.77 1.56 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.56 -56.98 0.11 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.261 162.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.474 ' H ' ' HB2' ' A' ' 13' ' ' TYR . . . 158.42 -136.6 4.84 Favored Glycine 0 CA--C 1.52 0.347 0 O-C-N 121.92 -0.753 . . . . 0.0 112.629 -167.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 p -137.58 23.8 2.91 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.25 1.02 . . . . 0.0 112.168 -166.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 t -167.59 166.44 14.06 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.784 1.234 . . . . 0.0 110.845 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.22 135.92 53.65 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.831 2.853 . . . . 0.0 112.647 174.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 m -147.14 84.78 1.59 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.575 1.15 . . . . 0.0 108.005 173.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -83.07 140.75 32.49 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.67 77.19 37.6 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -74.49 168.14 25.51 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 120.939 1.093 . . . . 0.0 109.387 165.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -162.19 160.82 27.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.68 1.992 . . . . 0.0 106.675 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.5 t70 60.53 -80.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.703 1.601 . . . . 0.0 111.918 -167.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 t -165.21 85.64 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.772 1.229 . . . . 0.0 108.009 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.4 m -135.85 24.48 3.35 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.03 122.28 20.62 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.191 1.396 . . . . 0.0 108.895 169.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.31 -175.69 36.85 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 119.042 0.837 . . . . 0.0 111.155 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.4 p -96.59 126.95 42.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.201 1.4 . . . . 0.0 109.029 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -128.39 -177.49 4.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 169.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 mt -139.51 143.19 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 129.645 3.178 . . . . 0.0 105.554 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.7 mt -121.2 -168.68 1.71 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.118 1.767 . . . . 0.0 110.18 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -129.98 51.23 2.11 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.056 1.342 . . . . 0.0 109.026 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.4 mt -82.05 125.0 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.182 0.993 . . . . 0.0 108.937 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 m -71.05 134.68 47.28 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.566 1.546 . . . . 0.0 109.411 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -144.52 108.71 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -167.35 170.84 11.14 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.693 0.759 . . . . 0.0 110.907 160.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.74 135.04 54.38 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.245 1.818 . . . . 0.0 108.105 161.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -114.82 123.17 48.52 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 125.563 1.545 . . . . 0.0 109.347 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 t -159.74 153.24 22.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.88 -82.81 0.07 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.095 1.807 . . . . 0.0 110.687 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -145.92 -1.13 0.78 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.074 1.35 . . . . 0.0 111.539 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 p -134.5 172.62 12.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.128 -1.607 . . . . 0.0 112.461 -162.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.0 p -130.71 123.06 28.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 127.415 2.286 . . . . 0.0 106.877 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.23 109.12 20.42 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.56 155.23 40.82 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.299 0.64 . . . . 0.0 109.545 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.2 mt -121.33 147.27 45.9 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.637 0.775 . . . . 0.0 110.961 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -79.67 160.16 26.42 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 168.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -138.97 174.67 10.27 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.277 1.031 . . . . 0.0 111.737 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -150.01 148.49 29.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.676 1.191 . . . . 0.0 109.47 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -150.81 160.78 43.65 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.278 1.831 . . . . 0.0 109.458 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 p 174.85 145.99 0.07 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.337 0.655 . . . . 0.0 110.471 -176.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.54 -91.3 0.1 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 168.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.27 164.58 3.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.86 2.064 . . . . 0.0 111.288 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 m -92.46 -1.1 57.22 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.74 1.616 . . . . 0.0 115.143 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 44.7 p-90 -129.54 29.84 5.01 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.198 1.399 . . . . 0.0 108.954 -174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.0 mt -142.81 88.29 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -88.42 171.89 9.78 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.939 0.896 . . . . 0.0 108.671 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -157.61 157.42 3.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.73 1.212 . . . . 0.0 108.752 166.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.45 -179.34 6.36 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.396 2.678 . . . . 0.0 108.014 172.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -45.18 -51.71 8.76 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.86 1.219 . . . . 0.0 113.544 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.0 m -124.87 -7.83 7.26 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 118.22 -0.895 . . . . 0.0 113.394 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 m -120.67 155.87 32.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.606 1.094 . . . . 0.0 110.625 -169.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -137.69 162.11 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.9 m -147.58 137.44 22.84 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 162.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -123.27 104.07 8.91 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -74.3 173.5 10.13 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 122.208 1.004 . . . . 0.0 112.365 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.424 ' HG3' HE22 ' A' ' 98' ' ' GLN . 4.9 tt0 -83.04 -165.71 1.15 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.153 2.181 . . . . 0.0 109.969 175.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -128.63 165.23 32.94 Favored Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 126.544 1.938 . . . . 0.0 109.492 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -93.91 -10.23 1.62 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.033 2.489 . . . . 0.0 113.226 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.27 139.65 51.73 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.734 1.214 . . . . 0.0 109.114 -171.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 12.12 8.19 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.283 0.633 . . . . 0.0 112.602 -160.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.53 158.25 36.44 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 170.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -67.84 159.28 30.69 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -132.83 145.22 50.77 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 m -118.41 77.69 1.19 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.312 1.445 . . . . 0.0 107.529 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -72.2 132.54 19.03 Favored Glycine 0 N--CA 1.464 0.552 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 tp -149.49 70.76 1.08 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.207 1.003 . . . . 0.0 112.3 -166.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.96 164.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.444 0.64 . . . . 0.0 110.337 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -111.93 158.01 19.99 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.271 1.029 . . . . 0.0 108.566 168.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.69 146.35 43.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 127.147 2.179 . . . . 0.0 107.35 -173.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -157.26 168.7 26.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.099 1.359 . . . . 0.0 107.797 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.402 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 5.8 tt0 -119.16 164.77 15.09 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.683 1.129 . . . . 0.0 110.61 -170.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -45.17 -55.87 5.34 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.55 1.94 . . . . 0.0 111.853 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -126.52 -1.73 6.81 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.089 1.756 . . . . 0.0 111.136 -169.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.38 -177.99 3.97 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.828 1.651 . . . . 0.0 110.945 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.4 8.55 0.09 OUTLIER Glycine 0 C--O 1.226 -0.401 0 C-N-CA 118.546 -1.788 . . . . 0.0 115.508 -149.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -78.2 97.29 5.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 p -78.69 114.19 17.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -167.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.16 130.04 35.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.7 m -83.4 125.51 31.76 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 165.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.94 104.16 10.25 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.969 1.708 . . . . 0.0 106.508 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -119.67 95.02 4.6 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.086 0.954 . . . . 0.0 109.797 -166.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.2 114.65 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 79.5 t -104.19 101.33 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.424 HE22 ' HG3' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -133.05 156.8 79.65 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.705 -177.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.85 -163.19 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.624 1 C-N-CA 126.589 4.859 . . . . 0.0 110.814 172.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.12 168.2 27.12 Favored Glycine 0 N--CA 1.445 -0.711 0 O-C-N 120.658 -1.276 . . . . 0.0 113.708 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -111.14 173.64 6.24 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.2 1.8 . . . . 0.0 110.159 175.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.25 92.56 2.12 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 170.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 t -138.39 -174.51 3.83 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.656 0.782 . . . . 0.0 109.364 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.7 mp -82.64 76.86 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 126.238 1.815 . . . . 0.0 108.528 175.45 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.894 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -64.6 88.74 0.06 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.852 1.261 . . . . 0.0 111.439 -172.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -140.57 158.45 43.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.299 1.84 . . . . 0.0 106.375 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.23 0.72 85.94 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.846 -0.974 . . . . 0.0 112.747 175.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 m -55.27 144.55 50.66 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-N 118.75 1.275 . . . . 0.0 109.905 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.08 155.23 70.66 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.703 1.602 . . . . 0.0 109.307 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.52 147.77 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -136.37 110.26 8.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 165.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -79.29 153.59 29.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 163.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -121.7 117.9 27.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -137.96 60.56 1.62 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.913 0.863 . . . . 0.0 110.951 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 p -154.41 -167.44 2.62 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.45 1.1 . . . . 0.0 109.075 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -65.3 -179.6 0.62 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.375 0.67 . . . . 0.0 111.262 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.56 -28.15 12.34 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 121.316 -0.865 . . . . 0.0 111.573 162.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.89 12.2 2.45 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.354 0.662 . . . . 0.0 111.874 -165.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.71 -67.66 0.14 Allowed Glycine 0 C--N 1.335 0.512 0 O-C-N 121.254 -0.904 . . . . 0.0 113.537 -152.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.38 -126.66 2.85 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -153.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.1 p -144.16 3.63 1.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -171.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 m -162.96 174.53 12.22 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.333 1.424 . . . . 0.0 111.175 174.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 144.1 50.13 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 128.016 2.527 . . . . 0.0 113.962 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -141.6 146.76 36.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.352 1.461 . . . . 0.0 108.139 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -136.77 163.13 31.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.174 -0.954 . . . . 0.0 110.702 157.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -135.88 76.19 53.54 Favored Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.21 171.99 10.68 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.493 2.129 . . . . 0.0 109.213 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -160.54 0.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -153.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -165.9 -73.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.7 t -165.24 97.27 0.71 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.483 1.913 . . . . 0.0 106.879 167.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -123.74 24.49 8.41 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 168.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.83 155.03 40.87 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 166.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.87 -151.12 22.28 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.2 m -135.27 102.55 5.21 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.012 0.906 . . . . 0.0 112.659 -173.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -123.32 -164.63 1.23 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.628 1.171 . . . . 0.0 113.201 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 mt -138.13 158.35 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 127.711 2.405 . . . . 0.0 107.2 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 98.2 mt -132.89 173.1 11.75 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.086 1.755 . . . . 0.0 111.016 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -109.63 88.04 2.65 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.042 -1.037 . . . . 0.0 110.363 -156.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.443 ' CG2' ' HE3' ' A' ' 90' ' ' LYS . 6.6 mt -129.88 158.51 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.646 1.178 . . . . 0.0 109.712 -163.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 m -122.93 142.53 50.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.308 1.043 . . . . 0.0 109.68 -172.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 p -159.99 36.35 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.668 -0.645 . . . . 0.0 112.679 -161.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -128.51 169.3 14.52 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.339 -1.476 . . . . 0.0 110.955 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.8 121.16 38.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.98 1.312 . . . . 0.0 107.49 170.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -90.77 139.81 30.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.0 t -164.91 133.13 3.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 50.0 -98.0 0.02 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.986 1.279 . . . . 0.0 110.845 -173.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -130.43 21.34 5.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.28 1.032 . . . . 0.0 112.27 -164.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 t -148.64 176.72 10.11 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.315 1.416 . . . . 0.0 111.29 167.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 p -136.94 91.87 2.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.65 1.98 . . . . 0.0 109.593 -173.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.49 104.27 5.14 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.65 146.9 44.22 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 172.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.3 mt -117.93 149.03 41.58 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.073 0.949 . . . . 0.0 110.497 -175.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.1 m -65.64 164.58 14.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.495 164.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -144.47 173.81 11.47 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.101 1.36 . . . . 0.0 110.081 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -135.37 175.01 9.98 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.013 0.925 . . . . 0.0 109.778 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.48 152.09 39.23 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 125.531 1.532 . . . . 0.0 109.066 172.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.28 140.15 8.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.58 -127.72 1.66 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -61.73 162.35 8.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.941 2.096 . . . . 0.0 111.939 -175.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.21 -18.64 57.58 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.353 1.861 . . . . 0.0 114.23 -168.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -121.22 15.01 11.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.291 1.836 . . . . 0.0 111.682 -165.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.7 mt -118.06 85.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.992 -2.595 . . . . 0.0 103.992 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -83.41 137.5 33.9 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.3 89.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -77.96 86.42 4.16 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -172.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.07 -104.42 0.88 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -97.61 -7.44 31.11 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.277 1.031 . . . . 0.0 113.089 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 m -83.69 164.56 19.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.696 1.135 . . . . 0.0 109.949 174.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.92 158.34 35.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.749 1.62 . . . . 0.0 108.274 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.8 t -156.42 158.53 37.47 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.156 1.782 . . . . 0.0 107.256 166.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -156.98 168.63 26.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 163.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.49 159.15 42.01 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.865 1.266 . . . . 0.0 107.818 -177.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -71.34 164.29 26.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.195 0.997 . . . . 0.0 113.15 -174.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -77.13 144.61 71.86 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.604 1.562 . . . . 0.0 108.623 168.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -90.13 -4.63 5.13 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.649 3.566 . . . . 0.0 113.648 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.98 161.58 13.93 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.173 -0.954 . . . . 0.0 109.927 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.55 62.93 0.85 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 123.334 1.54 . . . . 0.0 107.846 174.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -132.56 176.72 8.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.766 167.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -76.95 157.5 31.25 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 167.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.9 tpt85 -150.5 173.42 14.09 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 t -149.4 165.8 30.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 158.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.6 176.66 20.93 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 156.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tp -157.61 65.48 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.07 0.935 . . . . 0.0 113.109 177.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.9 m -76.62 171.76 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 121.123 -0.985 . . . . 0.0 111.071 -172.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -123.38 164.74 18.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.78 1.632 . . . . 0.0 108.48 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.04 170.65 11.53 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.817 1.247 . . . . 0.0 109.223 173.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -153.32 172.93 16.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.859 0.864 . . . . 0.0 109.651 161.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -111.7 172.23 7.02 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.379 0.991 . . . . 0.0 110.807 -176.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -56.63 -51.3 69.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.327 1.051 . . . . 0.0 112.153 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -111.17 -42.62 3.9 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.719 0.808 . . . . 0.0 109.766 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.4 -169.65 0.43 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.177 1.391 . . . . 0.0 111.301 -171.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -132.22 42.32 1.4 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 126.117 1.818 . . . . 0.0 109.023 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.443 ' HE3' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -58.34 97.61 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 117.78 0.79 . . . . 0.0 108.942 174.875 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -110.88 110.8 21.55 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.9 165.77 11.79 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 168.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.0 t -127.13 144.65 50.98 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.389 1.476 . . . . 0.0 107.891 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.83 104.38 8.01 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.606 1.562 . . . . 0.0 108.995 -170.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -116.94 101.4 8.48 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.373 0.669 . . . . 0.0 109.881 -169.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -98.01 86.67 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.48 88.57 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.94 158.77 41.4 Favored Pre-proline 0 C--O 1.24 0.596 0 C-N-CA 124.125 0.97 . . . . 0.0 111.577 -165.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.36 -163.39 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 124.312 3.341 . . . . 0.0 109.377 160.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.92 166.96 29.93 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 171.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.55 177.08 11.78 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.469 1.108 . . . . 0.0 110.404 -176.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.3 p -149.02 96.47 2.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 164.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.57 172.73 12.59 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.69 0.796 . . . . 0.0 111.288 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.6 pt -83.84 33.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 125.007 1.323 . . . . 0.0 109.913 166.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 117.18 -1.39 . . . . 0.0 107.809 163.657 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.941 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -63.93 164.42 10.38 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 141.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.0 ttt -156.43 155.07 31.46 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.28 96.75 1.25 Allowed Glycine 0 CA--C 1.52 0.395 0 N-CA-C 107.66 -2.176 . . . . 0.0 107.66 167.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.8 p -152.2 149.01 22.13 Favored Pre-proline 0 C--O 1.238 0.49 0 CA-C-N 117.982 0.891 . . . . 0.0 109.533 169.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.5 154.06 75.42 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.083 1.855 . . . . 0.0 108.607 167.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.02 129.6 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -79.72 127.19 31.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 168.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -108.75 152.53 24.72 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.278 0.945 . . . . 0.0 109.646 161.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -129.29 125.18 36.23 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.099 1.76 . . . . 0.0 106.91 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.96 23.42 0.5 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.618 1.967 . . . . 0.0 110.478 -169.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.4 p -149.68 174.08 12.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.3 1.04 . . . . 0.0 110.777 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -75.69 160.31 30.2 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.896 0.878 . . . . 0.0 112.482 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.87 -50.3 15.45 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.804 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -141.22 55.23 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.85 3.11 0.26 Allowed Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.394 -1.276 . . . . 0.0 113.593 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.25 -119.63 6.77 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 119.212 1.506 . . . . 0.0 110.977 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.94 5.58 2.83 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.124 0.962 . . . . 0.0 113.245 -173.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.7 162.51 39.8 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.472 0.709 . . . . 0.0 109.535 170.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.402 ' H ' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -112.71 139.76 48.05 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.065 1.746 . . . . 0.0 108.047 -175.564 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.2 m -146.9 89.19 1.79 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -91.49 136.16 33.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -118.98 64.37 6.59 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-O 118.678 -0.677 . . . . 0.0 110.307 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.11 -174.19 1.3 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.378 2.052 . . . . 0.0 111.462 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -117.17 -163.46 0.92 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.689 2.396 . . . . 0.0 109.935 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.425 ' C ' ' HG ' ' A' ' 27' ' ' SER . 0.4 OUTLIER -63.06 -18.26 63.17 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.727 1.611 . . . . 0.0 112.391 -174.021 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.425 ' HG ' ' C ' ' A' ' 26' ' ' ASP . 13.0 m -153.09 65.27 0.77 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.259 1.39 . . . . 0.0 112.185 178.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 t -150.95 24.89 0.74 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.16 167.68 4.85 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.092 -1.005 . . . . 0.0 110.495 159.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.01 -152.17 22.96 Favored Glycine 0 C--N 1.341 0.809 0 O-C-N 121.333 -0.854 . . . . 0.0 111.359 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -135.1 100.71 4.64 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.306 1.442 . . . . 0.0 111.017 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -118.83 -177.82 3.41 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.102 1.361 . . . . 0.0 112.717 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 mt -126.82 147.88 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.2 mt -119.49 173.98 6.66 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 127.013 2.125 . . . . 0.0 109.892 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -101.96 51.34 0.83 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 123.553 1.644 . . . . 0.0 109.928 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.0 mt -72.09 139.36 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.428 1.491 . . . . 0.0 107.199 174.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 m -113.37 132.47 55.59 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.9 t -152.49 72.69 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -167.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -158.21 172.73 17.86 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.49 -1.381 . . . . 0.0 111.372 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 146.43 42.76 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.813 0.845 . . . . 0.0 111.225 164.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -123.03 131.3 53.64 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.308 1.843 . . . . 0.0 109.027 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 t -165.89 171.4 12.73 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 105.685 -1.969 . . . . 0.0 105.685 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.49 -103.67 0.06 OUTLIER Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.526 1.536 . . . . 0.0 112.21 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -138.19 18.17 2.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.226 1.41 . . . . 0.0 111.697 -171.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 t -144.81 177.73 8.51 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.583 -1.323 . . . . 0.0 111.16 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.3 p -137.85 121.84 17.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.062 1.345 . . . . 0.0 109.081 167.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -93.22 118.54 31.37 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.9 156.9 28.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.3 0.64 . . . . 0.0 111.401 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.425 HD13 HE21 ' A' ' 85' ' ' GLN . 98.1 mt -120.31 133.8 55.39 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.541 1.136 . . . . 0.0 111.452 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.5 p -69.18 168.98 12.92 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.78 0.832 . . . . 0.0 109.498 164.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -144.09 166.16 25.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.033 0.933 . . . . 0.0 108.905 166.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -133.21 156.56 47.28 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.154 1.781 . . . . 0.0 108.203 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.68 141.24 25.47 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.989 1.316 . . . . 0.0 110.679 -166.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.84 157.92 8.54 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 119.576 1.08 . . . . 0.0 112.286 161.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.8 -100.69 0.15 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.075 1.797 . . . . 0.0 110.441 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.7 157.74 2.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.198 1.399 . . . . 0.0 109.939 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -79.4 -29.44 42.01 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.978 -1.076 . . . . 0.0 112.759 174.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -90.79 16.14 9.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.871 0.868 . . . . 0.0 111.742 -168.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mt -137.55 127.72 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -136.62 150.59 48.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.7 t -137.12 125.75 34.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -85.76 -178.6 6.66 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.916 0.887 . . . . 0.0 109.57 173.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.11 -8.53 43.62 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.989 -1.07 . . . . 0.0 114.435 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.7 p -144.86 -21.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.796 1.298 . . . . 0.0 113.12 166.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.1 m -104.02 156.87 17.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.046 1.294 . . . . 0.0 112.162 -168.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 t -95.63 158.64 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 126.417 1.887 . . . . 0.0 107.639 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.57 142.7 18.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.878 0.871 . . . . 0.0 108.881 163.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -148.74 148.5 30.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 161.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.58 -177.85 6.04 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.953 1.701 . . . . 0.0 109.058 174.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -119.29 165.97 13.6 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.284 1.034 . . . . 0.0 110.313 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.84 144.85 40.07 Favored Pre-proline 0 N--CA 1.453 -0.298 0 C-N-CA 124.147 0.979 . . . . 0.0 110.688 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -82.99 -6.06 11.32 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.68 3.586 . . . . 0.0 113.206 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.31 169.92 17.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.706 -0.621 . . . . 0.0 111.341 -164.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.23 1.87 14.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.602 173.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.21 135.49 46.1 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 165.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -72.26 167.1 21.09 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.331 1.052 . . . . 0.0 109.18 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 -130.4 161.72 30.74 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.515 -0.741 . . . . 0.0 109.255 165.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 46.1 m -137.68 84.13 2.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.45 142.43 48.31 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.1 tp -159.68 72.29 0.52 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 118.984 1.392 . . . . 0.0 112.388 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.24 173.6 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.183 -0.948 . . . . 0.0 109.99 167.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.9 m -117.69 153.02 34.07 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 164.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 mp -125.24 165.69 17.83 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.926 1.291 . . . . 0.0 109.464 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -157.21 161.7 39.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.051 1.74 . . . . 0.0 108.124 173.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.425 HE21 HD13 ' A' ' 49' ' ' LEU . 1.7 tt0 -105.99 169.4 8.52 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.075 1.35 . . . . 0.0 109.852 -164.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.71 -48.97 65.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -118.75 -18.73 8.88 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.2 m -97.53 -167.82 1.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.766 1.226 . . . . 0.0 108.497 162.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.79 31.0 0.15 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 119.21 -0.772 . . . . 0.0 111.427 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.89 112.72 1.96 Allowed 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 168.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 p -79.51 114.18 18.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.9 mp -88.57 165.96 14.47 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.313 1.045 . . . . 0.0 109.028 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.81 125.29 20.55 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.999 1.72 . . . . 0.0 107.838 174.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.12 86.02 5.25 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.328 1.451 . . . . 0.0 107.412 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -72.09 137.55 47.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.339 -1.476 . . . . 0.0 108.566 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 mp -130.62 116.53 35.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 162.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 68.6 t -116.0 71.81 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -106.12 154.41 39.62 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 121.571 -0.706 . . . . 0.0 110.711 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.76 174.64 6.31 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.655 2.903 . . . . 0.0 113.529 -172.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.57 113.63 3.68 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -62.44 123.85 19.37 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.778 0.789 . . . . 0.0 110.006 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.65 91.15 1.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 165.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.9 m -138.14 168.55 19.5 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.67 1.188 . . . . 0.0 110.624 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.9 tp -81.83 66.75 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.133 1.373 . . . . 0.0 107.93 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 123.777 0.831 . . . . 0.0 109.128 -167.75 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.188 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -149.59 172.6 14.77 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.7 ptp -154.84 -172.33 4.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.534 1.534 . . . . 0.0 108.3 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.59 84.56 0.06 OUTLIER Glycine 0 C--N 1.331 0.282 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.7 m -134.61 156.74 78.47 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-O 119.764 -0.16 . . . . 0.0 111.197 -154.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.2 -172.7 1.57 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.298 3.332 . . . . 0.0 111.328 172.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 p -86.79 156.34 3.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.164 1.386 . . . . 0.0 108.412 169.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 m -113.31 99.54 7.87 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 163.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -74.27 153.17 39.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 161.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -128.1 116.75 20.45 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.08 46.54 1.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.725 1.21 . . . . 0.0 108.983 -170.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 m -154.28 -178.37 7.08 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.107 0.963 . . . . 0.0 110.188 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -74.22 -170.81 1.03 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.498 0.666 . . . . 0.0 109.59 169.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.0 40.14 3.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.667 1.987 . . . . 0.0 109.733 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -156.43 -1.05 0.13 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -161.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.41 -7.42 46.88 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 117.418 -1.768 . . . . 0.0 115.319 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.41 174.11 15.16 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 120.504 2.152 . . . . 0.0 114.035 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.3 p -136.34 44.3 2.42 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.417 1.487 . . . . 0.0 111.054 -176.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.82 165.16 9.86 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.787 -1.195 . . . . 0.0 108.537 165.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -110.14 141.04 43.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.99 1.316 . . . . 0.0 107.84 165.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.9 m -147.28 146.72 29.85 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 164.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -140.32 157.75 45.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.545 0.688 . . . . 0.0 110.818 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -132.73 66.24 76.09 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.594 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.24 175.32 4.11 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.069 3.179 . . . . 0.0 111.881 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.47 -171.6 2.16 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.968 0.907 . . . . 0.0 110.183 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.69 11.83 0.17 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.062 2.545 . . . . 0.0 115.117 -162.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.1 m -150.52 5.68 0.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.792 1.637 . . . . 0.0 113.635 171.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -95.26 86.94 4.68 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.296 1.407 . . . . 0.0 112.023 -166.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.77 158.48 43.85 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.629 -0.669 . . . . 0.0 112.499 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.86 -149.2 15.61 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 161.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -124.13 113.41 18.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.608 1.163 . . . . 0.0 109.946 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -116.98 -166.75 1.2 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.244 1.018 . . . . 0.0 112.915 176.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.0 mt -132.14 157.08 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 128.067 2.547 . . . . 0.0 106.606 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.0 mt -131.06 172.49 12.03 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.668 1.987 . . . . 0.0 108.764 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -116.13 31.91 6.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.671 1.189 . . . . 0.0 111.918 -173.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.2 mt -52.96 147.91 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.911 2.085 . . . . 0.0 109.98 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 m -113.17 117.36 31.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.342 1.457 . . . . 0.0 107.994 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.9 t -141.46 82.21 1.81 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -153.95 169.21 24.0 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.294 -0.879 . . . . 0.0 111.34 175.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.94 129.6 51.78 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.516 1.527 . . . . 0.0 107.824 173.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -118.06 128.65 54.96 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -174.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 t -168.5 148.22 4.5 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.95 -107.09 0.57 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 125.416 1.484 . . . . 0.0 110.078 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -135.67 28.05 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.215 1.406 . . . . 0.0 110.084 -170.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.1 m -142.82 157.96 44.1 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.904 0.859 . . . . 0.0 111.165 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -123.84 124.71 43.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.477 1.911 . . . . 0.0 106.004 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.89 115.26 27.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 166.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.98 130.39 45.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 164.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.89 118.39 26.25 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 167.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 m -67.48 168.49 10.79 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 124.535 1.147 . . . . 0.0 109.541 164.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -150.09 175.46 11.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.797 1.639 . . . . 0.0 107.969 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -132.16 170.48 14.94 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 161.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.46 151.42 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.231 1.012 . . . . 0.0 108.892 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 p -158.98 141.43 14.06 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.989 -0.444 . . . . 0.0 109.815 -172.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.95 -105.1 0.23 Allowed Glycine 0 CA--C 1.52 0.375 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.68 161.62 20.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.381 1.473 . . . . 0.0 111.46 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 m -73.29 -51.83 16.12 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 126.116 1.766 . . . . 0.0 111.617 174.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -72.69 21.15 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.569 2.348 . . . . 0.0 113.21 -166.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.8 mt -133.63 140.5 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -127.17 132.12 50.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.8 t -139.85 110.1 4.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.41 87.0 1.85 Allowed 'General case' 0 N--CA 1.462 0.129 0 O-C-N 121.276 -0.89 . . . . 0.0 109.133 -172.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 47.07 -113.02 1.08 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.591 1.091 . . . . 0.0 110.979 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.9 m -79.81 36.92 0.34 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.834 1.653 . . . . 0.0 113.393 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.9 t -152.86 155.08 36.4 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 120.609 -1.307 . . . . 0.0 109.416 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 t -148.38 149.22 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.76 159.62 44.41 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.853 0.751 . . . . 0.0 110.724 163.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -142.83 127.2 17.73 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -81.2 160.27 24.37 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.308 1.052 . . . . 0.0 110.565 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.516 ' CD ' ' HE2' ' A' ' 101' ' ' LYS . 1.7 mt-10 -72.45 165.19 25.09 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 167.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -86.59 164.65 36.65 Favored Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 121.093 -1.005 . . . . 0.0 110.848 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.68 -8.19 5.26 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.242 3.294 . . . . 0.0 113.536 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.87 156.68 47.1 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.088 0.858 . . . . 0.0 110.142 -170.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.07 22.32 4.43 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.092 1.357 . . . . 0.0 112.105 -169.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -98.64 151.09 21.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -72.46 135.82 45.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.944 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 -113.6 123.5 50.12 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 171.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.3 m -76.55 104.32 7.0 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 155.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.51 142.13 45.61 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 163.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.95 131.43 25.32 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 164.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -139.45 143.39 31.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 165.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.4 m -113.56 156.56 23.41 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.628 1.571 . . . . 0.0 107.236 170.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.85 162.54 31.74 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.66 1.184 . . . . 0.0 110.78 172.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -146.06 127.7 15.19 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.549 0.613 . . . . 0.0 109.757 174.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -65.2 156.49 31.63 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.006 1.323 . . . . 0.0 111.45 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -50.16 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.763 2.825 . . . . 0.0 112.281 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -72.27 -25.16 61.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.939 1.296 . . . . 0.0 111.092 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.7 -153.15 0.5 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.991 2.117 . . . . 0.0 109.119 -164.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.69 13.74 0.02 OUTLIER Glycine 0 C--N 1.335 0.473 0 CA-C-O 117.158 -1.912 . . . . 0.0 116.595 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -62.86 98.05 0.12 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.609 2.205 . . . . 0.0 106.531 157.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.6 p -65.42 166.92 9.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.7 mt -132.17 144.06 50.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 170.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 m -84.79 129.08 34.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 167.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 34.5 tp -97.52 127.39 43.44 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 156.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -136.64 117.38 14.03 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.5 mp -109.42 124.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 169.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.9 t -111.97 92.59 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.81 158.5 35.5 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.872 -171.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -69.73 -164.58 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 125.186 3.924 . . . . 0.0 111.726 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.59 161.93 30.45 Favored Glycine 0 C--N 1.334 0.426 0 O-C-N 120.364 -1.46 . . . . 0.0 111.975 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.516 ' HE2' ' CD ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -144.64 175.82 9.88 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.088 1.355 . . . . 0.0 111.254 -173.284 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 p -163.35 86.36 0.52 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.595 1.558 . . . . 0.0 107.283 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.72 -178.6 7.15 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.238 1.381 . . . . 0.0 110.669 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.2 mt -81.96 86.15 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t0 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.073 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -73.59 160.13 32.08 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 160.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.85 158.88 41.41 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.6 1.16 . . . . 0.0 108.372 170.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.51 145.56 12.63 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.0 p -169.01 164.31 7.28 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 123.708 0.803 . . . . 0.0 109.168 -166.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.74 176.92 8.24 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.85 2.367 . . . . 0.0 110.894 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.0 t -81.51 106.78 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.975 -0.453 . . . . 0.0 110.386 -177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 m -101.24 118.6 37.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.679 1.592 . . . . 0.0 109.672 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -89.1 141.53 28.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.544 0.738 . . . . 0.0 109.314 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -105.1 138.44 41.3 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.526 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 3.9 p90 -153.73 56.17 0.74 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.349 -170.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.6 p -159.45 -172.42 3.71 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.65 -1.281 . . . . 0.0 109.305 170.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -67.92 157.33 35.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.033 1.288 . . . . 0.0 108.172 165.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.74 -12.34 22.4 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.872 1.269 . . . . 0.0 110.603 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.68 74.98 1.47 Allowed 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 153.44 -85.88 0.14 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 159.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -164.61 -123.29 0.64 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -158.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -138.18 28.78 2.53 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.602 0.701 . . . . 0.0 111.072 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.47 144.0 10.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.017 1.281 . . . . 0.0 109.764 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -96.3 148.37 22.82 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 162.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.3 m -142.54 137.88 30.48 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 159.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -112.39 144.12 42.36 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 168.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.62 71.57 38.97 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.02 177.79 6.06 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.423 2.082 . . . . 0.0 111.194 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -151.18 176.77 10.86 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.612 1.165 . . . . 0.0 108.097 173.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 56.51 -74.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.28 2.632 . . . . 0.0 114.184 -172.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.2 t -176.89 82.16 0.02 OUTLIER 'General case' 0 C--O 1.236 0.365 0 C-N-CA 129.002 2.921 . . . . 0.0 105.396 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -132.43 65.83 1.57 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -172.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.83 175.25 6.42 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.767 1.627 . . . . 0.0 110.285 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.06 -162.41 36.22 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 119.612 1.097 . . . . 0.0 112.667 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.0 p -135.69 95.65 3.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.877 1.271 . . . . 0.0 110.093 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -114.3 -177.06 3.04 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.959 0.903 . . . . 0.0 111.992 -173.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.9 mt -127.47 120.42 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.02 172.34 9.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.45 1.1 . . . . 0.0 109.006 171.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -106.08 36.86 2.43 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.905 -1.122 . . . . 0.0 109.546 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.89 134.95 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.067 -1.021 . . . . 0.0 108.346 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.9 138.8 37.23 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.8 p -167.87 83.37 0.19 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -153.76 170.97 19.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.26 120.77 39.99 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 171.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -96.0 146.26 24.76 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.946 0.879 . . . . 0.0 109.193 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.57 176.89 11.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.22 -52.72 8.24 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.142 1.353 . . . . 0.0 112.844 -168.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -131.04 23.71 4.92 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.702 0.801 . . . . 0.0 111.717 -172.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -144.3 150.95 38.68 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 122.462 1.125 . . . . 0.0 109.158 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 p -148.04 85.72 1.55 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.691 1.996 . . . . 0.0 107.688 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -73.9 127.78 33.78 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 166.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.03 164.7 23.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 166.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.55 132.3 54.25 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 126.324 1.85 . . . . 0.0 107.146 164.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.1 m -77.05 174.2 10.93 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.877 0.846 . . . . 0.0 110.069 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -149.87 171.53 16.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.219 1.808 . . . . 0.0 107.932 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.08 174.91 10.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.377 1.871 . . . . 0.0 107.444 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.62 167.67 20.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.593 1.157 . . . . 0.0 109.723 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.0 p -156.41 148.93 23.59 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.633 1.173 . . . . 0.0 108.801 160.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.75 -141.8 8.05 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.543 1.544 . . . . 0.0 109.806 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.62 133.22 46.54 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.307 1.043 . . . . 0.0 110.26 -173.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 m -69.78 3.43 2.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.273 1.829 . . . . 0.0 115.019 -167.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.9 p-90 -117.96 13.74 14.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.121 2.169 . . . . 0.0 111.305 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.4 mt -129.14 99.0 4.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -91.65 144.35 25.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.94 143.23 40.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 166.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.68 172.05 9.59 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.721 2.008 . . . . 0.0 107.108 172.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.45 -15.24 3.98 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.434 1.492 . . . . 0.0 116.336 -167.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.78 4.3 0.75 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.781 1.232 . . . . 0.0 112.82 168.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -128.0 153.42 46.77 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.586 1.539 . . . . 0.0 110.56 -163.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.88 156.54 24.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.079 1.352 . . . . 0.0 108.247 -173.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.98 150.49 34.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 153.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.35 155.11 43.65 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 146.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.0 176.04 5.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.266 166.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 71' ' ' ASN . 12.9 tt0 -86.44 168.37 13.83 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.768 0.794 . . . . 0.0 110.107 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.424 ' H ' ' HG2' ' A' ' 70' ' ' GLU . 12.3 p-10 -70.91 165.46 46.94 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.312 1.045 . . . . 0.0 110.176 174.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -95.3 -4.36 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.191 2.594 . . . . 0.0 114.293 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.32 166.04 25.59 Favored 'General case' 0 C--O 1.225 -0.228 0 O-C-N 121.362 -0.836 . . . . 0.0 111.834 -172.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 30.94 0.49 Allowed 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.621 -1.299 . . . . 0.0 112.044 -175.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -101.85 -175.96 2.99 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.373 1.069 . . . . 0.0 109.363 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -113.66 127.26 55.98 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 124.389 1.076 . . . . 0.0 111.705 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -159.22 103.19 1.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.816 0.846 . . . . 0.0 109.675 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.6 t -64.76 149.66 48.85 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 155.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.39 177.07 43.82 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 154.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tp -162.24 85.37 0.58 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.767 0.827 . . . . 0.0 109.803 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 m -79.9 169.83 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.217 -0.927 . . . . 0.0 111.123 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.6 m -116.74 153.33 32.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.026 2.131 . . . . 0.0 107.348 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 mp -135.95 163.01 31.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.668 1.187 . . . . 0.0 111.168 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -144.34 143.79 31.14 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.012 1.725 . . . . 0.0 108.003 167.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -79.16 165.96 22.74 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.401 1.48 . . . . 0.0 107.659 165.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.8 -83.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -81.89 -18.21 44.55 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.006 -1.684 . . . . 0.0 112.269 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.11 -162.51 0.94 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.28 26.04 0.24 Allowed Glycine 0 C--O 1.225 -0.424 0 O-C-N 119.66 -1.9 . . . . 0.0 110.919 -168.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.526 ' HE3' ' HA ' ' A' ' 11' ' ' PHE . 12.1 ttpp -47.97 129.93 14.95 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 127.749 2.419 . . . . 0.0 107.447 164.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 52.1 p -118.79 137.66 53.23 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.6 mt -139.49 155.47 47.54 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -102.03 160.17 14.73 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.974 0.91 . . . . 0.0 109.14 164.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tt -136.2 91.29 2.66 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -85.69 147.2 26.47 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.7 mt -137.18 80.09 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.98 93.75 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -171.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -117.18 160.5 37.12 Favored Pre-proline 0 C--O 1.242 0.685 0 C-N-CA 123.637 0.775 . . . . 0.0 110.525 -165.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -62.15 174.93 2.23 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.75 2.3 . . . . 0.0 109.912 165.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.96 162.81 23.12 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 163.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -145.84 150.21 35.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.378 1.071 . . . . 0.0 108.487 -173.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.4 p -153.11 87.93 1.29 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -136.53 -167.3 2.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.435 0.561 . . . . 0.0 110.727 -177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.2 mm -94.46 71.03 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--O 1.248 1.005 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -161.178 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.9 m -132.1 123.96 28.2 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 170.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -88.4 155.41 19.71 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.71 118.35 24.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.971 2.108 . . . . 0.0 105.823 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -150.15 67.98 0.98 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.952 0.901 . . . . 0.0 110.226 -166.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -152.27 -169.33 3.32 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.026 1.33 . . . . 0.0 109.029 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -77.99 -89.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 166.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -164.67 -41.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.424 1.49 . . . . 0.0 110.846 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -107.39 74.75 0.98 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.53 72.91 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 112.999 -1.91 . . . . 0.0 113.408 147.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -153.13 169.93 32.06 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-O 122.746 1.192 . . . . 0.0 112.924 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -135.67 13.7 3.43 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.089 1.756 . . . . 0.0 110.474 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p -152.98 125.86 8.4 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 120.499 -1.375 . . . . 0.0 112.833 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.65 153.37 23.51 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.688 1.195 . . . . 0.0 110.283 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.5 m -146.88 143.61 28.67 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.988 2.115 . . . . 0.0 105.75 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.77 152.14 50.82 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.15 0.886 . . . . 0.0 109.758 170.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -134.16 67.52 73.2 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.587 -0.72 . . . . 0.0 109.171 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.59 179.53 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.308 2.005 . . . . 0.0 112.029 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -149.1 174.9 11.83 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.8 t0 56.31 -85.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 129.112 2.965 . . . . 0.0 111.172 170.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -153.66 106.25 2.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.265 1.826 . . . . 0.0 106.363 161.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -135.43 107.7 7.26 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.129 -1.607 . . . . 0.0 111.017 167.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.56 150.29 35.22 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.635 1.974 . . . . 0.0 108.546 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.38 -169.5 40.53 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.3 p -100.99 120.57 40.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.836 1.655 . . . . 0.0 110.256 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -127.12 -173.86 3.01 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.712 0.805 . . . . 0.0 113.065 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.5 mt -129.13 155.47 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 127.219 2.207 . . . . 0.0 106.265 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 53.8 mt -135.83 149.68 49.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.996 1.271 . . . . 0.0 112.808 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -78.59 87.49 4.54 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.836 1.655 . . . . 0.0 108.941 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mt -123.69 152.69 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.71 1.204 . . . . 0.0 107.958 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 m -121.64 133.85 54.98 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.474 1.109 . . . . 0.0 109.072 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.2 t -157.08 81.71 0.92 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.17 0.988 . . . . 0.0 108.522 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -152.27 170.8 19.14 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.094 -1.004 . . . . 0.0 110.044 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.53 126.79 50.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 167.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -98.02 131.17 44.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -170.14 162.35 8.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.2 -113.35 2.86 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -141.22 51.55 1.59 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.298 1.439 . . . . 0.0 107.337 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 t -155.15 165.58 36.25 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.61 1.564 . . . . 0.0 109.151 -170.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.4 p -134.71 102.32 5.24 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -71.23 118.34 13.89 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 164.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.37 163.82 10.06 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.705 0.764 . . . . 0.0 109.955 166.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.5 mt -134.89 129.36 34.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.051 170.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.8 m -59.78 163.47 4.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 122.551 1.167 . . . . 0.0 110.139 163.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -134.34 165.97 23.9 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.507 170.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.95 164.21 22.8 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.609 1.164 . . . . 0.0 108.811 173.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.53 168.77 22.58 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.465 1.506 . . . . 0.0 109.867 -169.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.405 ' C ' HG13 ' A' ' 81' ' ' VAL . 11.3 p 178.49 168.36 0.84 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.74 1.616 . . . . 0.0 110.572 161.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.62 -110.27 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.83 163.14 14.82 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.925 0.89 . . . . 0.0 110.376 168.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p -71.77 -38.96 70.27 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.353 1.461 . . . . 0.0 112.369 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -90.23 21.56 3.74 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.269 1.427 . . . . 0.0 112.831 -159.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.505 HG23 ' CD2' ' A' ' 68' ' ' TYR . 70.5 mt -130.54 133.14 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -170.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -132.42 132.53 42.89 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.372 1.069 . . . . 0.0 109.379 -164.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.81 135.62 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.834 0.826 . . . . 0.0 110.297 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.71 75.28 1.52 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.457 0.703 . . . . 0.0 109.154 172.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 55.02 -117.22 7.84 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m -77.94 51.04 0.92 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.06 0.944 . . . . 0.0 111.612 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.63 152.08 34.82 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.63 139.63 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.7 m -145.38 150.26 36.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 164.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.505 ' CD2' HG23 ' A' ' 59' ' ' ILE . 1.5 m-85 -139.46 119.19 13.19 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.53 161.91 29.3 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.473 1.509 . . . . 0.0 110.372 -174.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -86.25 146.18 26.63 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.488 -0.757 . . . . 0.0 110.79 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -66.58 144.47 98.65 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -158.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.79 -9.75 6.39 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.525 2.816 . . . . 0.0 115.432 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -151.98 170.08 20.74 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.593 1.157 . . . . 0.0 108.246 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -81.12 -12.39 59.26 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.775 0.83 . . . . 0.0 113.078 -164.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.44 165.14 2.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 123.775 0.672 . . . . 0.0 109.633 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -107.5 121.38 44.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 168.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -105.38 170.41 7.9 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 126.448 1.899 . . . . 0.0 108.039 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.4 m -104.77 109.9 22.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 155.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.85 139.09 36.0 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 163.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 tp -138.79 133.09 31.65 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.299 1.049 . . . . 0.0 109.93 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.488 HG21 HG21 ' A' ' 59' ' ' ILE . 2.8 t -142.49 148.37 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.075 0.852 . . . . 0.0 109.027 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 m -104.82 176.73 5.06 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.491 1.517 . . . . 0.0 109.116 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.7 165.24 34.03 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.82 1.248 . . . . 0.0 109.798 162.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -151.94 158.3 42.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.782 2.033 . . . . 0.0 108.815 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.474 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 26.5 tt0 -97.87 161.32 13.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.423 1.01 . . . . 0.0 110.309 -173.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.81 -69.06 0.15 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.646 1.179 . . . . 0.0 112.99 173.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -88.97 -12.53 41.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.638 1.108 . . . . 0.0 112.428 -176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.2 t -132.04 -153.23 0.54 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.852 1.661 . . . . 0.0 109.249 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.25 46.87 0.88 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -164.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.474 ' H ' ' HB2' ' A' ' 85' ' ' GLN 0.35 0.0 OUTLIER -68.18 92.29 0.4 Allowed 'General case' 0 C--N 1.341 0.239 0 CA-C-N 118.238 1.019 . . . . 0.0 108.967 179.546 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 p -96.47 133.44 40.91 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 174.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.88 161.41 26.62 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 166.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.44 125.01 52.59 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.15 132.09 53.42 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -128.49 143.92 51.06 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.524 1.53 . . . . 0.0 108.391 171.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 mp -135.45 117.42 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 168.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 69.6 t -107.31 94.57 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -106.34 144.08 28.27 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.09 156.88 62.48 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.208 1.939 . . . . 0.0 107.624 165.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.07 166.88 27.5 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 121.269 -0.491 . . . . 0.0 113.418 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.18 0 C-N-CA 125.336 1.454 . . . . 0.0 109.636 -174.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 m -102.02 101.98 12.43 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -76.53 154.57 34.44 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 168.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -137.63 120.92 16.93 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 128.124 2.57 . . . . 0.0 105.424 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -148.32 43.87 1.04 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.239 1.016 . . . . 0.0 110.255 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 p -141.83 -176.75 4.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.886 1.274 . . . . 0.0 109.673 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -176.5 0.97 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.868 -1.145 . . . . 0.0 111.856 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.03 -20.79 6.18 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 162.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.92 -6.85 59.0 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -161.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.07 64.18 0.43 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 167.06 -165.16 38.39 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 p -151.49 45.23 0.79 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.246 1.418 . . . . 0.0 112.691 170.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.75 179.11 6.76 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.209 -1.557 . . . . 0.0 109.692 169.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.1 113.8 14.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.113 1.765 . . . . 0.0 107.955 172.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.5 m -133.72 130.24 37.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.041 -1.836 . . . . 0.0 106.041 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -129.65 147.1 51.41 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -124.12 67.24 43.78 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HG2' ' HB3' ' A' ' 98' ' ' GLN . 98.5 Cg_endo -69.44 177.09 5.7 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.83 1.687 . . . . 0.0 110.879 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -143.47 173.92 11.21 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.891 1.677 . . . . 0.0 107.29 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 55.19 -85.25 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.688 1.995 . . . . 0.0 112.234 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.2 m -154.36 102.59 2.44 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.6 2.36 . . . . 0.0 107.977 156.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.4 m -131.62 88.84 2.62 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 119.909 1.231 . . . . 0.0 111.22 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.61 167.12 23.0 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.435 1.894 . . . . 0.0 110.177 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.52 -161.1 31.1 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 p -97.42 123.42 41.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.774 1.229 . . . . 0.0 109.078 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -139.32 -169.22 2.62 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.711 1.605 . . . . 0.0 110.219 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 mt -138.39 144.91 29.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.268 1.427 . . . . 0.0 107.232 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.5 mt -129.21 161.84 29.22 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.597 1.559 . . . . 0.0 107.456 170.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -114.91 103.24 10.74 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.995 0.816 . . . . 0.0 111.447 -163.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.3 138.7 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.83 1.652 . . . . 0.0 109.126 -172.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 m -91.34 110.92 22.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.242 1.417 . . . . 0.0 109.536 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.5 m -138.27 78.68 1.69 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -160.36 164.78 32.19 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.381 0.672 . . . . 0.0 111.345 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.24 151.83 29.16 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.073 0.949 . . . . 0.0 109.363 166.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -121.67 125.68 47.22 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 127.163 2.185 . . . . 0.0 108.917 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.6 t -167.44 162.45 14.57 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.108 0.963 . . . . 0.0 109.014 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.19 -101.69 0.21 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 125.982 1.753 . . . . 0.0 109.62 -172.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -142.57 35.97 1.46 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.904 1.281 . . . . 0.0 110.403 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 m -155.81 169.54 24.15 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.133 -0.98 . . . . 0.0 110.485 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -115.37 155.71 26.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 156.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -138.86 121.99 16.87 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 126.097 1.759 . . . . 0.0 106.537 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.88 158.11 28.81 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.713 0.633 . . . . 0.0 109.812 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.6 mt -121.61 140.9 51.66 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.6 m -67.41 170.68 7.02 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 124.68 1.237 . . . . 0.0 109.839 172.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -138.63 174.56 10.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.782 1.233 . . . . 0.0 109.011 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.29 150.81 26.27 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 156.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.43 145.79 49.29 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 156.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.7 m -155.31 124.33 6.19 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.86 -161.23 9.71 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -156.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.72 19.14 10.4 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -171.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m 76.36 8.05 3.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 130.018 3.327 . . . . 0.0 114.874 168.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -111.83 7.34 20.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.487 0.715 . . . . 0.0 112.435 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 mt -135.39 140.6 44.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -134.82 140.52 45.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.925 2.09 . . . . 0.0 107.736 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.3 t -141.89 109.69 2.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.23 172.36 8.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.191 1.396 . . . . 0.0 109.689 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.24 -12.73 25.43 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.531 1.062 . . . . 0.0 114.477 -174.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -156.35 34.85 0.32 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.85 1.325 . . . . 0.0 110.476 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 t -159.25 161.95 36.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.664 1.12 . . . . 0.0 109.722 -170.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.18 139.43 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.584 1.154 . . . . 0.0 109.712 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.7 m -143.11 154.6 44.09 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.26 -0.9 . . . . 0.0 109.073 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -145.1 154.32 42.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 160.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -92.46 -166.2 1.49 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.425 ' HG2' HE21 ' A' ' 98' ' ' GLN . 19.0 mt-10 -118.47 169.84 9.44 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 122.901 1.334 . . . . 0.0 109.293 168.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -82.56 154.19 68.46 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 125.959 1.704 . . . . 0.0 112.247 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -88.99 -4.52 6.06 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.968 3.112 . . . . 0.0 114.853 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.18 167.79 10.38 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.716 0.806 . . . . 0.0 109.153 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.62 -3.28 55.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.964 0.905 . . . . 0.0 112.889 -169.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.5 164.16 25.67 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.037 -0.414 . . . . 0.0 110.779 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -95.92 135.3 37.85 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.879 1.272 . . . . 0.0 107.998 173.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -145.32 119.02 9.17 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.5 m -59.02 123.61 17.15 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -70.93 153.73 51.54 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.5 tp -146.85 117.52 7.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.504 1.522 . . . . 0.0 108.251 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.7 p -135.62 165.64 29.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 126.528 1.931 . . . . 0.0 106.235 165.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 m -124.96 171.52 10.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.814 1.646 . . . . 0.0 106.924 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -145.83 156.66 43.71 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 121.507 -0.745 . . . . 0.0 109.275 153.488 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -147.21 134.88 21.06 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.184 1.394 . . . . 0.0 107.361 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.05 174.66 4.34 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.89 0.876 . . . . 0.0 112.03 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -63.56 -84.97 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.2 2.6 . . . . 0.0 111.365 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -74.68 -32.65 62.28 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.083 -1.011 . . . . 0.0 110.343 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m -78.4 -159.11 0.15 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.731 1.213 . . . . 0.0 111.122 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.84 18.04 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 N-CA-C 116.775 1.47 . . . . 0.0 116.775 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -63.8 170.6 3.27 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.284 2.042 . . . . 0.0 108.451 146.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.1 p -134.35 156.28 48.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.513 ' HB2' HD21 ' A' ' 83' ' ' LEU . 58.5 mt -113.75 167.48 10.59 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 163.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.4 m -135.49 117.84 15.68 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.77 122.62 33.67 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 172.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -128.53 91.63 3.27 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.431 HD12 ' H ' ' A' ' 96' ' ' ILE . 3.4 mp -83.98 122.27 37.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 169.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.15 91.09 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 165.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.425 HE21 ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -111.66 146.42 34.67 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.124 -176.018 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 175.52 10.16 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 125.142 3.895 . . . . 0.0 110.694 169.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.97 173.38 19.88 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.8 pttt . . . . . 0 C--O 1.231 0.114 0 C-N-CA 125.252 1.421 . . . . 0.0 111.486 -177.852 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 121.004 0.431 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -135.5 106.17 6.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.666 1.586 . . . . 0.0 107.182 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -83.85 153.88 23.78 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 172.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.63 146.28 52.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.399 1.88 . . . . 0.0 108.273 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -168.51 42.02 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.235 1.014 . . . . 0.0 111.819 -160.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.4 p -142.52 176.73 8.79 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.749 -1.22 . . . . 0.0 111.03 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -84.64 158.99 20.68 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 165.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.0 59.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.572 0.349 . . . . 0.0 111.829 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.09 -8.23 29.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.183 1.393 . . . . 0.0 113.24 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.33 2.66 21.44 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 124.382 0.991 . . . . 0.0 112.948 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.53 177.3 17.06 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 119.24 1.52 . . . . 0.0 112.23 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 p -117.63 25.68 10.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.328 1.051 . . . . 0.0 109.628 172.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.3 t -144.85 147.95 33.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.49 -0.756 . . . . 0.0 109.212 171.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -99.52 140.4 33.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.888 1.675 . . . . 0.0 107.581 166.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.3 m -142.13 92.32 2.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.654 -1.609 . . . . 0.0 106.654 168.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.17 152.9 36.54 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.058 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -129.54 83.79 63.71 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 168.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.51 170.57 19.07 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.726 2.951 . . . . 0.0 110.46 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -155.4 165.68 35.88 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.872 1.669 . . . . 0.0 107.457 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t70 66.62 -78.69 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.104 2.161 . . . . 0.0 113.576 158.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.3 m -75.91 5.48 6.41 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.475 1.488 . . . . 0.0 112.859 165.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.255 3.8 p 58.81 -163.8 0.21 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.333 1.453 . . . . 0.0 111.173 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.11 172.45 0.2 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.306 1.042 . . . . 0.0 112.465 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.51 -160.1 14.31 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.37 112.48 18.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -131.76 -168.88 2.1 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.278 1.431 . . . . 0.0 110.762 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.8 mt -134.66 111.38 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.993 1.717 . . . . 0.0 107.159 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 74.2 mt -82.51 158.11 23.3 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.565 1.146 . . . . 0.0 110.859 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.56 80.69 4.31 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.53 128.82 57.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -95.57 120.03 35.11 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.644 1.178 . . . . 0.0 108.758 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.1 p -147.64 93.61 2.24 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.831 0.742 . . . . 0.0 109.209 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -157.06 169.11 25.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.278 0.631 . . . . 0.0 109.413 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.21 120.14 30.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.403 1.481 . . . . 0.0 107.472 172.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -93.47 132.62 37.56 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 t -168.14 154.78 7.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 54.18 -101.26 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -144.97 53.05 1.21 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.597 1.189 . . . . 0.0 109.119 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.4 m -155.34 168.01 28.49 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.534 -1.354 . . . . 0.0 110.862 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.29 87.76 2.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.416 1.486 . . . . 0.0 107.848 169.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.29 116.0 7.58 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.79 153.04 44.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.23 138.78 52.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 168.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 m -84.23 177.08 8.34 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.691 0.619 . . . . 0.0 110.042 168.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TRP . . . . . 0.604 ' HE1' HG21 ' A' ' 61' ' ' VAL . 36.4 p90 -132.9 169.91 16.09 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.829 1.252 . . . . 0.0 107.669 166.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -130.68 134.24 46.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.77 149.71 39.49 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.605 1.162 . . . . 0.0 109.614 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 p -165.33 144.78 6.64 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.525 0.679 . . . . 0.0 112.002 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.15 -119.15 1.19 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -47.97 147.39 2.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.904 2.082 . . . . 0.0 113.368 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.0 m -75.16 -12.91 60.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.021 1.328 . . . . 0.0 114.313 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -116.28 20.29 14.35 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.741 1.216 . . . . 0.0 111.259 -164.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 mt -133.97 104.31 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -117.17 144.57 44.59 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -166.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.604 HG21 ' HE1' ' A' ' 51' ' ' TRP . 2.8 p -145.56 140.39 22.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.386 0.613 . . . . 0.0 110.961 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.7 88.51 1.34 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.12 -123.35 24.55 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.925 1.25 . . . . 0.0 112.056 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 p -81.22 56.53 2.88 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.674 1.19 . . . . 0.0 110.034 171.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 m -152.28 148.6 27.73 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.863 1.665 . . . . 0.0 106.837 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.13 159.28 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 162.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -136.72 150.46 48.44 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 147.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -130.66 163.22 27.67 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 162.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -124.53 168.39 13.16 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.107 1.363 . . . . 0.0 108.813 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -120.47 161.67 20.85 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.95 0.881 . . . . 0.0 110.287 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.92 165.32 22.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 125.009 1.324 . . . . 0.0 111.622 -162.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.27 -34.59 0.55 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.133 1.888 . . . . 0.0 111.704 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.02 162.69 18.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.851 0.834 . . . . 0.0 109.447 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -82.25 12.91 3.86 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.131 -0.981 . . . . 0.0 110.408 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -68.75 164.41 21.81 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 162.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -124.03 132.93 53.74 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.566 -0.709 . . . . 0.0 109.36 -170.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -130.08 90.69 3.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.591 0.632 . . . . 0.0 111.365 -154.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.5 m -70.04 105.09 2.75 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -80.43 160.97 44.36 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 118.842 -0.977 . . . . 0.0 111.311 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.7 tp -159.93 72.82 0.52 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.435 1.118 . . . . 0.0 113.433 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.2 t -88.12 150.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 120.266 -1.521 . . . . 0.0 109.947 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.6 m -91.61 150.03 21.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 168.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.14 105.94 5.16 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.887 0.875 . . . . 0.0 109.271 162.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -95.19 141.76 28.42 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.277 1.431 . . . . 0.0 109.173 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -64.39 163.44 13.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.994 1.318 . . . . 0.0 110.801 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -56.28 -37.12 69.41 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.99 1.316 . . . . 0.0 112.905 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -135.59 -28.01 1.14 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -167.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -78.96 -156.42 0.1 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 166.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.42 -11.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 CA-C-O 118.323 -1.265 . . . . 0.0 114.475 -172.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.46 110.37 1.09 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.371 1.585 . . . . 0.0 110.388 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.0 p -76.07 116.63 16.96 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.03 118.29 23.42 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 m -75.96 145.0 40.66 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 tt -138.07 106.36 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -170.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -121.32 87.62 2.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.596 0.759 . . . . 0.0 110.024 -170.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.19 123.97 21.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 167.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.18 93.1 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 163.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -106.3 157.55 34.67 Favored Pre-proline 0 C--O 1.237 0.442 0 CA-C-O 117.641 -1.171 . . . . 0.0 109.641 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -69.94 -164.63 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.416 4.078 . . . . 0.0 111.374 172.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -132.63 143.6 15.28 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.017 0.818 . . . . 0.0 111.645 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt . . . . . 0 N--CA 1.467 0.407 0 C-N-CA 127.34 2.256 . . . . 0.0 111.262 -168.181 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 t -81.03 140.14 35.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -115.81 104.6 11.81 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.624 1.57 . . . . 0.0 109.216 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -85.3 114.75 22.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 1.7 t80 -147.89 77.09 1.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -152.05 169.37 22.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.122 0.969 . . . . 0.0 108.59 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 20' ' ' HIS . 86.8 m-85 -68.54 169.85 10.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.371 0.605 . . . . 0.0 109.604 164.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.47 -14.44 28.48 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.791 0.836 . . . . 0.0 111.457 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.4 p30 -105.66 -4.94 20.45 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -162.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.09 -56.41 0.04 OUTLIER Glycine 0 C--N 1.335 0.473 0 O-C-N 121.903 -0.498 . . . . 0.0 112.533 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.14 -115.27 0.55 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 118.792 1.296 . . . . 0.0 112.271 -168.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.5 p -127.05 19.56 7.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.629 0.772 . . . . 0.0 112.079 -170.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -149.88 157.46 43.2 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.349 -1.469 . . . . 0.0 110.546 167.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 8.4 t60 -123.92 152.61 42.23 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 165.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -143.55 133.7 24.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.5 156.6 38.73 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.869 1.268 . . . . 0.0 108.162 -178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -140.81 54.7 4.91 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 126.735 2.014 . . . . 0.0 111.389 -167.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.67 165.54 31.66 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 120.91 1.361 . . . . 0.0 110.858 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.5 162.46 35.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.936 0.895 . . . . 0.0 109.672 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.6 t70 67.26 -76.18 0.05 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.885 2.074 . . . . 0.0 110.347 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.0 t -162.13 89.73 0.72 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.828 1.251 . . . . 0.0 108.115 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.25 98.32 3.49 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.605 1.093 . . . . 0.0 112.123 171.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.12 168.46 19.96 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.11 -0.994 . . . . 0.0 109.285 167.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.6 -165.79 32.6 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 167.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.1 p -82.25 132.54 35.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 169.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -144.76 -177.58 5.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.698 1.199 . . . . 0.0 109.692 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.9 mt -129.02 157.47 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.4 mt -136.47 147.31 47.1 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.594 1.958 . . . . 0.0 107.822 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.52 93.54 6.69 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.72 131.42 72.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.71 1.204 . . . . 0.0 108.459 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 84.4 m -91.05 138.84 31.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.323 1.449 . . . . 0.0 108.854 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.9 p -155.88 74.89 0.88 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.796 -0.565 . . . . 0.0 110.6 -173.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -155.73 172.58 18.08 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.129 -0.982 . . . . 0.0 112.92 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 135.58 52.66 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.644 1.178 . . . . 0.0 109.86 172.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -114.34 128.9 56.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 125.367 1.467 . . . . 0.0 109.406 -172.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.4 t -170.29 159.23 7.1 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.46 0.704 . . . . 0.0 109.476 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.61 -93.4 0.08 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 125.1 1.333 . . . . 0.0 110.258 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -153.65 36.12 0.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.285 1.434 . . . . 0.0 109.508 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t -149.19 164.91 33.4 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.906 -1.121 . . . . 0.0 111.094 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 p -130.79 114.19 15.02 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.761 1.624 . . . . 0.0 107.939 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -88.7 130.09 35.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 163.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.57 165.05 21.91 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 124.0 0.813 . . . . 0.0 108.94 166.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.423 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 2.1 mm? -127.48 128.12 45.2 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.076 1.351 . . . . 0.0 108.473 173.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.5 m -73.85 163.35 28.05 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.631 0.729 . . . . 0.0 109.494 168.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -139.33 172.56 12.64 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.81 2.044 . . . . 0.0 109.565 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -143.68 164.04 31.57 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 167.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.18 -176.18 3.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.713 1.605 . . . . 0.0 110.413 -172.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m 174.59 143.77 0.05 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 128.042 2.537 . . . . 0.0 109.184 151.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.92 -110.1 0.23 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 167.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.73 142.61 54.94 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.355 1.062 . . . . 0.0 108.795 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 m -65.63 -8.21 19.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -111.08 15.5 21.6 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.347 1.459 . . . . 0.0 111.853 -174.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.7 mt -128.88 133.29 66.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -130.46 147.64 52.18 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.729 1.212 . . . . 0.0 109.475 -173.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.09 99.49 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -89.62 63.26 6.17 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.707 2.003 . . . . 0.0 109.599 174.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.6 -120.94 22.63 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 -162.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.6 p -65.88 -24.65 66.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.362 1.081 . . . . 0.0 113.688 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.6 94.85 6.38 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 119.679 1.127 . . . . 0.0 109.594 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.28 151.21 10.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.589 1.155 . . . . 0.0 108.122 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -150.81 158.4 44.09 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.029 -1.669 . . . . 0.0 109.055 164.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -153.81 162.27 41.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 165.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.39 156.22 24.87 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.59 1.156 . . . . 0.0 108.104 172.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.44 141.14 58.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.517 0.675 . . . . 0.0 109.331 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.72 145.29 98.03 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.926 0.89 . . . . 0.0 110.806 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -86.57 -4.83 8.28 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.018 3.145 . . . . 0.0 113.123 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.94 162.42 18.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.073 0.949 . . . . 0.0 109.163 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -12.12 33.66 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.59 159.79 31.7 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.87 -0.519 . . . . 0.0 110.359 171.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.43 140.99 38.62 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 163.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -148.2 82.53 1.49 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.08 0.952 . . . . 0.0 108.832 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.7 m -63.18 104.43 0.59 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.629 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.6 169.46 54.73 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 tt -159.9 125.33 4.08 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.089 0.556 . . . . 0.0 110.155 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.69 167.18 3.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 118.31 0.504 . . . . 0.0 110.182 174.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.04 161.36 15.6 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 167.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.574 HD13 ' HB2' ' A' ' 92' ' ' LEU . 2.7 mp -137.88 154.3 49.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.129 1.372 . . . . 0.0 107.37 169.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -137.88 146.4 43.32 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 163.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -85.2 171.53 11.89 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.877 0.736 . . . . 0.0 109.789 172.094 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.42 -78.9 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.769 1.628 . . . . 0.0 110.582 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -86.99 -21.41 26.18 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.063 -1.023 . . . . 0.0 111.896 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.46 -175.17 5.56 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.136 -0.978 . . . . 0.0 108.851 175.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.74 10.7 0.03 OUTLIER Glycine 0 N--CA 1.462 0.373 0 O-C-N 119.804 -1.81 . . . . 0.0 115.932 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -58.44 159.04 6.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.136 1.468 . . . . 0.0 108.381 155.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.1 p -119.67 107.5 13.31 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.574 ' HB2' HD13 ' A' ' 83' ' ' LEU . 63.7 mt -76.06 164.4 26.17 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 m -141.0 148.4 40.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.57 117.54 11.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -114.28 144.21 43.6 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.9 mt -135.05 98.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 -171.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.2 68.22 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -90.18 165.06 25.33 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.324 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.79 -166.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 124.225 3.283 . . . . 0.0 116.855 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.61 153.9 16.68 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 158.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt . . . . . 0 CA--C 1.517 -0.305 0 C-N-CA 125.057 1.343 . . . . 0.0 109.712 -164.528 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 m -84.84 120.37 26.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -96.86 132.94 42.11 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -102.12 123.41 45.93 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -154.48 67.49 0.71 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.832 0.853 . . . . 0.0 109.486 -171.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.7 p -155.73 -157.23 0.71 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.631 155.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -83.56 152.2 24.98 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.764 1.165 . . . . 0.0 108.217 166.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.85 -22.87 49.24 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.662 0.785 . . . . 0.0 111.544 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -60.61 -6.61 1.74 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.281 0.633 . . . . 0.0 111.934 163.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.81 10.19 73.05 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 118.851 -0.972 . . . . 0.0 112.0 168.018 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.56 -174.41 24.0 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 118.494 1.147 . . . . 0.0 111.857 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.7 p -128.78 20.62 6.0 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 124.204 1.002 . . . . 0.0 112.565 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.83 177.96 9.9 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 120.203 1.365 . . . . 0.0 112.772 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -148.21 135.55 20.48 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.343 166.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -138.59 108.46 6.31 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.611 1.164 . . . . 0.0 109.605 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -102.64 158.22 16.39 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 110.67 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -136.78 56.15 12.42 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.147 1.779 . . . . 0.0 110.157 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.55 177.8 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.891 2.394 . . . . 0.0 110.973 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -157.29 175.84 13.48 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.104 1.362 . . . . 0.0 111.837 171.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.9 t70 66.03 -81.73 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.578 2.751 . . . . 0.0 113.233 -174.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.7 p -148.62 6.81 0.74 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.571 1.149 . . . . 0.0 113.611 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -78.63 86.23 4.62 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.195 -0.941 . . . . 0.0 111.394 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.6 153.99 42.36 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.685 1.994 . . . . 0.0 108.525 170.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.57 160.79 9.55 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.8 p -66.22 130.21 42.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.197 0.599 . . . . 0.0 111.904 -166.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -129.13 -171.77 2.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.694 0.759 . . . . 0.0 112.037 170.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.1 mt -126.07 160.48 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.2 mt -134.6 159.08 42.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.18 43.51 0.88 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.925 1.29 . . . . 0.0 110.928 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.443 ' CG2' ' HE2' ' A' ' 90' ' ' LYS . 98.9 mt -70.89 142.52 15.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.362 1.465 . . . . 0.0 108.555 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.38 106.23 14.69 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.181 1.392 . . . . 0.0 108.132 -174.476 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -135.77 66.17 1.51 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.992 0.917 . . . . 0.0 110.119 -170.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -150.62 170.95 17.94 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.242 -0.912 . . . . 0.0 112.158 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 47' ' ' LYS . 30.7 pttt -110.6 160.81 16.33 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.27 1.028 . . . . 0.0 108.234 164.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -136.5 133.68 36.78 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 166.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.5 t -171.51 157.37 4.79 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.622 1.169 . . . . 0.0 108.448 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.36 -94.48 0.1 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -152.71 35.04 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.211 0.604 . . . . 0.0 111.634 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 t -147.62 170.18 18.05 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 120.996 -1.065 . . . . 0.0 111.106 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.2 p -121.2 96.73 5.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.148 1.379 . . . . 0.0 109.143 164.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -72.06 120.69 18.01 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 169.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.98 165.56 15.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.273 0.559 . . . . 0.0 109.633 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.49 131.85 55.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 168.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.83 170.32 4.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.251 2.22 . . . . 0.0 110.736 172.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -165.67 167.98 16.67 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.339 1.056 . . . . 0.0 111.617 167.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -155.25 154.87 32.83 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.35 1.86 . . . . 0.0 109.072 165.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.75 178.1 4.72 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.83 1.652 . . . . 0.0 111.268 -172.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.6 p -158.52 127.53 5.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.566 0.746 . . . . 0.0 111.782 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.08 -134.98 3.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.271 1.415 . . . . 0.0 110.346 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.25 147.26 10.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.485 1.914 . . . . 0.0 112.865 -174.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.54 6.1 1.56 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.782 2.433 . . . . 0.0 114.758 -172.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.404 ' CZ2' ' HA3' ' A' ' 79' ' ' GLY . 25.7 p-90 -133.04 10.53 4.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.125 1.77 . . . . 0.0 111.589 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.73 108.82 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -106.12 144.28 33.06 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.733 2.013 . . . . 0.0 108.237 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.38 130.57 24.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 172.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.41 70.36 1.42 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 49.64 -117.99 5.1 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -169.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 p -71.36 34.94 0.05 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.671 1.588 . . . . 0.0 114.273 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.2 t -147.81 148.28 30.74 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 p -149.47 155.55 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -171.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.19 138.61 13.85 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.801 1.241 . . . . 0.0 108.396 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -122.16 126.7 48.88 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 166.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.89 147.78 25.73 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.334 0.654 . . . . 0.0 110.172 -169.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -73.0 158.27 35.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.664 1.221 . . . . 0.0 110.4 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -103.73 147.11 33.74 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 126.695 1.998 . . . . 0.0 109.365 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -84.75 -4.25 9.88 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 124.548 3.499 . . . . 0.0 113.233 -163.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.38 153.57 22.04 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.695 -1.253 . . . . 0.0 107.733 166.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 4.81 11.21 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.207 1.003 . . . . 0.0 112.208 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -70.82 154.42 41.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.143 -0.973 . . . . 0.0 109.486 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.4 ttm105 -77.26 148.68 35.62 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 167.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -131.07 146.95 52.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 155.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.7 m -83.06 148.33 27.6 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 156.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.404 ' HA3' ' CZ2' ' A' ' 58' ' ' TRP . . . -119.26 157.36 15.4 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 125.103 1.335 . . . . 0.0 109.772 169.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.6 tp -153.08 126.65 8.75 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.611 0.765 . . . . 0.0 109.042 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 158.18 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 119.475 1.034 . . . . 0.0 109.549 167.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -100.7 155.61 17.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mp -132.54 168.12 18.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.187 1.795 . . . . 0.0 109.229 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -151.24 -160.2 1.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.28 1.832 . . . . 0.0 107.162 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.465 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -134.12 171.47 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.703 1.201 . . . . 0.0 108.07 170.361 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -51.35 -63.32 1.17 Allowed 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.593 1.557 . . . . 0.0 110.201 170.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -107.44 -27.18 10.59 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.763 1.225 . . . . 0.0 111.995 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 t -99.72 -168.64 1.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.893 1.277 . . . . 0.0 111.667 -174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.0 50.66 0.69 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 126.559 2.028 . . . . 0.0 109.702 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.465 ' HE3' ' OE1' ' A' ' 85' ' ' GLN . 3.4 mtmp? -61.39 97.16 0.06 Allowed 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 158.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.4 p -96.9 104.53 16.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.45 155.68 20.32 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 m -135.79 64.58 1.57 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.489 1.516 . . . . 0.0 107.067 -157.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.38 107.36 2.83 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -164.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -112.33 133.19 54.57 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.01 139.73 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.67 72.09 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -108.79 144.97 30.67 Favored Pre-proline 0 C--O 1.23 0.077 0 CA-C-O 117.366 -1.302 . . . . 0.0 108.017 -172.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.28 173.2 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.623 2.882 . . . . 0.0 110.463 169.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.67 169.68 37.49 Favored Glycine 0 C--N 1.331 0.255 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? . . . . . 0 C--O 1.233 0.204 0 C-N-CA 123.047 0.539 . . . . 0.0 109.766 -168.293 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.1 m -124.23 148.83 47.04 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.483 1.113 . . . . 0.0 108.442 166.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -124.55 159.05 31.51 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.379 1.072 . . . . 0.0 111.104 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -129.98 112.73 13.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.442 1.897 . . . . 0.0 106.344 -171.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -143.96 68.67 1.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.275 1.43 . . . . 0.0 108.801 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 p -154.26 173.06 16.66 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.991 0.917 . . . . 0.0 108.712 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -64.07 170.08 3.89 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 149.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.36 -23.43 30.15 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.812 -0.555 . . . . 0.0 111.498 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -148.67 31.23 0.8 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.953 0.901 . . . . 0.0 110.189 -166.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.38 3.15 0.06 OUTLIER Glycine 0 C--N 1.342 0.916 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 -169.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.9 -123.06 6.24 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 120.03 1.915 . . . . 0.0 110.077 174.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 p -135.65 25.3 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.534 1.167 . . . . 0.0 111.764 -167.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -160.26 163.52 33.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.3 155.2 42.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 161.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m -142.59 127.93 18.82 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -118.9 146.9 44.55 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -122.12 65.58 21.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 C-N-CA 124.787 1.235 . . . . 0.0 108.657 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.14 169.14 9.69 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.774 2.316 . . . . 0.0 111.391 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.38 -176.45 5.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t0 55.13 -78.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.43 2.292 . . . . 0.0 113.897 171.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -154.12 110.82 3.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 156.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -149.58 90.85 1.75 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.905 1.23 . . . . 0.0 111.841 167.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.61 177.82 7.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.092 1.757 . . . . 0.0 108.988 169.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.45 -157.77 27.5 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 170.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.2 p -124.57 105.57 9.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.835 1.654 . . . . 0.0 110.081 -170.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -124.16 -171.01 2.24 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.63 160.78 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.837 2.055 . . . . 0.0 107.197 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.3 mt -138.43 164.12 30.15 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.076 1.351 . . . . 0.0 110.61 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -83.83 89.07 7.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.308 1.843 . . . . 0.0 111.809 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.1 152.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 172.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.19 120.25 39.83 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.106 1.762 . . . . 0.0 106.659 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 p -155.0 70.53 0.76 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.686 0.794 . . . . 0.0 109.711 -161.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -159.94 176.86 11.38 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.62 0.768 . . . . 0.0 111.285 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 151.74 49.47 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.711 1.605 . . . . 0.0 109.682 168.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -131.48 130.78 42.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 126.07 1.748 . . . . 0.0 109.215 -167.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.7 t -177.47 144.61 0.4 Allowed 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.168 1.387 . . . . 0.0 108.821 -174.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.33 -88.79 0.2 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 125.947 1.737 . . . . 0.0 112.663 164.368 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -159.57 33.35 0.19 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.652 1.581 . . . . 0.0 109.172 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -145.9 155.59 42.97 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.619 -1.3 . . . . 0.0 109.564 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.03 80.91 1.85 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.335 1.064 . . . . 0.0 110.007 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -67.22 118.66 10.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.063 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.68 155.35 40.24 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.591 0.632 . . . . 0.0 109.46 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.5 128.28 50.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.021 1.329 . . . . 0.0 108.909 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 t -78.37 178.62 7.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.372 1.069 . . . . 0.0 110.749 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -147.27 -167.73 2.86 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.834 2.054 . . . . 0.0 109.169 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -139.96 -178.16 5.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.861 1.664 . . . . 0.0 107.466 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.36 156.7 47.37 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 165.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.01 150.29 5.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.121 0.969 . . . . 0.0 109.545 165.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.67 -102.65 0.22 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 171.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.56 151.24 47.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.104 0.962 . . . . 0.0 109.729 170.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 m -86.89 -34.16 19.52 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -72.59 19.8 0.08 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.967 1.707 . . . . 0.0 113.635 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mt -130.05 129.67 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -100.4 167.95 10.06 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.673 1.589 . . . . 0.0 108.659 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.97 151.08 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 166.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.59 68.82 1.08 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 166.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.14 -117.83 8.21 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.4 p -72.46 48.48 0.19 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.368 1.867 . . . . 0.0 112.192 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -151.59 147.6 26.97 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.691 1.597 . . . . 0.0 108.497 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -144.65 130.8 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.742 1.217 . . . . 0.0 109.238 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 m -143.19 152.51 41.85 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -153.17 150.46 29.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.611 0.764 . . . . 0.0 109.783 173.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.33 175.2 9.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.824 1.249 . . . . 0.0 108.819 168.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -89.82 175.65 7.14 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.475 1.131 . . . . 0.0 108.577 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.415 HD21 ' CA ' ' A' ' 100' ' ' GLY . 29.4 p30 -66.93 165.68 24.74 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 120.313 -1.492 . . . . 0.0 113.791 173.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -94.73 -4.62 2.32 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.693 3.595 . . . . 0.0 113.457 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.96 153.21 51.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.805 1.242 . . . . 0.0 108.889 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . 0.338 0.0 OUTLIER -90.14 35.61 0.86 Allowed 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.082 -1.011 . . . . 0.0 111.954 -168.045 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -86.11 167.31 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 167.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.83 136.88 32.86 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 166.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -151.81 162.15 41.51 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.838 0.855 . . . . 0.0 109.741 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.2 t -117.53 158.64 24.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 160.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.78 165.23 28.18 Favored Glycine 0 C--O 1.239 0.457 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 159.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.1 tp -158.21 100.29 1.68 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 m -84.68 -165.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 49.6 m -145.45 146.32 31.46 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 119.447 -2.033 . . . . 0.0 105.831 157.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.26 137.02 54.87 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 170.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -123.29 119.89 31.47 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.327 1.451 . . . . 0.0 108.221 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -65.32 148.46 51.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.453 1.101 . . . . 0.0 109.541 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -50.83 -84.92 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.864 2.466 . . . . 0.0 113.624 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -80.36 -15.8 56.02 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.367 -0.833 . . . . 0.0 111.445 -174.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.82 -153.47 0.33 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.556 1.942 . . . . 0.0 108.739 173.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.43 1.51 0.03 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-O 117.897 -1.501 . . . . 0.0 114.551 -174.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.59 102.14 2.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.887 1.844 . . . . 0.0 106.664 169.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 p -69.49 152.11 45.23 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.751 0.657 . . . . 0.0 110.101 -169.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.18 169.28 8.58 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.336 1.054 . . . . 0.0 108.773 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -147.89 146.33 29.0 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.017 1.327 . . . . 0.0 107.841 -169.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.9 tp -139.35 110.65 6.97 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 128.651 2.78 . . . . 0.0 105.909 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -128.52 128.11 43.68 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.0 mt -134.63 77.81 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -163.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 86.2 t -75.81 99.06 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.08 155.0 43.25 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 124.593 1.157 . . . . 0.0 111.94 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.49 -168.82 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 124.231 3.287 . . . . 0.0 108.883 160.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.415 ' CA ' HD21 ' A' ' 71' ' ' ASN . . . -139.74 167.5 25.31 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 118.786 -1.674 . . . . 0.0 114.994 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.117 0 CA-C-N 114.456 -0.872 . . . . 0.0 112.341 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -89.58 125.79 35.36 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 166.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -102.33 152.93 20.51 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.927 1.291 . . . . 0.0 109.638 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.06 110.74 10.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.297 2.239 . . . . 0.0 106.571 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.9 46.79 1.75 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.762 1.625 . . . . 0.0 108.529 -175.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -160.36 157.34 27.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.941 1.696 . . . . 0.0 107.625 -170.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -73.67 170.83 14.43 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.184 0.993 . . . . 0.0 109.5 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.41 -36.3 45.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.286 0.634 . . . . 0.0 112.641 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -142.49 47.28 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.33 -1.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 -172.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.59 -112.68 4.61 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 120.914 2.357 . . . . 0.0 109.111 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.3 p -119.98 7.31 10.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.268 1.034 . . . . 0.0 112.598 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 t -137.88 158.14 44.96 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.451 1.023 . . . . 0.0 108.58 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -102.85 165.31 11.12 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 148.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.4 m -141.14 163.16 33.72 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 153.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -144.81 150.6 37.45 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -131.96 77.34 72.01 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 126.955 2.102 . . . . 0.0 106.475 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.59 177.02 8.0 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.845 1.696 . . . . 0.0 109.757 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -151.88 161.19 43.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 108.879 172.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 54.52 -85.34 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.444 2.697 . . . . 0.0 110.488 -167.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t -150.24 106.04 3.42 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 165.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -128.55 89.96 2.98 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 122.432 1.11 . . . . 0.0 108.664 156.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.5 149.03 50.66 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.922 2.089 . . . . 0.0 106.844 164.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.04 -139.03 4.97 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 p -129.91 116.04 18.06 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.775 1.63 . . . . 0.0 110.321 -171.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -146.44 -171.74 3.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.781 1.233 . . . . 0.0 111.873 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.6 mt -133.16 130.2 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.201 1.8 . . . . 0.0 107.273 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.2 mt -91.63 161.59 14.86 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.453 1.501 . . . . 0.0 109.419 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.2 78.84 4.0 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mt -90.35 133.05 33.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.865 2.066 . . . . 0.0 107.397 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 m -110.4 107.98 17.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -135.53 67.65 1.48 Allowed 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.029 0.932 . . . . 0.0 108.771 -163.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -154.37 176.22 12.59 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.25 -0.906 . . . . 0.0 111.808 -176.767 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.96 154.56 40.99 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 125.94 1.696 . . . . 0.0 108.988 170.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -141.36 126.82 18.8 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.93 1.292 . . . . 0.0 109.938 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.6 t -177.62 160.06 1.53 Allowed 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.135 1.374 . . . . 0.0 108.932 -176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.4 -103.56 0.32 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -146.04 29.5 1.08 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.158 0.983 . . . . 0.0 111.871 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -146.85 169.34 19.32 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.216 -0.927 . . . . 0.0 110.064 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.48 113.2 10.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.514 1.525 . . . . 0.0 109.064 -172.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.85 108.96 20.02 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.68 109.84 3.99 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.479 1.036 . . . . 0.0 109.217 169.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.77 134.64 52.57 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -66.75 163.23 19.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.384 1.474 . . . . 0.0 108.996 166.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -149.42 -172.87 4.24 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.1 -175.15 5.21 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 153.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.33 166.38 19.6 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.745 1.618 . . . . 0.0 108.277 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.62 149.84 20.65 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 161.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.27 -142.92 8.31 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -64.95 143.34 58.01 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.278 0.631 . . . . 0.0 111.043 -168.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.82 -0.76 4.48 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.104 1.762 . . . . 0.0 114.782 -170.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -117.81 11.56 13.59 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.032 1.733 . . . . 0.0 111.653 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.02 133.03 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -134.5 111.37 10.04 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.977 1.711 . . . . 0.0 106.892 -165.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.4 t -112.56 98.33 6.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -94.41 79.29 3.89 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.32 -107.78 0.47 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 126.215 1.864 . . . . 0.0 111.44 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m -73.83 -19.25 60.8 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.821 1.248 . . . . 0.0 112.764 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -88.08 160.06 17.97 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.45 1.023 . . . . 0.0 110.694 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -132.04 145.64 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 167.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -150.74 148.79 28.98 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.05 160.56 42.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -125.45 148.87 48.67 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.357 1.063 . . . . 0.0 108.289 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -62.92 170.86 2.44 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 123.621 1.677 . . . . 0.0 112.537 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.5 HD21 ' HA2' ' A' ' 100' ' ' GLY . 21.5 p30 -78.03 157.18 79.02 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.069 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.43 -6.16 7.15 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.02 2.48 . . . . 0.0 112.397 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.93 154.47 46.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.96 1.304 . . . . 0.0 109.221 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 40.79 0.77 Allowed 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.793 1.237 . . . . 0.0 111.065 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.29 170.33 9.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.288 1.435 . . . . 0.0 109.884 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.82 113.04 20.47 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.1 mtp85 -135.14 -170.44 2.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.122 0.969 . . . . 0.0 109.609 -170.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.7 t -147.2 156.89 43.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.486 -1.384 . . . . 0.0 108.108 161.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -84.7 174.07 49.74 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 159.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.5 tp -162.67 80.21 0.5 Allowed 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.53 178.06 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 120.629 -1.294 . . . . 0.0 110.005 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.4 m -134.38 141.51 46.88 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.949 -1.095 . . . . 0.0 108.566 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -127.83 151.45 49.03 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.901 1.68 . . . . 0.0 107.846 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.38 134.97 20.96 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.735 0.698 . . . . 0.0 109.454 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -77.12 154.65 33.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.416 1.087 . . . . 0.0 110.564 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -53.45 -69.49 0.12 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.989 2.116 . . . . 0.0 113.001 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -85.12 -23.51 28.41 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.053 0.541 . . . . 0.0 111.132 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -86.08 -153.64 0.19 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.318 1.847 . . . . 0.0 109.878 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.26 -13.28 0.02 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-O 118.193 -1.337 . . . . 0.0 115.645 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.71 121.54 10.66 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.959 1.879 . . . . 0.0 106.932 169.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.2 p -81.38 145.11 30.98 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -93.5 158.23 15.81 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 168.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 m -124.98 152.54 44.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.63 1.172 . . . . 0.0 110.153 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tt -152.72 109.29 3.43 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -170.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -117.25 137.32 52.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.305 1.042 . . . . 0.0 109.391 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.507 HG22 ' CG ' ' A' ' 98' ' ' GLN . 10.8 mt -135.72 94.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -171.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.6 t -99.28 80.76 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.507 ' CG ' HG22 ' A' ' 96' ' ' ILE . 17.7 mt-30 -89.81 166.01 22.45 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 125.313 1.445 . . . . 0.0 110.126 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -60.91 -172.05 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.824 3.016 . . . . 0.0 112.018 160.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.5 ' HA2' HD21 ' A' ' 71' ' ' ASN . . . -121.26 139.04 12.93 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 124.817 1.198 . . . . 0.0 112.1 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm . . . . . 0 N--CA 1.463 0.177 0 C-N-CA 125.343 1.457 . . . . 0.0 110.372 -175.22 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -147.93 103.79 3.52 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -77.11 155.0 32.69 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -137.31 109.08 7.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.141 2.577 . . . . 0.0 106.367 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -132.73 93.03 3.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -164.66 161.17 20.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.347 1.059 . . . . 0.0 110.179 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -66.44 167.76 10.13 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.493 -0.754 . . . . 0.0 108.966 163.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -114.89 -0.78 13.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.234 1.013 . . . . 0.0 111.89 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -145.92 51.18 1.17 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 166.85 -97.57 0.14 Allowed Glycine 0 CA--C 1.523 0.564 0 O-C-N 121.371 -0.831 . . . . 0.0 111.109 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.65 -112.24 0.26 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 118.065 0.933 . . . . 0.0 112.379 -171.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.2 p -138.44 16.09 2.75 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.97 0.908 . . . . 0.0 112.242 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 t -152.95 140.93 20.26 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.438 1.017 . . . . 0.0 109.49 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.29 157.09 17.37 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.021 0.929 . . . . 0.0 109.893 174.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -150.82 102.14 2.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 154.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -89.04 155.57 19.39 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 118.819 -1.153 . . . . 0.0 109.482 165.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -128.88 69.24 80.36 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 126.396 1.879 . . . . 0.0 108.774 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.94 170.83 14.7 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.354 2.036 . . . . 0.0 111.144 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.0 158.5 42.12 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.455 0.702 . . . . 0.0 110.505 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.4 t70 62.52 -72.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.016 2.126 . . . . 0.0 113.662 -171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 m -165.57 75.84 0.24 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.937 1.695 . . . . 0.0 108.687 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.42 98.8 6.09 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.342 1.057 . . . . 0.0 110.098 174.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.3 165.1 28.09 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.318 2.247 . . . . 0.0 106.448 167.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 143.68 174.61 16.09 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 119.76 1.164 . . . . 0.0 112.088 165.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.5 p -92.01 113.17 25.37 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.895 0.478 . . . . 0.0 110.707 -161.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -122.76 -167.11 1.53 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.255 1.022 . . . . 0.0 112.945 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mt -135.67 143.21 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 127.771 2.429 . . . . 0.0 105.194 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.9 mt -123.16 162.88 21.66 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.294 1.038 . . . . 0.0 110.067 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -104.63 86.19 2.45 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.234 1.414 . . . . 0.0 107.187 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -114.52 128.43 71.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 m -79.31 115.16 18.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.139 1.376 . . . . 0.0 108.129 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.2 p -143.68 73.38 1.39 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.375 0.534 . . . . 0.0 111.126 -174.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -155.84 167.67 29.65 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.669 -0.644 . . . . 0.0 112.407 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.41 133.58 55.62 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.295 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -103.78 142.74 33.84 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.834 0.854 . . . . 0.0 109.174 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.59 76.96 0.97 Allowed 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -156.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.75 -94.55 0.09 OUTLIER Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.862 1.22 . . . . 0.0 111.035 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -113.87 9.85 17.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 m -134.76 153.68 51.91 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.566 0.746 . . . . 0.0 110.957 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -139.1 92.19 2.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.712 1.605 . . . . 0.0 110.193 -168.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -76.97 115.53 16.84 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.176 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.43 152.69 45.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.16 148.95 42.51 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.393 1.077 . . . . 0.0 108.149 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.2 p -87.95 -179.42 6.22 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.792 0.837 . . . . 0.0 110.175 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -143.71 154.29 43.33 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 109.512 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -89.48 160.06 16.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.04 1.336 . . . . 0.0 108.538 160.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.75 163.11 26.91 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.832 2.053 . . . . 0.0 106.434 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 m -170.86 141.8 1.81 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.332 0.969 . . . . 0.0 109.284 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.93 -128.75 3.84 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.226 1.393 . . . . 0.0 110.245 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.92 136.73 4.48 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.113 2.565 . . . . 0.0 111.699 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -71.58 4.32 3.21 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 -165.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -139.66 15.58 2.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.874 0.869 . . . . 0.0 112.338 -160.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.7 mt -123.42 87.88 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -73.33 126.57 30.44 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.9 t -137.38 84.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.93 59.07 3.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.679 1.192 . . . . 0.0 109.145 -173.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.31 -115.88 8.33 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -172.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -75.65 39.04 0.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.86 1.664 . . . . 0.0 112.8 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 m -152.4 149.14 28.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.78 139.52 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 t -143.32 108.8 5.07 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.09 106.71 17.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 165.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -66.81 168.01 10.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.383 1.473 . . . . 0.0 110.822 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -85.03 -176.85 6.38 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.431 -0.793 . . . . 0.0 109.162 171.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -112.03 161.07 27.54 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.882 1.673 . . . . 0.0 108.44 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -86.79 -10.41 6.1 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.795 2.33 . . . . 0.0 113.375 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.83 167.07 13.98 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.934 1.293 . . . . 0.0 110.732 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -100.01 13.26 34.59 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.763 1.024 . . . . 0.0 113.763 -175.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.95 171.77 13.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 164.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -108.7 144.33 36.62 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.63 -0.668 . . . . 0.0 109.604 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.69 165.74 18.67 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.237 -0.914 . . . . 0.0 109.272 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.2 m -117.33 117.55 29.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 158.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.72 158.59 52.46 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.8 tp -155.18 111.35 3.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.94 0.87 . . . . 0.0 109.629 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.1 t -130.53 124.19 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.9 m -87.7 135.98 33.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 175.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.35 145.7 38.4 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.751 0.82 . . . . 0.0 108.901 167.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -134.57 139.87 45.7 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 173.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -71.52 160.04 33.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.198 0.999 . . . . 0.0 109.322 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -50.44 -33.35 20.69 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.109 1.363 . . . . 0.0 113.937 168.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -127.95 -36.06 2.02 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 t -88.22 -156.2 0.35 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.564 0.746 . . . . 0.0 110.054 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.64 10.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.627 0 CA-C-O 118.113 -1.381 . . . . 0.0 114.937 -171.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.91 94.27 1.05 Allowed 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.141 1.97 . . . . 0.0 107.147 169.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 p -72.8 113.67 10.1 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mp -75.0 130.13 38.83 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 t -88.18 152.63 21.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 tt -149.02 98.54 2.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -172.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -105.47 149.61 26.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.2 134.89 41.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 168.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 t -121.4 79.4 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -84.79 164.08 43.7 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.68 1.192 . . . . 0.0 110.704 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.26 179.61 3.32 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.448 2.765 . . . . 0.0 110.518 160.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.95 147.82 18.89 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.106 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm . . . . . 0 C--O 1.236 0.352 0 C-N-CA 126.206 1.802 . . . . 0.0 111.455 -166.782 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -97.77 100.63 12.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -79.2 157.07 27.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.106 0.479 . . . . 0.0 110.153 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -131.42 107.01 8.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -130.79 69.06 1.47 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.35 2.26 . . . . 0.0 105.663 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.6 p -163.41 -174.98 3.99 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.893 -0.504 . . . . 0.0 111.724 165.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -65.66 173.37 2.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.486 0.585 . . . . 0.0 109.688 161.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -112.47 -8.11 13.89 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -156.67 58.02 0.55 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.055 0.931 . . . . 0.0 108.888 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.3 -91.66 0.08 OUTLIER Glycine 0 C--N 1.331 0.286 0 O-C-N 121.405 -0.809 . . . . 0.0 111.779 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.33 -123.31 0.78 Allowed Glycine 0 C--N 1.333 0.362 0 CA-C-N 117.781 0.79 . . . . 0.0 113.007 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 p -138.81 12.32 2.68 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.223 1.409 . . . . 0.0 114.127 -169.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 t -157.38 146.64 20.03 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 118.467 -1.293 . . . . 0.0 111.7 169.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.5 137.76 33.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.375 160.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m -136.05 162.16 33.67 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 170.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -152.81 154.47 35.22 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 159.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.4 54.64 14.18 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.602 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.57 174.52 9.23 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.23 1.286 . . . . 0.0 111.167 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -159.46 169.54 23.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t70 65.16 -78.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.48 1.912 . . . . 0.0 111.231 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 m -169.07 110.44 0.49 Allowed 'General case' 0 C--O 1.238 0.496 0 C-N-CA 128.479 2.712 . . . . 0.0 106.702 160.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.6 m -138.89 24.75 2.57 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.78 146.71 49.6 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.173 -0.954 . . . . 0.0 110.445 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.73 -158.95 27.37 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -121.98 116.11 23.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.385 1.474 . . . . 0.0 110.173 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -122.14 -177.85 3.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.317 1.447 . . . . 0.0 110.639 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mt -132.03 156.59 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 127.287 2.235 . . . . 0.0 105.897 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.5 mt -134.06 179.04 6.5 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.648 1.579 . . . . 0.0 109.287 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -109.31 71.57 0.77 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.651 1.181 . . . . 0.0 109.461 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 97.2 mt -97.5 138.88 21.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.38 131.32 51.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.46 1.504 . . . . 0.0 107.421 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.1 t -148.61 81.98 1.46 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -154.2 173.17 16.47 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.764 -0.585 . . . . 0.0 111.394 173.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.68 137.25 54.37 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.778 1.631 . . . . 0.0 108.602 169.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -115.29 134.63 54.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.307 1.843 . . . . 0.0 107.011 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.1 t -174.85 157.79 2.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.67 -110.8 0.89 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -135.12 32.4 3.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.844 1.258 . . . . 0.0 109.476 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m -144.53 161.55 38.81 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.884 0.874 . . . . 0.0 110.784 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 p -127.66 103.21 7.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.025 1.33 . . . . 0.0 108.002 166.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -78.57 116.33 18.88 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.35 148.48 46.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -112.65 142.95 44.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.09 163.47 20.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.797 0.839 . . . . 0.0 110.514 166.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -140.1 158.4 44.12 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.585 1.154 . . . . 0.0 108.898 165.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -138.26 151.16 47.37 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.479 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -141.4 162.14 36.19 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.369 1.068 . . . . 0.0 110.736 -163.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -168.96 152.42 5.23 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.292 1.037 . . . . 0.0 109.495 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.59 -138.88 5.47 Favored Glycine 0 C--N 1.333 0.38 0 O-C-N 121.506 -0.746 . . . . 0.0 111.709 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.47 ' HB2' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -55.84 137.33 50.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.153 1.381 . . . . 0.0 111.133 -178.93 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.5 m -69.4 3.43 2.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.745 2.418 . . . . 0.0 116.364 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -126.98 6.58 6.58 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.276 1.43 . . . . 0.0 111.963 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 56' ' ' ASP . 34.6 mt -117.27 91.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -76.77 110.23 11.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.614 1.166 . . . . 0.0 108.724 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 53' ' ' ALA . 8.0 p -94.41 143.13 12.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.17 0.988 . . . . 0.0 108.461 177.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.67 46.08 1.69 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.744 0.783 . . . . 0.0 111.061 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.18 -113.5 5.42 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.5 p -71.99 -7.35 48.2 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.2 m -110.31 144.65 38.72 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 119.671 1.123 . . . . 0.0 109.623 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.62 157.11 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.888 1.675 . . . . 0.0 107.775 -176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.29 152.58 26.21 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.529 1.132 . . . . 0.0 108.432 162.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -154.4 173.36 16.33 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.966 0.906 . . . . 0.0 109.557 159.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.93 170.81 8.06 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.784 1.233 . . . . 0.0 110.686 166.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -80.9 158.75 25.18 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 122.509 1.147 . . . . 0.0 108.305 165.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.63 167.37 5.74 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 126.304 1.842 . . . . 0.0 112.362 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -92.1 -10.8 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.377 3.385 . . . . 0.0 115.726 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.82 141.87 29.5 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 120.558 1.526 . . . . 0.0 109.926 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.585 ' H ' ' CD ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -72.0 8.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 128.668 2.787 . . . . 0.0 114.0 -155.042 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -61.58 166.65 4.0 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 163.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' A' ' 99' ' ' PRO . 8.4 ttm-85 -126.21 118.9 26.12 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.086 1.354 . . . . 0.0 110.253 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -136.94 -168.94 2.37 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.562 1.145 . . . . 0.0 110.25 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 8.8 t -131.82 156.12 46.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.653 0.781 . . . . 0.0 109.238 162.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.81 -179.3 40.43 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 160.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.7 tp -147.82 160.36 42.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.736 1.214 . . . . 0.0 108.383 159.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -135.78 151.48 29.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 163.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.2 m -124.37 154.87 39.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.782 HD21 ' HB2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -145.01 167.38 22.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.266 1.027 . . . . 0.0 109.968 -174.088 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -137.89 158.28 44.68 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 125.167 1.387 . . . . 0.0 108.077 167.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -114.98 139.46 49.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -44.7 -73.16 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.037 1.735 . . . . 0.0 113.743 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.26 -8.75 54.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.691 1.996 . . . . 0.0 112.957 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.76 -153.37 0.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.459 2.304 . . . . 0.0 106.771 174.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 0.21 0.04 OUTLIER Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.11 -1.519 . . . . 0.0 115.931 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -58.85 153.3 17.41 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 126.568 1.947 . . . . 0.0 110.925 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 p -122.42 146.79 47.03 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.782 ' HB2' HD21 ' A' ' 83' ' ' LEU . 59.5 mt -117.39 -170.42 1.85 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.845 1.658 . . . . 0.0 106.639 175.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.54 161.08 39.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.104 1.362 . . . . 0.0 108.776 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 tp -136.45 77.92 1.68 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.548 1.939 . . . . 0.0 108.438 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -82.25 89.08 6.5 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.687 -0.633 . . . . 0.0 110.312 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' THR . 17.4 mt -83.68 92.47 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 175.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.6 87.64 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.13 160.75 31.34 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 118.281 0.491 . . . . 0.0 109.895 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.4 ' HA ' ' HG3' ' A' ' 76' ' ' ARG . 31.1 Cg_endo -78.4 171.54 16.73 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.749 1.632 . . . . 0.0 109.781 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -88.92 164.53 32.59 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.46 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm . . . . . 0 C--O 1.239 0.543 0 CA-C-N 114.036 -1.082 . . . . 0.0 108.231 -163.344 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.64 111.48 21.32 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.145 0.978 . . . . 0.0 108.522 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -88.24 166.3 14.44 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 163.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -144.15 102.83 3.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.468 1.907 . . . . 0.0 106.333 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -128.63 65.23 1.42 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.819 1.648 . . . . 0.0 109.042 -169.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.68 174.06 12.56 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.037 -1.039 . . . . 0.0 110.195 172.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -62.98 149.45 44.83 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.948 1.249 . . . . 0.0 107.63 155.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.37 -24.41 59.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.149 -174.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -93.52 17.3 11.8 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.203 1.001 . . . . 0.0 111.845 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.32 58.03 1.17 Allowed Glycine 0 C--N 1.337 0.586 0 O-C-N 121.769 -0.582 . . . . 0.0 111.943 168.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.06 -169.39 38.22 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.61 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 p -137.82 7.19 2.72 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.778 1.231 . . . . 0.0 112.74 -163.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 t -162.05 159.85 26.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.187 -0.946 . . . . 0.0 109.102 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.72 129.03 55.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 167.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.2 m -132.73 119.64 20.6 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 166.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.56 145.31 42.77 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -130.5 74.03 80.63 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -75.12 174.59 12.54 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.419 2.079 . . . . 0.0 110.709 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -137.9 -1.84 1.96 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -162.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.03 -66.22 0.35 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.013 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.4 t -157.92 9.81 0.17 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.397 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.65 92.2 0.32 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.387 1.449 . . . . 0.0 112.692 -167.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.82 147.01 28.25 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.9 2.48 . . . . 0.0 106.834 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.01 -179.68 40.6 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 121.497 1.953 . . . . 0.0 110.066 -172.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.5 m -99.67 117.26 33.64 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.949 0.9 . . . . 0.0 109.774 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -139.71 -165.94 1.98 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.032 1.333 . . . . 0.0 110.599 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.0 mt -128.83 155.92 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.33 1.852 . . . . 0.0 107.485 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.2 mt -133.58 156.09 48.47 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.55 1.94 . . . . 0.0 106.729 173.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.22 98.06 7.66 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.92 142.89 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.96 112.98 23.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.18 55.93 1.62 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -174.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -152.39 168.02 26.81 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.02 -1.05 . . . . 0.0 113.524 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.3 145.33 47.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.971 1.309 . . . . 0.0 109.144 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HE3' ' CG2' ' A' ' 46' ' ' THR . 18.3 ttmt -112.95 143.82 43.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.806 2.442 . . . . 0.0 106.779 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.8 t -172.99 172.02 4.07 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.073 2.149 . . . . 0.0 105.606 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.43 -102.56 0.04 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 126.19 1.852 . . . . 0.0 112.407 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -146.37 41.46 1.15 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.902 1.681 . . . . 0.0 109.188 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -146.26 169.22 19.22 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.005 0.922 . . . . 0.0 110.61 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.468 ' CG2' ' HE3' ' A' ' 41' ' ' LYS . 52.3 p -135.16 104.66 6.0 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.992 0.917 . . . . 0.0 110.461 165.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -80.44 121.42 25.72 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 172.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.75 151.42 47.48 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 166.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.45 114.14 21.35 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.692 1.597 . . . . 0.0 106.871 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 m -67.45 150.15 49.29 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.994 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -120.17 160.57 22.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.465 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -107.15 165.13 11.59 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.035 1.734 . . . . 0.0 107.825 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.722 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -156.19 144.36 19.8 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.702 1.201 . . . . 0.0 108.327 166.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.67 152.4 27.06 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.306 0.643 . . . . 0.0 109.985 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.92 -62.16 0.11 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.01 148.82 39.75 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.229 1.012 . . . . 0.0 110.389 -168.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -60.07 -10.72 4.61 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.637 1.975 . . . . 0.0 114.952 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -130.72 14.38 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.429 1.492 . . . . 0.0 111.066 -163.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.489 HG23 ' CE1' ' A' ' 68' ' ' TYR . 23.6 mt -127.36 86.5 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -172.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -104.24 141.78 35.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.106 1.362 . . . . 0.0 111.522 -170.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.722 HG11 ' HB3' ' A' ' 53' ' ' ALA . 5.1 p -131.03 100.56 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.858 0.863 . . . . 0.0 109.552 -168.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -100.51 51.96 0.88 Allowed 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.606 -1.309 . . . . 0.0 109.921 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.66 -113.76 6.17 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.4 p -78.1 53.29 1.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.665 1.232 . . . . 0.0 110.773 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.9 m -165.02 150.52 9.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.605 2.362 . . . . 0.0 107.263 167.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.33 140.95 28.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.0 t -155.69 102.97 2.24 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.489 ' CE1' HG23 ' A' ' 59' ' ' ILE . 4.4 m-30 -113.96 136.72 52.58 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -103.7 172.02 7.03 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.001 1.321 . . . . 0.0 111.554 -173.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.42 156.71 36.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.89 0.853 . . . . 0.0 111.106 163.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -68.12 165.56 32.06 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.26 1.824 . . . . 0.0 110.888 165.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -88.27 -11.51 4.32 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.91 2.407 . . . . 0.0 113.969 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.03 159.71 38.01 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.204 1.002 . . . . 0.0 109.811 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 0.6 3.51 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.09 165.12 11.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.557 0.743 . . . . 0.0 109.615 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -92.06 146.42 23.75 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 168.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -136.98 154.81 50.32 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.6 m -113.48 106.43 14.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 163.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.39 149.67 47.93 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.5 tp -162.66 118.45 1.86 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.075 0.938 . . . . 0.0 109.53 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.66 166.81 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.195 0.998 . . . . 0.0 109.183 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.7 m -121.52 144.54 48.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 169.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.425 HD11 HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -124.58 160.58 28.08 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.356 1.863 . . . . 0.0 110.095 172.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -148.8 137.96 21.62 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.759 1.224 . . . . 0.0 108.257 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -68.35 165.59 18.37 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -55.56 -84.94 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.815 2.046 . . . . 0.0 111.553 170.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -91.42 -3.14 56.97 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.971 -1.081 . . . . 0.0 113.268 -167.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 t -116.27 -154.51 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.242 2.217 . . . . 0.0 108.028 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.06 41.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.528 0 O-C-N 120.941 -1.099 . . . . 0.0 110.54 -159.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . 0.305 0.0 OUTLIER -65.24 138.5 58.27 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 153.878 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.1 p -110.39 140.97 44.08 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 159.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.425 HD12 HD11 ' A' ' 83' ' ' LEU . 86.3 mt -121.24 112.04 18.14 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.9 m -65.07 137.72 57.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tt -140.48 96.61 3.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.094 0.861 . . . . 0.0 110.072 -175.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -98.23 137.18 37.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mp -118.53 117.54 54.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 158.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.3 t -108.79 79.15 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -106.14 158.94 31.38 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 123.377 0.671 . . . . 0.0 110.899 -171.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -65.66 -178.08 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.289 2.659 . . . . 0.0 109.979 162.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.2 165.27 22.58 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 121.854 -0.529 . . . . 0.0 112.38 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm . . . . . 0 C--N 1.326 -0.416 0 C-N-CA 124.034 0.934 . . . . 0.0 110.812 -158.737 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.54 144.36 50.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.919 1.688 . . . . 0.0 109.188 175.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.608 ' CZ ' ' HE2' ' A' ' 40' ' ' LYS . 6.8 m-85 -127.2 136.98 52.8 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.981 1.712 . . . . 0.0 107.715 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.63 115.17 22.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.989 2.116 . . . . 0.0 107.898 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.44 75.2 1.5 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.861 2.064 . . . . 0.0 105.797 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -170.25 174.89 5.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.677 0.791 . . . . 0.0 110.288 -175.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -82.95 157.49 22.98 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.664 -0.647 . . . . 0.0 109.938 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.4 -63.99 1.29 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.279 0.561 . . . . 0.0 109.724 165.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -107.92 28.37 8.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.062 1.745 . . . . 0.0 111.027 -160.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.4 -11.43 0.07 OUTLIER Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 170.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.04 -119.31 4.51 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 120.336 2.068 . . . . 0.0 113.796 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.17 9.14 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.636 1.174 . . . . 0.0 112.843 -165.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 t -154.13 -173.4 4.56 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.978 0.808 . . . . 0.0 110.534 161.179 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.96 105.61 5.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 127.785 2.434 . . . . 0.0 109.322 -171.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -130.35 88.84 2.69 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -83.97 136.48 34.05 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -121.45 70.65 24.42 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.815 1.246 . . . . 0.0 108.392 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.53 171.89 12.31 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.767 1.645 . . . . 0.0 110.307 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -153.43 157.62 40.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.75 1.22 . . . . 0.0 108.276 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.28 -85.52 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.583 2.353 . . . . 0.0 110.106 -170.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 t -146.44 96.43 2.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.979 1.712 . . . . 0.0 108.928 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 m -146.63 89.42 1.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.828 -1.17 . . . . 0.0 112.207 162.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.09 135.9 43.55 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.682 1.193 . . . . 0.0 108.417 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.34 -172.31 40.11 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-N 118.871 0.759 . . . . 0.0 112.498 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.0 p -111.33 108.69 18.38 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.21 1.404 . . . . 0.0 109.683 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -132.81 -174.86 3.59 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.015 1.326 . . . . 0.0 112.89 -175.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 mt -140.57 125.22 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.094 1.358 . . . . 0.0 107.91 -169.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.3 mt -109.17 165.73 11.38 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.997 1.319 . . . . 0.0 110.57 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -84.51 83.63 7.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.076 0.941 . . . . 0.0 110.888 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.0 mt -109.36 119.55 58.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.46 1.104 . . . . 0.0 109.449 -170.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.5 m -84.77 135.3 34.18 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.549 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.7 t -155.19 89.27 1.2 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -162.75 165.89 24.97 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.925 0.89 . . . . 0.0 111.506 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.608 ' HE2' ' CZ ' ' A' ' 9' ' ' TYR . 11.0 ptpt -110.71 161.19 16.01 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.206 1.003 . . . . 0.0 109.113 172.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -134.17 124.98 26.94 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 125.968 1.707 . . . . 0.0 108.001 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.0 t -173.82 175.54 2.85 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.104 1.362 . . . . 0.0 108.073 173.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.56 -107.52 0.92 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -152.15 68.23 0.87 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.617 1.567 . . . . 0.0 107.499 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.8 m -160.87 172.21 17.38 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.687 1.995 . . . . 0.0 110.653 171.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 p -135.39 89.5 2.52 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.076 0.951 . . . . 0.0 110.147 161.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -79.13 140.04 37.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.698 1.135 . . . . 0.0 109.963 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.96 166.79 5.34 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.165 1.386 . . . . 0.0 111.417 171.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 86' ' ' ASP . 22.5 mt -137.32 134.46 36.08 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.839 0.855 . . . . 0.0 109.512 162.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.5 p -71.63 173.68 7.76 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.817 1.647 . . . . 0.0 110.357 171.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -145.69 179.86 7.15 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.806 1.243 . . . . 0.0 111.318 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -125.88 162.44 25.18 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 127.27 2.228 . . . . 0.0 107.734 170.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.92 156.8 43.36 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.596 0.758 . . . . 0.0 109.236 165.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p 174.56 154.19 0.13 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.946 1.298 . . . . 0.0 112.64 167.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.41 -96.47 0.1 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.779 2.133 . . . . 0.0 109.055 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.21 167.72 11.7 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.898 0.849 . . . . 0.0 111.426 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.5 m -93.08 5.03 52.93 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -125.64 21.4 7.74 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.881 1.672 . . . . 0.0 112.461 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.7 mt -134.84 114.22 17.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -165.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -124.0 149.26 46.24 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.06 0.944 . . . . 0.0 109.898 -166.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -132.55 155.27 41.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -171.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.01 179.0 7.47 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.416 1.086 . . . . 0.0 108.849 165.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.72 -18.71 32.74 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 116.484 1.353 . . . . 0.0 116.484 -163.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 m -145.03 8.01 1.22 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.323 1.561 . . . . 0.0 111.16 163.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -109.99 151.45 27.13 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.697 1.599 . . . . 0.0 109.387 -163.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.19 138.25 53.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -142.18 152.26 42.98 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -159.23 168.02 27.54 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.855 0.862 . . . . 0.0 108.841 163.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -119.47 166.98 12.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.419 1.088 . . . . 0.0 110.565 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.13 175.31 7.62 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.403 1.097 . . . . 0.0 111.161 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.447 HD22 ' HD2' ' A' ' 77' ' ' ARG . 7.6 p-10 -99.8 166.94 11.88 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.957 2.503 . . . . 0.0 110.945 -170.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -76.76 -28.6 6.25 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.826 2.351 . . . . 0.0 114.775 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.91 168.5 19.67 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.673 1.124 . . . . 0.0 110.883 -165.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -75.0 1.11 13.73 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 120.733 -1.229 . . . . 0.0 111.918 -170.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -65.0 161.25 19.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.231 0.538 . . . . 0.0 110.749 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.92 129.13 34.18 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.447 ' HD2' HD22 ' A' ' 71' ' ' ASN . 0.0 OUTLIER -119.81 101.96 8.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 167.626 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.6 m -91.1 106.82 18.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 162.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.32 160.93 53.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.0 tp -161.46 93.94 0.95 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.38 0.59 . . . . 0.0 111.818 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 m -86.28 179.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.966 -0.458 . . . . 0.0 111.983 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.96 164.53 14.01 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 161.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.539 HD13 ' HB2' ' A' ' 92' ' ' LEU . 3.4 mp -134.01 164.78 26.54 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.848 1.659 . . . . 0.0 108.87 165.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -151.66 153.18 33.91 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 164.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -80.03 171.88 14.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 172.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.457 ' HB3' HD22 ' A' ' 49' ' ' LEU . 50.9 t0 -55.56 -39.41 70.6 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.902 1.281 . . . . 0.0 112.031 168.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -126.04 -44.97 1.73 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.893 -1.129 . . . . 0.0 111.845 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.4 t -79.47 -169.56 1.96 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.75 10.49 0.04 OUTLIER Glycine 0 C--O 1.223 -0.582 0 CA-C-O 117.09 -1.95 . . . . 0.0 116.422 -159.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.34 91.89 0.05 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 120.74 2.27 . . . . 0.0 109.194 169.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 p -71.6 145.01 49.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.539 ' HB2' HD13 ' A' ' 83' ' ' LEU . 75.1 mt -102.09 -179.06 3.89 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.16 -0.963 . . . . 0.0 108.57 176.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.93 86.73 1.87 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.148 1.379 . . . . 0.0 110.681 -167.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.99 73.12 8.04 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.469 1.108 . . . . 0.0 109.473 -169.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -78.4 91.77 4.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.462 HG22 ' CG ' ' A' ' 98' ' ' GLN . 26.3 mt -87.49 102.41 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.08 81.51 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -172.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.462 ' CG ' HG22 ' A' ' 96' ' ' ILE . 9.4 mt-30 -95.98 156.37 37.24 Favored Pre-proline 0 C--O 1.242 0.674 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.451 -171.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -61.89 156.79 46.86 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.692 1.594 . . . . 0.0 108.715 162.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.78 153.17 25.59 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 125.405 1.482 . . . . 0.0 110.759 -172.049 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.2 t -82.68 105.82 14.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.453 1.101 . . . . 0.0 108.351 -174.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -89.72 146.53 24.44 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.028 -1.045 . . . . 0.0 110.453 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -132.41 112.04 11.82 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.843 1.657 . . . . 0.0 108.884 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -144.51 92.32 2.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.036 0.934 . . . . 0.0 108.849 173.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 p -166.93 167.77 14.51 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.666 0.787 . . . . 0.0 110.018 172.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -72.97 172.33 11.15 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.027 0.531 . . . . 0.0 110.537 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.37 -22.1 44.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.463 0.705 . . . . 0.0 111.209 170.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -79.15 20.78 0.48 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.299 1.84 . . . . 0.0 112.468 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.88 52.17 52.2 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.636 -1.29 . . . . 0.0 112.693 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.92 -173.12 40.48 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.394 0.597 . . . . 0.0 113.564 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -131.96 17.3 4.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.108 2.163 . . . . 0.0 111.83 -166.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 t -151.58 137.42 18.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.521 -1.362 . . . . 0.0 108.835 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -108.08 125.49 51.64 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.0 m -130.69 93.71 3.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.04 143.82 31.28 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -122.09 65.91 21.89 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.85 1.26 . . . . 0.0 110.504 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.29 -176.49 2.95 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.031 1.821 . . . . 0.0 110.407 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -162.18 165.53 26.8 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.909 1.284 . . . . 0.0 108.023 -169.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 59.06 -77.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.651 2.38 . . . . 0.0 112.716 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.1 t -160.01 124.0 3.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.328 1.451 . . . . 0.0 107.584 149.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.93 31.31 3.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.947 0.794 . . . . 0.0 112.472 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.96 126.1 28.69 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.773 1.229 . . . . 0.0 111.221 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.04 -159.57 16.23 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.7 p -123.55 116.55 23.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.652 1.181 . . . . 0.0 109.265 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -130.14 -177.57 4.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.538 1.535 . . . . 0.0 110.821 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.1 mt -135.27 148.13 28.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.4 mt -128.11 161.12 29.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.612 1.165 . . . . 0.0 109.574 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -91.13 108.73 20.07 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.63 1.572 . . . . 0.0 108.668 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -119.82 138.63 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 C-N-CA 125.633 1.573 . . . . 0.0 107.954 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 m -79.92 129.33 34.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 117.868 -1.063 . . . . 0.0 108.852 164.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -148.29 71.61 1.17 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.199 1.363 . . . . 0.0 111.527 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -153.49 171.21 19.04 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.157 -0.965 . . . . 0.0 112.227 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.99 144.21 49.95 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.905 1.682 . . . . 0.0 108.827 167.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -117.42 133.8 55.56 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -172.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t 175.02 -171.47 0.06 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.603 2.361 . . . . 0.0 105.867 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 55.29 -107.93 0.88 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -143.21 26.05 1.68 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.16 0.984 . . . . 0.0 110.027 167.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.3 m -150.81 -164.89 2.12 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.002 1.321 . . . . 0.0 110.411 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 p -130.37 99.02 4.87 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.037 2.135 . . . . 0.0 107.856 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -73.05 123.03 22.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.32 161.21 14.39 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.656 0.782 . . . . 0.0 110.045 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.1 mt -138.03 153.49 49.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.223 1.009 . . . . 0.0 108.863 169.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -115.19 164.96 13.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.217 1.407 . . . . 0.0 109.808 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -145.71 165.69 28.03 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -168.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -121.83 153.91 37.74 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 127.441 2.297 . . . . 0.0 109.282 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.426 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -147.45 148.31 31.13 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.974 1.709 . . . . 0.0 108.157 169.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -166.94 154.55 9.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.305 0.642 . . . . 0.0 111.102 168.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.53 -69.23 0.06 OUTLIER Glycine 0 C--N 1.337 0.613 0 CA-C-O 121.322 0.401 . . . . 0.0 113.125 172.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.615 ' H ' HG12 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -75.74 -173.12 2.12 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.585 1.954 . . . . 0.0 109.69 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.21 23.14 11.48 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.5 1.52 . . . . 0.0 113.691 168.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -135.42 -3.24 2.41 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.7 mt -119.3 122.77 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.918 2.087 . . . . 0.0 107.955 -167.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -123.54 165.56 16.93 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.388 -0.82 . . . . 0.0 110.965 -169.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 53' ' ' ALA . 10.7 p -146.64 140.78 20.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.131 0.972 . . . . 0.0 108.56 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.01 66.88 1.48 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.38 -119.05 15.45 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.939 -2.065 . . . . 0.0 107.939 -165.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.5 p -56.82 -25.24 55.54 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.127 1.771 . . . . 0.0 114.265 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 m -93.28 146.62 23.57 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.444 1.097 . . . . 0.0 109.366 -167.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.45 145.17 23.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.585 1.154 . . . . 0.0 109.197 -173.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 m -143.25 154.39 43.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -152.09 125.58 8.84 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 168.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -105.94 114.61 28.86 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.264 10.6 pt-20 -75.37 165.68 24.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.982 0.896 . . . . 0.0 112.939 -166.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.35 149.81 97.93 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.75 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -74.81 -9.57 21.11 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.041 2.494 . . . . 0.0 113.071 -169.417 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.53 -178.65 3.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.597 1.189 . . . . 0.0 110.728 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.97 13.87 21.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.216 1.806 . . . . 0.0 112.157 -170.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -80.04 152.51 29.36 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 172.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -82.75 138.44 34.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.744 1.218 . . . . 0.0 107.931 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -144.09 92.55 2.34 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.222 1.374 . . . . 0.0 111.327 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.47 HG23 HG22 ' A' ' 97' ' ' VAL . 45.6 m -68.87 115.61 8.4 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.181 -0.324 . . . . 0.0 110.514 173.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.24 162.56 29.69 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.157 0.884 . . . . 0.0 112.91 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.1 tp -162.69 115.11 1.62 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.82 1.248 . . . . 0.0 111.247 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 56' ' ' ASP . 3.2 m -103.19 179.32 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.357 1.063 . . . . 0.0 109.828 164.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 m -129.38 162.87 27.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 163.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -143.74 158.82 43.41 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 125.794 1.638 . . . . 0.0 112.406 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -150.54 159.89 44.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.501 1.12 . . . . 0.0 109.548 168.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -103.76 164.69 11.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.275 1.43 . . . . 0.0 110.256 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -54.99 -57.15 12.84 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.736 1.214 . . . . 0.0 113.345 -172.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -118.59 -6.64 10.67 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.239 0.616 . . . . 0.0 112.468 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.1 m -80.3 -154.64 0.1 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.088 0.955 . . . . 0.0 109.562 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.04 -1.24 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 118.138 -1.368 . . . . 0.0 115.502 173.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -64.1 107.4 1.27 Allowed 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.029 1.914 . . . . 0.0 106.721 170.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.1 p -63.32 155.3 29.09 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 161.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.3 mt -101.74 -166.11 1.26 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 164.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t -146.32 111.68 5.47 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 160.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.9 tp -83.78 122.24 28.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -120.74 154.25 35.89 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -131.43 121.47 48.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 103.711 -2.699 . . . . 0.0 103.711 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 78' ' ' THR . 45.7 t -127.47 105.85 14.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.64 165.84 22.76 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 124.257 1.023 . . . . 0.0 111.142 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -63.51 -177.97 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.516 2.144 . . . . 0.0 110.867 156.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.32 175.11 18.77 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.458 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt . . . . . 0 C--O 1.236 0.351 0 C-N-CA 124.877 1.271 . . . . 0.0 112.054 -173.22 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.67 122.62 45.09 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 168.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -85.85 155.42 20.98 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 164.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -134.72 103.52 5.67 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 2.8 t80 -139.71 86.27 2.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 170.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.67 -170.03 3.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.838 2.055 . . . . 0.0 105.843 171.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -78.18 -89.31 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 166.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.79 -61.97 0.12 Allowed 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 119.073 -2.267 . . . . 0.0 110.788 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 p30 -127.12 2.48 6.47 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.844 2.058 . . . . 0.0 110.697 -167.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.25 -73.08 1.19 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 107.711 -2.155 . . . . 0.0 107.711 170.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.55 -154.8 25.55 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.7 p -79.85 20.11 0.64 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.468 1.907 . . . . 0.0 110.909 171.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.7 t -158.94 156.85 30.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.661 -1.274 . . . . 0.0 108.77 -165.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.9 157.4 46.47 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 157.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.0 m -131.45 152.34 50.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 158.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -133.94 150.78 51.31 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -127.88 74.33 78.7 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 126.11 1.764 . . . . 0.0 107.425 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.33 175.2 4.29 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.346 2.03 . . . . 0.0 109.846 167.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -161.03 173.92 14.51 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.395 -0.816 . . . . 0.0 109.11 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t0 55.93 -84.04 0.01 OUTLIER 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.963 2.505 . . . . 0.0 111.485 -173.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -145.39 125.71 13.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.103 2.561 . . . . 0.0 105.199 148.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 m -148.87 112.34 5.01 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.773 1.169 . . . . 0.0 110.4 163.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.6 179.24 6.68 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.0 1.72 . . . . 0.0 108.668 161.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.33 -176.56 32.91 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 174.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 m -109.17 101.61 10.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.835 1.254 . . . . 0.0 109.876 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -115.36 -165.01 0.99 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.465 1.906 . . . . 0.0 111.166 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.0 mt -127.53 148.14 32.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.586 1.554 . . . . 0.0 107.426 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.5 mt -132.03 165.32 24.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.849 2.059 . . . . 0.0 107.154 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.04 105.91 14.81 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -172.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.7 mt -132.52 142.13 43.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.67 1.588 . . . . 0.0 107.789 -163.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -112.23 129.9 56.11 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.063 1.345 . . . . 0.0 108.226 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -147.78 78.04 1.44 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.084 0.468 . . . . 0.0 110.162 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -157.04 175.76 13.65 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.774 -1.204 . . . . 0.0 111.567 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.58 148.54 43.2 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.989 0.916 . . . . 0.0 109.209 161.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -114.67 123.43 49.26 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 126.506 1.922 . . . . 0.0 107.413 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 t -173.98 -166.66 0.31 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.967 1.707 . . . . 0.0 107.113 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.33 -103.63 0.13 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.184 1.849 . . . . 0.0 109.552 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -147.11 21.14 1.23 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.976 0.91 . . . . 0.0 110.656 171.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 m -156.33 173.92 16.16 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 120.327 -1.483 . . . . 0.0 111.39 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -130.24 105.69 8.08 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.829 1.652 . . . . 0.0 107.087 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -83.23 139.83 32.88 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.2 146.12 45.77 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.641 0.655 . . . . 0.0 110.945 172.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.9 mt -101.77 133.14 46.96 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 165.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -73.2 166.52 22.99 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.753 1.221 . . . . 0.0 109.126 171.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.1 p90 -148.28 179.32 7.86 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.279 1.032 . . . . 0.0 111.844 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.93 172.31 12.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.782 1.633 . . . . 0.0 110.471 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.82 161.13 32.45 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.524 1.93 . . . . 0.0 109.617 169.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.9 p -153.64 140.25 18.88 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 163.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.19 -138.05 5.08 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.56 131.03 6.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.182 2.593 . . . . 0.0 111.076 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 m -80.27 30.99 0.27 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.93 1.292 . . . . 0.0 113.818 -173.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -133.52 23.65 4.04 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.584 1.554 . . . . 0.0 110.299 172.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -144.98 107.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -119.9 164.44 16.05 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.82 1.248 . . . . 0.0 108.925 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.34 152.76 13.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.281 0.562 . . . . 0.0 110.801 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.7 169.18 18.06 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 128.672 2.789 . . . . 0.0 109.433 166.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -58.68 -32.96 70.55 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.879 -0.4 . . . . 0.0 113.538 -177.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.36 11.5 8.7 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 t -153.47 142.81 21.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 119.553 1.069 . . . . 0.0 108.859 -170.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.7 t -120.91 150.97 23.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -171.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -139.0 134.18 32.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 165.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -127.34 138.15 52.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 155.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -99.33 -172.93 2.36 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -101.42 168.96 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.634 1.207 . . . . 0.0 108.825 170.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.483 HD21 ' HA2' ' A' ' 100' ' ' GLY . 27.5 p30 -76.28 160.54 77.62 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 124.738 1.215 . . . . 0.0 108.98 167.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -75.19 -47.23 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.245 1.964 . . . . 0.0 110.549 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.14 165.88 12.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.0 110.696 -170.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.23 2.32 50.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.049 0.94 . . . . 0.0 113.071 -171.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.42 148.85 46.51 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.523 -0.735 . . . . 0.0 110.129 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 139.6 58.38 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.65 0.78 . . . . 0.0 108.945 174.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -129.58 151.02 50.65 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.892 0.877 . . . . 0.0 109.858 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.9 m -120.61 100.65 7.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.849 1.26 . . . . 0.0 107.654 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.97 140.59 33.08 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.1 tp -152.79 103.18 2.75 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 117.886 0.843 . . . . 0.0 108.801 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.3 m -107.59 163.62 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 118.826 0.739 . . . . 0.0 110.592 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.6 m -107.72 158.08 17.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mp -138.22 158.46 44.25 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.313 1.845 . . . . 0.0 108.542 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.21 142.91 18.69 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.662 0.664 . . . . 0.0 110.678 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.523 ' HG2' ' H ' ' A' ' 88' ' ' SER . 7.9 tt0 -77.92 165.32 24.25 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 127.851 2.46 . . . . 0.0 111.013 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.63 -85.95 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.054 2.142 . . . . 0.0 112.719 167.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -89.53 -8.27 53.13 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.896 -1.127 . . . . 0.0 111.957 -168.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.523 ' H ' ' HG2' ' A' ' 85' ' ' GLN . 0.2 OUTLIER -136.95 -153.87 0.52 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.624 2.37 . . . . 0.0 108.076 177.684 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.92 44.52 0.02 OUTLIER Glycine 0 C--N 1.334 0.433 0 CA-C-N 120.467 1.485 . . . . 0.0 113.228 -151.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 103.18 0.15 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 148.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.6 p -69.25 133.35 47.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.75 155.53 19.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.37 151.65 21.94 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 157.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 tt -149.94 112.38 4.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.09 140.21 51.4 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -128.67 128.53 67.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 167.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.6 t -109.67 96.62 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 168.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -109.07 165.17 13.13 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 118.012 -0.994 . . . . 0.0 108.513 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -55.71 -162.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.553 1 C-N-CA 126.231 4.621 . . . . 0.0 112.906 163.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . 0.483 ' HA2' HD21 ' A' ' 71' ' ' ASN . . . -120.49 168.91 13.97 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 116.745 -2.645 . . . . 0.0 112.679 147.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt . . . . . 0 CA--C 1.536 0.436 0 C-N-CA 124.969 1.308 . . . . 0.0 111.072 -168.188 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -139.95 104.98 4.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.578 2.351 . . . . 0.0 107.878 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -86.02 152.8 22.62 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.797 1.239 . . . . 0.0 109.848 171.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.46 134.16 45.9 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.23 1.412 . . . . 0.0 107.332 -171.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -153.07 62.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.254 0.622 . . . . 0.0 111.173 -173.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.1 p -151.7 -169.24 3.31 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.017 -1.052 . . . . 0.0 110.663 176.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.637 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 70.3 m-85 -75.94 177.0 7.34 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 121.395 -0.816 . . . . 0.0 109.345 157.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.21 -23.7 14.0 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.609 1.164 . . . . 0.0 111.388 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -145.76 3.13 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.491 0.716 . . . . 0.0 112.28 -174.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.83 -79.42 1.46 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.637 ' H ' ' HB2' ' A' ' 13' ' ' TYR . . . 162.57 -125.12 1.37 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.436 1.97 . . . . 0.0 108.923 -172.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 p -135.25 17.19 3.43 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.577 1.551 . . . . 0.0 111.913 -168.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.51 175.11 12.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 120.471 -1.393 . . . . 0.0 110.827 166.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 122.53 32.46 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.785 2.034 . . . . 0.0 107.029 -173.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.474 HG22 ' CE1' ' A' ' 23' ' ' TYR . 26.4 m -149.62 88.27 1.55 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.58 139.24 38.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.474 ' CE1' HG22 ' A' ' 21' ' ' THR . 91.4 m-85 -124.88 74.62 65.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 170.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.89 173.86 11.35 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.258 2.639 . . . . 0.0 110.229 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.61 147.57 25.51 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.496 -0.752 . . . . 0.0 111.41 -169.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 61.86 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.96 2.104 . . . . 0.0 108.974 -164.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.5 t -160.18 114.57 2.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 172.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.18 112.37 8.59 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.01 157.66 44.33 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.467 1.507 . . . . 0.0 109.279 -174.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.88 -178.52 31.55 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 160.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.4 p -102.34 113.73 27.29 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.147 1.379 . . . . 0.0 109.847 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -130.89 -170.2 2.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.78 1.232 . . . . 0.0 112.835 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 mt -131.3 151.66 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.717 2.407 . . . . 0.0 107.194 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.5 mt -131.87 154.82 48.8 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.23 1.812 . . . . 0.0 109.07 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -86.14 55.85 3.72 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.015 1.326 . . . . 0.0 110.099 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.0 mt -71.53 156.85 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.787 1.235 . . . . 0.0 110.327 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 m -127.69 107.69 10.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.135 1.774 . . . . 0.0 109.27 -169.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.37 86.77 1.35 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 122.561 0.344 . . . . 0.0 110.328 -174.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -156.11 165.01 37.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.539 0.336 . . . . 0.0 110.883 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.98 130.92 55.95 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.92 1.688 . . . . 0.0 109.5 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -116.35 127.53 54.75 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.554 1.941 . . . . 0.0 106.781 -170.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.6 t -168.99 143.33 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.93 -104.69 0.77 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -133.8 21.03 3.86 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.003 0.921 . . . . 0.0 111.166 -170.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -149.21 162.89 39.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.874 1.321 . . . . 0.0 110.253 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -132.39 115.23 15.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 130.038 3.335 . . . . 0.0 105.629 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.08 111.36 20.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -170.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.49 157.55 37.4 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.259 0.35 . . . . 0.0 110.804 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.31 130.56 40.96 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.48 1.512 . . . . 0.0 110.76 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -71.12 178.39 3.3 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.43 1.492 . . . . 0.0 110.978 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -147.43 177.35 9.3 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.502 1.121 . . . . 0.0 109.702 168.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -139.25 165.73 26.42 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.644 1.577 . . . . 0.0 109.85 166.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.33 156.55 44.73 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.225 1.81 . . . . 0.0 109.099 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.1 m -155.35 144.12 20.59 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.314 1.046 . . . . 0.0 110.216 173.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.85 -86.88 0.1 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 167.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.7 160.11 30.89 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.37 1.085 . . . . 0.0 111.426 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -82.47 -8.12 59.62 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -129.87 28.15 5.11 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.748 1.158 . . . . 0.0 112.32 -160.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.8 mt -132.76 101.81 4.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -75.32 133.1 41.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.208 1.003 . . . . 0.0 109.884 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.57 142.35 41.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.963 1.305 . . . . 0.0 109.919 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.16 155.79 41.18 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 126.3 1.84 . . . . 0.0 107.533 177.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.45 -11.13 46.47 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.889 0.757 . . . . 0.0 114.245 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.6 m -134.72 -4.86 2.51 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.451 1.125 . . . . 0.0 113.463 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.7 m -140.05 164.77 29.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.876 1.671 . . . . 0.0 110.361 -167.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.19 154.85 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.588 1.155 . . . . 0.0 108.255 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.1 159.5 42.87 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 158.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -132.8 107.82 8.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 165.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.46 166.89 15.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.508 0.671 . . . . 0.0 109.592 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.91 174.37 6.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -108.5 163.92 15.89 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.851 0.86 . . . . 0.0 111.123 -168.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -89.82 -11.76 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.141 3.228 . . . . 0.0 113.978 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.33 130.69 31.11 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -171.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.28 22.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.451 1.9 . . . . 0.0 112.301 -164.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -66.45 166.48 12.4 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 160.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -85.5 156.07 20.95 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 163.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -135.28 157.67 46.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 164.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.9 m -135.21 97.21 3.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.39 163.83 45.56 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 117.934 0.334 . . . . 0.0 113.112 -168.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 tp -153.84 125.77 7.79 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.786 1.635 . . . . 0.0 109.403 159.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.14 155.01 31.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 160.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.9 m -100.63 156.24 17.42 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 159.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.02 161.25 31.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.373 1.869 . . . . 0.0 107.719 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.424 ' HE2' ' O ' ' A' ' 88' ' ' SER . 68.6 tttt -139.81 145.39 38.1 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -70.91 171.81 10.05 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 168.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -56.27 -65.11 0.66 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.617 0.767 . . . . 0.0 111.855 172.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -118.07 5.18 12.03 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.845 1.258 . . . . 0.0 112.211 -167.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.424 ' O ' ' HE2' ' A' ' 84' ' ' LYS . 17.8 t -135.81 -158.87 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.301 1.44 . . . . 0.0 107.913 162.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.51 72.8 0.36 Allowed Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 106.489 -2.644 . . . . 0.0 106.489 -170.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -61.42 86.74 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 147.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 p -97.5 113.69 25.43 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 104.286 -2.486 . . . . 0.0 104.286 170.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.5 mt -131.61 157.54 43.4 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 m -120.44 114.61 22.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.118 1.326 . . . . 0.0 108.406 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.91 71.43 3.43 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.66 0.743 . . . . 0.0 112.167 -162.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -85.64 82.8 8.09 Favored 'General case' 0 C--O 1.226 -0.184 0 O-C-N 121.066 -1.021 . . . . 0.0 109.423 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.49 125.93 34.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 163.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.52 67.11 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -99.39 151.8 37.56 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 123.711 0.805 . . . . 0.0 112.098 -170.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.03 -172.14 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.724 3.616 . . . . 0.0 112.707 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.72 166.27 22.57 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.228 0 C-N-CA 125.545 1.538 . . . . 0.0 108.691 -163.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 m -92.99 129.44 38.9 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 166.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -106.73 148.51 28.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 162.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -126.66 105.64 8.84 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.414 1.486 . . . . 0.0 107.308 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.08 56.77 1.78 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.777 1.631 . . . . 0.0 109.456 -165.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.9 p -159.78 -175.69 5.29 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.368 1.067 . . . . 0.0 109.136 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -65.85 161.08 21.84 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.46 -15.85 25.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.104 0.961 . . . . 0.0 112.322 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -148.47 41.21 0.95 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.596 0.713 . . . . 0.0 111.434 -170.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.71 -83.63 0.05 OUTLIER Glycine 0 C--N 1.335 0.501 0 O-C-N 121.274 -0.891 . . . . 0.0 111.607 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.65 -125.37 0.78 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 117.136 0.468 . . . . 0.0 113.384 -171.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -139.22 10.51 2.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.102 0.961 . . . . 0.0 112.245 -163.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.39 173.16 17.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.919 2.088 . . . . 0.0 109.498 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -128.53 142.92 50.92 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 127.715 2.406 . . . . 0.0 108.716 173.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -153.22 90.73 1.45 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.716 1.207 . . . . 0.0 108.834 172.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.31 151.03 23.46 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 121.718 -0.614 . . . . 0.0 109.554 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -134.58 69.23 72.57 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.398 1.079 . . . . 0.0 109.342 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.73 175.32 9.07 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.436 2.091 . . . . 0.0 111.117 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -149.19 172.25 15.14 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.377 1.471 . . . . 0.0 107.962 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t0 59.79 -85.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.167 2.587 . . . . 0.0 109.979 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.4 p -142.29 4.13 1.58 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.641 1.176 . . . . 0.0 113.986 -176.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -78.4 67.92 4.29 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -163.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.5 117.74 19.21 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 127.086 2.154 . . . . 0.0 107.899 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.25 -163.09 26.35 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -167.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.4 p -116.99 114.41 23.75 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 117.766 0.783 . . . . 0.0 111.773 -162.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -133.58 -169.92 2.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.752 1.221 . . . . 0.0 110.77 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.8 mt -142.91 146.49 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.819 1.648 . . . . 0.0 107.091 -170.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.5 mt -126.37 175.81 7.58 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.064 1.345 . . . . 0.0 111.396 -171.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -110.81 91.77 3.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -164.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mt -125.92 150.84 31.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -163.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.02 134.14 54.65 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.6 t -153.19 44.88 0.65 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.448 1.099 . . . . 0.0 109.549 -172.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -140.03 169.06 18.39 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 120.73 -1.231 . . . . 0.0 111.765 -172.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -117.63 158.56 24.42 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.56 1.144 . . . . 0.0 109.175 168.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -138.73 135.59 34.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.928 1.691 . . . . 0.0 108.379 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.0 t -176.27 149.47 0.85 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.43 -101.86 0.32 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.959 1.266 . . . . 0.0 111.345 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -141.71 34.29 1.61 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.425 1.09 . . . . 0.0 110.953 -171.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 m -151.52 174.11 13.8 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.96 -1.087 . . . . 0.0 110.58 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -122.44 154.92 37.13 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 155.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -138.62 123.93 19.31 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.46 160.75 26.86 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.959 0.787 . . . . 0.0 109.793 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.81 -159.08 0.68 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 162.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.1 m -130.36 174.92 9.39 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.343 1.857 . . . . 0.0 108.458 169.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -152.51 173.41 15.18 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.691 -0.631 . . . . 0.0 111.761 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -143.55 172.64 12.52 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.062 1.345 . . . . 0.0 109.93 172.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.65 159.24 38.23 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.237 1.815 . . . . 0.0 109.112 -175.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 p 179.18 161.02 0.74 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.647 0.779 . . . . 0.0 111.418 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.66 -78.09 0.09 OUTLIER Glycine 0 C--N 1.334 0.471 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -102.66 -160.72 0.8 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.449 1.5 . . . . 0.0 110.832 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.3 p -123.98 14.59 9.21 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -133.43 28.27 4.03 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.744 1.218 . . . . 0.0 111.013 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -135.68 84.76 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -171.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -59.82 125.17 22.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.3 t -118.71 152.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 163.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.55 173.26 11.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 159.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.44 -50.9 12.89 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -125.99 40.89 3.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.986 0.914 . . . . 0.0 111.169 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.16 163.23 35.01 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.98 0.809 . . . . 0.0 110.647 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.74 142.87 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.323 1.449 . . . . 0.0 107.641 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.89 168.55 26.85 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.337 -1.477 . . . . 0.0 109.047 163.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.99 154.1 41.52 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 172.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.61 151.25 35.3 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 122.718 0.407 . . . . 0.0 110.04 175.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -72.41 169.83 15.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.883 0.849 . . . . 0.0 111.567 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.51 154.09 43.96 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 124.565 1.146 . . . . 0.0 110.514 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.42 -5.68 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.945 2.43 . . . . 0.0 113.426 -166.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.91 167.18 11.18 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.986 0.898 . . . . 0.0 109.971 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -77.12 0.56 21.13 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 120.841 -1.162 . . . . 0.0 111.954 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -59.64 144.03 48.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.153 0.981 . . . . 0.0 108.917 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -77.42 136.71 38.42 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 161.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -122.37 134.14 54.64 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.502 1.121 . . . . 0.0 108.996 -175.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.7 m -122.94 105.32 9.89 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.708 1.203 . . . . 0.0 108.016 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.75 167.28 52.75 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 tp -155.96 59.89 0.59 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.6 t -72.53 148.44 9.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 121.649 -0.657 . . . . 0.0 109.733 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 170.62 8.06 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.54 0.736 . . . . 0.0 109.264 169.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -136.73 163.84 29.67 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.804 1.642 . . . . 0.0 109.444 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 85' ' ' GLN . 48.8 tttt -147.84 172.78 13.6 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.241 2.216 . . . . 0.0 106.621 163.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.46 ' H ' ' HG2' ' A' ' 84' ' ' LYS . 20.8 tt0 -126.24 162.55 25.19 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.398 1.479 . . . . 0.0 107.158 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -56.38 -59.3 5.17 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.685 0.794 . . . . 0.0 111.88 -165.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -99.93 -27.8 13.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 111.529 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -101.65 -162.51 0.94 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.261 1.024 . . . . 0.0 111.811 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.1 67.52 0.41 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -63.03 92.96 0.06 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 152.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.0 p -95.65 103.99 15.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 165.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.98 158.36 16.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.3 m -117.77 125.16 50.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.448 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 5.8 tp -107.92 95.83 5.96 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.476 1.511 . . . . 0.0 107.869 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -108.96 90.36 3.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 mp -72.44 141.59 16.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 160.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.8 t -128.03 92.97 2.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 165.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -112.67 147.45 37.16 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.697 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -67.44 -167.88 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.777 3.652 . . . . 0.0 110.777 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.8 160.28 26.59 Favored Glycine 0 C--O 1.24 0.5 0 O-C-N 121.769 -0.582 . . . . 0.0 111.905 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.238 0 C-N-CA 127.667 2.387 . . . . 0.0 108.191 -171.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 122.649 1.214 . . . . 0.0 107.965 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.2 t -74.02 145.46 44.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.635 1.574 . . . . 0.0 109.207 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -126.95 153.38 45.91 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.906 1.283 . . . . 0.0 109.307 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -134.81 115.28 13.5 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.951 2.1 . . . . 0.0 106.314 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 4.1 t80 -145.07 79.21 1.58 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.3 p -154.33 -175.88 5.61 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.967 0.507 . . . . 0.0 109.827 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.484 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 62.6 m-85 -63.89 165.19 9.05 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 157.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.48 -31.42 11.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.237 1.015 . . . . 0.0 110.972 168.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -130.53 73.77 1.56 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.56 -56.98 0.11 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.261 162.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' H ' ' HB2' ' A' ' 13' ' ' TYR . . . 158.42 -136.6 4.84 Favored Glycine 0 CA--C 1.52 0.347 0 O-C-N 121.92 -0.753 . . . . 0.0 112.629 -167.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 p -137.58 23.8 2.91 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.25 1.02 . . . . 0.0 112.168 -166.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 t -167.59 166.44 14.06 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.784 1.234 . . . . 0.0 110.845 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.22 135.92 53.65 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.831 2.853 . . . . 0.0 112.647 174.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 m -147.14 84.78 1.59 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.575 1.15 . . . . 0.0 108.005 173.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -83.07 140.75 32.49 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.67 77.19 37.6 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -74.49 168.14 25.51 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 120.939 1.093 . . . . 0.0 109.387 165.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -162.19 160.82 27.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.68 1.992 . . . . 0.0 106.675 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.5 t70 60.53 -80.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.703 1.601 . . . . 0.0 111.918 -167.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 t -165.21 85.64 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.772 1.229 . . . . 0.0 108.009 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.4 m -135.85 24.48 3.35 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.03 122.28 20.62 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.191 1.396 . . . . 0.0 108.895 169.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.31 -175.69 36.85 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 119.042 0.837 . . . . 0.0 111.155 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.4 p -96.59 126.95 42.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.201 1.4 . . . . 0.0 109.029 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -128.39 -177.49 4.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 169.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 mt -139.51 143.19 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 129.645 3.178 . . . . 0.0 105.554 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.7 mt -121.2 -168.68 1.71 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.118 1.767 . . . . 0.0 110.18 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -129.98 51.23 2.11 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.056 1.342 . . . . 0.0 109.026 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.4 mt -82.05 125.0 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.182 0.993 . . . . 0.0 108.937 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 m -71.05 134.68 47.28 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.566 1.546 . . . . 0.0 109.411 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -144.52 108.71 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -167.35 170.84 11.14 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.693 0.759 . . . . 0.0 110.907 160.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.74 135.04 54.38 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.245 1.818 . . . . 0.0 108.105 161.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -114.82 123.17 48.52 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 125.563 1.545 . . . . 0.0 109.347 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 t -159.74 153.24 22.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.88 -82.81 0.07 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.095 1.807 . . . . 0.0 110.687 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -145.92 -1.13 0.78 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.074 1.35 . . . . 0.0 111.539 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 p -134.5 172.62 12.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.128 -1.607 . . . . 0.0 112.461 -162.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.0 p -130.71 123.06 28.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 127.415 2.286 . . . . 0.0 106.877 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.23 109.12 20.42 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.56 155.23 40.82 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.299 0.64 . . . . 0.0 109.545 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.2 mt -121.33 147.27 45.9 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.637 0.775 . . . . 0.0 110.961 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -79.67 160.16 26.42 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 168.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -138.97 174.67 10.27 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.277 1.031 . . . . 0.0 111.737 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -150.01 148.49 29.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.676 1.191 . . . . 0.0 109.47 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.432 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -150.81 160.78 43.65 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.278 1.831 . . . . 0.0 109.458 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 p 174.85 145.99 0.07 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.337 0.655 . . . . 0.0 110.471 -176.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.54 -91.3 0.1 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 168.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.27 164.58 3.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.86 2.064 . . . . 0.0 111.288 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 m -92.46 -1.1 57.22 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.74 1.616 . . . . 0.0 115.143 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TRP . . . . . 0.411 ' CZ2' ' HA3' ' A' ' 79' ' ' GLY . 44.7 p-90 -129.54 29.84 5.01 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.198 1.399 . . . . 0.0 108.954 -174.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.0 mt -142.81 88.29 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -88.42 171.89 9.78 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.939 0.896 . . . . 0.0 108.671 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.432 HG11 ' HB3' ' A' ' 53' ' ' ALA . 11.5 p -157.61 157.42 3.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.73 1.212 . . . . 0.0 108.752 166.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.45 -179.34 6.36 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.396 2.678 . . . . 0.0 108.014 172.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -45.18 -51.71 8.76 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.86 1.219 . . . . 0.0 113.544 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.0 m -124.87 -7.83 7.26 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 118.22 -0.895 . . . . 0.0 113.394 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 m -120.67 155.87 32.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.606 1.094 . . . . 0.0 110.625 -169.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -137.69 162.11 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.9 m -147.58 137.44 22.84 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 162.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.431 ' CE1' HD11 ' A' ' 94' ' ' LEU . 6.0 m-85 -123.27 104.07 8.91 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -74.3 173.5 10.13 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 122.208 1.004 . . . . 0.0 112.365 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -83.04 -165.71 1.15 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.153 2.181 . . . . 0.0 109.969 175.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -128.63 165.23 32.94 Favored Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 126.544 1.938 . . . . 0.0 109.492 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -93.91 -10.23 1.62 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.033 2.489 . . . . 0.0 113.226 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.27 139.65 51.73 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.734 1.214 . . . . 0.0 109.114 -171.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 12.12 8.19 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.283 0.633 . . . . 0.0 112.602 -160.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.53 158.25 36.44 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 170.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -67.84 159.28 30.69 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -132.83 145.22 50.77 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 m -118.41 77.69 1.19 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.312 1.445 . . . . 0.0 107.529 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.411 ' HA3' ' CZ2' ' A' ' 58' ' ' TRP . . . -72.2 132.54 19.03 Favored Glycine 0 N--CA 1.464 0.552 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 tp -149.49 70.76 1.08 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.207 1.003 . . . . 0.0 112.3 -166.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.96 164.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.444 0.64 . . . . 0.0 110.337 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -111.93 158.01 19.99 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.271 1.029 . . . . 0.0 108.566 168.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.69 146.35 43.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 127.147 2.179 . . . . 0.0 107.35 -173.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -157.26 168.7 26.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.099 1.359 . . . . 0.0 107.797 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.437 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 5.8 tt0 -119.16 164.77 15.09 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.683 1.129 . . . . 0.0 110.61 -170.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -45.17 -55.87 5.34 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.55 1.94 . . . . 0.0 111.853 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -126.52 -1.73 6.81 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.089 1.756 . . . . 0.0 111.136 -169.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.38 -177.99 3.97 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.828 1.651 . . . . 0.0 110.945 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.4 8.55 0.09 OUTLIER Glycine 0 C--O 1.226 -0.401 0 C-N-CA 118.546 -1.788 . . . . 0.0 115.508 -149.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -78.2 97.29 5.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 p -78.69 114.19 17.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -167.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.16 130.04 35.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.7 m -83.4 125.51 31.76 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 165.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.431 HD11 ' CE1' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -118.94 104.16 10.25 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.969 1.708 . . . . 0.0 106.508 -177.032 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -119.67 95.02 4.6 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.086 0.954 . . . . 0.0 109.797 -166.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.2 114.65 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 79.5 t -104.19 101.33 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.05 156.8 79.65 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.705 -177.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.85 -163.19 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.624 1 C-N-CA 126.589 4.859 . . . . 0.0 110.814 172.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.12 168.2 27.12 Favored Glycine 0 N--CA 1.445 -0.711 0 O-C-N 120.658 -1.276 . . . . 0.0 113.708 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.9 pttt . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 126.2 1.8 . . . . 0.0 110.159 175.312 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -136.37 110.26 8.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 165.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -79.29 153.59 29.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 163.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -121.7 117.9 27.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -137.96 60.56 1.62 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.913 0.863 . . . . 0.0 110.951 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 p -154.41 -167.44 2.62 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.45 1.1 . . . . 0.0 109.075 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -65.3 -179.6 0.62 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.375 0.67 . . . . 0.0 111.262 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.56 -28.15 12.34 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 121.316 -0.865 . . . . 0.0 111.573 162.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.89 12.2 2.45 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.354 0.662 . . . . 0.0 111.874 -165.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.71 -67.66 0.14 Allowed Glycine 0 C--N 1.335 0.512 0 O-C-N 121.254 -0.904 . . . . 0.0 113.537 -152.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.38 -126.66 2.85 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -153.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.1 p -144.16 3.63 1.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -171.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 m -162.96 174.53 12.22 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.333 1.424 . . . . 0.0 111.175 174.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 144.1 50.13 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 128.016 2.527 . . . . 0.0 113.962 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -141.6 146.76 36.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.352 1.461 . . . . 0.0 108.139 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -136.77 163.13 31.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.174 -0.954 . . . . 0.0 110.702 157.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -135.88 76.19 53.54 Favored Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.21 171.99 10.68 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.493 2.129 . . . . 0.0 109.213 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -160.54 0.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -153.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -165.9 -73.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.7 t -165.24 97.27 0.71 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.483 1.913 . . . . 0.0 106.879 167.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -123.74 24.49 8.41 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 168.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.83 155.03 40.87 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 166.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.87 -151.12 22.28 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.2 m -135.27 102.55 5.21 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.012 0.906 . . . . 0.0 112.659 -173.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -123.32 -164.63 1.23 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.628 1.171 . . . . 0.0 113.201 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 mt -138.13 158.35 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 127.711 2.405 . . . . 0.0 107.2 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 98.2 mt -132.89 173.1 11.75 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.086 1.755 . . . . 0.0 111.016 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -109.63 88.04 2.65 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.042 -1.037 . . . . 0.0 110.363 -156.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.425 ' CG2' ' HE3' ' A' ' 90' ' ' LYS . 6.6 mt -129.88 158.51 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.646 1.178 . . . . 0.0 109.712 -163.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 m -122.93 142.53 50.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.308 1.043 . . . . 0.0 109.68 -172.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 p -159.99 36.35 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.668 -0.645 . . . . 0.0 112.679 -161.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -128.51 169.3 14.52 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.339 -1.476 . . . . 0.0 110.955 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.8 121.16 38.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.98 1.312 . . . . 0.0 107.49 170.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -90.77 139.81 30.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.0 t -164.91 133.13 3.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 50.0 -98.0 0.02 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.986 1.279 . . . . 0.0 110.845 -173.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -130.43 21.34 5.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.28 1.032 . . . . 0.0 112.27 -164.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 t -148.64 176.72 10.11 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.315 1.416 . . . . 0.0 111.29 167.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 p -136.94 91.87 2.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.65 1.98 . . . . 0.0 109.593 -173.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.49 104.27 5.14 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.65 146.9 44.22 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 172.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.3 mt -117.93 149.03 41.58 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.073 0.949 . . . . 0.0 110.497 -175.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.1 m -65.64 164.58 14.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.495 164.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -144.47 173.81 11.47 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.101 1.36 . . . . 0.0 110.081 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -135.37 175.01 9.98 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.013 0.925 . . . . 0.0 109.778 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.48 152.09 39.23 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 125.531 1.532 . . . . 0.0 109.066 172.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.28 140.15 8.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.58 -127.72 1.66 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' H ' HG12 ' A' ' 81' ' ' VAL . 3.3 m-20 -61.73 162.35 8.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.941 2.096 . . . . 0.0 111.939 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.21 -18.64 57.58 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.353 1.861 . . . . 0.0 114.23 -168.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -121.22 15.01 11.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.291 1.836 . . . . 0.0 111.682 -165.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.7 mt -118.06 85.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.992 -2.595 . . . . 0.0 103.992 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -83.41 137.5 33.9 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.3 89.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -77.96 86.42 4.16 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -172.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.07 -104.42 0.88 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -97.61 -7.44 31.11 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.277 1.031 . . . . 0.0 113.089 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 m -83.69 164.56 19.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.696 1.135 . . . . 0.0 109.949 174.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.92 158.34 35.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.749 1.62 . . . . 0.0 108.274 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.8 t -156.42 158.53 37.47 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.156 1.782 . . . . 0.0 107.256 166.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -156.98 168.63 26.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 163.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.49 159.15 42.01 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.865 1.266 . . . . 0.0 107.818 -177.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -71.34 164.29 26.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.195 0.997 . . . . 0.0 113.15 -174.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -77.13 144.61 71.86 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.604 1.562 . . . . 0.0 108.623 168.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -90.13 -4.63 5.13 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.649 3.566 . . . . 0.0 113.648 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.98 161.58 13.93 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.173 -0.954 . . . . 0.0 109.927 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.55 62.93 0.85 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 123.334 1.54 . . . . 0.0 107.846 174.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -132.56 176.72 8.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.766 167.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -76.95 157.5 31.25 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 167.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.9 tpt85 -150.5 173.42 14.09 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 t -149.4 165.8 30.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 158.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.6 176.66 20.93 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 156.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tp -157.61 65.48 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.07 0.935 . . . . 0.0 113.109 177.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 56' ' ' ASP . 2.9 m -76.62 171.76 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 121.123 -0.985 . . . . 0.0 111.071 -172.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -123.38 164.74 18.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.78 1.632 . . . . 0.0 108.48 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.04 170.65 11.53 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.817 1.247 . . . . 0.0 109.223 173.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -153.32 172.93 16.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.859 0.864 . . . . 0.0 109.651 161.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -111.7 172.23 7.02 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.379 0.991 . . . . 0.0 110.807 -176.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -56.63 -51.3 69.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.327 1.051 . . . . 0.0 112.153 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -111.17 -42.62 3.9 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.719 0.808 . . . . 0.0 109.766 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.4 -169.65 0.43 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.177 1.391 . . . . 0.0 111.301 -171.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -132.22 42.32 1.4 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 126.117 1.818 . . . . 0.0 109.023 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.425 ' HE3' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -58.34 97.61 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 117.78 0.79 . . . . 0.0 108.942 174.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -110.88 110.8 21.55 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.9 165.77 11.79 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 168.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.0 t -127.13 144.65 50.98 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.389 1.476 . . . . 0.0 107.891 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.83 104.38 8.01 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.606 1.562 . . . . 0.0 108.995 -170.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -116.94 101.4 8.48 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.373 0.669 . . . . 0.0 109.881 -169.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -98.01 86.67 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.48 88.57 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.94 158.77 41.4 Favored Pre-proline 0 C--O 1.24 0.596 0 C-N-CA 124.125 0.97 . . . . 0.0 111.577 -165.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.36 -163.39 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 124.312 3.341 . . . . 0.0 109.377 160.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.92 166.96 29.93 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 171.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.226 -0.145 0 C-N-CA 124.469 1.108 . . . . 0.0 110.404 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -79.72 127.19 31.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 168.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -108.75 152.53 24.72 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.278 0.945 . . . . 0.0 109.646 161.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -129.29 125.18 36.23 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.099 1.76 . . . . 0.0 106.91 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.96 23.42 0.5 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.618 1.967 . . . . 0.0 110.478 -169.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.4 p -149.68 174.08 12.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.3 1.04 . . . . 0.0 110.777 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -75.69 160.31 30.2 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.896 0.878 . . . . 0.0 112.482 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.87 -50.3 15.45 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.804 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -141.22 55.23 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.85 3.11 0.26 Allowed Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.394 -1.276 . . . . 0.0 113.593 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.25 -119.63 6.77 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 119.212 1.506 . . . . 0.0 110.977 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.94 5.58 2.83 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.124 0.962 . . . . 0.0 113.245 -173.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.7 162.51 39.8 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.472 0.709 . . . . 0.0 109.535 170.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.429 ' CD2' ' HG ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -112.71 139.76 48.05 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.065 1.746 . . . . 0.0 108.047 -175.564 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.2 m -146.9 89.19 1.79 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -91.49 136.16 33.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -118.98 64.37 6.59 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-O 118.678 -0.677 . . . . 0.0 110.307 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.11 -174.19 1.3 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.378 2.052 . . . . 0.0 111.462 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -117.17 -163.46 0.92 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.689 2.396 . . . . 0.0 109.935 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.06 -18.26 63.17 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.727 1.611 . . . . 0.0 112.391 -174.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.0 m -153.09 65.27 0.77 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.259 1.39 . . . . 0.0 112.185 178.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 t -150.95 24.89 0.74 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.16 167.68 4.85 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.092 -1.005 . . . . 0.0 110.495 159.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.01 -152.17 22.96 Favored Glycine 0 C--N 1.341 0.809 0 O-C-N 121.333 -0.854 . . . . 0.0 111.359 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -135.1 100.71 4.64 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.306 1.442 . . . . 0.0 111.017 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -118.83 -177.82 3.41 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.102 1.361 . . . . 0.0 112.717 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 mt -126.82 147.88 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.2 mt -119.49 173.98 6.66 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 127.013 2.125 . . . . 0.0 109.892 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -101.96 51.34 0.83 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 123.553 1.644 . . . . 0.0 109.928 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.0 mt -72.09 139.36 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.428 1.491 . . . . 0.0 107.199 174.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 m -113.37 132.47 55.59 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.9 t -152.49 72.69 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -167.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -158.21 172.73 17.86 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.49 -1.381 . . . . 0.0 111.372 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 146.43 42.76 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.813 0.845 . . . . 0.0 111.225 164.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -123.03 131.3 53.64 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.308 1.843 . . . . 0.0 109.027 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 t -165.89 171.4 12.73 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 105.685 -1.969 . . . . 0.0 105.685 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.49 -103.67 0.06 OUTLIER Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.526 1.536 . . . . 0.0 112.21 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -138.19 18.17 2.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.226 1.41 . . . . 0.0 111.697 -171.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 t -144.81 177.73 8.51 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.583 -1.323 . . . . 0.0 111.16 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.3 p -137.85 121.84 17.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.062 1.345 . . . . 0.0 109.081 167.19 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -93.22 118.54 31.37 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.9 156.9 28.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.3 0.64 . . . . 0.0 111.401 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 98.1 mt -120.31 133.8 55.39 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.541 1.136 . . . . 0.0 111.452 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.5 p -69.18 168.98 12.92 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.78 0.832 . . . . 0.0 109.498 164.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -144.09 166.16 25.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.033 0.933 . . . . 0.0 108.905 166.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -133.21 156.56 47.28 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.154 1.781 . . . . 0.0 108.203 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.68 141.24 25.47 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.989 1.316 . . . . 0.0 110.679 -166.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.84 157.92 8.54 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 119.576 1.08 . . . . 0.0 112.286 161.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.8 -100.69 0.15 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.075 1.797 . . . . 0.0 110.441 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.7 157.74 2.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.198 1.399 . . . . 0.0 109.939 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -79.4 -29.44 42.01 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.978 -1.076 . . . . 0.0 112.759 174.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -90.79 16.14 9.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.871 0.868 . . . . 0.0 111.742 -168.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mt -137.55 127.72 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -136.62 150.59 48.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.7 t -137.12 125.75 34.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -85.76 -178.6 6.66 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.916 0.887 . . . . 0.0 109.57 173.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.11 -8.53 43.62 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.989 -1.07 . . . . 0.0 114.435 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.7 p -144.86 -21.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.796 1.298 . . . . 0.0 113.12 166.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.1 m -104.02 156.87 17.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.046 1.294 . . . . 0.0 112.162 -168.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 t -95.63 158.64 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 126.417 1.887 . . . . 0.0 107.639 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.57 142.7 18.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.878 0.871 . . . . 0.0 108.881 163.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -148.74 148.5 30.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 161.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.58 -177.85 6.04 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.953 1.701 . . . . 0.0 109.058 174.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -119.29 165.97 13.6 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.284 1.034 . . . . 0.0 110.313 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.84 144.85 40.07 Favored Pre-proline 0 N--CA 1.453 -0.298 0 C-N-CA 124.147 0.979 . . . . 0.0 110.688 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -82.99 -6.06 11.32 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.68 3.586 . . . . 0.0 113.206 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.31 169.92 17.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.706 -0.621 . . . . 0.0 111.341 -164.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.23 1.87 14.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.602 173.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.21 135.49 46.1 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 165.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -72.26 167.1 21.09 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.331 1.052 . . . . 0.0 109.18 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 -130.4 161.72 30.74 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.515 -0.741 . . . . 0.0 109.255 165.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 46.1 m -137.68 84.13 2.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.45 142.43 48.31 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.1 tp -159.68 72.29 0.52 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 118.984 1.392 . . . . 0.0 112.388 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.24 173.6 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.183 -0.948 . . . . 0.0 109.99 167.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.9 m -117.69 153.02 34.07 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 164.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 mp -125.24 165.69 17.83 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.926 1.291 . . . . 0.0 109.464 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -157.21 161.7 39.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.051 1.74 . . . . 0.0 108.124 173.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -105.99 169.4 8.52 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.075 1.35 . . . . 0.0 109.852 -164.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.71 -48.97 65.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -118.75 -18.73 8.88 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.2 m -97.53 -167.82 1.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.766 1.226 . . . . 0.0 108.497 162.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.79 31.0 0.15 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 119.21 -0.772 . . . . 0.0 111.427 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.89 112.72 1.96 Allowed 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 168.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 p -79.51 114.18 18.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.9 mp -88.57 165.96 14.47 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.313 1.045 . . . . 0.0 109.028 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.81 125.29 20.55 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.999 1.72 . . . . 0.0 107.838 174.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.429 ' HG ' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -93.12 86.02 5.25 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.328 1.451 . . . . 0.0 107.412 178.35 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -72.09 137.55 47.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.339 -1.476 . . . . 0.0 108.566 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 mp -130.62 116.53 35.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 162.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 68.6 t -116.0 71.81 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -106.12 154.41 39.62 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 121.571 -0.706 . . . . 0.0 110.711 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.76 174.64 6.31 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.655 2.903 . . . . 0.0 113.529 -172.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.57 113.63 3.68 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt . . . . . 0 C--O 1.234 0.271 0 CA-C-N 117.778 0.789 . . . . 0.0 110.006 178.959 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 C--O 1.233 0.23 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 m -113.31 99.54 7.87 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 163.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -74.27 153.17 39.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 161.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -128.1 116.75 20.45 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.08 46.54 1.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.725 1.21 . . . . 0.0 108.983 -170.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 m -154.28 -178.37 7.08 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.107 0.963 . . . . 0.0 110.188 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -74.22 -170.81 1.03 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.498 0.666 . . . . 0.0 109.59 169.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.0 40.14 3.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.667 1.987 . . . . 0.0 109.733 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -156.43 -1.05 0.13 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -161.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.41 -7.42 46.88 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 117.418 -1.768 . . . . 0.0 115.319 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.41 174.11 15.16 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 120.504 2.152 . . . . 0.0 114.035 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.3 p -136.34 44.3 2.42 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.417 1.487 . . . . 0.0 111.054 -176.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.82 165.16 9.86 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.787 -1.195 . . . . 0.0 108.537 165.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.14 141.04 43.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.99 1.316 . . . . 0.0 107.84 165.811 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.9 m -147.28 146.72 29.85 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 164.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -140.32 157.75 45.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.545 0.688 . . . . 0.0 110.818 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -132.73 66.24 76.09 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.594 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.24 175.32 4.11 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.069 3.179 . . . . 0.0 111.881 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.47 -171.6 2.16 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.968 0.907 . . . . 0.0 110.183 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.69 11.83 0.17 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.062 2.545 . . . . 0.0 115.117 -162.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.1 m -150.52 5.68 0.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.792 1.637 . . . . 0.0 113.635 171.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -95.26 86.94 4.68 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.296 1.407 . . . . 0.0 112.023 -166.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.77 158.48 43.85 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.629 -0.669 . . . . 0.0 112.499 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.86 -149.2 15.61 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 161.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -124.13 113.41 18.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.608 1.163 . . . . 0.0 109.946 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -116.98 -166.75 1.2 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.244 1.018 . . . . 0.0 112.915 176.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.0 mt -132.14 157.08 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 128.067 2.547 . . . . 0.0 106.606 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.0 mt -131.06 172.49 12.03 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.668 1.987 . . . . 0.0 108.764 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -116.13 31.91 6.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.671 1.189 . . . . 0.0 111.918 -173.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.2 mt -52.96 147.91 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.911 2.085 . . . . 0.0 109.98 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 m -113.17 117.36 31.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.342 1.457 . . . . 0.0 107.994 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.9 t -141.46 82.21 1.81 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -153.95 169.21 24.0 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.294 -0.879 . . . . 0.0 111.34 175.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.94 129.6 51.78 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.516 1.527 . . . . 0.0 107.824 173.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -118.06 128.65 54.96 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -174.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 t -168.5 148.22 4.5 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.95 -107.09 0.57 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 125.416 1.484 . . . . 0.0 110.078 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -135.67 28.05 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.215 1.406 . . . . 0.0 110.084 -170.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.1 m -142.82 157.96 44.1 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.904 0.859 . . . . 0.0 111.165 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -123.84 124.71 43.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.477 1.911 . . . . 0.0 106.004 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -97.89 115.26 27.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 166.873 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.98 130.39 45.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 164.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.89 118.39 26.25 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 167.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 m -67.48 168.49 10.79 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 124.535 1.147 . . . . 0.0 109.541 164.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -150.09 175.46 11.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.797 1.639 . . . . 0.0 107.969 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -132.16 170.48 14.94 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 161.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.46 151.42 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.231 1.012 . . . . 0.0 108.892 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 p -158.98 141.43 14.06 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.989 -0.444 . . . . 0.0 109.815 -172.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.95 -105.1 0.23 Allowed Glycine 0 CA--C 1.52 0.375 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.68 161.62 20.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.381 1.473 . . . . 0.0 111.46 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 m -73.29 -51.83 16.12 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 126.116 1.766 . . . . 0.0 111.617 174.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -72.69 21.15 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.569 2.348 . . . . 0.0 113.21 -166.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.8 mt -133.63 140.5 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -127.17 132.12 50.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.8 t -139.85 110.1 4.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.41 87.0 1.85 Allowed 'General case' 0 N--CA 1.462 0.129 0 O-C-N 121.276 -0.89 . . . . 0.0 109.133 -172.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 47.07 -113.02 1.08 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.591 1.091 . . . . 0.0 110.979 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.9 m -79.81 36.92 0.34 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.834 1.653 . . . . 0.0 113.393 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.9 t -152.86 155.08 36.4 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 120.609 -1.307 . . . . 0.0 109.416 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 t -148.38 149.22 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.76 159.62 44.41 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.853 0.751 . . . . 0.0 110.724 163.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.525 ' CD1' HD11 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -142.83 127.2 17.73 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.151 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -81.2 160.27 24.37 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.308 1.052 . . . . 0.0 110.565 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.536 ' CD ' ' HE2' ' A' ' 101' ' ' LYS . 1.7 mt-10 -72.45 165.19 25.09 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 167.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -86.59 164.65 36.65 Favored Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 121.093 -1.005 . . . . 0.0 110.848 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.68 -8.19 5.26 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.242 3.294 . . . . 0.0 113.536 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.87 156.68 47.1 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.088 0.858 . . . . 0.0 110.142 -170.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -92.07 22.32 4.43 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.092 1.357 . . . . 0.0 112.105 -169.615 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -98.64 151.09 21.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -72.46 135.82 45.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.944 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 -113.6 123.5 50.12 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 171.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.3 m -76.55 104.32 7.0 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 155.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.51 142.13 45.61 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 163.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.95 131.43 25.32 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 164.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -139.45 143.39 31.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 165.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.4 m -113.56 156.56 23.41 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.628 1.571 . . . . 0.0 107.236 170.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 92' ' ' LEU . 0.6 OUTLIER -133.85 162.54 31.74 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.66 1.184 . . . . 0.0 110.78 172.002 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -146.06 127.7 15.19 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.549 0.613 . . . . 0.0 109.757 174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -65.2 156.49 31.63 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.006 1.323 . . . . 0.0 111.45 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -50.16 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.763 2.825 . . . . 0.0 112.281 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -72.27 -25.16 61.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.939 1.296 . . . . 0.0 111.092 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.7 -153.15 0.5 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.991 2.117 . . . . 0.0 109.119 -164.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.69 13.74 0.02 OUTLIER Glycine 0 C--N 1.335 0.473 0 CA-C-O 117.158 -1.912 . . . . 0.0 116.595 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -62.86 98.05 0.12 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.609 2.205 . . . . 0.0 106.531 157.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.6 p -65.42 166.92 9.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HB2' HD21 ' A' ' 83' ' ' LEU . 27.7 mt -132.17 144.06 50.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 170.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 m -84.79 129.08 34.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 167.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 34.5 tp -97.52 127.39 43.44 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 156.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -136.64 117.38 14.03 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 68' ' ' TYR . 2.5 mp -109.42 124.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 169.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.9 t -111.97 92.59 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.81 158.5 35.5 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.872 -171.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -69.73 -164.58 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 125.186 3.924 . . . . 0.0 111.726 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.59 161.93 30.45 Favored Glycine 0 C--N 1.334 0.426 0 O-C-N 120.364 -1.46 . . . . 0.0 111.975 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.536 ' HE2' ' CD ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.088 1.355 . . . . 0.0 111.254 -173.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.0 t . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.874 0.369 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 m -101.24 118.6 37.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.679 1.592 . . . . 0.0 109.672 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -89.1 141.53 28.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.544 0.738 . . . . 0.0 109.314 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -105.1 138.44 41.3 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.601 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 3.9 p90 -153.73 56.17 0.74 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.349 -170.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.6 p -159.45 -172.42 3.71 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.65 -1.281 . . . . 0.0 109.305 170.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -67.92 157.33 35.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.033 1.288 . . . . 0.0 108.172 165.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.74 -12.34 22.4 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.872 1.269 . . . . 0.0 110.603 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.68 74.98 1.47 Allowed 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 153.44 -85.88 0.14 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 159.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -164.61 -123.29 0.64 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -158.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -138.18 28.78 2.53 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.602 0.701 . . . . 0.0 111.072 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.47 144.0 10.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.017 1.281 . . . . 0.0 109.764 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -96.3 148.37 22.82 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 162.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.3 m -142.54 137.88 30.48 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 159.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -112.39 144.12 42.36 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 168.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.62 71.57 38.97 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.02 177.79 6.06 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.423 2.082 . . . . 0.0 111.194 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -151.18 176.77 10.86 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.612 1.165 . . . . 0.0 108.097 173.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 56.51 -74.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.28 2.632 . . . . 0.0 114.184 -172.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.2 t -176.89 82.16 0.02 OUTLIER 'General case' 0 C--O 1.236 0.365 0 C-N-CA 129.002 2.921 . . . . 0.0 105.396 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -132.43 65.83 1.57 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -172.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.83 175.25 6.42 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.767 1.627 . . . . 0.0 110.285 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.06 -162.41 36.22 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 119.612 1.097 . . . . 0.0 112.667 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.0 p -135.69 95.65 3.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.877 1.271 . . . . 0.0 110.093 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -114.3 -177.06 3.04 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.959 0.903 . . . . 0.0 111.992 -173.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.9 mt -127.47 120.42 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.02 172.34 9.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.45 1.1 . . . . 0.0 109.006 171.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -106.08 36.86 2.43 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.905 -1.122 . . . . 0.0 109.546 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.89 134.95 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.067 -1.021 . . . . 0.0 108.346 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.9 138.8 37.23 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.8 p -167.87 83.37 0.19 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -153.76 170.97 19.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.26 120.77 39.99 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 171.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -96.0 146.26 24.76 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.946 0.879 . . . . 0.0 109.193 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.57 176.89 11.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.22 -52.72 8.24 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.142 1.353 . . . . 0.0 112.844 -168.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -131.04 23.71 4.92 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.702 0.801 . . . . 0.0 111.717 -172.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -144.3 150.95 38.68 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 122.462 1.125 . . . . 0.0 109.158 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 p -148.04 85.72 1.55 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.691 1.996 . . . . 0.0 107.688 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -73.9 127.78 33.78 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 166.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.03 164.7 23.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 166.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.55 132.3 54.25 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 126.324 1.85 . . . . 0.0 107.146 164.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.1 m -77.05 174.2 10.93 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.877 0.846 . . . . 0.0 110.069 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -149.87 171.53 16.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.219 1.808 . . . . 0.0 107.932 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.08 174.91 10.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.377 1.871 . . . . 0.0 107.444 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.62 167.67 20.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.593 1.157 . . . . 0.0 109.723 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.0 p -156.41 148.93 23.59 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.633 1.173 . . . . 0.0 108.801 160.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.75 -141.8 8.05 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.543 1.544 . . . . 0.0 109.806 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.62 133.22 46.54 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.307 1.043 . . . . 0.0 110.26 -173.439 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 m -69.78 3.43 2.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.273 1.829 . . . . 0.0 115.019 -167.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.9 p-90 -117.96 13.74 14.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.121 2.169 . . . . 0.0 111.305 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.4 mt -129.14 99.0 4.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -91.65 144.35 25.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.94 143.23 40.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 166.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.68 172.05 9.59 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.721 2.008 . . . . 0.0 107.108 172.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.45 -15.24 3.98 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.434 1.492 . . . . 0.0 116.336 -167.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.78 4.3 0.75 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.781 1.232 . . . . 0.0 112.82 168.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -128.0 153.42 46.77 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.586 1.539 . . . . 0.0 110.56 -163.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.88 156.54 24.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.079 1.352 . . . . 0.0 108.247 -173.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.98 150.49 34.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 153.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.35 155.11 43.65 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 146.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.0 176.04 5.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.266 166.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -86.44 168.37 13.83 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.768 0.794 . . . . 0.0 110.107 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -70.91 165.46 46.94 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.312 1.045 . . . . 0.0 110.176 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -95.3 -4.36 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.191 2.594 . . . . 0.0 114.293 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.32 166.04 25.59 Favored 'General case' 0 C--O 1.225 -0.228 0 O-C-N 121.362 -0.836 . . . . 0.0 111.834 -172.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 30.94 0.49 Allowed 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.621 -1.299 . . . . 0.0 112.044 -175.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -101.85 -175.96 2.99 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.373 1.069 . . . . 0.0 109.363 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -113.66 127.26 55.98 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 124.389 1.076 . . . . 0.0 111.705 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -159.22 103.19 1.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.816 0.846 . . . . 0.0 109.675 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.6 t -64.76 149.66 48.85 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 155.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.39 177.07 43.82 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 154.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tp -162.24 85.37 0.58 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.767 0.827 . . . . 0.0 109.803 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 m -79.9 169.83 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.217 -0.927 . . . . 0.0 111.123 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.6 m -116.74 153.33 32.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.026 2.131 . . . . 0.0 107.348 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 mp -135.95 163.01 31.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.668 1.187 . . . . 0.0 111.168 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -144.34 143.79 31.14 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.012 1.725 . . . . 0.0 108.003 167.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -79.16 165.96 22.74 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.401 1.48 . . . . 0.0 107.659 165.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.8 -83.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -81.89 -18.21 44.55 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.006 -1.684 . . . . 0.0 112.269 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.11 -162.51 0.94 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.28 26.04 0.24 Allowed Glycine 0 C--O 1.225 -0.424 0 O-C-N 119.66 -1.9 . . . . 0.0 110.919 -168.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 11' ' ' PHE . 12.1 ttpp -47.97 129.93 14.95 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 127.749 2.419 . . . . 0.0 107.447 164.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 52.1 p -118.79 137.66 53.23 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.6 mt -139.49 155.47 47.54 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -102.03 160.17 14.73 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.974 0.91 . . . . 0.0 109.14 164.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tt -136.2 91.29 2.66 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -85.69 147.2 26.47 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.7 mt -137.18 80.09 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.98 93.75 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -171.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -117.18 160.5 37.12 Favored Pre-proline 0 C--O 1.242 0.685 0 C-N-CA 123.637 0.775 . . . . 0.0 110.525 -165.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -62.15 174.93 2.23 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.75 2.3 . . . . 0.0 109.912 165.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.96 162.81 23.12 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 163.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 124.378 1.071 . . . . 0.0 108.487 -173.031 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.782 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -135.17 -175.61 3.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.339 1.855 . . . . 0.0 108.96 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.8 mtp -125.55 163.94 21.62 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.668 1.587 . . . . 0.0 107.275 167.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.06 11.65 1.2 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.361 0.981 . . . . 0.0 113.511 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 m -81.75 159.19 66.88 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 119.194 1.497 . . . . 0.0 110.232 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.97 171.63 14.34 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.436 2.091 . . . . 0.0 110.968 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.4 p -60.63 148.78 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.529 0.732 . . . . 0.0 109.42 168.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.9 m -132.1 123.96 28.2 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 170.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -88.4 155.41 19.71 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.71 118.35 24.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.971 2.108 . . . . 0.0 105.823 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -150.15 67.98 0.98 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.952 0.901 . . . . 0.0 110.226 -166.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -152.27 -169.33 3.32 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.026 1.33 . . . . 0.0 109.029 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -77.99 -89.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 166.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -164.67 -41.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.424 1.49 . . . . 0.0 110.846 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -107.39 74.75 0.98 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.53 72.91 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 112.999 -1.91 . . . . 0.0 113.408 147.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -153.13 169.93 32.06 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-O 122.746 1.192 . . . . 0.0 112.924 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -135.67 13.7 3.43 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.089 1.756 . . . . 0.0 110.474 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p -152.98 125.86 8.4 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 120.499 -1.375 . . . . 0.0 112.833 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.65 153.37 23.51 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.688 1.195 . . . . 0.0 110.283 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.5 m -146.88 143.61 28.67 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.988 2.115 . . . . 0.0 105.75 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.77 152.14 50.82 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.15 0.886 . . . . 0.0 109.758 170.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -134.16 67.52 73.2 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.587 -0.72 . . . . 0.0 109.171 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.59 179.53 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.308 2.005 . . . . 0.0 112.029 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -149.1 174.9 11.83 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.8 t0 56.31 -85.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 129.112 2.965 . . . . 0.0 111.172 170.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -153.66 106.25 2.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.265 1.826 . . . . 0.0 106.363 161.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -135.43 107.7 7.26 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.129 -1.607 . . . . 0.0 111.017 167.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.56 150.29 35.22 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.635 1.974 . . . . 0.0 108.546 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.38 -169.5 40.53 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.3 p -100.99 120.57 40.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.836 1.655 . . . . 0.0 110.256 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -127.12 -173.86 3.01 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.712 0.805 . . . . 0.0 113.065 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.5 mt -129.13 155.47 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 127.219 2.207 . . . . 0.0 106.265 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 53.8 mt -135.83 149.68 49.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.996 1.271 . . . . 0.0 112.808 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -78.59 87.49 4.54 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.836 1.655 . . . . 0.0 108.941 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mt -123.69 152.69 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.71 1.204 . . . . 0.0 107.958 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 m -121.64 133.85 54.98 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.474 1.109 . . . . 0.0 109.072 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.2 t -157.08 81.71 0.92 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.17 0.988 . . . . 0.0 108.522 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -152.27 170.8 19.14 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.094 -1.004 . . . . 0.0 110.044 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.53 126.79 50.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 167.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -98.02 131.17 44.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -170.14 162.35 8.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.2 -113.35 2.86 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -141.22 51.55 1.59 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.298 1.439 . . . . 0.0 107.337 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 t -155.15 165.58 36.25 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.61 1.564 . . . . 0.0 109.151 -170.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.4 p -134.71 102.32 5.24 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -71.23 118.34 13.89 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 164.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.37 163.82 10.06 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.705 0.764 . . . . 0.0 109.955 166.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.5 mt -134.89 129.36 34.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.051 170.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.8 m -59.78 163.47 4.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 122.551 1.167 . . . . 0.0 110.139 163.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -134.34 165.97 23.9 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.507 170.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.95 164.21 22.8 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.609 1.164 . . . . 0.0 108.811 173.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.53 168.77 22.58 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.465 1.506 . . . . 0.0 109.867 -169.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.405 ' C ' HG13 ' A' ' 81' ' ' VAL . 11.3 p 178.49 168.36 0.84 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.74 1.616 . . . . 0.0 110.572 161.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.62 -110.27 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.83 163.14 14.82 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.925 0.89 . . . . 0.0 110.376 168.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p -71.77 -38.96 70.27 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.353 1.461 . . . . 0.0 112.369 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -90.23 21.56 3.74 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.269 1.427 . . . . 0.0 112.831 -159.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.505 HG23 ' CD2' ' A' ' 68' ' ' TYR . 70.5 mt -130.54 133.14 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -170.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -132.42 132.53 42.89 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.372 1.069 . . . . 0.0 109.379 -164.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.81 135.62 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.834 0.826 . . . . 0.0 110.297 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.71 75.28 1.52 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.457 0.703 . . . . 0.0 109.154 172.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 55.02 -117.22 7.84 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m -77.94 51.04 0.92 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.06 0.944 . . . . 0.0 111.612 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.63 152.08 34.82 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.63 139.63 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.7 m -145.38 150.26 36.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 164.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.505 ' CD2' HG23 ' A' ' 59' ' ' ILE . 1.5 m-85 -139.46 119.19 13.19 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.53 161.91 29.3 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.473 1.509 . . . . 0.0 110.372 -174.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -86.25 146.18 26.63 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.488 -0.757 . . . . 0.0 110.79 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -66.58 144.47 98.65 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -158.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.79 -9.75 6.39 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.525 2.816 . . . . 0.0 115.432 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -151.98 170.08 20.74 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.593 1.157 . . . . 0.0 108.246 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -81.12 -12.39 59.26 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.775 0.83 . . . . 0.0 113.078 -164.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.44 165.14 2.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 123.775 0.672 . . . . 0.0 109.633 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -107.5 121.38 44.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 168.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -105.38 170.41 7.9 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 126.448 1.899 . . . . 0.0 108.039 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.4 m -104.77 109.9 22.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 155.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.85 139.09 36.0 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 163.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 tp -138.79 133.09 31.65 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.299 1.049 . . . . 0.0 109.93 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.488 HG21 HG21 ' A' ' 59' ' ' ILE . 2.8 t -142.49 148.37 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.075 0.852 . . . . 0.0 109.027 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 m -104.82 176.73 5.06 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.491 1.517 . . . . 0.0 109.116 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.7 165.24 34.03 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.82 1.248 . . . . 0.0 109.798 162.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -151.94 158.3 42.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.782 2.033 . . . . 0.0 108.815 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.474 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 26.5 tt0 -97.87 161.32 13.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.423 1.01 . . . . 0.0 110.309 -173.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.81 -69.06 0.15 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.646 1.179 . . . . 0.0 112.99 173.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -88.97 -12.53 41.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.638 1.108 . . . . 0.0 112.428 -176.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.2 t -132.04 -153.23 0.54 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.852 1.661 . . . . 0.0 109.249 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.25 46.87 0.88 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -164.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.474 ' H ' ' HB2' ' A' ' 85' ' ' GLN 0.35 0.0 OUTLIER -68.18 92.29 0.4 Allowed 'General case' 0 C--N 1.341 0.239 0 CA-C-N 118.238 1.019 . . . . 0.0 108.967 179.546 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 p -96.47 133.44 40.91 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 174.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.88 161.41 26.62 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 166.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.44 125.01 52.59 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.15 132.09 53.42 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -128.49 143.92 51.06 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.524 1.53 . . . . 0.0 108.391 171.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 mp -135.45 117.42 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 168.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 69.6 t -107.31 94.57 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -106.34 144.08 28.27 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.09 156.88 62.48 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.208 1.939 . . . . 0.0 107.624 165.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.07 166.88 27.5 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 121.269 -0.491 . . . . 0.0 113.418 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.62 159.34 39.82 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.336 1.454 . . . . 0.0 109.636 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.0 p -145.27 89.41 1.94 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.496 1.918 . . . . 0.0 106.085 160.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 m -147.42 156.65 43.07 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.8 pt -74.28 45.04 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.515 1.126 . . . . 0.0 112.878 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.07 0 O-C-N 119.89 -1.756 . . . . 0.0 106.655 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.202 0 CA-C-O 117.433 -1.759 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.6 p80 46.43 -164.37 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.542 1.137 . . . . 0.0 111.507 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 tpt -136.74 171.99 13.67 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.8 139.62 3.67 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.3 p -169.67 163.19 6.92 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 126.28 1.832 . . . . 0.0 107.814 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.36 156.82 63.3 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.728 1.619 . . . . 0.0 109.509 167.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.11 138.42 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 172.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 m -102.02 101.98 12.43 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -76.53 154.57 34.44 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 168.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -137.63 120.92 16.93 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 128.124 2.57 . . . . 0.0 105.424 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -148.32 43.87 1.04 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.239 1.016 . . . . 0.0 110.255 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 p -141.83 -176.75 4.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.886 1.274 . . . . 0.0 109.673 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -176.5 0.97 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.868 -1.145 . . . . 0.0 111.856 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.03 -20.79 6.18 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 162.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.92 -6.85 59.0 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -161.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.07 64.18 0.43 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 167.06 -165.16 38.39 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 p -151.49 45.23 0.79 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.246 1.418 . . . . 0.0 112.691 170.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.75 179.11 6.76 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.209 -1.557 . . . . 0.0 109.692 169.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.1 113.8 14.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.113 1.765 . . . . 0.0 107.955 172.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.5 m -133.72 130.24 37.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.041 -1.836 . . . . 0.0 106.041 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -129.65 147.1 51.41 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -124.12 67.24 43.78 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HG2' ' HB3' ' A' ' 98' ' ' GLN . 98.5 Cg_endo -69.44 177.09 5.7 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.83 1.687 . . . . 0.0 110.879 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -143.47 173.92 11.21 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.891 1.677 . . . . 0.0 107.29 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 55.19 -85.25 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.688 1.995 . . . . 0.0 112.234 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.2 m -154.36 102.59 2.44 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.6 2.36 . . . . 0.0 107.977 156.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.4 m -131.62 88.84 2.62 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 119.909 1.231 . . . . 0.0 111.22 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.61 167.12 23.0 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.435 1.894 . . . . 0.0 110.177 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.52 -161.1 31.1 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 p -97.42 123.42 41.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.774 1.229 . . . . 0.0 109.078 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -139.32 -169.22 2.62 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.711 1.605 . . . . 0.0 110.219 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 mt -138.39 144.91 29.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.268 1.427 . . . . 0.0 107.232 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.5 mt -129.21 161.84 29.22 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.597 1.559 . . . . 0.0 107.456 170.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -114.91 103.24 10.74 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.995 0.816 . . . . 0.0 111.447 -163.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.3 138.7 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.83 1.652 . . . . 0.0 109.126 -172.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 m -91.34 110.92 22.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.242 1.417 . . . . 0.0 109.536 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.5 m -138.27 78.68 1.69 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -160.36 164.78 32.19 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.381 0.672 . . . . 0.0 111.345 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.24 151.83 29.16 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.073 0.949 . . . . 0.0 109.363 166.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -121.67 125.68 47.22 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 127.163 2.185 . . . . 0.0 108.917 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.6 t -167.44 162.45 14.57 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.108 0.963 . . . . 0.0 109.014 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.19 -101.69 0.21 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 125.982 1.753 . . . . 0.0 109.62 -172.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -142.57 35.97 1.46 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.904 1.281 . . . . 0.0 110.403 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 m -155.81 169.54 24.15 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.133 -0.98 . . . . 0.0 110.485 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -115.37 155.71 26.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 156.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -138.86 121.99 16.87 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 126.097 1.759 . . . . 0.0 106.537 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.88 158.11 28.81 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.713 0.633 . . . . 0.0 109.812 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.6 mt -121.61 140.9 51.66 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.6 m -67.41 170.68 7.02 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 124.68 1.237 . . . . 0.0 109.839 172.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -138.63 174.56 10.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.782 1.233 . . . . 0.0 109.011 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.29 150.81 26.27 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 156.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.43 145.79 49.29 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 156.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.7 m -155.31 124.33 6.19 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.86 -161.23 9.71 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -156.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.72 19.14 10.4 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -171.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m 76.36 8.05 3.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 130.018 3.327 . . . . 0.0 114.874 168.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -111.83 7.34 20.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.487 0.715 . . . . 0.0 112.435 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 mt -135.39 140.6 44.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -134.82 140.52 45.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.925 2.09 . . . . 0.0 107.736 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.3 t -141.89 109.69 2.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.23 172.36 8.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.191 1.396 . . . . 0.0 109.689 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.24 -12.73 25.43 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.531 1.062 . . . . 0.0 114.477 -174.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -156.35 34.85 0.32 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.85 1.325 . . . . 0.0 110.476 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 t -159.25 161.95 36.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.664 1.12 . . . . 0.0 109.722 -170.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.18 139.43 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.584 1.154 . . . . 0.0 109.712 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.7 m -143.11 154.6 44.09 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.26 -0.9 . . . . 0.0 109.073 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -145.1 154.32 42.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 160.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -92.46 -166.2 1.49 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.425 ' HG2' HE21 ' A' ' 98' ' ' GLN . 19.0 mt-10 -118.47 169.84 9.44 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 122.901 1.334 . . . . 0.0 109.293 168.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -82.56 154.19 68.46 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 125.959 1.704 . . . . 0.0 112.247 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -88.99 -4.52 6.06 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.968 3.112 . . . . 0.0 114.853 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.18 167.79 10.38 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.716 0.806 . . . . 0.0 109.153 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.552 ' HE2' HG21 ' A' ' 102' ' ' THR . 0.0 OUTLIER -92.62 -3.28 55.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.964 0.905 . . . . 0.0 112.889 -169.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.5 164.16 25.67 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.037 -0.414 . . . . 0.0 110.779 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -95.92 135.3 37.85 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.879 1.272 . . . . 0.0 107.998 173.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -145.32 119.02 9.17 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.5 m -59.02 123.61 17.15 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -70.93 153.73 51.54 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.5 tp -146.85 117.52 7.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.504 1.522 . . . . 0.0 108.251 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.7 p -135.62 165.64 29.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 126.528 1.931 . . . . 0.0 106.235 165.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 m -124.96 171.52 10.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.814 1.646 . . . . 0.0 106.924 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -145.83 156.66 43.71 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 121.507 -0.745 . . . . 0.0 109.275 153.488 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -147.21 134.88 21.06 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.184 1.394 . . . . 0.0 107.361 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.05 174.66 4.34 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.89 0.876 . . . . 0.0 112.03 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -63.56 -84.97 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.2 2.6 . . . . 0.0 111.365 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -74.68 -32.65 62.28 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.083 -1.011 . . . . 0.0 110.343 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m -78.4 -159.11 0.15 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.731 1.213 . . . . 0.0 111.122 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.84 18.04 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 N-CA-C 116.775 1.47 . . . . 0.0 116.775 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -63.8 170.6 3.27 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.284 2.042 . . . . 0.0 108.451 146.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.1 p -134.35 156.28 48.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.513 ' HB2' HD21 ' A' ' 83' ' ' LEU . 58.5 mt -113.75 167.48 10.59 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 163.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.4 m -135.49 117.84 15.68 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.77 122.62 33.67 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 172.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -128.53 91.63 3.27 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.431 HD12 ' H ' ' A' ' 96' ' ' ILE . 3.4 mp -83.98 122.27 37.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 169.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.15 91.09 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 165.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.425 HE21 ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -111.66 146.42 34.67 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.124 -176.018 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 175.52 10.16 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 125.142 3.895 . . . . 0.0 110.694 169.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.97 173.38 19.88 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -144.65 -177.67 5.62 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 125.252 1.421 . . . . 0.0 111.486 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.552 HG21 ' HE2' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -159.68 96.68 1.27 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.286 1.835 . . . . 0.0 106.556 171.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 m -145.98 164.64 31.41 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.404 1.081 . . . . 0.0 110.827 171.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.6 pt -74.45 64.88 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.703 1.601 . . . . 0.0 109.367 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 47.8 t0 . . . . . 0 C--O 1.254 1.298 0 CA-C-O 117.53 -1.224 . . . . 0.0 108.525 -161.346 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.156 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 74.34 -179.51 0.19 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.708 1.603 . . . . 0.0 112.286 164.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -153.86 172.6 17.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.975 2.51 . . . . 0.0 107.316 -166.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.34 -5.4 8.77 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.543 1.068 . . . . 0.0 113.197 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.4 p -58.39 152.17 45.24 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 118.364 1.082 . . . . 0.0 110.013 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.08 169.08 18.87 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.434 2.09 . . . . 0.0 112.52 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.04 151.41 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.384 1.074 . . . . 0.0 110.048 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -135.5 106.17 6.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.666 1.586 . . . . 0.0 107.182 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -83.85 153.88 23.78 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 172.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.63 146.28 52.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.399 1.88 . . . . 0.0 108.273 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -168.51 42.02 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.235 1.014 . . . . 0.0 111.819 -160.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.4 p -142.52 176.73 8.79 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.749 -1.22 . . . . 0.0 111.03 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -84.64 158.99 20.68 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 165.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.0 59.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.572 0.349 . . . . 0.0 111.829 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.09 -8.23 29.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.183 1.393 . . . . 0.0 113.24 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.33 2.66 21.44 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 124.382 0.991 . . . . 0.0 112.948 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.53 177.3 17.06 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 119.24 1.52 . . . . 0.0 112.23 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 p -117.63 25.68 10.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.328 1.051 . . . . 0.0 109.628 172.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.3 t -144.85 147.95 33.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.49 -0.756 . . . . 0.0 109.212 171.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -99.52 140.4 33.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.888 1.675 . . . . 0.0 107.581 166.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.3 m -142.13 92.32 2.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.654 -1.609 . . . . 0.0 106.654 168.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.17 152.9 36.54 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.058 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -129.54 83.79 63.71 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 168.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.51 170.57 19.07 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.726 2.951 . . . . 0.0 110.46 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -155.4 165.68 35.88 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.872 1.669 . . . . 0.0 107.457 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t70 66.62 -78.69 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.104 2.161 . . . . 0.0 113.576 158.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.3 m -75.91 5.48 6.41 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.475 1.488 . . . . 0.0 112.859 165.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.255 3.8 p 58.81 -163.8 0.21 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.333 1.453 . . . . 0.0 111.173 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.11 172.45 0.2 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.306 1.042 . . . . 0.0 112.465 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.51 -160.1 14.31 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.37 112.48 18.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -131.76 -168.88 2.1 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.278 1.431 . . . . 0.0 110.762 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.8 mt -134.66 111.38 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.993 1.717 . . . . 0.0 107.159 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 74.2 mt -82.51 158.11 23.3 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.565 1.146 . . . . 0.0 110.859 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.56 80.69 4.31 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.53 128.82 57.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -95.57 120.03 35.11 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.644 1.178 . . . . 0.0 108.758 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.1 p -147.64 93.61 2.24 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.831 0.742 . . . . 0.0 109.209 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -157.06 169.11 25.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.278 0.631 . . . . 0.0 109.413 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.21 120.14 30.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.403 1.481 . . . . 0.0 107.472 172.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -93.47 132.62 37.56 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 t -168.14 154.78 7.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 54.18 -101.26 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 176.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -144.97 53.05 1.21 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.597 1.189 . . . . 0.0 109.119 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.4 m -155.34 168.01 28.49 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.534 -1.354 . . . . 0.0 110.862 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.29 87.76 2.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.416 1.486 . . . . 0.0 107.848 169.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.29 116.0 7.58 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.79 153.04 44.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.23 138.78 52.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 168.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 m -84.23 177.08 8.34 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.691 0.619 . . . . 0.0 110.042 168.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TRP . . . . . 0.604 ' HE1' HG21 ' A' ' 61' ' ' VAL . 36.4 p90 -132.9 169.91 16.09 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.829 1.252 . . . . 0.0 107.669 166.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -130.68 134.24 46.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.77 149.71 39.49 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.605 1.162 . . . . 0.0 109.614 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 p -165.33 144.78 6.64 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.525 0.679 . . . . 0.0 112.002 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.15 -119.15 1.19 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -47.97 147.39 2.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.904 2.082 . . . . 0.0 113.368 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.0 m -75.16 -12.91 60.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.021 1.328 . . . . 0.0 114.313 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -116.28 20.29 14.35 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.741 1.216 . . . . 0.0 111.259 -164.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 mt -133.97 104.31 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -117.17 144.57 44.59 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -166.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.604 HG21 ' HE1' ' A' ' 51' ' ' TRP . 2.8 p -145.56 140.39 22.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.386 0.613 . . . . 0.0 110.961 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.7 88.51 1.34 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.12 -123.35 24.55 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.925 1.25 . . . . 0.0 112.056 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 p -81.22 56.53 2.88 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.674 1.19 . . . . 0.0 110.034 171.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 m -152.28 148.6 27.73 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.863 1.665 . . . . 0.0 106.837 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.13 159.28 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 162.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -136.72 150.46 48.44 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 147.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -130.66 163.22 27.67 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 162.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -124.53 168.39 13.16 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.107 1.363 . . . . 0.0 108.813 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -120.47 161.67 20.85 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.95 0.881 . . . . 0.0 110.287 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.92 165.32 22.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 125.009 1.324 . . . . 0.0 111.622 -162.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.27 -34.59 0.55 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.133 1.888 . . . . 0.0 111.704 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.02 162.69 18.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.851 0.834 . . . . 0.0 109.447 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -82.25 12.91 3.86 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.131 -0.981 . . . . 0.0 110.408 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -68.75 164.41 21.81 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 162.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -124.03 132.93 53.74 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.566 -0.709 . . . . 0.0 109.36 -170.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -130.08 90.69 3.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.591 0.632 . . . . 0.0 111.365 -154.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.5 m -70.04 105.09 2.75 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -80.43 160.97 44.36 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 118.842 -0.977 . . . . 0.0 111.311 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.7 tp -159.93 72.82 0.52 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.435 1.118 . . . . 0.0 113.433 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.2 t -88.12 150.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 120.266 -1.521 . . . . 0.0 109.947 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.6 m -91.61 150.03 21.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 168.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.14 105.94 5.16 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.887 0.875 . . . . 0.0 109.271 162.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -95.19 141.76 28.42 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.277 1.431 . . . . 0.0 109.173 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -64.39 163.44 13.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.994 1.318 . . . . 0.0 110.801 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -56.28 -37.12 69.41 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.99 1.316 . . . . 0.0 112.905 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -135.59 -28.01 1.14 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -167.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -78.96 -156.42 0.1 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 166.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.42 -11.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 CA-C-O 118.323 -1.265 . . . . 0.0 114.475 -172.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.46 110.37 1.09 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.371 1.585 . . . . 0.0 110.388 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.0 p -76.07 116.63 16.96 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.03 118.29 23.42 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 m -75.96 145.0 40.66 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 tt -138.07 106.36 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -170.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -121.32 87.62 2.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.596 0.759 . . . . 0.0 110.024 -170.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.19 123.97 21.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 167.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.18 93.1 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 163.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -106.3 157.55 34.67 Favored Pre-proline 0 C--O 1.237 0.442 0 CA-C-O 117.641 -1.171 . . . . 0.0 109.641 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -69.94 -164.63 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.416 4.078 . . . . 0.0 111.374 172.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -132.63 143.6 15.28 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.017 0.818 . . . . 0.0 111.645 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -93.94 160.9 14.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.34 2.256 . . . . 0.0 111.262 -168.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.32 92.48 0.98 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.7 m -144.66 172.87 12.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.547 0.689 . . . . 0.0 110.927 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.0 mt -77.47 81.27 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 169.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.4 t0 . . . . . 0 C--O 1.248 0.974 0 C-N-CA 124.672 1.189 . . . . 0.0 110.431 173.392 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.992 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -61.55 165.42 4.94 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.257 1.028 . . . . 0.0 108.666 156.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.1 mmt -145.81 168.28 21.16 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.658 2.383 . . . . 0.0 105.621 161.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.0 178.06 36.5 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 p -144.65 150.33 46.66 Favored Pre-proline 0 C--O 1.24 0.57 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.48 170.35 18.69 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.675 2.25 . . . . 0.0 110.677 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 t -70.49 112.22 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 124.161 0.984 . . . . 0.0 108.989 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 t -81.03 140.14 35.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -115.81 104.6 11.81 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.624 1.57 . . . . 0.0 109.216 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -85.3 114.75 22.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 1.7 t80 -147.89 77.09 1.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -152.05 169.37 22.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.122 0.969 . . . . 0.0 108.59 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 20' ' ' HIS . 86.8 m-85 -68.54 169.85 10.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.371 0.605 . . . . 0.0 109.604 164.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.47 -14.44 28.48 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.791 0.836 . . . . 0.0 111.457 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.4 p30 -105.66 -4.94 20.45 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -162.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.09 -56.41 0.04 OUTLIER Glycine 0 C--N 1.335 0.473 0 O-C-N 121.903 -0.498 . . . . 0.0 112.533 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.14 -115.27 0.55 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 118.792 1.296 . . . . 0.0 112.271 -168.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.5 p -127.05 19.56 7.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.629 0.772 . . . . 0.0 112.079 -170.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -149.88 157.46 43.2 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.349 -1.469 . . . . 0.0 110.546 167.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 8.4 t60 -123.92 152.61 42.23 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 165.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -143.55 133.7 24.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.5 156.6 38.73 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.869 1.268 . . . . 0.0 108.162 -178.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -140.81 54.7 4.91 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 126.735 2.014 . . . . 0.0 111.389 -167.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.67 165.54 31.66 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 120.91 1.361 . . . . 0.0 110.858 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.5 162.46 35.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.936 0.895 . . . . 0.0 109.672 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.6 t70 67.26 -76.18 0.05 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.885 2.074 . . . . 0.0 110.347 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.0 t -162.13 89.73 0.72 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.828 1.251 . . . . 0.0 108.115 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.25 98.32 3.49 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.605 1.093 . . . . 0.0 112.123 171.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.12 168.46 19.96 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.11 -0.994 . . . . 0.0 109.285 167.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.6 -165.79 32.6 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 167.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.1 p -82.25 132.54 35.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 169.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -144.76 -177.58 5.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.698 1.199 . . . . 0.0 109.692 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.9 mt -129.02 157.47 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.4 mt -136.47 147.31 47.1 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.594 1.958 . . . . 0.0 107.822 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.52 93.54 6.69 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.72 131.42 72.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.71 1.204 . . . . 0.0 108.459 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 84.4 m -91.05 138.84 31.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.323 1.449 . . . . 0.0 108.854 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.9 p -155.88 74.89 0.88 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.796 -0.565 . . . . 0.0 110.6 -173.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -155.73 172.58 18.08 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.129 -0.982 . . . . 0.0 112.92 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 135.58 52.66 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.644 1.178 . . . . 0.0 109.86 172.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -114.34 128.9 56.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 125.367 1.467 . . . . 0.0 109.406 -172.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.4 t -170.29 159.23 7.1 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.46 0.704 . . . . 0.0 109.476 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.61 -93.4 0.08 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 125.1 1.333 . . . . 0.0 110.258 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -153.65 36.12 0.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.285 1.434 . . . . 0.0 109.508 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t -149.19 164.91 33.4 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.906 -1.121 . . . . 0.0 111.094 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 p -130.79 114.19 15.02 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.761 1.624 . . . . 0.0 107.939 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -88.7 130.09 35.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 163.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.57 165.05 21.91 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 124.0 0.813 . . . . 0.0 108.94 166.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.423 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 2.1 mm? -127.48 128.12 45.2 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.076 1.351 . . . . 0.0 108.473 173.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.5 m -73.85 163.35 28.05 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.631 0.729 . . . . 0.0 109.494 168.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -139.33 172.56 12.64 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.81 2.044 . . . . 0.0 109.565 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -143.68 164.04 31.57 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 167.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.18 -176.18 3.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.713 1.605 . . . . 0.0 110.413 -172.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m 174.59 143.77 0.05 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 128.042 2.537 . . . . 0.0 109.184 151.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.92 -110.1 0.23 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 167.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.73 142.61 54.94 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.355 1.062 . . . . 0.0 108.795 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 m -65.63 -8.21 19.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -111.08 15.5 21.6 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.347 1.459 . . . . 0.0 111.853 -174.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.7 mt -128.88 133.29 66.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -130.46 147.64 52.18 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.729 1.212 . . . . 0.0 109.475 -173.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.09 99.49 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -89.62 63.26 6.17 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.707 2.003 . . . . 0.0 109.599 174.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.6 -120.94 22.63 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 -162.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.6 p -65.88 -24.65 66.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.362 1.081 . . . . 0.0 113.688 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.6 94.85 6.38 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 119.679 1.127 . . . . 0.0 109.594 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.28 151.21 10.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.589 1.155 . . . . 0.0 108.122 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -150.81 158.4 44.09 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.029 -1.669 . . . . 0.0 109.055 164.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -153.81 162.27 41.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 165.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.39 156.22 24.87 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.59 1.156 . . . . 0.0 108.104 172.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.44 141.14 58.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.517 0.675 . . . . 0.0 109.331 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.72 145.29 98.03 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.926 0.89 . . . . 0.0 110.806 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -86.57 -4.83 8.28 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.018 3.145 . . . . 0.0 113.123 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.94 162.42 18.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.073 0.949 . . . . 0.0 109.163 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -12.12 33.66 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.59 159.79 31.7 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.87 -0.519 . . . . 0.0 110.359 171.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.43 140.99 38.62 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 163.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -148.2 82.53 1.49 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.08 0.952 . . . . 0.0 108.832 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.7 m -63.18 104.43 0.59 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.629 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.6 169.46 54.73 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 tt -159.9 125.33 4.08 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.089 0.556 . . . . 0.0 110.155 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.69 167.18 3.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 118.31 0.504 . . . . 0.0 110.182 174.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.04 161.36 15.6 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 167.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.574 HD13 ' HB2' ' A' ' 92' ' ' LEU . 2.7 mp -137.88 154.3 49.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.129 1.372 . . . . 0.0 107.37 169.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -137.88 146.4 43.32 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 163.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -85.2 171.53 11.89 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.877 0.736 . . . . 0.0 109.789 172.094 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.42 -78.9 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.769 1.628 . . . . 0.0 110.582 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -86.99 -21.41 26.18 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.063 -1.023 . . . . 0.0 111.896 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.46 -175.17 5.56 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.136 -0.978 . . . . 0.0 108.851 175.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.74 10.7 0.03 OUTLIER Glycine 0 N--CA 1.462 0.373 0 O-C-N 119.804 -1.81 . . . . 0.0 115.932 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -58.44 159.04 6.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.136 1.468 . . . . 0.0 108.381 155.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.1 p -119.67 107.5 13.31 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.574 ' HB2' HD13 ' A' ' 83' ' ' LEU . 63.7 mt -76.06 164.4 26.17 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 m -141.0 148.4 40.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.57 117.54 11.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -114.28 144.21 43.6 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.9 mt -135.05 98.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 -171.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.2 68.22 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -90.18 165.06 25.33 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.324 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.79 -166.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 124.225 3.283 . . . . 0.0 116.855 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.61 153.9 16.68 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 158.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -129.45 126.08 37.93 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.057 1.343 . . . . 0.0 109.712 -164.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -152.3 88.93 1.39 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.296 1.039 . . . . 0.0 108.658 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.9 p -144.34 -165.25 2.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.774 1.23 . . . . 0.0 109.678 163.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.7 pt -102.09 14.83 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 126.594 1.957 . . . . 0.0 112.252 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.1 t70 . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.247 1.019 . . . . 0.0 112.845 -173.498 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.048 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 62.57 72.2 0.5 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.701 1.6 . . . . 0.0 111.597 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -135.53 162.15 33.49 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 167.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.97 63.34 0.05 OUTLIER Glycine 0 C--O 1.225 -0.416 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 p -160.27 163.99 20.73 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -64.79 165.26 21.56 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.016 1.811 . . . . 0.0 109.66 165.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.5 t -134.55 103.04 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.257 1.023 . . . . 0.0 108.375 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 m -84.84 120.37 26.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -96.86 132.94 42.11 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -102.12 123.41 45.93 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -154.48 67.49 0.71 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.832 0.853 . . . . 0.0 109.486 -171.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.7 p -155.73 -157.23 0.71 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.631 155.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -83.56 152.2 24.98 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.764 1.165 . . . . 0.0 108.217 166.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.85 -22.87 49.24 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.662 0.785 . . . . 0.0 111.544 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -60.61 -6.61 1.74 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.281 0.633 . . . . 0.0 111.934 163.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.81 10.19 73.05 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 118.851 -0.972 . . . . 0.0 112.0 168.018 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.56 -174.41 24.0 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 118.494 1.147 . . . . 0.0 111.857 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.7 p -128.78 20.62 6.0 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 124.204 1.002 . . . . 0.0 112.565 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.83 177.96 9.9 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 120.203 1.365 . . . . 0.0 112.772 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -148.21 135.55 20.48 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.343 166.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -138.59 108.46 6.31 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.611 1.164 . . . . 0.0 109.605 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -102.64 158.22 16.39 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 110.67 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -136.78 56.15 12.42 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.147 1.779 . . . . 0.0 110.157 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.55 177.8 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.891 2.394 . . . . 0.0 110.973 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -157.29 175.84 13.48 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.104 1.362 . . . . 0.0 111.837 171.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.9 t70 66.03 -81.73 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.578 2.751 . . . . 0.0 113.233 -174.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.7 p -148.62 6.81 0.74 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.571 1.149 . . . . 0.0 113.611 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -78.63 86.23 4.62 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.195 -0.941 . . . . 0.0 111.394 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.6 153.99 42.36 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.685 1.994 . . . . 0.0 108.525 170.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.57 160.79 9.55 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.8 p -66.22 130.21 42.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.197 0.599 . . . . 0.0 111.904 -166.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -129.13 -171.77 2.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.694 0.759 . . . . 0.0 112.037 170.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.1 mt -126.07 160.48 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.2 mt -134.6 159.08 42.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.18 43.51 0.88 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.925 1.29 . . . . 0.0 110.928 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.443 ' CG2' ' HE2' ' A' ' 90' ' ' LYS . 98.9 mt -70.89 142.52 15.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.362 1.465 . . . . 0.0 108.555 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.38 106.23 14.69 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.181 1.392 . . . . 0.0 108.132 -174.476 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -135.77 66.17 1.51 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.992 0.917 . . . . 0.0 110.119 -170.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -150.62 170.95 17.94 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.242 -0.912 . . . . 0.0 112.158 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 47' ' ' LYS . 30.7 pttt -110.6 160.81 16.33 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.27 1.028 . . . . 0.0 108.234 164.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -136.5 133.68 36.78 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 166.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.5 t -171.51 157.37 4.79 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.622 1.169 . . . . 0.0 108.448 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.36 -94.48 0.1 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -152.71 35.04 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.211 0.604 . . . . 0.0 111.634 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 t -147.62 170.18 18.05 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 120.996 -1.065 . . . . 0.0 111.106 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.2 p -121.2 96.73 5.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.148 1.379 . . . . 0.0 109.143 164.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -72.06 120.69 18.01 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 169.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.98 165.56 15.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.273 0.559 . . . . 0.0 109.633 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.49 131.85 55.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 168.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.83 170.32 4.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.251 2.22 . . . . 0.0 110.736 172.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -165.67 167.98 16.67 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.339 1.056 . . . . 0.0 111.617 167.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -155.25 154.87 32.83 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.35 1.86 . . . . 0.0 109.072 165.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.75 178.1 4.72 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.83 1.652 . . . . 0.0 111.268 -172.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.6 p -158.52 127.53 5.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.566 0.746 . . . . 0.0 111.782 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.08 -134.98 3.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.271 1.415 . . . . 0.0 110.346 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.25 147.26 10.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.485 1.914 . . . . 0.0 112.865 -174.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.54 6.1 1.56 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.782 2.433 . . . . 0.0 114.758 -172.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.404 ' CZ2' ' HA3' ' A' ' 79' ' ' GLY . 25.7 p-90 -133.04 10.53 4.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.125 1.77 . . . . 0.0 111.589 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.73 108.82 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -106.12 144.28 33.06 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.733 2.013 . . . . 0.0 108.237 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.38 130.57 24.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 172.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.41 70.36 1.42 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 49.64 -117.99 5.1 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -169.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 p -71.36 34.94 0.05 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.671 1.588 . . . . 0.0 114.273 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.2 t -147.81 148.28 30.74 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 p -149.47 155.55 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -171.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.19 138.61 13.85 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.801 1.241 . . . . 0.0 108.396 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -122.16 126.7 48.88 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 166.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.89 147.78 25.73 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.334 0.654 . . . . 0.0 110.172 -169.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -73.0 158.27 35.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.664 1.221 . . . . 0.0 110.4 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -103.73 147.11 33.74 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 126.695 1.998 . . . . 0.0 109.365 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -84.75 -4.25 9.88 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 124.548 3.499 . . . . 0.0 113.233 -163.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.38 153.57 22.04 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.695 -1.253 . . . . 0.0 107.733 166.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 4.81 11.21 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.207 1.003 . . . . 0.0 112.208 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -70.82 154.42 41.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.143 -0.973 . . . . 0.0 109.486 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.4 ttm105 -77.26 148.68 35.62 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 167.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -131.07 146.95 52.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 155.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.7 m -83.06 148.33 27.6 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 156.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.404 ' HA3' ' CZ2' ' A' ' 58' ' ' TRP . . . -119.26 157.36 15.4 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 125.103 1.335 . . . . 0.0 109.772 169.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.6 tp -153.08 126.65 8.75 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.611 0.765 . . . . 0.0 109.042 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 158.18 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 119.475 1.034 . . . . 0.0 109.549 167.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -100.7 155.61 17.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mp -132.54 168.12 18.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.187 1.795 . . . . 0.0 109.229 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -151.24 -160.2 1.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.28 1.832 . . . . 0.0 107.162 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.465 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -134.12 171.47 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.703 1.201 . . . . 0.0 108.07 170.361 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -51.35 -63.32 1.17 Allowed 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.593 1.557 . . . . 0.0 110.201 170.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -107.44 -27.18 10.59 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.763 1.225 . . . . 0.0 111.995 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 t -99.72 -168.64 1.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.893 1.277 . . . . 0.0 111.667 -174.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.0 50.66 0.69 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 126.559 2.028 . . . . 0.0 109.702 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.465 ' HE3' ' OE1' ' A' ' 85' ' ' GLN . 3.4 mtmp? -61.39 97.16 0.06 Allowed 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 158.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.4 p -96.9 104.53 16.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.45 155.68 20.32 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 m -135.79 64.58 1.57 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.489 1.516 . . . . 0.0 107.067 -157.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.38 107.36 2.83 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -164.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -112.33 133.19 54.57 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.01 139.73 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.67 72.09 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -108.79 144.97 30.67 Favored Pre-proline 0 C--O 1.23 0.077 0 CA-C-O 117.366 -1.302 . . . . 0.0 108.017 -172.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.28 173.2 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.623 2.882 . . . . 0.0 110.463 169.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.67 169.68 37.49 Favored Glycine 0 C--N 1.331 0.255 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -125.39 142.74 51.33 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.047 0.539 . . . . 0.0 109.766 -168.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -154.62 90.17 1.3 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.66 176.14 8.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.5 mm -83.22 82.07 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 164.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.249 1.072 0 C-N-CA 124.56 1.144 . . . . 0.0 109.488 171.666 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.636 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -151.37 121.16 7.03 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ttt -134.71 -166.4 1.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.744 1.217 . . . . 0.0 107.825 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.12 -45.52 3.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.8 m -50.67 144.48 12.71 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 124.966 1.306 . . . . 0.0 110.844 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.52 123.25 8.94 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.975 2.45 . . . . 0.0 110.137 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.96 149.72 3.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.1 m -124.23 148.83 47.04 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.483 1.113 . . . . 0.0 108.442 166.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -124.55 159.05 31.51 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.379 1.072 . . . . 0.0 111.104 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -129.98 112.73 13.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.442 1.897 . . . . 0.0 106.344 -171.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -143.96 68.67 1.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.275 1.43 . . . . 0.0 108.801 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 p -154.26 173.06 16.66 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.991 0.917 . . . . 0.0 108.712 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -64.07 170.08 3.89 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 149.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.36 -23.43 30.15 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.812 -0.555 . . . . 0.0 111.498 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -148.67 31.23 0.8 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.953 0.901 . . . . 0.0 110.189 -166.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.38 3.15 0.06 OUTLIER Glycine 0 C--N 1.342 0.916 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 -169.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.9 -123.06 6.24 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 120.03 1.915 . . . . 0.0 110.077 174.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 p -135.65 25.3 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.534 1.167 . . . . 0.0 111.764 -167.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -160.26 163.52 33.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.3 155.2 42.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 161.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m -142.59 127.93 18.82 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -118.9 146.9 44.55 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -122.12 65.58 21.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 C-N-CA 124.787 1.235 . . . . 0.0 108.657 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.14 169.14 9.69 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.774 2.316 . . . . 0.0 111.391 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.38 -176.45 5.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t0 55.13 -78.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.43 2.292 . . . . 0.0 113.897 171.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -154.12 110.82 3.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 156.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -149.58 90.85 1.75 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.905 1.23 . . . . 0.0 111.841 167.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.61 177.82 7.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.092 1.757 . . . . 0.0 108.988 169.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.45 -157.77 27.5 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 170.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.2 p -124.57 105.57 9.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.835 1.654 . . . . 0.0 110.081 -170.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -124.16 -171.01 2.24 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.63 160.78 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.837 2.055 . . . . 0.0 107.197 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.3 mt -138.43 164.12 30.15 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.076 1.351 . . . . 0.0 110.61 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -83.83 89.07 7.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.308 1.843 . . . . 0.0 111.809 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.1 152.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 172.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.19 120.25 39.83 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.106 1.762 . . . . 0.0 106.659 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 p -155.0 70.53 0.76 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.686 0.794 . . . . 0.0 109.711 -161.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -159.94 176.86 11.38 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.62 0.768 . . . . 0.0 111.285 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 151.74 49.47 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.711 1.605 . . . . 0.0 109.682 168.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -131.48 130.78 42.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 126.07 1.748 . . . . 0.0 109.215 -167.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.7 t -177.47 144.61 0.4 Allowed 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.168 1.387 . . . . 0.0 108.821 -174.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.33 -88.79 0.2 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 125.947 1.737 . . . . 0.0 112.663 164.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -159.57 33.35 0.19 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.652 1.581 . . . . 0.0 109.172 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -145.9 155.59 42.97 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.619 -1.3 . . . . 0.0 109.564 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.03 80.91 1.85 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.335 1.064 . . . . 0.0 110.007 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -67.22 118.66 10.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.063 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.68 155.35 40.24 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.591 0.632 . . . . 0.0 109.46 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.5 128.28 50.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.021 1.329 . . . . 0.0 108.909 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 t -78.37 178.62 7.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.372 1.069 . . . . 0.0 110.749 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -147.27 -167.73 2.86 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.834 2.054 . . . . 0.0 109.169 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -139.96 -178.16 5.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.861 1.664 . . . . 0.0 107.466 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.36 156.7 47.37 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 165.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.01 150.29 5.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.121 0.969 . . . . 0.0 109.545 165.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.67 -102.65 0.22 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 171.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.56 151.24 47.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.104 0.962 . . . . 0.0 109.729 170.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 m -86.89 -34.16 19.52 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -72.59 19.8 0.08 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.967 1.707 . . . . 0.0 113.635 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mt -130.05 129.67 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -100.4 167.95 10.06 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.673 1.589 . . . . 0.0 108.659 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.97 151.08 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 166.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.59 68.82 1.08 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 166.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.14 -117.83 8.21 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.4 p -72.46 48.48 0.19 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.368 1.867 . . . . 0.0 112.192 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -151.59 147.6 26.97 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.691 1.597 . . . . 0.0 108.497 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -144.65 130.8 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.742 1.217 . . . . 0.0 109.238 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 m -143.19 152.51 41.85 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -153.17 150.46 29.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.611 0.764 . . . . 0.0 109.783 173.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.33 175.2 9.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.824 1.249 . . . . 0.0 108.819 168.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -89.82 175.65 7.14 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.475 1.131 . . . . 0.0 108.577 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.415 HD21 ' CA ' ' A' ' 100' ' ' GLY . 29.4 p30 -66.93 165.68 24.74 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 120.313 -1.492 . . . . 0.0 113.791 173.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -94.73 -4.62 2.32 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.693 3.595 . . . . 0.0 113.457 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.96 153.21 51.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.805 1.242 . . . . 0.0 108.889 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . 0.338 0.0 OUTLIER -90.14 35.61 0.86 Allowed 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.082 -1.011 . . . . 0.0 111.954 -168.045 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -86.11 167.31 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 167.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.83 136.88 32.86 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 166.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -151.81 162.15 41.51 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.838 0.855 . . . . 0.0 109.741 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.2 t -117.53 158.64 24.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 160.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.78 165.23 28.18 Favored Glycine 0 C--O 1.239 0.457 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 159.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.1 tp -158.21 100.29 1.68 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 m -84.68 -165.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 49.6 m -145.45 146.32 31.46 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 119.447 -2.033 . . . . 0.0 105.831 157.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.26 137.02 54.87 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 170.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -123.29 119.89 31.47 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.327 1.451 . . . . 0.0 108.221 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -65.32 148.46 51.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.453 1.101 . . . . 0.0 109.541 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -50.83 -84.92 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.864 2.466 . . . . 0.0 113.624 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -80.36 -15.8 56.02 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.367 -0.833 . . . . 0.0 111.445 -174.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.82 -153.47 0.33 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.556 1.942 . . . . 0.0 108.739 173.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.43 1.51 0.03 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-O 117.897 -1.501 . . . . 0.0 114.551 -174.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.59 102.14 2.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.887 1.844 . . . . 0.0 106.664 169.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 p -69.49 152.11 45.23 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.751 0.657 . . . . 0.0 110.101 -169.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.18 169.28 8.58 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.336 1.054 . . . . 0.0 108.773 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -147.89 146.33 29.0 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.017 1.327 . . . . 0.0 107.841 -169.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.9 tp -139.35 110.65 6.97 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 128.651 2.78 . . . . 0.0 105.909 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -128.52 128.11 43.68 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.0 mt -134.63 77.81 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -163.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 86.2 t -75.81 99.06 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.08 155.0 43.25 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 124.593 1.157 . . . . 0.0 111.94 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.49 -168.82 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 124.231 3.287 . . . . 0.0 108.883 160.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.415 ' CA ' HD21 ' A' ' 71' ' ' ASN . . . -139.74 167.5 25.31 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 118.786 -1.674 . . . . 0.0 114.994 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.99 171.19 14.41 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.456 -0.872 . . . . 0.0 112.341 -175.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.3 p -160.87 91.78 0.9 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.289 2.236 . . . . 0.0 107.063 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 91.5 p -146.78 -164.15 1.92 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.021 0.928 . . . . 0.0 110.282 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.4 pt -107.42 8.41 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.782 1.233 . . . . 0.0 110.665 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.4 t0 . . . . . 0 C--O 1.245 0.826 0 C-N-CA 124.855 1.262 . . . . 0.0 109.327 175.462 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.23 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -140.15 97.47 3.24 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -162.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -163.3 -178.65 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.722 2.009 . . . . 0.0 106.633 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.98 -93.11 0.1 Allowed Glycine 0 C--O 1.227 -0.298 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.9 p -152.36 163.34 23.87 Favored Pre-proline 0 C--O 1.239 0.547 0 C-N-CA 124.328 1.051 . . . . 0.0 108.79 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.0 167.19 24.17 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.272 1.314 . . . . 0.0 111.953 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p -77.25 137.85 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 123.984 0.913 . . . . 0.0 110.371 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -89.58 125.79 35.36 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 166.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -102.33 152.93 20.51 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.927 1.291 . . . . 0.0 109.638 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.06 110.74 10.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.297 2.239 . . . . 0.0 106.571 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.9 46.79 1.75 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.762 1.625 . . . . 0.0 108.529 -175.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -160.36 157.34 27.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.941 1.696 . . . . 0.0 107.625 -170.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -73.67 170.83 14.43 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.184 0.993 . . . . 0.0 109.5 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.41 -36.3 45.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.286 0.634 . . . . 0.0 112.641 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -142.49 47.28 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.33 -1.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 -172.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.59 -112.68 4.61 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 120.914 2.357 . . . . 0.0 109.111 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.3 p -119.98 7.31 10.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.268 1.034 . . . . 0.0 112.598 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 t -137.88 158.14 44.96 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.451 1.023 . . . . 0.0 108.58 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -102.85 165.31 11.12 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 148.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.4 m -141.14 163.16 33.72 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 153.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -144.81 150.6 37.45 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -131.96 77.34 72.01 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 126.955 2.102 . . . . 0.0 106.475 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.59 177.02 8.0 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.845 1.696 . . . . 0.0 109.757 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -151.88 161.19 43.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 108.879 172.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 54.52 -85.34 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.444 2.697 . . . . 0.0 110.488 -167.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t -150.24 106.04 3.42 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 165.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -128.55 89.96 2.98 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 122.432 1.11 . . . . 0.0 108.664 156.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.5 149.03 50.66 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.922 2.089 . . . . 0.0 106.844 164.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.04 -139.03 4.97 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 p -129.91 116.04 18.06 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.775 1.63 . . . . 0.0 110.321 -171.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -146.44 -171.74 3.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.781 1.233 . . . . 0.0 111.873 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.6 mt -133.16 130.2 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.201 1.8 . . . . 0.0 107.273 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.2 mt -91.63 161.59 14.86 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.453 1.501 . . . . 0.0 109.419 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.2 78.84 4.0 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mt -90.35 133.05 33.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.865 2.066 . . . . 0.0 107.397 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 m -110.4 107.98 17.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -135.53 67.65 1.48 Allowed 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.029 0.932 . . . . 0.0 108.771 -163.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -154.37 176.22 12.59 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.25 -0.906 . . . . 0.0 111.808 -176.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.96 154.56 40.99 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 125.94 1.696 . . . . 0.0 108.988 170.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -141.36 126.82 18.8 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.93 1.292 . . . . 0.0 109.938 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.6 t -177.62 160.06 1.53 Allowed 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.135 1.374 . . . . 0.0 108.932 -176.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.4 -103.56 0.32 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -146.04 29.5 1.08 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.158 0.983 . . . . 0.0 111.871 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -146.85 169.34 19.32 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.216 -0.927 . . . . 0.0 110.064 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.48 113.2 10.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.514 1.525 . . . . 0.0 109.064 -172.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.85 108.96 20.02 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.68 109.84 3.99 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.479 1.036 . . . . 0.0 109.217 169.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.77 134.64 52.57 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -66.75 163.23 19.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.384 1.474 . . . . 0.0 108.996 166.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -149.42 -172.87 4.24 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.1 -175.15 5.21 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 153.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.33 166.38 19.6 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.745 1.618 . . . . 0.0 108.277 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.62 149.84 20.65 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 161.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.27 -142.92 8.31 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -64.95 143.34 58.01 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.278 0.631 . . . . 0.0 111.043 -168.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.82 -0.76 4.48 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.104 1.762 . . . . 0.0 114.782 -170.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -117.81 11.56 13.59 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.032 1.733 . . . . 0.0 111.653 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.02 133.03 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -134.5 111.37 10.04 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.977 1.711 . . . . 0.0 106.892 -165.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.4 t -112.56 98.33 6.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -94.41 79.29 3.89 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.32 -107.78 0.47 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 126.215 1.864 . . . . 0.0 111.44 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m -73.83 -19.25 60.8 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.821 1.248 . . . . 0.0 112.764 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -88.08 160.06 17.97 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.45 1.023 . . . . 0.0 110.694 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -132.04 145.64 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 167.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -150.74 148.79 28.98 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.05 160.56 42.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -125.45 148.87 48.67 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.357 1.063 . . . . 0.0 108.289 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -62.92 170.86 2.44 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 123.621 1.677 . . . . 0.0 112.537 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.5 HD21 ' HA2' ' A' ' 100' ' ' GLY . 21.5 p30 -78.03 157.18 79.02 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.069 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.43 -6.16 7.15 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.02 2.48 . . . . 0.0 112.397 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.93 154.47 46.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.96 1.304 . . . . 0.0 109.221 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 40.79 0.77 Allowed 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.793 1.237 . . . . 0.0 111.065 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.29 170.33 9.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.288 1.435 . . . . 0.0 109.884 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.82 113.04 20.47 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.1 mtp85 -135.14 -170.44 2.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.122 0.969 . . . . 0.0 109.609 -170.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.7 t -147.2 156.89 43.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.486 -1.384 . . . . 0.0 108.108 161.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -84.7 174.07 49.74 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 159.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.5 tp -162.67 80.21 0.5 Allowed 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.53 178.06 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 120.629 -1.294 . . . . 0.0 110.005 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.4 m -134.38 141.51 46.88 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.949 -1.095 . . . . 0.0 108.566 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -127.83 151.45 49.03 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.901 1.68 . . . . 0.0 107.846 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.38 134.97 20.96 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.735 0.698 . . . . 0.0 109.454 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -77.12 154.65 33.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.416 1.087 . . . . 0.0 110.564 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -53.45 -69.49 0.12 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.989 2.116 . . . . 0.0 113.001 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -85.12 -23.51 28.41 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.053 0.541 . . . . 0.0 111.132 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -86.08 -153.64 0.19 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.318 1.847 . . . . 0.0 109.878 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.26 -13.28 0.02 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-O 118.193 -1.337 . . . . 0.0 115.645 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.71 121.54 10.66 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.959 1.879 . . . . 0.0 106.932 169.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.2 p -81.38 145.11 30.98 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -93.5 158.23 15.81 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 168.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 m -124.98 152.54 44.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.63 1.172 . . . . 0.0 110.153 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tt -152.72 109.29 3.43 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -170.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -117.25 137.32 52.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.305 1.042 . . . . 0.0 109.391 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.507 HG22 ' CG ' ' A' ' 98' ' ' GLN . 10.8 mt -135.72 94.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -171.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.6 t -99.28 80.76 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.507 ' CG ' HG22 ' A' ' 96' ' ' ILE . 17.7 mt-30 -89.81 166.01 22.45 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 125.313 1.445 . . . . 0.0 110.126 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -60.91 -172.05 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.824 3.016 . . . . 0.0 112.018 160.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.5 ' HA2' HD21 ' A' ' 71' ' ' ASN . . . -121.26 139.04 12.93 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 124.817 1.198 . . . . 0.0 112.1 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -114.18 152.71 30.79 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.343 1.457 . . . . 0.0 110.372 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -148.85 91.3 1.85 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 160.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.6 t -146.1 169.86 17.84 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.344 0.52 . . . . 0.0 110.8 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.9 mp -81.4 71.52 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 128.019 2.528 . . . . 0.0 106.945 -173.057 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 CA-C-O 118.198 -1.335 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.2 m170 43.93 73.67 0.14 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.852 1.826 . . . . 0.0 112.388 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -144.05 170.64 15.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.16 0.984 . . . . 0.0 108.722 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.44 -42.0 3.06 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 p -61.23 155.52 56.03 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.932 1.293 . . . . 0.0 111.893 171.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.41 162.68 32.65 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.781 2.321 . . . . 0.0 111.346 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.67 157.57 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -147.93 103.79 3.52 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -77.11 155.0 32.69 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -137.31 109.08 7.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.141 2.577 . . . . 0.0 106.367 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -132.73 93.03 3.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -164.66 161.17 20.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.347 1.059 . . . . 0.0 110.179 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -66.44 167.76 10.13 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.493 -0.754 . . . . 0.0 108.966 163.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -114.89 -0.78 13.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.234 1.013 . . . . 0.0 111.89 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -145.92 51.18 1.17 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 166.85 -97.57 0.14 Allowed Glycine 0 CA--C 1.523 0.564 0 O-C-N 121.371 -0.831 . . . . 0.0 111.109 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.65 -112.24 0.26 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 118.065 0.933 . . . . 0.0 112.379 -171.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.2 p -138.44 16.09 2.75 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.97 0.908 . . . . 0.0 112.242 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 t -152.95 140.93 20.26 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.438 1.017 . . . . 0.0 109.49 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.29 157.09 17.37 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.021 0.929 . . . . 0.0 109.893 174.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -150.82 102.14 2.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 154.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -89.04 155.57 19.39 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 118.819 -1.153 . . . . 0.0 109.482 165.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -128.88 69.24 80.36 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 126.396 1.879 . . . . 0.0 108.774 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.94 170.83 14.7 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.354 2.036 . . . . 0.0 111.144 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.0 158.5 42.12 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.455 0.702 . . . . 0.0 110.505 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.4 t70 62.52 -72.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.016 2.126 . . . . 0.0 113.662 -171.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 m -165.57 75.84 0.24 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.937 1.695 . . . . 0.0 108.687 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.42 98.8 6.09 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.342 1.057 . . . . 0.0 110.098 174.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.3 165.1 28.09 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.318 2.247 . . . . 0.0 106.448 167.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 143.68 174.61 16.09 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 119.76 1.164 . . . . 0.0 112.088 165.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.5 p -92.01 113.17 25.37 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.895 0.478 . . . . 0.0 110.707 -161.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -122.76 -167.11 1.53 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.255 1.022 . . . . 0.0 112.945 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mt -135.67 143.21 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 127.771 2.429 . . . . 0.0 105.194 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.9 mt -123.16 162.88 21.66 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.294 1.038 . . . . 0.0 110.067 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -104.63 86.19 2.45 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.234 1.414 . . . . 0.0 107.187 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -114.52 128.43 71.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 m -79.31 115.16 18.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.139 1.376 . . . . 0.0 108.129 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.2 p -143.68 73.38 1.39 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.375 0.534 . . . . 0.0 111.126 -174.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -155.84 167.67 29.65 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.669 -0.644 . . . . 0.0 112.407 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.41 133.58 55.62 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.295 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -103.78 142.74 33.84 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.834 0.854 . . . . 0.0 109.174 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.59 76.96 0.97 Allowed 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -156.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.75 -94.55 0.09 OUTLIER Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.862 1.22 . . . . 0.0 111.035 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -113.87 9.85 17.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 m -134.76 153.68 51.91 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.566 0.746 . . . . 0.0 110.957 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -139.1 92.19 2.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.712 1.605 . . . . 0.0 110.193 -168.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -76.97 115.53 16.84 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.176 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.43 152.69 45.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.16 148.95 42.51 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.393 1.077 . . . . 0.0 108.149 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.2 p -87.95 -179.42 6.22 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.792 0.837 . . . . 0.0 110.175 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -143.71 154.29 43.33 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 109.512 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -89.48 160.06 16.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.04 1.336 . . . . 0.0 108.538 160.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.75 163.11 26.91 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.832 2.053 . . . . 0.0 106.434 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 m -170.86 141.8 1.81 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.332 0.969 . . . . 0.0 109.284 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.93 -128.75 3.84 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.226 1.393 . . . . 0.0 110.245 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.92 136.73 4.48 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.113 2.565 . . . . 0.0 111.699 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -71.58 4.32 3.21 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 -165.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -139.66 15.58 2.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.874 0.869 . . . . 0.0 112.338 -160.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.7 mt -123.42 87.88 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -73.33 126.57 30.44 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.9 t -137.38 84.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.93 59.07 3.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.679 1.192 . . . . 0.0 109.145 -173.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.31 -115.88 8.33 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -172.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -75.65 39.04 0.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.86 1.664 . . . . 0.0 112.8 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 m -152.4 149.14 28.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.78 139.52 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 t -143.32 108.8 5.07 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.09 106.71 17.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 165.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -66.81 168.01 10.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.383 1.473 . . . . 0.0 110.822 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -85.03 -176.85 6.38 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.431 -0.793 . . . . 0.0 109.162 171.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -112.03 161.07 27.54 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.882 1.673 . . . . 0.0 108.44 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -86.79 -10.41 6.1 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.795 2.33 . . . . 0.0 113.375 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.83 167.07 13.98 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.934 1.293 . . . . 0.0 110.732 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -100.01 13.26 34.59 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.763 1.024 . . . . 0.0 113.763 -175.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.95 171.77 13.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 164.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -108.7 144.33 36.62 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.63 -0.668 . . . . 0.0 109.604 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.69 165.74 18.67 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.237 -0.914 . . . . 0.0 109.272 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.2 m -117.33 117.55 29.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 158.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.72 158.59 52.46 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.8 tp -155.18 111.35 3.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.94 0.87 . . . . 0.0 109.629 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.1 t -130.53 124.19 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.9 m -87.7 135.98 33.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 175.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.35 145.7 38.4 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.751 0.82 . . . . 0.0 108.901 167.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -134.57 139.87 45.7 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 173.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -71.52 160.04 33.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.198 0.999 . . . . 0.0 109.322 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -50.44 -33.35 20.69 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.109 1.363 . . . . 0.0 113.937 168.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -127.95 -36.06 2.02 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 t -88.22 -156.2 0.35 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.564 0.746 . . . . 0.0 110.054 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.64 10.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.627 0 CA-C-O 118.113 -1.381 . . . . 0.0 114.937 -171.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.91 94.27 1.05 Allowed 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.141 1.97 . . . . 0.0 107.147 169.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 p -72.8 113.67 10.1 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mp -75.0 130.13 38.83 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 t -88.18 152.63 21.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 tt -149.02 98.54 2.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -172.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -105.47 149.61 26.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.2 134.89 41.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 168.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 t -121.4 79.4 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -84.79 164.08 43.7 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.68 1.192 . . . . 0.0 110.704 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.26 179.61 3.32 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.448 2.765 . . . . 0.0 110.518 160.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.95 147.82 18.89 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.106 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -85.39 135.2 33.97 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.206 1.802 . . . . 0.0 111.455 -166.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.11 89.1 2.0 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 155.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.1 m -133.8 167.53 20.39 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -172.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.4 mt -85.46 68.7 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 173.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 C--O 1.244 0.77 0 C-N-CA 127.814 2.445 . . . . 0.0 107.294 -166.693 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.397 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -62.08 113.95 3.13 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 165.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.9 mtp -147.96 159.97 43.31 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.114 1.766 . . . . 0.0 106.679 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.63 105.52 2.52 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 107.648 -2.181 . . . . 0.0 107.648 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 p -165.13 156.57 12.96 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 123.869 0.868 . . . . 0.0 108.816 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.65 115.82 4.38 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.001 2.468 . . . . 0.0 110.523 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.71 117.48 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -97.77 100.63 12.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -79.2 157.07 27.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.106 0.479 . . . . 0.0 110.153 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -131.42 107.01 8.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -130.79 69.06 1.47 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.35 2.26 . . . . 0.0 105.663 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.6 p -163.41 -174.98 3.99 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.893 -0.504 . . . . 0.0 111.724 165.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -65.66 173.37 2.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.486 0.585 . . . . 0.0 109.688 161.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -112.47 -8.11 13.89 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -156.67 58.02 0.55 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.055 0.931 . . . . 0.0 108.888 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.3 -91.66 0.08 OUTLIER Glycine 0 C--N 1.331 0.286 0 O-C-N 121.405 -0.809 . . . . 0.0 111.779 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.33 -123.31 0.78 Allowed Glycine 0 C--N 1.333 0.362 0 CA-C-N 117.781 0.79 . . . . 0.0 113.007 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 p -138.81 12.32 2.68 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.223 1.409 . . . . 0.0 114.127 -169.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 t -157.38 146.64 20.03 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 118.467 -1.293 . . . . 0.0 111.7 169.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.5 137.76 33.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.375 160.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m -136.05 162.16 33.67 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 170.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -152.81 154.47 35.22 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 159.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.4 54.64 14.18 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.602 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.57 174.52 9.23 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.23 1.286 . . . . 0.0 111.167 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -159.46 169.54 23.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t70 65.16 -78.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.48 1.912 . . . . 0.0 111.231 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 m -169.07 110.44 0.49 Allowed 'General case' 0 C--O 1.238 0.496 0 C-N-CA 128.479 2.712 . . . . 0.0 106.702 160.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.6 m -138.89 24.75 2.57 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.78 146.71 49.6 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.173 -0.954 . . . . 0.0 110.445 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.73 -158.95 27.37 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -121.98 116.11 23.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.385 1.474 . . . . 0.0 110.173 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -122.14 -177.85 3.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.317 1.447 . . . . 0.0 110.639 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mt -132.03 156.59 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 127.287 2.235 . . . . 0.0 105.897 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.5 mt -134.06 179.04 6.5 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.648 1.579 . . . . 0.0 109.287 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -109.31 71.57 0.77 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.651 1.181 . . . . 0.0 109.461 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 97.2 mt -97.5 138.88 21.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.38 131.32 51.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.46 1.504 . . . . 0.0 107.421 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.1 t -148.61 81.98 1.46 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -154.2 173.17 16.47 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.764 -0.585 . . . . 0.0 111.394 173.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.68 137.25 54.37 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.778 1.631 . . . . 0.0 108.602 169.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -115.29 134.63 54.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.307 1.843 . . . . 0.0 107.011 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.1 t -174.85 157.79 2.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.67 -110.8 0.89 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -135.12 32.4 3.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.844 1.258 . . . . 0.0 109.476 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m -144.53 161.55 38.81 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.884 0.874 . . . . 0.0 110.784 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 p -127.66 103.21 7.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.025 1.33 . . . . 0.0 108.002 166.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -78.57 116.33 18.88 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.35 148.48 46.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -112.65 142.95 44.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.09 163.47 20.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.797 0.839 . . . . 0.0 110.514 166.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -140.1 158.4 44.12 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.585 1.154 . . . . 0.0 108.898 165.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -138.26 151.16 47.37 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.479 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -141.4 162.14 36.19 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.369 1.068 . . . . 0.0 110.736 -163.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -168.96 152.42 5.23 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.292 1.037 . . . . 0.0 109.495 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.59 -138.88 5.47 Favored Glycine 0 C--N 1.333 0.38 0 O-C-N 121.506 -0.746 . . . . 0.0 111.709 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.47 ' HB2' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -55.84 137.33 50.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.153 1.381 . . . . 0.0 111.133 -178.93 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.5 m -69.4 3.43 2.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.745 2.418 . . . . 0.0 116.364 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -126.98 6.58 6.58 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.276 1.43 . . . . 0.0 111.963 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 56' ' ' ASP . 34.6 mt -117.27 91.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -76.77 110.23 11.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.614 1.166 . . . . 0.0 108.724 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 53' ' ' ALA . 8.0 p -94.41 143.13 12.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.17 0.988 . . . . 0.0 108.461 177.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.67 46.08 1.69 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.744 0.783 . . . . 0.0 111.061 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.18 -113.5 5.42 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.5 p -71.99 -7.35 48.2 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.2 m -110.31 144.65 38.72 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 119.671 1.123 . . . . 0.0 109.623 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.62 157.11 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.888 1.675 . . . . 0.0 107.775 -176.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.29 152.58 26.21 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.529 1.132 . . . . 0.0 108.432 162.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -154.4 173.36 16.33 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.966 0.906 . . . . 0.0 109.557 159.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.93 170.81 8.06 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.784 1.233 . . . . 0.0 110.686 166.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -80.9 158.75 25.18 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 122.509 1.147 . . . . 0.0 108.305 165.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.63 167.37 5.74 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 126.304 1.842 . . . . 0.0 112.362 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -92.1 -10.8 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.377 3.385 . . . . 0.0 115.726 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.82 141.87 29.5 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 120.558 1.526 . . . . 0.0 109.926 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.585 ' H ' ' CD ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -72.0 8.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 128.668 2.787 . . . . 0.0 114.0 -155.042 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -61.58 166.65 4.0 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 163.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' A' ' 99' ' ' PRO . 8.4 ttm-85 -126.21 118.9 26.12 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.086 1.354 . . . . 0.0 110.253 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -136.94 -168.94 2.37 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.562 1.145 . . . . 0.0 110.25 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 8.8 t -131.82 156.12 46.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.653 0.781 . . . . 0.0 109.238 162.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.81 -179.3 40.43 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 160.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.7 tp -147.82 160.36 42.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.736 1.214 . . . . 0.0 108.383 159.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -135.78 151.48 29.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 163.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.2 m -124.37 154.87 39.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.782 HD21 ' HB2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -145.01 167.38 22.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.266 1.027 . . . . 0.0 109.968 -174.088 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -137.89 158.28 44.68 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 125.167 1.387 . . . . 0.0 108.077 167.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -114.98 139.46 49.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -44.7 -73.16 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.037 1.735 . . . . 0.0 113.743 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.26 -8.75 54.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.691 1.996 . . . . 0.0 112.957 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.76 -153.37 0.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.459 2.304 . . . . 0.0 106.771 174.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 0.21 0.04 OUTLIER Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.11 -1.519 . . . . 0.0 115.931 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -58.85 153.3 17.41 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 126.568 1.947 . . . . 0.0 110.925 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 p -122.42 146.79 47.03 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.782 ' HB2' HD21 ' A' ' 83' ' ' LEU . 59.5 mt -117.39 -170.42 1.85 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.845 1.658 . . . . 0.0 106.639 175.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.54 161.08 39.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.104 1.362 . . . . 0.0 108.776 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 tp -136.45 77.92 1.68 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.548 1.939 . . . . 0.0 108.438 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -82.25 89.08 6.5 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.687 -0.633 . . . . 0.0 110.312 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' THR . 17.4 mt -83.68 92.47 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 175.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.6 87.64 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.13 160.75 31.34 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 118.281 0.491 . . . . 0.0 109.895 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.4 ' HA ' ' HG3' ' A' ' 76' ' ' ARG . 31.1 Cg_endo -78.4 171.54 16.73 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.749 1.632 . . . . 0.0 109.781 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -88.92 164.53 32.59 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.46 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -109.83 134.76 51.68 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.036 -1.082 . . . . 0.0 108.231 -163.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.86 90.45 1.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.64 -173.89 2.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.152 0.581 . . . . 0.0 109.763 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.49 43.89 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.583 1.553 . . . . 0.0 108.341 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 117.525 -1.226 . . . . 0.0 113.629 -160.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.846 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -153.73 129.32 9.98 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.253 1.421 . . . . 0.0 108.03 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.0 mtm -142.24 155.55 45.26 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.93 76.72 0.78 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.1 p -163.42 163.68 16.31 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.132 1.373 . . . . 0.0 108.783 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.19 -176.6 1.95 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.304 2.669 . . . . 0.0 111.436 171.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.3 t -79.67 113.34 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.637 1.175 . . . . 0.0 108.6 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.64 111.48 21.32 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.145 0.978 . . . . 0.0 108.522 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -88.24 166.3 14.44 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 163.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -144.15 102.83 3.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.468 1.907 . . . . 0.0 106.333 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -128.63 65.23 1.42 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.819 1.648 . . . . 0.0 109.042 -169.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.68 174.06 12.56 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.037 -1.039 . . . . 0.0 110.195 172.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -62.98 149.45 44.83 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.948 1.249 . . . . 0.0 107.63 155.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.37 -24.41 59.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.149 -174.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -93.52 17.3 11.8 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.203 1.001 . . . . 0.0 111.845 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.32 58.03 1.17 Allowed Glycine 0 C--N 1.337 0.586 0 O-C-N 121.769 -0.582 . . . . 0.0 111.943 168.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.06 -169.39 38.22 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.61 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 p -137.82 7.19 2.72 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.778 1.231 . . . . 0.0 112.74 -163.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 t -162.05 159.85 26.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.187 -0.946 . . . . 0.0 109.102 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.72 129.03 55.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 167.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.2 m -132.73 119.64 20.6 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 166.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.56 145.31 42.77 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -130.5 74.03 80.63 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -75.12 174.59 12.54 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.419 2.079 . . . . 0.0 110.709 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -137.9 -1.84 1.96 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -162.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.03 -66.22 0.35 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.013 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.4 t -157.92 9.81 0.17 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.397 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.65 92.2 0.32 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.387 1.449 . . . . 0.0 112.692 -167.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.82 147.01 28.25 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.9 2.48 . . . . 0.0 106.834 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.01 -179.68 40.6 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 121.497 1.953 . . . . 0.0 110.066 -172.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.5 m -99.67 117.26 33.64 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.949 0.9 . . . . 0.0 109.774 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -139.71 -165.94 1.98 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.032 1.333 . . . . 0.0 110.599 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.0 mt -128.83 155.92 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.33 1.852 . . . . 0.0 107.485 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.2 mt -133.58 156.09 48.47 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.55 1.94 . . . . 0.0 106.729 173.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.22 98.06 7.66 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.92 142.89 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.96 112.98 23.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.18 55.93 1.62 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -174.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -152.39 168.02 26.81 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.02 -1.05 . . . . 0.0 113.524 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.3 145.33 47.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.971 1.309 . . . . 0.0 109.144 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HE3' ' CG2' ' A' ' 46' ' ' THR . 18.3 ttmt -112.95 143.82 43.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.806 2.442 . . . . 0.0 106.779 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.8 t -172.99 172.02 4.07 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.073 2.149 . . . . 0.0 105.606 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.43 -102.56 0.04 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 126.19 1.852 . . . . 0.0 112.407 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -146.37 41.46 1.15 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.902 1.681 . . . . 0.0 109.188 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -146.26 169.22 19.22 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.005 0.922 . . . . 0.0 110.61 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.468 ' CG2' ' HE3' ' A' ' 41' ' ' LYS . 52.3 p -135.16 104.66 6.0 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.992 0.917 . . . . 0.0 110.461 165.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -80.44 121.42 25.72 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 172.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.75 151.42 47.48 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 166.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.45 114.14 21.35 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.692 1.597 . . . . 0.0 106.871 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 m -67.45 150.15 49.29 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.994 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -120.17 160.57 22.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.465 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -107.15 165.13 11.59 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.035 1.734 . . . . 0.0 107.825 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.722 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -156.19 144.36 19.8 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.702 1.201 . . . . 0.0 108.327 166.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.67 152.4 27.06 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.306 0.643 . . . . 0.0 109.985 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.92 -62.16 0.11 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.01 148.82 39.75 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.229 1.012 . . . . 0.0 110.389 -168.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -60.07 -10.72 4.61 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.637 1.975 . . . . 0.0 114.952 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -130.72 14.38 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.429 1.492 . . . . 0.0 111.066 -163.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.489 HG23 ' CE1' ' A' ' 68' ' ' TYR . 23.6 mt -127.36 86.5 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -172.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -104.24 141.78 35.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.106 1.362 . . . . 0.0 111.522 -170.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.722 HG11 ' HB3' ' A' ' 53' ' ' ALA . 5.1 p -131.03 100.56 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.858 0.863 . . . . 0.0 109.552 -168.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -100.51 51.96 0.88 Allowed 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.606 -1.309 . . . . 0.0 109.921 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.66 -113.76 6.17 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.4 p -78.1 53.29 1.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.665 1.232 . . . . 0.0 110.773 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.9 m -165.02 150.52 9.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.605 2.362 . . . . 0.0 107.263 167.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.33 140.95 28.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.0 t -155.69 102.97 2.24 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.489 ' CE1' HG23 ' A' ' 59' ' ' ILE . 4.4 m-30 -113.96 136.72 52.58 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -103.7 172.02 7.03 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.001 1.321 . . . . 0.0 111.554 -173.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.42 156.71 36.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.89 0.853 . . . . 0.0 111.106 163.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -68.12 165.56 32.06 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.26 1.824 . . . . 0.0 110.888 165.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -88.27 -11.51 4.32 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.91 2.407 . . . . 0.0 113.969 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.03 159.71 38.01 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.204 1.002 . . . . 0.0 109.811 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 0.6 3.51 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.09 165.12 11.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.557 0.743 . . . . 0.0 109.615 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -92.06 146.42 23.75 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 168.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -136.98 154.81 50.32 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.6 m -113.48 106.43 14.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 163.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.39 149.67 47.93 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.5 tp -162.66 118.45 1.86 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.075 0.938 . . . . 0.0 109.53 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.66 166.81 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.195 0.998 . . . . 0.0 109.183 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.7 m -121.52 144.54 48.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 169.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.425 HD11 HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -124.58 160.58 28.08 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.356 1.863 . . . . 0.0 110.095 172.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -148.8 137.96 21.62 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.759 1.224 . . . . 0.0 108.257 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -68.35 165.59 18.37 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -55.56 -84.94 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.815 2.046 . . . . 0.0 111.553 170.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -91.42 -3.14 56.97 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.971 -1.081 . . . . 0.0 113.268 -167.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 t -116.27 -154.51 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.242 2.217 . . . . 0.0 108.028 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.06 41.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.528 0 O-C-N 120.941 -1.099 . . . . 0.0 110.54 -159.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . 0.305 0.0 OUTLIER -65.24 138.5 58.27 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 153.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.1 p -110.39 140.97 44.08 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 159.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.425 HD12 HD11 ' A' ' 83' ' ' LEU . 86.3 mt -121.24 112.04 18.14 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.9 m -65.07 137.72 57.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tt -140.48 96.61 3.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.094 0.861 . . . . 0.0 110.072 -175.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -98.23 137.18 37.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mp -118.53 117.54 54.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 158.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.3 t -108.79 79.15 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -106.14 158.94 31.38 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 123.377 0.671 . . . . 0.0 110.899 -171.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -65.66 -178.08 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.289 2.659 . . . . 0.0 109.979 162.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.2 165.27 22.58 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 121.854 -0.529 . . . . 0.0 112.38 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -89.29 138.91 31.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.034 0.934 . . . . 0.0 110.812 -158.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 96.02 2.44 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 163.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.9 p -134.14 -165.0 1.58 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.317 1.047 . . . . 0.0 109.034 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.9 tp -109.89 14.96 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 125.49 1.516 . . . . 0.0 109.493 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--O 1.248 1.002 0 C-N-CA 124.69 1.196 . . . . 0.0 109.873 -177.969 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.237 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.35 77.72 1.13 Allowed 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.389 1.094 . . . . 0.0 108.14 -175.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mtm -164.43 174.71 10.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.381 2.272 . . . . 0.0 105.74 165.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.99 6.49 1.47 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.889 0.757 . . . . 0.0 112.275 -169.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.87 157.13 40.84 Favored Pre-proline 0 C--O 1.243 0.757 0 C-N-CA 126.705 2.002 . . . . 0.0 106.784 170.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.99 162.51 41.39 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.449 2.099 . . . . 0.0 109.243 172.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 p -72.06 147.22 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.54 144.36 50.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.919 1.688 . . . . 0.0 109.188 175.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.608 ' CZ ' ' HE2' ' A' ' 40' ' ' LYS . 6.8 m-85 -127.2 136.98 52.8 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.981 1.712 . . . . 0.0 107.715 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.63 115.17 22.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.989 2.116 . . . . 0.0 107.898 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.44 75.2 1.5 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.861 2.064 . . . . 0.0 105.797 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -170.25 174.89 5.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.677 0.791 . . . . 0.0 110.288 -175.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -82.95 157.49 22.98 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.664 -0.647 . . . . 0.0 109.938 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.4 -63.99 1.29 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.279 0.561 . . . . 0.0 109.724 165.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -107.92 28.37 8.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.062 1.745 . . . . 0.0 111.027 -160.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.4 -11.43 0.07 OUTLIER Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 170.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.04 -119.31 4.51 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 120.336 2.068 . . . . 0.0 113.796 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.17 9.14 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.636 1.174 . . . . 0.0 112.843 -165.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 t -154.13 -173.4 4.56 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.978 0.808 . . . . 0.0 110.534 161.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.96 105.61 5.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 127.785 2.434 . . . . 0.0 109.322 -171.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -130.35 88.84 2.69 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -83.97 136.48 34.05 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -121.45 70.65 24.42 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.815 1.246 . . . . 0.0 108.392 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.53 171.89 12.31 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.767 1.645 . . . . 0.0 110.307 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -153.43 157.62 40.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.75 1.22 . . . . 0.0 108.276 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.28 -85.52 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.583 2.353 . . . . 0.0 110.106 -170.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 t -146.44 96.43 2.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.979 1.712 . . . . 0.0 108.928 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 m -146.63 89.42 1.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.828 -1.17 . . . . 0.0 112.207 162.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.09 135.9 43.55 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.682 1.193 . . . . 0.0 108.417 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.34 -172.31 40.11 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-N 118.871 0.759 . . . . 0.0 112.498 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.0 p -111.33 108.69 18.38 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.21 1.404 . . . . 0.0 109.683 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -132.81 -174.86 3.59 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.015 1.326 . . . . 0.0 112.89 -175.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 mt -140.57 125.22 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.094 1.358 . . . . 0.0 107.91 -169.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.3 mt -109.17 165.73 11.38 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.997 1.319 . . . . 0.0 110.57 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -84.51 83.63 7.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.076 0.941 . . . . 0.0 110.888 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.0 mt -109.36 119.55 58.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.46 1.104 . . . . 0.0 109.449 -170.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.5 m -84.77 135.3 34.18 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.549 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.7 t -155.19 89.27 1.2 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -162.75 165.89 24.97 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.925 0.89 . . . . 0.0 111.506 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.608 ' HE2' ' CZ ' ' A' ' 9' ' ' TYR . 11.0 ptpt -110.71 161.19 16.01 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.206 1.003 . . . . 0.0 109.113 172.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -134.17 124.98 26.94 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 125.968 1.707 . . . . 0.0 108.001 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.0 t -173.82 175.54 2.85 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.104 1.362 . . . . 0.0 108.073 173.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.56 -107.52 0.92 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -152.15 68.23 0.87 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.617 1.567 . . . . 0.0 107.499 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.8 m -160.87 172.21 17.38 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.687 1.995 . . . . 0.0 110.653 171.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 p -135.39 89.5 2.52 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.076 0.951 . . . . 0.0 110.147 161.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -79.13 140.04 37.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.698 1.135 . . . . 0.0 109.963 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.96 166.79 5.34 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.165 1.386 . . . . 0.0 111.417 171.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 86' ' ' ASP . 22.5 mt -137.32 134.46 36.08 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.839 0.855 . . . . 0.0 109.512 162.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.5 p -71.63 173.68 7.76 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.817 1.647 . . . . 0.0 110.357 171.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -145.69 179.86 7.15 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.806 1.243 . . . . 0.0 111.318 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -125.88 162.44 25.18 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 127.27 2.228 . . . . 0.0 107.734 170.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.92 156.8 43.36 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.596 0.758 . . . . 0.0 109.236 165.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p 174.56 154.19 0.13 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.946 1.298 . . . . 0.0 112.64 167.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.41 -96.47 0.1 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.779 2.133 . . . . 0.0 109.055 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.21 167.72 11.7 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.898 0.849 . . . . 0.0 111.426 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.5 m -93.08 5.03 52.93 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -125.64 21.4 7.74 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.881 1.672 . . . . 0.0 112.461 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.7 mt -134.84 114.22 17.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -165.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -124.0 149.26 46.24 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.06 0.944 . . . . 0.0 109.898 -166.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -132.55 155.27 41.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -171.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.01 179.0 7.47 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.416 1.086 . . . . 0.0 108.849 165.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.72 -18.71 32.74 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 116.484 1.353 . . . . 0.0 116.484 -163.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 m -145.03 8.01 1.22 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.323 1.561 . . . . 0.0 111.16 163.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -109.99 151.45 27.13 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.697 1.599 . . . . 0.0 109.387 -163.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.19 138.25 53.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -142.18 152.26 42.98 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -159.23 168.02 27.54 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.855 0.862 . . . . 0.0 108.841 163.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -119.47 166.98 12.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.419 1.088 . . . . 0.0 110.565 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.13 175.31 7.62 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.403 1.097 . . . . 0.0 111.161 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.447 HD22 ' HD2' ' A' ' 77' ' ' ARG . 7.6 p-10 -99.8 166.94 11.88 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.957 2.503 . . . . 0.0 110.945 -170.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -76.76 -28.6 6.25 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.826 2.351 . . . . 0.0 114.775 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.91 168.5 19.67 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.673 1.124 . . . . 0.0 110.883 -165.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -75.0 1.11 13.73 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 120.733 -1.229 . . . . 0.0 111.918 -170.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -65.0 161.25 19.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.231 0.538 . . . . 0.0 110.749 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.92 129.13 34.18 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.447 ' HD2' HD22 ' A' ' 71' ' ' ASN . 0.0 OUTLIER -119.81 101.96 8.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 167.626 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.6 m -91.1 106.82 18.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 162.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.32 160.93 53.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.0 tp -161.46 93.94 0.95 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.38 0.59 . . . . 0.0 111.818 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 m -86.28 179.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.966 -0.458 . . . . 0.0 111.983 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.96 164.53 14.01 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 161.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.539 HD13 ' HB2' ' A' ' 92' ' ' LEU . 3.4 mp -134.01 164.78 26.54 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.848 1.659 . . . . 0.0 108.87 165.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -151.66 153.18 33.91 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 164.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -80.03 171.88 14.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 172.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.457 ' HB3' HD22 ' A' ' 49' ' ' LEU . 50.9 t0 -55.56 -39.41 70.6 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.902 1.281 . . . . 0.0 112.031 168.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -126.04 -44.97 1.73 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.893 -1.129 . . . . 0.0 111.845 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.4 t -79.47 -169.56 1.96 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.75 10.49 0.04 OUTLIER Glycine 0 C--O 1.223 -0.582 0 CA-C-O 117.09 -1.95 . . . . 0.0 116.422 -159.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.34 91.89 0.05 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 120.74 2.27 . . . . 0.0 109.194 169.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 p -71.6 145.01 49.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.539 ' HB2' HD13 ' A' ' 83' ' ' LEU . 75.1 mt -102.09 -179.06 3.89 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.16 -0.963 . . . . 0.0 108.57 176.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.93 86.73 1.87 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.148 1.379 . . . . 0.0 110.681 -167.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.99 73.12 8.04 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.469 1.108 . . . . 0.0 109.473 -169.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -78.4 91.77 4.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.462 HG22 ' CG ' ' A' ' 98' ' ' GLN . 26.3 mt -87.49 102.41 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.08 81.51 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -172.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.462 ' CG ' HG22 ' A' ' 96' ' ' ILE . 9.4 mt-30 -95.98 156.37 37.24 Favored Pre-proline 0 C--O 1.242 0.674 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.451 -171.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -61.89 156.79 46.86 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.692 1.594 . . . . 0.0 108.715 162.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.78 153.17 25.59 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -94.95 155.33 16.79 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.405 1.482 . . . . 0.0 110.759 -172.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.06 101.72 0.87 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.5 p -147.15 179.41 7.65 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.162 0.985 . . . . 0.0 110.725 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.7 mp -77.44 84.92 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 103.825 -2.658 . . . . 0.0 103.825 160.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.456 -1.735 . . . . 0.0 109.869 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.141 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.9 p80 177.59 59.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -163.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -163.05 149.22 12.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.87 166.91 31.28 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 107.641 -2.184 . . . . 0.0 107.641 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 72.8 p -158.19 165.74 17.96 Favored Pre-proline 0 C--O 1.244 0.78 0 CA-C-N 117.745 0.772 . . . . 0.0 109.191 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -55.58 161.03 8.24 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.864 1.709 . . . . 0.0 110.99 163.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.9 p -74.83 113.92 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.69 1.196 . . . . 0.0 108.731 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.2 t -82.68 105.82 14.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.453 1.101 . . . . 0.0 108.351 -174.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -89.72 146.53 24.44 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.028 -1.045 . . . . 0.0 110.453 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -132.41 112.04 11.82 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.843 1.657 . . . . 0.0 108.884 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -144.51 92.32 2.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.036 0.934 . . . . 0.0 108.849 173.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 p -166.93 167.77 14.51 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.666 0.787 . . . . 0.0 110.018 172.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -72.97 172.33 11.15 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.027 0.531 . . . . 0.0 110.537 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.37 -22.1 44.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.463 0.705 . . . . 0.0 111.209 170.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -79.15 20.78 0.48 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.299 1.84 . . . . 0.0 112.468 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.88 52.17 52.2 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.636 -1.29 . . . . 0.0 112.693 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.92 -173.12 40.48 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.394 0.597 . . . . 0.0 113.564 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -131.96 17.3 4.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.108 2.163 . . . . 0.0 111.83 -166.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 t -151.58 137.42 18.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.521 -1.362 . . . . 0.0 108.835 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -108.08 125.49 51.64 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.0 m -130.69 93.71 3.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.04 143.82 31.28 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -122.09 65.91 21.89 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.85 1.26 . . . . 0.0 110.504 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.29 -176.49 2.95 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.031 1.821 . . . . 0.0 110.407 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -162.18 165.53 26.8 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.909 1.284 . . . . 0.0 108.023 -169.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 59.06 -77.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.651 2.38 . . . . 0.0 112.716 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.1 t -160.01 124.0 3.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.328 1.451 . . . . 0.0 107.584 149.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.93 31.31 3.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.947 0.794 . . . . 0.0 112.472 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.96 126.1 28.69 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.773 1.229 . . . . 0.0 111.221 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.04 -159.57 16.23 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.7 p -123.55 116.55 23.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.652 1.181 . . . . 0.0 109.265 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -130.14 -177.57 4.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.538 1.535 . . . . 0.0 110.821 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.1 mt -135.27 148.13 28.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.4 mt -128.11 161.12 29.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.612 1.165 . . . . 0.0 109.574 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -91.13 108.73 20.07 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.63 1.572 . . . . 0.0 108.668 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -119.82 138.63 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 C-N-CA 125.633 1.573 . . . . 0.0 107.954 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 m -79.92 129.33 34.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 117.868 -1.063 . . . . 0.0 108.852 164.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -148.29 71.61 1.17 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.199 1.363 . . . . 0.0 111.527 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -153.49 171.21 19.04 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.157 -0.965 . . . . 0.0 112.227 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.99 144.21 49.95 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.905 1.682 . . . . 0.0 108.827 167.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -117.42 133.8 55.56 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -172.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t 175.02 -171.47 0.06 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.603 2.361 . . . . 0.0 105.867 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 55.29 -107.93 0.88 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -143.21 26.05 1.68 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.16 0.984 . . . . 0.0 110.027 167.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.3 m -150.81 -164.89 2.12 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.002 1.321 . . . . 0.0 110.411 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 p -130.37 99.02 4.87 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.037 2.135 . . . . 0.0 107.856 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -73.05 123.03 22.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.32 161.21 14.39 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.656 0.782 . . . . 0.0 110.045 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.1 mt -138.03 153.49 49.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.223 1.009 . . . . 0.0 108.863 169.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -115.19 164.96 13.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.217 1.407 . . . . 0.0 109.808 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -145.71 165.69 28.03 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -168.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -121.83 153.91 37.74 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 127.441 2.297 . . . . 0.0 109.282 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.426 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -147.45 148.31 31.13 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.974 1.709 . . . . 0.0 108.157 169.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -166.94 154.55 9.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.305 0.642 . . . . 0.0 111.102 168.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.53 -69.23 0.06 OUTLIER Glycine 0 C--N 1.337 0.613 0 CA-C-O 121.322 0.401 . . . . 0.0 113.125 172.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.615 ' H ' HG12 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -75.74 -173.12 2.12 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.585 1.954 . . . . 0.0 109.69 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.21 23.14 11.48 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.5 1.52 . . . . 0.0 113.691 168.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -135.42 -3.24 2.41 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.7 mt -119.3 122.77 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.918 2.087 . . . . 0.0 107.955 -167.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -123.54 165.56 16.93 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.388 -0.82 . . . . 0.0 110.965 -169.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 53' ' ' ALA . 10.7 p -146.64 140.78 20.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.131 0.972 . . . . 0.0 108.56 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.01 66.88 1.48 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.38 -119.05 15.45 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.939 -2.065 . . . . 0.0 107.939 -165.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.5 p -56.82 -25.24 55.54 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.127 1.771 . . . . 0.0 114.265 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 m -93.28 146.62 23.57 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.444 1.097 . . . . 0.0 109.366 -167.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.45 145.17 23.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.585 1.154 . . . . 0.0 109.197 -173.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 m -143.25 154.39 43.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -152.09 125.58 8.84 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 168.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -105.94 114.61 28.86 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.264 10.6 pt-20 -75.37 165.68 24.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.982 0.896 . . . . 0.0 112.939 -166.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.35 149.81 97.93 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.75 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -74.81 -9.57 21.11 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.041 2.494 . . . . 0.0 113.071 -169.417 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.53 -178.65 3.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.597 1.189 . . . . 0.0 110.728 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.97 13.87 21.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.216 1.806 . . . . 0.0 112.157 -170.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -80.04 152.51 29.36 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 172.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -82.75 138.44 34.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.744 1.218 . . . . 0.0 107.931 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -144.09 92.55 2.34 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.222 1.374 . . . . 0.0 111.327 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.47 HG23 HG22 ' A' ' 97' ' ' VAL . 45.6 m -68.87 115.61 8.4 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.181 -0.324 . . . . 0.0 110.514 173.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.24 162.56 29.69 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.157 0.884 . . . . 0.0 112.91 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.1 tp -162.69 115.11 1.62 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.82 1.248 . . . . 0.0 111.247 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 56' ' ' ASP . 3.2 m -103.19 179.32 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.357 1.063 . . . . 0.0 109.828 164.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 m -129.38 162.87 27.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 163.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -143.74 158.82 43.41 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 125.794 1.638 . . . . 0.0 112.406 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -150.54 159.89 44.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.501 1.12 . . . . 0.0 109.548 168.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -103.76 164.69 11.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.275 1.43 . . . . 0.0 110.256 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -54.99 -57.15 12.84 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.736 1.214 . . . . 0.0 113.345 -172.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -118.59 -6.64 10.67 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.239 0.616 . . . . 0.0 112.468 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.1 m -80.3 -154.64 0.1 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.088 0.955 . . . . 0.0 109.562 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.04 -1.24 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 118.138 -1.368 . . . . 0.0 115.502 173.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -64.1 107.4 1.27 Allowed 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.029 1.914 . . . . 0.0 106.721 170.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.1 p -63.32 155.3 29.09 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 161.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.3 mt -101.74 -166.11 1.26 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 164.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t -146.32 111.68 5.47 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 160.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.9 tp -83.78 122.24 28.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -120.74 154.25 35.89 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -131.43 121.47 48.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 103.711 -2.699 . . . . 0.0 103.711 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 78' ' ' THR . 45.7 t -127.47 105.85 14.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.64 165.84 22.76 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 124.257 1.023 . . . . 0.0 111.142 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -63.51 -177.97 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.516 2.144 . . . . 0.0 110.867 156.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.32 175.11 18.77 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.458 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -76.01 136.66 39.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.877 1.271 . . . . 0.0 112.054 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.53 8.07 0.09 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.976 2.11 . . . . 0.0 113.001 174.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.5 p -85.74 -173.02 4.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.321 1.049 . . . . 0.0 110.226 -162.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.472 HD12 ' H ' ' A' ' 104' ' ' ILE . 3.5 mp -74.38 73.15 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 161.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.922 0 C-N-CA 126.318 1.847 . . . . 0.0 106.853 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -67.88 161.68 25.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 169.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.4 tpt -64.5 144.34 57.26 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 157.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.04 -83.41 0.05 OUTLIER Glycine 0 C--O 1.225 -0.442 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 p -140.62 165.33 30.64 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 124.081 0.952 . . . . 0.0 109.52 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -61.3 136.72 65.95 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 N-CA-C 108.453 -1.403 . . . . 0.0 108.453 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 t -107.37 135.49 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 165.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.67 122.62 45.09 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 168.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -85.85 155.42 20.98 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 164.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -134.72 103.52 5.67 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 2.8 t80 -139.71 86.27 2.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 170.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.67 -170.03 3.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.838 2.055 . . . . 0.0 105.843 171.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -78.18 -89.31 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 166.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.79 -61.97 0.12 Allowed 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 119.073 -2.267 . . . . 0.0 110.788 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 p30 -127.12 2.48 6.47 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.844 2.058 . . . . 0.0 110.697 -167.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.25 -73.08 1.19 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 107.711 -2.155 . . . . 0.0 107.711 170.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.55 -154.8 25.55 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.7 p -79.85 20.11 0.64 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.468 1.907 . . . . 0.0 110.909 171.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.7 t -158.94 156.85 30.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.661 -1.274 . . . . 0.0 108.77 -165.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.9 157.4 46.47 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 157.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.0 m -131.45 152.34 50.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 158.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -133.94 150.78 51.31 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -127.88 74.33 78.7 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 126.11 1.764 . . . . 0.0 107.425 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.33 175.2 4.29 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.346 2.03 . . . . 0.0 109.846 167.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -161.03 173.92 14.51 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.395 -0.816 . . . . 0.0 109.11 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t0 55.93 -84.04 0.01 OUTLIER 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.963 2.505 . . . . 0.0 111.485 -173.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -145.39 125.71 13.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.103 2.561 . . . . 0.0 105.199 148.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 m -148.87 112.34 5.01 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.773 1.169 . . . . 0.0 110.4 163.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.6 179.24 6.68 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.0 1.72 . . . . 0.0 108.668 161.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.33 -176.56 32.91 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 174.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 m -109.17 101.61 10.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.835 1.254 . . . . 0.0 109.876 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -115.36 -165.01 0.99 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.465 1.906 . . . . 0.0 111.166 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.0 mt -127.53 148.14 32.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.586 1.554 . . . . 0.0 107.426 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.5 mt -132.03 165.32 24.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.849 2.059 . . . . 0.0 107.154 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.04 105.91 14.81 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -172.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.7 mt -132.52 142.13 43.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.67 1.588 . . . . 0.0 107.789 -163.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -112.23 129.9 56.11 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.063 1.345 . . . . 0.0 108.226 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -147.78 78.04 1.44 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.084 0.468 . . . . 0.0 110.162 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -157.04 175.76 13.65 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.774 -1.204 . . . . 0.0 111.567 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.58 148.54 43.2 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.989 0.916 . . . . 0.0 109.209 161.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -114.67 123.43 49.26 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 126.506 1.922 . . . . 0.0 107.413 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 t -173.98 -166.66 0.31 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.967 1.707 . . . . 0.0 107.113 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.33 -103.63 0.13 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.184 1.849 . . . . 0.0 109.552 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -147.11 21.14 1.23 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.976 0.91 . . . . 0.0 110.656 171.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 m -156.33 173.92 16.16 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 120.327 -1.483 . . . . 0.0 111.39 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -130.24 105.69 8.08 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.829 1.652 . . . . 0.0 107.087 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -83.23 139.83 32.88 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.2 146.12 45.77 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.641 0.655 . . . . 0.0 110.945 172.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.9 mt -101.77 133.14 46.96 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 165.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -73.2 166.52 22.99 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.753 1.221 . . . . 0.0 109.126 171.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.1 p90 -148.28 179.32 7.86 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.279 1.032 . . . . 0.0 111.844 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.93 172.31 12.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.782 1.633 . . . . 0.0 110.471 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.82 161.13 32.45 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.524 1.93 . . . . 0.0 109.617 169.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.9 p -153.64 140.25 18.88 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 163.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.19 -138.05 5.08 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.56 131.03 6.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.182 2.593 . . . . 0.0 111.076 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 m -80.27 30.99 0.27 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.93 1.292 . . . . 0.0 113.818 -173.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -133.52 23.65 4.04 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.584 1.554 . . . . 0.0 110.299 172.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -144.98 107.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -119.9 164.44 16.05 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.82 1.248 . . . . 0.0 108.925 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.34 152.76 13.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.281 0.562 . . . . 0.0 110.801 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.7 169.18 18.06 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 128.672 2.789 . . . . 0.0 109.433 166.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -58.68 -32.96 70.55 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.879 -0.4 . . . . 0.0 113.538 -177.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.36 11.5 8.7 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 t -153.47 142.81 21.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 119.553 1.069 . . . . 0.0 108.859 -170.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.7 t -120.91 150.97 23.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -171.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -139.0 134.18 32.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 165.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -127.34 138.15 52.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 155.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -99.33 -172.93 2.36 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -101.42 168.96 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.634 1.207 . . . . 0.0 108.825 170.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.483 HD21 ' HA2' ' A' ' 100' ' ' GLY . 27.5 p30 -76.28 160.54 77.62 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 124.738 1.215 . . . . 0.0 108.98 167.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -75.19 -47.23 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.245 1.964 . . . . 0.0 110.549 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.14 165.88 12.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.0 110.696 -170.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.23 2.32 50.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.049 0.94 . . . . 0.0 113.071 -171.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.42 148.85 46.51 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.523 -0.735 . . . . 0.0 110.129 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 139.6 58.38 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.65 0.78 . . . . 0.0 108.945 174.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -129.58 151.02 50.65 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.892 0.877 . . . . 0.0 109.858 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.9 m -120.61 100.65 7.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.849 1.26 . . . . 0.0 107.654 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.97 140.59 33.08 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.1 tp -152.79 103.18 2.75 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 117.886 0.843 . . . . 0.0 108.801 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.3 m -107.59 163.62 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 118.826 0.739 . . . . 0.0 110.592 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.6 m -107.72 158.08 17.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mp -138.22 158.46 44.25 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.313 1.845 . . . . 0.0 108.542 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.21 142.91 18.69 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.662 0.664 . . . . 0.0 110.678 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.523 ' HG2' ' H ' ' A' ' 88' ' ' SER . 7.9 tt0 -77.92 165.32 24.25 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 127.851 2.46 . . . . 0.0 111.013 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.63 -85.95 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.054 2.142 . . . . 0.0 112.719 167.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -89.53 -8.27 53.13 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.896 -1.127 . . . . 0.0 111.957 -168.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.523 ' H ' ' HG2' ' A' ' 85' ' ' GLN . 0.2 OUTLIER -136.95 -153.87 0.52 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.624 2.37 . . . . 0.0 108.076 177.684 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.92 44.52 0.02 OUTLIER Glycine 0 C--N 1.334 0.433 0 CA-C-N 120.467 1.485 . . . . 0.0 113.228 -151.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 103.18 0.15 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 148.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.6 p -69.25 133.35 47.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.75 155.53 19.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.37 151.65 21.94 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 157.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 tt -149.94 112.38 4.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.09 140.21 51.4 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -128.67 128.53 67.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 167.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.6 t -109.67 96.62 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 168.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -109.07 165.17 13.13 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 118.012 -0.994 . . . . 0.0 108.513 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -55.71 -162.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.553 1 C-N-CA 126.231 4.621 . . . . 0.0 112.906 163.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.483 ' HA2' HD21 ' A' ' 71' ' ' ASN . . . -120.49 168.91 13.97 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 116.745 -2.645 . . . . 0.0 112.679 147.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -103.6 158.86 16.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.969 1.308 . . . . 0.0 111.072 -168.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.41 103.01 0.72 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.447 2.299 . . . . 0.0 105.387 164.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 t -148.55 -175.72 5.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.425 1.011 . . . . 0.0 109.915 166.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -87.72 80.7 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t0 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 123.344 0.657 . . . . 0.0 110.024 177.722 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.21 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -59.36 155.32 14.92 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.444 1.122 . . . . 0.0 109.354 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.2 mtp -139.56 -168.1 2.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.834 1.653 . . . . 0.0 107.528 175.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.56 -43.18 3.16 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.4 p -49.39 144.53 8.64 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 124.693 1.197 . . . . 0.0 111.144 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.09 178.45 4.76 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.034 2.49 . . . . 0.0 110.86 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.87 162.19 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.34 1.056 . . . . 0.0 108.94 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -139.95 104.98 4.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.578 2.351 . . . . 0.0 107.878 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -86.02 152.8 22.62 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.797 1.239 . . . . 0.0 109.848 171.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.46 134.16 45.9 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.23 1.412 . . . . 0.0 107.332 -171.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -153.07 62.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.254 0.622 . . . . 0.0 111.173 -173.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.1 p -151.7 -169.24 3.31 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.017 -1.052 . . . . 0.0 110.663 176.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.637 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 70.3 m-85 -75.94 177.0 7.34 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 121.395 -0.816 . . . . 0.0 109.345 157.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.21 -23.7 14.0 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.609 1.164 . . . . 0.0 111.388 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -145.76 3.13 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.491 0.716 . . . . 0.0 112.28 -174.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.83 -79.42 1.46 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.637 ' H ' ' HB2' ' A' ' 13' ' ' TYR . . . 162.57 -125.12 1.37 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.436 1.97 . . . . 0.0 108.923 -172.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 p -135.25 17.19 3.43 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.577 1.551 . . . . 0.0 111.913 -168.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.51 175.11 12.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 120.471 -1.393 . . . . 0.0 110.827 166.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 122.53 32.46 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.785 2.034 . . . . 0.0 107.029 -173.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.474 HG22 ' CE1' ' A' ' 23' ' ' TYR . 26.4 m -149.62 88.27 1.55 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.58 139.24 38.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.474 ' CE1' HG22 ' A' ' 21' ' ' THR . 91.4 m-85 -124.88 74.62 65.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 170.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.89 173.86 11.35 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.258 2.639 . . . . 0.0 110.229 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.61 147.57 25.51 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.496 -0.752 . . . . 0.0 111.41 -169.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 61.86 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.96 2.104 . . . . 0.0 108.974 -164.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.5 t -160.18 114.57 2.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 172.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.18 112.37 8.59 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.01 157.66 44.33 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.467 1.507 . . . . 0.0 109.279 -174.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.88 -178.52 31.55 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 160.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.4 p -102.34 113.73 27.29 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.147 1.379 . . . . 0.0 109.847 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -130.89 -170.2 2.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.78 1.232 . . . . 0.0 112.835 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 mt -131.3 151.66 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.717 2.407 . . . . 0.0 107.194 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.5 mt -131.87 154.82 48.8 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.23 1.812 . . . . 0.0 109.07 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -86.14 55.85 3.72 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.015 1.326 . . . . 0.0 110.099 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.0 mt -71.53 156.85 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.787 1.235 . . . . 0.0 110.327 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 m -127.69 107.69 10.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.135 1.774 . . . . 0.0 109.27 -169.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.37 86.77 1.35 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 122.561 0.344 . . . . 0.0 110.328 -174.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -156.11 165.01 37.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.539 0.336 . . . . 0.0 110.883 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.98 130.92 55.95 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.92 1.688 . . . . 0.0 109.5 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -116.35 127.53 54.75 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.554 1.941 . . . . 0.0 106.781 -170.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.6 t -168.99 143.33 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.93 -104.69 0.77 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -133.8 21.03 3.86 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.003 0.921 . . . . 0.0 111.166 -170.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -149.21 162.89 39.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.874 1.321 . . . . 0.0 110.253 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -132.39 115.23 15.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 130.038 3.335 . . . . 0.0 105.629 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.08 111.36 20.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -170.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.49 157.55 37.4 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.259 0.35 . . . . 0.0 110.804 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.31 130.56 40.96 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.48 1.512 . . . . 0.0 110.76 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -71.12 178.39 3.3 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.43 1.492 . . . . 0.0 110.978 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -147.43 177.35 9.3 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.502 1.121 . . . . 0.0 109.702 168.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.4 p30 -139.25 165.73 26.42 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.644 1.577 . . . . 0.0 109.85 166.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.33 156.55 44.73 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.225 1.81 . . . . 0.0 109.099 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.1 m -155.35 144.12 20.59 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.314 1.046 . . . . 0.0 110.216 173.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.85 -86.88 0.1 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 167.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.7 160.11 30.89 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.37 1.085 . . . . 0.0 111.426 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -82.47 -8.12 59.62 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -129.87 28.15 5.11 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.748 1.158 . . . . 0.0 112.32 -160.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.8 mt -132.76 101.81 4.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -75.32 133.1 41.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.208 1.003 . . . . 0.0 109.884 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.57 142.35 41.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.963 1.305 . . . . 0.0 109.919 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.16 155.79 41.18 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 126.3 1.84 . . . . 0.0 107.533 177.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.45 -11.13 46.47 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.889 0.757 . . . . 0.0 114.245 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.6 m -134.72 -4.86 2.51 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.451 1.125 . . . . 0.0 113.463 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.7 m -140.05 164.77 29.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.876 1.671 . . . . 0.0 110.361 -167.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.19 154.85 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.588 1.155 . . . . 0.0 108.255 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.1 159.5 42.87 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 158.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -132.8 107.82 8.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 165.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.46 166.89 15.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.508 0.671 . . . . 0.0 109.592 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.91 174.37 6.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -108.5 163.92 15.89 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.851 0.86 . . . . 0.0 111.123 -168.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -89.82 -11.76 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.141 3.228 . . . . 0.0 113.978 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.33 130.69 31.11 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -171.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.28 22.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.451 1.9 . . . . 0.0 112.301 -164.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -66.45 166.48 12.4 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 160.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -85.5 156.07 20.95 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 163.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -135.28 157.67 46.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 164.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.9 m -135.21 97.21 3.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -176.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.39 163.83 45.56 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 117.934 0.334 . . . . 0.0 113.112 -168.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 tp -153.84 125.77 7.79 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.786 1.635 . . . . 0.0 109.403 159.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.14 155.01 31.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 160.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.9 m -100.63 156.24 17.42 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 159.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.02 161.25 31.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.373 1.869 . . . . 0.0 107.719 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.424 ' HE2' ' O ' ' A' ' 88' ' ' SER . 68.6 tttt -139.81 145.39 38.1 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -70.91 171.81 10.05 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 168.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -56.27 -65.11 0.66 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.617 0.767 . . . . 0.0 111.855 172.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -118.07 5.18 12.03 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.845 1.258 . . . . 0.0 112.211 -167.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.424 ' O ' ' HE2' ' A' ' 84' ' ' LYS . 17.8 t -135.81 -158.87 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.301 1.44 . . . . 0.0 107.913 162.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.51 72.8 0.36 Allowed Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 106.489 -2.644 . . . . 0.0 106.489 -170.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -61.42 86.74 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 147.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 p -97.5 113.69 25.43 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 104.286 -2.486 . . . . 0.0 104.286 170.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.5 mt -131.61 157.54 43.4 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 m -120.44 114.61 22.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.118 1.326 . . . . 0.0 108.406 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.91 71.43 3.43 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.66 0.743 . . . . 0.0 112.167 -162.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -85.64 82.8 8.09 Favored 'General case' 0 C--O 1.226 -0.184 0 O-C-N 121.066 -1.021 . . . . 0.0 109.423 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.49 125.93 34.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 163.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.52 67.11 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -99.39 151.8 37.56 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 123.711 0.805 . . . . 0.0 112.098 -170.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.03 -172.14 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.724 3.616 . . . . 0.0 112.707 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.72 166.27 22.57 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.97 144.8 50.18 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.545 1.538 . . . . 0.0 108.691 -163.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.9 p -152.34 64.63 0.82 Allowed 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.478 1.111 . . . . 0.0 109.848 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -140.03 -172.28 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.442 -0.786 . . . . 0.0 110.867 -164.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 49.1 mt -93.04 70.03 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 C--O 1.241 0.653 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -178.891 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.344 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -128.99 72.67 1.47 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 74.9 mtm -147.81 160.25 42.96 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 164.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.47 93.8 1.02 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 106.441 -2.663 . . . . 0.0 106.441 -168.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -145.69 158.52 49.66 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 124.236 1.014 . . . . 0.0 108.877 -166.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -67.56 173.12 9.36 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.393 2.062 . . . . 0.0 111.554 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.78 140.75 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.642 1.177 . . . . 0.0 109.231 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 m -92.99 129.44 38.9 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 166.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -106.73 148.51 28.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 162.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -126.66 105.64 8.84 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.414 1.486 . . . . 0.0 107.308 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.08 56.77 1.78 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.777 1.631 . . . . 0.0 109.456 -165.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.9 p -159.78 -175.69 5.29 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.368 1.067 . . . . 0.0 109.136 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -65.85 161.08 21.84 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.46 -15.85 25.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.104 0.961 . . . . 0.0 112.322 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -148.47 41.21 0.95 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.596 0.713 . . . . 0.0 111.434 -170.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.71 -83.63 0.05 OUTLIER Glycine 0 C--N 1.335 0.501 0 O-C-N 121.274 -0.891 . . . . 0.0 111.607 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.65 -125.37 0.78 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 117.136 0.468 . . . . 0.0 113.384 -171.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -139.22 10.51 2.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.102 0.961 . . . . 0.0 112.245 -163.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.39 173.16 17.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.919 2.088 . . . . 0.0 109.498 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -128.53 142.92 50.92 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 127.715 2.406 . . . . 0.0 108.716 173.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -153.22 90.73 1.45 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.716 1.207 . . . . 0.0 108.834 172.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.31 151.03 23.46 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 121.718 -0.614 . . . . 0.0 109.554 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -134.58 69.23 72.57 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.398 1.079 . . . . 0.0 109.342 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.73 175.32 9.07 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.436 2.091 . . . . 0.0 111.117 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -149.19 172.25 15.14 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.377 1.471 . . . . 0.0 107.962 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t0 59.79 -85.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.167 2.587 . . . . 0.0 109.979 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.4 p -142.29 4.13 1.58 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.641 1.176 . . . . 0.0 113.986 -176.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -78.4 67.92 4.29 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -163.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.5 117.74 19.21 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 127.086 2.154 . . . . 0.0 107.899 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.25 -163.09 26.35 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -167.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.4 p -116.99 114.41 23.75 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 117.766 0.783 . . . . 0.0 111.773 -162.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -133.58 -169.92 2.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.752 1.221 . . . . 0.0 110.77 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.8 mt -142.91 146.49 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.819 1.648 . . . . 0.0 107.091 -170.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.5 mt -126.37 175.81 7.58 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.064 1.345 . . . . 0.0 111.396 -171.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -110.81 91.77 3.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -164.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mt -125.92 150.84 31.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -163.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.02 134.14 54.65 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.6 t -153.19 44.88 0.65 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.448 1.099 . . . . 0.0 109.549 -172.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -140.03 169.06 18.39 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 120.73 -1.231 . . . . 0.0 111.765 -172.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -117.63 158.56 24.42 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.56 1.144 . . . . 0.0 109.175 168.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -138.73 135.59 34.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.928 1.691 . . . . 0.0 108.379 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.0 t -176.27 149.47 0.85 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.43 -101.86 0.32 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.959 1.266 . . . . 0.0 111.345 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -141.71 34.29 1.61 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.425 1.09 . . . . 0.0 110.953 -171.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 m -151.52 174.11 13.8 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.96 -1.087 . . . . 0.0 110.58 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -122.44 154.92 37.13 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 155.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -138.62 123.93 19.31 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.46 160.75 26.86 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.959 0.787 . . . . 0.0 109.793 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.81 -159.08 0.68 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 162.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.1 m -130.36 174.92 9.39 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.343 1.857 . . . . 0.0 108.458 169.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -152.51 173.41 15.18 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.691 -0.631 . . . . 0.0 111.761 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -143.55 172.64 12.52 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.062 1.345 . . . . 0.0 109.93 172.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.65 159.24 38.23 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.237 1.815 . . . . 0.0 109.112 -175.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 p 179.18 161.02 0.74 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.647 0.779 . . . . 0.0 111.418 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.66 -78.09 0.09 OUTLIER Glycine 0 C--N 1.334 0.471 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -102.66 -160.72 0.8 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.449 1.5 . . . . 0.0 110.832 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.3 p -123.98 14.59 9.21 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -133.43 28.27 4.03 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.744 1.218 . . . . 0.0 111.013 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -135.68 84.76 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -171.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -59.82 125.17 22.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.3 t -118.71 152.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 163.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.55 173.26 11.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 159.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.44 -50.9 12.89 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -125.99 40.89 3.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.986 0.914 . . . . 0.0 111.169 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.16 163.23 35.01 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.98 0.809 . . . . 0.0 110.647 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.74 142.87 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.323 1.449 . . . . 0.0 107.641 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.89 168.55 26.85 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.337 -1.477 . . . . 0.0 109.047 163.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.99 154.1 41.52 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 172.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.61 151.25 35.3 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 122.718 0.407 . . . . 0.0 110.04 175.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -72.41 169.83 15.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.883 0.849 . . . . 0.0 111.567 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.51 154.09 43.96 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 124.565 1.146 . . . . 0.0 110.514 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.42 -5.68 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.945 2.43 . . . . 0.0 113.426 -166.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.91 167.18 11.18 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.986 0.898 . . . . 0.0 109.971 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -77.12 0.56 21.13 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 120.841 -1.162 . . . . 0.0 111.954 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -59.64 144.03 48.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.153 0.981 . . . . 0.0 108.917 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -77.42 136.71 38.42 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 161.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -122.37 134.14 54.64 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.502 1.121 . . . . 0.0 108.996 -175.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.7 m -122.94 105.32 9.89 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.708 1.203 . . . . 0.0 108.016 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.75 167.28 52.75 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 tp -155.96 59.89 0.59 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.6 t -72.53 148.44 9.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 121.649 -0.657 . . . . 0.0 109.733 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 170.62 8.06 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.54 0.736 . . . . 0.0 109.264 169.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -136.73 163.84 29.67 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.804 1.642 . . . . 0.0 109.444 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 85' ' ' GLN . 48.8 tttt -147.84 172.78 13.6 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.241 2.216 . . . . 0.0 106.621 163.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.46 ' H ' ' HG2' ' A' ' 84' ' ' LYS . 20.8 tt0 -126.24 162.55 25.19 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.398 1.479 . . . . 0.0 107.158 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -56.38 -59.3 5.17 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.685 0.794 . . . . 0.0 111.88 -165.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -99.93 -27.8 13.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 111.529 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -101.65 -162.51 0.94 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.261 1.024 . . . . 0.0 111.811 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.1 67.52 0.41 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -63.03 92.96 0.06 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 152.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.0 p -95.65 103.99 15.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 165.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.98 158.36 16.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.3 m -117.77 125.16 50.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.448 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 5.8 tp -107.92 95.83 5.96 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.476 1.511 . . . . 0.0 107.869 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -108.96 90.36 3.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 mp -72.44 141.59 16.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 160.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.8 t -128.03 92.97 2.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 165.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -112.67 147.45 37.16 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.697 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -67.44 -167.88 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.777 3.652 . . . . 0.0 110.777 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.8 160.28 26.59 Favored Glycine 0 C--O 1.24 0.5 0 O-C-N 121.769 -0.582 . . . . 0.0 111.905 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.93 177.37 7.88 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.667 2.387 . . . . 0.0 108.191 -171.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.2 p -148.38 97.26 2.73 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.9 p -130.12 -164.86 1.46 Allowed 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 125.015 1.326 . . . . 0.0 108.324 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.45 66.4 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 C--O 1.249 1.05 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 174.194 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.684 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -129.08 84.67 2.25 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -167.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.9 ptm -72.2 144.58 48.46 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.07 67.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -176.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.8 p -149.0 165.33 17.99 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 123.828 0.851 . . . . 0.0 109.401 174.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.68 -176.92 2.22 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.092 1.862 . . . . 0.0 110.958 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.8 95.95 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 127.29 2.236 . . . . 0.0 107.965 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.2 t -74.02 145.46 44.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.635 1.574 . . . . 0.0 109.207 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -126.95 153.38 45.91 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.906 1.283 . . . . 0.0 109.307 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -134.81 115.28 13.5 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.951 2.1 . . . . 0.0 106.314 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 4.1 t80 -145.07 79.21 1.58 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.3 p -154.33 -175.88 5.61 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.967 0.507 . . . . 0.0 109.827 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.484 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 62.6 m-85 -63.89 165.19 9.05 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 157.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.48 -31.42 11.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.237 1.015 . . . . 0.0 110.972 168.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -130.53 73.77 1.56 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.56 -56.98 0.11 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.261 162.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' H ' ' HB2' ' A' ' 13' ' ' TYR . . . 158.42 -136.6 4.84 Favored Glycine 0 CA--C 1.52 0.347 0 O-C-N 121.92 -0.753 . . . . 0.0 112.629 -167.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 p -137.58 23.8 2.91 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.25 1.02 . . . . 0.0 112.168 -166.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 t -167.59 166.44 14.06 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.784 1.234 . . . . 0.0 110.845 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.22 135.92 53.65 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.831 2.853 . . . . 0.0 112.647 174.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 m -147.14 84.78 1.59 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.575 1.15 . . . . 0.0 108.005 173.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -83.07 140.75 32.49 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.67 77.19 37.6 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -74.49 168.14 25.51 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 120.939 1.093 . . . . 0.0 109.387 165.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -162.19 160.82 27.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.68 1.992 . . . . 0.0 106.675 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.5 t70 60.53 -80.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.703 1.601 . . . . 0.0 111.918 -167.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 t -165.21 85.64 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.772 1.229 . . . . 0.0 108.009 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.4 m -135.85 24.48 3.35 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.03 122.28 20.62 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.191 1.396 . . . . 0.0 108.895 169.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.31 -175.69 36.85 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 119.042 0.837 . . . . 0.0 111.155 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.4 p -96.59 126.95 42.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.201 1.4 . . . . 0.0 109.029 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -128.39 -177.49 4.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 169.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 mt -139.51 143.19 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 129.645 3.178 . . . . 0.0 105.554 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.7 mt -121.2 -168.68 1.71 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.118 1.767 . . . . 0.0 110.18 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -129.98 51.23 2.11 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.056 1.342 . . . . 0.0 109.026 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.4 mt -82.05 125.0 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.182 0.993 . . . . 0.0 108.937 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 m -71.05 134.68 47.28 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.566 1.546 . . . . 0.0 109.411 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -144.52 108.71 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -167.35 170.84 11.14 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.693 0.759 . . . . 0.0 110.907 160.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.74 135.04 54.38 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.245 1.818 . . . . 0.0 108.105 161.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -114.82 123.17 48.52 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 125.563 1.545 . . . . 0.0 109.347 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 t -159.74 153.24 22.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.88 -82.81 0.07 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.095 1.807 . . . . 0.0 110.687 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -145.92 -1.13 0.78 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.074 1.35 . . . . 0.0 111.539 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 p -134.5 172.62 12.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.128 -1.607 . . . . 0.0 112.461 -162.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.0 p -130.71 123.06 28.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 127.415 2.286 . . . . 0.0 106.877 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.23 109.12 20.42 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.56 155.23 40.82 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.299 0.64 . . . . 0.0 109.545 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.2 mt -121.33 147.27 45.9 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.637 0.775 . . . . 0.0 110.961 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -79.67 160.16 26.42 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 168.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -138.97 174.67 10.27 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.277 1.031 . . . . 0.0 111.737 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -150.01 148.49 29.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.676 1.191 . . . . 0.0 109.47 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.432 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -150.81 160.78 43.65 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.278 1.831 . . . . 0.0 109.458 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 p 174.85 145.99 0.07 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.337 0.655 . . . . 0.0 110.471 -176.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.54 -91.3 0.1 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 168.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.27 164.58 3.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.86 2.064 . . . . 0.0 111.288 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 m -92.46 -1.1 57.22 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.74 1.616 . . . . 0.0 115.143 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TRP . . . . . 0.411 ' CZ2' ' HA3' ' A' ' 79' ' ' GLY . 44.7 p-90 -129.54 29.84 5.01 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.198 1.399 . . . . 0.0 108.954 -174.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.0 mt -142.81 88.29 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -88.42 171.89 9.78 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.939 0.896 . . . . 0.0 108.671 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.432 HG11 ' HB3' ' A' ' 53' ' ' ALA . 11.5 p -157.61 157.42 3.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.73 1.212 . . . . 0.0 108.752 166.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.45 -179.34 6.36 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.396 2.678 . . . . 0.0 108.014 172.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -45.18 -51.71 8.76 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.86 1.219 . . . . 0.0 113.544 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.0 m -124.87 -7.83 7.26 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 118.22 -0.895 . . . . 0.0 113.394 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 m -120.67 155.87 32.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.606 1.094 . . . . 0.0 110.625 -169.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -137.69 162.11 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.9 m -147.58 137.44 22.84 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 162.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.431 ' CE1' HD11 ' A' ' 94' ' ' LEU . 6.0 m-85 -123.27 104.07 8.91 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -74.3 173.5 10.13 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 122.208 1.004 . . . . 0.0 112.365 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -83.04 -165.71 1.15 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.153 2.181 . . . . 0.0 109.969 175.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -128.63 165.23 32.94 Favored Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 126.544 1.938 . . . . 0.0 109.492 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -93.91 -10.23 1.62 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.033 2.489 . . . . 0.0 113.226 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.27 139.65 51.73 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.734 1.214 . . . . 0.0 109.114 -171.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 12.12 8.19 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.283 0.633 . . . . 0.0 112.602 -160.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.53 158.25 36.44 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 170.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -67.84 159.28 30.69 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -132.83 145.22 50.77 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 m -118.41 77.69 1.19 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.312 1.445 . . . . 0.0 107.529 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.411 ' HA3' ' CZ2' ' A' ' 58' ' ' TRP . . . -72.2 132.54 19.03 Favored Glycine 0 N--CA 1.464 0.552 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 tp -149.49 70.76 1.08 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.207 1.003 . . . . 0.0 112.3 -166.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.96 164.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.444 0.64 . . . . 0.0 110.337 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -111.93 158.01 19.99 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.271 1.029 . . . . 0.0 108.566 168.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.69 146.35 43.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 127.147 2.179 . . . . 0.0 107.35 -173.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -157.26 168.7 26.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.099 1.359 . . . . 0.0 107.797 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.437 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 5.8 tt0 -119.16 164.77 15.09 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.683 1.129 . . . . 0.0 110.61 -170.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -45.17 -55.87 5.34 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.55 1.94 . . . . 0.0 111.853 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -126.52 -1.73 6.81 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.089 1.756 . . . . 0.0 111.136 -169.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.38 -177.99 3.97 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.828 1.651 . . . . 0.0 110.945 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.4 8.55 0.09 OUTLIER Glycine 0 C--O 1.226 -0.401 0 C-N-CA 118.546 -1.788 . . . . 0.0 115.508 -149.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -78.2 97.29 5.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 p -78.69 114.19 17.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -167.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.16 130.04 35.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.7 m -83.4 125.51 31.76 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 165.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.431 HD11 ' CE1' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -118.94 104.16 10.25 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.969 1.708 . . . . 0.0 106.508 -177.032 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -119.67 95.02 4.6 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.086 0.954 . . . . 0.0 109.797 -166.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.2 114.65 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 79.5 t -104.19 101.33 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.05 156.8 79.65 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.705 -177.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.85 -163.19 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.624 1 C-N-CA 126.589 4.859 . . . . 0.0 110.814 172.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.12 168.2 27.12 Favored Glycine 0 N--CA 1.445 -0.711 0 O-C-N 120.658 -1.276 . . . . 0.0 113.708 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -111.14 173.64 6.24 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.2 1.8 . . . . 0.0 110.159 175.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.25 92.56 2.12 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 170.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 t -138.39 -174.51 3.83 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.656 0.782 . . . . 0.0 109.364 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.7 mp -82.64 76.86 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 126.238 1.815 . . . . 0.0 108.528 175.45 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.894 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -64.6 88.74 0.06 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.852 1.261 . . . . 0.0 111.439 -172.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -140.57 158.45 43.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.299 1.84 . . . . 0.0 106.375 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.23 0.72 85.94 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.846 -0.974 . . . . 0.0 112.747 175.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 m -55.27 144.55 50.66 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-N 118.75 1.275 . . . . 0.0 109.905 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.08 155.23 70.66 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.703 1.602 . . . . 0.0 109.307 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.52 147.77 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -136.37 110.26 8.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 165.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -79.29 153.59 29.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 163.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -121.7 117.9 27.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -137.96 60.56 1.62 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.913 0.863 . . . . 0.0 110.951 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 p -154.41 -167.44 2.62 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.45 1.1 . . . . 0.0 109.075 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -65.3 -179.6 0.62 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.375 0.67 . . . . 0.0 111.262 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.56 -28.15 12.34 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 121.316 -0.865 . . . . 0.0 111.573 162.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.89 12.2 2.45 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.354 0.662 . . . . 0.0 111.874 -165.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.71 -67.66 0.14 Allowed Glycine 0 C--N 1.335 0.512 0 O-C-N 121.254 -0.904 . . . . 0.0 113.537 -152.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.38 -126.66 2.85 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -153.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.1 p -144.16 3.63 1.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -171.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 m -162.96 174.53 12.22 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.333 1.424 . . . . 0.0 111.175 174.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 144.1 50.13 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 128.016 2.527 . . . . 0.0 113.962 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -141.6 146.76 36.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.352 1.461 . . . . 0.0 108.139 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -136.77 163.13 31.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.174 -0.954 . . . . 0.0 110.702 157.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -135.88 76.19 53.54 Favored Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.21 171.99 10.68 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.493 2.129 . . . . 0.0 109.213 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -160.54 0.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -153.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -165.9 -73.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.7 t -165.24 97.27 0.71 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.483 1.913 . . . . 0.0 106.879 167.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -123.74 24.49 8.41 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 168.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.83 155.03 40.87 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 166.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.87 -151.12 22.28 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.2 m -135.27 102.55 5.21 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.012 0.906 . . . . 0.0 112.659 -173.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -123.32 -164.63 1.23 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.628 1.171 . . . . 0.0 113.201 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 mt -138.13 158.35 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 127.711 2.405 . . . . 0.0 107.2 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 98.2 mt -132.89 173.1 11.75 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.086 1.755 . . . . 0.0 111.016 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -109.63 88.04 2.65 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.042 -1.037 . . . . 0.0 110.363 -156.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.425 ' CG2' ' HE3' ' A' ' 90' ' ' LYS . 6.6 mt -129.88 158.51 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.646 1.178 . . . . 0.0 109.712 -163.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 m -122.93 142.53 50.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.308 1.043 . . . . 0.0 109.68 -172.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 p -159.99 36.35 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.668 -0.645 . . . . 0.0 112.679 -161.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -128.51 169.3 14.52 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.339 -1.476 . . . . 0.0 110.955 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.8 121.16 38.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.98 1.312 . . . . 0.0 107.49 170.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -90.77 139.81 30.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.0 t -164.91 133.13 3.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 50.0 -98.0 0.02 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.986 1.279 . . . . 0.0 110.845 -173.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -130.43 21.34 5.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.28 1.032 . . . . 0.0 112.27 -164.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 t -148.64 176.72 10.11 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.315 1.416 . . . . 0.0 111.29 167.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 p -136.94 91.87 2.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.65 1.98 . . . . 0.0 109.593 -173.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.49 104.27 5.14 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.65 146.9 44.22 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 172.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.3 mt -117.93 149.03 41.58 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.073 0.949 . . . . 0.0 110.497 -175.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.1 m -65.64 164.58 14.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.495 164.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -144.47 173.81 11.47 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.101 1.36 . . . . 0.0 110.081 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -135.37 175.01 9.98 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.013 0.925 . . . . 0.0 109.778 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.48 152.09 39.23 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 125.531 1.532 . . . . 0.0 109.066 172.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.28 140.15 8.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.58 -127.72 1.66 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' H ' HG12 ' A' ' 81' ' ' VAL . 3.3 m-20 -61.73 162.35 8.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.941 2.096 . . . . 0.0 111.939 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.21 -18.64 57.58 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.353 1.861 . . . . 0.0 114.23 -168.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -121.22 15.01 11.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.291 1.836 . . . . 0.0 111.682 -165.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.7 mt -118.06 85.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.992 -2.595 . . . . 0.0 103.992 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -83.41 137.5 33.9 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.3 89.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -77.96 86.42 4.16 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -172.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.07 -104.42 0.88 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -97.61 -7.44 31.11 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.277 1.031 . . . . 0.0 113.089 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 m -83.69 164.56 19.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.696 1.135 . . . . 0.0 109.949 174.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.92 158.34 35.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.749 1.62 . . . . 0.0 108.274 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.8 t -156.42 158.53 37.47 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.156 1.782 . . . . 0.0 107.256 166.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -156.98 168.63 26.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 163.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.49 159.15 42.01 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.865 1.266 . . . . 0.0 107.818 -177.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -71.34 164.29 26.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.195 0.997 . . . . 0.0 113.15 -174.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -77.13 144.61 71.86 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.604 1.562 . . . . 0.0 108.623 168.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -90.13 -4.63 5.13 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.649 3.566 . . . . 0.0 113.648 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.98 161.58 13.93 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.173 -0.954 . . . . 0.0 109.927 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.55 62.93 0.85 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 123.334 1.54 . . . . 0.0 107.846 174.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -132.56 176.72 8.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.766 167.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -76.95 157.5 31.25 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 167.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.9 tpt85 -150.5 173.42 14.09 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 t -149.4 165.8 30.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 158.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.6 176.66 20.93 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 156.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tp -157.61 65.48 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.07 0.935 . . . . 0.0 113.109 177.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 56' ' ' ASP . 2.9 m -76.62 171.76 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 121.123 -0.985 . . . . 0.0 111.071 -172.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -123.38 164.74 18.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.78 1.632 . . . . 0.0 108.48 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.04 170.65 11.53 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.817 1.247 . . . . 0.0 109.223 173.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -153.32 172.93 16.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.859 0.864 . . . . 0.0 109.651 161.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -111.7 172.23 7.02 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.379 0.991 . . . . 0.0 110.807 -176.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -56.63 -51.3 69.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.327 1.051 . . . . 0.0 112.153 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -111.17 -42.62 3.9 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.719 0.808 . . . . 0.0 109.766 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.4 -169.65 0.43 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.177 1.391 . . . . 0.0 111.301 -171.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -132.22 42.32 1.4 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 126.117 1.818 . . . . 0.0 109.023 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.425 ' HE3' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -58.34 97.61 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 117.78 0.79 . . . . 0.0 108.942 174.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -110.88 110.8 21.55 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.9 165.77 11.79 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 168.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.0 t -127.13 144.65 50.98 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.389 1.476 . . . . 0.0 107.891 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.83 104.38 8.01 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.606 1.562 . . . . 0.0 108.995 -170.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -116.94 101.4 8.48 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.373 0.669 . . . . 0.0 109.881 -169.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -98.01 86.67 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.48 88.57 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.94 158.77 41.4 Favored Pre-proline 0 C--O 1.24 0.596 0 C-N-CA 124.125 0.97 . . . . 0.0 111.577 -165.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.36 -163.39 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 124.312 3.341 . . . . 0.0 109.377 160.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.92 166.96 29.93 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 171.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.55 177.08 11.78 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.469 1.108 . . . . 0.0 110.404 -176.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.3 p -149.02 96.47 2.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 164.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.57 172.73 12.59 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.69 0.796 . . . . 0.0 111.288 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.6 pt -83.84 33.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 125.007 1.323 . . . . 0.0 109.913 166.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 117.18 -1.39 . . . . 0.0 107.809 163.657 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.941 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -63.93 164.42 10.38 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 141.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.0 ttt -156.43 155.07 31.46 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.28 96.75 1.25 Allowed Glycine 0 CA--C 1.52 0.395 0 N-CA-C 107.66 -2.176 . . . . 0.0 107.66 167.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.8 p -152.2 149.01 22.13 Favored Pre-proline 0 C--O 1.238 0.49 0 CA-C-N 117.982 0.891 . . . . 0.0 109.533 169.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.5 154.06 75.42 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.083 1.855 . . . . 0.0 108.607 167.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.02 129.6 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -79.72 127.19 31.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 168.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -108.75 152.53 24.72 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.278 0.945 . . . . 0.0 109.646 161.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -129.29 125.18 36.23 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.099 1.76 . . . . 0.0 106.91 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.96 23.42 0.5 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.618 1.967 . . . . 0.0 110.478 -169.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.4 p -149.68 174.08 12.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.3 1.04 . . . . 0.0 110.777 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -75.69 160.31 30.2 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.896 0.878 . . . . 0.0 112.482 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.87 -50.3 15.45 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.804 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -141.22 55.23 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.85 3.11 0.26 Allowed Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.394 -1.276 . . . . 0.0 113.593 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.25 -119.63 6.77 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 119.212 1.506 . . . . 0.0 110.977 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.94 5.58 2.83 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.124 0.962 . . . . 0.0 113.245 -173.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.7 162.51 39.8 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.472 0.709 . . . . 0.0 109.535 170.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.429 ' CD2' ' HG ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -112.71 139.76 48.05 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.065 1.746 . . . . 0.0 108.047 -175.564 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.2 m -146.9 89.19 1.79 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -91.49 136.16 33.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -118.98 64.37 6.59 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-O 118.678 -0.677 . . . . 0.0 110.307 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.11 -174.19 1.3 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.378 2.052 . . . . 0.0 111.462 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -117.17 -163.46 0.92 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.689 2.396 . . . . 0.0 109.935 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.06 -18.26 63.17 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.727 1.611 . . . . 0.0 112.391 -174.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.0 m -153.09 65.27 0.77 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.259 1.39 . . . . 0.0 112.185 178.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 t -150.95 24.89 0.74 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.16 167.68 4.85 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.092 -1.005 . . . . 0.0 110.495 159.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.01 -152.17 22.96 Favored Glycine 0 C--N 1.341 0.809 0 O-C-N 121.333 -0.854 . . . . 0.0 111.359 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -135.1 100.71 4.64 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.306 1.442 . . . . 0.0 111.017 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -118.83 -177.82 3.41 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.102 1.361 . . . . 0.0 112.717 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 mt -126.82 147.88 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.2 mt -119.49 173.98 6.66 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 127.013 2.125 . . . . 0.0 109.892 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -101.96 51.34 0.83 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 123.553 1.644 . . . . 0.0 109.928 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.0 mt -72.09 139.36 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.428 1.491 . . . . 0.0 107.199 174.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 m -113.37 132.47 55.59 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.9 t -152.49 72.69 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -167.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -158.21 172.73 17.86 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.49 -1.381 . . . . 0.0 111.372 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 146.43 42.76 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.813 0.845 . . . . 0.0 111.225 164.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -123.03 131.3 53.64 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.308 1.843 . . . . 0.0 109.027 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 t -165.89 171.4 12.73 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 105.685 -1.969 . . . . 0.0 105.685 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.49 -103.67 0.06 OUTLIER Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.526 1.536 . . . . 0.0 112.21 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -138.19 18.17 2.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.226 1.41 . . . . 0.0 111.697 -171.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 t -144.81 177.73 8.51 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.583 -1.323 . . . . 0.0 111.16 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.3 p -137.85 121.84 17.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.062 1.345 . . . . 0.0 109.081 167.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -93.22 118.54 31.37 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.9 156.9 28.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.3 0.64 . . . . 0.0 111.401 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 98.1 mt -120.31 133.8 55.39 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.541 1.136 . . . . 0.0 111.452 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.5 p -69.18 168.98 12.92 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.78 0.832 . . . . 0.0 109.498 164.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -144.09 166.16 25.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.033 0.933 . . . . 0.0 108.905 166.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -133.21 156.56 47.28 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.154 1.781 . . . . 0.0 108.203 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.68 141.24 25.47 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.989 1.316 . . . . 0.0 110.679 -166.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.84 157.92 8.54 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 119.576 1.08 . . . . 0.0 112.286 161.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.8 -100.69 0.15 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.075 1.797 . . . . 0.0 110.441 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.7 157.74 2.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.198 1.399 . . . . 0.0 109.939 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -79.4 -29.44 42.01 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.978 -1.076 . . . . 0.0 112.759 174.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -90.79 16.14 9.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.871 0.868 . . . . 0.0 111.742 -168.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mt -137.55 127.72 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -136.62 150.59 48.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.7 t -137.12 125.75 34.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -85.76 -178.6 6.66 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.916 0.887 . . . . 0.0 109.57 173.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.11 -8.53 43.62 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.989 -1.07 . . . . 0.0 114.435 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.7 p -144.86 -21.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.796 1.298 . . . . 0.0 113.12 166.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.1 m -104.02 156.87 17.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.046 1.294 . . . . 0.0 112.162 -168.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 t -95.63 158.64 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 126.417 1.887 . . . . 0.0 107.639 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.57 142.7 18.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.878 0.871 . . . . 0.0 108.881 163.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -148.74 148.5 30.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 161.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.58 -177.85 6.04 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.953 1.701 . . . . 0.0 109.058 174.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -119.29 165.97 13.6 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.284 1.034 . . . . 0.0 110.313 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.84 144.85 40.07 Favored Pre-proline 0 N--CA 1.453 -0.298 0 C-N-CA 124.147 0.979 . . . . 0.0 110.688 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -82.99 -6.06 11.32 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.68 3.586 . . . . 0.0 113.206 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.31 169.92 17.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.706 -0.621 . . . . 0.0 111.341 -164.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.23 1.87 14.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.602 173.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.21 135.49 46.1 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 165.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -72.26 167.1 21.09 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.331 1.052 . . . . 0.0 109.18 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 -130.4 161.72 30.74 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.515 -0.741 . . . . 0.0 109.255 165.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 46.1 m -137.68 84.13 2.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.45 142.43 48.31 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.1 tp -159.68 72.29 0.52 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 118.984 1.392 . . . . 0.0 112.388 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.24 173.6 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.183 -0.948 . . . . 0.0 109.99 167.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.9 m -117.69 153.02 34.07 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 164.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 mp -125.24 165.69 17.83 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.926 1.291 . . . . 0.0 109.464 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -157.21 161.7 39.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.051 1.74 . . . . 0.0 108.124 173.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -105.99 169.4 8.52 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.075 1.35 . . . . 0.0 109.852 -164.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.71 -48.97 65.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -118.75 -18.73 8.88 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.2 m -97.53 -167.82 1.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.766 1.226 . . . . 0.0 108.497 162.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.79 31.0 0.15 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 119.21 -0.772 . . . . 0.0 111.427 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.89 112.72 1.96 Allowed 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 168.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 p -79.51 114.18 18.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.9 mp -88.57 165.96 14.47 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.313 1.045 . . . . 0.0 109.028 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.81 125.29 20.55 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.999 1.72 . . . . 0.0 107.838 174.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.429 ' HG ' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -93.12 86.02 5.25 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.328 1.451 . . . . 0.0 107.412 178.35 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -72.09 137.55 47.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.339 -1.476 . . . . 0.0 108.566 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 mp -130.62 116.53 35.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 162.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 68.6 t -116.0 71.81 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -106.12 154.41 39.62 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 121.571 -0.706 . . . . 0.0 110.711 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.76 174.64 6.31 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.655 2.903 . . . . 0.0 113.529 -172.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.57 113.63 3.68 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -62.44 123.85 19.37 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.778 0.789 . . . . 0.0 110.006 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.65 91.15 1.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 165.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.9 m -138.14 168.55 19.5 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.67 1.188 . . . . 0.0 110.624 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.9 tp -81.83 66.75 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.133 1.373 . . . . 0.0 107.93 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 123.777 0.831 . . . . 0.0 109.128 -167.75 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.188 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -149.59 172.6 14.77 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.7 ptp -154.84 -172.33 4.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.534 1.534 . . . . 0.0 108.3 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.59 84.56 0.06 OUTLIER Glycine 0 C--N 1.331 0.282 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.7 m -134.61 156.74 78.47 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-O 119.764 -0.16 . . . . 0.0 111.197 -154.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.2 -172.7 1.57 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.298 3.332 . . . . 0.0 111.328 172.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 p -86.79 156.34 3.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.164 1.386 . . . . 0.0 108.412 169.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 m -113.31 99.54 7.87 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 163.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -74.27 153.17 39.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 161.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -128.1 116.75 20.45 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.08 46.54 1.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.725 1.21 . . . . 0.0 108.983 -170.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 m -154.28 -178.37 7.08 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.107 0.963 . . . . 0.0 110.188 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -74.22 -170.81 1.03 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.498 0.666 . . . . 0.0 109.59 169.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.0 40.14 3.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.667 1.987 . . . . 0.0 109.733 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -156.43 -1.05 0.13 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -161.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.41 -7.42 46.88 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 117.418 -1.768 . . . . 0.0 115.319 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.41 174.11 15.16 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 120.504 2.152 . . . . 0.0 114.035 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.3 p -136.34 44.3 2.42 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.417 1.487 . . . . 0.0 111.054 -176.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.82 165.16 9.86 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.787 -1.195 . . . . 0.0 108.537 165.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.14 141.04 43.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.99 1.316 . . . . 0.0 107.84 165.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.9 m -147.28 146.72 29.85 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 164.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -140.32 157.75 45.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.545 0.688 . . . . 0.0 110.818 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -132.73 66.24 76.09 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.594 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.24 175.32 4.11 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.069 3.179 . . . . 0.0 111.881 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.47 -171.6 2.16 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.968 0.907 . . . . 0.0 110.183 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.69 11.83 0.17 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.062 2.545 . . . . 0.0 115.117 -162.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.1 m -150.52 5.68 0.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.792 1.637 . . . . 0.0 113.635 171.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -95.26 86.94 4.68 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.296 1.407 . . . . 0.0 112.023 -166.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.77 158.48 43.85 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.629 -0.669 . . . . 0.0 112.499 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.86 -149.2 15.61 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 161.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -124.13 113.41 18.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.608 1.163 . . . . 0.0 109.946 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -116.98 -166.75 1.2 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.244 1.018 . . . . 0.0 112.915 176.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.0 mt -132.14 157.08 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 128.067 2.547 . . . . 0.0 106.606 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.0 mt -131.06 172.49 12.03 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.668 1.987 . . . . 0.0 108.764 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -116.13 31.91 6.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.671 1.189 . . . . 0.0 111.918 -173.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.2 mt -52.96 147.91 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.911 2.085 . . . . 0.0 109.98 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 m -113.17 117.36 31.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.342 1.457 . . . . 0.0 107.994 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.9 t -141.46 82.21 1.81 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -153.95 169.21 24.0 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.294 -0.879 . . . . 0.0 111.34 175.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.94 129.6 51.78 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.516 1.527 . . . . 0.0 107.824 173.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -118.06 128.65 54.96 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -174.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 t -168.5 148.22 4.5 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.95 -107.09 0.57 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 125.416 1.484 . . . . 0.0 110.078 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -135.67 28.05 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.215 1.406 . . . . 0.0 110.084 -170.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.1 m -142.82 157.96 44.1 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.904 0.859 . . . . 0.0 111.165 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -123.84 124.71 43.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.477 1.911 . . . . 0.0 106.004 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -97.89 115.26 27.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 166.873 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.98 130.39 45.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 164.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.89 118.39 26.25 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 167.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 m -67.48 168.49 10.79 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 124.535 1.147 . . . . 0.0 109.541 164.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -150.09 175.46 11.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.797 1.639 . . . . 0.0 107.969 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -132.16 170.48 14.94 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 161.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.46 151.42 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.231 1.012 . . . . 0.0 108.892 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 p -158.98 141.43 14.06 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.989 -0.444 . . . . 0.0 109.815 -172.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.95 -105.1 0.23 Allowed Glycine 0 CA--C 1.52 0.375 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.68 161.62 20.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.381 1.473 . . . . 0.0 111.46 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 m -73.29 -51.83 16.12 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 126.116 1.766 . . . . 0.0 111.617 174.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -72.69 21.15 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.569 2.348 . . . . 0.0 113.21 -166.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.8 mt -133.63 140.5 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -127.17 132.12 50.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.8 t -139.85 110.1 4.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.41 87.0 1.85 Allowed 'General case' 0 N--CA 1.462 0.129 0 O-C-N 121.276 -0.89 . . . . 0.0 109.133 -172.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 47.07 -113.02 1.08 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.591 1.091 . . . . 0.0 110.979 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.9 m -79.81 36.92 0.34 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.834 1.653 . . . . 0.0 113.393 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.9 t -152.86 155.08 36.4 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 120.609 -1.307 . . . . 0.0 109.416 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 t -148.38 149.22 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.76 159.62 44.41 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.853 0.751 . . . . 0.0 110.724 163.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.525 ' CD1' HD11 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -142.83 127.2 17.73 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.151 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -81.2 160.27 24.37 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.308 1.052 . . . . 0.0 110.565 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.536 ' CD ' ' HE2' ' A' ' 101' ' ' LYS . 1.7 mt-10 -72.45 165.19 25.09 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 167.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -86.59 164.65 36.65 Favored Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 121.093 -1.005 . . . . 0.0 110.848 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.68 -8.19 5.26 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.242 3.294 . . . . 0.0 113.536 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.87 156.68 47.1 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.088 0.858 . . . . 0.0 110.142 -170.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -92.07 22.32 4.43 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.092 1.357 . . . . 0.0 112.105 -169.615 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -98.64 151.09 21.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -72.46 135.82 45.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.944 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 -113.6 123.5 50.12 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 171.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.3 m -76.55 104.32 7.0 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 155.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.51 142.13 45.61 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 163.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.95 131.43 25.32 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 164.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -139.45 143.39 31.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 165.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.4 m -113.56 156.56 23.41 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.628 1.571 . . . . 0.0 107.236 170.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 92' ' ' LEU . 0.6 OUTLIER -133.85 162.54 31.74 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.66 1.184 . . . . 0.0 110.78 172.002 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -146.06 127.7 15.19 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.549 0.613 . . . . 0.0 109.757 174.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -65.2 156.49 31.63 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.006 1.323 . . . . 0.0 111.45 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -50.16 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.763 2.825 . . . . 0.0 112.281 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -72.27 -25.16 61.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.939 1.296 . . . . 0.0 111.092 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.7 -153.15 0.5 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.991 2.117 . . . . 0.0 109.119 -164.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.69 13.74 0.02 OUTLIER Glycine 0 C--N 1.335 0.473 0 CA-C-O 117.158 -1.912 . . . . 0.0 116.595 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -62.86 98.05 0.12 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.609 2.205 . . . . 0.0 106.531 157.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.6 p -65.42 166.92 9.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HB2' HD21 ' A' ' 83' ' ' LEU . 27.7 mt -132.17 144.06 50.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 170.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 m -84.79 129.08 34.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 167.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 34.5 tp -97.52 127.39 43.44 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 156.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -136.64 117.38 14.03 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 68' ' ' TYR . 2.5 mp -109.42 124.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 169.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.9 t -111.97 92.59 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.81 158.5 35.5 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.872 -171.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -69.73 -164.58 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 125.186 3.924 . . . . 0.0 111.726 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.59 161.93 30.45 Favored Glycine 0 C--N 1.334 0.426 0 O-C-N 120.364 -1.46 . . . . 0.0 111.975 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.536 ' HE2' ' CD ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -144.64 175.82 9.88 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.088 1.355 . . . . 0.0 111.254 -173.284 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 p -163.35 86.36 0.52 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.595 1.558 . . . . 0.0 107.283 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.72 -178.6 7.15 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.238 1.381 . . . . 0.0 110.669 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.2 mt -81.96 86.15 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t0 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.073 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -73.59 160.13 32.08 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 160.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.85 158.88 41.41 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.6 1.16 . . . . 0.0 108.372 170.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.51 145.56 12.63 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.0 p -169.01 164.31 7.28 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 123.708 0.803 . . . . 0.0 109.168 -166.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.74 176.92 8.24 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.85 2.367 . . . . 0.0 110.894 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.0 t -81.51 106.78 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.975 -0.453 . . . . 0.0 110.386 -177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 m -101.24 118.6 37.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.679 1.592 . . . . 0.0 109.672 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -89.1 141.53 28.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.544 0.738 . . . . 0.0 109.314 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -105.1 138.44 41.3 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.601 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 3.9 p90 -153.73 56.17 0.74 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.349 -170.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.6 p -159.45 -172.42 3.71 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.65 -1.281 . . . . 0.0 109.305 170.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -67.92 157.33 35.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.033 1.288 . . . . 0.0 108.172 165.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.74 -12.34 22.4 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.872 1.269 . . . . 0.0 110.603 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.68 74.98 1.47 Allowed 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 153.44 -85.88 0.14 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 159.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -164.61 -123.29 0.64 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -158.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -138.18 28.78 2.53 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.602 0.701 . . . . 0.0 111.072 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.47 144.0 10.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.017 1.281 . . . . 0.0 109.764 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -96.3 148.37 22.82 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 162.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.3 m -142.54 137.88 30.48 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 159.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -112.39 144.12 42.36 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 168.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.62 71.57 38.97 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.02 177.79 6.06 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.423 2.082 . . . . 0.0 111.194 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -151.18 176.77 10.86 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.612 1.165 . . . . 0.0 108.097 173.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 56.51 -74.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.28 2.632 . . . . 0.0 114.184 -172.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.2 t -176.89 82.16 0.02 OUTLIER 'General case' 0 C--O 1.236 0.365 0 C-N-CA 129.002 2.921 . . . . 0.0 105.396 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -132.43 65.83 1.57 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -172.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.83 175.25 6.42 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.767 1.627 . . . . 0.0 110.285 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.06 -162.41 36.22 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 119.612 1.097 . . . . 0.0 112.667 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.0 p -135.69 95.65 3.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.877 1.271 . . . . 0.0 110.093 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -114.3 -177.06 3.04 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.959 0.903 . . . . 0.0 111.992 -173.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.9 mt -127.47 120.42 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.02 172.34 9.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.45 1.1 . . . . 0.0 109.006 171.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -106.08 36.86 2.43 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.905 -1.122 . . . . 0.0 109.546 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.89 134.95 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.067 -1.021 . . . . 0.0 108.346 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.9 138.8 37.23 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.8 p -167.87 83.37 0.19 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -153.76 170.97 19.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.26 120.77 39.99 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 171.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -96.0 146.26 24.76 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.946 0.879 . . . . 0.0 109.193 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.57 176.89 11.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.22 -52.72 8.24 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.142 1.353 . . . . 0.0 112.844 -168.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -131.04 23.71 4.92 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.702 0.801 . . . . 0.0 111.717 -172.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -144.3 150.95 38.68 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 122.462 1.125 . . . . 0.0 109.158 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 p -148.04 85.72 1.55 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.691 1.996 . . . . 0.0 107.688 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -73.9 127.78 33.78 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 166.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.03 164.7 23.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 166.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.55 132.3 54.25 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 126.324 1.85 . . . . 0.0 107.146 164.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.1 m -77.05 174.2 10.93 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.877 0.846 . . . . 0.0 110.069 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -149.87 171.53 16.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.219 1.808 . . . . 0.0 107.932 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.08 174.91 10.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.377 1.871 . . . . 0.0 107.444 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.62 167.67 20.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.593 1.157 . . . . 0.0 109.723 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.0 p -156.41 148.93 23.59 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.633 1.173 . . . . 0.0 108.801 160.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.75 -141.8 8.05 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.543 1.544 . . . . 0.0 109.806 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.62 133.22 46.54 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.307 1.043 . . . . 0.0 110.26 -173.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 m -69.78 3.43 2.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.273 1.829 . . . . 0.0 115.019 -167.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.9 p-90 -117.96 13.74 14.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.121 2.169 . . . . 0.0 111.305 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.4 mt -129.14 99.0 4.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -91.65 144.35 25.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.94 143.23 40.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 166.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.68 172.05 9.59 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.721 2.008 . . . . 0.0 107.108 172.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.45 -15.24 3.98 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.434 1.492 . . . . 0.0 116.336 -167.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.78 4.3 0.75 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.781 1.232 . . . . 0.0 112.82 168.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -128.0 153.42 46.77 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.586 1.539 . . . . 0.0 110.56 -163.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.88 156.54 24.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.079 1.352 . . . . 0.0 108.247 -173.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.98 150.49 34.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 153.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.35 155.11 43.65 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 146.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.0 176.04 5.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.266 166.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -86.44 168.37 13.83 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.768 0.794 . . . . 0.0 110.107 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -70.91 165.46 46.94 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.312 1.045 . . . . 0.0 110.176 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -95.3 -4.36 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.191 2.594 . . . . 0.0 114.293 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.32 166.04 25.59 Favored 'General case' 0 C--O 1.225 -0.228 0 O-C-N 121.362 -0.836 . . . . 0.0 111.834 -172.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 30.94 0.49 Allowed 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.621 -1.299 . . . . 0.0 112.044 -175.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -101.85 -175.96 2.99 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.373 1.069 . . . . 0.0 109.363 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -113.66 127.26 55.98 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 124.389 1.076 . . . . 0.0 111.705 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -159.22 103.19 1.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.816 0.846 . . . . 0.0 109.675 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.6 t -64.76 149.66 48.85 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 155.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.39 177.07 43.82 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 154.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tp -162.24 85.37 0.58 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.767 0.827 . . . . 0.0 109.803 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 m -79.9 169.83 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.217 -0.927 . . . . 0.0 111.123 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.6 m -116.74 153.33 32.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.026 2.131 . . . . 0.0 107.348 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 mp -135.95 163.01 31.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.668 1.187 . . . . 0.0 111.168 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -144.34 143.79 31.14 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.012 1.725 . . . . 0.0 108.003 167.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -79.16 165.96 22.74 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.401 1.48 . . . . 0.0 107.659 165.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.8 -83.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -81.89 -18.21 44.55 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.006 -1.684 . . . . 0.0 112.269 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.11 -162.51 0.94 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.28 26.04 0.24 Allowed Glycine 0 C--O 1.225 -0.424 0 O-C-N 119.66 -1.9 . . . . 0.0 110.919 -168.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 11' ' ' PHE . 12.1 ttpp -47.97 129.93 14.95 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 127.749 2.419 . . . . 0.0 107.447 164.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 52.1 p -118.79 137.66 53.23 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.6 mt -139.49 155.47 47.54 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -102.03 160.17 14.73 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.974 0.91 . . . . 0.0 109.14 164.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tt -136.2 91.29 2.66 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -85.69 147.2 26.47 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.7 mt -137.18 80.09 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.98 93.75 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -171.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -117.18 160.5 37.12 Favored Pre-proline 0 C--O 1.242 0.685 0 C-N-CA 123.637 0.775 . . . . 0.0 110.525 -165.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -62.15 174.93 2.23 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.75 2.3 . . . . 0.0 109.912 165.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.96 162.81 23.12 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 163.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -145.84 150.21 35.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.378 1.071 . . . . 0.0 108.487 -173.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.4 p -153.11 87.93 1.29 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -136.53 -167.3 2.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.435 0.561 . . . . 0.0 110.727 -177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.2 mm -94.46 71.03 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--O 1.248 1.005 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -161.178 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.9 m -132.1 123.96 28.2 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 170.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -88.4 155.41 19.71 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.71 118.35 24.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.971 2.108 . . . . 0.0 105.823 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -150.15 67.98 0.98 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.952 0.901 . . . . 0.0 110.226 -166.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -152.27 -169.33 3.32 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.026 1.33 . . . . 0.0 109.029 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -77.99 -89.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 166.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -164.67 -41.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.424 1.49 . . . . 0.0 110.846 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -107.39 74.75 0.98 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.53 72.91 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 112.999 -1.91 . . . . 0.0 113.408 147.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -153.13 169.93 32.06 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-O 122.746 1.192 . . . . 0.0 112.924 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -135.67 13.7 3.43 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.089 1.756 . . . . 0.0 110.474 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p -152.98 125.86 8.4 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 120.499 -1.375 . . . . 0.0 112.833 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.65 153.37 23.51 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.688 1.195 . . . . 0.0 110.283 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.5 m -146.88 143.61 28.67 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.988 2.115 . . . . 0.0 105.75 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.77 152.14 50.82 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.15 0.886 . . . . 0.0 109.758 170.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -134.16 67.52 73.2 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.587 -0.72 . . . . 0.0 109.171 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.59 179.53 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.308 2.005 . . . . 0.0 112.029 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -149.1 174.9 11.83 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.8 t0 56.31 -85.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 129.112 2.965 . . . . 0.0 111.172 170.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -153.66 106.25 2.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.265 1.826 . . . . 0.0 106.363 161.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -135.43 107.7 7.26 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.129 -1.607 . . . . 0.0 111.017 167.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.56 150.29 35.22 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.635 1.974 . . . . 0.0 108.546 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.38 -169.5 40.53 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.3 p -100.99 120.57 40.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.836 1.655 . . . . 0.0 110.256 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -127.12 -173.86 3.01 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.712 0.805 . . . . 0.0 113.065 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.5 mt -129.13 155.47 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 127.219 2.207 . . . . 0.0 106.265 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 53.8 mt -135.83 149.68 49.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.996 1.271 . . . . 0.0 112.808 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -78.59 87.49 4.54 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.836 1.655 . . . . 0.0 108.941 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mt -123.69 152.69 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.71 1.204 . . . . 0.0 107.958 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 m -121.64 133.85 54.98 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.474 1.109 . . . . 0.0 109.072 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.2 t -157.08 81.71 0.92 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.17 0.988 . . . . 0.0 108.522 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -152.27 170.8 19.14 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.094 -1.004 . . . . 0.0 110.044 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.53 126.79 50.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 167.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -98.02 131.17 44.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -170.14 162.35 8.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.2 -113.35 2.86 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -141.22 51.55 1.59 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.298 1.439 . . . . 0.0 107.337 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 t -155.15 165.58 36.25 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.61 1.564 . . . . 0.0 109.151 -170.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.4 p -134.71 102.32 5.24 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -71.23 118.34 13.89 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 164.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.37 163.82 10.06 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.705 0.764 . . . . 0.0 109.955 166.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.5 mt -134.89 129.36 34.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.051 170.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.8 m -59.78 163.47 4.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 122.551 1.167 . . . . 0.0 110.139 163.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -134.34 165.97 23.9 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.507 170.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.95 164.21 22.8 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.609 1.164 . . . . 0.0 108.811 173.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.53 168.77 22.58 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.465 1.506 . . . . 0.0 109.867 -169.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.405 ' C ' HG13 ' A' ' 81' ' ' VAL . 11.3 p 178.49 168.36 0.84 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.74 1.616 . . . . 0.0 110.572 161.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.62 -110.27 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.83 163.14 14.82 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.925 0.89 . . . . 0.0 110.376 168.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p -71.77 -38.96 70.27 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.353 1.461 . . . . 0.0 112.369 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -90.23 21.56 3.74 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.269 1.427 . . . . 0.0 112.831 -159.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.505 HG23 ' CD2' ' A' ' 68' ' ' TYR . 70.5 mt -130.54 133.14 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -170.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -132.42 132.53 42.89 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.372 1.069 . . . . 0.0 109.379 -164.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.81 135.62 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.834 0.826 . . . . 0.0 110.297 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.71 75.28 1.52 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.457 0.703 . . . . 0.0 109.154 172.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 55.02 -117.22 7.84 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m -77.94 51.04 0.92 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.06 0.944 . . . . 0.0 111.612 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.63 152.08 34.82 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.63 139.63 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.7 m -145.38 150.26 36.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 164.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.505 ' CD2' HG23 ' A' ' 59' ' ' ILE . 1.5 m-85 -139.46 119.19 13.19 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.53 161.91 29.3 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.473 1.509 . . . . 0.0 110.372 -174.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -86.25 146.18 26.63 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.488 -0.757 . . . . 0.0 110.79 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -66.58 144.47 98.65 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -158.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.79 -9.75 6.39 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.525 2.816 . . . . 0.0 115.432 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -151.98 170.08 20.74 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.593 1.157 . . . . 0.0 108.246 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -81.12 -12.39 59.26 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.775 0.83 . . . . 0.0 113.078 -164.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.44 165.14 2.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 123.775 0.672 . . . . 0.0 109.633 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -107.5 121.38 44.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 168.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -105.38 170.41 7.9 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 126.448 1.899 . . . . 0.0 108.039 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.4 m -104.77 109.9 22.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 155.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.85 139.09 36.0 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 163.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 tp -138.79 133.09 31.65 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.299 1.049 . . . . 0.0 109.93 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.488 HG21 HG21 ' A' ' 59' ' ' ILE . 2.8 t -142.49 148.37 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.075 0.852 . . . . 0.0 109.027 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 m -104.82 176.73 5.06 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.491 1.517 . . . . 0.0 109.116 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.7 165.24 34.03 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.82 1.248 . . . . 0.0 109.798 162.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -151.94 158.3 42.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.782 2.033 . . . . 0.0 108.815 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.474 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 26.5 tt0 -97.87 161.32 13.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.423 1.01 . . . . 0.0 110.309 -173.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.81 -69.06 0.15 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.646 1.179 . . . . 0.0 112.99 173.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -88.97 -12.53 41.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.638 1.108 . . . . 0.0 112.428 -176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.2 t -132.04 -153.23 0.54 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.852 1.661 . . . . 0.0 109.249 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.25 46.87 0.88 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -164.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.474 ' H ' ' HB2' ' A' ' 85' ' ' GLN 0.35 0.0 OUTLIER -68.18 92.29 0.4 Allowed 'General case' 0 C--N 1.341 0.239 0 CA-C-N 118.238 1.019 . . . . 0.0 108.967 179.546 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 p -96.47 133.44 40.91 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 174.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.88 161.41 26.62 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 166.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.44 125.01 52.59 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.15 132.09 53.42 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -128.49 143.92 51.06 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.524 1.53 . . . . 0.0 108.391 171.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 mp -135.45 117.42 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 168.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 69.6 t -107.31 94.57 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -106.34 144.08 28.27 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.09 156.88 62.48 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.208 1.939 . . . . 0.0 107.624 165.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.07 166.88 27.5 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 121.269 -0.491 . . . . 0.0 113.418 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.332 -0.18 0 C-N-CA 125.336 1.454 . . . . 0.0 109.636 -174.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 CA--C 1.533 0.322 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 m -102.02 101.98 12.43 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -76.53 154.57 34.44 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 168.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -137.63 120.92 16.93 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 128.124 2.57 . . . . 0.0 105.424 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -148.32 43.87 1.04 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.239 1.016 . . . . 0.0 110.255 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 p -141.83 -176.75 4.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.886 1.274 . . . . 0.0 109.673 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -176.5 0.97 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.868 -1.145 . . . . 0.0 111.856 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.03 -20.79 6.18 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 162.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.92 -6.85 59.0 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -161.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.07 64.18 0.43 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 167.06 -165.16 38.39 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 p -151.49 45.23 0.79 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.246 1.418 . . . . 0.0 112.691 170.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.75 179.11 6.76 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.209 -1.557 . . . . 0.0 109.692 169.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.1 113.8 14.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.113 1.765 . . . . 0.0 107.955 172.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.5 m -133.72 130.24 37.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.041 -1.836 . . . . 0.0 106.041 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -129.65 147.1 51.41 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -124.12 67.24 43.78 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HG2' ' HB3' ' A' ' 98' ' ' GLN . 98.5 Cg_endo -69.44 177.09 5.7 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.83 1.687 . . . . 0.0 110.879 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -143.47 173.92 11.21 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.891 1.677 . . . . 0.0 107.29 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 55.19 -85.25 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.688 1.995 . . . . 0.0 112.234 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.2 m -154.36 102.59 2.44 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.6 2.36 . . . . 0.0 107.977 156.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.4 m -131.62 88.84 2.62 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 119.909 1.231 . . . . 0.0 111.22 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.61 167.12 23.0 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.435 1.894 . . . . 0.0 110.177 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.52 -161.1 31.1 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 p -97.42 123.42 41.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.774 1.229 . . . . 0.0 109.078 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -139.32 -169.22 2.62 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.711 1.605 . . . . 0.0 110.219 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 mt -138.39 144.91 29.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.268 1.427 . . . . 0.0 107.232 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.5 mt -129.21 161.84 29.22 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.597 1.559 . . . . 0.0 107.456 170.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -114.91 103.24 10.74 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.995 0.816 . . . . 0.0 111.447 -163.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.3 138.7 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.83 1.652 . . . . 0.0 109.126 -172.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 m -91.34 110.92 22.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.242 1.417 . . . . 0.0 109.536 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.5 m -138.27 78.68 1.69 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -160.36 164.78 32.19 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.381 0.672 . . . . 0.0 111.345 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.24 151.83 29.16 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.073 0.949 . . . . 0.0 109.363 166.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -121.67 125.68 47.22 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 127.163 2.185 . . . . 0.0 108.917 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.6 t -167.44 162.45 14.57 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.108 0.963 . . . . 0.0 109.014 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.19 -101.69 0.21 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 125.982 1.753 . . . . 0.0 109.62 -172.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -142.57 35.97 1.46 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.904 1.281 . . . . 0.0 110.403 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 m -155.81 169.54 24.15 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.133 -0.98 . . . . 0.0 110.485 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -115.37 155.71 26.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 156.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -138.86 121.99 16.87 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 126.097 1.759 . . . . 0.0 106.537 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.88 158.11 28.81 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.713 0.633 . . . . 0.0 109.812 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.6 mt -121.61 140.9 51.66 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.6 m -67.41 170.68 7.02 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 124.68 1.237 . . . . 0.0 109.839 172.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -138.63 174.56 10.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.782 1.233 . . . . 0.0 109.011 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.29 150.81 26.27 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 156.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.43 145.79 49.29 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 156.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.7 m -155.31 124.33 6.19 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.86 -161.23 9.71 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -156.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.72 19.14 10.4 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -171.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m 76.36 8.05 3.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 130.018 3.327 . . . . 0.0 114.874 168.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -111.83 7.34 20.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.487 0.715 . . . . 0.0 112.435 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 mt -135.39 140.6 44.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -134.82 140.52 45.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.925 2.09 . . . . 0.0 107.736 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.3 t -141.89 109.69 2.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.23 172.36 8.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.191 1.396 . . . . 0.0 109.689 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.24 -12.73 25.43 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.531 1.062 . . . . 0.0 114.477 -174.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -156.35 34.85 0.32 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.85 1.325 . . . . 0.0 110.476 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 t -159.25 161.95 36.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.664 1.12 . . . . 0.0 109.722 -170.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.18 139.43 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.584 1.154 . . . . 0.0 109.712 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.7 m -143.11 154.6 44.09 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.26 -0.9 . . . . 0.0 109.073 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -145.1 154.32 42.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 160.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -92.46 -166.2 1.49 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.425 ' HG2' HE21 ' A' ' 98' ' ' GLN . 19.0 mt-10 -118.47 169.84 9.44 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 122.901 1.334 . . . . 0.0 109.293 168.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -82.56 154.19 68.46 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 125.959 1.704 . . . . 0.0 112.247 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -88.99 -4.52 6.06 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.968 3.112 . . . . 0.0 114.853 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.18 167.79 10.38 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.716 0.806 . . . . 0.0 109.153 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.62 -3.28 55.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.964 0.905 . . . . 0.0 112.889 -169.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.5 164.16 25.67 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.037 -0.414 . . . . 0.0 110.779 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -95.92 135.3 37.85 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.879 1.272 . . . . 0.0 107.998 173.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -145.32 119.02 9.17 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.5 m -59.02 123.61 17.15 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -70.93 153.73 51.54 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.5 tp -146.85 117.52 7.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.504 1.522 . . . . 0.0 108.251 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.7 p -135.62 165.64 29.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 126.528 1.931 . . . . 0.0 106.235 165.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 m -124.96 171.52 10.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.814 1.646 . . . . 0.0 106.924 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -145.83 156.66 43.71 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 121.507 -0.745 . . . . 0.0 109.275 153.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -147.21 134.88 21.06 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.184 1.394 . . . . 0.0 107.361 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.05 174.66 4.34 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.89 0.876 . . . . 0.0 112.03 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -63.56 -84.97 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.2 2.6 . . . . 0.0 111.365 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -74.68 -32.65 62.28 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.083 -1.011 . . . . 0.0 110.343 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m -78.4 -159.11 0.15 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.731 1.213 . . . . 0.0 111.122 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.84 18.04 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 N-CA-C 116.775 1.47 . . . . 0.0 116.775 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -63.8 170.6 3.27 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.284 2.042 . . . . 0.0 108.451 146.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.1 p -134.35 156.28 48.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.513 ' HB2' HD21 ' A' ' 83' ' ' LEU . 58.5 mt -113.75 167.48 10.59 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 163.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.4 m -135.49 117.84 15.68 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.77 122.62 33.67 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 172.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -128.53 91.63 3.27 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.431 HD12 ' H ' ' A' ' 96' ' ' ILE . 3.4 mp -83.98 122.27 37.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 169.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.15 91.09 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 165.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.425 HE21 ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -111.66 146.42 34.67 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.124 -176.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 175.52 10.16 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 125.142 3.895 . . . . 0.0 110.694 169.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.97 173.38 19.88 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.8 pttt . . . . . 0 C--O 1.231 0.114 0 C-N-CA 125.252 1.421 . . . . 0.0 111.486 -177.852 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 CA--C 1.535 0.389 0 CA-C-O 121.004 0.431 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -135.5 106.17 6.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.666 1.586 . . . . 0.0 107.182 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -83.85 153.88 23.78 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 172.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.63 146.28 52.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.399 1.88 . . . . 0.0 108.273 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -168.51 42.02 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.235 1.014 . . . . 0.0 111.819 -160.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.4 p -142.52 176.73 8.79 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.749 -1.22 . . . . 0.0 111.03 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -84.64 158.99 20.68 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 165.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.0 59.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.572 0.349 . . . . 0.0 111.829 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.09 -8.23 29.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.183 1.393 . . . . 0.0 113.24 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.33 2.66 21.44 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 124.382 0.991 . . . . 0.0 112.948 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.53 177.3 17.06 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 119.24 1.52 . . . . 0.0 112.23 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 p -117.63 25.68 10.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.328 1.051 . . . . 0.0 109.628 172.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.3 t -144.85 147.95 33.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.49 -0.756 . . . . 0.0 109.212 171.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -99.52 140.4 33.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.888 1.675 . . . . 0.0 107.581 166.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.3 m -142.13 92.32 2.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.654 -1.609 . . . . 0.0 106.654 168.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.17 152.9 36.54 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.058 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -129.54 83.79 63.71 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 168.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.51 170.57 19.07 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.726 2.951 . . . . 0.0 110.46 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -155.4 165.68 35.88 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.872 1.669 . . . . 0.0 107.457 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t70 66.62 -78.69 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.104 2.161 . . . . 0.0 113.576 158.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.3 m -75.91 5.48 6.41 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.475 1.488 . . . . 0.0 112.859 165.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.255 3.8 p 58.81 -163.8 0.21 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.333 1.453 . . . . 0.0 111.173 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.11 172.45 0.2 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.306 1.042 . . . . 0.0 112.465 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.51 -160.1 14.31 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.37 112.48 18.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -131.76 -168.88 2.1 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.278 1.431 . . . . 0.0 110.762 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.8 mt -134.66 111.38 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.993 1.717 . . . . 0.0 107.159 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 74.2 mt -82.51 158.11 23.3 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.565 1.146 . . . . 0.0 110.859 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.56 80.69 4.31 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.53 128.82 57.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -95.57 120.03 35.11 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.644 1.178 . . . . 0.0 108.758 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.1 p -147.64 93.61 2.24 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.831 0.742 . . . . 0.0 109.209 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -157.06 169.11 25.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.278 0.631 . . . . 0.0 109.413 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.21 120.14 30.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.403 1.481 . . . . 0.0 107.472 172.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -93.47 132.62 37.56 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 t -168.14 154.78 7.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 54.18 -101.26 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -144.97 53.05 1.21 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.597 1.189 . . . . 0.0 109.119 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.4 m -155.34 168.01 28.49 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.534 -1.354 . . . . 0.0 110.862 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.29 87.76 2.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.416 1.486 . . . . 0.0 107.848 169.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.29 116.0 7.58 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.79 153.04 44.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.23 138.78 52.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 168.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 m -84.23 177.08 8.34 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.691 0.619 . . . . 0.0 110.042 168.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . 0.604 ' HE1' HG21 ' A' ' 61' ' ' VAL . 36.4 p90 -132.9 169.91 16.09 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.829 1.252 . . . . 0.0 107.669 166.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -130.68 134.24 46.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.77 149.71 39.49 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.605 1.162 . . . . 0.0 109.614 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 p -165.33 144.78 6.64 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.525 0.679 . . . . 0.0 112.002 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.15 -119.15 1.19 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -47.97 147.39 2.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.904 2.082 . . . . 0.0 113.368 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.0 m -75.16 -12.91 60.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.021 1.328 . . . . 0.0 114.313 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -116.28 20.29 14.35 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.741 1.216 . . . . 0.0 111.259 -164.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 mt -133.97 104.31 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -117.17 144.57 44.59 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -166.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.604 HG21 ' HE1' ' A' ' 51' ' ' TRP . 2.8 p -145.56 140.39 22.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.386 0.613 . . . . 0.0 110.961 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.7 88.51 1.34 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.12 -123.35 24.55 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.925 1.25 . . . . 0.0 112.056 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 p -81.22 56.53 2.88 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.674 1.19 . . . . 0.0 110.034 171.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 m -152.28 148.6 27.73 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.863 1.665 . . . . 0.0 106.837 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.13 159.28 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 162.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -136.72 150.46 48.44 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 147.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -130.66 163.22 27.67 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 162.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -124.53 168.39 13.16 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.107 1.363 . . . . 0.0 108.813 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -120.47 161.67 20.85 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.95 0.881 . . . . 0.0 110.287 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.92 165.32 22.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 125.009 1.324 . . . . 0.0 111.622 -162.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.27 -34.59 0.55 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.133 1.888 . . . . 0.0 111.704 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.02 162.69 18.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.851 0.834 . . . . 0.0 109.447 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -82.25 12.91 3.86 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.131 -0.981 . . . . 0.0 110.408 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -68.75 164.41 21.81 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 162.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -124.03 132.93 53.74 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.566 -0.709 . . . . 0.0 109.36 -170.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -130.08 90.69 3.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.591 0.632 . . . . 0.0 111.365 -154.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.5 m -70.04 105.09 2.75 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -80.43 160.97 44.36 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 118.842 -0.977 . . . . 0.0 111.311 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.7 tp -159.93 72.82 0.52 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.435 1.118 . . . . 0.0 113.433 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.2 t -88.12 150.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 120.266 -1.521 . . . . 0.0 109.947 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.6 m -91.61 150.03 21.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 168.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.14 105.94 5.16 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.887 0.875 . . . . 0.0 109.271 162.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -95.19 141.76 28.42 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.277 1.431 . . . . 0.0 109.173 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -64.39 163.44 13.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.994 1.318 . . . . 0.0 110.801 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -56.28 -37.12 69.41 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.99 1.316 . . . . 0.0 112.905 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -135.59 -28.01 1.14 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -167.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -78.96 -156.42 0.1 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 166.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.42 -11.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 CA-C-O 118.323 -1.265 . . . . 0.0 114.475 -172.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.46 110.37 1.09 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.371 1.585 . . . . 0.0 110.388 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.0 p -76.07 116.63 16.96 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.03 118.29 23.42 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 m -75.96 145.0 40.66 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 tt -138.07 106.36 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -170.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -121.32 87.62 2.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.596 0.759 . . . . 0.0 110.024 -170.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.19 123.97 21.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 167.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.18 93.1 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 163.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -106.3 157.55 34.67 Favored Pre-proline 0 C--O 1.237 0.442 0 CA-C-O 117.641 -1.171 . . . . 0.0 109.641 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -69.94 -164.63 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.416 4.078 . . . . 0.0 111.374 172.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -132.63 143.6 15.28 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.017 0.818 . . . . 0.0 111.645 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt . . . . . 0 N--CA 1.467 0.407 0 C-N-CA 127.34 2.256 . . . . 0.0 111.262 -168.181 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 t -81.03 140.14 35.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -115.81 104.6 11.81 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.624 1.57 . . . . 0.0 109.216 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -85.3 114.75 22.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 1.7 t80 -147.89 77.09 1.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -152.05 169.37 22.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.122 0.969 . . . . 0.0 108.59 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 20' ' ' HIS . 86.8 m-85 -68.54 169.85 10.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.371 0.605 . . . . 0.0 109.604 164.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.47 -14.44 28.48 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.791 0.836 . . . . 0.0 111.457 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.4 p30 -105.66 -4.94 20.45 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -162.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.09 -56.41 0.04 OUTLIER Glycine 0 C--N 1.335 0.473 0 O-C-N 121.903 -0.498 . . . . 0.0 112.533 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.14 -115.27 0.55 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 118.792 1.296 . . . . 0.0 112.271 -168.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.5 p -127.05 19.56 7.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.629 0.772 . . . . 0.0 112.079 -170.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -149.88 157.46 43.2 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.349 -1.469 . . . . 0.0 110.546 167.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 8.4 t60 -123.92 152.61 42.23 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 165.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -143.55 133.7 24.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.5 156.6 38.73 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.869 1.268 . . . . 0.0 108.162 -178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -140.81 54.7 4.91 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 126.735 2.014 . . . . 0.0 111.389 -167.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.67 165.54 31.66 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 120.91 1.361 . . . . 0.0 110.858 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.5 162.46 35.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.936 0.895 . . . . 0.0 109.672 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.6 t70 67.26 -76.18 0.05 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.885 2.074 . . . . 0.0 110.347 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.0 t -162.13 89.73 0.72 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.828 1.251 . . . . 0.0 108.115 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.25 98.32 3.49 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.605 1.093 . . . . 0.0 112.123 171.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.12 168.46 19.96 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.11 -0.994 . . . . 0.0 109.285 167.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.6 -165.79 32.6 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 167.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.1 p -82.25 132.54 35.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 169.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -144.76 -177.58 5.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.698 1.199 . . . . 0.0 109.692 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.9 mt -129.02 157.47 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.4 mt -136.47 147.31 47.1 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.594 1.958 . . . . 0.0 107.822 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.52 93.54 6.69 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.72 131.42 72.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.71 1.204 . . . . 0.0 108.459 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 84.4 m -91.05 138.84 31.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.323 1.449 . . . . 0.0 108.854 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.9 p -155.88 74.89 0.88 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.796 -0.565 . . . . 0.0 110.6 -173.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -155.73 172.58 18.08 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.129 -0.982 . . . . 0.0 112.92 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 135.58 52.66 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.644 1.178 . . . . 0.0 109.86 172.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -114.34 128.9 56.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 125.367 1.467 . . . . 0.0 109.406 -172.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.4 t -170.29 159.23 7.1 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.46 0.704 . . . . 0.0 109.476 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.61 -93.4 0.08 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 125.1 1.333 . . . . 0.0 110.258 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -153.65 36.12 0.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.285 1.434 . . . . 0.0 109.508 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t -149.19 164.91 33.4 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.906 -1.121 . . . . 0.0 111.094 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 p -130.79 114.19 15.02 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.761 1.624 . . . . 0.0 107.939 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -88.7 130.09 35.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 163.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.57 165.05 21.91 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 124.0 0.813 . . . . 0.0 108.94 166.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.423 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 2.1 mm? -127.48 128.12 45.2 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.076 1.351 . . . . 0.0 108.473 173.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.5 m -73.85 163.35 28.05 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.631 0.729 . . . . 0.0 109.494 168.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -139.33 172.56 12.64 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.81 2.044 . . . . 0.0 109.565 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -143.68 164.04 31.57 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 167.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.18 -176.18 3.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.713 1.605 . . . . 0.0 110.413 -172.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m 174.59 143.77 0.05 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 128.042 2.537 . . . . 0.0 109.184 151.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.92 -110.1 0.23 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 167.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.73 142.61 54.94 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.355 1.062 . . . . 0.0 108.795 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 m -65.63 -8.21 19.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -111.08 15.5 21.6 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.347 1.459 . . . . 0.0 111.853 -174.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.7 mt -128.88 133.29 66.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -130.46 147.64 52.18 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.729 1.212 . . . . 0.0 109.475 -173.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.09 99.49 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -89.62 63.26 6.17 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.707 2.003 . . . . 0.0 109.599 174.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.6 -120.94 22.63 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 -162.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.6 p -65.88 -24.65 66.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.362 1.081 . . . . 0.0 113.688 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.6 94.85 6.38 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 119.679 1.127 . . . . 0.0 109.594 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.28 151.21 10.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.589 1.155 . . . . 0.0 108.122 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -150.81 158.4 44.09 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.029 -1.669 . . . . 0.0 109.055 164.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -153.81 162.27 41.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 165.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.39 156.22 24.87 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.59 1.156 . . . . 0.0 108.104 172.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.44 141.14 58.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.517 0.675 . . . . 0.0 109.331 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.72 145.29 98.03 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.926 0.89 . . . . 0.0 110.806 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -86.57 -4.83 8.28 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.018 3.145 . . . . 0.0 113.123 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.94 162.42 18.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.073 0.949 . . . . 0.0 109.163 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -12.12 33.66 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.59 159.79 31.7 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.87 -0.519 . . . . 0.0 110.359 171.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.43 140.99 38.62 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 163.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -148.2 82.53 1.49 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.08 0.952 . . . . 0.0 108.832 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.7 m -63.18 104.43 0.59 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.629 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.6 169.46 54.73 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 tt -159.9 125.33 4.08 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.089 0.556 . . . . 0.0 110.155 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.69 167.18 3.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 118.31 0.504 . . . . 0.0 110.182 174.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.04 161.36 15.6 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 167.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.574 HD13 ' HB2' ' A' ' 92' ' ' LEU . 2.7 mp -137.88 154.3 49.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.129 1.372 . . . . 0.0 107.37 169.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -137.88 146.4 43.32 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 163.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -85.2 171.53 11.89 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.877 0.736 . . . . 0.0 109.789 172.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.42 -78.9 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.769 1.628 . . . . 0.0 110.582 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -86.99 -21.41 26.18 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.063 -1.023 . . . . 0.0 111.896 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.46 -175.17 5.56 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.136 -0.978 . . . . 0.0 108.851 175.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.74 10.7 0.03 OUTLIER Glycine 0 N--CA 1.462 0.373 0 O-C-N 119.804 -1.81 . . . . 0.0 115.932 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -58.44 159.04 6.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.136 1.468 . . . . 0.0 108.381 155.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.1 p -119.67 107.5 13.31 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.574 ' HB2' HD13 ' A' ' 83' ' ' LEU . 63.7 mt -76.06 164.4 26.17 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 m -141.0 148.4 40.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.57 117.54 11.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -114.28 144.21 43.6 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.9 mt -135.05 98.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 -171.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.2 68.22 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -90.18 165.06 25.33 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.324 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.79 -166.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 124.225 3.283 . . . . 0.0 116.855 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.61 153.9 16.68 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 158.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt . . . . . 0 CA--C 1.517 -0.305 0 C-N-CA 125.057 1.343 . . . . 0.0 109.712 -164.528 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.45 -0.45 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 m -84.84 120.37 26.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -96.86 132.94 42.11 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -102.12 123.41 45.93 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -154.48 67.49 0.71 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.832 0.853 . . . . 0.0 109.486 -171.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.7 p -155.73 -157.23 0.71 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.631 155.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -83.56 152.2 24.98 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.764 1.165 . . . . 0.0 108.217 166.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.85 -22.87 49.24 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.662 0.785 . . . . 0.0 111.544 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -60.61 -6.61 1.74 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.281 0.633 . . . . 0.0 111.934 163.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.81 10.19 73.05 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 118.851 -0.972 . . . . 0.0 112.0 168.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.56 -174.41 24.0 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 118.494 1.147 . . . . 0.0 111.857 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.7 p -128.78 20.62 6.0 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 124.204 1.002 . . . . 0.0 112.565 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.83 177.96 9.9 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 120.203 1.365 . . . . 0.0 112.772 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -148.21 135.55 20.48 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.343 166.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -138.59 108.46 6.31 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.611 1.164 . . . . 0.0 109.605 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -102.64 158.22 16.39 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 110.67 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -136.78 56.15 12.42 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.147 1.779 . . . . 0.0 110.157 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.55 177.8 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.891 2.394 . . . . 0.0 110.973 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -157.29 175.84 13.48 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.104 1.362 . . . . 0.0 111.837 171.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.9 t70 66.03 -81.73 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.578 2.751 . . . . 0.0 113.233 -174.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.7 p -148.62 6.81 0.74 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.571 1.149 . . . . 0.0 113.611 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -78.63 86.23 4.62 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.195 -0.941 . . . . 0.0 111.394 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.6 153.99 42.36 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.685 1.994 . . . . 0.0 108.525 170.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.57 160.79 9.55 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.8 p -66.22 130.21 42.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.197 0.599 . . . . 0.0 111.904 -166.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -129.13 -171.77 2.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.694 0.759 . . . . 0.0 112.037 170.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.1 mt -126.07 160.48 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.2 mt -134.6 159.08 42.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.18 43.51 0.88 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.925 1.29 . . . . 0.0 110.928 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.443 ' CG2' ' HE2' ' A' ' 90' ' ' LYS . 98.9 mt -70.89 142.52 15.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.362 1.465 . . . . 0.0 108.555 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.38 106.23 14.69 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.181 1.392 . . . . 0.0 108.132 -174.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -135.77 66.17 1.51 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.992 0.917 . . . . 0.0 110.119 -170.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -150.62 170.95 17.94 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.242 -0.912 . . . . 0.0 112.158 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 47' ' ' LYS . 30.7 pttt -110.6 160.81 16.33 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.27 1.028 . . . . 0.0 108.234 164.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -136.5 133.68 36.78 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 166.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.5 t -171.51 157.37 4.79 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.622 1.169 . . . . 0.0 108.448 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.36 -94.48 0.1 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -152.71 35.04 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.211 0.604 . . . . 0.0 111.634 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 t -147.62 170.18 18.05 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 120.996 -1.065 . . . . 0.0 111.106 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.2 p -121.2 96.73 5.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.148 1.379 . . . . 0.0 109.143 164.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -72.06 120.69 18.01 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 169.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.98 165.56 15.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.273 0.559 . . . . 0.0 109.633 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.49 131.85 55.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 168.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.83 170.32 4.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.251 2.22 . . . . 0.0 110.736 172.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -165.67 167.98 16.67 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.339 1.056 . . . . 0.0 111.617 167.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -155.25 154.87 32.83 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.35 1.86 . . . . 0.0 109.072 165.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.75 178.1 4.72 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.83 1.652 . . . . 0.0 111.268 -172.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.6 p -158.52 127.53 5.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.566 0.746 . . . . 0.0 111.782 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.08 -134.98 3.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.271 1.415 . . . . 0.0 110.346 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.25 147.26 10.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.485 1.914 . . . . 0.0 112.865 -174.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.54 6.1 1.56 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.782 2.433 . . . . 0.0 114.758 -172.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.404 ' CZ2' ' HA3' ' A' ' 79' ' ' GLY . 25.7 p-90 -133.04 10.53 4.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.125 1.77 . . . . 0.0 111.589 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.73 108.82 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -106.12 144.28 33.06 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.733 2.013 . . . . 0.0 108.237 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.38 130.57 24.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 172.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.41 70.36 1.42 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 49.64 -117.99 5.1 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -169.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 p -71.36 34.94 0.05 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.671 1.588 . . . . 0.0 114.273 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.2 t -147.81 148.28 30.74 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 p -149.47 155.55 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -171.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.19 138.61 13.85 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.801 1.241 . . . . 0.0 108.396 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -122.16 126.7 48.88 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 166.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.89 147.78 25.73 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.334 0.654 . . . . 0.0 110.172 -169.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -73.0 158.27 35.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.664 1.221 . . . . 0.0 110.4 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -103.73 147.11 33.74 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 126.695 1.998 . . . . 0.0 109.365 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -84.75 -4.25 9.88 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 124.548 3.499 . . . . 0.0 113.233 -163.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.38 153.57 22.04 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.695 -1.253 . . . . 0.0 107.733 166.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 4.81 11.21 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.207 1.003 . . . . 0.0 112.208 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -70.82 154.42 41.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.143 -0.973 . . . . 0.0 109.486 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.4 ttm105 -77.26 148.68 35.62 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 167.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -131.07 146.95 52.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 155.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.7 m -83.06 148.33 27.6 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 156.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.404 ' HA3' ' CZ2' ' A' ' 58' ' ' TRP . . . -119.26 157.36 15.4 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 125.103 1.335 . . . . 0.0 109.772 169.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.6 tp -153.08 126.65 8.75 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.611 0.765 . . . . 0.0 109.042 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 158.18 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 119.475 1.034 . . . . 0.0 109.549 167.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -100.7 155.61 17.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mp -132.54 168.12 18.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.187 1.795 . . . . 0.0 109.229 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -151.24 -160.2 1.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.28 1.832 . . . . 0.0 107.162 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.465 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -134.12 171.47 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.703 1.201 . . . . 0.0 108.07 170.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -51.35 -63.32 1.17 Allowed 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.593 1.557 . . . . 0.0 110.201 170.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -107.44 -27.18 10.59 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.763 1.225 . . . . 0.0 111.995 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 t -99.72 -168.64 1.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.893 1.277 . . . . 0.0 111.667 -174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.0 50.66 0.69 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 126.559 2.028 . . . . 0.0 109.702 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.465 ' HE3' ' OE1' ' A' ' 85' ' ' GLN . 3.4 mtmp? -61.39 97.16 0.06 Allowed 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 158.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.4 p -96.9 104.53 16.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.45 155.68 20.32 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 m -135.79 64.58 1.57 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.489 1.516 . . . . 0.0 107.067 -157.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.38 107.36 2.83 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -164.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -112.33 133.19 54.57 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.01 139.73 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.67 72.09 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -108.79 144.97 30.67 Favored Pre-proline 0 C--O 1.23 0.077 0 CA-C-O 117.366 -1.302 . . . . 0.0 108.017 -172.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.28 173.2 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.623 2.882 . . . . 0.0 110.463 169.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.67 169.68 37.49 Favored Glycine 0 C--N 1.331 0.255 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? . . . . . 0 C--O 1.233 0.204 0 C-N-CA 123.047 0.539 . . . . 0.0 109.766 -168.293 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.1 m -124.23 148.83 47.04 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.483 1.113 . . . . 0.0 108.442 166.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -124.55 159.05 31.51 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.379 1.072 . . . . 0.0 111.104 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -129.98 112.73 13.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.442 1.897 . . . . 0.0 106.344 -171.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -143.96 68.67 1.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.275 1.43 . . . . 0.0 108.801 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 p -154.26 173.06 16.66 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.991 0.917 . . . . 0.0 108.712 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -64.07 170.08 3.89 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 149.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.36 -23.43 30.15 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.812 -0.555 . . . . 0.0 111.498 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -148.67 31.23 0.8 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.953 0.901 . . . . 0.0 110.189 -166.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.38 3.15 0.06 OUTLIER Glycine 0 C--N 1.342 0.916 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 -169.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.9 -123.06 6.24 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 120.03 1.915 . . . . 0.0 110.077 174.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 p -135.65 25.3 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.534 1.167 . . . . 0.0 111.764 -167.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -160.26 163.52 33.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.3 155.2 42.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 161.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m -142.59 127.93 18.82 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -118.9 146.9 44.55 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -122.12 65.58 21.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 C-N-CA 124.787 1.235 . . . . 0.0 108.657 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.14 169.14 9.69 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.774 2.316 . . . . 0.0 111.391 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.38 -176.45 5.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t0 55.13 -78.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.43 2.292 . . . . 0.0 113.897 171.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -154.12 110.82 3.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 156.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -149.58 90.85 1.75 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.905 1.23 . . . . 0.0 111.841 167.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.61 177.82 7.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.092 1.757 . . . . 0.0 108.988 169.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.45 -157.77 27.5 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 170.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.2 p -124.57 105.57 9.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.835 1.654 . . . . 0.0 110.081 -170.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -124.16 -171.01 2.24 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.63 160.78 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.837 2.055 . . . . 0.0 107.197 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.3 mt -138.43 164.12 30.15 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.076 1.351 . . . . 0.0 110.61 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -83.83 89.07 7.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.308 1.843 . . . . 0.0 111.809 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.1 152.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 172.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.19 120.25 39.83 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.106 1.762 . . . . 0.0 106.659 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 p -155.0 70.53 0.76 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.686 0.794 . . . . 0.0 109.711 -161.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -159.94 176.86 11.38 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.62 0.768 . . . . 0.0 111.285 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 151.74 49.47 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.711 1.605 . . . . 0.0 109.682 168.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -131.48 130.78 42.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 126.07 1.748 . . . . 0.0 109.215 -167.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.7 t -177.47 144.61 0.4 Allowed 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.168 1.387 . . . . 0.0 108.821 -174.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.33 -88.79 0.2 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 125.947 1.737 . . . . 0.0 112.663 164.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -159.57 33.35 0.19 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.652 1.581 . . . . 0.0 109.172 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -145.9 155.59 42.97 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.619 -1.3 . . . . 0.0 109.564 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.03 80.91 1.85 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.335 1.064 . . . . 0.0 110.007 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -67.22 118.66 10.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.063 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.68 155.35 40.24 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.591 0.632 . . . . 0.0 109.46 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.5 128.28 50.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.021 1.329 . . . . 0.0 108.909 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 t -78.37 178.62 7.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.372 1.069 . . . . 0.0 110.749 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -147.27 -167.73 2.86 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.834 2.054 . . . . 0.0 109.169 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -139.96 -178.16 5.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.861 1.664 . . . . 0.0 107.466 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.36 156.7 47.37 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 165.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.01 150.29 5.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.121 0.969 . . . . 0.0 109.545 165.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.67 -102.65 0.22 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 171.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.56 151.24 47.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.104 0.962 . . . . 0.0 109.729 170.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 m -86.89 -34.16 19.52 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -72.59 19.8 0.08 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.967 1.707 . . . . 0.0 113.635 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mt -130.05 129.67 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -100.4 167.95 10.06 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.673 1.589 . . . . 0.0 108.659 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.97 151.08 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 166.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.59 68.82 1.08 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 166.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.14 -117.83 8.21 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.4 p -72.46 48.48 0.19 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.368 1.867 . . . . 0.0 112.192 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -151.59 147.6 26.97 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.691 1.597 . . . . 0.0 108.497 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -144.65 130.8 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.742 1.217 . . . . 0.0 109.238 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 m -143.19 152.51 41.85 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -153.17 150.46 29.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.611 0.764 . . . . 0.0 109.783 173.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.33 175.2 9.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.824 1.249 . . . . 0.0 108.819 168.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -89.82 175.65 7.14 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.475 1.131 . . . . 0.0 108.577 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.415 HD21 ' CA ' ' A' ' 100' ' ' GLY . 29.4 p30 -66.93 165.68 24.74 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 120.313 -1.492 . . . . 0.0 113.791 173.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -94.73 -4.62 2.32 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.693 3.595 . . . . 0.0 113.457 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.96 153.21 51.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.805 1.242 . . . . 0.0 108.889 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . 0.338 0.0 OUTLIER -90.14 35.61 0.86 Allowed 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.082 -1.011 . . . . 0.0 111.954 -168.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -86.11 167.31 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 167.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.83 136.88 32.86 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 166.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -151.81 162.15 41.51 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.838 0.855 . . . . 0.0 109.741 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.2 t -117.53 158.64 24.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 160.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.78 165.23 28.18 Favored Glycine 0 C--O 1.239 0.457 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 159.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.1 tp -158.21 100.29 1.68 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 m -84.68 -165.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 49.6 m -145.45 146.32 31.46 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 119.447 -2.033 . . . . 0.0 105.831 157.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.26 137.02 54.87 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 170.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -123.29 119.89 31.47 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.327 1.451 . . . . 0.0 108.221 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -65.32 148.46 51.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.453 1.101 . . . . 0.0 109.541 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -50.83 -84.92 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.864 2.466 . . . . 0.0 113.624 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -80.36 -15.8 56.02 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.367 -0.833 . . . . 0.0 111.445 -174.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.82 -153.47 0.33 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.556 1.942 . . . . 0.0 108.739 173.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.43 1.51 0.03 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-O 117.897 -1.501 . . . . 0.0 114.551 -174.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.59 102.14 2.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.887 1.844 . . . . 0.0 106.664 169.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 p -69.49 152.11 45.23 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.751 0.657 . . . . 0.0 110.101 -169.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.18 169.28 8.58 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.336 1.054 . . . . 0.0 108.773 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -147.89 146.33 29.0 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.017 1.327 . . . . 0.0 107.841 -169.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.9 tp -139.35 110.65 6.97 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 128.651 2.78 . . . . 0.0 105.909 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -128.52 128.11 43.68 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.0 mt -134.63 77.81 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -163.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 86.2 t -75.81 99.06 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.08 155.0 43.25 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 124.593 1.157 . . . . 0.0 111.94 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.49 -168.82 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 124.231 3.287 . . . . 0.0 108.883 160.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.415 ' CA ' HD21 ' A' ' 71' ' ' ASN . . . -139.74 167.5 25.31 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 118.786 -1.674 . . . . 0.0 114.994 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.117 0 CA-C-N 114.456 -0.872 . . . . 0.0 112.341 -175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -89.58 125.79 35.36 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 166.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -102.33 152.93 20.51 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.927 1.291 . . . . 0.0 109.638 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.06 110.74 10.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.297 2.239 . . . . 0.0 106.571 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.9 46.79 1.75 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.762 1.625 . . . . 0.0 108.529 -175.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -160.36 157.34 27.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.941 1.696 . . . . 0.0 107.625 -170.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -73.67 170.83 14.43 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.184 0.993 . . . . 0.0 109.5 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.41 -36.3 45.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.286 0.634 . . . . 0.0 112.641 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -142.49 47.28 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.33 -1.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 -172.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.59 -112.68 4.61 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 120.914 2.357 . . . . 0.0 109.111 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.3 p -119.98 7.31 10.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.268 1.034 . . . . 0.0 112.598 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 t -137.88 158.14 44.96 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.451 1.023 . . . . 0.0 108.58 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -102.85 165.31 11.12 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 148.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.4 m -141.14 163.16 33.72 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 153.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -144.81 150.6 37.45 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -131.96 77.34 72.01 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 126.955 2.102 . . . . 0.0 106.475 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.59 177.02 8.0 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.845 1.696 . . . . 0.0 109.757 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -151.88 161.19 43.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 108.879 172.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 54.52 -85.34 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.444 2.697 . . . . 0.0 110.488 -167.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t -150.24 106.04 3.42 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 165.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -128.55 89.96 2.98 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 122.432 1.11 . . . . 0.0 108.664 156.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.5 149.03 50.66 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.922 2.089 . . . . 0.0 106.844 164.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.04 -139.03 4.97 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 p -129.91 116.04 18.06 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.775 1.63 . . . . 0.0 110.321 -171.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -146.44 -171.74 3.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.781 1.233 . . . . 0.0 111.873 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.6 mt -133.16 130.2 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.201 1.8 . . . . 0.0 107.273 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.2 mt -91.63 161.59 14.86 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.453 1.501 . . . . 0.0 109.419 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.2 78.84 4.0 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mt -90.35 133.05 33.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.865 2.066 . . . . 0.0 107.397 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 m -110.4 107.98 17.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -135.53 67.65 1.48 Allowed 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.029 0.932 . . . . 0.0 108.771 -163.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -154.37 176.22 12.59 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.25 -0.906 . . . . 0.0 111.808 -176.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.96 154.56 40.99 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 125.94 1.696 . . . . 0.0 108.988 170.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -141.36 126.82 18.8 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.93 1.292 . . . . 0.0 109.938 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.6 t -177.62 160.06 1.53 Allowed 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.135 1.374 . . . . 0.0 108.932 -176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.4 -103.56 0.32 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -146.04 29.5 1.08 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.158 0.983 . . . . 0.0 111.871 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -146.85 169.34 19.32 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.216 -0.927 . . . . 0.0 110.064 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.48 113.2 10.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.514 1.525 . . . . 0.0 109.064 -172.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.85 108.96 20.02 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.68 109.84 3.99 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.479 1.036 . . . . 0.0 109.217 169.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.77 134.64 52.57 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -66.75 163.23 19.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.384 1.474 . . . . 0.0 108.996 166.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -149.42 -172.87 4.24 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.1 -175.15 5.21 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 153.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.33 166.38 19.6 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.745 1.618 . . . . 0.0 108.277 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.62 149.84 20.65 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 161.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.27 -142.92 8.31 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -64.95 143.34 58.01 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.278 0.631 . . . . 0.0 111.043 -168.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.82 -0.76 4.48 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.104 1.762 . . . . 0.0 114.782 -170.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -117.81 11.56 13.59 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.032 1.733 . . . . 0.0 111.653 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.02 133.03 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -134.5 111.37 10.04 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.977 1.711 . . . . 0.0 106.892 -165.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.4 t -112.56 98.33 6.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -94.41 79.29 3.89 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.32 -107.78 0.47 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 126.215 1.864 . . . . 0.0 111.44 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m -73.83 -19.25 60.8 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.821 1.248 . . . . 0.0 112.764 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -88.08 160.06 17.97 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.45 1.023 . . . . 0.0 110.694 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -132.04 145.64 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 167.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -150.74 148.79 28.98 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.05 160.56 42.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -125.45 148.87 48.67 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.357 1.063 . . . . 0.0 108.289 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -62.92 170.86 2.44 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 123.621 1.677 . . . . 0.0 112.537 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.5 HD21 ' HA2' ' A' ' 100' ' ' GLY . 21.5 p30 -78.03 157.18 79.02 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.069 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.43 -6.16 7.15 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.02 2.48 . . . . 0.0 112.397 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.93 154.47 46.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.96 1.304 . . . . 0.0 109.221 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 40.79 0.77 Allowed 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.793 1.237 . . . . 0.0 111.065 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.29 170.33 9.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.288 1.435 . . . . 0.0 109.884 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.82 113.04 20.47 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.1 mtp85 -135.14 -170.44 2.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.122 0.969 . . . . 0.0 109.609 -170.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.7 t -147.2 156.89 43.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.486 -1.384 . . . . 0.0 108.108 161.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -84.7 174.07 49.74 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 159.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.5 tp -162.67 80.21 0.5 Allowed 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.53 178.06 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 120.629 -1.294 . . . . 0.0 110.005 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.4 m -134.38 141.51 46.88 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.949 -1.095 . . . . 0.0 108.566 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -127.83 151.45 49.03 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.901 1.68 . . . . 0.0 107.846 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.38 134.97 20.96 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.735 0.698 . . . . 0.0 109.454 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -77.12 154.65 33.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.416 1.087 . . . . 0.0 110.564 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -53.45 -69.49 0.12 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.989 2.116 . . . . 0.0 113.001 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -85.12 -23.51 28.41 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.053 0.541 . . . . 0.0 111.132 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -86.08 -153.64 0.19 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.318 1.847 . . . . 0.0 109.878 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.26 -13.28 0.02 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-O 118.193 -1.337 . . . . 0.0 115.645 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.71 121.54 10.66 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.959 1.879 . . . . 0.0 106.932 169.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.2 p -81.38 145.11 30.98 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -93.5 158.23 15.81 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 168.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 m -124.98 152.54 44.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.63 1.172 . . . . 0.0 110.153 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tt -152.72 109.29 3.43 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -170.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -117.25 137.32 52.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.305 1.042 . . . . 0.0 109.391 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.507 HG22 ' CG ' ' A' ' 98' ' ' GLN . 10.8 mt -135.72 94.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -171.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.6 t -99.28 80.76 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.507 ' CG ' HG22 ' A' ' 96' ' ' ILE . 17.7 mt-30 -89.81 166.01 22.45 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 125.313 1.445 . . . . 0.0 110.126 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -60.91 -172.05 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.824 3.016 . . . . 0.0 112.018 160.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.5 ' HA2' HD21 ' A' ' 71' ' ' ASN . . . -121.26 139.04 12.93 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 124.817 1.198 . . . . 0.0 112.1 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm . . . . . 0 N--CA 1.463 0.177 0 C-N-CA 125.343 1.457 . . . . 0.0 110.372 -175.22 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 N--CA 1.45 -0.444 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -147.93 103.79 3.52 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -77.11 155.0 32.69 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -137.31 109.08 7.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.141 2.577 . . . . 0.0 106.367 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -132.73 93.03 3.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -164.66 161.17 20.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.347 1.059 . . . . 0.0 110.179 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -66.44 167.76 10.13 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.493 -0.754 . . . . 0.0 108.966 163.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -114.89 -0.78 13.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.234 1.013 . . . . 0.0 111.89 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -145.92 51.18 1.17 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 166.85 -97.57 0.14 Allowed Glycine 0 CA--C 1.523 0.564 0 O-C-N 121.371 -0.831 . . . . 0.0 111.109 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.65 -112.24 0.26 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 118.065 0.933 . . . . 0.0 112.379 -171.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.2 p -138.44 16.09 2.75 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.97 0.908 . . . . 0.0 112.242 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 t -152.95 140.93 20.26 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.438 1.017 . . . . 0.0 109.49 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.29 157.09 17.37 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.021 0.929 . . . . 0.0 109.893 174.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -150.82 102.14 2.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 154.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -89.04 155.57 19.39 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 118.819 -1.153 . . . . 0.0 109.482 165.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -128.88 69.24 80.36 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 126.396 1.879 . . . . 0.0 108.774 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.94 170.83 14.7 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.354 2.036 . . . . 0.0 111.144 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.0 158.5 42.12 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.455 0.702 . . . . 0.0 110.505 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.4 t70 62.52 -72.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.016 2.126 . . . . 0.0 113.662 -171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 m -165.57 75.84 0.24 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.937 1.695 . . . . 0.0 108.687 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.42 98.8 6.09 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.342 1.057 . . . . 0.0 110.098 174.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.3 165.1 28.09 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.318 2.247 . . . . 0.0 106.448 167.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 143.68 174.61 16.09 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 119.76 1.164 . . . . 0.0 112.088 165.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.5 p -92.01 113.17 25.37 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.895 0.478 . . . . 0.0 110.707 -161.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -122.76 -167.11 1.53 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.255 1.022 . . . . 0.0 112.945 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mt -135.67 143.21 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 127.771 2.429 . . . . 0.0 105.194 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.9 mt -123.16 162.88 21.66 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.294 1.038 . . . . 0.0 110.067 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -104.63 86.19 2.45 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.234 1.414 . . . . 0.0 107.187 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -114.52 128.43 71.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 m -79.31 115.16 18.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.139 1.376 . . . . 0.0 108.129 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.2 p -143.68 73.38 1.39 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.375 0.534 . . . . 0.0 111.126 -174.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -155.84 167.67 29.65 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.669 -0.644 . . . . 0.0 112.407 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.41 133.58 55.62 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -103.78 142.74 33.84 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.834 0.854 . . . . 0.0 109.174 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.59 76.96 0.97 Allowed 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -156.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.75 -94.55 0.09 OUTLIER Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.862 1.22 . . . . 0.0 111.035 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -113.87 9.85 17.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 m -134.76 153.68 51.91 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.566 0.746 . . . . 0.0 110.957 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -139.1 92.19 2.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.712 1.605 . . . . 0.0 110.193 -168.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -76.97 115.53 16.84 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.43 152.69 45.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.16 148.95 42.51 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.393 1.077 . . . . 0.0 108.149 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.2 p -87.95 -179.42 6.22 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.792 0.837 . . . . 0.0 110.175 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -143.71 154.29 43.33 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 109.512 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -89.48 160.06 16.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.04 1.336 . . . . 0.0 108.538 160.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.75 163.11 26.91 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.832 2.053 . . . . 0.0 106.434 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 m -170.86 141.8 1.81 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.332 0.969 . . . . 0.0 109.284 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.93 -128.75 3.84 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.226 1.393 . . . . 0.0 110.245 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.92 136.73 4.48 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.113 2.565 . . . . 0.0 111.699 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -71.58 4.32 3.21 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 -165.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -139.66 15.58 2.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.874 0.869 . . . . 0.0 112.338 -160.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.7 mt -123.42 87.88 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -73.33 126.57 30.44 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.9 t -137.38 84.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.93 59.07 3.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.679 1.192 . . . . 0.0 109.145 -173.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.31 -115.88 8.33 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -172.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -75.65 39.04 0.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.86 1.664 . . . . 0.0 112.8 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 m -152.4 149.14 28.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.78 139.52 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 t -143.32 108.8 5.07 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.09 106.71 17.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 165.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -66.81 168.01 10.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.383 1.473 . . . . 0.0 110.822 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -85.03 -176.85 6.38 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.431 -0.793 . . . . 0.0 109.162 171.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -112.03 161.07 27.54 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.882 1.673 . . . . 0.0 108.44 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -86.79 -10.41 6.1 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.795 2.33 . . . . 0.0 113.375 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.83 167.07 13.98 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.934 1.293 . . . . 0.0 110.732 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -100.01 13.26 34.59 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.763 1.024 . . . . 0.0 113.763 -175.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.95 171.77 13.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 164.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -108.7 144.33 36.62 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.63 -0.668 . . . . 0.0 109.604 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.69 165.74 18.67 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.237 -0.914 . . . . 0.0 109.272 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.2 m -117.33 117.55 29.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 158.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.72 158.59 52.46 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.8 tp -155.18 111.35 3.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.94 0.87 . . . . 0.0 109.629 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.1 t -130.53 124.19 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.9 m -87.7 135.98 33.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 175.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.35 145.7 38.4 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.751 0.82 . . . . 0.0 108.901 167.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -134.57 139.87 45.7 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 173.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -71.52 160.04 33.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.198 0.999 . . . . 0.0 109.322 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -50.44 -33.35 20.69 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.109 1.363 . . . . 0.0 113.937 168.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -127.95 -36.06 2.02 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 t -88.22 -156.2 0.35 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.564 0.746 . . . . 0.0 110.054 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.64 10.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.627 0 CA-C-O 118.113 -1.381 . . . . 0.0 114.937 -171.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.91 94.27 1.05 Allowed 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.141 1.97 . . . . 0.0 107.147 169.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 p -72.8 113.67 10.1 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mp -75.0 130.13 38.83 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 t -88.18 152.63 21.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 tt -149.02 98.54 2.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -172.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -105.47 149.61 26.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.2 134.89 41.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 168.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 t -121.4 79.4 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -84.79 164.08 43.7 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.68 1.192 . . . . 0.0 110.704 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.26 179.61 3.32 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.448 2.765 . . . . 0.0 110.518 160.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.95 147.82 18.89 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.106 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm . . . . . 0 C--O 1.236 0.352 0 C-N-CA 126.206 1.802 . . . . 0.0 111.455 -166.782 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.0 t . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -97.77 100.63 12.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -79.2 157.07 27.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.106 0.479 . . . . 0.0 110.153 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -131.42 107.01 8.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -130.79 69.06 1.47 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.35 2.26 . . . . 0.0 105.663 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.6 p -163.41 -174.98 3.99 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.893 -0.504 . . . . 0.0 111.724 165.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -65.66 173.37 2.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.486 0.585 . . . . 0.0 109.688 161.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -112.47 -8.11 13.89 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -156.67 58.02 0.55 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.055 0.931 . . . . 0.0 108.888 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.3 -91.66 0.08 OUTLIER Glycine 0 C--N 1.331 0.286 0 O-C-N 121.405 -0.809 . . . . 0.0 111.779 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.33 -123.31 0.78 Allowed Glycine 0 C--N 1.333 0.362 0 CA-C-N 117.781 0.79 . . . . 0.0 113.007 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 p -138.81 12.32 2.68 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.223 1.409 . . . . 0.0 114.127 -169.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 t -157.38 146.64 20.03 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 118.467 -1.293 . . . . 0.0 111.7 169.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.5 137.76 33.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.375 160.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m -136.05 162.16 33.67 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 170.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -152.81 154.47 35.22 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 159.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.4 54.64 14.18 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.602 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.57 174.52 9.23 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.23 1.286 . . . . 0.0 111.167 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -159.46 169.54 23.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t70 65.16 -78.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.48 1.912 . . . . 0.0 111.231 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 m -169.07 110.44 0.49 Allowed 'General case' 0 C--O 1.238 0.496 0 C-N-CA 128.479 2.712 . . . . 0.0 106.702 160.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.6 m -138.89 24.75 2.57 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.78 146.71 49.6 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.173 -0.954 . . . . 0.0 110.445 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.73 -158.95 27.37 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -121.98 116.11 23.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.385 1.474 . . . . 0.0 110.173 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -122.14 -177.85 3.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.317 1.447 . . . . 0.0 110.639 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mt -132.03 156.59 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 127.287 2.235 . . . . 0.0 105.897 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.5 mt -134.06 179.04 6.5 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.648 1.579 . . . . 0.0 109.287 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -109.31 71.57 0.77 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.651 1.181 . . . . 0.0 109.461 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 97.2 mt -97.5 138.88 21.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.38 131.32 51.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.46 1.504 . . . . 0.0 107.421 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.1 t -148.61 81.98 1.46 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -154.2 173.17 16.47 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.764 -0.585 . . . . 0.0 111.394 173.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.68 137.25 54.37 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.778 1.631 . . . . 0.0 108.602 169.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -115.29 134.63 54.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.307 1.843 . . . . 0.0 107.011 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.1 t -174.85 157.79 2.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.67 -110.8 0.89 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -135.12 32.4 3.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.844 1.258 . . . . 0.0 109.476 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m -144.53 161.55 38.81 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.884 0.874 . . . . 0.0 110.784 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 p -127.66 103.21 7.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.025 1.33 . . . . 0.0 108.002 166.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -78.57 116.33 18.88 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.35 148.48 46.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -112.65 142.95 44.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.09 163.47 20.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.797 0.839 . . . . 0.0 110.514 166.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -140.1 158.4 44.12 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.585 1.154 . . . . 0.0 108.898 165.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -138.26 151.16 47.37 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.479 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -141.4 162.14 36.19 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.369 1.068 . . . . 0.0 110.736 -163.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -168.96 152.42 5.23 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.292 1.037 . . . . 0.0 109.495 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.59 -138.88 5.47 Favored Glycine 0 C--N 1.333 0.38 0 O-C-N 121.506 -0.746 . . . . 0.0 111.709 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.47 ' HB2' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -55.84 137.33 50.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.153 1.381 . . . . 0.0 111.133 -178.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.5 m -69.4 3.43 2.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.745 2.418 . . . . 0.0 116.364 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -126.98 6.58 6.58 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.276 1.43 . . . . 0.0 111.963 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 56' ' ' ASP . 34.6 mt -117.27 91.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -76.77 110.23 11.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.614 1.166 . . . . 0.0 108.724 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 53' ' ' ALA . 8.0 p -94.41 143.13 12.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.17 0.988 . . . . 0.0 108.461 177.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.67 46.08 1.69 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.744 0.783 . . . . 0.0 111.061 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.18 -113.5 5.42 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.5 p -71.99 -7.35 48.2 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.2 m -110.31 144.65 38.72 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 119.671 1.123 . . . . 0.0 109.623 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.62 157.11 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.888 1.675 . . . . 0.0 107.775 -176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.29 152.58 26.21 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.529 1.132 . . . . 0.0 108.432 162.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -154.4 173.36 16.33 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.966 0.906 . . . . 0.0 109.557 159.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.93 170.81 8.06 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.784 1.233 . . . . 0.0 110.686 166.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -80.9 158.75 25.18 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 122.509 1.147 . . . . 0.0 108.305 165.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.63 167.37 5.74 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 126.304 1.842 . . . . 0.0 112.362 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -92.1 -10.8 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.377 3.385 . . . . 0.0 115.726 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.82 141.87 29.5 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 120.558 1.526 . . . . 0.0 109.926 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.585 ' H ' ' CD ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -72.0 8.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 128.668 2.787 . . . . 0.0 114.0 -155.042 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -61.58 166.65 4.0 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 163.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' A' ' 99' ' ' PRO . 8.4 ttm-85 -126.21 118.9 26.12 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.086 1.354 . . . . 0.0 110.253 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -136.94 -168.94 2.37 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.562 1.145 . . . . 0.0 110.25 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 8.8 t -131.82 156.12 46.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.653 0.781 . . . . 0.0 109.238 162.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.81 -179.3 40.43 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 160.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.7 tp -147.82 160.36 42.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.736 1.214 . . . . 0.0 108.383 159.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -135.78 151.48 29.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 163.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.2 m -124.37 154.87 39.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.782 HD21 ' HB2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -145.01 167.38 22.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.266 1.027 . . . . 0.0 109.968 -174.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -137.89 158.28 44.68 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 125.167 1.387 . . . . 0.0 108.077 167.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -114.98 139.46 49.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -44.7 -73.16 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.037 1.735 . . . . 0.0 113.743 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.26 -8.75 54.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.691 1.996 . . . . 0.0 112.957 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.76 -153.37 0.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.459 2.304 . . . . 0.0 106.771 174.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 0.21 0.04 OUTLIER Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.11 -1.519 . . . . 0.0 115.931 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -58.85 153.3 17.41 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 126.568 1.947 . . . . 0.0 110.925 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 p -122.42 146.79 47.03 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.782 ' HB2' HD21 ' A' ' 83' ' ' LEU . 59.5 mt -117.39 -170.42 1.85 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.845 1.658 . . . . 0.0 106.639 175.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.54 161.08 39.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.104 1.362 . . . . 0.0 108.776 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 tp -136.45 77.92 1.68 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.548 1.939 . . . . 0.0 108.438 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -82.25 89.08 6.5 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.687 -0.633 . . . . 0.0 110.312 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' THR . 17.4 mt -83.68 92.47 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 175.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.6 87.64 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.13 160.75 31.34 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 118.281 0.491 . . . . 0.0 109.895 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.4 ' HA ' ' HG3' ' A' ' 76' ' ' ARG . 31.1 Cg_endo -78.4 171.54 16.73 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.749 1.632 . . . . 0.0 109.781 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -88.92 164.53 32.59 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.46 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm . . . . . 0 C--O 1.239 0.543 0 CA-C-N 114.036 -1.082 . . . . 0.0 108.231 -163.344 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.3 t . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.64 111.48 21.32 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.145 0.978 . . . . 0.0 108.522 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -88.24 166.3 14.44 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 163.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -144.15 102.83 3.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.468 1.907 . . . . 0.0 106.333 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -128.63 65.23 1.42 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.819 1.648 . . . . 0.0 109.042 -169.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.68 174.06 12.56 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.037 -1.039 . . . . 0.0 110.195 172.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -62.98 149.45 44.83 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.948 1.249 . . . . 0.0 107.63 155.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.37 -24.41 59.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.149 -174.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -93.52 17.3 11.8 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.203 1.001 . . . . 0.0 111.845 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.32 58.03 1.17 Allowed Glycine 0 C--N 1.337 0.586 0 O-C-N 121.769 -0.582 . . . . 0.0 111.943 168.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.06 -169.39 38.22 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.61 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 p -137.82 7.19 2.72 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.778 1.231 . . . . 0.0 112.74 -163.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 t -162.05 159.85 26.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.187 -0.946 . . . . 0.0 109.102 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.72 129.03 55.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 167.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.2 m -132.73 119.64 20.6 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 166.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.56 145.31 42.77 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -130.5 74.03 80.63 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -75.12 174.59 12.54 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.419 2.079 . . . . 0.0 110.709 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -137.9 -1.84 1.96 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -162.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.03 -66.22 0.35 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.013 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.4 t -157.92 9.81 0.17 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.397 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.65 92.2 0.32 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.387 1.449 . . . . 0.0 112.692 -167.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.82 147.01 28.25 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.9 2.48 . . . . 0.0 106.834 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.01 -179.68 40.6 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 121.497 1.953 . . . . 0.0 110.066 -172.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.5 m -99.67 117.26 33.64 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.949 0.9 . . . . 0.0 109.774 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -139.71 -165.94 1.98 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.032 1.333 . . . . 0.0 110.599 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.0 mt -128.83 155.92 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.33 1.852 . . . . 0.0 107.485 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.2 mt -133.58 156.09 48.47 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.55 1.94 . . . . 0.0 106.729 173.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.22 98.06 7.66 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.92 142.89 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.96 112.98 23.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.18 55.93 1.62 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -174.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -152.39 168.02 26.81 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.02 -1.05 . . . . 0.0 113.524 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.3 145.33 47.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.971 1.309 . . . . 0.0 109.144 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HE3' ' CG2' ' A' ' 46' ' ' THR . 18.3 ttmt -112.95 143.82 43.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.806 2.442 . . . . 0.0 106.779 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.8 t -172.99 172.02 4.07 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.073 2.149 . . . . 0.0 105.606 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.43 -102.56 0.04 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 126.19 1.852 . . . . 0.0 112.407 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -146.37 41.46 1.15 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.902 1.681 . . . . 0.0 109.188 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -146.26 169.22 19.22 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.005 0.922 . . . . 0.0 110.61 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.468 ' CG2' ' HE3' ' A' ' 41' ' ' LYS . 52.3 p -135.16 104.66 6.0 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.992 0.917 . . . . 0.0 110.461 165.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -80.44 121.42 25.72 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 172.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.75 151.42 47.48 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 166.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.45 114.14 21.35 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.692 1.597 . . . . 0.0 106.871 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 m -67.45 150.15 49.29 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.994 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -120.17 160.57 22.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.465 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -107.15 165.13 11.59 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.035 1.734 . . . . 0.0 107.825 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.722 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -156.19 144.36 19.8 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.702 1.201 . . . . 0.0 108.327 166.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.67 152.4 27.06 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.306 0.643 . . . . 0.0 109.985 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.92 -62.16 0.11 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.01 148.82 39.75 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.229 1.012 . . . . 0.0 110.389 -168.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -60.07 -10.72 4.61 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.637 1.975 . . . . 0.0 114.952 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -130.72 14.38 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.429 1.492 . . . . 0.0 111.066 -163.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.489 HG23 ' CE1' ' A' ' 68' ' ' TYR . 23.6 mt -127.36 86.5 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -172.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -104.24 141.78 35.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.106 1.362 . . . . 0.0 111.522 -170.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.722 HG11 ' HB3' ' A' ' 53' ' ' ALA . 5.1 p -131.03 100.56 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.858 0.863 . . . . 0.0 109.552 -168.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -100.51 51.96 0.88 Allowed 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.606 -1.309 . . . . 0.0 109.921 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.66 -113.76 6.17 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.4 p -78.1 53.29 1.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.665 1.232 . . . . 0.0 110.773 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.9 m -165.02 150.52 9.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.605 2.362 . . . . 0.0 107.263 167.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.33 140.95 28.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.0 t -155.69 102.97 2.24 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.489 ' CE1' HG23 ' A' ' 59' ' ' ILE . 4.4 m-30 -113.96 136.72 52.58 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -103.7 172.02 7.03 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.001 1.321 . . . . 0.0 111.554 -173.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.42 156.71 36.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.89 0.853 . . . . 0.0 111.106 163.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -68.12 165.56 32.06 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.26 1.824 . . . . 0.0 110.888 165.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -88.27 -11.51 4.32 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.91 2.407 . . . . 0.0 113.969 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.03 159.71 38.01 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.204 1.002 . . . . 0.0 109.811 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 0.6 3.51 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.09 165.12 11.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.557 0.743 . . . . 0.0 109.615 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -92.06 146.42 23.75 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 168.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -136.98 154.81 50.32 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.6 m -113.48 106.43 14.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 163.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.39 149.67 47.93 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.5 tp -162.66 118.45 1.86 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.075 0.938 . . . . 0.0 109.53 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.66 166.81 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.195 0.998 . . . . 0.0 109.183 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.7 m -121.52 144.54 48.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 169.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.425 HD11 HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -124.58 160.58 28.08 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.356 1.863 . . . . 0.0 110.095 172.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -148.8 137.96 21.62 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.759 1.224 . . . . 0.0 108.257 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -68.35 165.59 18.37 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -55.56 -84.94 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.815 2.046 . . . . 0.0 111.553 170.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -91.42 -3.14 56.97 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.971 -1.081 . . . . 0.0 113.268 -167.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 t -116.27 -154.51 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.242 2.217 . . . . 0.0 108.028 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.06 41.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.528 0 O-C-N 120.941 -1.099 . . . . 0.0 110.54 -159.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . 0.305 0.0 OUTLIER -65.24 138.5 58.27 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 153.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.1 p -110.39 140.97 44.08 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 159.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.425 HD12 HD11 ' A' ' 83' ' ' LEU . 86.3 mt -121.24 112.04 18.14 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.9 m -65.07 137.72 57.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tt -140.48 96.61 3.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.094 0.861 . . . . 0.0 110.072 -175.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -98.23 137.18 37.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mp -118.53 117.54 54.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 158.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.3 t -108.79 79.15 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -106.14 158.94 31.38 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 123.377 0.671 . . . . 0.0 110.899 -171.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -65.66 -178.08 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.289 2.659 . . . . 0.0 109.979 162.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.2 165.27 22.58 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 121.854 -0.529 . . . . 0.0 112.38 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm . . . . . 0 C--N 1.326 -0.416 0 C-N-CA 124.034 0.934 . . . . 0.0 110.812 -158.737 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 CA--C 1.533 0.32 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.54 144.36 50.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.919 1.688 . . . . 0.0 109.188 175.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.608 ' CZ ' ' HE2' ' A' ' 40' ' ' LYS . 6.8 m-85 -127.2 136.98 52.8 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.981 1.712 . . . . 0.0 107.715 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.63 115.17 22.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.989 2.116 . . . . 0.0 107.898 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.44 75.2 1.5 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.861 2.064 . . . . 0.0 105.797 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -170.25 174.89 5.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.677 0.791 . . . . 0.0 110.288 -175.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -82.95 157.49 22.98 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.664 -0.647 . . . . 0.0 109.938 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.4 -63.99 1.29 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.279 0.561 . . . . 0.0 109.724 165.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -107.92 28.37 8.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.062 1.745 . . . . 0.0 111.027 -160.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.4 -11.43 0.07 OUTLIER Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 170.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.04 -119.31 4.51 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 120.336 2.068 . . . . 0.0 113.796 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.17 9.14 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.636 1.174 . . . . 0.0 112.843 -165.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 t -154.13 -173.4 4.56 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.978 0.808 . . . . 0.0 110.534 161.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.96 105.61 5.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 127.785 2.434 . . . . 0.0 109.322 -171.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -130.35 88.84 2.69 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -83.97 136.48 34.05 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -121.45 70.65 24.42 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.815 1.246 . . . . 0.0 108.392 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.53 171.89 12.31 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.767 1.645 . . . . 0.0 110.307 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -153.43 157.62 40.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.75 1.22 . . . . 0.0 108.276 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.28 -85.52 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.583 2.353 . . . . 0.0 110.106 -170.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 t -146.44 96.43 2.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.979 1.712 . . . . 0.0 108.928 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 m -146.63 89.42 1.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.828 -1.17 . . . . 0.0 112.207 162.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.09 135.9 43.55 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.682 1.193 . . . . 0.0 108.417 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.34 -172.31 40.11 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-N 118.871 0.759 . . . . 0.0 112.498 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.0 p -111.33 108.69 18.38 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.21 1.404 . . . . 0.0 109.683 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -132.81 -174.86 3.59 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.015 1.326 . . . . 0.0 112.89 -175.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 mt -140.57 125.22 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.094 1.358 . . . . 0.0 107.91 -169.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.3 mt -109.17 165.73 11.38 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.997 1.319 . . . . 0.0 110.57 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -84.51 83.63 7.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.076 0.941 . . . . 0.0 110.888 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.0 mt -109.36 119.55 58.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.46 1.104 . . . . 0.0 109.449 -170.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.5 m -84.77 135.3 34.18 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.549 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.7 t -155.19 89.27 1.2 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -162.75 165.89 24.97 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.925 0.89 . . . . 0.0 111.506 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.608 ' HE2' ' CZ ' ' A' ' 9' ' ' TYR . 11.0 ptpt -110.71 161.19 16.01 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.206 1.003 . . . . 0.0 109.113 172.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -134.17 124.98 26.94 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 125.968 1.707 . . . . 0.0 108.001 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.0 t -173.82 175.54 2.85 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.104 1.362 . . . . 0.0 108.073 173.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.56 -107.52 0.92 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -152.15 68.23 0.87 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.617 1.567 . . . . 0.0 107.499 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.8 m -160.87 172.21 17.38 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.687 1.995 . . . . 0.0 110.653 171.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 p -135.39 89.5 2.52 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.076 0.951 . . . . 0.0 110.147 161.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -79.13 140.04 37.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.698 1.135 . . . . 0.0 109.963 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.96 166.79 5.34 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.165 1.386 . . . . 0.0 111.417 171.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 86' ' ' ASP . 22.5 mt -137.32 134.46 36.08 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.839 0.855 . . . . 0.0 109.512 162.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.5 p -71.63 173.68 7.76 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.817 1.647 . . . . 0.0 110.357 171.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -145.69 179.86 7.15 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.806 1.243 . . . . 0.0 111.318 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -125.88 162.44 25.18 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 127.27 2.228 . . . . 0.0 107.734 170.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.92 156.8 43.36 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.596 0.758 . . . . 0.0 109.236 165.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p 174.56 154.19 0.13 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.946 1.298 . . . . 0.0 112.64 167.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.41 -96.47 0.1 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.779 2.133 . . . . 0.0 109.055 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.21 167.72 11.7 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.898 0.849 . . . . 0.0 111.426 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.5 m -93.08 5.03 52.93 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -125.64 21.4 7.74 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.881 1.672 . . . . 0.0 112.461 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.7 mt -134.84 114.22 17.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -165.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -124.0 149.26 46.24 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.06 0.944 . . . . 0.0 109.898 -166.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -132.55 155.27 41.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -171.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.01 179.0 7.47 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.416 1.086 . . . . 0.0 108.849 165.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.72 -18.71 32.74 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 116.484 1.353 . . . . 0.0 116.484 -163.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 m -145.03 8.01 1.22 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.323 1.561 . . . . 0.0 111.16 163.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -109.99 151.45 27.13 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.697 1.599 . . . . 0.0 109.387 -163.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.19 138.25 53.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -142.18 152.26 42.98 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -159.23 168.02 27.54 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.855 0.862 . . . . 0.0 108.841 163.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -119.47 166.98 12.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.419 1.088 . . . . 0.0 110.565 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.13 175.31 7.62 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.403 1.097 . . . . 0.0 111.161 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.447 HD22 ' HD2' ' A' ' 77' ' ' ARG . 7.6 p-10 -99.8 166.94 11.88 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.957 2.503 . . . . 0.0 110.945 -170.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -76.76 -28.6 6.25 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.826 2.351 . . . . 0.0 114.775 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.91 168.5 19.67 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.673 1.124 . . . . 0.0 110.883 -165.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -75.0 1.11 13.73 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 120.733 -1.229 . . . . 0.0 111.918 -170.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -65.0 161.25 19.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.231 0.538 . . . . 0.0 110.749 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.92 129.13 34.18 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.447 ' HD2' HD22 ' A' ' 71' ' ' ASN . 0.0 OUTLIER -119.81 101.96 8.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 167.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.6 m -91.1 106.82 18.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 162.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.32 160.93 53.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.0 tp -161.46 93.94 0.95 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.38 0.59 . . . . 0.0 111.818 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 m -86.28 179.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.966 -0.458 . . . . 0.0 111.983 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.96 164.53 14.01 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 161.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.539 HD13 ' HB2' ' A' ' 92' ' ' LEU . 3.4 mp -134.01 164.78 26.54 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.848 1.659 . . . . 0.0 108.87 165.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -151.66 153.18 33.91 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 164.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -80.03 171.88 14.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 172.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.457 ' HB3' HD22 ' A' ' 49' ' ' LEU . 50.9 t0 -55.56 -39.41 70.6 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.902 1.281 . . . . 0.0 112.031 168.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -126.04 -44.97 1.73 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.893 -1.129 . . . . 0.0 111.845 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.4 t -79.47 -169.56 1.96 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.75 10.49 0.04 OUTLIER Glycine 0 C--O 1.223 -0.582 0 CA-C-O 117.09 -1.95 . . . . 0.0 116.422 -159.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.34 91.89 0.05 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 120.74 2.27 . . . . 0.0 109.194 169.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 p -71.6 145.01 49.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.539 ' HB2' HD13 ' A' ' 83' ' ' LEU . 75.1 mt -102.09 -179.06 3.89 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.16 -0.963 . . . . 0.0 108.57 176.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.93 86.73 1.87 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.148 1.379 . . . . 0.0 110.681 -167.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.99 73.12 8.04 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.469 1.108 . . . . 0.0 109.473 -169.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -78.4 91.77 4.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.462 HG22 ' CG ' ' A' ' 98' ' ' GLN . 26.3 mt -87.49 102.41 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.08 81.51 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -172.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.462 ' CG ' HG22 ' A' ' 96' ' ' ILE . 9.4 mt-30 -95.98 156.37 37.24 Favored Pre-proline 0 C--O 1.242 0.674 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.451 -171.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -61.89 156.79 46.86 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.692 1.594 . . . . 0.0 108.715 162.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.78 153.17 25.59 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt . . . . . 0 CA--C 1.534 0.338 0 C-N-CA 125.405 1.482 . . . . 0.0 110.759 -172.049 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.2 t -82.68 105.82 14.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.453 1.101 . . . . 0.0 108.351 -174.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -89.72 146.53 24.44 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.028 -1.045 . . . . 0.0 110.453 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -132.41 112.04 11.82 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.843 1.657 . . . . 0.0 108.884 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -144.51 92.32 2.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.036 0.934 . . . . 0.0 108.849 173.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 p -166.93 167.77 14.51 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.666 0.787 . . . . 0.0 110.018 172.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -72.97 172.33 11.15 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.027 0.531 . . . . 0.0 110.537 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.37 -22.1 44.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.463 0.705 . . . . 0.0 111.209 170.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -79.15 20.78 0.48 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.299 1.84 . . . . 0.0 112.468 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.88 52.17 52.2 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.636 -1.29 . . . . 0.0 112.693 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.92 -173.12 40.48 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.394 0.597 . . . . 0.0 113.564 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -131.96 17.3 4.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.108 2.163 . . . . 0.0 111.83 -166.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 t -151.58 137.42 18.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.521 -1.362 . . . . 0.0 108.835 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -108.08 125.49 51.64 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.0 m -130.69 93.71 3.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.04 143.82 31.28 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -122.09 65.91 21.89 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.85 1.26 . . . . 0.0 110.504 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.29 -176.49 2.95 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.031 1.821 . . . . 0.0 110.407 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -162.18 165.53 26.8 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.909 1.284 . . . . 0.0 108.023 -169.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 59.06 -77.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.651 2.38 . . . . 0.0 112.716 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.1 t -160.01 124.0 3.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.328 1.451 . . . . 0.0 107.584 149.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.93 31.31 3.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.947 0.794 . . . . 0.0 112.472 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.96 126.1 28.69 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.773 1.229 . . . . 0.0 111.221 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.04 -159.57 16.23 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.7 p -123.55 116.55 23.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.652 1.181 . . . . 0.0 109.265 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -130.14 -177.57 4.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.538 1.535 . . . . 0.0 110.821 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.1 mt -135.27 148.13 28.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.4 mt -128.11 161.12 29.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.612 1.165 . . . . 0.0 109.574 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -91.13 108.73 20.07 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.63 1.572 . . . . 0.0 108.668 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -119.82 138.63 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 C-N-CA 125.633 1.573 . . . . 0.0 107.954 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 m -79.92 129.33 34.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 117.868 -1.063 . . . . 0.0 108.852 164.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -148.29 71.61 1.17 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.199 1.363 . . . . 0.0 111.527 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -153.49 171.21 19.04 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.157 -0.965 . . . . 0.0 112.227 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.99 144.21 49.95 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.905 1.682 . . . . 0.0 108.827 167.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -117.42 133.8 55.56 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -172.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t 175.02 -171.47 0.06 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.603 2.361 . . . . 0.0 105.867 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 55.29 -107.93 0.88 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -143.21 26.05 1.68 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.16 0.984 . . . . 0.0 110.027 167.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.3 m -150.81 -164.89 2.12 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.002 1.321 . . . . 0.0 110.411 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 p -130.37 99.02 4.87 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.037 2.135 . . . . 0.0 107.856 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -73.05 123.03 22.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.32 161.21 14.39 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.656 0.782 . . . . 0.0 110.045 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.1 mt -138.03 153.49 49.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.223 1.009 . . . . 0.0 108.863 169.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -115.19 164.96 13.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.217 1.407 . . . . 0.0 109.808 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -145.71 165.69 28.03 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -168.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -121.83 153.91 37.74 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 127.441 2.297 . . . . 0.0 109.282 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.426 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -147.45 148.31 31.13 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.974 1.709 . . . . 0.0 108.157 169.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -166.94 154.55 9.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.305 0.642 . . . . 0.0 111.102 168.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.53 -69.23 0.06 OUTLIER Glycine 0 C--N 1.337 0.613 0 CA-C-O 121.322 0.401 . . . . 0.0 113.125 172.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.615 ' H ' HG12 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -75.74 -173.12 2.12 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.585 1.954 . . . . 0.0 109.69 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.21 23.14 11.48 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.5 1.52 . . . . 0.0 113.691 168.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -135.42 -3.24 2.41 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.7 mt -119.3 122.77 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.918 2.087 . . . . 0.0 107.955 -167.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -123.54 165.56 16.93 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.388 -0.82 . . . . 0.0 110.965 -169.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 53' ' ' ALA . 10.7 p -146.64 140.78 20.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.131 0.972 . . . . 0.0 108.56 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.01 66.88 1.48 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.38 -119.05 15.45 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.939 -2.065 . . . . 0.0 107.939 -165.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.5 p -56.82 -25.24 55.54 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.127 1.771 . . . . 0.0 114.265 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 m -93.28 146.62 23.57 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.444 1.097 . . . . 0.0 109.366 -167.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.45 145.17 23.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.585 1.154 . . . . 0.0 109.197 -173.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 m -143.25 154.39 43.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -152.09 125.58 8.84 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 168.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -105.94 114.61 28.86 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.264 10.6 pt-20 -75.37 165.68 24.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.982 0.896 . . . . 0.0 112.939 -166.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.35 149.81 97.93 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.75 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -74.81 -9.57 21.11 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.041 2.494 . . . . 0.0 113.071 -169.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.53 -178.65 3.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.597 1.189 . . . . 0.0 110.728 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.97 13.87 21.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.216 1.806 . . . . 0.0 112.157 -170.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -80.04 152.51 29.36 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 172.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -82.75 138.44 34.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.744 1.218 . . . . 0.0 107.931 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -144.09 92.55 2.34 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.222 1.374 . . . . 0.0 111.327 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.47 HG23 HG22 ' A' ' 97' ' ' VAL . 45.6 m -68.87 115.61 8.4 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.181 -0.324 . . . . 0.0 110.514 173.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.24 162.56 29.69 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.157 0.884 . . . . 0.0 112.91 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.1 tp -162.69 115.11 1.62 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.82 1.248 . . . . 0.0 111.247 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 56' ' ' ASP . 3.2 m -103.19 179.32 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.357 1.063 . . . . 0.0 109.828 164.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 m -129.38 162.87 27.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 163.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -143.74 158.82 43.41 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 125.794 1.638 . . . . 0.0 112.406 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -150.54 159.89 44.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.501 1.12 . . . . 0.0 109.548 168.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -103.76 164.69 11.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.275 1.43 . . . . 0.0 110.256 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -54.99 -57.15 12.84 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.736 1.214 . . . . 0.0 113.345 -172.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -118.59 -6.64 10.67 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.239 0.616 . . . . 0.0 112.468 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.1 m -80.3 -154.64 0.1 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.088 0.955 . . . . 0.0 109.562 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.04 -1.24 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 118.138 -1.368 . . . . 0.0 115.502 173.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -64.1 107.4 1.27 Allowed 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.029 1.914 . . . . 0.0 106.721 170.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.1 p -63.32 155.3 29.09 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 161.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.3 mt -101.74 -166.11 1.26 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 164.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t -146.32 111.68 5.47 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 160.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.9 tp -83.78 122.24 28.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -120.74 154.25 35.89 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -131.43 121.47 48.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 103.711 -2.699 . . . . 0.0 103.711 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 78' ' ' THR . 45.7 t -127.47 105.85 14.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.64 165.84 22.76 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 124.257 1.023 . . . . 0.0 111.142 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -63.51 -177.97 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.516 2.144 . . . . 0.0 110.867 156.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.32 175.11 18.77 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.458 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt . . . . . 0 C--O 1.236 0.351 0 C-N-CA 124.877 1.271 . . . . 0.0 112.054 -173.22 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.447 -0.577 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.67 122.62 45.09 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 168.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -85.85 155.42 20.98 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 164.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -134.72 103.52 5.67 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 2.8 t80 -139.71 86.27 2.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 170.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.67 -170.03 3.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.838 2.055 . . . . 0.0 105.843 171.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -78.18 -89.31 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 166.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.79 -61.97 0.12 Allowed 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 119.073 -2.267 . . . . 0.0 110.788 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 p30 -127.12 2.48 6.47 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.844 2.058 . . . . 0.0 110.697 -167.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.25 -73.08 1.19 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 107.711 -2.155 . . . . 0.0 107.711 170.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.55 -154.8 25.55 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.7 p -79.85 20.11 0.64 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.468 1.907 . . . . 0.0 110.909 171.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.7 t -158.94 156.85 30.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.661 -1.274 . . . . 0.0 108.77 -165.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.9 157.4 46.47 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 157.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.0 m -131.45 152.34 50.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 158.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -133.94 150.78 51.31 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -127.88 74.33 78.7 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 126.11 1.764 . . . . 0.0 107.425 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.33 175.2 4.29 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.346 2.03 . . . . 0.0 109.846 167.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -161.03 173.92 14.51 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.395 -0.816 . . . . 0.0 109.11 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t0 55.93 -84.04 0.01 OUTLIER 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.963 2.505 . . . . 0.0 111.485 -173.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -145.39 125.71 13.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.103 2.561 . . . . 0.0 105.199 148.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 m -148.87 112.34 5.01 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.773 1.169 . . . . 0.0 110.4 163.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.6 179.24 6.68 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.0 1.72 . . . . 0.0 108.668 161.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.33 -176.56 32.91 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 174.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 m -109.17 101.61 10.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.835 1.254 . . . . 0.0 109.876 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -115.36 -165.01 0.99 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.465 1.906 . . . . 0.0 111.166 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.0 mt -127.53 148.14 32.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.586 1.554 . . . . 0.0 107.426 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.5 mt -132.03 165.32 24.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.849 2.059 . . . . 0.0 107.154 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.04 105.91 14.81 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -172.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.7 mt -132.52 142.13 43.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.67 1.588 . . . . 0.0 107.789 -163.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -112.23 129.9 56.11 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.063 1.345 . . . . 0.0 108.226 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -147.78 78.04 1.44 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.084 0.468 . . . . 0.0 110.162 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -157.04 175.76 13.65 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.774 -1.204 . . . . 0.0 111.567 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.58 148.54 43.2 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.989 0.916 . . . . 0.0 109.209 161.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -114.67 123.43 49.26 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 126.506 1.922 . . . . 0.0 107.413 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 t -173.98 -166.66 0.31 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.967 1.707 . . . . 0.0 107.113 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.33 -103.63 0.13 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.184 1.849 . . . . 0.0 109.552 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -147.11 21.14 1.23 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.976 0.91 . . . . 0.0 110.656 171.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 m -156.33 173.92 16.16 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 120.327 -1.483 . . . . 0.0 111.39 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -130.24 105.69 8.08 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.829 1.652 . . . . 0.0 107.087 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -83.23 139.83 32.88 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.2 146.12 45.77 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.641 0.655 . . . . 0.0 110.945 172.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.9 mt -101.77 133.14 46.96 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 165.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -73.2 166.52 22.99 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.753 1.221 . . . . 0.0 109.126 171.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.1 p90 -148.28 179.32 7.86 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.279 1.032 . . . . 0.0 111.844 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.93 172.31 12.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.782 1.633 . . . . 0.0 110.471 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.82 161.13 32.45 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.524 1.93 . . . . 0.0 109.617 169.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.9 p -153.64 140.25 18.88 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 163.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.19 -138.05 5.08 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.56 131.03 6.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.182 2.593 . . . . 0.0 111.076 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 m -80.27 30.99 0.27 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.93 1.292 . . . . 0.0 113.818 -173.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -133.52 23.65 4.04 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.584 1.554 . . . . 0.0 110.299 172.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -144.98 107.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -119.9 164.44 16.05 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.82 1.248 . . . . 0.0 108.925 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.34 152.76 13.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.281 0.562 . . . . 0.0 110.801 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.7 169.18 18.06 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 128.672 2.789 . . . . 0.0 109.433 166.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -58.68 -32.96 70.55 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.879 -0.4 . . . . 0.0 113.538 -177.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.36 11.5 8.7 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 t -153.47 142.81 21.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 119.553 1.069 . . . . 0.0 108.859 -170.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.7 t -120.91 150.97 23.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -171.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -139.0 134.18 32.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 165.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -127.34 138.15 52.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 155.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -99.33 -172.93 2.36 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -101.42 168.96 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.634 1.207 . . . . 0.0 108.825 170.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.483 HD21 ' HA2' ' A' ' 100' ' ' GLY . 27.5 p30 -76.28 160.54 77.62 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 124.738 1.215 . . . . 0.0 108.98 167.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -75.19 -47.23 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.245 1.964 . . . . 0.0 110.549 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.14 165.88 12.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.0 110.696 -170.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.23 2.32 50.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.049 0.94 . . . . 0.0 113.071 -171.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.42 148.85 46.51 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.523 -0.735 . . . . 0.0 110.129 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 139.6 58.38 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.65 0.78 . . . . 0.0 108.945 174.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -129.58 151.02 50.65 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.892 0.877 . . . . 0.0 109.858 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.9 m -120.61 100.65 7.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.849 1.26 . . . . 0.0 107.654 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.97 140.59 33.08 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.1 tp -152.79 103.18 2.75 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 117.886 0.843 . . . . 0.0 108.801 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.3 m -107.59 163.62 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 118.826 0.739 . . . . 0.0 110.592 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.6 m -107.72 158.08 17.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mp -138.22 158.46 44.25 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.313 1.845 . . . . 0.0 108.542 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.21 142.91 18.69 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.662 0.664 . . . . 0.0 110.678 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.523 ' HG2' ' H ' ' A' ' 88' ' ' SER . 7.9 tt0 -77.92 165.32 24.25 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 127.851 2.46 . . . . 0.0 111.013 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.63 -85.95 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.054 2.142 . . . . 0.0 112.719 167.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -89.53 -8.27 53.13 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.896 -1.127 . . . . 0.0 111.957 -168.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.523 ' H ' ' HG2' ' A' ' 85' ' ' GLN . 0.2 OUTLIER -136.95 -153.87 0.52 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.624 2.37 . . . . 0.0 108.076 177.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.92 44.52 0.02 OUTLIER Glycine 0 C--N 1.334 0.433 0 CA-C-N 120.467 1.485 . . . . 0.0 113.228 -151.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 103.18 0.15 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 148.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.6 p -69.25 133.35 47.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.75 155.53 19.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.37 151.65 21.94 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 157.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 tt -149.94 112.38 4.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.09 140.21 51.4 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -128.67 128.53 67.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 167.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.6 t -109.67 96.62 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 168.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -109.07 165.17 13.13 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 118.012 -0.994 . . . . 0.0 108.513 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -55.71 -162.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.553 1 C-N-CA 126.231 4.621 . . . . 0.0 112.906 163.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . 0.483 ' HA2' HD21 ' A' ' 71' ' ' ASN . . . -120.49 168.91 13.97 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 116.745 -2.645 . . . . 0.0 112.679 147.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt . . . . . 0 CA--C 1.536 0.436 0 C-N-CA 124.969 1.308 . . . . 0.0 111.072 -168.188 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -139.95 104.98 4.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.578 2.351 . . . . 0.0 107.878 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -86.02 152.8 22.62 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.797 1.239 . . . . 0.0 109.848 171.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.46 134.16 45.9 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.23 1.412 . . . . 0.0 107.332 -171.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -153.07 62.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.254 0.622 . . . . 0.0 111.173 -173.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.1 p -151.7 -169.24 3.31 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.017 -1.052 . . . . 0.0 110.663 176.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.637 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 70.3 m-85 -75.94 177.0 7.34 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 121.395 -0.816 . . . . 0.0 109.345 157.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.21 -23.7 14.0 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.609 1.164 . . . . 0.0 111.388 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -145.76 3.13 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.491 0.716 . . . . 0.0 112.28 -174.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.83 -79.42 1.46 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.637 ' H ' ' HB2' ' A' ' 13' ' ' TYR . . . 162.57 -125.12 1.37 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.436 1.97 . . . . 0.0 108.923 -172.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 p -135.25 17.19 3.43 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.577 1.551 . . . . 0.0 111.913 -168.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.51 175.11 12.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 120.471 -1.393 . . . . 0.0 110.827 166.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 122.53 32.46 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.785 2.034 . . . . 0.0 107.029 -173.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.474 HG22 ' CE1' ' A' ' 23' ' ' TYR . 26.4 m -149.62 88.27 1.55 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.58 139.24 38.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.474 ' CE1' HG22 ' A' ' 21' ' ' THR . 91.4 m-85 -124.88 74.62 65.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 170.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.89 173.86 11.35 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.258 2.639 . . . . 0.0 110.229 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.61 147.57 25.51 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.496 -0.752 . . . . 0.0 111.41 -169.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 61.86 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.96 2.104 . . . . 0.0 108.974 -164.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.5 t -160.18 114.57 2.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 172.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.18 112.37 8.59 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.01 157.66 44.33 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.467 1.507 . . . . 0.0 109.279 -174.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.88 -178.52 31.55 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 160.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.4 p -102.34 113.73 27.29 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.147 1.379 . . . . 0.0 109.847 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -130.89 -170.2 2.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.78 1.232 . . . . 0.0 112.835 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 mt -131.3 151.66 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.717 2.407 . . . . 0.0 107.194 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.5 mt -131.87 154.82 48.8 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.23 1.812 . . . . 0.0 109.07 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -86.14 55.85 3.72 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.015 1.326 . . . . 0.0 110.099 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.0 mt -71.53 156.85 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.787 1.235 . . . . 0.0 110.327 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 m -127.69 107.69 10.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.135 1.774 . . . . 0.0 109.27 -169.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.37 86.77 1.35 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 122.561 0.344 . . . . 0.0 110.328 -174.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -156.11 165.01 37.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.539 0.336 . . . . 0.0 110.883 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.98 130.92 55.95 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.92 1.688 . . . . 0.0 109.5 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -116.35 127.53 54.75 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.554 1.941 . . . . 0.0 106.781 -170.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.6 t -168.99 143.33 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.93 -104.69 0.77 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -133.8 21.03 3.86 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.003 0.921 . . . . 0.0 111.166 -170.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -149.21 162.89 39.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.874 1.321 . . . . 0.0 110.253 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -132.39 115.23 15.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 130.038 3.335 . . . . 0.0 105.629 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.08 111.36 20.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -170.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.49 157.55 37.4 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.259 0.35 . . . . 0.0 110.804 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.31 130.56 40.96 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.48 1.512 . . . . 0.0 110.76 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -71.12 178.39 3.3 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.43 1.492 . . . . 0.0 110.978 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -147.43 177.35 9.3 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.502 1.121 . . . . 0.0 109.702 168.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.25 165.73 26.42 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.644 1.577 . . . . 0.0 109.85 166.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.33 156.55 44.73 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.225 1.81 . . . . 0.0 109.099 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.1 m -155.35 144.12 20.59 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.314 1.046 . . . . 0.0 110.216 173.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.85 -86.88 0.1 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 167.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.7 160.11 30.89 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.37 1.085 . . . . 0.0 111.426 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -82.47 -8.12 59.62 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -129.87 28.15 5.11 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.748 1.158 . . . . 0.0 112.32 -160.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.8 mt -132.76 101.81 4.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -75.32 133.1 41.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.208 1.003 . . . . 0.0 109.884 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.57 142.35 41.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.963 1.305 . . . . 0.0 109.919 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.16 155.79 41.18 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 126.3 1.84 . . . . 0.0 107.533 177.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.45 -11.13 46.47 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.889 0.757 . . . . 0.0 114.245 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.6 m -134.72 -4.86 2.51 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.451 1.125 . . . . 0.0 113.463 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.7 m -140.05 164.77 29.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.876 1.671 . . . . 0.0 110.361 -167.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.19 154.85 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.588 1.155 . . . . 0.0 108.255 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.1 159.5 42.87 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 158.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -132.8 107.82 8.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 165.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.46 166.89 15.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.508 0.671 . . . . 0.0 109.592 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.91 174.37 6.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -108.5 163.92 15.89 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.851 0.86 . . . . 0.0 111.123 -168.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -89.82 -11.76 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.141 3.228 . . . . 0.0 113.978 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.33 130.69 31.11 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -171.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.28 22.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.451 1.9 . . . . 0.0 112.301 -164.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -66.45 166.48 12.4 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 160.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -85.5 156.07 20.95 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 163.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -135.28 157.67 46.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 164.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.9 m -135.21 97.21 3.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.39 163.83 45.56 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 117.934 0.334 . . . . 0.0 113.112 -168.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 tp -153.84 125.77 7.79 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.786 1.635 . . . . 0.0 109.403 159.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.14 155.01 31.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 160.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.9 m -100.63 156.24 17.42 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 159.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.02 161.25 31.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.373 1.869 . . . . 0.0 107.719 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.424 ' HE2' ' O ' ' A' ' 88' ' ' SER . 68.6 tttt -139.81 145.39 38.1 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -70.91 171.81 10.05 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 168.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -56.27 -65.11 0.66 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.617 0.767 . . . . 0.0 111.855 172.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -118.07 5.18 12.03 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.845 1.258 . . . . 0.0 112.211 -167.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.424 ' O ' ' HE2' ' A' ' 84' ' ' LYS . 17.8 t -135.81 -158.87 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.301 1.44 . . . . 0.0 107.913 162.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.51 72.8 0.36 Allowed Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 106.489 -2.644 . . . . 0.0 106.489 -170.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -61.42 86.74 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 147.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 p -97.5 113.69 25.43 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 104.286 -2.486 . . . . 0.0 104.286 170.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.5 mt -131.61 157.54 43.4 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 m -120.44 114.61 22.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.118 1.326 . . . . 0.0 108.406 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.91 71.43 3.43 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.66 0.743 . . . . 0.0 112.167 -162.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -85.64 82.8 8.09 Favored 'General case' 0 C--O 1.226 -0.184 0 O-C-N 121.066 -1.021 . . . . 0.0 109.423 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.49 125.93 34.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 163.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.52 67.11 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -99.39 151.8 37.56 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 123.711 0.805 . . . . 0.0 112.098 -170.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.03 -172.14 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.724 3.616 . . . . 0.0 112.707 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.72 166.27 22.57 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.228 0 C-N-CA 125.545 1.538 . . . . 0.0 108.691 -163.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 m -92.99 129.44 38.9 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 166.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -106.73 148.51 28.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 162.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -126.66 105.64 8.84 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.414 1.486 . . . . 0.0 107.308 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.08 56.77 1.78 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.777 1.631 . . . . 0.0 109.456 -165.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.9 p -159.78 -175.69 5.29 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.368 1.067 . . . . 0.0 109.136 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -65.85 161.08 21.84 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.46 -15.85 25.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.104 0.961 . . . . 0.0 112.322 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -148.47 41.21 0.95 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.596 0.713 . . . . 0.0 111.434 -170.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.71 -83.63 0.05 OUTLIER Glycine 0 C--N 1.335 0.501 0 O-C-N 121.274 -0.891 . . . . 0.0 111.607 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.65 -125.37 0.78 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 117.136 0.468 . . . . 0.0 113.384 -171.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -139.22 10.51 2.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.102 0.961 . . . . 0.0 112.245 -163.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.39 173.16 17.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.919 2.088 . . . . 0.0 109.498 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -128.53 142.92 50.92 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 127.715 2.406 . . . . 0.0 108.716 173.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -153.22 90.73 1.45 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.716 1.207 . . . . 0.0 108.834 172.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.31 151.03 23.46 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 121.718 -0.614 . . . . 0.0 109.554 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -134.58 69.23 72.57 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.398 1.079 . . . . 0.0 109.342 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.73 175.32 9.07 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.436 2.091 . . . . 0.0 111.117 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -149.19 172.25 15.14 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.377 1.471 . . . . 0.0 107.962 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t0 59.79 -85.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.167 2.587 . . . . 0.0 109.979 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.4 p -142.29 4.13 1.58 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.641 1.176 . . . . 0.0 113.986 -176.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -78.4 67.92 4.29 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -163.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.5 117.74 19.21 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 127.086 2.154 . . . . 0.0 107.899 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.25 -163.09 26.35 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -167.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.4 p -116.99 114.41 23.75 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 117.766 0.783 . . . . 0.0 111.773 -162.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -133.58 -169.92 2.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.752 1.221 . . . . 0.0 110.77 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.8 mt -142.91 146.49 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.819 1.648 . . . . 0.0 107.091 -170.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.5 mt -126.37 175.81 7.58 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.064 1.345 . . . . 0.0 111.396 -171.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -110.81 91.77 3.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -164.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mt -125.92 150.84 31.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -163.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.02 134.14 54.65 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.6 t -153.19 44.88 0.65 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.448 1.099 . . . . 0.0 109.549 -172.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -140.03 169.06 18.39 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 120.73 -1.231 . . . . 0.0 111.765 -172.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -117.63 158.56 24.42 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.56 1.144 . . . . 0.0 109.175 168.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -138.73 135.59 34.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.928 1.691 . . . . 0.0 108.379 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.0 t -176.27 149.47 0.85 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.43 -101.86 0.32 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.959 1.266 . . . . 0.0 111.345 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -141.71 34.29 1.61 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.425 1.09 . . . . 0.0 110.953 -171.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 m -151.52 174.11 13.8 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.96 -1.087 . . . . 0.0 110.58 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -122.44 154.92 37.13 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 155.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -138.62 123.93 19.31 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.46 160.75 26.86 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.959 0.787 . . . . 0.0 109.793 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.81 -159.08 0.68 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 162.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.1 m -130.36 174.92 9.39 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.343 1.857 . . . . 0.0 108.458 169.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -152.51 173.41 15.18 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.691 -0.631 . . . . 0.0 111.761 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -143.55 172.64 12.52 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.062 1.345 . . . . 0.0 109.93 172.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.65 159.24 38.23 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.237 1.815 . . . . 0.0 109.112 -175.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 p 179.18 161.02 0.74 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.647 0.779 . . . . 0.0 111.418 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.66 -78.09 0.09 OUTLIER Glycine 0 C--N 1.334 0.471 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -102.66 -160.72 0.8 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.449 1.5 . . . . 0.0 110.832 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.3 p -123.98 14.59 9.21 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -133.43 28.27 4.03 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.744 1.218 . . . . 0.0 111.013 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -135.68 84.76 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -171.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -59.82 125.17 22.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.3 t -118.71 152.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 163.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.55 173.26 11.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 159.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.44 -50.9 12.89 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -125.99 40.89 3.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.986 0.914 . . . . 0.0 111.169 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.16 163.23 35.01 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.98 0.809 . . . . 0.0 110.647 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.74 142.87 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.323 1.449 . . . . 0.0 107.641 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.89 168.55 26.85 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.337 -1.477 . . . . 0.0 109.047 163.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.99 154.1 41.52 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 172.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.61 151.25 35.3 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 122.718 0.407 . . . . 0.0 110.04 175.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -72.41 169.83 15.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.883 0.849 . . . . 0.0 111.567 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.51 154.09 43.96 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 124.565 1.146 . . . . 0.0 110.514 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.42 -5.68 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.945 2.43 . . . . 0.0 113.426 -166.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.91 167.18 11.18 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.986 0.898 . . . . 0.0 109.971 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -77.12 0.56 21.13 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 120.841 -1.162 . . . . 0.0 111.954 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -59.64 144.03 48.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.153 0.981 . . . . 0.0 108.917 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -77.42 136.71 38.42 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 161.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -122.37 134.14 54.64 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.502 1.121 . . . . 0.0 108.996 -175.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.7 m -122.94 105.32 9.89 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.708 1.203 . . . . 0.0 108.016 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.75 167.28 52.75 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 tp -155.96 59.89 0.59 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.6 t -72.53 148.44 9.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 121.649 -0.657 . . . . 0.0 109.733 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 170.62 8.06 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.54 0.736 . . . . 0.0 109.264 169.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -136.73 163.84 29.67 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.804 1.642 . . . . 0.0 109.444 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 85' ' ' GLN . 48.8 tttt -147.84 172.78 13.6 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.241 2.216 . . . . 0.0 106.621 163.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.46 ' H ' ' HG2' ' A' ' 84' ' ' LYS . 20.8 tt0 -126.24 162.55 25.19 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.398 1.479 . . . . 0.0 107.158 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -56.38 -59.3 5.17 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.685 0.794 . . . . 0.0 111.88 -165.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -99.93 -27.8 13.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 111.529 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -101.65 -162.51 0.94 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.261 1.024 . . . . 0.0 111.811 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.1 67.52 0.41 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -63.03 92.96 0.06 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 152.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.0 p -95.65 103.99 15.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 165.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.98 158.36 16.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.3 m -117.77 125.16 50.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.448 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 5.8 tp -107.92 95.83 5.96 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.476 1.511 . . . . 0.0 107.869 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -108.96 90.36 3.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 mp -72.44 141.59 16.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 160.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.8 t -128.03 92.97 2.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 165.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -112.67 147.45 37.16 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.697 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -67.44 -167.88 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.777 3.652 . . . . 0.0 110.777 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.8 160.28 26.59 Favored Glycine 0 C--O 1.24 0.5 0 O-C-N 121.769 -0.582 . . . . 0.0 111.905 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.238 0 C-N-CA 127.667 2.387 . . . . 0.0 108.191 -171.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 122.649 1.214 . . . . 0.0 107.965 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.2 t -74.02 145.46 44.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.635 1.574 . . . . 0.0 109.207 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -126.95 153.38 45.91 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.906 1.283 . . . . 0.0 109.307 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -134.81 115.28 13.5 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.951 2.1 . . . . 0.0 106.314 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 4.1 t80 -145.07 79.21 1.58 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.3 p -154.33 -175.88 5.61 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.967 0.507 . . . . 0.0 109.827 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.484 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 62.6 m-85 -63.89 165.19 9.05 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 157.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.48 -31.42 11.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.237 1.015 . . . . 0.0 110.972 168.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -130.53 73.77 1.56 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.56 -56.98 0.11 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.261 162.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.484 ' H ' ' HB2' ' A' ' 13' ' ' TYR . . . 158.42 -136.6 4.84 Favored Glycine 0 CA--C 1.52 0.347 0 O-C-N 121.92 -0.753 . . . . 0.0 112.629 -167.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 p -137.58 23.8 2.91 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.25 1.02 . . . . 0.0 112.168 -166.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 t -167.59 166.44 14.06 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.784 1.234 . . . . 0.0 110.845 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.22 135.92 53.65 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.831 2.853 . . . . 0.0 112.647 174.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 m -147.14 84.78 1.59 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.575 1.15 . . . . 0.0 108.005 173.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -83.07 140.75 32.49 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.67 77.19 37.6 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -74.49 168.14 25.51 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 120.939 1.093 . . . . 0.0 109.387 165.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -162.19 160.82 27.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.68 1.992 . . . . 0.0 106.675 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.5 t70 60.53 -80.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.703 1.601 . . . . 0.0 111.918 -167.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 t -165.21 85.64 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.772 1.229 . . . . 0.0 108.009 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.4 m -135.85 24.48 3.35 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.03 122.28 20.62 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.191 1.396 . . . . 0.0 108.895 169.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.31 -175.69 36.85 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 119.042 0.837 . . . . 0.0 111.155 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.4 p -96.59 126.95 42.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.201 1.4 . . . . 0.0 109.029 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -128.39 -177.49 4.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 169.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 mt -139.51 143.19 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 129.645 3.178 . . . . 0.0 105.554 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.7 mt -121.2 -168.68 1.71 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.118 1.767 . . . . 0.0 110.18 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -129.98 51.23 2.11 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.056 1.342 . . . . 0.0 109.026 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.4 mt -82.05 125.0 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.182 0.993 . . . . 0.0 108.937 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 m -71.05 134.68 47.28 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.566 1.546 . . . . 0.0 109.411 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -144.52 108.71 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -167.35 170.84 11.14 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.693 0.759 . . . . 0.0 110.907 160.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.74 135.04 54.38 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.245 1.818 . . . . 0.0 108.105 161.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -114.82 123.17 48.52 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 125.563 1.545 . . . . 0.0 109.347 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 t -159.74 153.24 22.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.88 -82.81 0.07 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.095 1.807 . . . . 0.0 110.687 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -145.92 -1.13 0.78 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.074 1.35 . . . . 0.0 111.539 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 p -134.5 172.62 12.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.128 -1.607 . . . . 0.0 112.461 -162.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.0 p -130.71 123.06 28.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 127.415 2.286 . . . . 0.0 106.877 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.23 109.12 20.42 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.56 155.23 40.82 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.299 0.64 . . . . 0.0 109.545 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.2 mt -121.33 147.27 45.9 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.637 0.775 . . . . 0.0 110.961 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -79.67 160.16 26.42 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 168.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -138.97 174.67 10.27 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.277 1.031 . . . . 0.0 111.737 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -150.01 148.49 29.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.676 1.191 . . . . 0.0 109.47 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.432 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -150.81 160.78 43.65 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.278 1.831 . . . . 0.0 109.458 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 p 174.85 145.99 0.07 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.337 0.655 . . . . 0.0 110.471 -176.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.54 -91.3 0.1 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 168.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.27 164.58 3.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.86 2.064 . . . . 0.0 111.288 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 m -92.46 -1.1 57.22 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.74 1.616 . . . . 0.0 115.143 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . 0.411 ' CZ2' ' HA3' ' A' ' 79' ' ' GLY . 44.7 p-90 -129.54 29.84 5.01 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.198 1.399 . . . . 0.0 108.954 -174.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.0 mt -142.81 88.29 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -88.42 171.89 9.78 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.939 0.896 . . . . 0.0 108.671 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.432 HG11 ' HB3' ' A' ' 53' ' ' ALA . 11.5 p -157.61 157.42 3.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.73 1.212 . . . . 0.0 108.752 166.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.45 -179.34 6.36 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.396 2.678 . . . . 0.0 108.014 172.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -45.18 -51.71 8.76 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.86 1.219 . . . . 0.0 113.544 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.0 m -124.87 -7.83 7.26 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 118.22 -0.895 . . . . 0.0 113.394 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 m -120.67 155.87 32.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.606 1.094 . . . . 0.0 110.625 -169.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -137.69 162.11 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.9 m -147.58 137.44 22.84 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 162.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.431 ' CE1' HD11 ' A' ' 94' ' ' LEU . 6.0 m-85 -123.27 104.07 8.91 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -74.3 173.5 10.13 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 122.208 1.004 . . . . 0.0 112.365 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.471 ' HG3' HE22 ' A' ' 98' ' ' GLN . 4.9 tt0 -83.04 -165.71 1.15 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.153 2.181 . . . . 0.0 109.969 175.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -128.63 165.23 32.94 Favored Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 126.544 1.938 . . . . 0.0 109.492 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -93.91 -10.23 1.62 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.033 2.489 . . . . 0.0 113.226 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.27 139.65 51.73 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.734 1.214 . . . . 0.0 109.114 -171.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 12.12 8.19 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.283 0.633 . . . . 0.0 112.602 -160.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.53 158.25 36.44 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 170.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -67.84 159.28 30.69 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -132.83 145.22 50.77 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 m -118.41 77.69 1.19 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.312 1.445 . . . . 0.0 107.529 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.411 ' HA3' ' CZ2' ' A' ' 58' ' ' TRP . . . -72.2 132.54 19.03 Favored Glycine 0 N--CA 1.464 0.552 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 tp -149.49 70.76 1.08 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.207 1.003 . . . . 0.0 112.3 -166.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.96 164.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.444 0.64 . . . . 0.0 110.337 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -111.93 158.01 19.99 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.271 1.029 . . . . 0.0 108.566 168.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.69 146.35 43.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 127.147 2.179 . . . . 0.0 107.35 -173.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -157.26 168.7 26.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.099 1.359 . . . . 0.0 107.797 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.437 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 5.8 tt0 -119.16 164.77 15.09 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.683 1.129 . . . . 0.0 110.61 -170.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -45.17 -55.87 5.34 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.55 1.94 . . . . 0.0 111.853 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -126.52 -1.73 6.81 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.089 1.756 . . . . 0.0 111.136 -169.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.38 -177.99 3.97 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.828 1.651 . . . . 0.0 110.945 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.4 8.55 0.09 OUTLIER Glycine 0 C--O 1.226 -0.401 0 C-N-CA 118.546 -1.788 . . . . 0.0 115.508 -149.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -78.2 97.29 5.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 p -78.69 114.19 17.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -167.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.16 130.04 35.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.7 m -83.4 125.51 31.76 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 165.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.431 HD11 ' CE1' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -118.94 104.16 10.25 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.969 1.708 . . . . 0.0 106.508 -177.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -119.67 95.02 4.6 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.086 0.954 . . . . 0.0 109.797 -166.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.2 114.65 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 79.5 t -104.19 101.33 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.471 HE22 ' HG3' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -133.05 156.8 79.65 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.705 -177.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.85 -163.19 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.624 1 C-N-CA 126.589 4.859 . . . . 0.0 110.814 172.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.12 168.2 27.12 Favored Glycine 0 N--CA 1.445 -0.711 0 O-C-N 120.658 -1.276 . . . . 0.0 113.708 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.9 pttt . . . . . 0 N--CA 1.464 0.27 0 C-N-CA 126.2 1.8 . . . . 0.0 110.159 175.312 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.45 -0.436 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -136.37 110.26 8.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 165.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -79.29 153.59 29.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 163.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -121.7 117.9 27.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -137.96 60.56 1.62 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.913 0.863 . . . . 0.0 110.951 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 p -154.41 -167.44 2.62 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.45 1.1 . . . . 0.0 109.075 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -65.3 -179.6 0.62 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.375 0.67 . . . . 0.0 111.262 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.56 -28.15 12.34 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 121.316 -0.865 . . . . 0.0 111.573 162.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.89 12.2 2.45 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.354 0.662 . . . . 0.0 111.874 -165.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.71 -67.66 0.14 Allowed Glycine 0 C--N 1.335 0.512 0 O-C-N 121.254 -0.904 . . . . 0.0 113.537 -152.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.38 -126.66 2.85 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -153.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.1 p -144.16 3.63 1.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -171.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 m -162.96 174.53 12.22 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.333 1.424 . . . . 0.0 111.175 174.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 144.1 50.13 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 128.016 2.527 . . . . 0.0 113.962 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -141.6 146.76 36.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.352 1.461 . . . . 0.0 108.139 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -136.77 163.13 31.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.174 -0.954 . . . . 0.0 110.702 157.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -135.88 76.19 53.54 Favored Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.21 171.99 10.68 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.493 2.129 . . . . 0.0 109.213 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -160.54 0.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -153.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -165.9 -73.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.7 t -165.24 97.27 0.71 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.483 1.913 . . . . 0.0 106.879 167.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -123.74 24.49 8.41 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 168.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.83 155.03 40.87 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 166.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.87 -151.12 22.28 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.2 m -135.27 102.55 5.21 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.012 0.906 . . . . 0.0 112.659 -173.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -123.32 -164.63 1.23 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.628 1.171 . . . . 0.0 113.201 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 mt -138.13 158.35 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 127.711 2.405 . . . . 0.0 107.2 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 98.2 mt -132.89 173.1 11.75 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.086 1.755 . . . . 0.0 111.016 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -109.63 88.04 2.65 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.042 -1.037 . . . . 0.0 110.363 -156.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.425 ' CG2' ' HE3' ' A' ' 90' ' ' LYS . 6.6 mt -129.88 158.51 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.646 1.178 . . . . 0.0 109.712 -163.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 m -122.93 142.53 50.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.308 1.043 . . . . 0.0 109.68 -172.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 p -159.99 36.35 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.668 -0.645 . . . . 0.0 112.679 -161.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -128.51 169.3 14.52 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.339 -1.476 . . . . 0.0 110.955 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.8 121.16 38.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.98 1.312 . . . . 0.0 107.49 170.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -90.77 139.81 30.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.0 t -164.91 133.13 3.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 50.0 -98.0 0.02 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.986 1.279 . . . . 0.0 110.845 -173.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -130.43 21.34 5.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.28 1.032 . . . . 0.0 112.27 -164.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 t -148.64 176.72 10.11 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.315 1.416 . . . . 0.0 111.29 167.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 p -136.94 91.87 2.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.65 1.98 . . . . 0.0 109.593 -173.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.49 104.27 5.14 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.65 146.9 44.22 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 172.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.3 mt -117.93 149.03 41.58 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.073 0.949 . . . . 0.0 110.497 -175.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.1 m -65.64 164.58 14.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.495 164.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -144.47 173.81 11.47 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.101 1.36 . . . . 0.0 110.081 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -135.37 175.01 9.98 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.013 0.925 . . . . 0.0 109.778 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.48 152.09 39.23 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 125.531 1.532 . . . . 0.0 109.066 172.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.28 140.15 8.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.58 -127.72 1.66 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.53 ' H ' HG12 ' A' ' 81' ' ' VAL . 3.3 m-20 -61.73 162.35 8.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.941 2.096 . . . . 0.0 111.939 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.21 -18.64 57.58 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.353 1.861 . . . . 0.0 114.23 -168.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -121.22 15.01 11.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.291 1.836 . . . . 0.0 111.682 -165.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.7 mt -118.06 85.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.992 -2.595 . . . . 0.0 103.992 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -83.41 137.5 33.9 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.3 89.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -77.96 86.42 4.16 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -172.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.07 -104.42 0.88 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -97.61 -7.44 31.11 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.277 1.031 . . . . 0.0 113.089 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 m -83.69 164.56 19.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.696 1.135 . . . . 0.0 109.949 174.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.92 158.34 35.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.749 1.62 . . . . 0.0 108.274 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.8 t -156.42 158.53 37.47 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.156 1.782 . . . . 0.0 107.256 166.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -156.98 168.63 26.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 163.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.49 159.15 42.01 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.865 1.266 . . . . 0.0 107.818 -177.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -71.34 164.29 26.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.195 0.997 . . . . 0.0 113.15 -174.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -77.13 144.61 71.86 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.604 1.562 . . . . 0.0 108.623 168.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -90.13 -4.63 5.13 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.649 3.566 . . . . 0.0 113.648 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.98 161.58 13.93 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.173 -0.954 . . . . 0.0 109.927 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.55 62.93 0.85 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 123.334 1.54 . . . . 0.0 107.846 174.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -132.56 176.72 8.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.766 167.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -76.95 157.5 31.25 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 167.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.9 tpt85 -150.5 173.42 14.09 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 t -149.4 165.8 30.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 158.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.6 176.66 20.93 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 156.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tp -157.61 65.48 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.07 0.935 . . . . 0.0 113.109 177.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 56' ' ' ASP . 2.9 m -76.62 171.76 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 121.123 -0.985 . . . . 0.0 111.071 -172.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -123.38 164.74 18.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.78 1.632 . . . . 0.0 108.48 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.04 170.65 11.53 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.817 1.247 . . . . 0.0 109.223 173.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -153.32 172.93 16.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.859 0.864 . . . . 0.0 109.651 161.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -111.7 172.23 7.02 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.379 0.991 . . . . 0.0 110.807 -176.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -56.63 -51.3 69.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.327 1.051 . . . . 0.0 112.153 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -111.17 -42.62 3.9 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.719 0.808 . . . . 0.0 109.766 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.4 -169.65 0.43 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.177 1.391 . . . . 0.0 111.301 -171.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -132.22 42.32 1.4 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 126.117 1.818 . . . . 0.0 109.023 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.425 ' HE3' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -58.34 97.61 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 117.78 0.79 . . . . 0.0 108.942 174.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -110.88 110.8 21.55 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.9 165.77 11.79 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 168.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.0 t -127.13 144.65 50.98 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.389 1.476 . . . . 0.0 107.891 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.83 104.38 8.01 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.606 1.562 . . . . 0.0 108.995 -170.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -116.94 101.4 8.48 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.373 0.669 . . . . 0.0 109.881 -169.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -98.01 86.67 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.48 88.57 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.94 158.77 41.4 Favored Pre-proline 0 C--O 1.24 0.596 0 C-N-CA 124.125 0.97 . . . . 0.0 111.577 -165.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.36 -163.39 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 124.312 3.341 . . . . 0.0 109.377 160.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.92 166.96 29.93 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 171.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.226 -0.145 0 C-N-CA 124.469 1.108 . . . . 0.0 110.404 -176.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -79.72 127.19 31.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 168.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -108.75 152.53 24.72 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.278 0.945 . . . . 0.0 109.646 161.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -129.29 125.18 36.23 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.099 1.76 . . . . 0.0 106.91 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.96 23.42 0.5 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.618 1.967 . . . . 0.0 110.478 -169.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.4 p -149.68 174.08 12.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.3 1.04 . . . . 0.0 110.777 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -75.69 160.31 30.2 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.896 0.878 . . . . 0.0 112.482 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.87 -50.3 15.45 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.804 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -141.22 55.23 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.85 3.11 0.26 Allowed Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.394 -1.276 . . . . 0.0 113.593 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.25 -119.63 6.77 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 119.212 1.506 . . . . 0.0 110.977 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.94 5.58 2.83 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.124 0.962 . . . . 0.0 113.245 -173.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.7 162.51 39.8 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.472 0.709 . . . . 0.0 109.535 170.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.46 ' H ' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -112.71 139.76 48.05 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.065 1.746 . . . . 0.0 108.047 -175.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.2 m -146.9 89.19 1.79 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -91.49 136.16 33.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -118.98 64.37 6.59 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-O 118.678 -0.677 . . . . 0.0 110.307 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.11 -174.19 1.3 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.378 2.052 . . . . 0.0 111.462 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -117.17 -163.46 0.92 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.689 2.396 . . . . 0.0 109.935 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.06 -18.26 63.17 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.727 1.611 . . . . 0.0 112.391 -174.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.0 m -153.09 65.27 0.77 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.259 1.39 . . . . 0.0 112.185 178.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 t -150.95 24.89 0.74 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.16 167.68 4.85 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.092 -1.005 . . . . 0.0 110.495 159.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.01 -152.17 22.96 Favored Glycine 0 C--N 1.341 0.809 0 O-C-N 121.333 -0.854 . . . . 0.0 111.359 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -135.1 100.71 4.64 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.306 1.442 . . . . 0.0 111.017 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -118.83 -177.82 3.41 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.102 1.361 . . . . 0.0 112.717 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 mt -126.82 147.88 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.2 mt -119.49 173.98 6.66 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 127.013 2.125 . . . . 0.0 109.892 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -101.96 51.34 0.83 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 123.553 1.644 . . . . 0.0 109.928 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.0 mt -72.09 139.36 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.428 1.491 . . . . 0.0 107.199 174.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 m -113.37 132.47 55.59 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.9 t -152.49 72.69 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -167.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -158.21 172.73 17.86 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.49 -1.381 . . . . 0.0 111.372 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 146.43 42.76 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.813 0.845 . . . . 0.0 111.225 164.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -123.03 131.3 53.64 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.308 1.843 . . . . 0.0 109.027 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 t -165.89 171.4 12.73 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 105.685 -1.969 . . . . 0.0 105.685 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.49 -103.67 0.06 OUTLIER Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.526 1.536 . . . . 0.0 112.21 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -138.19 18.17 2.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.226 1.41 . . . . 0.0 111.697 -171.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 t -144.81 177.73 8.51 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.583 -1.323 . . . . 0.0 111.16 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.3 p -137.85 121.84 17.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.062 1.345 . . . . 0.0 109.081 167.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -93.22 118.54 31.37 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.9 156.9 28.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.3 0.64 . . . . 0.0 111.401 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.64 HD12 HE21 ' A' ' 85' ' ' GLN . 98.1 mt -120.31 133.8 55.39 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.541 1.136 . . . . 0.0 111.452 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.5 p -69.18 168.98 12.92 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.78 0.832 . . . . 0.0 109.498 164.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -144.09 166.16 25.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.033 0.933 . . . . 0.0 108.905 166.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -133.21 156.56 47.28 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.154 1.781 . . . . 0.0 108.203 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.68 141.24 25.47 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.989 1.316 . . . . 0.0 110.679 -166.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.84 157.92 8.54 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 119.576 1.08 . . . . 0.0 112.286 161.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.8 -100.69 0.15 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.075 1.797 . . . . 0.0 110.441 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.7 157.74 2.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.198 1.399 . . . . 0.0 109.939 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -79.4 -29.44 42.01 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.978 -1.076 . . . . 0.0 112.759 174.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -90.79 16.14 9.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.871 0.868 . . . . 0.0 111.742 -168.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mt -137.55 127.72 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -136.62 150.59 48.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.7 t -137.12 125.75 34.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -85.76 -178.6 6.66 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.916 0.887 . . . . 0.0 109.57 173.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.11 -8.53 43.62 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.989 -1.07 . . . . 0.0 114.435 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.7 p -144.86 -21.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.796 1.298 . . . . 0.0 113.12 166.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.1 m -104.02 156.87 17.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.046 1.294 . . . . 0.0 112.162 -168.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 t -95.63 158.64 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 126.417 1.887 . . . . 0.0 107.639 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.57 142.7 18.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.878 0.871 . . . . 0.0 108.881 163.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -148.74 148.5 30.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 161.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.58 -177.85 6.04 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.953 1.701 . . . . 0.0 109.058 174.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -119.29 165.97 13.6 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.284 1.034 . . . . 0.0 110.313 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.84 144.85 40.07 Favored Pre-proline 0 N--CA 1.453 -0.298 0 C-N-CA 124.147 0.979 . . . . 0.0 110.688 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -82.99 -6.06 11.32 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.68 3.586 . . . . 0.0 113.206 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.31 169.92 17.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.706 -0.621 . . . . 0.0 111.341 -164.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.23 1.87 14.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.602 173.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.21 135.49 46.1 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 165.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -72.26 167.1 21.09 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.331 1.052 . . . . 0.0 109.18 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 -130.4 161.72 30.74 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.515 -0.741 . . . . 0.0 109.255 165.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 46.1 m -137.68 84.13 2.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.45 142.43 48.31 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.1 tp -159.68 72.29 0.52 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 118.984 1.392 . . . . 0.0 112.388 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.24 173.6 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.183 -0.948 . . . . 0.0 109.99 167.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.9 m -117.69 153.02 34.07 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 164.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 mp -125.24 165.69 17.83 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.926 1.291 . . . . 0.0 109.464 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -157.21 161.7 39.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.051 1.74 . . . . 0.0 108.124 173.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.64 HE21 HD12 ' A' ' 49' ' ' LEU . 1.7 tt0 -105.99 169.4 8.52 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.075 1.35 . . . . 0.0 109.852 -164.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.71 -48.97 65.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -118.75 -18.73 8.88 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.2 m -97.53 -167.82 1.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.766 1.226 . . . . 0.0 108.497 162.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.79 31.0 0.15 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 119.21 -0.772 . . . . 0.0 111.427 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.89 112.72 1.96 Allowed 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 168.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 p -79.51 114.18 18.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.9 mp -88.57 165.96 14.47 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.313 1.045 . . . . 0.0 109.028 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.81 125.29 20.55 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.999 1.72 . . . . 0.0 107.838 174.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.12 86.02 5.25 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.328 1.451 . . . . 0.0 107.412 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -72.09 137.55 47.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.339 -1.476 . . . . 0.0 108.566 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 mp -130.62 116.53 35.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 162.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 68.6 t -116.0 71.81 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -106.12 154.41 39.62 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 121.571 -0.706 . . . . 0.0 110.711 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.76 174.64 6.31 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.655 2.903 . . . . 0.0 113.529 -172.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.57 113.63 3.68 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt . . . . . 0 C--O 1.234 0.271 0 CA-C-N 117.778 0.789 . . . . 0.0 110.006 178.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 p . . . . . 0 C--O 1.233 0.23 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 m -113.31 99.54 7.87 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 163.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -74.27 153.17 39.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 161.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -128.1 116.75 20.45 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.08 46.54 1.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.725 1.21 . . . . 0.0 108.983 -170.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 m -154.28 -178.37 7.08 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.107 0.963 . . . . 0.0 110.188 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -74.22 -170.81 1.03 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.498 0.666 . . . . 0.0 109.59 169.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.0 40.14 3.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.667 1.987 . . . . 0.0 109.733 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -156.43 -1.05 0.13 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -161.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.41 -7.42 46.88 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 117.418 -1.768 . . . . 0.0 115.319 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.41 174.11 15.16 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 120.504 2.152 . . . . 0.0 114.035 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.3 p -136.34 44.3 2.42 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.417 1.487 . . . . 0.0 111.054 -176.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.82 165.16 9.86 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.787 -1.195 . . . . 0.0 108.537 165.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.14 141.04 43.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.99 1.316 . . . . 0.0 107.84 165.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.9 m -147.28 146.72 29.85 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 164.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -140.32 157.75 45.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.545 0.688 . . . . 0.0 110.818 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -132.73 66.24 76.09 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.594 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.24 175.32 4.11 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.069 3.179 . . . . 0.0 111.881 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.47 -171.6 2.16 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.968 0.907 . . . . 0.0 110.183 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.69 11.83 0.17 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.062 2.545 . . . . 0.0 115.117 -162.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.1 m -150.52 5.68 0.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.792 1.637 . . . . 0.0 113.635 171.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -95.26 86.94 4.68 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.296 1.407 . . . . 0.0 112.023 -166.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.77 158.48 43.85 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.629 -0.669 . . . . 0.0 112.499 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.86 -149.2 15.61 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 161.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -124.13 113.41 18.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.608 1.163 . . . . 0.0 109.946 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -116.98 -166.75 1.2 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.244 1.018 . . . . 0.0 112.915 176.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.0 mt -132.14 157.08 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 128.067 2.547 . . . . 0.0 106.606 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.0 mt -131.06 172.49 12.03 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.668 1.987 . . . . 0.0 108.764 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -116.13 31.91 6.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.671 1.189 . . . . 0.0 111.918 -173.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.2 mt -52.96 147.91 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.911 2.085 . . . . 0.0 109.98 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 m -113.17 117.36 31.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.342 1.457 . . . . 0.0 107.994 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.9 t -141.46 82.21 1.81 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -153.95 169.21 24.0 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.294 -0.879 . . . . 0.0 111.34 175.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.94 129.6 51.78 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.516 1.527 . . . . 0.0 107.824 173.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -118.06 128.65 54.96 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -174.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 t -168.5 148.22 4.5 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.95 -107.09 0.57 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 125.416 1.484 . . . . 0.0 110.078 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -135.67 28.05 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.215 1.406 . . . . 0.0 110.084 -170.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.1 m -142.82 157.96 44.1 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.904 0.859 . . . . 0.0 111.165 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -123.84 124.71 43.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.477 1.911 . . . . 0.0 106.004 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -97.89 115.26 27.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 166.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.98 130.39 45.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 164.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.89 118.39 26.25 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 167.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 m -67.48 168.49 10.79 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 124.535 1.147 . . . . 0.0 109.541 164.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -150.09 175.46 11.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.797 1.639 . . . . 0.0 107.969 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -132.16 170.48 14.94 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 161.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.46 151.42 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.231 1.012 . . . . 0.0 108.892 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 p -158.98 141.43 14.06 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.989 -0.444 . . . . 0.0 109.815 -172.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.95 -105.1 0.23 Allowed Glycine 0 CA--C 1.52 0.375 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.68 161.62 20.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.381 1.473 . . . . 0.0 111.46 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 m -73.29 -51.83 16.12 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 126.116 1.766 . . . . 0.0 111.617 174.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -72.69 21.15 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.569 2.348 . . . . 0.0 113.21 -166.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.8 mt -133.63 140.5 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -127.17 132.12 50.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.8 t -139.85 110.1 4.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.41 87.0 1.85 Allowed 'General case' 0 N--CA 1.462 0.129 0 O-C-N 121.276 -0.89 . . . . 0.0 109.133 -172.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 47.07 -113.02 1.08 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.591 1.091 . . . . 0.0 110.979 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.9 m -79.81 36.92 0.34 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.834 1.653 . . . . 0.0 113.393 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.9 t -152.86 155.08 36.4 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 120.609 -1.307 . . . . 0.0 109.416 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 t -148.38 149.22 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.76 159.62 44.41 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.853 0.751 . . . . 0.0 110.724 163.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.525 ' CD1' HD11 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -142.83 127.2 17.73 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -81.2 160.27 24.37 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.308 1.052 . . . . 0.0 110.565 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.536 ' CD ' ' HE2' ' A' ' 101' ' ' LYS . 1.7 mt-10 -72.45 165.19 25.09 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 167.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -86.59 164.65 36.65 Favored Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 121.093 -1.005 . . . . 0.0 110.848 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.68 -8.19 5.26 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.242 3.294 . . . . 0.0 113.536 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.87 156.68 47.1 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.088 0.858 . . . . 0.0 110.142 -170.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -92.07 22.32 4.43 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.092 1.357 . . . . 0.0 112.105 -169.615 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -98.64 151.09 21.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -72.46 135.82 45.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.944 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 -113.6 123.5 50.12 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 171.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.3 m -76.55 104.32 7.0 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 155.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.51 142.13 45.61 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 163.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.95 131.43 25.32 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 164.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -139.45 143.39 31.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 165.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.4 m -113.56 156.56 23.41 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.628 1.571 . . . . 0.0 107.236 170.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 92' ' ' LEU . 0.6 OUTLIER -133.85 162.54 31.74 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.66 1.184 . . . . 0.0 110.78 172.002 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -146.06 127.7 15.19 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.549 0.613 . . . . 0.0 109.757 174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -65.2 156.49 31.63 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.006 1.323 . . . . 0.0 111.45 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -50.16 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.763 2.825 . . . . 0.0 112.281 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -72.27 -25.16 61.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.939 1.296 . . . . 0.0 111.092 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.7 -153.15 0.5 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.991 2.117 . . . . 0.0 109.119 -164.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.69 13.74 0.02 OUTLIER Glycine 0 C--N 1.335 0.473 0 CA-C-O 117.158 -1.912 . . . . 0.0 116.595 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -62.86 98.05 0.12 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.609 2.205 . . . . 0.0 106.531 157.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.6 p -65.42 166.92 9.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HB2' HD21 ' A' ' 83' ' ' LEU . 27.7 mt -132.17 144.06 50.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 170.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 m -84.79 129.08 34.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 167.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 34.5 tp -97.52 127.39 43.44 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 156.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -136.64 117.38 14.03 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 68' ' ' TYR . 2.5 mp -109.42 124.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 169.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.9 t -111.97 92.59 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.81 158.5 35.5 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.872 -171.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -69.73 -164.58 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 125.186 3.924 . . . . 0.0 111.726 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.59 161.93 30.45 Favored Glycine 0 C--N 1.334 0.426 0 O-C-N 120.364 -1.46 . . . . 0.0 111.975 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.536 ' HE2' ' CD ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.261 0 C-N-CA 125.088 1.355 . . . . 0.0 111.254 -173.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.0 t . . . . . 0 CA--C 1.536 0.411 0 CA-C-O 120.874 0.369 . . . . 0.0 110.386 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 m -101.24 118.6 37.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.679 1.592 . . . . 0.0 109.672 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -89.1 141.53 28.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.544 0.738 . . . . 0.0 109.314 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -105.1 138.44 41.3 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.601 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 3.9 p90 -153.73 56.17 0.74 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.349 -170.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.6 p -159.45 -172.42 3.71 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.65 -1.281 . . . . 0.0 109.305 170.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -67.92 157.33 35.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.033 1.288 . . . . 0.0 108.172 165.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.74 -12.34 22.4 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.872 1.269 . . . . 0.0 110.603 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.68 74.98 1.47 Allowed 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 153.44 -85.88 0.14 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 159.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -164.61 -123.29 0.64 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -158.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -138.18 28.78 2.53 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.602 0.701 . . . . 0.0 111.072 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.47 144.0 10.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.017 1.281 . . . . 0.0 109.764 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -96.3 148.37 22.82 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 162.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.3 m -142.54 137.88 30.48 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 159.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -112.39 144.12 42.36 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 168.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.62 71.57 38.97 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.02 177.79 6.06 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.423 2.082 . . . . 0.0 111.194 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -151.18 176.77 10.86 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.612 1.165 . . . . 0.0 108.097 173.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 56.51 -74.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.28 2.632 . . . . 0.0 114.184 -172.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.2 t -176.89 82.16 0.02 OUTLIER 'General case' 0 C--O 1.236 0.365 0 C-N-CA 129.002 2.921 . . . . 0.0 105.396 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -132.43 65.83 1.57 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -172.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.83 175.25 6.42 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.767 1.627 . . . . 0.0 110.285 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.06 -162.41 36.22 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 119.612 1.097 . . . . 0.0 112.667 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.0 p -135.69 95.65 3.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.877 1.271 . . . . 0.0 110.093 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -114.3 -177.06 3.04 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.959 0.903 . . . . 0.0 111.992 -173.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.9 mt -127.47 120.42 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.02 172.34 9.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.45 1.1 . . . . 0.0 109.006 171.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -106.08 36.86 2.43 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.905 -1.122 . . . . 0.0 109.546 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.89 134.95 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.067 -1.021 . . . . 0.0 108.346 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.9 138.8 37.23 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.8 p -167.87 83.37 0.19 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -153.76 170.97 19.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.26 120.77 39.99 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 171.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -96.0 146.26 24.76 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.946 0.879 . . . . 0.0 109.193 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.57 176.89 11.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.22 -52.72 8.24 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.142 1.353 . . . . 0.0 112.844 -168.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -131.04 23.71 4.92 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.702 0.801 . . . . 0.0 111.717 -172.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -144.3 150.95 38.68 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 122.462 1.125 . . . . 0.0 109.158 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 p -148.04 85.72 1.55 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.691 1.996 . . . . 0.0 107.688 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -73.9 127.78 33.78 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 166.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.03 164.7 23.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 166.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.55 132.3 54.25 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 126.324 1.85 . . . . 0.0 107.146 164.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.1 m -77.05 174.2 10.93 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.877 0.846 . . . . 0.0 110.069 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -149.87 171.53 16.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.219 1.808 . . . . 0.0 107.932 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.08 174.91 10.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.377 1.871 . . . . 0.0 107.444 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.62 167.67 20.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.593 1.157 . . . . 0.0 109.723 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.0 p -156.41 148.93 23.59 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.633 1.173 . . . . 0.0 108.801 160.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.75 -141.8 8.05 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.543 1.544 . . . . 0.0 109.806 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.62 133.22 46.54 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.307 1.043 . . . . 0.0 110.26 -173.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 m -69.78 3.43 2.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.273 1.829 . . . . 0.0 115.019 -167.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.9 p-90 -117.96 13.74 14.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.121 2.169 . . . . 0.0 111.305 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.4 mt -129.14 99.0 4.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -91.65 144.35 25.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.94 143.23 40.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 166.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.68 172.05 9.59 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.721 2.008 . . . . 0.0 107.108 172.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.45 -15.24 3.98 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.434 1.492 . . . . 0.0 116.336 -167.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.78 4.3 0.75 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.781 1.232 . . . . 0.0 112.82 168.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -128.0 153.42 46.77 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.586 1.539 . . . . 0.0 110.56 -163.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.88 156.54 24.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.079 1.352 . . . . 0.0 108.247 -173.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.98 150.49 34.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 153.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.35 155.11 43.65 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 146.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.0 176.04 5.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.266 166.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -86.44 168.37 13.83 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.768 0.794 . . . . 0.0 110.107 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -70.91 165.46 46.94 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.312 1.045 . . . . 0.0 110.176 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -95.3 -4.36 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.191 2.594 . . . . 0.0 114.293 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.32 166.04 25.59 Favored 'General case' 0 C--O 1.225 -0.228 0 O-C-N 121.362 -0.836 . . . . 0.0 111.834 -172.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 30.94 0.49 Allowed 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.621 -1.299 . . . . 0.0 112.044 -175.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -101.85 -175.96 2.99 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.373 1.069 . . . . 0.0 109.363 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -113.66 127.26 55.98 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 124.389 1.076 . . . . 0.0 111.705 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -159.22 103.19 1.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.816 0.846 . . . . 0.0 109.675 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.6 t -64.76 149.66 48.85 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 155.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.39 177.07 43.82 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 154.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tp -162.24 85.37 0.58 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.767 0.827 . . . . 0.0 109.803 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 m -79.9 169.83 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.217 -0.927 . . . . 0.0 111.123 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.6 m -116.74 153.33 32.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.026 2.131 . . . . 0.0 107.348 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 mp -135.95 163.01 31.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.668 1.187 . . . . 0.0 111.168 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -144.34 143.79 31.14 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.012 1.725 . . . . 0.0 108.003 167.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -79.16 165.96 22.74 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.401 1.48 . . . . 0.0 107.659 165.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.8 -83.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -81.89 -18.21 44.55 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.006 -1.684 . . . . 0.0 112.269 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.11 -162.51 0.94 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.28 26.04 0.24 Allowed Glycine 0 C--O 1.225 -0.424 0 O-C-N 119.66 -1.9 . . . . 0.0 110.919 -168.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 11' ' ' PHE . 12.1 ttpp -47.97 129.93 14.95 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 127.749 2.419 . . . . 0.0 107.447 164.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 52.1 p -118.79 137.66 53.23 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.6 mt -139.49 155.47 47.54 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -102.03 160.17 14.73 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.974 0.91 . . . . 0.0 109.14 164.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tt -136.2 91.29 2.66 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -85.69 147.2 26.47 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.7 mt -137.18 80.09 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.98 93.75 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -171.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -117.18 160.5 37.12 Favored Pre-proline 0 C--O 1.242 0.685 0 C-N-CA 123.637 0.775 . . . . 0.0 110.525 -165.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -62.15 174.93 2.23 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.75 2.3 . . . . 0.0 109.912 165.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.96 162.81 23.12 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 163.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 124.378 1.071 . . . . 0.0 108.487 -173.031 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.782 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -135.17 -175.61 3.98 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 126.339 1.855 . . . . 0.0 108.96 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.8 mtp -125.55 163.94 21.62 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 125.668 1.587 . . . . 0.0 107.275 167.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.06 11.65 1.2 Allowed Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.361 0.981 . . . . 0.0 113.511 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 69.9 m -81.75 159.19 66.88 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 119.194 1.497 . . . . 0.0 110.232 175.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.97 171.63 14.34 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.436 2.091 . . . . 0.0 110.968 171.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.4 p -60.63 148.78 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 123.529 0.732 . . . . 0.0 109.42 168.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.9 m -132.1 123.96 28.2 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 170.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -88.4 155.41 19.71 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 171.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -126.71 118.35 24.56 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 126.971 2.108 . . . . 0.0 105.823 -177.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -150.15 67.98 0.98 Allowed 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.952 0.901 . . . . 0.0 110.226 -166.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -152.27 -169.33 3.32 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 125.026 1.33 . . . . 0.0 109.029 -176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -77.99 -89.98 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 166.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -164.67 -41.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 125.424 1.49 . . . . 0.0 110.846 173.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -107.39 74.75 0.98 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 77.29 21.53 72.91 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 112.999 -1.91 . . . . 0.0 113.408 147.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -153.13 169.93 32.06 Favored Glycine 0 N--CA 1.439 -1.106 0 CA-C-O 122.746 1.192 . . . . 0.0 112.924 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.1 p -135.67 13.7 3.43 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 126.089 1.756 . . . . 0.0 110.474 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p -152.98 125.86 8.4 Favored 'General case' 0 N--CA 1.443 -0.805 0 O-C-N 120.499 -1.375 . . . . 0.0 112.833 -174.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.65 153.37 23.51 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.688 1.195 . . . . 0.0 110.283 175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.5 m -146.88 143.61 28.67 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.988 2.115 . . . . 0.0 105.75 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.77 152.14 50.82 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 119.15 0.886 . . . . 0.0 109.758 170.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -134.16 67.52 73.2 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-O 118.587 -0.72 . . . . 0.0 109.171 -177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -66.59 179.53 2.07 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.308 2.005 . . . . 0.0 112.029 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -149.1 174.9 11.83 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 106.239 -1.763 . . . . 0.0 106.239 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 40.8 t0 56.31 -85.89 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 129.112 2.965 . . . . 0.0 111.172 170.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 36.0 m -153.66 106.25 2.88 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.265 1.826 . . . . 0.0 106.363 161.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.6 m -135.43 107.7 7.26 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.129 -1.607 . . . . 0.0 111.017 167.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -146.56 150.29 35.22 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.635 1.974 . . . . 0.0 108.546 172.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.38 -169.5 40.53 Favored Glycine 0 C--N 1.335 0.519 0 N-CA-C 110.175 -1.17 . . . . 0.0 110.175 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.3 p -100.99 120.57 40.37 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 125.836 1.655 . . . . 0.0 110.256 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -127.12 -173.86 3.01 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.712 0.805 . . . . 0.0 113.065 168.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.5 mt -129.13 155.47 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 C-N-CA 127.219 2.207 . . . . 0.0 106.265 -178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 53.8 mt -135.83 149.68 49.15 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.996 1.271 . . . . 0.0 112.808 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -78.59 87.49 4.54 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.836 1.655 . . . . 0.0 108.941 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.6 mt -123.69 152.69 29.1 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 124.71 1.204 . . . . 0.0 107.958 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.5 m -121.64 133.85 54.98 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 124.474 1.109 . . . . 0.0 109.072 179.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 9.2 t -157.08 81.71 0.92 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.17 0.988 . . . . 0.0 108.522 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -152.27 170.8 19.14 Favored 'General case' 0 C--O 1.233 0.215 0 O-C-N 121.094 -1.004 . . . . 0.0 110.044 173.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.53 126.79 50.02 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 167.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.5 ttmt -98.02 131.17 44.68 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 106.59 -1.633 . . . . 0.0 106.59 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -170.14 162.35 8.82 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.2 -113.35 2.86 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -168.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -141.22 51.55 1.59 Allowed 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.298 1.439 . . . . 0.0 107.337 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 40.6 t -155.15 165.58 36.25 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.61 1.564 . . . . 0.0 109.151 -170.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.4 p -134.71 102.32 5.24 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -71.23 118.34 13.89 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 164.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.37 163.82 10.06 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.705 0.764 . . . . 0.0 109.955 166.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 63.5 mt -134.89 129.36 34.24 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.051 170.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.8 m -59.78 163.47 4.44 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 122.551 1.167 . . . . 0.0 110.139 163.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 44.8 p90 -134.34 165.97 23.9 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.511 -1.222 . . . . 0.0 108.507 170.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -127.95 164.21 22.8 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 124.609 1.164 . . . . 0.0 108.811 173.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -149.53 168.77 22.58 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.465 1.506 . . . . 0.0 109.867 -169.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.405 ' C ' HG13 ' A' ' 81' ' ' VAL . 11.3 p 178.49 168.36 0.84 Allowed 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.74 1.616 . . . . 0.0 110.572 161.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.62 -110.27 0.36 Allowed Glycine 0 CA--C 1.523 0.578 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.83 163.14 14.82 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.925 0.89 . . . . 0.0 110.376 168.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p -71.77 -38.96 70.27 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 125.353 1.461 . . . . 0.0 112.369 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -90.23 21.56 3.74 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.269 1.427 . . . . 0.0 112.831 -159.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.505 HG23 ' CD2' ' A' ' 68' ' ' TYR . 70.5 mt -130.54 133.14 64.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -170.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.0 m-70 -132.42 132.53 42.89 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.372 1.069 . . . . 0.0 109.379 -164.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.4 p -125.81 135.62 63.33 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 CA-C-O 121.834 0.826 . . . . 0.0 110.297 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.71 75.28 1.52 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.457 0.703 . . . . 0.0 109.154 172.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 55.02 -117.22 7.84 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m -77.94 51.04 0.92 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.06 0.944 . . . . 0.0 111.612 174.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -149.63 152.08 34.82 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 174.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.6 t -146.63 139.63 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.013 -1.847 . . . . 0.0 106.013 -174.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.7 m -145.38 150.26 36.24 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 164.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.505 ' CD2' HG23 ' A' ' 59' ' ' ILE . 1.5 m-85 -139.46 119.19 13.19 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 174.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -74.53 161.91 29.3 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 125.473 1.509 . . . . 0.0 110.372 -174.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -86.25 146.18 26.63 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 121.488 -0.757 . . . . 0.0 110.79 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -66.58 144.47 98.65 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 -158.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -86.79 -9.75 6.39 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.525 2.816 . . . . 0.0 115.432 -172.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -151.98 170.08 20.74 Favored 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 124.593 1.157 . . . . 0.0 108.246 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 2.0 mptt -81.12 -12.39 59.26 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 123.775 0.83 . . . . 0.0 113.078 -164.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -59.44 165.14 2.96 Favored 'General case' 0 N--CA 1.45 -0.448 0 O-C-N 123.775 0.672 . . . . 0.0 109.633 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 42.2 ttm-85 -107.5 121.38 44.52 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 168.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 10.1 mmt85 -105.38 170.41 7.9 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 126.448 1.899 . . . . 0.0 108.039 169.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 43.4 m -104.77 109.9 22.03 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 155.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.85 139.09 36.0 Favored Glycine 0 CA--C 1.521 0.428 0 N-CA-C 107.499 -2.24 . . . . 0.0 107.499 163.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.6 tp -138.79 133.09 31.65 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.299 1.049 . . . . 0.0 109.93 -173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.488 HG21 HG21 ' A' ' 59' ' ' ILE . 2.8 t -142.49 148.37 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 119.075 0.852 . . . . 0.0 109.027 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 m -104.82 176.73 5.06 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.491 1.517 . . . . 0.0 109.116 173.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.7 165.24 34.03 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.82 1.248 . . . . 0.0 109.798 162.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -151.94 158.3 42.95 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.782 2.033 . . . . 0.0 108.815 172.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.474 ' HB2' ' H ' ' A' ' 90' ' ' LYS . 26.5 tt0 -97.87 161.32 13.8 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 119.423 1.01 . . . . 0.0 110.309 -173.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -55.81 -69.06 0.15 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.646 1.179 . . . . 0.0 112.99 173.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -88.97 -12.53 41.26 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 119.638 1.108 . . . . 0.0 112.428 -176.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.2 t -132.04 -153.23 0.54 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.852 1.661 . . . . 0.0 109.249 -170.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -141.25 46.87 0.88 Allowed Glycine 0 N--CA 1.442 -0.926 0 N-CA-C 108.465 -1.854 . . . . 0.0 108.465 -164.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.474 ' H ' ' HB2' ' A' ' 85' ' ' GLN 0.35 0.0 OUTLIER -68.18 92.29 0.4 Allowed 'General case' 0 C--N 1.341 0.239 0 CA-C-N 118.238 1.019 . . . . 0.0 108.967 179.546 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 29.0 p -96.47 133.44 40.91 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 174.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -124.88 161.41 26.62 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 166.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -115.44 125.01 52.59 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 168.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.15 132.09 53.42 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 174.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt -128.49 143.92 51.06 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.524 1.53 . . . . 0.0 108.391 171.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 mp -135.45 117.42 21.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.541 -2.022 . . . . 0.0 105.541 168.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 69.6 t -107.31 94.57 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 171.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 16.1 pt20 -106.34 144.08 28.27 Favored Pre-proline 0 C--O 1.241 0.636 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 175.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -66.09 156.88 62.48 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.208 1.939 . . . . 0.0 107.624 165.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -94.07 166.88 27.5 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 121.269 -0.491 . . . . 0.0 113.418 -169.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.62 159.34 39.82 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 125.336 1.454 . . . . 0.0 109.636 -174.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.0 p -145.27 89.41 1.94 Allowed 'General case' 0 C--O 1.239 0.551 0 C-N-CA 126.496 1.918 . . . . 0.0 106.085 160.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 m -147.42 156.65 43.07 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -178.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 42.8 pt -74.28 45.04 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 124.515 1.126 . . . . 0.0 112.878 -176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.07 0 O-C-N 119.89 -1.756 . . . . 0.0 106.655 -176.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.202 0 CA-C-O 117.433 -1.759 . . . . 0.0 108.728 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 31.6 p80 46.43 -164.37 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.542 1.137 . . . . 0.0 111.507 -168.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 tpt -136.74 171.99 13.67 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 141.8 139.62 3.67 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 110.071 -1.212 . . . . 0.0 110.071 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.3 p -169.67 163.19 6.92 Favored Pre-proline 0 C--O 1.241 0.628 0 C-N-CA 126.28 1.832 . . . . 0.0 107.814 170.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -66.36 156.82 63.3 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 121.728 1.619 . . . . 0.0 109.509 167.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.1 p -59.11 138.42 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 172.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.4 m -102.02 101.98 12.43 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 176.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -76.53 154.57 34.44 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 168.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -137.63 120.92 16.93 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 128.124 2.57 . . . . 0.0 105.424 178.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -148.32 43.87 1.04 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.239 1.016 . . . . 0.0 110.255 -175.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 p -141.83 -176.75 4.89 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.886 1.274 . . . . 0.0 109.673 178.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -69.38 -176.5 0.97 Allowed 'General case' 0 CA--C 1.537 0.472 0 O-C-N 120.868 -1.145 . . . . 0.0 111.856 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -122.03 -20.79 6.18 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 162.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -85.92 -6.85 59.0 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 -161.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 114.07 64.18 0.43 Allowed Glycine 0 C--N 1.336 0.574 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 167.06 -165.16 38.39 Favored Glycine 0 CA--C 1.528 0.853 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.8 p -151.49 45.23 0.79 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 125.246 1.418 . . . . 0.0 112.691 170.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.75 179.11 6.76 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.209 -1.557 . . . . 0.0 109.692 169.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.1 113.8 14.96 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.113 1.765 . . . . 0.0 107.955 172.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 4.5 m -133.72 130.24 37.85 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.041 -1.836 . . . . 0.0 106.041 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -129.65 147.1 51.41 Favored 'General case' 0 CA--C 1.513 -0.48 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 174.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -124.12 67.24 43.78 Favored Pre-proline 0 N--CA 1.452 -0.344 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HG2' ' HB3' ' A' ' 98' ' ' GLN . 98.5 Cg_endo -69.44 177.09 5.7 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 121.83 1.687 . . . . 0.0 110.879 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -143.47 173.92 11.21 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 125.891 1.677 . . . . 0.0 107.29 -177.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 55.19 -85.25 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.688 1.995 . . . . 0.0 112.234 167.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 71.2 m -154.36 102.59 2.44 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 127.6 2.36 . . . . 0.0 107.977 156.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.4 m -131.62 88.84 2.62 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 119.909 1.231 . . . . 0.0 111.22 173.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.61 167.12 23.0 Favored 'General case' 0 C--O 1.237 0.442 0 C-N-CA 126.435 1.894 . . . . 0.0 110.177 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.52 -161.1 31.1 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 176.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 p -97.42 123.42 41.25 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.774 1.229 . . . . 0.0 109.078 175.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -139.32 -169.22 2.62 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.711 1.605 . . . . 0.0 110.219 175.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.6 mt -138.39 144.91 29.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 C-N-CA 125.268 1.427 . . . . 0.0 107.232 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 78.5 mt -129.21 161.84 29.22 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 125.597 1.559 . . . . 0.0 107.456 170.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 26.5 m-20 -114.91 103.24 10.74 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 118.995 0.816 . . . . 0.0 111.447 -163.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 mp -119.3 138.7 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 125.83 1.652 . . . . 0.0 109.126 -172.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.4 m -91.34 110.92 22.23 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.242 1.417 . . . . 0.0 109.536 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 67.5 m -138.27 78.68 1.69 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -175.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.2 p90 -160.36 164.78 32.19 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 123.381 0.672 . . . . 0.0 111.345 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.24 151.83 29.16 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.073 0.949 . . . . 0.0 109.363 166.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.0 ttmt -121.67 125.68 47.22 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 127.163 2.185 . . . . 0.0 108.917 178.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.6 t -167.44 162.45 14.57 Favored 'General case' 0 C--O 1.242 0.682 0 C-N-CA 124.108 0.963 . . . . 0.0 109.014 174.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 58.19 -101.69 0.21 Allowed Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 125.982 1.753 . . . . 0.0 109.62 -172.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -142.57 35.97 1.46 Allowed 'General case' 0 C--O 1.236 0.343 0 C-N-CA 124.904 1.281 . . . . 0.0 110.403 -176.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.1 m -155.81 169.54 24.15 Favored 'General case' 0 C--O 1.236 0.363 0 O-C-N 121.133 -0.98 . . . . 0.0 110.485 -179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 17.5 p -115.37 155.71 26.86 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 156.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -138.86 121.99 16.87 Favored 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 126.097 1.759 . . . . 0.0 106.537 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.88 158.11 28.81 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.713 0.633 . . . . 0.0 109.812 174.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 82.6 mt -121.61 140.9 51.66 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 169.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 75.6 m -67.41 170.68 7.02 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 124.68 1.237 . . . . 0.0 109.839 172.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 41.8 p90 -138.63 174.56 10.41 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.782 1.233 . . . . 0.0 109.011 169.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -107.29 150.81 26.27 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 156.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -124.43 145.79 49.29 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 156.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.7 m -155.31 124.33 6.19 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -173.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -149.86 -161.23 9.71 Favored Glycine 0 N--CA 1.45 -0.377 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 -156.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -94.72 19.14 10.4 Favored 'General case' 0 N--CA 1.469 0.481 0 N-CA-C 112.93 0.715 . . . . 0.0 112.93 -171.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.1 m 76.36 8.05 3.35 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 130.018 3.327 . . . . 0.0 114.874 168.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -111.83 7.34 20.09 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.487 0.715 . . . . 0.0 112.435 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 mt -135.39 140.6 44.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 -171.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -134.82 140.52 45.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.925 2.09 . . . . 0.0 107.736 -174.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 27.3 t -141.89 109.69 2.23 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 173.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.23 172.36 8.16 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.191 1.396 . . . . 0.0 109.689 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -60.24 -12.73 25.43 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.531 1.062 . . . . 0.0 114.477 -174.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.1 m -156.35 34.85 0.32 Allowed 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.85 1.325 . . . . 0.0 110.476 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.6 t -159.25 161.95 36.08 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 119.664 1.12 . . . . 0.0 109.722 -170.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.7 p -150.18 139.43 15.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 124.584 1.154 . . . . 0.0 109.712 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.7 m -143.11 154.6 44.09 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.26 -0.9 . . . . 0.0 109.073 172.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -145.1 154.32 42.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 160.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -92.46 -166.2 1.49 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 166.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.425 ' HG2' HE21 ' A' ' 98' ' ' GLN . 19.0 mt-10 -118.47 169.84 9.44 Favored 'General case' 0 C--O 1.24 0.576 0 CA-C-O 122.901 1.334 . . . . 0.0 109.293 168.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -82.56 154.19 68.46 Favored Pre-proline 0 C--N 1.324 -0.524 0 C-N-CA 125.959 1.704 . . . . 0.0 112.247 -175.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -88.99 -4.52 6.06 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 123.968 3.112 . . . . 0.0 114.853 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.18 167.79 10.38 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 123.716 0.806 . . . . 0.0 109.153 176.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.552 ' HE2' HG21 ' A' ' 102' ' ' THR . 0.0 OUTLIER -92.62 -3.28 55.22 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.964 0.905 . . . . 0.0 112.889 -169.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -77.5 164.16 25.67 Favored 'General case' 0 C--N 1.329 -0.293 0 O-C-N 122.037 -0.414 . . . . 0.0 110.779 179.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.4 mtm-85 -95.92 135.3 37.85 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 124.879 1.272 . . . . 0.0 107.998 173.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.9 mtt-85 -145.32 119.02 9.17 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 171.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 85.5 m -59.02 123.61 17.15 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 172.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -70.93 153.73 51.54 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.426 -1.07 . . . . 0.0 110.426 168.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 23.5 tp -146.85 117.52 7.56 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.504 1.522 . . . . 0.0 108.251 177.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 1.7 p -135.62 165.64 29.6 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 C-N-CA 126.528 1.931 . . . . 0.0 106.235 165.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.0 m -124.96 171.52 10.14 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.814 1.646 . . . . 0.0 106.924 -177.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.513 HD21 ' HB2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -145.83 156.66 43.71 Favored 'General case' 0 CA--C 1.511 -0.52 0 O-C-N 121.507 -0.745 . . . . 0.0 109.275 153.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -147.21 134.88 21.06 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.184 1.394 . . . . 0.0 107.361 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -69.05 174.66 4.34 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.89 0.876 . . . . 0.0 112.03 -178.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 39.2 t0 -63.56 -84.97 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 128.2 2.6 . . . . 0.0 111.365 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -74.68 -32.65 62.28 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.083 -1.011 . . . . 0.0 110.343 -178.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.8 m -78.4 -159.11 0.15 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.731 1.213 . . . . 0.0 111.122 -172.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.84 18.04 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 N-CA-C 116.775 1.47 . . . . 0.0 116.775 -175.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.3 mtpm? -63.8 170.6 3.27 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.284 2.042 . . . . 0.0 108.451 146.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.1 p -134.35 156.28 48.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 172.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.513 ' HB2' HD21 ' A' ' 83' ' ' LEU . 58.5 mt -113.75 167.48 10.59 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 163.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.4 m -135.49 117.84 15.68 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 -172.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.77 122.62 33.67 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 107.371 -1.344 . . . . 0.0 107.371 172.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 5.1 mtpm? -128.53 91.63 3.27 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.431 HD12 ' H ' ' A' ' 96' ' ' ILE . 3.4 mp -83.98 122.27 37.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 169.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 53.5 t -105.15 91.09 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 105.555 -2.017 . . . . 0.0 105.555 165.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.425 HE21 ' HG2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -111.66 146.42 34.67 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-O 118.454 -0.784 . . . . 0.0 109.124 -176.018 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.74 175.52 10.16 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 125.142 3.895 . . . . 0.0 110.694 169.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -105.97 173.38 19.88 Favored Glycine 0 CA--C 1.521 0.468 0 N-CA-C 115.722 1.049 . . . . 0.0 115.722 -174.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -144.65 -177.67 5.62 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 125.252 1.421 . . . . 0.0 111.486 -177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.552 HG21 ' HE2' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -159.68 96.68 1.27 Allowed 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 126.286 1.835 . . . . 0.0 106.556 171.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.6 m -145.98 164.64 31.41 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.404 1.081 . . . . 0.0 110.827 171.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 15.6 pt -74.45 64.88 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 C-N-CA 125.703 1.601 . . . . 0.0 109.367 172.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 47.8 t0 . . . . . 0 C--O 1.254 1.298 0 CA-C-O 117.53 -1.224 . . . . 0.0 108.525 -161.346 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.156 0 N-CA-C 107.842 -2.103 . . . . 0.0 107.842 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 74.34 -179.51 0.19 Allowed 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.708 1.603 . . . . 0.0 112.286 164.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -153.86 172.6 17.13 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.975 2.51 . . . . 0.0 107.316 -166.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.34 -5.4 8.77 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.543 1.068 . . . . 0.0 113.197 174.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.4 p -58.39 152.17 45.24 Favored Pre-proline 0 CA--C 1.541 0.618 0 CA-C-N 118.364 1.082 . . . . 0.0 110.013 173.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -69.08 169.08 18.87 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.434 2.09 . . . . 0.0 112.52 -172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 p -58.04 151.41 3.86 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.384 1.074 . . . . 0.0 110.048 166.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 8.3 t -135.5 106.17 6.53 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.666 1.586 . . . . 0.0 107.182 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 -83.85 153.88 23.78 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 172.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -130.63 146.28 52.09 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.399 1.88 . . . . 0.0 108.273 177.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -168.51 42.02 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.235 1.014 . . . . 0.0 111.819 -160.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 89.4 p -142.52 176.73 8.79 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 120.749 -1.22 . . . . 0.0 111.03 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -84.64 158.99 20.68 Favored 'General case' 0 C--O 1.241 0.642 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 165.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.26 -26.0 59.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 122.572 0.349 . . . . 0.0 111.829 178.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -67.09 -8.23 29.05 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.183 1.393 . . . . 0.0 113.24 -174.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 115.33 2.66 21.44 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 124.382 0.991 . . . . 0.0 112.948 173.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -125.53 177.3 17.06 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 119.24 1.52 . . . . 0.0 112.23 -173.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.5 p -117.63 25.68 10.24 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.328 1.051 . . . . 0.0 109.628 172.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 39.3 t -144.85 147.95 33.42 Favored 'General case' 0 N--CA 1.45 -0.471 0 O-C-N 121.49 -0.756 . . . . 0.0 109.212 171.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -99.52 140.4 33.76 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.888 1.675 . . . . 0.0 107.581 166.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.3 m -142.13 92.32 2.42 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.654 -1.609 . . . . 0.0 106.654 168.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -76.17 152.9 36.54 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.058 174.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -129.54 83.79 63.71 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 168.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -77.51 170.57 19.07 Favored 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.726 2.951 . . . . 0.0 110.46 171.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -155.4 165.68 35.88 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.872 1.669 . . . . 0.0 107.457 177.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.8 t70 66.62 -78.69 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.104 2.161 . . . . 0.0 113.576 158.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 70.3 m -75.91 5.48 6.41 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 120.475 1.488 . . . . 0.0 112.859 165.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . 0.255 3.8 p 58.81 -163.8 0.21 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.333 1.453 . . . . 0.0 111.173 178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.11 172.45 0.2 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.306 1.042 . . . . 0.0 112.465 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -167.51 -160.1 14.31 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 -176.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -122.37 112.48 18.15 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -174.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 11.0 p90 -131.76 -168.88 2.1 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.278 1.431 . . . . 0.0 110.762 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.8 mt -134.66 111.38 14.12 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.993 1.717 . . . . 0.0 107.159 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 74.2 mt -82.51 158.11 23.3 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.565 1.146 . . . . 0.0 110.859 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -93.56 80.69 4.31 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 174.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.0 mt -104.53 128.82 57.8 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -95.57 120.03 35.11 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.644 1.178 . . . . 0.0 108.758 174.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 52.1 p -147.64 93.61 2.24 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 118.831 0.742 . . . . 0.0 109.209 172.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.7 p90 -157.06 169.11 25.56 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.278 0.631 . . . . 0.0 109.413 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.21 120.14 30.45 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 125.403 1.481 . . . . 0.0 107.472 172.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 35.6 tttt -93.47 132.62 37.56 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 177.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.3 t -168.14 154.78 7.63 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 54.18 -101.26 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 176.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -144.97 53.05 1.21 Allowed 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 122.597 1.189 . . . . 0.0 109.119 174.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 75.4 m -155.34 168.01 28.49 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.534 -1.354 . . . . 0.0 110.862 172.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.29 87.76 2.55 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.416 1.486 . . . . 0.0 107.848 169.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -67.29 116.0 7.58 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 176.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.79 153.04 44.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 172.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -118.23 138.78 52.11 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 168.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 39.7 m -84.23 177.08 8.34 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 123.691 0.619 . . . . 0.0 110.042 168.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . 0.604 ' HE1' HG21 ' A' ' 61' ' ' VAL . 36.4 p90 -132.9 169.91 16.09 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.829 1.252 . . . . 0.0 107.669 166.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -130.68 134.24 46.77 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -116.77 149.71 39.49 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.605 1.162 . . . . 0.0 109.614 -171.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 13.9 p -165.33 144.78 6.64 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.525 0.679 . . . . 0.0 112.002 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 145.15 -119.15 1.19 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 -177.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -47.97 147.39 2.08 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.904 2.082 . . . . 0.0 113.368 -176.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.0 m -75.16 -12.91 60.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.021 1.328 . . . . 0.0 114.313 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -116.28 20.29 14.35 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 124.741 1.216 . . . . 0.0 111.259 -164.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.2 mt -133.97 104.31 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 104.406 -2.442 . . . . 0.0 104.406 -169.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -117.17 144.57 44.59 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -166.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.604 HG21 ' HE1' ' A' ' 51' ' ' TRP . 2.8 p -145.56 140.39 22.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.386 0.613 . . . . 0.0 110.961 -177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -152.7 88.51 1.34 Allowed 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 176.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.12 -123.35 24.55 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.925 1.25 . . . . 0.0 112.056 177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.7 p -81.22 56.53 2.88 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.674 1.19 . . . . 0.0 110.034 171.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.2 m -152.28 148.6 27.73 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.863 1.665 . . . . 0.0 106.837 169.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.13 159.28 42.28 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 162.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.0 m -136.72 150.46 48.44 Favored 'General case' 0 N--CA 1.44 -0.93 0 N-CA-C 105.876 -1.898 . . . . 0.0 105.876 147.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -130.66 163.22 27.67 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 162.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -124.53 168.39 13.16 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.107 1.363 . . . . 0.0 108.813 178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -120.47 161.67 20.85 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.95 0.881 . . . . 0.0 110.287 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -90.92 165.32 22.4 Favored Pre-proline 0 C--N 1.324 -0.522 0 C-N-CA 125.009 1.324 . . . . 0.0 111.622 -162.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.27 -34.59 0.55 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.133 1.888 . . . . 0.0 111.704 -173.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -86.02 162.69 18.36 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-O 121.851 0.834 . . . . 0.0 109.447 -174.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -82.25 12.91 3.86 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.131 -0.981 . . . . 0.0 110.408 169.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -68.75 164.41 21.81 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 162.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.4 ttp180 -124.03 132.93 53.74 Favored 'General case' 0 C--O 1.237 0.42 0 O-C-N 121.566 -0.709 . . . . 0.0 109.36 -170.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.5 mmm-85 -130.08 90.69 3.0 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.591 0.632 . . . . 0.0 111.365 -154.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.5 m -70.04 105.09 2.75 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -80.43 160.97 44.36 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-O 118.842 -0.977 . . . . 0.0 111.311 172.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.7 tp -159.93 72.82 0.52 Allowed 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.435 1.118 . . . . 0.0 113.433 -168.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 25.2 t -88.12 150.17 3.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 O-C-N 120.266 -1.521 . . . . 0.0 109.947 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 56.6 m -91.61 150.03 21.37 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 168.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.14 105.94 5.16 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.887 0.875 . . . . 0.0 109.271 162.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -95.19 141.76 28.42 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 125.277 1.431 . . . . 0.0 109.173 170.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -64.39 163.44 13.15 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.994 1.318 . . . . 0.0 110.801 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -56.28 -37.12 69.41 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.99 1.316 . . . . 0.0 112.905 171.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -135.59 -28.01 1.14 Allowed 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 -167.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.0 t -78.96 -156.42 0.1 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 166.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -156.42 -11.73 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.32 0 CA-C-O 118.323 -1.265 . . . . 0.0 114.475 -172.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.8 tmtp? -59.46 110.37 1.09 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 119.371 1.585 . . . . 0.0 110.388 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 24.0 p -76.07 116.63 16.96 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 72.9 mt -83.03 118.29 23.42 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 m -75.96 145.0 40.66 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 tt -138.07 106.36 5.78 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 -170.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 mtpt -121.32 87.62 2.79 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 123.596 0.759 . . . . 0.0 110.024 -170.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -67.19 123.97 21.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 167.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.1 t -115.18 93.1 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.937 -2.245 . . . . 0.0 104.937 163.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -106.3 157.55 34.67 Favored Pre-proline 0 C--O 1.237 0.442 0 CA-C-O 117.641 -1.171 . . . . 0.0 109.641 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -69.94 -164.63 0.14 Allowed 'Trans proline' 0 CA--C 1.539 0.742 1 C-N-CA 125.416 4.078 . . . . 0.0 111.374 172.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -132.63 143.6 15.28 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.017 0.818 . . . . 0.0 111.645 -176.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 11.4 ttmt -93.94 160.9 14.52 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 127.34 2.256 . . . . 0.0 111.262 -168.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.32 92.48 0.98 Allowed 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 170.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 11.7 m -144.66 172.87 12.38 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 121.547 0.689 . . . . 0.0 110.927 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.0 mt -77.47 81.27 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 105.681 -1.97 . . . . 0.0 105.681 169.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 38.4 t0 . . . . . 0 C--O 1.248 0.974 0 C-N-CA 124.672 1.189 . . . . 0.0 110.431 173.392 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.992 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.7 m170 -61.55 165.42 4.94 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.257 1.028 . . . . 0.0 108.666 156.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.1 mmt -145.81 168.28 21.16 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 127.658 2.383 . . . . 0.0 105.621 161.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 163.0 178.06 36.5 Favored Glycine 0 CA--C 1.521 0.429 0 N-CA-C 110.249 -1.141 . . . . 0.0 110.249 178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.3 p -144.65 150.33 46.66 Favored Pre-proline 0 C--O 1.24 0.57 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 177.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.48 170.35 18.69 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.675 2.25 . . . . 0.0 110.677 -177.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.6 t -70.49 112.22 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 124.161 0.984 . . . . 0.0 108.989 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 18.7 t -81.03 140.14 35.32 Favored 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 173.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -115.81 104.6 11.81 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 125.624 1.57 . . . . 0.0 109.216 177.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -85.3 114.75 22.62 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 1.7 t80 -147.89 77.09 1.41 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.7 m -152.05 169.37 22.53 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.122 0.969 . . . . 0.0 108.59 -177.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' CZ ' ' HB2' ' A' ' 20' ' ' HIS . 86.8 m-85 -68.54 169.85 10.22 Favored 'General case' 0 C--O 1.239 0.525 0 CA-C-O 121.371 0.605 . . . . 0.0 109.604 164.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.47 -14.44 28.48 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.791 0.836 . . . . 0.0 111.457 164.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.4 p30 -105.66 -4.94 20.45 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -162.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -172.09 -56.41 0.04 OUTLIER Glycine 0 C--N 1.335 0.473 0 O-C-N 121.903 -0.498 . . . . 0.0 112.533 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 173.14 -115.27 0.55 Allowed Glycine 0 C--N 1.335 0.511 0 CA-C-N 118.792 1.296 . . . . 0.0 112.271 -168.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 41.5 p -127.05 19.56 7.03 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.629 0.772 . . . . 0.0 112.079 -170.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 48.8 m -149.88 157.46 43.2 Favored 'General case' 0 CA--C 1.53 0.201 0 O-C-N 120.349 -1.469 . . . . 0.0 110.546 167.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.42 ' HB2' ' CZ ' ' A' ' 13' ' ' TYR . 8.4 t60 -123.92 152.61 42.23 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 165.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.1 m -143.55 133.7 24.38 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 174.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.5 156.6 38.73 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 124.869 1.268 . . . . 0.0 108.162 -178.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -140.81 54.7 4.91 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 126.735 2.014 . . . . 0.0 111.389 -167.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.67 165.54 31.66 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 CA-C-N 120.91 1.361 . . . . 0.0 110.858 -176.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -159.5 162.46 35.53 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.936 0.895 . . . . 0.0 109.672 -176.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.6 t70 67.26 -76.18 0.05 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 126.885 2.074 . . . . 0.0 110.347 -172.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.0 t -162.13 89.73 0.72 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.828 1.251 . . . . 0.0 108.115 172.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -139.25 98.32 3.49 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 119.605 1.093 . . . . 0.0 112.123 171.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.12 168.46 19.96 Favored 'General case' 0 C--O 1.237 0.443 0 O-C-N 121.11 -0.994 . . . . 0.0 109.285 167.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.6 -165.79 32.6 Favored Glycine 0 C--N 1.336 0.528 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 167.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 94.1 p -82.25 132.54 35.23 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 169.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 23.0 p90 -144.76 -177.58 5.58 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.698 1.199 . . . . 0.0 109.692 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 38.9 mt -129.02 157.47 41.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.627 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 65.4 mt -136.47 147.31 47.1 Favored 'General case' 0 C--O 1.232 0.181 0 C-N-CA 126.594 1.958 . . . . 0.0 107.822 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.52 93.54 6.69 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 64.2 mt -119.72 131.42 72.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.71 1.204 . . . . 0.0 108.459 -175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 84.4 m -91.05 138.84 31.3 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.323 1.449 . . . . 0.0 108.854 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.9 p -155.88 74.89 0.88 Allowed 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.796 -0.565 . . . . 0.0 110.6 -173.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -155.73 172.58 18.08 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.129 -0.982 . . . . 0.0 112.92 -178.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.27 135.58 52.66 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 124.644 1.178 . . . . 0.0 109.86 172.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -114.34 128.9 56.58 Favored 'General case' 0 CA--C 1.511 -0.552 0 C-N-CA 125.367 1.467 . . . . 0.0 109.406 -172.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.4 t -170.29 159.23 7.1 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.46 0.704 . . . . 0.0 109.476 -179.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.61 -93.4 0.08 OUTLIER Glycine 0 C--N 1.336 0.543 0 C-N-CA 125.1 1.333 . . . . 0.0 110.258 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -153.65 36.12 0.45 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.285 1.434 . . . . 0.0 109.508 174.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t -149.19 164.91 33.4 Favored 'General case' 0 C--O 1.236 0.394 0 O-C-N 120.906 -1.121 . . . . 0.0 111.094 -177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.6 p -130.79 114.19 15.02 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.761 1.624 . . . . 0.0 107.939 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 31.0 mtpt -88.7 130.09 35.39 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 163.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.57 165.05 21.91 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 124.0 0.813 . . . . 0.0 108.94 166.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.423 ' HB3' ' HG2' ' A' ' 85' ' ' GLN . 2.1 mm? -127.48 128.12 45.2 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.076 1.351 . . . . 0.0 108.473 173.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.5 m -73.85 163.35 28.05 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.631 0.729 . . . . 0.0 109.494 168.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 32.8 p90 -139.33 172.56 12.64 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 126.81 2.044 . . . . 0.0 109.565 -176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -143.68 164.04 31.57 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 167.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -118.18 -176.18 3.01 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.713 1.605 . . . . 0.0 110.413 -172.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 m 174.59 143.77 0.05 Allowed 'General case' 0 C--O 1.239 0.516 0 C-N-CA 128.042 2.537 . . . . 0.0 109.184 151.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -171.92 -110.1 0.23 Allowed Glycine 0 N--CA 1.448 -0.559 0 N-CA-C 110.805 -0.918 . . . . 0.0 110.805 167.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.73 142.61 54.94 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 124.355 1.062 . . . . 0.0 108.795 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 9.2 m -65.63 -8.21 19.13 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.134 1.161 . . . . 0.0 114.134 -177.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 61.2 p-90 -111.08 15.5 21.6 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.347 1.459 . . . . 0.0 111.853 -174.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 53.7 mt -128.88 133.29 66.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -130.46 147.64 52.18 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.729 1.212 . . . . 0.0 109.475 -173.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 43.6 t -137.09 99.49 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.607 -1.256 . . . . 0.0 107.607 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -89.62 63.26 6.17 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.707 2.003 . . . . 0.0 109.599 174.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 56.6 -120.94 22.63 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 -162.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.6 p -65.88 -24.65 66.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 118.362 1.081 . . . . 0.0 113.688 -178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.6 94.85 6.38 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 119.679 1.127 . . . . 0.0 109.594 -177.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.8 p -69.28 151.21 10.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 C-N-CA 124.589 1.155 . . . . 0.0 108.122 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.6 m -150.81 158.4 44.09 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 120.029 -1.669 . . . . 0.0 109.055 164.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -153.81 162.27 41.37 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 165.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.39 156.22 24.87 Favored 'General case' 0 N--CA 1.464 0.235 0 C-N-CA 124.59 1.156 . . . . 0.0 108.104 172.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -65.44 141.14 58.61 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.517 0.675 . . . . 0.0 109.331 171.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -67.72 145.29 98.03 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 123.926 0.89 . . . . 0.0 110.806 173.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -86.57 -4.83 8.28 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 124.018 3.145 . . . . 0.0 113.123 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.94 162.42 18.56 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.073 0.949 . . . . 0.0 109.163 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -12.12 33.66 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 -176.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -74.59 159.79 31.7 Favored 'General case' 0 C--N 1.331 -0.202 0 O-C-N 121.87 -0.519 . . . . 0.0 110.359 171.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.43 140.99 38.62 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 163.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -148.2 82.53 1.49 Allowed 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 124.08 0.952 . . . . 0.0 108.832 -169.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.7 m -63.18 104.43 0.59 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 119.686 -0.197 . . . . 0.0 110.629 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -75.6 169.46 54.73 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 171.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 8.5 tt -159.9 125.33 4.08 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 123.089 0.556 . . . . 0.0 110.155 175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.1 m -105.69 167.18 3.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-N 118.31 0.504 . . . . 0.0 110.182 174.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -110.04 161.36 15.6 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 167.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.574 HD13 ' HB2' ' A' ' 92' ' ' LEU . 2.7 mp -137.88 154.3 49.47 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.129 1.372 . . . . 0.0 107.37 169.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -137.88 146.4 43.32 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 163.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -85.2 171.53 11.89 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 123.877 0.736 . . . . 0.0 109.789 172.094 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -61.42 -78.9 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.769 1.628 . . . . 0.0 110.582 175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -86.99 -21.41 26.18 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.063 -1.023 . . . . 0.0 111.896 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -85.46 -175.17 5.56 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.136 -0.978 . . . . 0.0 108.851 175.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.74 10.7 0.03 OUTLIER Glycine 0 N--CA 1.462 0.373 0 O-C-N 119.804 -1.81 . . . . 0.0 115.932 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.3 mttm -58.44 159.04 6.7 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.136 1.468 . . . . 0.0 108.381 155.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 26.1 p -119.67 107.5 13.31 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 -177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.574 ' HB2' HD13 ' A' ' 83' ' ' LEU . 63.7 mt -76.06 164.4 26.17 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.2 m -141.0 148.4 40.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 14.5 tp -140.57 117.54 11.13 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 104.073 -2.566 . . . . 0.0 104.073 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -114.28 144.21 43.6 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 172.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.9 mt -135.05 98.36 2.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 105.831 -1.915 . . . . 0.0 105.831 -171.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.2 t -93.2 68.22 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.2 pt20 -90.18 165.06 25.33 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-O 117.232 -1.366 . . . . 0.0 109.324 -178.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -63.79 -166.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 124.225 3.283 . . . . 0.0 116.855 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.61 153.9 16.68 Favored Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 158.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.6 ttmt -129.45 126.08 37.93 Favored 'General case' 0 CA--C 1.517 -0.305 0 C-N-CA 125.057 1.343 . . . . 0.0 109.712 -164.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -152.3 88.93 1.39 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.296 1.039 . . . . 0.0 108.658 173.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 52.9 p -144.34 -165.25 2.09 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.774 1.23 . . . . 0.0 109.678 163.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 45.7 pt -102.09 14.83 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 126.594 1.957 . . . . 0.0 112.252 -176.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 31.1 t70 . . . . . 0 C--O 1.249 1.05 0 C-N-CA 124.247 1.019 . . . . 0.0 112.845 -173.498 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.048 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 62.57 72.2 0.5 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.701 1.6 . . . . 0.0 111.597 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -135.53 162.15 33.49 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 167.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 173.97 63.34 0.05 OUTLIER Glycine 0 C--O 1.225 -0.416 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -177.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 31.9 p -160.27 163.99 20.73 Favored Pre-proline 0 C--O 1.24 0.604 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -172.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -64.79 165.26 21.56 Favored 'Trans proline' 0 CA--C 1.533 0.466 0 C-N-CA 122.016 1.811 . . . . 0.0 109.66 165.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.5 t -134.55 103.04 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 124.257 1.023 . . . . 0.0 108.375 177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 32.8 m -84.84 120.37 26.38 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -96.86 132.94 42.11 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 84.3 m-85 -102.12 123.41 45.93 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 171.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.4 p90 -154.48 67.49 0.71 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.832 0.853 . . . . 0.0 109.486 -171.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.7 p -155.73 -157.23 0.71 Allowed 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 118.105 -0.95 . . . . 0.0 109.631 155.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -83.56 152.2 24.98 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 119.764 1.165 . . . . 0.0 108.217 166.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.85 -22.87 49.24 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 123.662 0.785 . . . . 0.0 111.544 177.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -60.61 -6.61 1.74 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.281 0.633 . . . . 0.0 111.934 163.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.81 10.19 73.05 Favored Glycine 0 N--CA 1.448 -0.542 0 CA-C-O 118.851 -0.972 . . . . 0.0 112.0 168.018 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -105.56 -174.41 24.0 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-N 118.494 1.147 . . . . 0.0 111.857 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.7 p -128.78 20.62 6.0 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 124.204 1.002 . . . . 0.0 112.565 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.83 177.96 9.9 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-N 120.203 1.365 . . . . 0.0 112.772 178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 10.2 t60 -148.21 135.55 20.48 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.343 166.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.0 m -138.59 108.46 6.31 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 124.611 1.164 . . . . 0.0 109.605 171.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -102.64 158.22 16.39 Favored 'General case' 0 C--O 1.239 0.534 0 CA-C-O 120.965 0.412 . . . . 0.0 110.67 175.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -136.78 56.15 12.42 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 126.147 1.779 . . . . 0.0 110.157 -176.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.55 177.8 7.02 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 122.891 2.394 . . . . 0.0 110.973 -177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -157.29 175.84 13.48 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.104 1.362 . . . . 0.0 111.837 171.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.9 t70 66.03 -81.73 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 128.578 2.751 . . . . 0.0 113.233 -174.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 79.7 p -148.62 6.81 0.74 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.571 1.149 . . . . 0.0 113.611 -174.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.5 m -78.63 86.23 4.62 Favored 'General case' 0 C--O 1.237 0.426 0 O-C-N 121.195 -0.941 . . . . 0.0 111.394 -176.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.6 153.99 42.36 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.685 1.994 . . . . 0.0 108.525 170.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.57 160.79 9.55 Favored Glycine 0 C--N 1.336 0.576 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 178.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.8 p -66.22 130.21 42.44 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 123.197 0.599 . . . . 0.0 111.904 -166.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -129.13 -171.77 2.57 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.694 0.759 . . . . 0.0 112.037 170.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 39.1 mt -126.07 160.48 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 173.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 62.2 mt -134.6 159.08 42.32 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.18 43.51 0.88 Allowed 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 124.925 1.29 . . . . 0.0 110.928 -174.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.443 ' CG2' ' HE2' ' A' ' 90' ' ' LYS . 98.9 mt -70.89 142.52 15.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.362 1.465 . . . . 0.0 108.555 -175.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.38 106.23 14.69 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 125.181 1.392 . . . . 0.0 108.132 -174.476 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 50.3 m -135.77 66.17 1.51 Allowed 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 123.992 0.917 . . . . 0.0 110.119 -170.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -150.62 170.95 17.94 Favored 'General case' 0 C--O 1.236 0.367 0 O-C-N 121.242 -0.912 . . . . 0.0 112.158 -178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 47' ' ' LYS . 30.7 pttt -110.6 160.81 16.33 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.27 1.028 . . . . 0.0 108.234 164.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -136.5 133.68 36.78 Favored 'General case' 0 C--O 1.237 0.425 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 166.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 11.5 t -171.51 157.37 4.79 Favored 'General case' 0 C--O 1.24 0.568 0 C-N-CA 124.622 1.169 . . . . 0.0 108.448 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 62.36 -94.48 0.1 Allowed Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 109.146 -1.581 . . . . 0.0 109.146 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -152.71 35.04 0.49 Allowed 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.211 0.604 . . . . 0.0 111.634 177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 t -147.62 170.18 18.05 Favored 'General case' 0 C--O 1.239 0.526 0 O-C-N 120.996 -1.065 . . . . 0.0 111.106 173.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 31.2 p -121.2 96.73 5.21 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.148 1.379 . . . . 0.0 109.143 164.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -72.06 120.69 18.01 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 169.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.98 165.56 15.36 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.273 0.559 . . . . 0.0 109.633 174.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -119.49 131.85 55.66 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 168.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.83 170.32 4.33 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 127.251 2.22 . . . . 0.0 110.736 172.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 29.7 p90 -165.67 167.98 16.67 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.339 1.056 . . . . 0.0 111.617 167.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -155.25 154.87 32.83 Favored 'General case' 0 C--O 1.234 0.273 0 C-N-CA 126.35 1.86 . . . . 0.0 109.072 165.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.75 178.1 4.72 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.83 1.652 . . . . 0.0 111.268 -172.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.6 p -158.52 127.53 5.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 123.566 0.746 . . . . 0.0 111.782 169.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 172.08 -134.98 3.2 Favored Glycine 0 CA--C 1.53 0.983 0 C-N-CA 125.271 1.415 . . . . 0.0 110.346 173.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.25 147.26 10.42 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 126.485 1.914 . . . . 0.0 112.865 -174.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.54 6.1 1.56 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.782 2.433 . . . . 0.0 114.758 -172.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.404 ' CZ2' ' HA3' ' A' ' 79' ' ' GLY . 25.7 p-90 -133.04 10.53 4.21 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 126.125 1.77 . . . . 0.0 111.589 -173.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.5 mt -121.73 108.82 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 105.428 -2.064 . . . . 0.0 105.428 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -106.12 144.28 33.06 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.733 2.013 . . . . 0.0 108.237 -174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.38 130.57 24.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 N-CA-C 105.701 -1.963 . . . . 0.0 105.701 172.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -129.41 70.36 1.42 Allowed 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 178.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 49.64 -117.99 5.1 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 -169.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.8 p -71.36 34.94 0.05 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.671 1.588 . . . . 0.0 114.273 177.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.2 t -147.81 148.28 30.74 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.422 -1.696 . . . . 0.0 106.422 170.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.0 p -149.47 155.55 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.626 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -171.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.19 138.61 13.85 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 124.801 1.241 . . . . 0.0 108.396 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -122.16 126.7 48.88 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 166.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.89 147.78 25.73 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.334 0.654 . . . . 0.0 110.172 -169.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -73.0 158.27 35.77 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 122.664 1.221 . . . . 0.0 110.4 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -103.73 147.11 33.74 Favored Pre-proline 0 N--CA 1.451 -0.414 0 C-N-CA 126.695 1.998 . . . . 0.0 109.365 -175.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -84.75 -4.25 9.88 Favored 'Trans proline' 0 CA--C 1.532 0.381 0 C-N-CA 124.548 3.499 . . . . 0.0 113.233 -163.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -106.38 153.57 22.04 Favored 'General case' 0 C--N 1.33 -0.247 0 O-C-N 120.695 -1.253 . . . . 0.0 107.733 166.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.98 4.81 11.21 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.207 1.003 . . . . 0.0 112.208 177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -70.82 154.42 41.85 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.143 -0.973 . . . . 0.0 109.486 171.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.4 ttm105 -77.26 148.68 35.62 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 167.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -131.07 146.95 52.55 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 155.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 95.7 m -83.06 148.33 27.6 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 156.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.404 ' HA3' ' CZ2' ' A' ' 58' ' ' TRP . . . -119.26 157.36 15.4 Favored Glycine 0 C--N 1.334 0.452 0 C-N-CA 125.103 1.335 . . . . 0.0 109.772 169.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 18.6 tp -153.08 126.65 8.75 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 123.611 0.765 . . . . 0.0 109.042 178.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 2.8 m -128.07 158.18 40.01 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.205 0 CA-C-N 119.475 1.034 . . . . 0.0 109.549 167.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -100.7 155.61 17.8 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 171.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mp -132.54 168.12 18.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 126.187 1.795 . . . . 0.0 109.229 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.7 tptm -151.24 -160.2 1.13 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.28 1.832 . . . . 0.0 107.162 173.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.465 ' OE1' ' HE3' ' A' ' 90' ' ' LYS . 0.3 OUTLIER -134.12 171.47 14.18 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.703 1.201 . . . . 0.0 108.07 170.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -51.35 -63.32 1.17 Allowed 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 125.593 1.557 . . . . 0.0 110.201 170.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -107.44 -27.18 10.59 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.763 1.225 . . . . 0.0 111.995 -176.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.3 t -99.72 -168.64 1.63 Allowed 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.893 1.277 . . . . 0.0 111.667 -174.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.0 50.66 0.69 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 126.559 2.028 . . . . 0.0 109.702 -170.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.465 ' HE3' ' OE1' ' A' ' 85' ' ' GLN . 3.4 mtmp? -61.39 97.16 0.06 Allowed 'General case' 0 CA--C 1.519 -0.241 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 158.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 46.4 p -96.9 104.53 16.55 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 105.443 -2.058 . . . . 0.0 105.443 174.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.7 mp -108.45 155.68 20.32 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 m -135.79 64.58 1.57 Allowed 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 125.489 1.516 . . . . 0.0 107.067 -157.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -68.38 107.36 2.83 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -164.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -112.33 133.19 54.57 Favored 'General case' 0 CA--C 1.515 -0.394 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 -176.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.7 mp -127.01 139.73 51.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.809 -2.293 . . . . 0.0 104.809 172.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 t -131.67 72.09 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 177.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -108.79 144.97 30.67 Favored Pre-proline 0 C--O 1.23 0.077 0 CA-C-O 117.366 -1.302 . . . . 0.0 108.017 -172.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -63.28 173.2 4.37 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 123.623 2.882 . . . . 0.0 110.463 169.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -88.67 169.68 37.49 Favored Glycine 0 C--N 1.331 0.255 0 N-CA-C 110.894 -0.883 . . . . 0.0 110.894 177.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -125.39 142.74 51.33 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 123.047 0.539 . . . . 0.0 109.766 -168.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.1 p -154.62 90.17 1.3 Allowed 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.66 176.14 8.03 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 24.5 mm -83.22 82.07 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 N-CA-C 105.271 -2.122 . . . . 0.0 105.271 164.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.249 1.072 0 C-N-CA 124.56 1.144 . . . . 0.0 109.488 171.666 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.636 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.6 t-80 -151.37 121.16 7.03 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ttt -134.71 -166.4 1.81 Allowed 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.744 1.217 . . . . 0.0 107.825 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.12 -45.52 3.5 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.166 -1.173 . . . . 0.0 110.166 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.8 m -50.67 144.48 12.71 Favored Pre-proline 0 C--O 1.239 0.531 0 C-N-CA 124.966 1.306 . . . . 0.0 110.844 176.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.52 123.25 8.94 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.975 2.45 . . . . 0.0 110.137 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.3 t -89.96 149.72 3.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.1 m -124.23 148.83 47.04 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 124.483 1.113 . . . . 0.0 108.442 166.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -124.55 159.05 31.51 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.379 1.072 . . . . 0.0 111.104 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 -129.98 112.73 13.78 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 126.442 1.897 . . . . 0.0 106.344 -171.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -143.96 68.67 1.27 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 125.275 1.43 . . . . 0.0 108.801 -177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.1 p -154.26 173.06 16.66 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 123.991 0.917 . . . . 0.0 108.712 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 42.3 m-85 -64.07 170.08 3.89 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 149.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.36 -23.43 30.15 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 121.812 -0.555 . . . . 0.0 111.498 171.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -148.67 31.23 0.8 Allowed 'General case' 0 C--O 1.236 0.352 0 C-N-CA 123.953 0.901 . . . . 0.0 110.189 -166.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -163.38 3.15 0.06 OUTLIER Glycine 0 C--N 1.342 0.916 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 -169.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 85.9 -123.06 6.24 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 120.03 1.915 . . . . 0.0 110.077 174.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 14.7 p -135.65 25.3 3.41 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 118.534 1.167 . . . . 0.0 111.764 -167.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -160.26 163.52 33.38 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.3 155.2 42.35 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 161.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m -142.59 127.93 18.82 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -118.9 146.9 44.55 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 167.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -122.12 65.58 21.5 Favored Pre-proline 0 C--N 1.328 -0.36 0 C-N-CA 124.787 1.235 . . . . 0.0 108.657 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -63.14 169.14 9.69 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.774 2.316 . . . . 0.0 111.391 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -158.38 -176.45 5.91 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t0 55.13 -78.34 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.43 2.292 . . . . 0.0 113.897 171.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.3 t -154.12 110.82 3.34 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 104.299 -2.482 . . . . 0.0 104.299 156.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.3 m -149.58 90.85 1.75 Allowed 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.905 1.23 . . . . 0.0 111.841 167.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.61 177.82 7.22 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.092 1.757 . . . . 0.0 108.988 169.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.45 -157.77 27.5 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 170.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.2 p -124.57 105.57 9.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.835 1.654 . . . . 0.0 110.081 -170.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -124.16 -171.01 2.24 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.5 mt -133.63 160.78 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.745 0 C-N-CA 126.837 2.055 . . . . 0.0 107.197 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 51.3 mt -138.43 164.12 30.15 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.076 1.351 . . . . 0.0 110.61 177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -83.83 89.07 7.13 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.308 1.843 . . . . 0.0 111.809 178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.2 mp -98.1 152.54 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 172.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.19 120.25 39.83 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 126.106 1.762 . . . . 0.0 106.659 172.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 1.2 p -155.0 70.53 0.76 Allowed 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.686 0.794 . . . . 0.0 109.711 -161.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -159.94 176.86 11.38 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.62 0.768 . . . . 0.0 111.285 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 151.74 49.47 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 125.711 1.605 . . . . 0.0 109.682 168.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 19.5 tttm -131.48 130.78 42.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 126.07 1.748 . . . . 0.0 109.215 -167.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 1.7 t -177.47 144.61 0.4 Allowed 'General case' 0 C--O 1.239 0.542 0 C-N-CA 125.168 1.387 . . . . 0.0 108.821 -174.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 68.33 -88.79 0.2 Allowed Glycine 0 C--N 1.335 0.474 0 C-N-CA 125.947 1.737 . . . . 0.0 112.663 164.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -159.57 33.35 0.19 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.652 1.581 . . . . 0.0 109.172 176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m -145.9 155.59 42.97 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 120.619 -1.3 . . . . 0.0 109.564 175.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.03 80.91 1.85 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 122.335 1.064 . . . . 0.0 110.007 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 12.1 tppt? -67.22 118.66 10.92 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.616 -1.175 . . . . 0.0 108.063 -177.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.68 155.35 40.24 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 118.591 0.632 . . . . 0.0 109.46 168.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -122.5 128.28 50.62 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 125.021 1.329 . . . . 0.0 108.909 173.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.0 t -78.37 178.62 7.54 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.372 1.069 . . . . 0.0 110.749 174.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 36.2 p90 -147.27 -167.73 2.86 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 126.834 2.054 . . . . 0.0 109.169 -178.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -139.96 -178.16 5.31 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.861 1.664 . . . . 0.0 107.466 173.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.36 156.7 47.37 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 165.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.01 150.29 5.51 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 124.121 0.969 . . . . 0.0 109.545 165.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.67 -102.65 0.22 Allowed Glycine 0 CA--C 1.523 0.536 0 N-CA-C 108.815 -1.714 . . . . 0.0 108.815 171.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -68.56 151.24 47.03 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.104 0.962 . . . . 0.0 109.729 170.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.1 m -86.89 -34.16 19.52 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 50.3 p-90 -72.59 19.8 0.08 Allowed 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.967 1.707 . . . . 0.0 113.635 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mt -130.05 129.67 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -100.4 167.95 10.06 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.673 1.589 . . . . 0.0 108.659 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.3 p -140.97 151.08 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 106.266 -1.753 . . . . 0.0 106.266 166.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -148.59 68.82 1.08 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.011 -1.478 . . . . 0.0 107.011 166.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 54.14 -117.83 8.21 Favored Glycine 0 CA--C 1.522 0.483 0 N-CA-C 109.44 -1.464 . . . . 0.0 109.44 -172.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 6.4 p -72.46 48.48 0.19 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.368 1.867 . . . . 0.0 112.192 172.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.8 m -151.59 147.6 26.97 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 125.691 1.597 . . . . 0.0 108.497 171.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -144.65 130.8 15.14 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.742 1.217 . . . . 0.0 109.238 -173.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.0 m -143.19 152.51 41.85 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -153.17 150.46 29.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.611 0.764 . . . . 0.0 109.783 173.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.33 175.2 9.04 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.824 1.249 . . . . 0.0 108.819 168.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -89.82 175.65 7.14 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-O 122.475 1.131 . . . . 0.0 108.577 158.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.415 HD21 ' CA ' ' A' ' 100' ' ' GLY . 29.4 p30 -66.93 165.68 24.74 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 120.313 -1.492 . . . . 0.0 113.791 173.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -94.73 -4.62 2.32 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 124.693 3.595 . . . . 0.0 113.457 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.96 153.21 51.48 Favored 'General case' 0 CA--C 1.517 -0.326 0 C-N-CA 124.805 1.242 . . . . 0.0 108.889 -172.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . 0.338 0.0 OUTLIER -90.14 35.61 0.86 Allowed 'General case' 0 C--O 1.234 0.24 0 O-C-N 121.082 -1.011 . . . . 0.0 111.954 -168.045 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -86.11 167.31 15.07 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 167.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.83 136.88 32.86 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 166.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -151.81 162.15 41.51 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 123.838 0.855 . . . . 0.0 109.741 172.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 10.2 t -117.53 158.64 24.2 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 160.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.78 165.23 28.18 Favored Glycine 0 C--O 1.239 0.457 0 N-CA-C 108.598 -1.801 . . . . 0.0 108.598 159.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 12.1 tp -158.21 100.29 1.68 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 173.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 m -84.68 -165.03 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 169.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 49.6 m -145.45 146.32 31.46 Favored 'General case' 0 C--N 1.324 -0.512 0 O-C-N 119.447 -2.033 . . . . 0.0 105.831 157.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -121.26 137.02 54.87 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 170.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.9 tmtt? -123.29 119.89 31.47 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.327 1.451 . . . . 0.0 108.221 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -65.32 148.46 51.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.453 1.101 . . . . 0.0 109.541 174.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -50.83 -84.92 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.864 2.466 . . . . 0.0 113.624 -175.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -80.36 -15.8 56.02 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.367 -0.833 . . . . 0.0 111.445 -174.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.82 -153.47 0.33 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.556 1.942 . . . . 0.0 108.739 173.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 172.43 1.51 0.03 OUTLIER Glycine 0 CA--C 1.521 0.461 0 CA-C-O 117.897 -1.501 . . . . 0.0 114.551 -174.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.59 102.14 2.67 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 119.887 1.844 . . . . 0.0 106.664 169.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.7 p -69.49 152.11 45.23 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.751 0.657 . . . . 0.0 110.101 -169.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.3 mp -104.18 169.28 8.58 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 124.336 1.054 . . . . 0.0 108.773 167.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.4 t -147.89 146.33 29.0 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.017 1.327 . . . . 0.0 107.841 -169.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 21.9 tp -139.35 110.65 6.97 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 128.651 2.78 . . . . 0.0 105.909 -170.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.8 tttt -128.52 128.11 43.68 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -169.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 7.0 mt -134.63 77.81 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 -163.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 86.2 t -75.81 99.06 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 106.077 -1.823 . . . . 0.0 106.077 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -111.08 155.0 43.25 Favored Pre-proline 0 C--O 1.24 0.597 0 C-N-CA 124.593 1.157 . . . . 0.0 111.94 173.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -69.49 -168.82 0.28 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 124.231 3.287 . . . . 0.0 108.883 160.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.415 ' CA ' HD21 ' A' ' 71' ' ' ASN . . . -139.74 167.5 25.31 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 118.786 -1.674 . . . . 0.0 114.994 176.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.99 171.19 14.41 Favored 'General case' 0 CA--C 1.522 -0.117 0 CA-C-N 114.456 -0.872 . . . . 0.0 112.341 -175.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.3 p -160.87 91.78 0.9 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.289 2.236 . . . . 0.0 107.063 -173.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 91.5 p -146.78 -164.15 1.92 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.021 0.928 . . . . 0.0 110.282 179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.4 pt -107.42 8.41 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 124.782 1.233 . . . . 0.0 110.665 173.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.4 t0 . . . . . 0 C--O 1.245 0.826 0 C-N-CA 124.855 1.262 . . . . 0.0 109.327 175.462 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.23 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -140.15 97.47 3.24 Favored 'General case' 0 CA--C 1.521 -0.148 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 -162.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.2 ptt? -163.3 -178.65 6.07 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 126.722 2.009 . . . . 0.0 106.633 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.98 -93.11 0.1 Allowed Glycine 0 C--O 1.227 -0.298 0 N-CA-C 107.858 -2.097 . . . . 0.0 107.858 168.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 18.9 p -152.36 163.34 23.87 Favored Pre-proline 0 C--O 1.239 0.547 0 C-N-CA 124.328 1.051 . . . . 0.0 108.79 -177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -69.0 167.19 24.17 Favored 'Trans proline' 0 N--CA 1.453 -0.885 0 C-N-CA 121.272 1.314 . . . . 0.0 111.953 178.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.7 p -77.25 137.85 21.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 C-N-CA 123.984 0.913 . . . . 0.0 110.371 176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 m -89.58 125.79 35.36 Favored 'General case' 0 C--O 1.231 0.126 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 166.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -102.33 152.93 20.51 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.927 1.291 . . . . 0.0 109.638 171.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -132.06 110.74 10.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 127.297 2.239 . . . . 0.0 106.571 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.9 46.79 1.75 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.762 1.625 . . . . 0.0 108.529 -175.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.3 p -160.36 157.34 27.7 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.941 1.696 . . . . 0.0 107.625 -170.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -73.67 170.83 14.43 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 124.184 0.993 . . . . 0.0 109.5 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -78.41 -36.3 45.92 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 123.286 0.634 . . . . 0.0 112.641 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -142.49 47.28 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -172.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -164.33 -1.78 0.05 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 116.337 1.295 . . . . 0.0 116.337 -172.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 69.59 -112.68 4.61 Favored Glycine 0 C--N 1.336 0.542 0 CA-C-N 120.914 2.357 . . . . 0.0 109.111 179.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 25.3 p -119.98 7.31 10.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.268 1.034 . . . . 0.0 112.598 -177.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.8 t -137.88 158.14 44.96 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 119.451 1.023 . . . . 0.0 108.58 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -102.85 165.31 11.12 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 148.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 80.4 m -141.14 163.16 33.72 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 153.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -144.81 150.6 37.45 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 166.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -131.96 77.34 72.01 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 126.955 2.102 . . . . 0.0 106.475 177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -72.59 177.02 8.0 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 121.845 1.696 . . . . 0.0 109.757 176.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -151.88 161.19 43.05 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.849 0.86 . . . . 0.0 108.879 172.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 54.52 -85.34 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 128.444 2.697 . . . . 0.0 110.488 -167.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.4 t -150.24 106.04 3.42 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 165.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.8 m -128.55 89.96 2.98 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 122.432 1.11 . . . . 0.0 108.664 156.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.5 149.03 50.66 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.922 2.089 . . . . 0.0 106.844 164.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.04 -139.03 4.97 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 174.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.2 p -129.91 116.04 18.06 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 125.775 1.63 . . . . 0.0 110.321 -171.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -146.44 -171.74 3.8 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.781 1.233 . . . . 0.0 111.873 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 54.6 mt -133.16 130.2 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 126.201 1.8 . . . . 0.0 107.273 -174.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 70.2 mt -91.63 161.59 14.86 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.453 1.501 . . . . 0.0 109.419 174.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -94.2 78.84 4.0 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.3 mt -90.35 133.05 33.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 126.865 2.066 . . . . 0.0 107.397 175.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.7 m -110.4 107.98 17.86 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 -177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 31.7 t -135.53 67.65 1.48 Allowed 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 124.029 0.932 . . . . 0.0 108.771 -163.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -154.37 176.22 12.59 Favored 'General case' 0 C--O 1.232 0.173 0 O-C-N 121.25 -0.906 . . . . 0.0 111.808 -176.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.96 154.56 40.99 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 125.94 1.696 . . . . 0.0 108.988 170.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -141.36 126.82 18.8 Favored 'General case' 0 C--O 1.239 0.536 0 C-N-CA 124.93 1.292 . . . . 0.0 109.938 -171.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.6 t -177.62 160.06 1.53 Allowed 'General case' 0 C--O 1.237 0.43 0 C-N-CA 125.135 1.374 . . . . 0.0 108.932 -176.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 57.4 -103.56 0.32 Allowed Glycine 0 C--N 1.336 0.535 0 N-CA-C 108.538 -1.825 . . . . 0.0 108.538 -173.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -146.04 29.5 1.08 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.158 0.983 . . . . 0.0 111.871 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t -146.85 169.34 19.32 Favored 'General case' 0 C--O 1.238 0.47 0 O-C-N 121.216 -0.927 . . . . 0.0 110.064 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -136.48 113.2 10.22 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.514 1.525 . . . . 0.0 109.064 -172.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.85 108.96 20.02 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 175.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.68 109.84 3.99 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.479 1.036 . . . . 0.0 109.217 169.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.77 134.64 52.57 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 174.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.9 m -66.75 163.23 19.64 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.384 1.474 . . . . 0.0 108.996 166.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.3 p90 -149.42 -172.87 4.24 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 173.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -153.1 -175.15 5.21 Favored 'General case' 0 C--O 1.234 0.287 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 153.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.33 166.38 19.6 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 125.745 1.618 . . . . 0.0 108.277 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -158.62 149.84 20.65 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 161.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.27 -142.92 8.31 Favored Glycine 0 N--CA 1.449 -0.446 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 -177.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -64.95 143.34 58.01 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.278 0.631 . . . . 0.0 111.043 -168.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.82 -0.76 4.48 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.104 1.762 . . . . 0.0 114.782 -170.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 48.4 p-90 -117.81 11.56 13.59 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.032 1.733 . . . . 0.0 111.653 179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 72.6 mt -121.02 133.03 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -134.5 111.37 10.04 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.977 1.711 . . . . 0.0 106.892 -165.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.4 t -112.56 98.33 6.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 105.588 -2.005 . . . . 0.0 105.588 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -94.41 79.29 3.89 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 106.685 -1.598 . . . . 0.0 106.685 178.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 51.32 -107.78 0.47 Allowed Glycine 0 CA--C 1.52 0.361 0 C-N-CA 126.215 1.864 . . . . 0.0 111.44 -171.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m -73.83 -19.25 60.8 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.821 1.248 . . . . 0.0 112.764 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.9 m -88.08 160.06 17.97 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 119.45 1.023 . . . . 0.0 110.694 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.4 p -132.04 145.64 34.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 106.568 -1.642 . . . . 0.0 106.568 167.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -150.74 148.79 28.98 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 172.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -154.05 160.56 42.05 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -125.45 148.87 48.67 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.357 1.063 . . . . 0.0 108.289 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -62.92 170.86 2.44 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 123.621 1.677 . . . . 0.0 112.537 -176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.5 HD21 ' HA2' ' A' ' 100' ' ' GLY . 21.5 p30 -78.03 157.18 79.02 Favored Pre-proline 0 CA--C 1.536 0.421 0 CA-C-N 114.902 -1.044 . . . . 0.0 110.069 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -87.43 -6.16 7.15 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 123.02 2.48 . . . . 0.0 112.397 178.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -128.93 154.47 46.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.96 1.304 . . . . 0.0 109.221 -174.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.0 40.79 0.77 Allowed 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.793 1.237 . . . . 0.0 111.065 -176.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -96.29 170.33 9.32 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 125.288 1.435 . . . . 0.0 109.884 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.82 113.04 20.47 Favored 'General case' 0 CA--C 1.517 -0.295 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 176.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 34.1 mtp85 -135.14 -170.44 2.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.122 0.969 . . . . 0.0 109.609 -170.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.7 t -147.2 156.89 43.35 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 120.486 -1.384 . . . . 0.0 108.108 161.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -84.7 174.07 49.74 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 108.242 -1.943 . . . . 0.0 108.242 159.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.5 tp -162.67 80.21 0.5 Allowed 'General case' 0 C--O 1.239 0.55 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 m -77.53 178.06 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 O-C-N 120.629 -1.294 . . . . 0.0 110.005 -176.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.4 m -134.38 141.51 46.88 Favored 'General case' 0 C--O 1.234 0.263 0 O-C-N 120.949 -1.095 . . . . 0.0 108.566 170.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -127.83 151.45 49.03 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.901 1.68 . . . . 0.0 107.846 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -147.38 134.97 20.96 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 118.735 0.698 . . . . 0.0 109.454 176.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -77.12 154.65 33.04 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.416 1.087 . . . . 0.0 110.564 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -53.45 -69.49 0.12 Allowed 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 126.989 2.116 . . . . 0.0 113.001 -176.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -85.12 -23.51 28.41 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 123.053 0.541 . . . . 0.0 111.132 -177.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.5 m -86.08 -153.64 0.19 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.318 1.847 . . . . 0.0 109.878 -176.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -178.26 -13.28 0.02 OUTLIER Glycine 0 C--N 1.336 0.558 0 CA-C-O 118.193 -1.337 . . . . 0.0 115.645 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -57.71 121.54 10.66 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 119.959 1.879 . . . . 0.0 106.932 169.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.2 p -81.38 145.11 30.98 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.647 -0.872 . . . . 0.0 108.647 177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 87.2 mt -93.5 158.23 15.81 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 168.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 m -124.98 152.54 44.06 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.63 1.172 . . . . 0.0 110.153 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 tt -152.72 109.29 3.43 Favored 'General case' 0 C--O 1.231 0.13 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 -170.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -117.25 137.32 52.46 Favored 'General case' 0 CA--C 1.516 -0.334 0 C-N-CA 124.305 1.042 . . . . 0.0 109.391 -175.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.507 HG22 ' CG ' ' A' ' 98' ' ' GLN . 10.8 mt -135.72 94.45 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 -171.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 20.6 t -99.28 80.76 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -173.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.507 ' CG ' HG22 ' A' ' 96' ' ' ILE . 17.7 mt-30 -89.81 166.01 22.45 Favored Pre-proline 0 C--O 1.235 0.33 0 C-N-CA 125.313 1.445 . . . . 0.0 110.126 -172.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -60.91 -172.05 0.08 OUTLIER 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 123.824 3.016 . . . . 0.0 112.018 160.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.5 ' HA2' HD21 ' A' ' 71' ' ' ASN . . . -121.26 139.04 12.93 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 124.817 1.198 . . . . 0.0 112.1 176.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.7 ttmm -114.18 152.71 30.79 Favored 'General case' 0 N--CA 1.463 0.177 0 C-N-CA 125.343 1.457 . . . . 0.0 110.372 -175.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -148.85 91.3 1.85 Allowed 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 160.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.6 t -146.1 169.86 17.84 Favored 'General case' 0 C--O 1.238 0.463 0 CA-C-N 118.344 0.52 . . . . 0.0 110.8 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.9 mp -81.4 71.52 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 174.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--O 1.252 1.218 0 C-N-CA 128.019 2.528 . . . . 0.0 106.945 -173.057 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.697 0 CA-C-O 118.198 -1.335 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 29.2 m170 43.93 73.67 0.14 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 119.852 1.826 . . . . 0.0 112.388 172.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 ptt? -144.05 170.64 15.57 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.16 0.984 . . . . 0.0 108.722 -174.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.44 -42.0 3.06 Favored Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.3 p -61.23 155.52 56.03 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.932 1.293 . . . . 0.0 111.893 171.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.41 162.68 32.65 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.781 2.321 . . . . 0.0 111.346 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.2 t -132.67 157.57 43.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 m -147.93 103.79 3.52 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -77.11 155.0 32.69 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -137.31 109.08 7.05 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 128.141 2.577 . . . . 0.0 106.367 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -132.73 93.03 3.14 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 106.312 -1.736 . . . . 0.0 106.312 168.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.0 p -164.66 161.17 20.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.347 1.059 . . . . 0.0 110.179 -176.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -66.44 167.76 10.13 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 121.493 -0.754 . . . . 0.0 108.966 163.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -114.89 -0.78 13.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.234 1.013 . . . . 0.0 111.89 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -145.92 51.18 1.17 Allowed 'General case' 0 C--O 1.232 0.162 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 166.85 -97.57 0.14 Allowed Glycine 0 CA--C 1.523 0.564 0 O-C-N 121.371 -0.831 . . . . 0.0 111.109 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -166.65 -112.24 0.26 Allowed Glycine 0 C--N 1.336 0.583 0 CA-C-N 118.065 0.933 . . . . 0.0 112.379 -171.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 44.2 p -138.44 16.09 2.75 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.97 0.908 . . . . 0.0 112.242 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.0 t -152.95 140.93 20.26 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 119.438 1.017 . . . . 0.0 109.49 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -104.29 157.09 17.37 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.021 0.929 . . . . 0.0 109.893 174.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 7.8 m -150.82 102.14 2.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 154.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -89.04 155.57 19.39 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 118.819 -1.153 . . . . 0.0 109.482 165.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -128.88 69.24 80.36 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 126.396 1.879 . . . . 0.0 108.774 -174.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -68.94 170.83 14.7 Favored 'Trans proline' 0 C--O 1.238 0.518 0 C-N-CA 122.354 2.036 . . . . 0.0 111.144 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -153.0 158.5 42.12 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.455 0.702 . . . . 0.0 110.505 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.4 t70 62.52 -72.16 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.016 2.126 . . . . 0.0 113.662 -171.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.0 m -165.57 75.84 0.24 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 125.937 1.695 . . . . 0.0 108.687 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -122.42 98.8 6.09 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.342 1.057 . . . . 0.0 110.098 174.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.3 165.1 28.09 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 127.318 2.247 . . . . 0.0 106.448 167.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 143.68 174.61 16.09 Favored Glycine 0 C--N 1.338 0.661 0 CA-C-N 119.76 1.164 . . . . 0.0 112.088 165.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.5 p -92.01 113.17 25.37 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 122.895 0.478 . . . . 0.0 110.707 -161.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -122.76 -167.11 1.53 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.255 1.022 . . . . 0.0 112.945 172.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.0 mt -135.67 143.21 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 127.771 2.429 . . . . 0.0 105.194 -178.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.9 mt -123.16 162.88 21.66 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.294 1.038 . . . . 0.0 110.067 -178.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -104.63 86.19 2.45 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.234 1.414 . . . . 0.0 107.187 179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 12.9 mt -114.52 128.43 71.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -176.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.0 m -79.31 115.16 18.79 Favored 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 125.139 1.376 . . . . 0.0 108.129 -175.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 21.2 p -143.68 73.38 1.39 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 118.375 0.534 . . . . 0.0 111.126 -174.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -155.84 167.67 29.65 Favored 'General case' 0 C--O 1.233 0.213 0 O-C-N 121.669 -0.644 . . . . 0.0 112.407 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -114.41 133.58 55.62 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.295 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -103.78 142.74 33.84 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 123.834 0.854 . . . . 0.0 109.174 -178.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.59 76.96 0.97 Allowed 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 -156.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.75 -94.55 0.09 OUTLIER Glycine 0 C--N 1.339 0.71 0 C-N-CA 124.862 1.22 . . . . 0.0 111.035 -178.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.2 t30 -113.87 9.85 17.61 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.5 m -134.76 153.68 51.91 Favored 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.566 0.746 . . . . 0.0 110.957 -179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.7 p -139.1 92.19 2.57 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.712 1.605 . . . . 0.0 110.193 -168.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -76.97 115.53 16.84 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 105.5 -2.037 . . . . 0.0 105.5 178.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -68.43 152.69 45.05 Favored 'General case' 0 N--CA 1.454 -0.233 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.16 148.95 42.51 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 124.393 1.077 . . . . 0.0 108.149 174.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.2 p -87.95 -179.42 6.22 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.792 0.837 . . . . 0.0 110.175 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 48.4 p90 -143.71 154.29 43.33 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.681 1.192 . . . . 0.0 109.512 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -89.48 160.06 16.94 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 125.04 1.336 . . . . 0.0 108.538 160.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -129.75 163.11 26.91 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.832 2.053 . . . . 0.0 106.434 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.1 m -170.86 141.8 1.81 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-N 119.332 0.969 . . . . 0.0 109.284 175.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.93 -128.75 3.84 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.226 1.393 . . . . 0.0 110.245 176.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -44.92 136.73 4.48 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 128.113 2.565 . . . . 0.0 111.699 -177.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -71.58 4.32 3.21 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 117.352 2.353 . . . . 0.0 117.352 -165.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 44.8 p-90 -139.66 15.58 2.52 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 123.874 0.869 . . . . 0.0 112.338 -160.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 63.7 mt -123.42 87.88 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.95 -2.241 . . . . 0.0 104.95 -170.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -73.33 126.57 30.44 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 172.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 18.9 t -137.38 84.2 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 173.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -90.93 59.07 3.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.679 1.192 . . . . 0.0 109.145 -173.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 60.31 -115.88 8.33 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 110.227 -1.149 . . . . 0.0 110.227 -172.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 3.3 p -75.65 39.04 0.16 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.86 1.664 . . . . 0.0 112.8 174.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.3 m -152.4 149.14 28.29 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 165.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.9 p -149.78 139.52 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.8 t -143.32 108.8 5.07 Favored 'General case' 0 CA--C 1.522 -0.108 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 168.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -86.09 106.71 17.42 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 165.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -66.81 168.01 10.39 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.383 1.473 . . . . 0.0 110.822 179.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.6 tt0 -85.03 -176.85 6.38 Favored 'General case' 0 CA--C 1.542 0.649 0 O-C-N 121.431 -0.793 . . . . 0.0 109.162 171.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 52.9 p-10 -112.03 161.07 27.54 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 125.882 1.673 . . . . 0.0 108.44 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -86.79 -10.41 6.1 Favored 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.795 2.33 . . . . 0.0 113.375 -177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -122.83 167.07 13.98 Favored 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 124.934 1.293 . . . . 0.0 110.732 -177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -100.01 13.26 34.59 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.763 1.024 . . . . 0.0 113.763 -175.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -75.95 171.77 13.86 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 164.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -108.7 144.33 36.62 Favored 'General case' 0 C--O 1.236 0.369 0 O-C-N 121.63 -0.668 . . . . 0.0 109.604 -176.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.69 165.74 18.67 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.237 -0.914 . . . . 0.0 109.272 176.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 88.2 m -117.33 117.55 29.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 N-CA-C 104.037 -2.579 . . . . 0.0 104.037 158.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -73.72 158.59 52.46 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 171.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.8 tp -155.18 111.35 3.17 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.94 0.87 . . . . 0.0 109.629 174.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 98.1 t -130.53 124.19 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.9 m -87.7 135.98 33.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 175.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.35 145.7 38.4 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.751 0.82 . . . . 0.0 108.901 167.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 68.7 tttt -134.57 139.87 45.7 Favored 'General case' 0 CA--C 1.52 -0.177 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 173.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 -71.52 160.04 33.4 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 124.198 0.999 . . . . 0.0 109.322 -178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -50.44 -33.35 20.69 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 125.109 1.363 . . . . 0.0 113.937 168.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -127.95 -36.06 2.02 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -172.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.1 t -88.22 -156.2 0.35 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.564 0.746 . . . . 0.0 110.054 -176.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.64 10.18 0.05 OUTLIER Glycine 0 CA--C 1.524 0.627 0 CA-C-O 118.113 -1.381 . . . . 0.0 114.937 -171.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.91 94.27 1.05 Allowed 'General case' 0 C--N 1.342 0.282 0 CA-C-N 120.141 1.97 . . . . 0.0 107.147 169.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 p -72.8 113.67 10.1 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -171.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.0 mp -75.0 130.13 38.83 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 6.6 t -88.18 152.63 21.85 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 168.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.1 tt -149.02 98.54 2.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 -172.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.4 mtpt -105.47 149.61 26.04 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.0 mp -139.2 134.89 41.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 168.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.9 t -121.4 79.4 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 174.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -84.79 164.08 43.7 Favored Pre-proline 0 CA--C 1.534 0.361 0 C-N-CA 124.68 1.192 . . . . 0.0 110.704 -179.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -69.26 179.61 3.32 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.448 2.765 . . . . 0.0 110.518 160.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -116.95 147.82 18.89 Favored Glycine 0 N--CA 1.438 -1.211 0 CA-C-N 116.044 -0.526 . . . . 0.0 113.106 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.9 ttmm -85.39 135.2 33.97 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 126.206 1.802 . . . . 0.0 111.455 -166.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.11 89.1 2.0 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 155.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.1 m -133.8 167.53 20.39 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -172.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 12.4 mt -85.46 68.7 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 173.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 21.7 t70 . . . . . 0 C--O 1.244 0.77 0 C-N-CA 127.814 2.445 . . . . 0.0 107.294 -166.693 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.397 0 N-CA-C 109.046 -1.621 . . . . 0.0 109.046 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -62.08 113.95 3.13 Favored 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 165.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.9 mtp -147.96 159.97 43.31 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 126.114 1.766 . . . . 0.0 106.679 -175.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 115.63 105.52 2.52 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 107.648 -2.181 . . . . 0.0 107.648 -171.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 p -165.13 156.57 12.96 Favored Pre-proline 0 CA--C 1.535 0.369 0 C-N-CA 123.869 0.868 . . . . 0.0 108.816 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.65 115.82 4.38 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 123.001 2.468 . . . . 0.0 110.523 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.0 t -95.71 117.48 39.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -97.77 100.63 12.01 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -79.2 157.07 27.92 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.106 0.479 . . . . 0.0 110.153 170.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -131.42 107.01 8.61 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 104.967 -2.234 . . . . 0.0 104.967 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -130.79 69.06 1.47 Allowed 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 127.35 2.26 . . . . 0.0 105.663 175.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.6 p -163.41 -174.98 3.99 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 121.893 -0.504 . . . . 0.0 111.724 165.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -65.66 173.37 2.83 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.486 0.585 . . . . 0.0 109.688 161.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -112.47 -8.11 13.89 Favored 'General case' 0 N--CA 1.462 0.145 0 N-CA-C 112.805 0.669 . . . . 0.0 112.805 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 39.7 t0 -156.67 58.02 0.55 Allowed 'General case' 0 C--O 1.236 0.389 0 CA-C-O 122.055 0.931 . . . . 0.0 108.888 179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.3 -91.66 0.08 OUTLIER Glycine 0 C--N 1.331 0.286 0 O-C-N 121.405 -0.809 . . . . 0.0 111.779 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.33 -123.31 0.78 Allowed Glycine 0 C--N 1.333 0.362 0 CA-C-N 117.781 0.79 . . . . 0.0 113.007 -167.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 30.9 p -138.81 12.32 2.68 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 125.223 1.409 . . . . 0.0 114.127 -169.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.9 t -157.38 146.64 20.03 Favored 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 118.467 -1.293 . . . . 0.0 111.7 169.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -84.5 137.76 33.16 Favored 'General case' 0 N--CA 1.439 -1.022 0 CA-C-N 112.776 -2.011 . . . . 0.0 107.375 160.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.4 m -136.05 162.16 33.67 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 103.001 -2.963 . . . . 0.0 103.001 170.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -152.81 154.47 35.22 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 159.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -128.4 54.64 14.18 Favored Pre-proline 0 CA--C 1.54 0.56 0 CA-C-O 118.38 -0.819 . . . . 0.0 110.602 -179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.57 174.52 9.23 Favored 'Trans proline' 0 N--CA 1.453 -0.867 0 C-N-CA 121.23 1.286 . . . . 0.0 111.167 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -159.46 169.54 23.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.676 -1.602 . . . . 0.0 106.676 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.2 t70 65.16 -78.87 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.48 1.912 . . . . 0.0 111.231 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 3.8 m -169.07 110.44 0.49 Allowed 'General case' 0 C--O 1.238 0.496 0 C-N-CA 128.479 2.712 . . . . 0.0 106.702 160.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.6 m -138.89 24.75 2.57 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 171.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -70.78 146.71 49.6 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 121.173 -0.954 . . . . 0.0 110.445 173.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 174.73 -158.95 27.37 Favored Glycine 0 C--N 1.336 0.533 0 N-CA-C 109.976 -1.25 . . . . 0.0 109.976 -177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -121.98 116.11 23.74 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.385 1.474 . . . . 0.0 110.173 -177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -122.14 -177.85 3.71 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.317 1.447 . . . . 0.0 110.639 175.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mt -132.03 156.59 42.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 127.287 2.235 . . . . 0.0 105.897 -178.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.5 mt -134.06 179.04 6.5 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 125.648 1.579 . . . . 0.0 109.287 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -109.31 71.57 0.77 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.651 1.181 . . . . 0.0 109.461 178.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 97.2 mt -97.5 138.88 21.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -104.38 131.32 51.86 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.46 1.504 . . . . 0.0 107.421 -175.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 48.1 t -148.61 81.98 1.46 Allowed 'General case' 0 C--O 1.236 0.37 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 176.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -154.2 173.17 16.47 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 121.764 -0.585 . . . . 0.0 111.394 173.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.68 137.25 54.37 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 125.778 1.631 . . . . 0.0 108.602 169.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -115.29 134.63 54.95 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.307 1.843 . . . . 0.0 107.011 -178.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.1 t -174.85 157.79 2.48 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 49.67 -110.8 0.89 Allowed Glycine 0 C--N 1.334 0.464 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -174.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -135.12 32.4 3.17 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.844 1.258 . . . . 0.0 109.476 -173.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m -144.53 161.55 38.81 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 123.884 0.874 . . . . 0.0 110.784 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.9 p -127.66 103.21 7.19 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.025 1.33 . . . . 0.0 108.002 166.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -78.57 116.33 18.88 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 169.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -71.35 148.48 46.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 169.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -112.65 142.95 44.65 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 173.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.09 163.47 20.02 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 123.797 0.839 . . . . 0.0 110.514 166.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 27.7 p90 -140.1 158.4 44.12 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.585 1.154 . . . . 0.0 108.898 165.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -138.26 151.16 47.37 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.066 -1.086 . . . . 0.0 108.066 -178.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.479 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -141.4 162.14 36.19 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.369 1.068 . . . . 0.0 110.736 -163.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.8 p -168.96 152.42 5.23 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 124.292 1.037 . . . . 0.0 109.495 178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.59 -138.88 5.47 Favored Glycine 0 C--N 1.333 0.38 0 O-C-N 121.506 -0.746 . . . . 0.0 111.709 -175.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.47 ' HB2' HD12 ' A' ' 59' ' ' ILE . 0.9 OUTLIER -55.84 137.33 50.38 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.153 1.381 . . . . 0.0 111.133 -178.93 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.5 m -69.4 3.43 2.3 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 127.745 2.418 . . . . 0.0 116.364 -171.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 15.3 p-90 -126.98 6.58 6.58 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.276 1.43 . . . . 0.0 111.963 -173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 56' ' ' ASP . 34.6 mt -117.27 91.65 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -76.77 110.23 11.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 124.614 1.166 . . . . 0.0 108.724 -176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.479 HG11 ' HB3' ' A' ' 53' ' ' ALA . 8.0 p -94.41 143.13 12.32 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 C-N-CA 124.17 0.988 . . . . 0.0 108.461 177.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.67 46.08 1.69 Allowed 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 121.744 0.783 . . . . 0.0 111.061 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 68.18 -113.5 5.42 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 108.582 -1.807 . . . . 0.0 108.582 -172.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.5 p -71.99 -7.35 48.2 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.2 m -110.31 144.65 38.72 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 119.671 1.123 . . . . 0.0 109.623 178.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.62 157.11 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 125.888 1.675 . . . . 0.0 107.775 -176.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -157.29 152.58 26.21 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 124.529 1.132 . . . . 0.0 108.432 162.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.1 p90 -154.4 173.36 16.33 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 123.966 0.906 . . . . 0.0 109.557 159.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -114.93 170.81 8.06 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 124.784 1.233 . . . . 0.0 110.686 166.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -80.9 158.75 25.18 Favored 'General case' 0 C--O 1.238 0.496 0 CA-C-O 122.509 1.147 . . . . 0.0 108.305 165.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.63 167.37 5.74 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 126.304 1.842 . . . . 0.0 112.362 175.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -92.1 -10.8 2.24 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 124.377 3.385 . . . . 0.0 115.726 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.82 141.87 29.5 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 120.558 1.526 . . . . 0.0 109.926 -174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.585 ' H ' ' CD ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -72.0 8.87 1.08 Allowed 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 128.668 2.787 . . . . 0.0 114.0 -155.042 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -61.58 166.65 4.0 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 163.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.4 ' HG3' ' HA ' ' A' ' 99' ' ' PRO . 8.4 ttm-85 -126.21 118.9 26.12 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.086 1.354 . . . . 0.0 110.253 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 3.0 mmt180 -136.94 -168.94 2.37 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.562 1.145 . . . . 0.0 110.25 -177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 96' ' ' ILE . 8.8 t -131.82 156.12 46.59 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.653 0.781 . . . . 0.0 109.238 162.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -92.81 -179.3 40.43 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 160.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.7 tp -147.82 160.36 42.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.736 1.214 . . . . 0.0 108.383 159.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.0 t -135.78 151.48 29.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 N-CA-C 105.08 -2.192 . . . . 0.0 105.08 163.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.2 m -124.37 154.87 39.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.782 HD21 ' HB2' ' A' ' 92' ' ' LEU . 0.4 OUTLIER -145.01 167.38 22.8 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.266 1.027 . . . . 0.0 109.968 -174.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.5 tttt -137.89 158.28 44.68 Favored 'General case' 0 CA--C 1.521 -0.154 0 C-N-CA 125.167 1.387 . . . . 0.0 108.077 167.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -114.98 139.46 49.82 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -44.7 -73.16 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 126.037 1.735 . . . . 0.0 113.743 -166.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -88.26 -8.75 54.74 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 126.691 1.996 . . . . 0.0 112.957 -174.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.76 -153.37 0.47 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 127.459 2.304 . . . . 0.0 106.771 174.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -165.97 0.21 0.04 OUTLIER Glycine 0 CA--C 1.521 0.443 0 C-N-CA 119.11 -1.519 . . . . 0.0 115.931 178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -58.85 153.3 17.41 Favored 'General case' 0 N--CA 1.418 -2.068 0 C-N-CA 126.568 1.947 . . . . 0.0 110.925 -178.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 19.0 p -122.42 146.79 47.03 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.451 -1.315 . . . . 0.0 107.451 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.782 ' HB2' HD21 ' A' ' 83' ' ' LEU . 59.5 mt -117.39 -170.42 1.85 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.845 1.658 . . . . 0.0 106.639 175.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.54 161.08 39.39 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.104 1.362 . . . . 0.0 108.776 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 tp -136.45 77.92 1.68 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 126.548 1.939 . . . . 0.0 108.438 178.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -82.25 89.08 6.5 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 121.687 -0.633 . . . . 0.0 110.312 -179.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 78' ' ' THR . 17.4 mt -83.68 92.47 2.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 175.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.6 87.64 2.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 172.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.13 160.75 31.34 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 118.281 0.491 . . . . 0.0 109.895 -178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.4 ' HA ' ' HG3' ' A' ' 76' ' ' ARG . 31.1 Cg_endo -78.4 171.54 16.73 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.749 1.632 . . . . 0.0 109.781 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.483 ' HA3' ' HA ' ' A' ' 74' ' ' LYS . . . -88.92 164.53 32.59 Favored Glycine 0 N--CA 1.427 -1.932 0 CA-C-N 113.798 -1.546 . . . . 0.0 111.46 170.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 18.9 ttmm -109.83 134.76 51.68 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-N 114.036 -1.082 . . . . 0.0 108.231 -163.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.86 90.45 1.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -126.64 -173.89 2.99 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.152 0.581 . . . . 0.0 109.763 -179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 26.9 pt -110.49 43.89 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 125.583 1.553 . . . . 0.0 108.341 178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.246 0.911 0 CA-C-O 117.525 -1.226 . . . . 0.0 113.629 -160.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.846 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -153.73 129.32 9.98 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 125.253 1.421 . . . . 0.0 108.03 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.0 mtm -142.24 155.55 45.26 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 112.93 76.72 0.78 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 -173.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.1 p -163.42 163.68 16.31 Favored Pre-proline 0 CA--C 1.543 0.675 0 C-N-CA 125.132 1.373 . . . . 0.0 108.783 172.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -71.19 -176.6 1.95 Allowed 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 123.304 2.669 . . . . 0.0 111.436 171.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.3 t -79.67 113.34 18.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.637 1.175 . . . . 0.0 108.6 -177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -87.64 111.48 21.32 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.145 0.978 . . . . 0.0 108.522 178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -88.24 166.3 14.44 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 163.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -144.15 102.83 3.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 126.468 1.907 . . . . 0.0 106.333 -178.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -128.63 65.23 1.42 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.819 1.648 . . . . 0.0 109.042 -169.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -148.68 174.06 12.56 Favored 'General case' 0 N--CA 1.473 0.717 0 O-C-N 121.037 -1.039 . . . . 0.0 110.195 172.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -62.98 149.45 44.83 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.948 1.249 . . . . 0.0 107.63 155.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -74.37 -24.41 59.15 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 120.334 -0.546 . . . . 0.0 112.149 -174.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 55.4 m-20 -93.52 17.3 11.8 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 124.203 1.001 . . . . 0.0 111.845 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 95.32 58.03 1.17 Allowed Glycine 0 C--N 1.337 0.586 0 O-C-N 121.769 -0.582 . . . . 0.0 111.943 168.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -177.06 -169.39 38.22 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 118.726 -1.702 . . . . 0.0 115.61 171.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.7 p -137.82 7.19 2.72 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.778 1.231 . . . . 0.0 112.74 -163.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.6 t -162.05 159.85 26.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 121.187 -0.946 . . . . 0.0 109.102 178.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -117.72 129.03 55.46 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 167.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 71.2 m -132.73 119.64 20.6 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 166.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -115.56 145.31 42.77 Favored 'General case' 0 C--O 1.238 0.5 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -130.5 74.03 80.63 Favored Pre-proline 0 N--CA 1.446 -0.628 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -75.12 174.59 12.54 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.419 2.079 . . . . 0.0 110.709 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -137.9 -1.84 1.96 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -162.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -144.03 -66.22 0.35 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.013 -179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 14.4 t -157.92 9.81 0.17 Allowed 'General case' 0 CA--C 1.543 0.699 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.397 -169.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.65 92.2 0.32 Allowed 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 120.387 1.449 . . . . 0.0 112.692 -167.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.82 147.01 28.25 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.9 2.48 . . . . 0.0 106.834 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.01 -179.68 40.6 Favored Glycine 0 C--N 1.34 0.792 0 CA-C-N 121.497 1.953 . . . . 0.0 110.066 -172.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 68.5 m -99.67 117.26 33.64 Favored 'General case' 0 C--O 1.238 0.487 0 C-N-CA 123.949 0.9 . . . . 0.0 109.774 -176.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 17.6 p90 -139.71 -165.94 1.98 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.032 1.333 . . . . 0.0 110.599 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 30.0 mt -128.83 155.92 41.08 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 C-N-CA 126.33 1.852 . . . . 0.0 107.485 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 61.2 mt -133.58 156.09 48.47 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 126.55 1.94 . . . . 0.0 106.729 173.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -108.22 98.06 7.66 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.92 142.89 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 173.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.96 112.98 23.99 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 170.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.18 55.93 1.62 Allowed 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -174.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -152.39 168.02 26.81 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.02 -1.05 . . . . 0.0 113.524 -175.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.3 145.33 47.2 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.971 1.309 . . . . 0.0 109.144 173.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.468 ' HE3' ' CG2' ' A' ' 46' ' ' THR . 18.3 ttmt -112.95 143.82 43.57 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 127.806 2.442 . . . . 0.0 106.779 175.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.8 t -172.99 172.02 4.07 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.073 2.149 . . . . 0.0 105.606 177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.43 -102.56 0.04 OUTLIER Glycine 0 CA--C 1.526 0.761 0 C-N-CA 126.19 1.852 . . . . 0.0 112.407 175.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -146.37 41.46 1.15 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.902 1.681 . . . . 0.0 109.188 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -146.26 169.22 19.22 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 124.005 0.922 . . . . 0.0 110.61 -176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.468 ' CG2' ' HE3' ' A' ' 41' ' ' LYS . 52.3 p -135.16 104.66 6.0 Favored 'General case' 0 C--O 1.239 0.549 0 C-N-CA 123.992 0.917 . . . . 0.0 110.461 165.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.8 ttpt -80.44 121.42 25.72 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 172.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -66.75 151.42 47.48 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 166.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 19.6 mt -120.45 114.14 21.35 Favored 'General case' 0 CA--C 1.504 -0.795 0 C-N-CA 125.692 1.597 . . . . 0.0 106.871 175.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.6 m -67.45 150.15 49.29 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 113.71 -1.586 . . . . 0.0 109.994 -177.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 31.7 p90 -120.17 160.57 22.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.465 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -107.15 165.13 11.59 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 126.035 1.734 . . . . 0.0 107.825 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.722 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -156.19 144.36 19.8 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.702 1.201 . . . . 0.0 108.327 166.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.67 152.4 27.06 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.306 0.643 . . . . 0.0 109.985 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 174.92 -62.16 0.11 Allowed Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.792 -0.923 . . . . 0.0 110.792 172.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -116.01 148.82 39.75 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.229 1.012 . . . . 0.0 110.389 -168.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.7 m -60.07 -10.72 4.61 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 126.637 1.975 . . . . 0.0 114.952 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.4 p-90 -130.72 14.38 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 125.429 1.492 . . . . 0.0 111.066 -163.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.489 HG23 ' CE1' ' A' ' 68' ' ' TYR . 23.6 mt -127.36 86.5 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -172.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -104.24 141.78 35.68 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.106 1.362 . . . . 0.0 111.522 -170.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.722 HG11 ' HB3' ' A' ' 53' ' ' ALA . 5.1 p -131.03 100.56 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 C-N-CA 123.858 0.863 . . . . 0.0 109.552 -168.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -100.51 51.96 0.88 Allowed 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 120.606 -1.309 . . . . 0.0 109.921 -177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 62.66 -113.76 6.17 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.4 p -78.1 53.29 1.19 Allowed 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 118.665 1.232 . . . . 0.0 110.773 170.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 21.9 m -165.02 150.52 9.65 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 127.605 2.362 . . . . 0.0 107.263 167.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 14.9 p -142.33 140.95 28.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.0 t -155.69 102.97 2.24 Favored 'General case' 0 CA--C 1.507 -0.689 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.489 ' CE1' HG23 ' A' ' 59' ' ' ILE . 4.4 m-30 -113.96 136.72 52.58 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -103.7 172.02 7.03 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.001 1.321 . . . . 0.0 111.554 -173.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -74.42 156.71 36.71 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 121.89 0.853 . . . . 0.0 111.106 163.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.5 p30 -68.12 165.56 32.06 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 126.26 1.824 . . . . 0.0 110.888 165.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -88.27 -11.51 4.32 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 122.91 2.407 . . . . 0.0 113.969 -175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -132.03 159.71 38.01 Favored 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 124.204 1.002 . . . . 0.0 109.811 -174.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 0.6 3.51 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 -169.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -65.09 165.12 11.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.557 0.743 . . . . 0.0 109.615 -174.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.0 ttm-85 -92.06 146.42 23.75 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 168.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -136.98 154.81 50.32 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 168.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 55.6 m -113.48 106.43 14.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 104.914 -2.254 . . . . 0.0 104.914 163.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -62.39 149.67 47.93 Favored Glycine 0 CA--C 1.522 0.527 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 171.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.5 tp -162.66 118.45 1.86 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 118.075 0.938 . . . . 0.0 109.53 174.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.66 166.81 20.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 C-N-CA 124.195 0.998 . . . . 0.0 109.183 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.7 m -121.52 144.54 48.66 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 169.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.425 HD11 HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -124.58 160.58 28.08 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 126.356 1.863 . . . . 0.0 110.095 172.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.5 tttt -148.8 137.96 21.62 Favored 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 124.759 1.224 . . . . 0.0 108.257 173.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -68.35 165.59 18.37 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 168.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -55.56 -84.94 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.815 2.046 . . . . 0.0 111.553 170.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -91.42 -3.14 56.97 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 120.971 -1.081 . . . . 0.0 113.268 -167.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 t -116.27 -154.51 0.55 Allowed 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 127.242 2.217 . . . . 0.0 108.028 173.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.06 41.37 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.528 0 O-C-N 120.941 -1.099 . . . . 0.0 110.54 -159.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . 0.305 0.0 OUTLIER -65.24 138.5 58.27 Favored 'General case' 0 N--CA 1.416 -2.162 0 N-CA-C 104.709 -2.33 . . . . 0.0 104.709 153.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.1 p -110.39 140.97 44.08 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 103.817 -2.66 . . . . 0.0 103.817 159.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.425 HD12 HD11 ' A' ' 83' ' ' LEU . 86.3 mt -121.24 112.04 18.14 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -177.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.9 m -65.07 137.72 57.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -175.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tt -140.48 96.61 3.06 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.094 0.861 . . . . 0.0 110.072 -175.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 42.2 mtmt -98.23 137.18 37.36 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 4.8 mp -118.53 117.54 54.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 158.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.3 t -108.79 79.15 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -106.14 158.94 31.38 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 123.377 0.671 . . . . 0.0 110.899 -171.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -65.66 -178.08 0.87 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 123.289 2.659 . . . . 0.0 109.979 162.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.2 165.27 22.58 Favored Glycine 0 N--CA 1.448 -0.563 0 O-C-N 121.854 -0.529 . . . . 0.0 112.38 177.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 17.7 ttmm -89.29 138.91 31.01 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.034 0.934 . . . . 0.0 110.812 -158.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -149.4 96.02 2.44 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 163.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 96.9 p -134.14 -165.0 1.58 Allowed 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 124.317 1.047 . . . . 0.0 109.034 174.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 10.9 tp -109.89 14.96 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 125.49 1.516 . . . . 0.0 109.493 173.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 . . . . . 0 C--O 1.248 1.002 0 C-N-CA 124.69 1.196 . . . . 0.0 109.873 -177.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.237 0 N-CA-C 109.087 -1.605 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -116.35 77.72 1.13 Allowed 'General case' 0 C--O 1.224 -0.251 0 CA-C-N 118.389 1.094 . . . . 0.0 108.14 -175.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.6 mtm -164.43 174.71 10.68 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 127.381 2.272 . . . . 0.0 105.74 165.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.99 6.49 1.47 Allowed Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.889 0.757 . . . . 0.0 112.275 -169.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -148.87 157.13 40.84 Favored Pre-proline 0 C--O 1.243 0.757 0 C-N-CA 126.705 2.002 . . . . 0.0 106.784 170.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -68.99 162.51 41.39 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.449 2.099 . . . . 0.0 109.243 172.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.1 p -72.06 147.22 10.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 170.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.54 144.36 50.59 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 125.919 1.688 . . . . 0.0 109.188 175.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.608 ' CZ ' ' HE2' ' A' ' 40' ' ' LYS . 6.8 m-85 -127.2 136.98 52.8 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.981 1.712 . . . . 0.0 107.715 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 85.2 m-85 -121.63 115.17 22.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.989 2.116 . . . . 0.0 107.898 -174.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -140.44 75.2 1.5 Allowed 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.861 2.064 . . . . 0.0 105.797 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -170.25 174.89 5.13 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 123.677 0.791 . . . . 0.0 110.288 -175.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -82.95 157.49 22.98 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.664 -0.647 . . . . 0.0 109.938 177.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.4 -63.99 1.29 Allowed 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 121.279 0.561 . . . . 0.0 109.724 165.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.1 p-10 -107.92 28.37 8.3 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 126.062 1.745 . . . . 0.0 111.027 -160.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.4 -11.43 0.07 OUTLIER Glycine 0 CA--C 1.533 1.199 0 N-CA-C 116.634 1.414 . . . . 0.0 116.634 170.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 116.04 -119.31 4.51 Favored Glycine 0 C--N 1.338 0.69 0 CA-C-N 120.336 2.068 . . . . 0.0 113.796 172.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.17 9.14 2.51 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.636 1.174 . . . . 0.0 112.843 -165.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 t -154.13 -173.4 4.56 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.978 0.808 . . . . 0.0 110.534 161.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.96 105.61 5.12 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 127.785 2.434 . . . . 0.0 109.322 -171.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.0 m -130.35 88.84 2.69 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -83.97 136.48 34.05 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -121.45 70.65 24.42 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 124.815 1.246 . . . . 0.0 108.392 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -68.53 171.89 12.31 Favored 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 121.767 1.645 . . . . 0.0 110.307 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -153.43 157.62 40.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.75 1.22 . . . . 0.0 108.276 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 t70 54.28 -85.52 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 127.583 2.353 . . . . 0.0 110.106 -170.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.3 t -146.44 96.43 2.77 Favored 'General case' 0 N--CA 1.45 -0.429 0 C-N-CA 125.979 1.712 . . . . 0.0 108.928 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 m -146.63 89.42 1.84 Allowed 'General case' 0 CA--C 1.54 0.586 0 O-C-N 120.828 -1.17 . . . . 0.0 112.207 162.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -134.09 135.9 43.55 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 124.682 1.193 . . . . 0.0 108.417 170.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -175.34 -172.31 40.11 Favored Glycine 0 C--N 1.338 0.693 0 CA-C-N 118.871 0.759 . . . . 0.0 112.498 -169.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.0 p -111.33 108.69 18.38 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 125.21 1.404 . . . . 0.0 109.683 -174.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -132.81 -174.86 3.59 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.015 1.326 . . . . 0.0 112.89 -175.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.0 mt -140.57 125.22 18.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.094 1.358 . . . . 0.0 107.91 -169.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 36.3 mt -109.17 165.73 11.38 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.997 1.319 . . . . 0.0 110.57 -176.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -84.51 83.63 7.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 122.076 0.941 . . . . 0.0 110.888 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 47.0 mt -109.36 119.55 58.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 C-N-CA 124.46 1.104 . . . . 0.0 109.449 -170.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.5 m -84.77 135.3 34.18 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.702 -1.136 . . . . 0.0 108.549 173.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 13.7 t -155.19 89.27 1.2 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -162.75 165.89 24.97 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 123.925 0.89 . . . . 0.0 111.506 179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.608 ' HE2' ' CZ ' ' A' ' 9' ' ' TYR . 11.0 ptpt -110.71 161.19 16.01 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 124.206 1.003 . . . . 0.0 109.113 172.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -134.17 124.98 26.94 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 125.968 1.707 . . . . 0.0 108.001 177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 15.0 t -173.82 175.54 2.85 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 125.104 1.362 . . . . 0.0 108.073 173.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 56.56 -107.52 0.92 Allowed Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 108.02 -2.032 . . . . 0.0 108.02 -178.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -152.15 68.23 0.87 Allowed 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.617 1.567 . . . . 0.0 107.499 168.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 38.8 m -160.87 172.21 17.38 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 126.687 1.995 . . . . 0.0 110.653 171.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.1 p -135.39 89.5 2.52 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.076 0.951 . . . . 0.0 110.147 161.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -79.13 140.04 37.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 119.698 1.135 . . . . 0.0 109.963 172.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -62.96 166.79 5.34 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 125.165 1.386 . . . . 0.0 111.417 171.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 86' ' ' ASP . 22.5 mt -137.32 134.46 36.08 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.839 0.855 . . . . 0.0 109.512 162.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.5 p -71.63 173.68 7.76 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 125.817 1.647 . . . . 0.0 110.357 171.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 45.8 p90 -145.69 179.86 7.15 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 124.806 1.243 . . . . 0.0 111.318 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -125.88 162.44 25.18 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 127.27 2.228 . . . . 0.0 107.734 170.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.92 156.8 43.36 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.596 0.758 . . . . 0.0 109.236 165.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.1 p 174.56 154.19 0.13 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.946 1.298 . . . . 0.0 112.64 167.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.41 -96.47 0.1 Allowed Glycine 0 CA--C 1.527 0.792 0 C-N-CA 126.779 2.133 . . . . 0.0 109.055 175.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -67.21 167.72 11.7 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 117.898 0.849 . . . . 0.0 111.426 178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.5 m -93.08 5.03 52.93 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -171.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.4 p-90 -125.64 21.4 7.74 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.881 1.672 . . . . 0.0 112.461 -174.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 44.7 mt -134.84 114.22 17.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 -165.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -124.0 149.26 46.24 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 124.06 0.944 . . . . 0.0 109.898 -166.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -132.55 155.27 41.18 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 108.542 -0.911 . . . . 0.0 108.542 -171.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -144.01 179.0 7.47 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 124.416 1.086 . . . . 0.0 108.849 165.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -57.72 -18.71 32.74 Favored Glycine 0 CA--C 1.532 1.151 0 N-CA-C 116.484 1.353 . . . . 0.0 116.484 -163.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 m -145.03 8.01 1.22 Allowed 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 119.323 1.561 . . . . 0.0 111.16 163.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.1 m -109.99 151.45 27.13 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.697 1.599 . . . . 0.0 109.387 -163.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.3 p -131.19 138.25 53.76 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.1 m -142.18 152.26 42.98 Favored 'General case' 0 C--O 1.24 0.567 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 172.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -159.23 168.02 27.54 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.855 0.862 . . . . 0.0 108.841 163.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -119.47 166.98 12.4 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.419 1.088 . . . . 0.0 110.565 -179.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -74.13 175.31 7.62 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 122.403 1.097 . . . . 0.0 111.161 170.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.447 HD22 ' HD2' ' A' ' 77' ' ' ARG . 7.6 p-10 -99.8 166.94 11.88 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 127.957 2.503 . . . . 0.0 110.945 -170.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -76.76 -28.6 6.25 Favored 'Trans proline' 0 N--CA 1.455 -0.741 0 C-N-CA 122.826 2.351 . . . . 0.0 114.775 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.91 168.5 19.67 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 119.673 1.124 . . . . 0.0 110.883 -165.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -75.0 1.11 13.73 Favored 'General case' 0 C--O 1.233 0.192 0 O-C-N 120.733 -1.229 . . . . 0.0 111.918 -170.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -65.0 161.25 19.07 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.231 0.538 . . . . 0.0 110.749 173.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -78.92 129.13 34.18 Favored 'General case' 0 C--O 1.239 0.532 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 174.203 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.447 ' HD2' HD22 ' A' ' 71' ' ' ASN . 0.0 OUTLIER -119.81 101.96 8.25 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 104.735 -2.32 . . . . 0.0 104.735 167.626 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.6 m -91.1 106.82 18.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 162.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -74.32 160.93 53.48 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 20.0 tp -161.46 93.94 0.95 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-N 117.38 0.59 . . . . 0.0 111.818 -179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 15.1 m -86.28 179.34 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.966 -0.458 . . . . 0.0 111.983 177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.96 164.53 14.01 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 161.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.539 HD13 ' HB2' ' A' ' 92' ' ' LEU . 3.4 mp -134.01 164.78 26.54 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 125.848 1.659 . . . . 0.0 108.87 165.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.1 tttt -151.66 153.18 33.91 Favored 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 164.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -80.03 171.88 14.52 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 172.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.457 ' HB3' HD22 ' A' ' 49' ' ' LEU . 50.9 t0 -55.56 -39.41 70.6 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.902 1.281 . . . . 0.0 112.031 168.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -126.04 -44.97 1.73 Allowed 'General case' 0 N--CA 1.469 0.514 0 O-C-N 120.893 -1.129 . . . . 0.0 111.845 -177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.4 t -79.47 -169.56 1.96 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.75 10.49 0.04 OUTLIER Glycine 0 C--O 1.223 -0.582 0 CA-C-O 117.09 -1.95 . . . . 0.0 116.422 -159.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -63.34 91.89 0.05 Allowed 'General case' 0 C--N 1.341 0.198 0 CA-C-N 120.74 2.27 . . . . 0.0 109.194 169.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 32.6 p -71.6 145.01 49.28 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -174.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.539 ' HB2' HD13 ' A' ' 83' ' ' LEU . 75.1 mt -102.09 -179.06 3.89 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.16 -0.963 . . . . 0.0 108.57 176.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -143.93 86.73 1.87 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.148 1.379 . . . . 0.0 110.681 -167.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 15.0 tp -80.99 73.12 8.04 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.469 1.108 . . . . 0.0 109.473 -169.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 73.8 mttt -78.4 91.77 4.52 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.462 HG22 ' CG ' ' A' ' 98' ' ' GLN . 26.3 mt -87.49 102.41 12.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 105.634 -1.988 . . . . 0.0 105.634 176.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.08 81.51 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -172.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.462 ' CG ' HG22 ' A' ' 96' ' ' ILE . 9.4 mt-30 -95.98 156.37 37.24 Favored Pre-proline 0 C--O 1.242 0.674 0 CA-C-O 118.144 -0.931 . . . . 0.0 109.451 -171.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -61.89 156.79 46.86 Favored 'Trans proline' 0 N--CA 1.456 -0.73 0 C-N-CA 121.692 1.594 . . . . 0.0 108.715 162.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -86.78 153.17 25.59 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.65 -0.98 . . . . 0.0 110.65 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 32.2 ttmt -94.95 155.33 16.79 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.405 1.482 . . . . 0.0 110.759 -172.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.06 101.72 0.87 Allowed 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 173.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.5 p -147.15 179.41 7.65 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.162 0.985 . . . . 0.0 110.725 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.7 mp -77.44 84.92 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 N-CA-C 103.825 -2.658 . . . . 0.0 103.825 160.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.251 1.132 0 CA-C-O 116.456 -1.735 . . . . 0.0 109.869 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.141 0 N-CA-C 108.175 -1.97 . . . . 0.0 108.175 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.9 p80 177.59 59.55 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 -163.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.2 tmm? -163.05 149.22 12.17 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 177.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.87 166.91 31.28 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 107.641 -2.184 . . . . 0.0 107.641 176.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 72.8 p -158.19 165.74 17.96 Favored Pre-proline 0 C--O 1.244 0.78 0 CA-C-N 117.745 0.772 . . . . 0.0 109.191 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -55.58 161.03 8.24 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 121.864 1.709 . . . . 0.0 110.99 163.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.9 p -74.83 113.92 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 124.69 1.196 . . . . 0.0 108.731 178.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.2 t -82.68 105.82 14.03 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.453 1.101 . . . . 0.0 108.351 -174.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -89.72 146.53 24.44 Favored 'General case' 0 N--CA 1.465 0.302 0 O-C-N 121.028 -1.045 . . . . 0.0 110.453 176.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -132.41 112.04 11.82 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 125.843 1.657 . . . . 0.0 108.884 -177.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -144.51 92.32 2.29 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.036 0.934 . . . . 0.0 108.849 173.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 p -166.93 167.77 14.51 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.666 0.787 . . . . 0.0 110.018 172.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -72.97 172.33 11.15 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.027 0.531 . . . . 0.0 110.537 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.37 -22.1 44.86 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.463 0.705 . . . . 0.0 111.209 170.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -79.15 20.78 0.48 Allowed 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 126.299 1.84 . . . . 0.0 112.468 -174.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 61.88 52.17 52.2 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 120.636 -1.29 . . . . 0.0 112.693 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -174.92 -173.12 40.48 Favored Glycine 0 CA--C 1.527 0.842 0 CA-C-N 117.394 0.597 . . . . 0.0 113.564 178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 17.5 p -131.96 17.3 4.64 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.108 2.163 . . . . 0.0 111.83 -166.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 1.5 t -151.58 137.42 18.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 120.521 -1.362 . . . . 0.0 108.835 -173.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -108.08 125.49 51.64 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 170.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.0 m -130.69 93.71 3.48 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.04 143.82 31.28 Favored 'General case' 0 C--O 1.242 0.67 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -122.09 65.91 21.89 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.85 1.26 . . . . 0.0 110.504 176.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -75.29 -176.49 2.95 Favored 'Trans proline' 0 CA--C 1.537 0.646 0 C-N-CA 122.031 1.821 . . . . 0.0 110.407 176.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -162.18 165.53 26.8 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 124.909 1.284 . . . . 0.0 108.023 -169.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 59.06 -77.58 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 127.651 2.38 . . . . 0.0 112.716 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 38.1 t -160.01 124.0 3.7 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.328 1.451 . . . . 0.0 107.584 149.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.93 31.31 3.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.947 0.794 . . . . 0.0 112.472 171.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.96 126.1 28.69 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 124.773 1.229 . . . . 0.0 111.221 169.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.04 -159.57 16.23 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.732 -0.947 . . . . 0.0 110.732 178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.7 p -123.55 116.55 23.35 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.652 1.181 . . . . 0.0 109.265 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 10.9 p90 -130.14 -177.57 4.36 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.538 1.535 . . . . 0.0 110.821 -178.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.1 mt -135.27 148.13 28.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 N-CA-C 106.347 -1.723 . . . . 0.0 106.347 -177.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 47.4 mt -128.11 161.12 29.98 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.612 1.165 . . . . 0.0 109.574 -177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -91.13 108.73 20.07 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 125.63 1.572 . . . . 0.0 108.668 175.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.6 mp -119.82 138.63 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.117 0 C-N-CA 125.633 1.573 . . . . 0.0 107.954 175.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 m -79.92 129.33 34.4 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 117.868 -1.063 . . . . 0.0 108.852 164.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.9 p -148.29 71.61 1.17 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 120.199 1.363 . . . . 0.0 111.527 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -153.49 171.21 19.04 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.157 -0.965 . . . . 0.0 112.227 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.99 144.21 49.95 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 125.905 1.682 . . . . 0.0 108.827 167.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 70.6 tttt -117.42 133.8 55.56 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -172.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.8 t 175.02 -171.47 0.06 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 127.603 2.361 . . . . 0.0 105.867 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 55.29 -107.93 0.88 Allowed Glycine 0 C--N 1.333 0.415 0 N-CA-C 108.193 -1.963 . . . . 0.0 108.193 -171.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -143.21 26.05 1.68 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.16 0.984 . . . . 0.0 110.027 167.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.3 m -150.81 -164.89 2.12 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.002 1.321 . . . . 0.0 110.411 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.0 p -130.37 99.02 4.87 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 127.037 2.135 . . . . 0.0 107.856 -172.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -73.05 123.03 22.74 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 174.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -63.32 161.21 14.39 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 123.656 0.782 . . . . 0.0 110.045 172.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 78.1 mt -138.03 153.49 49.37 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 124.223 1.009 . . . . 0.0 108.863 169.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.8 m -115.19 164.96 13.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.217 1.407 . . . . 0.0 109.808 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 33.5 p90 -145.71 165.69 28.03 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -168.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -121.83 153.91 37.74 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 127.441 2.297 . . . . 0.0 109.282 176.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.426 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -147.45 148.31 31.13 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.974 1.709 . . . . 0.0 108.157 169.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -166.94 154.55 9.3 Favored 'General case' 0 C--O 1.24 0.592 0 C-N-CA 123.305 0.642 . . . . 0.0 111.102 168.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -177.53 -69.23 0.06 OUTLIER Glycine 0 C--N 1.337 0.613 0 CA-C-O 121.322 0.401 . . . . 0.0 113.125 172.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.615 ' H ' HG12 ' A' ' 81' ' ' VAL . 1.0 OUTLIER -75.74 -173.12 2.12 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.585 1.954 . . . . 0.0 109.69 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.21 23.14 11.48 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 125.5 1.52 . . . . 0.0 113.691 168.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 11.5 p-90 -135.42 -3.24 2.41 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 177.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 46.7 mt -119.3 122.77 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 126.918 2.087 . . . . 0.0 107.955 -167.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -123.54 165.56 16.93 Favored 'General case' 0 C--O 1.237 0.434 0 O-C-N 121.388 -0.82 . . . . 0.0 110.965 -169.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.426 HG11 ' HB3' ' A' ' 53' ' ' ALA . 10.7 p -146.64 140.78 20.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.131 0.972 . . . . 0.0 108.56 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -136.01 66.88 1.48 Allowed 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 58.38 -119.05 15.45 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 107.939 -2.065 . . . . 0.0 107.939 -165.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.5 p -56.82 -25.24 55.54 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 126.127 1.771 . . . . 0.0 114.265 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.2 m -93.28 146.62 23.57 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.444 1.097 . . . . 0.0 109.366 -167.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 3.1 p -142.45 145.17 23.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 124.585 1.154 . . . . 0.0 109.197 -173.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.5 m -143.25 154.39 43.77 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -152.09 125.58 8.84 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 168.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -105.94 114.61 28.86 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 -174.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.264 10.6 pt-20 -75.37 165.68 24.78 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.982 0.896 . . . . 0.0 112.939 -166.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -68.35 149.81 97.93 Favored Pre-proline 0 CA--C 1.537 0.445 0 CA-C-N 115.362 -0.836 . . . . 0.0 109.75 -173.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -74.81 -9.57 21.11 Favored 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.041 2.494 . . . . 0.0 113.071 -169.417 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -119.53 -178.65 3.66 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 122.597 1.189 . . . . 0.0 110.728 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.97 13.87 21.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 126.216 1.806 . . . . 0.0 112.157 -170.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -80.04 152.51 29.36 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 107.572 -1.269 . . . . 0.0 107.572 172.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.4 ttm-85 -82.75 138.44 34.05 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.744 1.218 . . . . 0.0 107.931 -177.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -144.09 92.55 2.34 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 120.222 1.374 . . . . 0.0 111.327 176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.47 HG23 HG22 ' A' ' 97' ' ' VAL . 45.6 m -68.87 115.61 8.4 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 122.181 -0.324 . . . . 0.0 110.514 173.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.24 162.56 29.69 Favored Glycine 0 CA--C 1.531 1.051 0 C-N-CA 124.157 0.884 . . . . 0.0 112.91 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.1 tp -162.69 115.11 1.62 Allowed 'General case' 0 C--O 1.239 0.544 0 C-N-CA 124.82 1.248 . . . . 0.0 111.247 175.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.615 HG12 ' H ' ' A' ' 56' ' ' ASP . 3.2 m -103.19 179.32 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 124.357 1.063 . . . . 0.0 109.828 164.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 m -129.38 162.87 27.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 163.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 0.7 OUTLIER -143.74 158.82 43.41 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 125.794 1.638 . . . . 0.0 112.406 -179.878 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 57.3 tttt -150.54 159.89 44.17 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.501 1.12 . . . . 0.0 109.548 168.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -103.76 164.69 11.51 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.275 1.43 . . . . 0.0 110.256 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -54.99 -57.15 12.84 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.736 1.214 . . . . 0.0 113.345 -172.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -118.59 -6.64 10.67 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.239 0.616 . . . . 0.0 112.468 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.1 m -80.3 -154.64 0.1 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.088 0.955 . . . . 0.0 109.562 173.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.04 -1.24 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 118.138 -1.368 . . . . 0.0 115.502 173.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 20.5 mttm -64.1 107.4 1.27 Allowed 'General case' 0 CA--C 1.513 -0.478 0 CA-C-N 120.029 1.914 . . . . 0.0 106.721 170.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 66.1 p -63.32 155.3 29.09 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 161.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 83.3 mt -101.74 -166.11 1.26 Allowed 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 164.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 t -146.32 111.68 5.47 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 105.505 -2.035 . . . . 0.0 105.505 160.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 31.9 tp -83.78 122.24 28.39 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 164.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -120.74 154.25 35.89 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.4 mp -131.43 121.47 48.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 103.711 -2.699 . . . . 0.0 103.711 172.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 78' ' ' THR . 45.7 t -127.47 105.85 14.33 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.24 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.64 165.84 22.76 Favored Pre-proline 0 C--O 1.235 0.302 0 C-N-CA 124.257 1.023 . . . . 0.0 111.142 -176.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -63.51 -177.97 0.46 Allowed 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.516 2.144 . . . . 0.0 110.867 156.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -109.32 175.11 18.77 Favored Glycine 0 CA--C 1.531 1.09 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.458 173.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 38.6 mtmt -76.01 136.66 39.97 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.877 1.271 . . . . 0.0 112.054 -173.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.53 8.07 0.09 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.976 2.11 . . . . 0.0 113.001 174.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.5 p -85.74 -173.02 4.41 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 124.321 1.049 . . . . 0.0 110.226 -162.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.472 HD12 ' H ' ' A' ' 104' ' ' ILE . 3.5 mp -74.38 73.15 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 105.006 -2.22 . . . . 0.0 105.006 161.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.247 0.922 0 C-N-CA 126.318 1.847 . . . . 0.0 106.853 173.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.66 0 N-CA-C 110.674 -0.97 . . . . 0.0 110.674 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.0 m170 -67.88 161.68 25.81 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 169.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.4 tpt -64.5 144.34 57.26 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 157.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.04 -83.41 0.05 OUTLIER Glycine 0 C--O 1.225 -0.442 0 N-CA-C 108.59 -1.804 . . . . 0.0 108.59 174.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 p -140.62 165.33 30.64 Favored Pre-proline 0 C--O 1.238 0.5 0 C-N-CA 124.081 0.952 . . . . 0.0 109.52 -178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -61.3 136.72 65.95 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 N-CA-C 108.453 -1.403 . . . . 0.0 108.453 161.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.5 t -107.37 135.49 45.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 165.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.67 122.62 45.09 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 168.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -85.85 155.42 20.98 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 164.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -134.72 103.52 5.67 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 2.8 t80 -139.71 86.27 2.09 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 170.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.67 -170.03 3.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.838 2.055 . . . . 0.0 105.843 171.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -78.18 -89.31 0.05 OUTLIER 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 166.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -154.79 -61.97 0.12 Allowed 'General case' 0 CA--C 1.517 -0.301 0 O-C-N 119.073 -2.267 . . . . 0.0 110.788 172.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.0 p30 -127.12 2.48 6.47 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 126.844 2.058 . . . . 0.0 110.697 -167.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.25 -73.08 1.19 Allowed Glycine 0 C--N 1.335 0.515 0 N-CA-C 107.711 -2.155 . . . . 0.0 107.711 170.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.55 -154.8 25.55 Favored Glycine 0 N--CA 1.448 -0.566 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 20.7 p -79.85 20.11 0.64 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.468 1.907 . . . . 0.0 110.909 171.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 12.7 t -158.94 156.85 30.25 Favored 'General case' 0 N--CA 1.447 -0.613 0 O-C-N 120.661 -1.274 . . . . 0.0 108.77 -165.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.9 157.4 46.47 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 157.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 85.0 m -131.45 152.34 50.77 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 158.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -133.94 150.78 51.31 Favored 'General case' 0 C--O 1.241 0.609 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 169.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -127.88 74.33 78.7 Favored Pre-proline 0 C--O 1.239 0.552 0 C-N-CA 126.11 1.764 . . . . 0.0 107.425 174.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.33 175.2 4.29 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 122.346 2.03 . . . . 0.0 109.846 167.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -161.03 173.92 14.51 Favored 'General case' 0 C--N 1.332 -0.193 0 O-C-N 121.395 -0.816 . . . . 0.0 109.11 -172.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.9 t0 55.93 -84.04 0.01 OUTLIER 'General case' 0 C--O 1.235 0.331 0 C-N-CA 127.963 2.505 . . . . 0.0 111.485 -173.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 1.2 m -145.39 125.71 13.9 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 128.103 2.561 . . . . 0.0 105.199 148.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.1 m -148.87 112.34 5.01 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.773 1.169 . . . . 0.0 110.4 163.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.6 179.24 6.68 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 126.0 1.72 . . . . 0.0 108.668 161.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.33 -176.56 32.91 Favored Glycine 0 CA--C 1.523 0.54 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 174.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.5 m -109.17 101.61 10.63 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.835 1.254 . . . . 0.0 109.876 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -115.36 -165.01 0.99 Allowed 'General case' 0 N--CA 1.465 0.322 0 C-N-CA 126.465 1.906 . . . . 0.0 111.166 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 44.0 mt -127.53 148.14 32.25 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 125.586 1.554 . . . . 0.0 107.426 -178.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.5 mt -132.03 165.32 24.24 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 126.849 2.059 . . . . 0.0 107.154 178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -111.04 105.91 14.81 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -172.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 33.7 mt -132.52 142.13 43.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 C-N-CA 125.67 1.588 . . . . 0.0 107.789 -163.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -112.23 129.9 56.11 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.063 1.345 . . . . 0.0 108.226 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 32.6 t -147.78 78.04 1.44 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.084 0.468 . . . . 0.0 110.162 -175.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -157.04 175.76 13.65 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 120.774 -1.204 . . . . 0.0 111.567 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.58 148.54 43.2 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 123.989 0.916 . . . . 0.0 109.209 161.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -114.67 123.43 49.26 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 126.506 1.922 . . . . 0.0 107.413 -178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 10.7 t -173.98 -166.66 0.31 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.967 1.707 . . . . 0.0 107.113 173.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 52.33 -103.63 0.13 Allowed Glycine 0 C--N 1.336 0.53 0 C-N-CA 126.184 1.849 . . . . 0.0 109.552 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -147.11 21.14 1.23 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.976 0.91 . . . . 0.0 110.656 171.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.0 m -156.33 173.92 16.16 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 120.327 -1.483 . . . . 0.0 111.39 -176.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.6 p -130.24 105.69 8.08 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 125.829 1.652 . . . . 0.0 107.087 176.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -83.23 139.83 32.88 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 167.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.2 146.12 45.77 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 118.641 0.655 . . . . 0.0 110.945 172.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 80.9 mt -101.77 133.14 46.96 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 165.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.6 m -73.2 166.52 22.99 Favored 'General case' 0 C--O 1.239 0.541 0 C-N-CA 124.753 1.221 . . . . 0.0 109.126 171.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.1 p90 -148.28 179.32 7.86 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.279 1.032 . . . . 0.0 111.844 178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.93 172.31 12.86 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.782 1.633 . . . . 0.0 110.471 174.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.82 161.13 32.45 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.524 1.93 . . . . 0.0 109.617 169.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.9 p -153.64 140.25 18.88 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 163.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.19 -138.05 5.08 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 176.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -44.56 131.03 6.78 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 128.182 2.593 . . . . 0.0 111.076 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.8 m -80.27 30.99 0.27 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.93 1.292 . . . . 0.0 113.818 -173.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.3 p-90 -133.52 23.65 4.04 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.584 1.554 . . . . 0.0 110.299 172.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 47.0 mt -144.98 107.88 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -170.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -119.9 164.44 16.05 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.82 1.248 . . . . 0.0 108.925 -178.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 p -146.34 152.76 13.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.281 0.562 . . . . 0.0 110.801 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.7 169.18 18.06 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 128.672 2.789 . . . . 0.0 109.433 166.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -58.68 -32.96 70.55 Favored Glycine 0 CA--C 1.531 1.093 0 CA-C-O 119.879 -0.4 . . . . 0.0 113.538 -177.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.36 11.5 8.7 Favored 'General case' 0 N--CA 1.464 0.241 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 -178.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 t -153.47 142.81 21.58 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 119.553 1.069 . . . . 0.0 108.859 -170.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.7 t -120.91 150.97 23.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 N-CA-C 105.342 -2.096 . . . . 0.0 105.342 -171.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.3 m -139.0 134.18 32.71 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 165.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -127.34 138.15 52.96 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 105.514 -2.032 . . . . 0.0 105.514 155.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -99.33 -172.93 2.36 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 170.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -101.42 168.96 9.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 122.634 1.207 . . . . 0.0 108.825 170.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.483 HD21 ' HA2' ' A' ' 100' ' ' GLY . 27.5 p30 -76.28 160.54 77.62 Favored Pre-proline 0 C--N 1.327 -0.398 0 C-N-CA 124.738 1.215 . . . . 0.0 108.98 167.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -75.19 -47.23 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 122.245 1.964 . . . . 0.0 110.549 175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.14 165.88 12.61 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 121.118 0.485 . . . . 0.0 110.696 -170.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.23 2.32 50.4 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.049 0.94 . . . . 0.0 113.071 -171.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -71.42 148.85 46.51 Favored 'General case' 0 C--O 1.236 0.378 0 O-C-N 121.523 -0.735 . . . . 0.0 110.129 172.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.95 139.6 58.38 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.65 0.78 . . . . 0.0 108.945 174.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 11.9 mmp_? -129.58 151.02 50.65 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 123.892 0.877 . . . . 0.0 109.858 175.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.9 m -120.61 100.65 7.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.849 1.26 . . . . 0.0 107.654 174.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -69.97 140.59 33.08 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 176.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.1 tp -152.79 103.18 2.75 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 117.886 0.843 . . . . 0.0 108.801 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.3 m -107.59 163.62 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 CA-C-N 118.826 0.739 . . . . 0.0 110.592 176.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.6 m -107.72 158.08 17.58 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.4 mp -138.22 158.46 44.25 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.313 1.845 . . . . 0.0 108.542 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.21 142.91 18.69 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 118.662 0.664 . . . . 0.0 110.678 174.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.523 ' HG2' ' H ' ' A' ' 88' ' ' SER . 7.9 tt0 -77.92 165.32 24.25 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 127.851 2.46 . . . . 0.0 111.013 175.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -51.63 -85.95 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 127.054 2.142 . . . . 0.0 112.719 167.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -89.53 -8.27 53.13 Favored 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.896 -1.127 . . . . 0.0 111.957 -168.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.523 ' H ' ' HG2' ' A' ' 85' ' ' GLN . 0.2 OUTLIER -136.95 -153.87 0.52 Allowed 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 127.624 2.37 . . . . 0.0 108.076 177.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.92 44.52 0.02 OUTLIER Glycine 0 C--N 1.334 0.433 0 CA-C-N 120.467 1.485 . . . . 0.0 113.228 -151.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.86 103.18 0.15 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 105.288 -2.116 . . . . 0.0 105.288 148.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 80.6 p -69.25 133.35 47.81 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 97.4 mt -87.75 155.53 19.87 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.37 151.65 21.94 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 157.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.6 tt -149.94 112.38 4.71 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 169.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -120.09 140.21 51.4 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -128.67 128.53 67.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 167.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 73.6 t -109.67 96.62 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 104.847 -2.279 . . . . 0.0 104.847 168.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -109.07 165.17 13.13 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-O 118.012 -0.994 . . . . 0.0 108.513 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -55.71 -162.16 0.01 OUTLIER 'Trans proline' 0 CA--C 1.535 0.553 1 C-N-CA 126.231 4.621 . . . . 0.0 112.906 163.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.483 ' HA2' HD21 ' A' ' 71' ' ' ASN . . . -120.49 168.91 13.97 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 116.745 -2.645 . . . . 0.0 112.679 147.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 8.3 ttmt -103.6 158.86 16.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.969 1.308 . . . . 0.0 111.072 -168.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -165.41 103.01 0.72 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 127.447 2.299 . . . . 0.0 105.387 164.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 t -148.55 -175.72 5.03 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.425 1.011 . . . . 0.0 109.915 166.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 69.1 mt -87.72 80.7 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 176.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.2 t0 . . . . . 0 C--O 1.252 1.188 0 C-N-CA 123.344 0.657 . . . . 0.0 110.024 177.722 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.21 0 N-CA-C 109.636 -1.385 . . . . 0.0 109.636 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -59.36 155.32 14.92 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 118.444 1.122 . . . . 0.0 109.354 170.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 78.2 mtp -139.56 -168.1 2.4 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.834 1.653 . . . . 0.0 107.528 175.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.56 -43.18 3.16 Favored Glycine 0 CA--C 1.522 0.49 0 N-CA-C 110.515 -1.034 . . . . 0.0 110.515 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.4 p -49.39 144.53 8.64 Favored Pre-proline 0 C--O 1.241 0.611 0 C-N-CA 124.693 1.197 . . . . 0.0 111.144 174.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -70.09 178.45 4.76 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.034 2.49 . . . . 0.0 110.86 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.87 162.19 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 C-N-CA 124.34 1.056 . . . . 0.0 108.94 -176.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.4 m -139.95 104.98 4.99 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 127.578 2.351 . . . . 0.0 107.878 172.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -86.02 152.8 22.62 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.797 1.239 . . . . 0.0 109.848 171.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.46 134.16 45.9 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 125.23 1.412 . . . . 0.0 107.332 -171.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 4.5 p90 -153.07 62.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.254 0.622 . . . . 0.0 111.173 -173.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 97.1 p -151.7 -169.24 3.31 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 121.017 -1.052 . . . . 0.0 110.663 176.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.637 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 70.3 m-85 -75.94 177.0 7.34 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 121.395 -0.816 . . . . 0.0 109.345 157.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.21 -23.7 14.0 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.609 1.164 . . . . 0.0 111.388 172.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -145.76 3.13 0.95 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 123.491 0.716 . . . . 0.0 112.28 -174.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.83 -79.42 1.46 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 178.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.637 ' H ' ' HB2' ' A' ' 13' ' ' TYR . . . 162.57 -125.12 1.37 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 126.436 1.97 . . . . 0.0 108.923 -172.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 5.1 p -135.25 17.19 3.43 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 125.577 1.551 . . . . 0.0 111.913 -168.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -161.51 175.11 12.48 Favored 'General case' 0 N--CA 1.451 -0.392 0 O-C-N 120.471 -1.393 . . . . 0.0 110.827 166.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.02 122.53 32.46 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 126.785 2.034 . . . . 0.0 107.029 -173.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.474 HG22 ' CE1' ' A' ' 23' ' ' TYR . 26.4 m -149.62 88.27 1.55 Allowed 'General case' 0 C--O 1.234 0.269 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -78.58 139.24 38.61 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 177.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.474 ' CE1' HG22 ' A' ' 21' ' ' THR . 91.4 m-85 -124.88 74.62 65.55 Favored Pre-proline 0 CA--C 1.538 0.489 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 170.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -70.89 173.86 11.35 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.258 2.639 . . . . 0.0 110.229 177.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -153.61 147.57 25.51 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.496 -0.752 . . . . 0.0 111.41 -169.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.0 t70 61.86 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 126.96 2.104 . . . . 0.0 108.974 -164.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 45.5 t -160.18 114.57 2.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 103.821 -2.659 . . . . 0.0 103.821 172.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -138.18 112.37 8.59 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 169.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -143.01 157.66 44.33 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.467 1.507 . . . . 0.0 109.279 -174.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.88 -178.52 31.55 Favored Glycine 0 C--N 1.337 0.591 0 N-CA-C 110.275 -1.13 . . . . 0.0 110.275 160.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.4 p -102.34 113.73 27.29 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 125.147 1.379 . . . . 0.0 109.847 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -130.89 -170.2 2.31 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.78 1.232 . . . . 0.0 112.835 -175.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.9 mt -131.3 151.66 36.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 127.717 2.407 . . . . 0.0 107.194 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 83.5 mt -131.87 154.82 48.8 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 126.23 1.812 . . . . 0.0 109.07 173.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -86.14 55.85 3.72 Favored 'General case' 0 N--CA 1.464 0.274 0 C-N-CA 125.015 1.326 . . . . 0.0 110.099 -174.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 44.0 mt -71.53 156.85 6.88 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.787 1.235 . . . . 0.0 110.327 -176.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.0 m -127.69 107.69 10.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 126.135 1.774 . . . . 0.0 109.27 -169.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -151.37 86.77 1.35 Allowed 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 122.561 0.344 . . . . 0.0 110.328 -174.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -156.11 165.01 37.69 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 122.539 0.336 . . . . 0.0 110.883 -178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.98 130.92 55.95 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.92 1.688 . . . . 0.0 109.5 176.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 62.9 tttt -116.35 127.53 54.75 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.554 1.941 . . . . 0.0 106.781 -170.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.6 t -168.99 143.33 3.05 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 61.93 -104.69 0.77 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -176.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.4 m-80 -133.8 21.03 3.86 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.003 0.921 . . . . 0.0 111.166 -170.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.2 t -149.21 162.89 39.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 122.874 1.321 . . . . 0.0 110.253 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.1 p -132.39 115.23 15.31 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 130.038 3.335 . . . . 0.0 105.629 -172.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -115.08 111.36 20.95 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 -170.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -72.49 157.55 37.4 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.259 0.35 . . . . 0.0 110.804 -177.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 38.7 mt -132.31 130.56 40.96 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 125.48 1.512 . . . . 0.0 110.76 -177.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 5.1 m -71.12 178.39 3.3 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.43 1.492 . . . . 0.0 110.978 176.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 39.5 p90 -147.43 177.35 9.3 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 124.502 1.121 . . . . 0.0 109.702 168.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.25 165.73 26.42 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 125.644 1.577 . . . . 0.0 109.85 166.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.33 156.55 44.73 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 126.225 1.81 . . . . 0.0 109.099 177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.1 m -155.35 144.12 20.59 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.314 1.046 . . . . 0.0 110.216 173.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.85 -86.88 0.1 Allowed Glycine 0 CA--C 1.528 0.851 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 167.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -68.7 160.11 30.89 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 118.37 1.085 . . . . 0.0 111.426 -177.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.2 t -82.47 -8.12 59.62 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -174.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -129.87 28.15 5.11 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.748 1.158 . . . . 0.0 112.32 -160.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 70.8 mt -132.76 101.81 4.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 106.868 -1.531 . . . . 0.0 106.868 -169.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -75.32 133.1 41.34 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.208 1.003 . . . . 0.0 109.884 172.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -124.57 142.35 41.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 124.963 1.305 . . . . 0.0 109.919 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.16 155.79 41.18 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 126.3 1.84 . . . . 0.0 107.533 177.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -64.45 -11.13 46.47 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 123.889 0.757 . . . . 0.0 114.245 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 62.6 m -134.72 -4.86 2.51 Favored 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 118.451 1.125 . . . . 0.0 113.463 173.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.7 m -140.05 164.77 29.13 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 120.876 1.671 . . . . 0.0 110.361 -167.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.5 p -146.19 154.85 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 C-N-CA 124.588 1.155 . . . . 0.0 108.255 -176.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.1 159.5 42.87 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 158.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -132.8 107.82 8.59 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 104.928 -2.249 . . . . 0.0 104.928 165.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -68.46 166.89 15.9 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.508 0.671 . . . . 0.0 109.592 178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -97.91 174.37 6.61 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -108.5 163.92 15.89 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 123.851 0.86 . . . . 0.0 111.123 -168.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -89.82 -11.76 3.16 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.141 3.228 . . . . 0.0 113.978 -178.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -137.33 130.69 31.11 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -171.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.28 22.27 0.33 Allowed 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 126.451 1.9 . . . . 0.0 112.301 -164.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -66.45 166.48 12.4 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 160.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 41.4 ttm-85 -85.5 156.07 20.95 Favored 'General case' 0 C--O 1.24 0.605 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 163.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -135.28 157.67 46.31 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 106.341 -1.726 . . . . 0.0 106.341 164.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 84.9 m -135.21 97.21 3.66 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -176.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -67.39 163.83 45.56 Favored Glycine 0 CA--C 1.534 1.246 0 CA-C-N 117.934 0.334 . . . . 0.0 113.112 -168.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 tp -153.84 125.77 7.79 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.786 1.635 . . . . 0.0 109.403 159.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.14 155.01 31.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 160.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 65.9 m -100.63 156.24 17.42 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 159.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -130.02 161.25 31.38 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.373 1.869 . . . . 0.0 107.719 175.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.424 ' HE2' ' O ' ' A' ' 88' ' ' SER . 68.6 tttt -139.81 145.39 38.1 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -70.91 171.81 10.05 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 168.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -56.27 -65.11 0.66 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.617 0.767 . . . . 0.0 111.855 172.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -118.07 5.18 12.03 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.845 1.258 . . . . 0.0 112.211 -167.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.424 ' O ' ' HE2' ' A' ' 84' ' ' LYS . 17.8 t -135.81 -158.87 0.91 Allowed 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.301 1.44 . . . . 0.0 107.913 162.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -143.51 72.8 0.36 Allowed Glycine 0 N--CA 1.438 -1.221 0 N-CA-C 106.489 -2.644 . . . . 0.0 106.489 -170.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mtmp? -61.42 86.74 0.02 OUTLIER 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 147.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 p -97.5 113.69 25.43 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 104.286 -2.486 . . . . 0.0 104.286 170.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 37.5 mt -131.61 157.54 43.4 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 -178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.8 m -120.44 114.61 22.06 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.118 1.326 . . . . 0.0 108.406 -172.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.91 71.43 3.43 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 121.66 0.743 . . . . 0.0 112.167 -162.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -85.64 82.8 8.09 Favored 'General case' 0 C--O 1.226 -0.184 0 O-C-N 121.066 -1.021 . . . . 0.0 109.423 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 mp -74.49 125.93 34.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 163.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 2.4 t -112.52 67.11 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -99.39 151.8 37.56 Favored Pre-proline 0 C--O 1.239 0.522 0 C-N-CA 123.711 0.805 . . . . 0.0 112.098 -170.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -65.03 -172.14 0.2 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 124.724 3.616 . . . . 0.0 112.707 168.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -130.72 166.27 22.57 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.97 144.8 50.18 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 125.545 1.538 . . . . 0.0 108.691 -163.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.9 p -152.34 64.63 0.82 Allowed 'General case' 0 C--O 1.241 0.649 0 C-N-CA 124.478 1.111 . . . . 0.0 109.848 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.5 m -140.03 -172.28 3.37 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.442 -0.786 . . . . 0.0 110.867 -164.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 49.1 mt -93.04 70.03 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 . . . . . 0 C--O 1.241 0.653 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 -178.891 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.344 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -128.99 72.67 1.47 Allowed 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 74.9 mtm -147.81 160.25 42.96 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 104.884 -2.265 . . . . 0.0 104.884 164.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 124.47 93.8 1.02 Allowed Glycine 0 C--N 1.332 0.349 0 N-CA-C 106.441 -2.663 . . . . 0.0 106.441 -168.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.4 p -145.69 158.52 49.66 Favored Pre-proline 0 C--O 1.238 0.464 0 C-N-CA 124.236 1.014 . . . . 0.0 108.877 -166.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -67.56 173.12 9.36 Favored 'Trans proline' 0 N--CA 1.455 -0.776 0 C-N-CA 122.393 2.062 . . . . 0.0 111.554 -175.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.78 140.75 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 124.642 1.177 . . . . 0.0 109.231 169.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.1 m -92.99 129.44 38.9 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 166.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -106.73 148.51 28.33 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 162.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -126.66 105.64 8.84 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.414 1.486 . . . . 0.0 107.308 -172.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -137.08 56.77 1.78 Allowed 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.777 1.631 . . . . 0.0 109.456 -165.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.9 p -159.78 -175.69 5.29 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.368 1.067 . . . . 0.0 109.136 168.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -65.85 161.08 21.84 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 172.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.46 -15.85 25.15 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.104 0.961 . . . . 0.0 112.322 174.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -148.47 41.21 0.95 Allowed 'General case' 0 CA--C 1.529 0.145 0 CA-C-O 121.596 0.713 . . . . 0.0 111.434 -170.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.71 -83.63 0.05 OUTLIER Glycine 0 C--N 1.335 0.501 0 O-C-N 121.274 -0.891 . . . . 0.0 111.607 177.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -168.65 -125.37 0.78 Allowed Glycine 0 C--N 1.334 0.45 0 CA-C-N 117.136 0.468 . . . . 0.0 113.384 -171.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.3 p -139.22 10.51 2.55 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.102 0.961 . . . . 0.0 112.245 -163.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -156.39 173.16 17.3 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 126.919 2.088 . . . . 0.0 109.498 177.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.448 ' CE1' ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -128.53 142.92 50.92 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 127.715 2.406 . . . . 0.0 108.716 173.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.6 m -153.22 90.73 1.45 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.716 1.207 . . . . 0.0 108.834 172.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.31 151.03 23.46 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 121.718 -0.614 . . . . 0.0 109.554 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -134.58 69.23 72.57 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.398 1.079 . . . . 0.0 109.342 -178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -70.73 175.32 9.07 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 C-N-CA 122.436 2.091 . . . . 0.0 111.117 -176.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -149.19 172.25 15.14 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.377 1.471 . . . . 0.0 107.962 172.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.6 t0 59.79 -85.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 128.167 2.587 . . . . 0.0 109.979 -179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.4 p -142.29 4.13 1.58 Allowed 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 124.641 1.176 . . . . 0.0 113.986 -176.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.5 m -78.4 67.92 4.29 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -163.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -131.5 117.74 19.21 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 127.086 2.154 . . . . 0.0 107.899 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -173.25 -163.09 26.35 Favored Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 109.042 -1.623 . . . . 0.0 109.042 -167.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.4 p -116.99 114.41 23.75 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 117.766 0.783 . . . . 0.0 111.773 -162.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -133.58 -169.92 2.38 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.752 1.221 . . . . 0.0 110.77 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.8 mt -142.91 146.49 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 125.819 1.648 . . . . 0.0 107.091 -170.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.5 mt -126.37 175.81 7.58 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.064 1.345 . . . . 0.0 111.396 -171.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -110.81 91.77 3.79 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 -164.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 28.8 mt -125.92 150.84 31.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 -163.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.02 134.14 54.65 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 18.6 t -153.19 44.88 0.65 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.448 1.099 . . . . 0.0 109.549 -172.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -140.03 169.06 18.39 Favored 'General case' 0 C--O 1.233 0.2 0 O-C-N 120.73 -1.231 . . . . 0.0 111.765 -172.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 6.8 pttm -117.63 158.56 24.42 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.56 1.144 . . . . 0.0 109.175 168.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 49.2 tttm -138.73 135.59 34.89 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 125.928 1.691 . . . . 0.0 108.379 178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.0 t -176.27 149.47 0.85 Allowed 'General case' 0 C--O 1.24 0.554 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 60.43 -101.86 0.32 Allowed Glycine 0 CA--C 1.523 0.563 0 C-N-CA 124.959 1.266 . . . . 0.0 111.345 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -141.71 34.29 1.61 Allowed 'General case' 0 C--O 1.235 0.326 0 C-N-CA 124.425 1.09 . . . . 0.0 110.953 -171.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.6 m -151.52 174.11 13.8 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 120.96 -1.087 . . . . 0.0 110.58 173.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 p -122.44 154.92 37.13 Favored 'General case' 0 N--CA 1.439 -1.016 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 155.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.0 ttpp -138.62 123.93 19.31 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -67.46 160.75 26.86 Favored 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.959 0.787 . . . . 0.0 109.793 169.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -106.81 -159.08 0.68 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 162.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.1 m -130.36 174.92 9.39 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 126.343 1.857 . . . . 0.0 108.458 169.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 26.3 p90 -152.51 173.41 15.18 Favored 'General case' 0 C--O 1.234 0.243 0 O-C-N 121.691 -0.631 . . . . 0.0 111.761 173.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -143.55 172.64 12.52 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 125.062 1.345 . . . . 0.0 109.93 172.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -156.65 159.24 38.23 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.237 1.815 . . . . 0.0 109.112 -175.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.7 p 179.18 161.02 0.74 Allowed 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.647 0.779 . . . . 0.0 111.418 -179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.66 -78.09 0.09 OUTLIER Glycine 0 C--N 1.334 0.471 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -102.66 -160.72 0.8 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.449 1.5 . . . . 0.0 110.832 -169.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.3 p -123.98 14.59 9.21 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.741 1.386 . . . . 0.0 114.741 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 38.1 p-90 -133.43 28.27 4.03 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.744 1.218 . . . . 0.0 111.013 -177.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 78.2 mt -135.68 84.76 0.6 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.463 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -171.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -59.82 125.17 22.59 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.3 t -118.71 152.09 20.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 163.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.55 173.26 11.85 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 159.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -46.44 -50.9 12.89 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -174.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -125.99 40.89 3.64 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.986 0.914 . . . . 0.0 111.169 178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.16 163.23 35.01 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-N 118.98 0.809 . . . . 0.0 110.647 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.74 142.87 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 C-N-CA 125.323 1.449 . . . . 0.0 107.641 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -155.89 168.55 26.85 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 120.337 -1.477 . . . . 0.0 109.047 163.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -145.99 154.1 41.52 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 105.274 -2.121 . . . . 0.0 105.274 172.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -115.61 151.25 35.3 Favored 'General case' 0 CA--C 1.512 -0.514 0 C-N-CA 122.718 0.407 . . . . 0.0 110.04 175.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -72.41 169.83 15.54 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.883 0.849 . . . . 0.0 111.567 175.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.51 154.09 43.96 Favored Pre-proline 0 C--N 1.329 -0.319 0 C-N-CA 124.565 1.146 . . . . 0.0 110.514 -177.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -84.42 -5.68 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.945 2.43 . . . . 0.0 113.426 -166.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -115.91 167.18 11.18 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.986 0.898 . . . . 0.0 109.971 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -77.12 0.56 21.13 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 120.841 -1.162 . . . . 0.0 111.954 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 79.8 mt-10 -59.64 144.03 48.91 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.153 0.981 . . . . 0.0 108.917 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.8 ttm-85 -77.42 136.71 38.42 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 161.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -122.37 134.14 54.64 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.502 1.121 . . . . 0.0 108.996 -175.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 17.7 m -122.94 105.32 9.89 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 124.708 1.203 . . . . 0.0 108.016 -175.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -78.75 167.28 52.75 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.269 -1.132 . . . . 0.0 110.269 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.0 tp -155.96 59.89 0.59 Allowed 'General case' 0 C--O 1.237 0.405 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 175.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.6 t -72.53 148.44 9.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 O-C-N 121.649 -0.657 . . . . 0.0 109.733 176.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.71 170.62 8.06 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.54 0.736 . . . . 0.0 109.264 169.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.5 mp -136.73 163.84 29.67 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.804 1.642 . . . . 0.0 109.444 175.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.46 ' HG2' ' H ' ' A' ' 85' ' ' GLN . 48.8 tttt -147.84 172.78 13.6 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.241 2.216 . . . . 0.0 106.621 163.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.46 ' H ' ' HG2' ' A' ' 84' ' ' LYS . 20.8 tt0 -126.24 162.55 25.19 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 125.398 1.479 . . . . 0.0 107.158 -171.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -56.38 -59.3 5.17 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.685 0.794 . . . . 0.0 111.88 -165.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -99.93 -27.8 13.41 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.168 0.987 . . . . 0.0 111.529 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.1 m -101.65 -162.51 0.94 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.261 1.024 . . . . 0.0 111.811 -174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -146.1 67.52 0.41 Allowed Glycine 0 N--CA 1.443 -0.887 0 N-CA-C 107.847 -2.101 . . . . 0.0 107.847 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 2.6 mtmm -63.03 92.96 0.06 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 105.569 -2.012 . . . . 0.0 105.569 152.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 27.0 p -95.65 103.99 15.88 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 165.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.4 mp -101.98 158.36 16.2 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 172.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.3 m -117.77 125.16 50.11 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 177.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.448 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 5.8 tp -107.92 95.83 5.96 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 125.476 1.511 . . . . 0.0 107.869 -178.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -108.96 90.36 3.27 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 107.289 -1.375 . . . . 0.0 107.289 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 mp -72.44 141.59 16.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 160.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.8 t -128.03 92.97 2.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 165.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -112.67 147.45 37.16 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.697 -176.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -67.44 -167.88 0.16 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 124.777 3.652 . . . . 0.0 110.777 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.8 160.28 26.59 Favored Glycine 0 C--O 1.24 0.5 0 O-C-N 121.769 -0.582 . . . . 0.0 111.905 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.93 177.37 7.88 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 127.667 2.387 . . . . 0.0 108.191 -171.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.2 p -148.38 97.26 2.73 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 104.195 -2.52 . . . . 0.0 104.195 178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 33.9 p -130.12 -164.86 1.46 Allowed 'General case' 0 C--N 1.32 -0.684 0 C-N-CA 125.015 1.326 . . . . 0.0 108.324 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.45 66.4 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 169.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 C--O 1.249 1.05 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 174.194 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.684 0 N-CA-C 110.567 -1.013 . . . . 0.0 110.567 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 9.1 m80 -129.08 84.67 2.25 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 -167.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.9 ptm -72.2 144.58 48.46 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 157.07 67.77 0.01 OUTLIER Glycine 0 CA--C 1.525 0.688 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -176.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.8 p -149.0 165.33 17.99 Favored Pre-proline 0 C--O 1.245 0.829 0 C-N-CA 123.828 0.851 . . . . 0.0 109.401 174.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.68 -176.92 2.22 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.092 1.862 . . . . 0.0 110.958 174.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 78.5 t -65.8 95.95 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 127.29 2.236 . . . . 0.0 107.965 -177.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 24.2 t -74.02 145.46 44.51 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.635 1.574 . . . . 0.0 109.207 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -126.95 153.38 45.91 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 124.906 1.283 . . . . 0.0 109.307 174.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -134.81 115.28 13.5 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 126.951 2.1 . . . . 0.0 106.314 -177.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 85' ' ' GLN . 4.1 t80 -145.07 79.21 1.58 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 176.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 86.3 p -154.33 -175.88 5.61 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 122.967 0.507 . . . . 0.0 109.827 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.484 ' HB2' ' H ' ' A' ' 17' ' ' GLY . 62.6 m-85 -63.89 165.19 9.05 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 157.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.48 -31.42 11.64 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 124.237 1.015 . . . . 0.0 110.972 168.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -130.53 73.77 1.56 Allowed 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 175.56 -56.98 0.11 Allowed Glycine 0 N--CA 1.453 -0.176 0 C-N-CA 119.514 -1.327 . . . . 0.0 112.261 162.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.484 ' H ' ' HB2' ' A' ' 13' ' ' TYR . . . 158.42 -136.6 4.84 Favored Glycine 0 CA--C 1.52 0.347 0 O-C-N 121.92 -0.753 . . . . 0.0 112.629 -167.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.0 p -137.58 23.8 2.91 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.25 1.02 . . . . 0.0 112.168 -166.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.3 t -167.59 166.44 14.06 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 124.784 1.234 . . . . 0.0 110.845 174.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.22 135.92 53.65 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 128.831 2.853 . . . . 0.0 112.647 174.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 9.5 m -147.14 84.78 1.59 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.575 1.15 . . . . 0.0 108.005 173.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -83.07 140.75 32.49 Favored 'General case' 0 C--O 1.238 0.476 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 176.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -121.67 77.19 37.6 Favored Pre-proline 0 N--CA 1.452 -0.331 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -74.49 168.14 25.51 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 120.939 1.093 . . . . 0.0 109.387 165.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -162.19 160.82 27.52 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.68 1.992 . . . . 0.0 106.675 176.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 20.5 t70 60.53 -80.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 125.703 1.601 . . . . 0.0 111.918 -167.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.7 t -165.21 85.64 0.39 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.772 1.229 . . . . 0.0 108.009 -175.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 16.4 m -135.85 24.48 3.35 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 172.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -72.03 122.28 20.62 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 125.191 1.396 . . . . 0.0 108.895 169.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -166.31 -175.69 36.85 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-N 119.042 0.837 . . . . 0.0 111.155 -174.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 54.4 p -96.59 126.95 42.13 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 125.201 1.4 . . . . 0.0 109.029 177.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -128.39 -177.49 4.19 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 169.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.2 mt -139.51 143.19 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 129.645 3.178 . . . . 0.0 105.554 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 84.7 mt -121.2 -168.68 1.71 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 126.118 1.767 . . . . 0.0 110.18 -175.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -129.98 51.23 2.11 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 125.056 1.342 . . . . 0.0 109.026 -179.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 60.4 mt -82.05 125.0 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 124.182 0.993 . . . . 0.0 108.937 -176.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.1 m -71.05 134.68 47.28 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.566 1.546 . . . . 0.0 109.411 176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.2 t -144.52 108.71 4.79 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 168.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -167.35 170.84 11.14 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.693 0.759 . . . . 0.0 110.907 160.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.74 135.04 54.38 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.245 1.818 . . . . 0.0 108.105 161.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.3 tttt -114.82 123.17 48.52 Favored 'General case' 0 CA--C 1.512 -0.507 0 C-N-CA 125.563 1.545 . . . . 0.0 109.347 -175.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.6 t -159.74 153.24 22.47 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 64.88 -82.81 0.07 OUTLIER Glycine 0 C--N 1.337 0.603 0 C-N-CA 126.095 1.807 . . . . 0.0 110.687 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -145.92 -1.13 0.78 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.074 1.35 . . . . 0.0 111.539 -177.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 p -134.5 172.62 12.66 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 120.128 -1.607 . . . . 0.0 112.461 -162.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.0 p -130.71 123.06 28.45 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 127.415 2.286 . . . . 0.0 106.877 -177.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.23 109.12 20.42 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 176.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.56 155.23 40.82 Favored 'General case' 0 C--O 1.233 0.237 0 C-N-CA 123.299 0.64 . . . . 0.0 109.545 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.2 mt -121.33 147.27 45.9 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 123.637 0.775 . . . . 0.0 110.961 176.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 m -79.67 160.16 26.42 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 168.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 43.3 p90 -138.97 174.67 10.27 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 124.277 1.031 . . . . 0.0 111.737 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -150.01 148.49 29.11 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.676 1.191 . . . . 0.0 109.47 -168.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.432 ' HB3' HG11 ' A' ' 61' ' ' VAL . . . -150.81 160.78 43.65 Favored 'General case' 0 C--O 1.232 0.183 0 C-N-CA 126.278 1.831 . . . . 0.0 109.458 -178.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.4 p 174.85 145.99 0.07 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.337 0.655 . . . . 0.0 110.471 -176.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 170.54 -91.3 0.1 OUTLIER Glycine 0 CA--C 1.525 0.718 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 168.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.27 164.58 3.14 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.86 2.064 . . . . 0.0 111.288 -178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.2 m -92.46 -1.1 57.22 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.74 1.616 . . . . 0.0 115.143 -176.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . 0.411 ' CZ2' ' HA3' ' A' ' 79' ' ' GLY . 44.7 p-90 -129.54 29.84 5.01 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 125.198 1.399 . . . . 0.0 108.954 -174.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 51.0 mt -142.81 88.29 0.38 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.626 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 -176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 43.1 m-70 -88.42 171.89 9.78 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.939 0.896 . . . . 0.0 108.671 177.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.432 HG11 ' HB3' ' A' ' 53' ' ' ALA . 11.5 p -157.61 157.42 3.61 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 C-N-CA 124.73 1.212 . . . . 0.0 108.752 166.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -143.45 -179.34 6.36 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 128.396 2.678 . . . . 0.0 108.014 172.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -45.18 -51.71 8.76 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.86 1.219 . . . . 0.0 113.544 -176.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.0 m -124.87 -7.83 7.26 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-O 118.22 -0.895 . . . . 0.0 113.394 179.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.8 m -120.67 155.87 32.93 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 119.606 1.094 . . . . 0.0 110.625 -169.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.7 t -137.69 162.11 32.56 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -173.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.9 m -147.58 137.44 22.84 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 162.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.431 ' CE1' HD11 ' A' ' 94' ' ' LEU . 6.0 m-85 -123.27 104.07 8.91 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 169.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -74.3 173.5 10.13 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 122.208 1.004 . . . . 0.0 112.365 -178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.471 ' HG3' HE22 ' A' ' 98' ' ' GLN . 4.9 tt0 -83.04 -165.71 1.15 Allowed 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 127.153 2.181 . . . . 0.0 109.969 175.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 35.1 p30 -128.63 165.23 32.94 Favored Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 126.544 1.938 . . . . 0.0 109.492 -172.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -93.91 -10.23 1.62 Allowed 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.033 2.489 . . . . 0.0 113.226 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -129.27 139.65 51.73 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 124.734 1.214 . . . . 0.0 109.114 -171.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.99 12.12 8.19 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 123.283 0.633 . . . . 0.0 112.602 -160.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -70.53 158.25 36.44 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 170.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 33.3 ttp180 -67.84 159.28 30.69 Favored 'General case' 0 C--O 1.241 0.657 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 15.4 tpt180 -132.83 145.22 50.77 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 6.5 m -118.41 77.69 1.19 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.312 1.445 . . . . 0.0 107.529 176.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.411 ' HA3' ' CZ2' ' A' ' 58' ' ' TRP . . . -72.2 132.54 19.03 Favored Glycine 0 N--CA 1.464 0.552 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -177.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 tp -149.49 70.76 1.08 Allowed 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.207 1.003 . . . . 0.0 112.3 -166.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 24.7 t -74.96 164.07 3.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.444 0.64 . . . . 0.0 110.337 175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -111.93 158.01 19.99 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.271 1.029 . . . . 0.0 108.566 168.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -137.69 146.35 43.69 Favored 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 127.147 2.179 . . . . 0.0 107.35 -173.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -157.26 168.7 26.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.099 1.359 . . . . 0.0 107.797 173.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.437 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 5.8 tt0 -119.16 164.77 15.09 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 119.683 1.129 . . . . 0.0 110.61 -170.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -45.17 -55.87 5.34 Favored 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 126.55 1.94 . . . . 0.0 111.853 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -126.52 -1.73 6.81 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.089 1.756 . . . . 0.0 111.136 -169.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.38 -177.99 3.97 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 125.828 1.651 . . . . 0.0 110.945 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.4 8.55 0.09 OUTLIER Glycine 0 C--O 1.226 -0.401 0 C-N-CA 118.546 -1.788 . . . . 0.0 115.508 -149.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -78.2 97.29 5.45 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.25 -1.759 . . . . 0.0 106.25 174.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 18.2 p -78.69 114.19 17.39 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 -167.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.16 130.04 35.87 Favored 'General case' 0 C--O 1.235 0.318 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 -177.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.7 m -83.4 125.51 31.76 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 165.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.431 HD11 ' CE1' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -118.94 104.16 10.25 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.969 1.708 . . . . 0.0 106.508 -177.032 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -119.67 95.02 4.6 Favored 'General case' 0 C--O 1.226 -0.16 0 C-N-CA 124.086 0.954 . . . . 0.0 109.797 -166.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -94.2 114.65 31.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 106.999 -1.482 . . . . 0.0 106.999 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 79.5 t -104.19 101.33 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 105.732 -1.951 . . . . 0.0 105.732 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.471 HE22 ' HG3' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -133.05 156.8 79.65 Favored Pre-proline 0 CA--C 1.54 0.561 0 CA-C-O 118.848 -0.596 . . . . 0.0 111.705 -177.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.85 -163.19 0.11 Allowed 'Trans proline' 0 C--N 1.35 0.624 1 C-N-CA 126.589 4.859 . . . . 0.0 110.814 172.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.12 168.2 27.12 Favored Glycine 0 N--CA 1.445 -0.711 0 O-C-N 120.658 -1.276 . . . . 0.0 113.708 173.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 16.9 pttt -111.14 173.64 6.24 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 126.2 1.8 . . . . 0.0 110.159 175.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.25 92.56 2.12 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 170.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 t -138.39 -174.51 3.83 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 123.656 0.782 . . . . 0.0 109.364 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 4.7 mp -82.64 76.86 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 178.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 24.4 t70 . . . . . 0 C--O 1.247 0.973 0 C-N-CA 126.238 1.815 . . . . 0.0 108.528 175.45 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.894 0 N-CA-C 109.229 -1.548 . . . . 0.0 109.229 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -64.6 88.74 0.06 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.852 1.261 . . . . 0.0 111.439 -172.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -140.57 158.45 43.97 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.299 1.84 . . . . 0.0 106.375 167.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.23 0.72 85.94 Favored Glycine 0 CA--C 1.53 0.977 0 CA-C-O 118.846 -0.974 . . . . 0.0 112.747 175.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 m -55.27 144.55 50.66 Favored Pre-proline 0 C--O 1.237 0.446 0 CA-C-N 118.75 1.275 . . . . 0.0 109.905 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -66.08 155.23 70.66 Favored 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 121.703 1.602 . . . . 0.0 109.307 175.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -124.52 147.77 28.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 51.1 m -136.37 110.26 8.19 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 165.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -79.29 153.59 29.76 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 163.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -121.7 117.9 27.77 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 13.8 p90 -137.96 60.56 1.62 Allowed 'General case' 0 CA--C 1.528 0.115 0 CA-C-O 121.913 0.863 . . . . 0.0 110.951 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.0 p -154.41 -167.44 2.62 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.45 1.1 . . . . 0.0 109.075 177.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -65.3 -179.6 0.62 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.375 0.67 . . . . 0.0 111.262 170.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -102.56 -28.15 12.34 Favored 'General case' 0 C--N 1.333 -0.15 0 O-C-N 121.316 -0.865 . . . . 0.0 111.573 162.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.89 12.2 2.45 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.354 0.662 . . . . 0.0 111.874 -165.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -127.71 -67.66 0.14 Allowed Glycine 0 C--N 1.335 0.512 0 O-C-N 121.254 -0.904 . . . . 0.0 113.537 -152.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.38 -126.66 2.85 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 108.835 -1.706 . . . . 0.0 108.835 -153.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.1 p -144.16 3.63 1.21 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -171.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.9 m -162.96 174.53 12.22 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.333 1.424 . . . . 0.0 111.175 174.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -124.2 144.1 50.13 Favored 'General case' 0 C--O 1.242 0.666 0 C-N-CA 128.016 2.527 . . . . 0.0 113.962 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.4 m -141.6 146.76 36.64 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 125.352 1.461 . . . . 0.0 108.139 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -136.77 163.13 31.35 Favored 'General case' 0 N--CA 1.449 -0.515 0 O-C-N 121.174 -0.954 . . . . 0.0 110.702 157.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -135.88 76.19 53.54 Favored Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 105.046 -2.205 . . . . 0.0 105.046 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -67.21 171.99 10.68 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.493 2.129 . . . . 0.0 109.213 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -160.54 0.1 0.07 Allowed 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 113.302 0.852 . . . . 0.0 113.302 -153.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -165.9 -73.05 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -173.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.7 t -165.24 97.27 0.71 Allowed 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.483 1.913 . . . . 0.0 106.879 167.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.6 m -123.74 24.49 8.41 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.58 0.955 . . . . 0.0 113.58 168.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -71.83 155.03 40.87 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 166.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 157.87 -151.12 22.28 Favored Glycine 0 C--N 1.336 0.572 0 N-CA-C 109.226 -1.549 . . . . 0.0 109.226 175.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.2 m -135.27 102.55 5.21 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 118.012 0.906 . . . . 0.0 112.659 -173.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 3.3 p90 -123.32 -164.63 1.23 Allowed 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 124.628 1.171 . . . . 0.0 113.201 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.6 mt -138.13 158.35 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.907 0 C-N-CA 127.711 2.405 . . . . 0.0 107.2 175.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 98.2 mt -132.89 173.1 11.75 Favored 'General case' 0 C--N 1.346 0.415 0 C-N-CA 126.086 1.755 . . . . 0.0 111.016 178.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -109.63 88.04 2.65 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.042 -1.037 . . . . 0.0 110.363 -156.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.425 ' CG2' ' HE3' ' A' ' 90' ' ' LYS . 6.6 mt -129.88 158.51 42.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.646 1.178 . . . . 0.0 109.712 -163.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.4 m -122.93 142.53 50.71 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.308 1.043 . . . . 0.0 109.68 -172.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 2.7 p -159.99 36.35 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 O-C-N 121.668 -0.645 . . . . 0.0 112.679 -161.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -128.51 169.3 14.52 Favored 'General case' 0 N--CA 1.466 0.371 0 O-C-N 120.339 -1.476 . . . . 0.0 110.955 -170.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.8 121.16 38.51 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 124.98 1.312 . . . . 0.0 107.49 170.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -90.77 139.81 30.38 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.51 -2.033 . . . . 0.0 105.51 172.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.0 t -164.91 133.13 3.28 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 170.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 50.0 -98.0 0.02 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.986 1.279 . . . . 0.0 110.845 -173.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -130.43 21.34 5.17 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.28 1.032 . . . . 0.0 112.27 -164.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.3 t -148.64 176.72 10.11 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 120.315 1.416 . . . . 0.0 111.29 167.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 p -136.94 91.87 2.67 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.65 1.98 . . . . 0.0 109.593 -173.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.49 104.27 5.14 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 178.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -73.65 146.9 44.22 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 172.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.3 mt -117.93 149.03 41.58 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 124.073 0.949 . . . . 0.0 110.497 -175.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.1 m -65.64 164.58 14.06 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.495 164.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 19.5 p90 -144.47 173.81 11.47 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.101 1.36 . . . . 0.0 110.081 173.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -135.37 175.01 9.98 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 124.013 0.925 . . . . 0.0 109.778 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.48 152.09 39.23 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 125.531 1.532 . . . . 0.0 109.066 172.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -162.28 140.15 8.63 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.58 -127.72 1.66 Allowed Glycine 0 CA--C 1.523 0.537 0 N-CA-C 108.665 -1.774 . . . . 0.0 108.665 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.53 ' H ' HG12 ' A' ' 81' ' ' VAL . 3.3 m-20 -61.73 162.35 8.75 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.941 2.096 . . . . 0.0 111.939 -175.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.21 -18.64 57.58 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 126.353 1.861 . . . . 0.0 114.23 -168.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.2 p-90 -121.22 15.01 11.4 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.291 1.836 . . . . 0.0 111.682 -165.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 61.7 mt -118.06 85.04 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 103.992 -2.595 . . . . 0.0 103.992 -178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 70.4 m-70 -83.41 137.5 33.9 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 -174.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -136.3 89.69 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -171.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -77.96 86.42 4.16 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -172.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 64.07 -104.42 0.88 Allowed Glycine 0 CA--C 1.52 0.404 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 1.6 p -97.61 -7.44 31.11 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.277 1.031 . . . . 0.0 113.089 178.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.2 m -83.69 164.56 19.57 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 119.696 1.135 . . . . 0.0 109.949 174.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 2.6 p -125.92 158.34 35.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 C-N-CA 125.749 1.62 . . . . 0.0 108.274 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 35.8 t -156.42 158.53 37.47 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 126.156 1.782 . . . . 0.0 107.256 166.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -156.98 168.63 26.93 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 163.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.49 159.15 42.01 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.865 1.266 . . . . 0.0 107.818 -177.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -71.34 164.29 26.02 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 122.195 0.997 . . . . 0.0 113.15 -174.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -77.13 144.61 71.86 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 125.604 1.562 . . . . 0.0 108.623 168.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -90.13 -4.63 5.13 Favored 'Trans proline' 0 CA--C 1.538 0.682 0 C-N-CA 124.649 3.566 . . . . 0.0 113.648 179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -95.98 161.58 13.93 Favored 'General case' 0 CA--C 1.53 0.175 0 O-C-N 121.173 -0.954 . . . . 0.0 109.927 173.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.55 62.93 0.85 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 123.334 1.54 . . . . 0.0 107.846 174.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -132.56 176.72 8.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 113.278 -1.783 . . . . 0.0 107.766 167.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -76.95 157.5 31.25 Favored 'General case' 0 C--O 1.24 0.573 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 167.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 6.9 tpt85 -150.5 173.42 14.09 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 168.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 15.1 t -149.4 165.8 30.96 Favored 'General case' 0 C--O 1.241 0.632 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 158.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.6 176.66 20.93 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 108.218 -1.953 . . . . 0.0 108.218 156.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.1 tp -157.61 65.48 0.48 Allowed 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 118.07 0.935 . . . . 0.0 113.109 177.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 56' ' ' ASP . 2.9 m -76.62 171.76 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 O-C-N 121.123 -0.985 . . . . 0.0 111.071 -172.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.6 m -123.38 164.74 18.26 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.78 1.632 . . . . 0.0 108.48 178.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.04 170.65 11.53 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 124.817 1.247 . . . . 0.0 109.223 173.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -153.32 172.93 16.28 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.859 0.864 . . . . 0.0 109.651 161.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -111.7 172.23 7.02 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 119.379 0.991 . . . . 0.0 110.807 -176.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -56.63 -51.3 69.23 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.327 1.051 . . . . 0.0 112.153 178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -111.17 -42.62 3.9 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 123.719 0.808 . . . . 0.0 109.766 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.4 -169.65 0.43 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.177 1.391 . . . . 0.0 111.301 -171.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -132.22 42.32 1.4 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 126.117 1.818 . . . . 0.0 109.023 -178.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.425 ' HE3' ' CG2' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -58.34 97.61 0.03 OUTLIER 'General case' 0 CA--C 1.513 -0.476 0 CA-C-N 117.78 0.79 . . . . 0.0 108.942 174.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 2.2 p -110.88 110.8 21.55 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.5 mp -111.9 165.77 11.79 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 104.58 -2.378 . . . . 0.0 104.58 168.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 42.0 t -127.13 144.65 50.98 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 125.389 1.476 . . . . 0.0 107.891 176.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -126.83 104.38 8.01 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.606 1.562 . . . . 0.0 108.995 -170.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -116.94 101.4 8.48 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.373 0.669 . . . . 0.0 109.881 -169.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.3 mt -98.01 86.67 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.311 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -178.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 t -83.48 88.57 2.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.94 158.77 41.4 Favored Pre-proline 0 C--O 1.24 0.596 0 C-N-CA 124.125 0.97 . . . . 0.0 111.577 -165.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -69.36 -163.39 0.1 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 124.312 3.341 . . . . 0.0 109.377 160.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.92 166.96 29.93 Favored Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 110.478 -1.049 . . . . 0.0 110.478 171.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.55 177.08 11.78 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 124.469 1.108 . . . . 0.0 110.404 -176.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 19.3 p -149.02 96.47 2.55 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 164.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -136.57 172.73 12.59 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 123.69 0.796 . . . . 0.0 111.288 176.413 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.6 pt -83.84 33.18 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.71 0 C-N-CA 125.007 1.323 . . . . 0.0 109.913 166.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 C--O 1.245 0.835 0 CA-C-O 117.18 -1.39 . . . . 0.0 107.809 163.657 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.941 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -63.93 164.42 10.38 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 141.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.0 ttt -156.43 155.07 31.46 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.201 -1.777 . . . . 0.0 106.201 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -77.28 96.75 1.25 Allowed Glycine 0 CA--C 1.52 0.395 0 N-CA-C 107.66 -2.176 . . . . 0.0 107.66 167.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.8 p -152.2 149.01 22.13 Favored Pre-proline 0 C--O 1.238 0.49 0 CA-C-N 117.982 0.891 . . . . 0.0 109.533 169.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.5 154.06 75.42 Favored 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 122.083 1.855 . . . . 0.0 108.607 167.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.02 129.6 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 174.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 t -79.72 127.19 31.9 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 168.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -108.75 152.53 24.72 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 119.278 0.945 . . . . 0.0 109.646 161.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -129.29 125.18 36.23 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 126.099 1.76 . . . . 0.0 106.91 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -153.96 23.42 0.5 Allowed 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.618 1.967 . . . . 0.0 110.478 -169.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 96.4 p -149.68 174.08 12.98 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.3 1.04 . . . . 0.0 110.777 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 76.5 m-85 -75.69 160.31 30.2 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.896 0.878 . . . . 0.0 112.482 -175.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -75.87 -50.3 15.45 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.804 174.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -141.22 55.23 1.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 105.918 -1.882 . . . . 0.0 105.918 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -153.85 3.11 0.26 Allowed Glycine 0 CA--C 1.527 0.839 0 CA-C-N 114.394 -1.276 . . . . 0.0 113.593 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.25 -119.63 6.77 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-N 119.212 1.506 . . . . 0.0 110.977 177.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.94 5.58 2.83 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 118.124 0.962 . . . . 0.0 113.245 -173.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -156.7 162.51 39.8 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.472 0.709 . . . . 0.0 109.535 170.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.46 ' H ' ' CD2' ' A' ' 20' ' ' HIS . 0.0 OUTLIER -112.71 139.76 48.05 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 126.065 1.746 . . . . 0.0 108.047 -175.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.2 m -146.9 89.19 1.79 Allowed 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 105.851 -1.907 . . . . 0.0 105.851 -174.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -91.49 136.16 33.32 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -176.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -118.98 64.37 6.59 Favored Pre-proline 0 CA--C 1.543 0.688 0 CA-C-O 118.678 -0.677 . . . . 0.0 110.307 -176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -72.11 -174.19 1.3 Allowed 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.378 2.052 . . . . 0.0 111.462 176.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -117.17 -163.46 0.92 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 127.689 2.396 . . . . 0.0 109.935 -169.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.06 -18.26 63.17 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.727 1.611 . . . . 0.0 112.391 -174.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.0 m -153.09 65.27 0.77 Allowed 'General case' 0 CA--C 1.543 0.695 0 CA-C-N 120.259 1.39 . . . . 0.0 112.185 178.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.1 t -150.95 24.89 0.74 Allowed 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 114.085 1.142 . . . . 0.0 114.085 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.16 167.68 4.85 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 121.092 -1.005 . . . . 0.0 110.495 159.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.01 -152.17 22.96 Favored Glycine 0 C--N 1.341 0.809 0 O-C-N 121.333 -0.854 . . . . 0.0 111.359 176.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -135.1 100.71 4.64 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 125.306 1.442 . . . . 0.0 111.017 -174.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 16.5 p90 -118.83 -177.82 3.41 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.102 1.361 . . . . 0.0 112.717 -179.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 mt -126.82 147.88 31.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 59.2 mt -119.49 173.98 6.66 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 127.013 2.125 . . . . 0.0 109.892 -175.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -101.96 51.34 0.83 Allowed 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 123.553 1.644 . . . . 0.0 109.928 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 87.0 mt -72.09 139.36 19.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 C-N-CA 125.428 1.491 . . . . 0.0 107.199 174.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 m -113.37 132.47 55.59 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 4.9 t -152.49 72.69 0.99 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -167.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -158.21 172.73 17.86 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 120.49 -1.381 . . . . 0.0 111.372 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.69 146.43 42.76 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.813 0.845 . . . . 0.0 111.225 164.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -123.03 131.3 53.64 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.308 1.843 . . . . 0.0 109.027 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.7 t -165.89 171.4 12.73 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 105.685 -1.969 . . . . 0.0 105.685 174.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 45.49 -103.67 0.06 OUTLIER Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.526 1.536 . . . . 0.0 112.21 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -138.19 18.17 2.78 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.226 1.41 . . . . 0.0 111.697 -171.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.4 t -144.81 177.73 8.51 Favored 'General case' 0 C--O 1.241 0.611 0 O-C-N 120.583 -1.323 . . . . 0.0 111.16 -174.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 61.3 p -137.85 121.84 17.81 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.062 1.345 . . . . 0.0 109.081 167.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.4 tmmm? -93.22 118.54 31.37 Favored 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.9 156.9 28.4 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.3 0.64 . . . . 0.0 111.401 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.64 HD12 HE21 ' A' ' 85' ' ' GLN . 98.1 mt -120.31 133.8 55.39 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 124.541 1.136 . . . . 0.0 111.452 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.5 p -69.18 168.98 12.92 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.78 0.832 . . . . 0.0 109.498 164.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 38.3 p90 -144.09 166.16 25.79 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.033 0.933 . . . . 0.0 108.905 166.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -133.21 156.56 47.28 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 126.154 1.781 . . . . 0.0 108.203 -176.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.68 141.24 25.47 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.989 1.316 . . . . 0.0 110.679 -166.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -168.84 157.92 8.54 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 119.576 1.08 . . . . 0.0 112.286 161.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.8 -100.69 0.15 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.075 1.797 . . . . 0.0 110.441 173.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -54.7 157.74 2.91 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.198 1.399 . . . . 0.0 109.939 172.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.7 m -79.4 -29.44 42.01 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 120.978 -1.076 . . . . 0.0 112.759 174.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 56.5 p-90 -90.79 16.14 9.86 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 123.871 0.868 . . . . 0.0 111.742 -168.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.1 mt -137.55 127.72 37.33 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 -169.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -136.62 150.59 48.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 20.7 t -137.12 125.75 34.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -85.76 -178.6 6.66 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.916 0.887 . . . . 0.0 109.57 173.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.11 -8.53 43.62 Favored Glycine 0 CA--C 1.533 1.212 0 O-C-N 120.989 -1.07 . . . . 0.0 114.435 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.7 p -144.86 -21.16 0.51 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.796 1.298 . . . . 0.0 113.12 166.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.1 m -104.02 156.87 17.51 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 120.046 1.294 . . . . 0.0 112.162 -168.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 4.5 t -95.63 158.64 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 126.417 1.887 . . . . 0.0 107.639 176.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -156.57 142.7 18.11 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.878 0.871 . . . . 0.0 108.881 163.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -148.74 148.5 30.07 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 161.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.58 -177.85 6.04 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.953 1.701 . . . . 0.0 109.058 174.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -119.29 165.97 13.6 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.284 1.034 . . . . 0.0 110.313 -177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.84 144.85 40.07 Favored Pre-proline 0 N--CA 1.453 -0.298 0 C-N-CA 124.147 0.979 . . . . 0.0 110.688 -175.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -82.99 -6.06 11.32 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 124.68 3.586 . . . . 0.0 113.206 -178.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.31 169.92 17.83 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.706 -0.621 . . . . 0.0 111.341 -164.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -76.23 1.87 14.74 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.602 173.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -72.21 135.49 46.1 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 165.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.1 ttm105 -72.26 167.1 21.09 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 124.331 1.052 . . . . 0.0 109.18 179.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 83.5 mmt-85 -130.4 161.72 30.74 Favored 'General case' 0 C--N 1.332 -0.171 0 O-C-N 121.515 -0.741 . . . . 0.0 109.255 165.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 46.1 m -137.68 84.13 2.03 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 105.341 -2.096 . . . . 0.0 105.341 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -61.45 142.43 48.31 Favored Glycine 0 CA--C 1.526 0.765 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -178.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.1 tp -159.68 72.29 0.52 Allowed 'General case' 0 C--O 1.241 0.612 0 CA-C-N 118.984 1.392 . . . . 0.0 112.388 175.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.1 m -71.24 173.6 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 O-C-N 121.183 -0.948 . . . . 0.0 109.99 167.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 99.9 m -117.69 153.02 34.07 Favored 'General case' 0 C--O 1.237 0.421 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 164.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 mp -125.24 165.69 17.83 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.926 1.291 . . . . 0.0 109.464 167.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 43.5 tttt -157.21 161.7 39.27 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.051 1.74 . . . . 0.0 108.124 173.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.64 HE21 HD12 ' A' ' 49' ' ' LEU . 1.7 tt0 -105.99 169.4 8.52 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.075 1.35 . . . . 0.0 109.852 -164.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -67.71 -48.97 65.01 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 175.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -118.75 -18.73 8.88 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 114.124 1.157 . . . . 0.0 114.124 -174.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 3.2 m -97.53 -167.82 1.59 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.766 1.226 . . . . 0.0 108.497 162.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.79 31.0 0.15 Allowed Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 119.21 -0.772 . . . . 0.0 111.427 -176.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.89 112.72 1.96 Allowed 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 105.866 -1.902 . . . . 0.0 105.866 168.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 p -79.51 114.18 18.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 177.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 4.9 mp -88.57 165.96 14.47 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.313 1.045 . . . . 0.0 109.028 173.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -138.81 125.29 20.55 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 125.999 1.72 . . . . 0.0 107.838 174.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.12 86.02 5.25 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.328 1.451 . . . . 0.0 107.412 178.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.7 mttm -72.09 137.55 47.16 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 120.339 -1.476 . . . . 0.0 108.566 175.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.5 mp -130.62 116.53 35.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 162.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 68.6 t -116.0 71.81 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -106.12 154.41 39.62 Favored Pre-proline 0 CA--C 1.534 0.329 0 O-C-N 121.571 -0.706 . . . . 0.0 110.711 -171.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.76 174.64 6.31 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.655 2.903 . . . . 0.0 113.529 -172.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -80.57 113.63 3.68 Favored Glycine 0 N--CA 1.439 -1.101 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 175.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 10.2 ttmt -62.44 123.85 19.37 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 117.778 0.789 . . . . 0.0 110.006 178.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.65 91.15 1.54 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 165.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.9 m -138.14 168.55 19.5 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 124.67 1.188 . . . . 0.0 110.624 171.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 7.9 tp -81.83 66.75 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.133 1.373 . . . . 0.0 107.93 178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 12.3 t70 . . . . . 0 C--O 1.253 1.255 0 C-N-CA 123.777 0.831 . . . . 0.0 109.128 -167.75 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.188 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 15.0 t-80 -149.59 172.6 14.77 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 174.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.7 ptp -154.84 -172.33 4.16 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.534 1.534 . . . . 0.0 108.3 174.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -179.59 84.56 0.06 OUTLIER Glycine 0 C--N 1.331 0.282 0 N-CA-C 106.864 -2.494 . . . . 0.0 106.864 -175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.7 m -134.61 156.74 78.47 Favored Pre-proline 0 C--O 1.239 0.551 0 CA-C-O 119.764 -0.16 . . . . 0.0 111.197 -154.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.2 -172.7 1.57 Allowed 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 124.298 3.332 . . . . 0.0 111.328 172.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.4 p -86.79 156.34 3.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 125.164 1.386 . . . . 0.0 108.412 169.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 m -113.31 99.54 7.87 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 163.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -74.27 153.17 39.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 161.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -128.1 116.75 20.45 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 103.995 -2.594 . . . . 0.0 103.995 175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -146.08 46.54 1.24 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.725 1.21 . . . . 0.0 108.983 -170.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.3 m -154.28 -178.37 7.08 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.107 0.963 . . . . 0.0 110.188 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -74.22 -170.81 1.03 Allowed 'General case' 0 CA--C 1.543 0.691 0 CA-C-O 121.498 0.666 . . . . 0.0 109.59 169.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -123.0 40.14 3.78 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.667 1.987 . . . . 0.0 109.733 -174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.3 p30 -156.43 -1.05 0.13 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 115.143 1.534 . . . . 0.0 115.143 -161.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 104.41 -7.42 46.88 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 117.418 -1.768 . . . . 0.0 115.319 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -118.41 174.11 15.16 Favored Glycine 0 CA--C 1.534 1.281 0 CA-C-N 120.504 2.152 . . . . 0.0 114.035 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.3 p -136.34 44.3 2.42 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.417 1.487 . . . . 0.0 111.054 -176.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -169.82 165.16 9.86 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 120.787 -1.195 . . . . 0.0 108.537 165.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.417 ' CE1' ' HB2' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -110.14 141.04 43.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.99 1.316 . . . . 0.0 107.84 165.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 34.9 m -147.28 146.72 29.85 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 164.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -140.32 157.75 45.08 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.545 0.688 . . . . 0.0 110.818 173.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -132.73 66.24 76.09 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 114.176 -1.375 . . . . 0.0 107.594 -175.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -65.24 175.32 4.11 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 124.069 3.179 . . . . 0.0 111.881 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -119.47 -171.6 2.16 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 123.968 0.907 . . . . 0.0 110.183 175.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -68.69 11.83 0.17 Allowed 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 128.062 2.545 . . . . 0.0 115.117 -162.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 51.1 m -150.52 5.68 0.53 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.792 1.637 . . . . 0.0 113.635 171.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -95.26 86.94 4.68 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 120.296 1.407 . . . . 0.0 112.023 -166.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.77 158.48 43.85 Favored 'General case' 0 C--O 1.238 0.463 0 O-C-N 121.629 -0.669 . . . . 0.0 112.499 -177.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 164.86 -149.2 15.61 Favored Glycine 0 C--N 1.34 0.779 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 161.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 m -124.13 113.41 18.31 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.608 1.163 . . . . 0.0 109.946 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -116.98 -166.75 1.2 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.244 1.018 . . . . 0.0 112.915 176.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 18.0 mt -132.14 157.08 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 128.067 2.547 . . . . 0.0 106.606 178.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 85.0 mt -131.06 172.49 12.03 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 126.668 1.987 . . . . 0.0 108.764 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -116.13 31.91 6.43 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.671 1.189 . . . . 0.0 111.918 -173.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.2 mt -52.96 147.91 1.9 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 126.911 2.085 . . . . 0.0 109.98 177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.4 m -113.17 117.36 31.71 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.342 1.457 . . . . 0.0 107.994 176.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 29.9 t -141.46 82.21 1.81 Allowed 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 53.1 p90 -153.95 169.21 24.0 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 121.294 -0.879 . . . . 0.0 111.34 175.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.94 129.6 51.78 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 125.516 1.527 . . . . 0.0 107.824 173.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -118.06 128.65 54.96 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 -174.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 t -168.5 148.22 4.5 Favored 'General case' 0 C--O 1.239 0.5 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 53.95 -107.09 0.57 Allowed Glycine 0 CA--C 1.523 0.546 0 C-N-CA 125.416 1.484 . . . . 0.0 110.078 -172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -135.67 28.05 3.3 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 125.215 1.406 . . . . 0.0 110.084 -170.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 41.1 m -142.82 157.96 44.1 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-O 121.904 0.859 . . . . 0.0 111.165 178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -123.84 124.71 43.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 126.477 1.911 . . . . 0.0 106.004 169.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HE3' ' HA ' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -97.89 115.26 27.75 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 166.873 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.98 130.39 45.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 164.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -86.89 118.39 26.25 Favored 'General case' 0 CA--C 1.509 -0.617 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 167.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 m -67.48 168.49 10.79 Favored 'General case' 0 N--CA 1.445 -0.686 0 O-C-N 124.535 1.147 . . . . 0.0 109.541 164.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 42.7 p90 -150.09 175.46 11.71 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.797 1.639 . . . . 0.0 107.969 173.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -132.16 170.48 14.94 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 161.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.46 151.42 44.84 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.231 1.012 . . . . 0.0 108.892 -175.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.2 p -158.98 141.43 14.06 Favored 'General case' 0 C--O 1.234 0.265 0 O-C-N 121.989 -0.444 . . . . 0.0 109.815 -172.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.95 -105.1 0.23 Allowed Glycine 0 CA--C 1.52 0.375 0 N-CA-C 108.684 -1.766 . . . . 0.0 108.684 -175.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -84.68 161.62 20.0 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.381 1.473 . . . . 0.0 111.46 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.9 m -73.29 -51.83 16.12 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 126.116 1.766 . . . . 0.0 111.617 174.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -72.69 21.15 0.07 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 127.569 2.348 . . . . 0.0 113.21 -166.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.8 mt -133.63 140.5 46.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -174.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -127.17 132.12 50.57 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -174.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 19.8 t -139.85 110.1 4.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -169.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -144.41 87.0 1.85 Allowed 'General case' 0 N--CA 1.462 0.129 0 O-C-N 121.276 -0.89 . . . . 0.0 109.133 -172.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 47.07 -113.02 1.08 Allowed Glycine 0 CA--C 1.522 0.525 0 C-N-CA 124.591 1.091 . . . . 0.0 110.979 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.9 m -79.81 36.92 0.34 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.834 1.653 . . . . 0.0 113.393 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 39.9 t -152.86 155.08 36.4 Favored 'General case' 0 C--O 1.24 0.587 0 O-C-N 120.609 -1.307 . . . . 0.0 109.416 -179.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 1.5 t -148.38 149.22 15.36 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 -176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -150.76 159.62 44.41 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.853 0.751 . . . . 0.0 110.724 163.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.525 ' CD1' HD11 ' A' ' 96' ' ' ILE . 0.3 OUTLIER -142.83 127.2 17.73 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.151 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -81.2 160.27 24.37 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 122.308 1.052 . . . . 0.0 110.565 172.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.536 ' CD ' ' HE2' ' A' ' 101' ' ' LYS . 1.7 mt-10 -72.45 165.19 25.09 Favored 'General case' 0 CA--C 1.544 0.746 0 O-C-N 121.263 -0.898 . . . . 0.0 109.573 167.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 22.5 p30 -86.59 164.65 36.65 Favored Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 121.093 -1.005 . . . . 0.0 110.848 -179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -88.68 -8.19 5.26 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 124.242 3.294 . . . . 0.0 113.536 172.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.87 156.68 47.1 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.088 0.858 . . . . 0.0 110.142 -170.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.414 ' HG3' ' H ' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -92.07 22.32 4.43 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 125.092 1.357 . . . . 0.0 112.105 -169.615 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -98.64 151.09 21.07 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 168.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.2 ttm105 -72.46 135.82 45.83 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-N 115.004 -0.998 . . . . 0.0 108.944 -177.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 -113.6 123.5 50.12 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 171.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.3 m -76.55 104.32 7.0 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 155.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -58.51 142.13 45.61 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 163.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 14.1 tp -140.95 131.43 25.32 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 164.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.0 t -139.45 143.39 31.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 165.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.4 m -113.56 156.56 23.41 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 125.628 1.571 . . . . 0.0 107.236 170.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 92' ' ' LEU . 0.6 OUTLIER -133.85 162.54 31.74 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.66 1.184 . . . . 0.0 110.78 172.002 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.6 tmtt? -146.06 127.7 15.19 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 118.549 0.613 . . . . 0.0 109.757 174.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -65.2 156.49 31.63 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 125.006 1.323 . . . . 0.0 111.45 175.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -50.16 -85.03 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.763 2.825 . . . . 0.0 112.281 174.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -72.27 -25.16 61.49 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.939 1.296 . . . . 0.0 111.092 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.7 -153.15 0.5 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 126.991 2.117 . . . . 0.0 109.119 -164.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 167.69 13.74 0.02 OUTLIER Glycine 0 C--N 1.335 0.473 0 CA-C-O 117.158 -1.912 . . . . 0.0 116.595 -170.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 28.0 mttm -62.86 98.05 0.12 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 120.609 2.205 . . . . 0.0 106.531 157.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 25.6 p -65.42 166.92 9.42 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 171.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.572 ' HB2' HD21 ' A' ' 83' ' ' LEU . 27.7 mt -132.17 144.06 50.4 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 170.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.4 m -84.79 129.08 34.87 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 167.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.417 ' HB2' ' CE1' ' A' ' 20' ' ' HIS . 34.5 tp -97.52 127.39 43.44 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 105.21 -2.145 . . . . 0.0 105.21 156.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 36.2 mtpt -136.64 117.38 14.03 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 176.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.525 HD11 ' CD1' ' A' ' 68' ' ' TYR . 2.5 mp -109.42 124.29 65.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 169.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 46.9 t -111.97 92.59 2.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 174.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.81 158.5 35.5 Favored Pre-proline 0 CA--C 1.537 0.477 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.872 -171.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -69.73 -164.58 0.13 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 125.186 3.924 . . . . 0.0 111.726 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -154.59 161.93 30.45 Favored Glycine 0 C--N 1.334 0.426 0 O-C-N 120.364 -1.46 . . . . 0.0 111.975 175.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.536 ' HE2' ' CD ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -144.64 175.82 9.88 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.088 1.355 . . . . 0.0 111.254 -173.284 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 6.2 p -163.35 86.36 0.52 Allowed 'General case' 0 C--O 1.236 0.366 0 C-N-CA 125.595 1.558 . . . . 0.0 107.283 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.72 -178.6 7.15 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 120.238 1.381 . . . . 0.0 110.669 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 63.2 mt -81.96 86.15 1.72 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 167.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 10.2 t0 . . . . . 0 C--O 1.249 1.07 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.073 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.7 p80 -73.59 160.13 32.08 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 160.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -132.85 158.88 41.41 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.6 1.16 . . . . 0.0 108.372 170.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -155.51 145.56 12.63 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 106.978 -2.449 . . . . 0.0 106.978 175.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.0 p -169.01 164.31 7.28 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 123.708 0.803 . . . . 0.0 109.168 -166.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -72.74 176.92 8.24 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.85 2.367 . . . . 0.0 110.894 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.0 t -81.51 106.78 12.99 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 O-C-N 121.975 -0.453 . . . . 0.0 110.386 -177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 61.4 m -101.24 118.6 37.31 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 125.679 1.592 . . . . 0.0 109.672 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -89.1 141.53 28.42 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 123.544 0.738 . . . . 0.0 109.314 174.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -105.1 138.44 41.3 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 172.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.601 ' HA ' ' HE3' ' A' ' 90' ' ' LYS . 3.9 p90 -153.73 56.17 0.74 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.349 -170.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.6 p -159.45 -172.42 3.71 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 120.65 -1.281 . . . . 0.0 109.305 170.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -67.92 157.33 35.22 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 120.033 1.288 . . . . 0.0 108.172 165.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.74 -12.34 22.4 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.872 1.269 . . . . 0.0 110.603 176.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -142.68 74.98 1.47 Allowed 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 153.44 -85.88 0.14 Allowed Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 159.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -164.61 -123.29 0.64 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -158.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 80.5 p -138.18 28.78 2.53 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.602 0.701 . . . . 0.0 111.072 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.47 144.0 10.48 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 120.017 1.281 . . . . 0.0 109.764 176.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -96.3 148.37 22.82 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 162.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 86.3 m -142.54 137.88 30.48 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 159.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -112.39 144.12 42.36 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 168.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.62 71.57 38.97 Favored Pre-proline 0 CA--C 1.536 0.413 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.02 177.79 6.06 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 122.423 2.082 . . . . 0.0 111.194 178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -151.18 176.77 10.86 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.612 1.165 . . . . 0.0 108.097 173.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 56.51 -74.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 128.28 2.632 . . . . 0.0 114.184 -172.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 11.2 t -176.89 82.16 0.02 OUTLIER 'General case' 0 C--O 1.236 0.365 0 C-N-CA 129.002 2.921 . . . . 0.0 105.396 177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 m -132.43 65.83 1.57 Allowed 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -172.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -96.83 175.25 6.42 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.767 1.627 . . . . 0.0 110.285 171.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 167.06 -162.41 36.22 Favored Glycine 0 C--N 1.345 1.072 0 CA-C-N 119.612 1.097 . . . . 0.0 112.667 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 65.0 p -135.69 95.65 3.29 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.877 1.271 . . . . 0.0 110.093 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PHE . . . . . . . . . . . . . 36.3 p90 -114.3 -177.06 3.04 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.959 0.903 . . . . 0.0 111.992 -173.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.9 mt -127.47 120.42 54.67 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 177.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.9 mt -88.02 172.34 9.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.45 1.1 . . . . 0.0 109.006 171.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -106.08 36.86 2.43 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 120.905 -1.122 . . . . 0.0 109.546 -177.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 96.8 mt -57.89 134.95 22.43 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 O-C-N 121.067 -1.021 . . . . 0.0 108.346 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.9 138.8 37.23 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 177.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.8 p -167.87 83.37 0.19 Allowed 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 171.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 14.5 p90 -153.76 170.97 19.64 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 173.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.26 120.77 39.99 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 171.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -96.0 146.26 24.76 Favored 'General case' 0 CA--C 1.495 -1.151 0 CA-C-O 121.946 0.879 . . . . 0.0 109.193 176.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -154.57 176.89 11.83 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 171.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -45.22 -52.72 8.24 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.142 1.353 . . . . 0.0 112.844 -168.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -131.04 23.71 4.92 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 123.702 0.801 . . . . 0.0 111.717 -172.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.8 t -144.3 150.95 38.68 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 122.462 1.125 . . . . 0.0 109.158 177.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.9 p -148.04 85.72 1.55 Allowed 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 126.691 1.996 . . . . 0.0 107.688 171.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -73.9 127.78 33.78 Favored 'General case' 0 C--O 1.237 0.43 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 166.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -70.03 164.7 23.43 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 166.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -122.55 132.3 54.25 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 126.324 1.85 . . . . 0.0 107.146 164.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.1 m -77.05 174.2 10.93 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.877 0.846 . . . . 0.0 110.069 168.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TRP . . . . . . . . . . . . . 8.6 p90 -149.87 171.53 16.62 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.219 1.808 . . . . 0.0 107.932 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -142.08 174.91 10.16 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 126.377 1.871 . . . . 0.0 107.444 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -135.62 167.67 20.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.593 1.157 . . . . 0.0 109.723 174.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.0 p -156.41 148.93 23.59 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.633 1.173 . . . . 0.0 108.801 160.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 157.75 -141.8 8.05 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 125.543 1.544 . . . . 0.0 109.806 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -54.62 133.22 46.54 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.307 1.043 . . . . 0.0 110.26 -173.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 29.8 m -69.78 3.43 2.56 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 126.273 1.829 . . . . 0.0 115.019 -167.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TRP . . . . . . . . . . . . . 36.9 p-90 -117.96 13.74 14.03 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.121 2.169 . . . . 0.0 111.305 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 55.4 mt -129.14 99.0 4.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 -177.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -91.65 144.35 25.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 34.3 t -132.94 143.23 40.11 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 166.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -124.68 172.05 9.59 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 126.721 2.008 . . . . 0.0 107.108 172.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -53.45 -15.24 3.98 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 125.434 1.492 . . . . 0.0 116.336 -167.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.78 4.3 0.75 Allowed 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.781 1.232 . . . . 0.0 112.82 168.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.6 m -128.0 153.42 46.77 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 120.586 1.539 . . . . 0.0 110.56 -163.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 5.8 t -120.88 156.54 24.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 C-N-CA 125.079 1.352 . . . . 0.0 108.247 -173.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.98 150.49 34.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 153.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -144.35 155.11 43.65 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 146.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -98.0 176.04 5.91 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.266 166.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 tt0 -86.44 168.37 13.83 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 121.768 0.794 . . . . 0.0 110.107 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.3 p-10 -70.91 165.46 46.94 Favored Pre-proline 0 CA--C 1.551 0.987 0 C-N-CA 124.312 1.045 . . . . 0.0 110.176 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -95.3 -4.36 2.09 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 123.191 2.594 . . . . 0.0 114.293 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.32 166.04 25.59 Favored 'General case' 0 C--O 1.225 -0.228 0 O-C-N 121.362 -0.836 . . . . 0.0 111.834 -172.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.92 30.94 0.49 Allowed 'General case' 0 N--CA 1.464 0.24 0 O-C-N 120.621 -1.299 . . . . 0.0 112.044 -175.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -101.85 -175.96 2.99 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.373 1.069 . . . . 0.0 109.363 177.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 ttp180 -113.66 127.26 55.98 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 124.389 1.076 . . . . 0.0 111.705 -178.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.8 mmt180 -159.22 103.19 1.62 Allowed 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 123.816 0.846 . . . . 0.0 109.675 177.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.6 t -64.76 149.66 48.85 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 155.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.39 177.07 43.82 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 108.819 -1.713 . . . . 0.0 108.819 154.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 tp -162.24 85.37 0.58 Allowed 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.767 0.827 . . . . 0.0 109.803 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 m -79.9 169.83 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 O-C-N 121.217 -0.927 . . . . 0.0 111.123 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 44.6 m -116.74 153.33 32.59 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 127.026 2.131 . . . . 0.0 107.348 174.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.9 mp -135.95 163.01 31.26 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.668 1.187 . . . . 0.0 111.168 -176.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 45.8 tttt -144.34 143.79 31.14 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.012 1.725 . . . . 0.0 108.003 167.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -79.16 165.96 22.74 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.401 1.48 . . . . 0.0 107.659 165.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.8 -83.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 176.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -81.89 -18.21 44.55 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 120.006 -1.684 . . . . 0.0 112.269 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.11 -162.51 0.94 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 171.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -162.28 26.04 0.24 Allowed Glycine 0 C--O 1.225 -0.424 0 O-C-N 119.66 -1.9 . . . . 0.0 110.919 -168.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.601 ' HE3' ' HA ' ' A' ' 11' ' ' PHE . 12.1 ttpp -47.97 129.93 14.95 Favored 'General case' 0 N--CA 1.417 -2.112 0 C-N-CA 127.749 2.419 . . . . 0.0 107.447 164.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 52.1 p -118.79 137.66 53.23 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 171.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 89.6 mt -139.49 155.47 47.54 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 -175.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 30.2 m -102.03 160.17 14.73 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 123.974 0.91 . . . . 0.0 109.14 164.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 tt -136.2 91.29 2.66 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 103.886 -2.635 . . . . 0.0 103.886 174.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -85.69 147.2 26.47 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 173.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 20.7 mt -137.18 80.09 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.6 t -86.98 93.75 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 -171.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.5 pt20 -117.18 160.5 37.12 Favored Pre-proline 0 C--O 1.242 0.685 0 C-N-CA 123.637 0.775 . . . . 0.0 110.525 -165.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -62.15 174.93 2.23 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.75 2.3 . . . . 0.0 109.912 165.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -95.96 162.81 23.12 Favored Glycine 0 N--CA 1.426 -1.997 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 163.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 4.5 tmmm? -145.84 150.21 35.74 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.378 1.071 . . . . 0.0 108.487 -173.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.4 p -153.11 87.93 1.29 Allowed 'General case' 0 C--O 1.234 0.253 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 178.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.4 t -136.53 -167.3 2.04 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 118.435 0.561 . . . . 0.0 110.727 -177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.2 mm -94.46 71.03 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 170.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 14.7 t70 . . . . . 0 C--O 1.248 1.005 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 -161.178 . . . . . . . . 0 0 . 1 stop_ save_